Compound ID,DC50 (nM),Dmax (%),DC50 (nM) Origin,Dmax (%) Origin,Uniprot,Target,E3 ligase,PDB,Name,Smiles,Assay (DC50/Dmax),Percent degradation (%),Assay (Percent degradation),"IC50 (nM, Protac to Target)","Assay (Protac to Target, IC50)","EC50 (nM, Protac to Target)","Assay (Protac to Target, EC50)","Kd (nM, Protac to Target)","Assay (Protac to Target, Kd)","Ki (nM, Protac to Target)","Assay (Protac to Target, Ki)","delta G (kcal/mol, Protac to Target)","delta H (kcal/mol, Protac to Target)","-T*delta S (kcal/mol, Protac to Target)","Assay (Protac to Target, G/H/-TS)","kon (1/Ms, Protac to Target)","koff (1/s, Protac to Target)","t1/2 (s, Protac to Target)","Assay (Protac to Target, kon/koff/t1/2)","IC50 (nM, Protac to E3)","Assay (Protac to E3, IC50)","EC50 (nM, Protac to E3)","Assay (Protac to E3, EC50)","Kd (nM, Protac to E3)","Assay (Protac to E3, Kd)","Ki (nM, Protac to E3)","Assay (Protac to E3, Ki)","delta G (kcal/mol, Protac to E3)","delta H (kcal/mol, Protac to E3)","-T*delta S (kcal/mol, Protac to E3)","Assay (Protac to E3, G/H/-TS)","kon (1/Ms, Protac to E3)","koff (1/s, Protac to E3)","t1/2 (s, Protac to E3)","Assay (Protac to E3, kon/koff/t1/2)","IC50 (nM, Ternary complex)","Assay (Ternary complex, IC50)","EC50 (nM, Ternary complex)","Assay (Ternary complex, EC50)","Kd (nM, Ternary complex)","Assay (Ternary complex, Kd)","Ki (nM, Ternary complex)","Assay (Ternary complex, Ki)","delta G (kcal/mol, Ternary complex)","delta H (kcal/mol, Ternary complex)","-T*delta S (kcal/mol, Ternary complex)","Assay (Ternary complex, G/H/-TS)","kon (1/Ms, Ternary complex)","koff (1/s, Ternary complex)","t1/2 (s, Ternary complex)","Assay (Ternary complex, kon/koff/t1/2)","IC50 (nM, Cellular activities)","Assay (Cellular activities, IC50)","EC50 (nM, Cellular activities)","Assay (Cellular activities, EC50)","GI50 (nM, Cellular activities)","Assay (Cellular activities, GI50)","ED50 (nM, Cellular activities)","Assay (Cellular activities, ED50)","GR50 (nM, Cellular activities)","Assay (Cellular activities, GR50)","PAMPA Papp (nm/s, Permeability)","Assay (Permeability, PAMPA Papp)","Caco-2 A2B Papp (nm/s, Permeability)","Assay (Permeability, Caco-2 A2B Papp)","Caco-2 B2A Papp (nm/s, Permeability)","Assay (Permeability, Caco-2 B2A Papp)",Article DOI,Molecular Weight,Exact Mass,XLogP3,Heavy Atom Count,Ring Count,Hydrogen Bond Acceptor Count,Hydrogen Bond Donor Count,Rotatable Bond Count,Topological Polar Surface Area,Molecular Formula,InChI,InChI Key
11,560,80,560,80,Q9H8M2,BRD9,VHL,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCOCCOCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,Degradation of BRD9 in HeLa cells after 4 h treatment,,,,,,,8.8,ITC,,,-11,-11.4,0.44,ITC,,,,,,,,,87/70,ITC/FP,,,-9.64,-6.56,-3.1,ITC,,,,,,,,,83/60,ITC/FP,,,-9.7,-6.4,-3.3,ITC between VHL and BRD9-BD:PROTAC,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,1041.257,1040.48414,3.69,74,8,16,3,22,199.15,C54H69FN8O10S,"InChI=1S/C54H69FN8O10S/c1-34-47(74-33-58-34)35-8-9-36(28-57-49(65)43-27-38(64)30-63(43)51(67)48(53(2,3)4)59-52(68)54(55)11-12-54)44(24-35)73-23-22-72-21-20-71-19-18-61-14-16-62(17-15-61)32-42-45(69-6)25-37(26-46(42)70-7)41-31-60(5)50(66)40-29-56-13-10-39(40)41/h8-10,13,24-26,29,31,33,38,43,48,64H,11-12,14-23,27-28,30,32H2,1-7H3,(H,57,65)(H,59,68)/t38-,43+,48-/m1/s1",MXAKQOVZPDLCDK-UDVNCTHFSA-N
22,1.76,95,1.76,95,Q9H8M2,BRD9,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,Degradation of BRD9 in RI-1 cells after 8 h treatment,,,,,,,5.1,ITC,,,-11.35,-12.8,1.485,ITC,,,,,,,,,26/35,ITC/FP,,,-10.4,-7.04,-3.4,ITC,,,,,,,,,27/35,ITC/FP,,,-10.33,-5.1,-5.3,ITC between VHL and BRD9-BD:PROTAC,,,,,,,3/40,Inhibit proliferation of EOL-1/A-402 cells,,,,,,,0.01,Compounds were administered at 10000 nM and incubated for 5 h,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
22,,,4,,Q9H8M2,BRD9,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,Degradation of HiBiT-BRD9 in HEK293 cells after 24 h treatment using CRISPR/Cas9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
22,,,45696,,Q9H8M2,BRD9,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,Degradation of BRD9 in EOL-1/A-204 cells after 18 h treatment on a WES capillary electrophoresis instrument,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
22,,,4.5,95,Q9NPI1,BRD7,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,Degradation of BRD7 in RI-1 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,26/35,ITC/FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/40,Inhibit proliferation of EOL-1/A-402 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
22,,,34.5,,Q9NPI1,BRD7,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,Degradation of HiBiT-BRD7 in HEK293 cells after 24 h treatment using CRISPR/Cas9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
77,0.17,95,0.17/0.43,>95/>95,P03372,ER,VHL,,ERD-308,CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)C1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)CCOC1=CC=C(C(=O)C2=C(C3=CC=C(O)C=C3)SC3=CC(O)=CC=C23)C=C1,Degradation of ER in MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.77,Inhibit proliferation of MCF-7 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01572,1004.285,1003.422371,9.05,71,7,13,5,22,190.86,C55H65N5O9S2,"InChI=1S/C55H65N5O9S2/c1-7-59(26-28-69-43-22-17-37(18-23-43)49(65)48-44-24-21-41(62)30-46(44)71-51(48)39-15-19-40(61)20-16-39)25-9-8-10-27-68-32-47(64)58-52(55(4,5)6)54(67)60-31-42(63)29-45(60)53(66)57-34(2)36-11-13-38(14-12-36)50-35(3)56-33-70-50/h11-24,30,33-34,42,45,52,61-63H,7-10,25-29,31-32H2,1-6H3,(H,57,66)(H,58,64)/t34-,42+,45-,52+/m0/s1",BQXUPNKLZNSUMC-YUQWMIPFSA-N
118,1,95,7.2/1,>95/>95,P10275,AR,VHL,,ARD-61,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(N3CCC(C#CC4=CC=C(C(=O)N[C@H]5C(C)(C)[C@H](OC6=CC=C(C#N)C(Cl)=C6)C5(C)C)C=C4)CC3)CC2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of AR in LNCaP/VCaP AR+ cells after 6 h treatment,76/>95/>99,% AR degradation in LNCaP cells after 6 h treatment at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,02�� 02��,Inhibit growth of LNCaP/VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01393,1095.808,1094.485495,9.31,78,9,12,3,14,194.23,C61H71ClN8O7S,"InChI=1S/C61H71ClN8O7S/c1-36(2)53(51-29-37(3)67-77-51)57(75)70-34-46(71)30-50(70)56(74)65-49(41-15-17-42(18-16-41)54-38(4)64-35-78-54)32-52(72)69-27-23-45(24-28-69)68-25-21-40(22-26-68)10-9-39-11-13-43(14-12-39)55(73)66-58-60(5,6)59(61(58,7)8)76-47-20-19-44(33-63)48(62)31-47/h11-20,29,31,35-36,40,45-46,49-50,53,58-59,71H,21-28,30,32,34H2,1-8H3,(H,65,74)(H,66,73)/t46-,49+,50+,53-,58-,59-/m1/s1",RGPUSLXMPBTXNU-MLMZQBPXSA-N
120,0.86,95,0.86/0.76/10.4,>95/>95/>95,P10275,AR,VHL,,ARD-69,CC1=C(C2=CC=C([C@H](CC(=O)N3CCC(N4CCC(C#CC5=CC=C(C(=O)N[C@H]6C(C)(C)[C@H](OC7=CC=C(C#N)C(Cl)=C7)C6(C)C)C=C5)CC4)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP/VCaP/22Rv1 cells after 24 h treatment,89/99/100,% AR degradation in LNCaP cells after 6 h treatment at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.25/0.34/183,Inhibit growth of LNCaP/VCaP/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01631,1129.841,1128.507374,9.29,80,9,11,4,14,197.3,C62H74ClFN8O7S,"InChI=1S/C62H74ClFN8O7S/c1-37-51(80-36-66-37)41-17-15-40(16-18-41)48(67-54(76)49-31-45(73)35-72(49)55(77)52(59(2,3)4)68-58(78)62(64)25-26-62)33-50(74)71-29-23-44(24-30-71)70-27-21-39(22-28-70)10-9-38-11-13-42(14-12-38)53(75)69-56-60(5,6)57(61(56,7)8)79-46-20-19-43(34-65)47(63)32-46/h11-20,32,36,39,44-45,48-49,52,56-57,73H,21-31,33,35H2,1-8H3,(H,67,76)(H,68,78)(H,69,75)/t45-,48+,49+,52-,56-,57-/m1/s1",CWGVEMFBQJUWLU-RXFAPWBBSA-N
146,490,95,490/500,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1C=C(COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,781.255,780.1993775,2.39,55,8,14,2,10,195.66,C37H33ClN10O6S,"InChI=1S/C37H33ClN10O6S/c1-18-19(2)55-37-30(18)32(21-7-9-22(38)10-8-21)40-25(33-44-42-20(3)47(33)37)15-29(50)39-13-14-46-16-23(43-45-46)17-54-27-6-4-5-24-31(27)36(53)48(35(24)52)26-11-12-28(49)41-34(26)51/h4-10,16,25-26H,11-15,17H2,1-3H3,(H,39,50)(H,41,49,51)/t25-,26?/m0/s1",CBYYXVFBNBBZJH-PMCHYTPCSA-N
147,130,95,>5000/130,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1C=C(COCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,825.308,824.2255922,2.25,58,8,15,2,13,204.89,C39H37ClN10O7S,"InChI=1S/C39H37ClN10O7S/c1-20-21(2)58-39-32(20)34(23-7-9-24(40)10-8-23)42-27(35-46-44-22(3)49(35)39)17-31(52)41-13-14-48-18-25(45-47-48)19-56-15-16-57-29-6-4-5-26-33(29)38(55)50(37(26)54)28-11-12-30(51)43-36(28)53/h4-10,18,27-28H,11-17,19H2,1-3H3,(H,41,52)(H,43,51,53)/t27-,28?/m0/s1",ABDSEHSFEXENQJ-MBMZGMDYSA-N
148,1260,95,>5000/1260,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1C=C(COCCOCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,869.361,868.251807,2.1,61,8,16,2,16,214.12,C41H41ClN10O8S,"InChI=1S/C41H41ClN10O8S/c1-22-23(2)61-41-34(22)36(25-7-9-26(42)10-8-25)44-29(37-48-46-24(3)51(37)41)19-33(54)43-13-14-50-20-27(47-49-50)21-59-16-15-58-17-18-60-31-6-4-5-28-35(31)40(57)52(39(28)56)30-11-12-32(53)45-38(30)55/h4-10,20,29-30H,11-19,21H2,1-3H3,(H,43,54)(H,45,53,55)/t29-,30?/m0/s1",QDKBKEFTDKCTPJ-UFXYQILXSA-N
149,250,95,450/250,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1C=C(COCCOCCOCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,913.414,912.2780217,1.95,64,8,17,2,19,223.35,C43H45ClN10O9S,"InChI=1S/C43H45ClN10O9S/c1-24-25(2)64-43-36(24)38(27-7-9-28(44)10-8-27)46-31(39-50-48-26(3)53(39)43)21-35(56)45-13-14-52-22-29(49-51-52)23-62-18-17-60-15-16-61-19-20-63-33-6-4-5-30-37(33)42(59)54(41(30)58)32-11-12-34(55)47-40(32)57/h4-10,22,31-32H,11-21,23H2,1-3H3,(H,45,56)(H,47,55,57)/t31-,32?/m0/s1",SVZFVYLDQTZFKW-CYZZXXEPSA-N
150,150,95,200/150,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1C=C(COCCOCCOCCOCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,957.467,956.3042364,1.8,67,8,18,2,22,232.58,C45H49ClN10O10S,"InChI=1S/C45H49ClN10O10S/c1-26-27(2)67-45-38(26)40(29-7-9-30(46)10-8-29)48-33(41-52-50-28(3)55(41)45)23-37(58)47-13-14-54-24-31(51-53-54)25-65-20-19-63-16-15-62-17-18-64-21-22-66-35-6-4-5-32-39(35)44(61)56(43(32)60)34-11-12-36(57)49-42(34)59/h4-10,24,33-34H,11-23,25H2,1-3H3,(H,47,58)(H,49,57,59)/t33-,34?/m0/s1",NQCJKUWEAOYMRX-CDRRMRQFSA-N
151,518,91,518,91,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6620000,0.038,18.7,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,995.633,994.3497472,4.49,69,8,16,4,16,223.74,C48H55ClN12O6S2,"InChI=1S/C48H55ClN12O6S2/c1-26-28(3)69-47-40(26)41(31-12-14-33(49)15-13-31)53-36(44-57-55-29(4)61(44)47)19-38(63)50-16-17-59-21-34(56-58-59)23-67-24-39(64)54-43(48(5,6)7)46(66)60-22-35(62)18-37(60)45(65)51-20-30-8-10-32(11-9-30)42-27(2)52-25-68-42/h8-15,21,25,35-37,43,62H,16-20,22-24H2,1-7H3,(H,50,63)(H,51,65)(H,54,64)/t35-,36+,37+,43-/m1/s1",KEXVSUAHVFYWJC-AYWQWSHZSA-N
151,,,59/550,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,995.633,994.3497472,4.49,69,8,16,4,16,223.74,C48H55ClN12O6S2,"InChI=1S/C48H55ClN12O6S2/c1-26-28(3)69-47-40(26)41(31-12-14-33(49)15-13-31)53-36(44-57-55-29(4)61(44)47)19-38(63)50-16-17-59-21-34(56-58-59)23-67-24-39(64)54-43(48(5,6)7)46(66)60-22-35(62)18-37(60)45(65)51-20-30-8-10-32(11-9-30)42-27(2)52-25-68-42/h8-15,21,25,35-37,43,62H,16-20,22-24H2,1-7H3,(H,50,63)(H,51,65)(H,54,64)/t35-,36+,37+,43-/m1/s1",KEXVSUAHVFYWJC-AYWQWSHZSA-N
152,726,78,726,78,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6340000,0.058,12.2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1039.686,1038.375962,4.34,72,8,17,4,19,232.97,C50H59ClN12O7S2,"InChI=1S/C50H59ClN12O7S2/c1-28-30(3)72-49-42(28)43(33-12-14-35(51)15-13-33)55-38(46-59-57-31(4)63(46)49)21-40(65)52-16-17-61-23-36(58-60-61)25-69-18-19-70-26-41(66)56-45(50(5,6)7)48(68)62-24-37(64)20-39(62)47(67)53-22-32-8-10-34(11-9-32)44-29(2)54-27-71-44/h8-15,23,27,37-39,45,64H,16-22,24-26H2,1-7H3,(H,52,65)(H,53,67)(H,56,66)/t37-,38+,39+,45-/m1/s1",LJQXZKRBYGZAEU-DPSJZEHMSA-N
152,,,83/470,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,1039.686,1038.375962,4.34,72,8,17,4,19,232.97,C50H59ClN12O7S2,"InChI=1S/C50H59ClN12O7S2/c1-28-30(3)72-49-42(28)43(33-12-14-35(51)15-13-33)55-38(46-59-57-31(4)63(46)49)21-40(65)52-16-17-61-23-36(58-60-61)25-69-18-19-70-26-41(66)56-45(50(5,6)7)48(68)62-24-37(64)20-39(62)47(67)53-22-32-8-10-34(11-9-32)44-29(2)54-27-71-44/h8-15,23,27,37-39,45,64H,16-22,24-26H2,1-7H3,(H,52,65)(H,53,67)(H,56,66)/t37-,38+,39+,45-/m1/s1",LJQXZKRBYGZAEU-DPSJZEHMSA-N
153,2260,69,2260,69,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9640000,0.25,4.4,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1083.739,1082.402177,4.19,75,8,18,4,22,242.2,C52H63ClN12O8S2,"InChI=1S/C52H63ClN12O8S2/c1-30-32(3)75-51-44(30)45(35-12-14-37(53)15-13-35)57-40(48-61-59-33(4)65(48)51)23-42(67)54-16-17-63-25-38(60-62-63)27-72-20-18-71-19-21-73-28-43(68)58-47(52(5,6)7)50(70)64-26-39(66)22-41(64)49(69)55-24-34-8-10-36(11-9-34)46-31(2)56-29-74-46/h8-15,25,29,39-41,47,66H,16-24,26-28H2,1-7H3,(H,54,67)(H,55,69)(H,58,68)/t39-,40+,41+,47-/m1/s1",IVAWBGJHAWQINS-XRFVFAKVSA-N
153,,,240/1670,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,1083.739,1082.402177,4.19,75,8,18,4,22,242.2,C52H63ClN12O8S2,"InChI=1S/C52H63ClN12O8S2/c1-30-32(3)75-51-44(30)45(35-12-14-37(53)15-13-35)57-40(48-61-59-33(4)65(48)51)23-42(67)54-16-17-63-25-38(60-62-63)27-72-20-18-71-19-21-73-28-43(68)58-47(52(5,6)7)50(70)64-26-39(66)22-41(64)49(69)55-24-34-8-10-36(11-9-34)46-31(2)56-29-74-46/h8-15,25,29,39-41,47,66H,16-24,26-28H2,1-7H3,(H,54,67)(H,55,69)(H,58,68)/t39-,40+,41+,47-/m1/s1",IVAWBGJHAWQINS-XRFVFAKVSA-N
154,460,95,460/3660,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,1127.792,1126.428391,4.05,78,8,19,4,25,251.43,C54H67ClN12O9S2,"InChI=1S/C54H67ClN12O9S2/c1-32-34(3)78-53-46(32)47(37-12-14-39(55)15-13-37)59-42(50-63-61-35(4)67(50)53)25-44(69)56-16-17-65-27-40(62-64-65)29-75-22-20-73-18-19-74-21-23-76-30-45(70)60-49(54(5,6)7)52(72)66-28-41(68)24-43(66)51(71)57-26-36-8-10-38(11-9-36)48-33(2)58-31-77-48/h8-15,27,31,41-43,49,68H,16-26,28-30H2,1-7H3,(H,56,69)(H,57,71)(H,60,70)/t41-,42+,43+,49-/m1/s1",MEUHHKBLLJDOBF-ADSXHIEZSA-N
154,,,>10000,N.D.,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3100000,0.13,5.5,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1127.792,1126.428391,4.05,78,8,19,4,25,251.43,C54H67ClN12O9S2,"InChI=1S/C54H67ClN12O9S2/c1-32-34(3)78-53-46(32)47(37-12-14-39(55)15-13-37)59-42(50-63-61-35(4)67(50)53)25-44(69)56-16-17-65-27-40(62-64-65)29-75-22-20-73-18-19-74-21-23-76-30-45(70)60-49(54(5,6)7)52(72)66-28-41(68)24-43(66)51(71)57-26-36-8-10-38(11-9-36)48-33(2)58-31-77-48/h8-15,27,31,41-43,49,68H,16-26,28-30H2,1-7H3,(H,56,69)(H,57,71)(H,60,70)/t41-,42+,43+,49-/m1/s1",MEUHHKBLLJDOBF-ADSXHIEZSA-N
155,630,95,630/2730,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in NCI-H661/NCI-H838 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01781,1171.845,1170.454606,3.9,81,8,20,4,28,260.66,C56H71ClN12O10S2,"InChI=1S/C56H71ClN12O10S2/c1-34-36(3)81-55-48(34)49(39-12-14-41(57)15-13-39)61-44(52-65-63-37(4)69(52)55)27-46(71)58-16-17-67-29-42(64-66-67)31-78-24-22-76-20-18-75-19-21-77-23-25-79-32-47(72)62-51(56(5,6)7)54(74)68-30-43(70)26-45(68)53(73)59-28-38-8-10-40(11-9-38)50-35(2)60-33-80-50/h8-15,29,33,43-45,51,70H,16-28,30-32H2,1-7H3,(H,58,71)(H,59,73)(H,62,72)/t43-,44+,45+,51-/m1/s1",VACBBPVTGHKINF-WQZGMAASSA-N
155,,,>10000,N.D.,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N.D.,N.D.,2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1171.845,1170.454606,3.9,81,8,20,4,28,260.66,C56H71ClN12O10S2,"InChI=1S/C56H71ClN12O10S2/c1-34-36(3)81-55-48(34)49(39-12-14-41(57)15-13-39)61-44(52-65-63-37(4)69(52)55)27-46(71)58-16-17-67-29-42(64-66-67)31-78-24-22-76-20-18-75-19-21-77-23-25-79-32-47(72)62-51(56(5,6)7)54(74)68-30-43(70)26-45(68)53(73)59-28-38-8-10-40(11-9-38)50-35(2)60-33-80-50/h8-15,29,33,43-45,51,70H,16-28,30-32H2,1-7H3,(H,58,71)(H,59,73)(H,62,72)/t43-,44+,45+,51-/m1/s1",VACBBPVTGHKINF-WQZGMAASSA-N
159,0.2,98,0.2,98,O60885,BRD4,CRBN,,BD-764,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,686.754,686.2059871,3.41,50,8,12,2,7,153.34,C36H30N8O5S,"InChI=1S/C36H30N8O5S/c1-21-40-41-30-20-49-19-26-25(16-22-6-3-2-4-7-22)29(50-36(26)43(21)30)12-10-23-17-38-42(18-23)15-14-37-27-9-5-8-24-32(27)35(48)44(34(24)47)28-11-13-31(45)39-33(28)46/h2-9,17-18,28,37H,11,13-16,19-20H2,1H3,(H,39,45,46)",OCRZEXONTRGXJJ-UHFFFAOYSA-N
159,,,0.5,99,P25440,BRD2,CRBN,,BD-764,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,686.754,686.2059871,3.41,50,8,12,2,7,153.34,C36H30N8O5S,"InChI=1S/C36H30N8O5S/c1-21-40-41-30-20-49-19-26-25(16-22-6-3-2-4-7-22)29(50-36(26)43(21)30)12-10-23-17-38-42(18-23)15-14-37-27-9-5-8-24-32(27)35(48)44(34(24)47)28-11-13-31(45)39-33(28)46/h2-9,17-18,28,37H,11,13-16,19-20H2,1H3,(H,39,45,46)",OCRZEXONTRGXJJ-UHFFFAOYSA-N
159,,,0.5,98,Q15059,BRD3,CRBN,,BD-764,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,686.754,686.2059871,3.41,50,8,12,2,7,153.34,C36H30N8O5S,"InChI=1S/C36H30N8O5S/c1-21-40-41-30-20-49-19-26-25(16-22-6-3-2-4-7-22)29(50-36(26)43(21)30)12-10-23-17-38-42(18-23)15-14-37-27-9-5-8-24-32(27)35(48)44(34(24)47)28-11-13-31(45)39-33(28)46/h2-9,17-18,28,37H,11,13-16,19-20H2,1H3,(H,39,45,46)",OCRZEXONTRGXJJ-UHFFFAOYSA-N
174,367.8,85.1,367.8,85.1,Q96SW2,CRBN,VHL,,TD-343,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,876.002,875.3523765,2.33,62,6,14,5,19,234.9,C43H53N7O11S,"InChI=1S/C43H53N7O11S/c1-25-36(62-24-46-25)27-10-8-26(9-11-27)21-45-38(54)32-20-28(51)22-49(32)42(58)37(43(2,3)4)47-34(53)23-61-19-18-60-17-16-59-15-14-44-30-7-5-6-29-35(30)41(57)50(40(29)56)31-12-13-33(52)48-39(31)55/h5-11,24,28,31-32,37,44,51H,12-23H2,1-4H3,(H,45,54)(H,47,53)(H,48,52,55)/t28-,31?,32+,37-/m1/s1",JJODRHXPKVBYEY-JPQBYMPPSA-N
176,1.5,95,1.5,,Q96SW2,CRBN,VHL,,CRBN-6-5-5-VHL,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOCCCCCOCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in MM1S cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c8cc09541h,972.219,971.4826624,5.6,69,6,13,5,26,225.67,C51H69N7O10S,"InChI=1S/C51H69N7O10S/c1-33-44(69-32-54-33)35-20-18-34(19-21-35)30-53-46(62)40-29-36(59)31-57(40)50(66)45(51(2,3)4)55-41(60)17-8-13-28-68-27-12-7-11-26-67-25-10-6-5-9-24-52-38-16-14-15-37-43(38)49(65)58(48(37)64)39-22-23-42(61)56-47(39)63/h14-16,18-21,32,36,39-40,45,52,59H,5-13,17,22-31H2,1-4H3,(H,53,62)(H,55,60)(H,56,61,63)/t36-,39?,40+,45-/m1/s1",LIMCHOLAKDUZDS-XARBDFOFSA-N
181,40.1,92.6,40.1,92.6,Q16539,p38alpha,VHL,,SJF-6693,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1078.205,1077.411783,7.21,77,8,14,5,23,228.87,C56H61F2N7O11S,"InChI=1S/C56H61F2N7O11S/c1-33-49(77-32-61-33)35-8-6-34(7-9-35)30-60-51(68)43-27-39(66)31-65(43)52(69)50(55(2,3)4)64-48(67)17-21-73-22-23-74-24-25-75-47-29-42-40(28-46(47)72-5)44(16-20-59-42)76-45-15-14-38(26-41(45)58)63-54(71)56(18-19-56)53(70)62-37-12-10-36(57)11-13-37/h6-16,20,26,28-29,32,39,43,50,66H,17-19,21-25,27,30-31H2,1-5H3,(H,60,68)(H,62,70)(H,63,71)(H,64,67)/t39-,43+,50-/m1/s1",FCEBHUUCGVQXGJ-XPMRVQNBSA-N
181,,,51.4,81.8,O15264,p38delta,VHL,,SJF-6693,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1078.205,1077.411783,7.21,77,8,14,5,23,228.87,C56H61F2N7O11S,"InChI=1S/C56H61F2N7O11S/c1-33-49(77-32-61-33)35-8-6-34(7-9-35)30-60-51(68)43-27-39(66)31-65(43)52(69)50(55(2,3)4)64-48(67)17-21-73-22-23-74-24-25-75-47-29-42-40(28-46(47)72-5)44(16-20-59-42)76-45-15-14-38(26-41(45)58)63-54(71)56(18-19-56)53(70)62-37-12-10-36(57)11-13-37/h6-16,20,26,28-29,32,39,43,50,66H,17-19,21-25,27,30-31H2,1-5H3,(H,60,68)(H,62,70)(H,63,71)(H,64,67)/t39-,43+,50-/m1/s1",FCEBHUUCGVQXGJ-XPMRVQNBSA-N
182,18.8,99.4,18.8,99.4,Q16539,p38alpha,VHL,,SJF-6690,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1092.232,1091.427433,7.57,78,8,14,5,24,228.87,C57H63F2N7O11S,"InChI=1S/C57H63F2N7O11S/c1-34-50(78-33-62-34)36-9-7-35(8-10-36)31-61-52(69)44-28-40(67)32-66(44)53(70)51(56(2,3)4)65-49(68)18-24-75-26-25-74-22-6-23-76-48-30-43-41(29-47(48)73-5)45(17-21-60-43)77-46-16-15-39(27-42(46)59)64-55(72)57(19-20-57)54(71)63-38-13-11-37(58)12-14-38/h7-17,21,27,29-30,33,40,44,51,67H,6,18-20,22-26,28,31-32H2,1-5H3,(H,61,69)(H,63,71)(H,64,72)(H,65,68)/t40-,44+,51-/m1/s1",PCRYOGWRHSLIEZ-XZVMHGATSA-N
182,,,91.7,96.7,O15264,p38delta,VHL,,SJF-6690,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1092.232,1091.427433,7.57,78,8,14,5,24,228.87,C57H63F2N7O11S,"InChI=1S/C57H63F2N7O11S/c1-34-50(78-33-62-34)36-9-7-35(8-10-36)31-61-52(69)44-28-40(67)32-66(44)53(70)51(56(2,3)4)65-49(68)18-24-75-26-25-74-22-6-23-76-48-30-43-41(29-47(48)73-5)45(17-21-60-43)77-46-16-15-39(27-42(46)59)64-55(72)57(19-20-57)54(71)63-38-13-11-37(58)12-14-38/h7-17,21,27,29-30,33,40,44,51,67H,6,18-20,22-26,28,31-32H2,1-5H3,(H,61,69)(H,63,71)(H,64,72)(H,65,68)/t40-,44+,51-/m1/s1",PCRYOGWRHSLIEZ-XZVMHGATSA-N
183,210,91,210,91,Q16539,p38alpha,VHL,,SJF-8240,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38alpha in MDA-MB-231 cells after 24 h treatment,,,,,,,5300,Kd was assessed by competition binding assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.010,1106.259,1105.443083,7.93,79,8,14,5,25,228.87,C58H65F2N7O11S,"InChI=1S/C58H65F2N7O11S/c1-35-51(79-34-63-35)37-10-8-36(9-11-37)32-62-53(70)45-29-41(68)33-67(45)54(71)52(57(2,3)4)66-50(69)19-27-76-24-6-23-75-25-7-26-77-49-31-44-42(30-48(49)74-5)46(18-22-61-44)78-47-17-16-40(28-43(47)60)65-56(73)58(20-21-58)55(72)64-39-14-12-38(59)13-15-39/h8-18,22,28,30-31,34,41,45,52,68H,6-7,19-21,23-27,29,32-33H2,1-5H3,(H,62,70)(H,64,72)(H,65,73)(H,66,69)/t41-,45+,52-/m1/s1",SCUZPTNDZHEHLB-ZWUDBOSPSA-N
183,,,230,90.1,Q16539,p38alpha,VHL,,SJF-8240,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1106.259,1105.443083,7.93,79,8,14,5,25,228.87,C58H65F2N7O11S,"InChI=1S/C58H65F2N7O11S/c1-35-51(79-34-63-35)37-10-8-36(9-11-37)32-62-53(70)45-29-41(68)33-67(45)54(71)52(57(2,3)4)66-50(69)19-27-76-24-6-23-75-25-7-26-77-49-31-44-42(30-48(49)74-5)46(18-22-61-44)78-47-17-16-40(28-43(47)60)65-56(73)58(20-21-58)55(72)64-39-14-12-38(59)13-15-39/h8-18,22,28,30-31,34,41,45,52,68H,6-7,19-21,23-27,29,32-33H2,1-5H3,(H,62,70)(H,64,72)(H,65,73)(H,66,69)/t41-,45+,52-/m1/s1",SCUZPTNDZHEHLB-ZWUDBOSPSA-N
183,,,456,54.3,O15264,p38delta,VHL,,SJF-8240,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1106.259,1105.443083,7.93,79,8,14,5,25,228.87,C58H65F2N7O11S,"InChI=1S/C58H65F2N7O11S/c1-35-51(79-34-63-35)37-10-8-36(9-11-37)32-62-53(70)45-29-41(68)33-67(45)54(71)52(57(2,3)4)66-50(69)19-27-76-24-6-23-75-25-7-26-77-49-31-44-42(30-48(49)74-5)46(18-22-61-44)78-47-17-16-40(28-43(47)60)65-56(73)58(20-21-58)55(72)64-39-14-12-38(59)13-15-39/h8-18,22,28,30-31,34,41,45,52,68H,6-7,19-21,23-27,29,32-33H2,1-5H3,(H,62,70)(H,64,72)(H,65,73)(H,66,69)/t41-,45+,52-/m1/s1",SCUZPTNDZHEHLB-ZWUDBOSPSA-N
184,9.5,99.6,9.5,99.6,Q16539,p38alpha,VHL,,SJF-6696,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1120.286,1119.458733,8.74,80,8,14,5,26,228.87,C59H67F2N7O11S,"InChI=1S/C59H67F2N7O11S/c1-36-52(80-35-64-36)38-12-10-37(11-13-38)32-63-54(71)46-29-42(69)33-68(46)55(72)53(58(2,3)4)67-51(70)34-77-26-7-6-24-76-25-8-9-27-78-50-31-45-43(30-49(50)75-5)47(20-23-62-45)79-48-19-18-41(28-44(48)61)66-57(74)59(21-22-59)56(73)65-40-16-14-39(60)15-17-40/h10-20,23,28,30-31,35,42,46,53,69H,6-9,21-22,24-27,29,32-34H2,1-5H3,(H,63,71)(H,65,73)(H,66,74)(H,67,70)/t42-,46+,53-/m1/s1",GXDYWQXTEYENEU-WFYKIECOSA-N
184,,,1160,25.1,O15264,p38delta,VHL,,SJF-6696,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of p38delta in MDA-MB-231 cells,,,,,,,500,SPR,,,,,,,,,,,,,,,5000,SPR,,,,,,,,,,,,,,,1200,SPR,,,,,,,70100,0.072,8,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1120.286,1119.458733,8.74,80,8,14,5,26,228.87,C59H67F2N7O11S,"InChI=1S/C59H67F2N7O11S/c1-36-52(80-35-64-36)38-12-10-37(11-13-38)32-63-54(71)46-29-42(69)33-68(46)55(72)53(58(2,3)4)67-51(70)34-77-26-7-6-24-76-25-8-9-27-78-50-31-45-43(30-49(50)75-5)47(20-23-62-45)79-48-19-18-41(28-44(48)61)66-57(74)59(21-22-59)56(73)65-40-16-14-39(60)15-17-40/h10-20,23,28,30-31,35,42,46,53,69H,6-9,21-22,24-27,29,32-34H2,1-5H3,(H,63,71)(H,65,73)(H,66,74)(H,67,70)/t42-,46+,53-/m1/s1",GXDYWQXTEYENEU-WFYKIECOSA-N
185,79.2,98.4,79.2,98.4,O15264,p38delta,VHL,,SJF-6683,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38delta in MDA-MB-231 cells,,,,,,,550,SPR,,,,,,,,,,,,,,,3500,SPR,,,,,,,,,,,,,,,436,SPR,,,,,,,39600,0.018,38,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1168.286,1167.422348,8.27,84,10,15,4,25,229.31,C62H63F2N7O12S,"InChI=1S/C62H63F2N7O12S/c1-36(2)55(71-33-40-7-5-6-8-45(40)58(71)74)59(75)70-34-44(72)29-49(70)57(73)66-32-39-10-9-38(56-37(3)67-35-84-56)27-52(39)81-25-23-79-21-22-80-24-26-82-54-31-48-46(30-53(54)78-4)50(17-20-65-48)83-51-16-15-43(28-47(51)64)69-61(77)62(18-19-62)60(76)68-42-13-11-41(63)12-14-42/h5-17,20,27-28,30-31,35-36,44,49,55,72H,18-19,21-26,29,32-34H2,1-4H3,(H,66,73)(H,68,76)(H,69,77)/t44-,49+,55+/m1/s1",LYUUIIZKBMBNQV-CHOFKVETSA-N
185,,,45.9,34.5,Q16539,p38alpha,VHL,,SJF-6683,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1168.286,1167.422348,8.27,84,10,15,4,25,229.31,C62H63F2N7O12S,"InChI=1S/C62H63F2N7O12S/c1-36(2)55(71-33-40-7-5-6-8-45(40)58(71)74)59(75)70-34-44(72)29-49(70)57(73)66-32-39-10-9-38(56-37(3)67-35-84-56)27-52(39)81-25-23-79-21-22-80-24-26-82-54-31-48-46(30-53(54)78-4)50(17-20-65-48)83-51-16-15-43(28-47(51)64)69-61(77)62(18-19-62)60(76)68-42-13-11-41(63)12-14-42/h5-17,20,27-28,30-31,35-36,44,49,55,72H,18-19,21-26,29,32-34H2,1-4H3,(H,66,73)(H,68,76)(H,69,77)/t44-,49+,55+/m1/s1",LYUUIIZKBMBNQV-CHOFKVETSA-N
186,106,43.5,106,43.5,O15264,p38delta,VHL,,SJF-6677,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1180.341,1179.458733,9.84,85,10,14,4,26,220.08,C64H67F2N7O11S,"InChI=1S/C64H67F2N7O11S/c1-38(2)57(73-35-42-11-5-6-12-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-14-13-40(58-39(3)69-37-85-58)29-54(41)82-27-9-7-25-81-26-8-10-28-83-56-33-50-48(32-55(56)80-4)52(21-24-67-50)84-53-20-19-45(30-49(53)66)71-63(79)64(22-23-64)62(78)70-44-17-15-43(65)16-18-44/h5-6,11-21,24,29-30,32-33,37-38,46,51,57,74H,7-10,22-23,25-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",LCBLIBYLVHDHMI-JCYIICMFSA-N
186,,,127,25.3,Q16539,p38alpha,VHL,,SJF-6677,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1180.341,1179.458733,9.84,85,10,14,4,26,220.08,C64H67F2N7O11S,"InChI=1S/C64H67F2N7O11S/c1-38(2)57(73-35-42-11-5-6-12-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-14-13-40(58-39(3)69-37-85-58)29-54(41)82-27-9-7-25-81-26-8-10-28-83-56-33-50-48(32-55(56)80-4)52(21-24-67-50)84-53-20-19-45(30-49(53)66)71-63(79)64(22-23-64)62(78)70-44-17-15-43(65)16-18-44/h5-6,11-21,24,29-30,32-33,37-38,46,51,57,74H,7-10,22-23,25-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",LCBLIBYLVHDHMI-JCYIICMFSA-N
187,1890,78.7,1890,78.7,O15264,p38delta,VHL,,BES-4612,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1196.34,1195.453648,8.98,86,10,15,4,27,229.31,C64H67F2N7O12S,"InChI=1S/C64H67F2N7O12S/c1-38(2)57(73-35-42-9-5-6-10-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-12-11-40(58-39(3)69-37-86-58)29-54(41)83-25-7-23-81-27-28-82-24-8-26-84-56-33-50-48(32-55(56)80-4)52(19-22-67-50)85-53-18-17-45(30-49(53)66)71-63(79)64(20-21-64)62(78)70-44-15-13-43(65)14-16-44/h5-6,9-19,22,29-30,32-33,37-38,46,51,57,74H,7-8,20-21,23-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",RZMAGXNWPGZVNP-JCYIICMFSA-N
187,,,760,16.8,Q16539,p38alpha,VHL,,BES-4612,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1196.34,1195.453648,8.98,86,10,15,4,27,229.31,C64H67F2N7O12S,"InChI=1S/C64H67F2N7O12S/c1-38(2)57(73-35-42-9-5-6-10-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-12-11-40(58-39(3)69-37-86-58)29-54(41)83-25-7-23-81-27-28-82-24-8-26-84-56-33-50-48(32-55(56)80-4)52(19-22-67-50)85-53-18-17-45(30-49(53)66)71-63(79)64(20-21-64)62(78)70-44-15-13-43(65)14-16-44/h5-6,9-19,22,29-30,32-33,37-38,46,51,57,74H,7-8,20-21,23-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",RZMAGXNWPGZVNP-JCYIICMFSA-N
188,304,19.9,304,19.9,Q16539,p38alpha,VHL,,SJF-6685,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1210.367,1209.469298,9.34,87,10,15,4,28,229.31,C65H69F2N7O12S,"InChI=1S/C65H69F2N7O12S/c1-39(2)58(74-36-43-10-5-6-11-48(43)61(74)77)62(78)73-37-47(75)32-52(73)60(76)69-35-42-13-12-41(59-40(3)70-38-87-59)30-55(42)84-28-8-26-82-24-7-25-83-27-9-29-85-57-34-51-49(33-56(57)81-4)53(20-23-68-51)86-54-19-18-46(31-50(54)67)72-64(80)65(21-22-65)63(79)71-45-16-14-44(66)15-17-45/h5-6,10-20,23,30-31,33-34,38-39,47,52,58,75H,7-9,21-22,24-29,32,35-37H2,1-4H3,(H,69,76)(H,71,79)(H,72,80)/t47-,52+,58+/m1/s1",LVQCYBJKHQGJSR-LVSOZEIGSA-N
188,1140,33.5,1140,33.5,O15264,p38delta,VHL,,SJF-6685,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1210.367,1209.469298,9.34,87,10,15,4,28,229.31,C65H69F2N7O12S,"InChI=1S/C65H69F2N7O12S/c1-39(2)58(74-36-43-10-5-6-11-48(43)61(74)77)62(78)73-37-47(75)32-52(73)60(76)69-35-42-13-12-41(59-40(3)70-38-87-59)30-55(42)84-28-8-26-82-24-7-25-83-27-9-29-85-57-34-51-49(33-56(57)81-4)53(20-23-68-51)86-54-19-18-46(31-50(54)67)72-64(80)65(21-22-65)63(79)71-45-16-14-44(66)15-17-45/h5-6,10-20,23,30-31,33-34,38-39,47,52,58,75H,7-9,21-22,24-29,32,35-37H2,1-4H3,(H,69,76)(H,71,79)(H,72,80)/t47-,52+,58+/m1/s1",LVQCYBJKHQGJSR-LVSOZEIGSA-N
194,0.5,95,<0.5,,P25440,BRD2,CRBN,,SIAIS213110,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC1=CC=CC3=C1CN(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.7/0.9/125.4,Inhibit proliferation of MM.1S/MV-4-11/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1021/acs.orglett.9b01326,727.291,726.2503504,4.3,51,7,10,3,11,150.68,C37H39ClN8O4S,"InChI=1S/C37H39ClN8O4S/c1-20-21(2)51-37-32(20)33(23-10-12-24(38)13-11-23)41-28(34-44-43-22(3)46(34)37)18-31(48)40-17-6-4-5-16-39-27-9-7-8-25-26(27)19-45(36(25)50)29-14-15-30(47)42-35(29)49/h7-13,28-29,39H,4-6,14-19H2,1-3H3,(H,40,48)(H,42,47,49)/t28-,29?/m0/s1",UYBVSBAZZWUPHH-XLTVJXRZSA-N
194,,,<0.5,,Q15059,BRD3,CRBN,,SIAIS213110,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC1=CC=CC3=C1CN(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.7/0.9/125.4,Inhibit proliferation of MM.1S/MV-4-11/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1021/acs.orglett.9b01326,727.291,726.2503504,4.3,51,7,10,3,11,150.68,C37H39ClN8O4S,"InChI=1S/C37H39ClN8O4S/c1-20-21(2)51-37-32(20)33(23-10-12-24(38)13-11-23)41-28(34-44-43-22(3)46(34)37)18-31(48)40-17-6-4-5-16-39-27-9-7-8-25-26(27)19-45(36(25)50)29-14-15-30(47)42-35(29)49/h7-13,28-29,39H,4-6,14-19H2,1-3H3,(H,40,48)(H,42,47,49)/t28-,29?/m0/s1",UYBVSBAZZWUPHH-XLTVJXRZSA-N
194,,,<0.5,,O60885,BRD4,CRBN,,SIAIS213110,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC1=CC=CC3=C1CN(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.7/0.9/125.4,Inhibit proliferation of MM.1S/MV-4-11/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1021/acs.orglett.9b01326,727.291,726.2503504,4.3,51,7,10,3,11,150.68,C37H39ClN8O4S,"InChI=1S/C37H39ClN8O4S/c1-20-21(2)51-37-32(20)33(23-10-12-24(38)13-11-23)41-28(34-44-43-22(3)46(34)37)18-31(48)40-17-6-4-5-16-39-27-9-7-8-25-26(27)19-45(36(25)50)29-14-15-30(47)42-35(29)49/h7-13,28-29,39H,4-6,14-19H2,1-3H3,(H,40,48)(H,42,47,49)/t28-,29?/m0/s1",UYBVSBAZZWUPHH-XLTVJXRZSA-N
208,32,98,32,98,O60885,BRD4,MDM2,,A1874,COC1=CC(C(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)=CC=C1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(C2=CC=C(Cl)C=C2F)[C@H]1C1=CC=CC(Cl)=C1F,Degradation of BRD4 in HCT116 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46.5/86.3/236,Inhibit viability of SJSA1/HCT116/A375 cells,,,,,,,,,,,,,,,10.1158/0008-5472.CAN-18-2918,1173.612,1171.352656,8.94,80,8,14,4,22,203.11,C58H62Cl3F2N9O7S,"InChI=1S/C58H62Cl3F2N9O7S/c1-32-33(2)80-56-48(32)51(35-11-14-37(59)15-12-35)67-44(53-71-70-34(3)72(53)56)29-47(73)65-19-21-77-23-25-79-26-24-78-22-20-66-54(74)36-13-18-43(45(27-36)76-7)68-55(75)52-49(39-9-8-10-41(61)50(39)63)58(31-64,46(69-52)30-57(4,5)6)40-17-16-38(60)28-42(40)62/h8-18,27-28,44,46,49,52,69H,19-26,29-30H2,1-7H3,(H,65,73)(H,66,74)(H,68,75)/t44-,46-,49-,52+,58-/m0/s1",IPNTVOAQOGRLQB-JJMBTQCASA-N
209,23.1,89,23.1,89,O60885,BRD4,VHL,,A743,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOCCCOC3=CC=C(NC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in HCT116 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1158/0008-5472.CAN-18-2918,1092.786,1091.41643,7.71,76,8,15,4,22,211.49,C56H66ClN9O8S2,"InChI=1S/C56H66ClN9O8S2/c1-33-35(3)76-55-48(33)49(38-15-17-40(57)18-16-38)61-44(52-64-63-36(4)66(52)55)28-46(68)60-41-19-21-43(22-20-41)74-26-10-25-72-23-8-9-24-73-31-47(69)62-51(56(5,6)7)54(71)65-30-42(67)27-45(65)53(70)58-29-37-11-13-39(14-12-37)50-34(2)59-32-75-50/h11-22,32,42,44-45,51,67H,8-10,23-31H2,1-7H3,(H,58,70)(H,60,68)(H,62,69)/t42-,44+,45+,51-/m1/s1",LIRKMAWQWVEHBG-QEFNCWSLSA-N
214,1487,64,1487/(n/a),64/36,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,1150,SPR,,,,,,,,,,,,,,,8800,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,844.829,844.299196,3.2,61,7,14,4,16,239.74,C41H42F2N8O10,"InChI=1S/C41H42F2N8O10/c42-24-8-12-31(28(43)21-24)61-26-9-6-23(7-10-26)35-34(37(45)53)36(44)51(48-35)25-3-2-15-49(22-25)41(57)60-20-19-59-18-17-58-16-14-46-29-5-1-4-27-33(29)40(56)50(39(27)55)30-11-13-32(52)47-38(30)54/h1,4-10,12,21,25,30,46H,2-3,11,13-20,22,44H2,(H2,45,53)(H,47,52,54)/t25-,30?/m1/s1",MAECKIKUFSSWJT-GOWJNXQMSA-N
215,36.9,85,36.9/398.5,85/68,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,71,SPR,,,,,,,,,,,,,,,2500,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,888.882,888.3254107,3.05,64,7,15,4,19,248.97,C43H46F2N8O11,"InChI=1S/C43H46F2N8O11/c44-26-8-12-33(30(45)23-26)64-28-9-6-25(7-10-28)37-36(39(47)55)38(46)53(50-37)27-3-2-15-51(24-27)43(59)63-22-21-62-20-19-61-18-17-60-16-14-48-31-5-1-4-29-35(31)42(58)52(41(29)57)32-11-13-34(54)49-40(32)56/h1,4-10,12,23,27,32,48H,2-3,11,13-22,24,46H2,(H2,47,55)(H,49,54,56)/t27-,32?/m1/s1",IDIGRNKYBBGIKH-XIDOUCRZSA-N
216,21.8,84,21.8/469.9,84/63,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)COCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,79,SPR,,,,,,,,,,,,,,,2700,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,902.909,902.3410608,2.53,65,7,15,4,21,248.97,C44H48F2N8O11,"InChI=1S/C44H48F2N8O11/c45-27-8-12-34(31(46)23-27)65-29-9-6-26(7-10-29)39-38(41(48)57)40(47)54(51-39)28-3-2-15-52(24-28)36(56)25-64-22-21-63-20-19-62-18-17-61-16-14-49-32-5-1-4-30-37(32)44(60)53(43(30)59)33-11-13-35(55)50-42(33)58/h1,4-10,12,23,28,33,49H,2-3,11,13-22,24-25,47H2,(H2,48,57)(H,50,55,58)/t28-,33?/m1/s1",PZNXLFVCWNTMGE-TUDONDPESA-N
217,4.5,87,4.5/90.5,87/75,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,80,SPR,,,,,,,,,,,,,,,3600,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,932.935,932.3516255,2.91,67,7,16,4,22,258.2,C45H50F2N8O12,"InChI=1S/C45H50F2N8O12/c46-28-8-12-35(32(47)25-28)67-30-9-6-27(7-10-30)39-38(41(49)57)40(48)55(52-39)29-3-2-15-53(26-29)45(61)66-24-23-65-22-21-64-20-19-63-18-17-62-16-14-50-33-5-1-4-31-37(33)44(60)54(43(31)59)34-11-13-36(56)51-42(34)58/h1,4-10,12,25,29,34,50H,2-3,11,13-24,26,48H2,(H2,49,57)(H,51,56,58)/t29-,34?/m1/s1",HIEUPGKCAGGMLO-QMUARQKKSA-N
218,5.9,85,5.9/217.7,85/71,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)COCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,74,SPR,,,,,,,,,,,,,,,3200,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,946.962,946.3672755,2.39,68,7,16,4,24,258.2,C46H52F2N8O12,"InChI=1S/C46H52F2N8O12/c47-29-8-12-36(33(48)25-29)68-31-9-6-28(7-10-31)41-40(43(50)59)42(49)56(53-41)30-3-2-15-54(26-30)38(58)27-67-24-23-66-22-21-65-20-19-64-18-17-63-16-14-51-34-5-1-4-32-39(34)46(62)55(45(32)61)35-11-13-37(57)52-44(35)60/h1,4-10,12,25,30,35,51H,2-3,11,13-24,26-27,49H2,(H2,50,59)(H,52,57,60)/t30-,35?/m1/s1",PDQGUWCWGITGBA-OSRRZMJMSA-N
219,1.1,87,1.1/37.4,87/80,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,61,SPR,,,,,,,,,,,,,,,3000,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,976.988,976.3778402,2.76,70,7,17,4,25,267.43,C47H54F2N8O13,"InChI=1S/C47H54F2N8O13/c48-30-8-12-37(34(49)27-30)70-32-9-6-29(7-10-32)41-40(43(51)59)42(50)57(54-41)31-3-2-15-55(28-31)47(63)69-26-25-68-24-23-67-22-21-66-20-19-65-18-17-64-16-14-52-35-5-1-4-33-39(35)46(62)56(45(33)61)36-11-13-38(58)53-44(36)60/h1,4-10,12,27,31,36,52H,2-3,11,13-26,28,50H2,(H2,51,59)(H,53,58,60)/t31-,36?/m1/s1",XXNGOJVDXDGATG-RACIXVTASA-N
220,9.7,85,9.7/184.1,85/70,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)COCCOCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,138,SPR,,,,,,,,,,,,,,,3100,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,991.015,990.3934903,2.24,71,7,17,4,27,267.43,C48H56F2N8O13,"InChI=1S/C48H56F2N8O13/c49-31-8-12-38(35(50)27-31)71-33-9-6-30(7-10-33)43-42(45(52)61)44(51)58(55-43)32-3-2-15-56(28-32)40(60)29-70-26-25-69-24-23-68-22-21-67-20-19-66-18-17-65-16-14-53-36-5-1-4-34-41(36)48(64)57(47(34)63)37-11-13-39(59)54-46(37)62/h1,4-10,12,27,32,37,53H,2-3,11,13-26,28-29,51H2,(H2,52,61)(H,54,59,62)/t32-,37?/m1/s1",VRWPZJRZYSWRQV-ZIQZBVCVSA-N
221,182,95,182,,Q06187,BTK,cIAP1,6W8I,BC5P,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC2=CC(OCCOCCOCCOCCOCCOC(=O)N3CCC[C@@H](N4N=C(C5=CC=C(OC6=CC=C(F)C=C6F)C=C5)C(C(N)=O)=C4N)C3)=CC=C2C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C(C)(C)C,Degradation of BTK in THP-1 cells,,,,,,,259,BLI,,,,,,,,,,,,,,,7,BLI in cIAP1 Bir3,,,,,,,,,,,,,,,474,BLI,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-00686-2,1180.361,1179.581625,6.23,85,8,16,5,27,262.39,C62H79F2N9O12,"InChI=1S/C62H79F2N9O12/c1-39(67-5)58(75)69-55(62(2,3)4)60(77)72-37-43-34-47(21-17-42(43)35-51(72)59(76)68-50-14-8-11-40-10-6-7-13-48(40)50)83-32-30-81-28-26-79-24-25-80-27-29-82-31-33-84-61(78)71-23-9-12-45(38-71)73-56(65)53(57(66)74)54(70-73)41-15-19-46(20-16-41)85-52-22-18-44(63)36-49(52)64/h6-7,10,13,15-22,34,36,39,45,50-51,55,67H,8-9,11-12,14,23-33,35,37-38,65H2,1-5H3,(H2,66,74)(H,68,76)(H,69,75)/t39-,45+,50+,51-,55+/m0/s1",ZYNKGHHFEDYPKB-HQBWEIPVSA-N
223,3,94,3/34,,Q9UM73,ALK,CRBN,,MS4077,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of NPM-ALK/EML4-ALK in SU-DHL-1/NCI-H2228 cells after 16 h treatment,,,,,,,37,Kd was assessed by a competitive binding assay using DNA tag labeled ALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46,Inhibit proliferation of SU-DHL-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2018.03.071,1134.751,1133.465882,5.93,79,7,19,5,31,267.28,C55H72ClN9O13S,"InChI=1S/C55H72ClN9O13S/c1-35(2)78-46-32-40(37(5)31-44(46)61-55-59-33-41(56)51(63-55)60-42-10-6-7-12-47(42)79(71,72)36(3)4)38-15-19-64(20-16-38)34-49(67)58-18-22-74-24-26-76-28-30-77-29-27-75-25-23-73-21-17-57-43-11-8-9-39-50(43)54(70)65(53(39)69)45-13-14-48(66)62-52(45)68/h6-12,31-33,35-36,38,45,57H,13-30,34H2,1-5H3,(H,58,67)(H,62,66,68)(H2,59,60,61,63)",VEKJQNCZEPLNJF-UHFFFAOYSA-N
224,11,95,11/59,,Q9UM73,ALK,CRBN,,MS4078,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CC(=O)NCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of NPM-ALK/EML4-ALK in SU-DHL-1/NCI-H2228 cells after 16 h treatment,,,,,,,19,Kd was assessed by a competitive binding assay using DNA tag labeled ALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33,Inhibit proliferation of SU-DHL-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2018.03.071,914.486,913.3348083,6.66,64,7,14,5,16,221.13,C45H52ClN9O8S,"InChI=1S/C45H52ClN9O8S/c1-25(2)63-36-22-30(27(5)21-34(36)51-45-49-23-31(46)41(53-45)50-32-10-6-7-12-37(32)64(61,62)26(3)4)28-15-19-54(20-16-28)24-39(57)48-18-17-47-33-11-8-9-29-40(33)44(60)55(43(29)59)35-13-14-38(56)52-42(35)58/h6-12,21-23,25-26,28,35,47H,13-20,24H2,1-5H3,(H,48,57)(H,52,56,58)(H2,49,50,51,53)",AYMGZLUKTNXEMY-UHFFFAOYSA-N
227,9.12,84.07,9.12,84.07,Q9UBN7,HDAC6,CRBN,,dHDAC6,O=C(CCCCCCC(=O)N/N=C/C1=CC=C(OCCOCCOCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)NO,Degradation of HDAC6 in MM1S cells after 6 h treatment,47.9/73.5,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,775.82,775.3289386,1,56,5,15,5,23,244.77,C37H45N9O10,"InChI=1S/C37H45N9O10/c47-31-15-14-30(35(50)40-31)46-36(51)28-6-5-7-29(34(28)37(46)52)38-23-26-24-45(44-41-26)16-17-54-18-19-55-20-21-56-27-12-10-25(11-13-27)22-39-42-32(48)8-3-1-2-4-9-33(49)43-53/h5-7,10-13,22,24,30,38,53H,1-4,8-9,14-21,23H2,(H,42,48)(H,43,49)(H,40,47,50)/b39-22+",MHILTYZXXFOWJH-WVKHYPTHSA-N
227,34,70.5,34,70.5,Q9UBN7,HDAC6,CRBN,,dHDAC6,O=C(CCCCCCC(=O)N/N=C/C1=CC=C(OCCOCCOCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)NO,Degradation of HDAC6 in MCF-7 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2018.05.057,775.82,775.3289386,1,56,5,15,5,23,244.77,C37H45N9O10,"InChI=1S/C37H45N9O10/c47-31-15-14-30(35(50)40-31)46-36(51)28-6-5-7-29(34(28)37(46)52)38-23-26-24-45(44-41-26)16-17-54-18-19-55-20-21-56-27-12-10-25(11-13-27)22-39-42-32(48)8-3-1-2-4-9-33(49)43-53/h5-7,10-13,22,24,30,38,53H,1-4,8-9,14-21,23H2,(H,42,48)(H,43,49)(H,40,47,50)/b39-22+",MHILTYZXXFOWJH-WVKHYPTHSA-N
229,1,95,1~3,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3[C@@H](F)[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in HeLa cells after 24 h treatment,,,,,,,28,ITC in BRD4 BD2,,,-10.3,-10.4,0.1,ITC in BRD4 BD2,,,,,,,,,249,ITC,,,-9.01,-7.9,-1.1,ITC,,,,,,,,,26,Kd between VHL and the complex of protac and BRD4 BD2 was tested by ITC,,,-10.13,-10.9,-0.6,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,316,Inhibit proliferation of MV4;11 cells,,,,,,,,,,,,,10.1021/jacs.8b05807,1020.651,1019.360058,5.02,70,7,15,4,20,211.49,C49H59ClFN9O8S2,"InChI=1S/C49H59ClFN9O8S2/c1-27-29(3)70-48-39(27)41(32-12-14-34(50)15-13-32)55-35(45-58-57-30(4)60(45)48)22-37(62)52-16-17-66-18-19-67-20-21-68-25-38(63)56-44(49(5,6)7)47(65)59-24-36(61)40(51)42(59)46(64)53-23-31-8-10-33(11-9-31)43-28(2)54-26-69-43/h8-15,26,35-36,40,42,44,61H,16-25H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t35-,36-,40-,42-,44+/m0/s1",MYXWOZYARUULQX-LWKHJFSZSA-N
229,10,95,10,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3[C@@H](F)[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,97,ITC in BRD2 BD1,,,-9.57,-13.7,4.2,ITC in BRD2 BD1,,,,,,,,,249,ITC,,,-9.01,-7.9,-1.1,ITC,,,,,,,,,64,Kd between VHL and the complex of protac and BRD2 BD1 was tested by ITC,,,-9.85,-9.17,-0.6,ITC between VHL and BRD2 BD1:PROTAC,,,,,,,316,Inhibit proliferation of MV4;11 cells,,,,,,,,,,,,,10.1021/jacs.8b05807,1020.651,1019.360058,5.02,70,7,15,4,20,211.49,C49H59ClFN9O8S2,"InChI=1S/C49H59ClFN9O8S2/c1-27-29(3)70-48-39(27)41(32-12-14-34(50)15-13-32)55-35(45-58-57-30(4)60(45)48)22-37(62)52-16-17-66-18-19-67-20-21-68-25-38(63)56-44(49(5,6)7)47(65)59-24-36(61)40(51)42(59)46(64)53-23-31-8-10-33(11-9-31)43-28(2)54-26-69-43/h8-15,26,35-36,40,42,44,61H,16-25H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t35-,36-,40-,42-,44+/m0/s1",MYXWOZYARUULQX-LWKHJFSZSA-N
229,10,95,10,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3[C@@H](F)[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,249,ITC,,,-9.01,-7.9,-1.1,ITC,,,,,,,,,,,,,,,,,,,,,,,316,Inhibit proliferation of MV4;11 cells,,,,,,,,,,,,,10.1021/jacs.8b05807,1020.651,1019.360058,5.02,70,7,15,4,20,211.49,C49H59ClFN9O8S2,"InChI=1S/C49H59ClFN9O8S2/c1-27-29(3)70-48-39(27)41(32-12-14-34(50)15-13-32)55-35(45-58-57-30(4)60(45)48)22-37(62)52-16-17-66-18-19-67-20-21-68-25-38(63)56-44(49(5,6)7)47(65)59-24-36(61)40(51)42(59)46(64)53-23-31-8-10-33(11-9-31)43-28(2)54-26-69-43/h8-15,26,35-36,40,42,44,61H,16-25H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t35-,36-,40-,42-,44+/m0/s1",MYXWOZYARUULQX-LWKHJFSZSA-N
230,3000,95,3000,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3[C@H](F)[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,111,ITC in BRD2 BD1,,,-9.49,-14.1,4.9,ITC in BRD2 BD1,,,,,,,,,603,ITC,,,-8.49,-5,-3.7,ITC,,,,,,,,,500,Kd between VHL and the complex of protac and BRD2 BD1 was tested by ITC,,,-8.6,-5.1,-3.6,ITC between VHL and BRD2 BD1:PROTAC,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b05807,1020.651,1019.360058,5.02,70,7,15,4,20,211.49,C49H59ClFN9O8S2,"InChI=1S/C49H59ClFN9O8S2/c1-27-29(3)70-48-39(27)41(32-12-14-34(50)15-13-32)55-35(45-58-57-30(4)60(45)48)22-37(62)52-16-17-66-18-19-67-20-21-68-25-38(63)56-44(49(5,6)7)47(65)59-24-36(61)40(51)42(59)46(64)53-23-31-8-10-33(11-9-31)43-28(2)54-26-69-43/h8-15,26,35-36,40,42,44,61H,16-25H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t35-,36-,40+,42-,44+/m0/s1",MYXWOZYARUULQX-JHKZXAJTSA-N
230,,,3000,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3[C@H](F)[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,603,ITC,,,-8.49,-5,-3.7,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b05807,1020.651,1019.360058,5.02,70,7,15,4,20,211.49,C49H59ClFN9O8S2,"InChI=1S/C49H59ClFN9O8S2/c1-27-29(3)70-48-39(27)41(32-12-14-34(50)15-13-32)55-35(45-58-57-30(4)60(45)48)22-37(62)52-16-17-66-18-19-67-20-21-68-25-38(63)56-44(49(5,6)7)47(65)59-24-36(61)40(51)42(59)46(64)53-23-31-8-10-33(11-9-31)43-28(2)54-26-69-43/h8-15,26,35-36,40,42,44,61H,16-25H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t35-,36-,40+,42-,44+/m0/s1",MYXWOZYARUULQX-JHKZXAJTSA-N
230,,,45960,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3[C@H](F)[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in HeLa cells after 24 h treatment,,,,,,,32,ITC in BRD4 BD2,,,-10.3,-9.3,-0.9,ITC in BRD4 BD2,,,,,,,,,603,ITC,,,-8.49,-5,-3.7,ITC,,,,,,,,,42,Kd between VHL and the complex of protac and BRD4 BD2 was tested by ITC,,,-10.01,-7.75,-2.34,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b05807,1020.651,1019.360058,5.02,70,7,15,4,20,211.49,C49H59ClFN9O8S2,"InChI=1S/C49H59ClFN9O8S2/c1-27-29(3)70-48-39(27)41(32-12-14-34(50)15-13-32)55-35(45-58-57-30(4)60(45)48)22-37(62)52-16-17-66-18-19-67-20-21-68-25-38(63)56-44(49(5,6)7)47(65)59-24-36(61)40(51)42(59)46(64)53-23-31-8-10-33(11-9-31)43-28(2)54-26-69-43/h8-15,26,35-36,40,42,44,61H,16-25H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t35-,36-,40+,42-,44+/m0/s1",MYXWOZYARUULQX-JHKZXAJTSA-N
233,3.3,95,3.3,,O60885,BRD4,CRBN,,TD-188,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)N=N4)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.01.023,879.4,878.2725424,5.63,62,8,16,3,16,205.84,C43H43ClN10O7S,"InChI=1S/C43H43ClN10O7S/c1-24-25(2)62-43-37(24)39(27-7-9-28(44)10-8-27)47-33(40-51-49-26(3)53(40)43)23-36(56)46-29-11-13-30(14-12-29)61-22-21-60-20-19-59-18-17-45-31-5-4-6-32-38(31)42(58)54(52-50-32)34-15-16-35(55)48-41(34)57/h4-14,33-34,45H,15-23H2,1-3H3,(H,46,56)(H,48,55,57)/t33-,34?/m0/s1",VQRXXRRZSHERKG-CDRRMRQFSA-N
234,0.32,95,0.32,,O60885,BRD4,CRBN,,TD-428,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=CC(OCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)N=N4)=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.01.023,879.4,878.2725424,5.63,62,8,16,3,16,205.84,C43H43ClN10O7S,"InChI=1S/C43H43ClN10O7S/c1-24-25(2)62-43-37(24)39(27-10-12-28(44)13-11-27)47-33(40-51-49-26(3)53(40)43)23-36(56)46-29-6-4-7-30(22-29)61-21-20-60-19-18-59-17-16-45-31-8-5-9-32-38(31)42(58)54(52-50-32)34-14-15-35(55)48-41(34)57/h4-13,22,33-34,45H,14-21,23H2,1-3H3,(H,46,56)(H,48,55,57)/t33-,34?/m0/s1",XEZUBGASURUNMF-CDRRMRQFSA-N
239,13,95,13,,Q00534,CDK6,CRBN,,CP-7,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,50,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,936.04,935.428987,1.62,68,8,18,4,21,248.62,C47H57N11O10,"InChI=1S/C47H57N11O10/c1-29-34-27-51-47(54-42(34)57(31-6-3-4-7-31)45(64)40(29)30(2)59)52-37-12-10-32(26-50-37)56-18-16-55(17-19-56)28-39(61)49-15-21-67-23-25-68-24-22-66-20-14-48-35-9-5-8-33-41(35)46(65)58(44(33)63)36-11-13-38(60)53-43(36)62/h5,8-10,12,26-27,31,36,48H,3-4,6-7,11,13-25,28H2,1-2H3,(H,49,61)(H,53,60,62)(H,50,51,52,54)",UTSBHEVQCONLCR-UHFFFAOYSA-N
239,,,>100,,P11802,CDK4,CRBN,,CP-7,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,936.04,935.428987,1.62,68,8,18,4,21,248.62,C47H57N11O10,"InChI=1S/C47H57N11O10/c1-29-34-27-51-47(54-42(34)57(31-6-3-4-7-31)45(64)40(29)30(2)59)52-37-12-10-32(26-50-37)56-18-16-55(17-19-56)28-39(61)49-15-21-67-23-25-68-24-22-66-20-14-48-35-9-5-8-33-41(35)46(65)58(44(33)63)36-11-13-38(60)53-43(36)62/h5,8-10,12,26-27,31,36,48H,3-4,6-7,11,13-25,28H2,1-2H3,(H,49,61)(H,53,60,62)(H,50,51,52,54)",UTSBHEVQCONLCR-UHFFFAOYSA-N
239,,,126,,P11802,CDK4,CRBN,,CP-7,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,20,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,936.04,935.428987,1.62,68,8,18,4,21,248.62,C47H57N11O10,"InChI=1S/C47H57N11O10/c1-29-34-27-51-47(54-42(34)57(31-6-3-4-7-31)45(64)40(29)30(2)59)52-37-12-10-32(26-50-37)56-18-16-55(17-19-56)28-39(61)49-15-21-67-23-25-68-24-22-66-20-14-48-35-9-5-8-33-41(35)46(65)58(44(33)63)36-11-13-38(60)53-43(36)62/h5,8-10,12,26-27,31,36,48H,3-4,6-7,11,13-25,28H2,1-2H3,(H,49,61)(H,53,60,62)(H,50,51,52,54)",UTSBHEVQCONLCR-UHFFFAOYSA-N
239,,,14.3,,Q00534,CDK6,CRBN,,CP-7,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,936.04,935.428987,1.62,68,8,18,4,21,248.62,C47H57N11O10,"InChI=1S/C47H57N11O10/c1-29-34-27-51-47(54-42(34)57(31-6-3-4-7-31)45(64)40(29)30(2)59)52-37-12-10-32(26-50-37)56-18-16-55(17-19-56)28-39(61)49-15-21-67-23-25-68-24-22-66-20-14-48-35-9-5-8-33-41(35)46(65)58(44(33)63)36-11-13-38(60)53-43(36)62/h5,8-10,12,26-27,31,36,48H,3-4,6-7,11,13-25,28H2,1-2H3,(H,49,61)(H,53,60,62)(H,50,51,52,54)",UTSBHEVQCONLCR-UHFFFAOYSA-N
242,6.3,95,8.5/6.3/9.2/11.4,,Q06187,BTK,CRBN,,P13I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK in RAMOS/HBL-1/Mino/IgE MM cells after 48 h treatment,,,95,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5/>1000,Inhibit viability of HBL-1/RAMOS cells,,,,,,,,,,,10.1038/s41422-018-0055-1,912.965,912.3667211,2.67,67,9,18,3,19,253.14,C46H48N12O9,"InChI=1S/C46H48N12O9/c47-41-39-40(29-11-13-32(14-12-29)67-31-7-2-1-3-8-31)53-58(42(39)50-28-49-41)30-6-5-18-55(26-30)45(62)35-27-56(54-52-35)19-21-65-23-25-66-24-22-64-20-17-48-34-10-4-9-33-38(34)46(63)57(44(33)61)36-15-16-37(59)51-43(36)60/h1-4,7-14,27-28,30,36,48H,5-6,15-26H2,(H2,47,49,50)(H,51,59,60)/t30-,36?/m1/s1",DAKOVCJVMZQQAH-XMGIQNEDSA-N
256,15,76,15,76,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in VCaP cells after 20 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<1,Compounds were administered at 10000 nM and incubated for 5 h,0.35,Compounds were administered at 10000 nM and incubated for 2 h,0.24,Compounds were administered at 10000 nM and incubated for 2 h,10.1038/s42003-018-0105-8; 10.1021/acsmedchemlett.0c00194,1020.21,1019.389689,7.45,71,6,12,3,21,186.66,C51H60F3N7O8S2,"InChI=1S/C51H60F3N7O8S2/c1-32-43(71-31-57-32)34-13-11-33(12-14-34)28-56-45(64)41-26-38(62)29-59(41)46(65)44(49(2,3)4)58-42(63)30-68-23-10-22-67-21-8-7-9-24-69-39-19-17-36(18-20-39)61-48(70)60(47(66)50(61,5)6)37-16-15-35(27-55)40(25-37)51(52,53)54/h11-20,25,31,38,41,44,62H,7-10,21-24,26,28-30H2,1-6H3,(H,56,64)(H,58,63)/t38-,41+,44-/m1/s1",MTZBLTXMAXNSIO-UMWCMSNQSA-N
257,5,98,5,98,P10275,AR,VHL,,ARCC-4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOC3=CC=C(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in VCaP cells after 20 h treatment,,,36,Inhibition of AR by AR radioligand binding assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,150,Inhibit proliferation of VCaP cells,,,,,,,,,,,,,,,10.1038/s42003-018-0105-8,1024.201,1023.363474,8.51,72,7,11,3,17,177.43,C53H56F3N7O7S2,"InChI=1S/C53H56F3N7O7S2/c1-32-45(72-31-59-32)36-11-9-33(10-12-36)28-58-47(66)43-26-40(64)29-61(43)48(67)46(51(2,3)4)60-44(65)30-69-23-7-8-24-70-41-21-16-35(17-22-41)34-13-18-38(19-14-34)63-50(71)62(49(68)52(63,5)6)39-20-15-37(27-57)42(25-39)53(54,55)56/h9-22,25,31,40,43,46,64H,7-8,23-24,26,28-30H2,1-6H3,(H,58,66)(H,60,65)/t40-,43+,46-/m1/s1",DUPAJELXESPTNF-PPZGWQTASA-N
265,23.2,99,23.2,99,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of Fak in PC3 cells after 24 h treatment,,,10.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,982.121,981.3488863,5.86,68,6,14,5,19,217.31,C46H54F3N9O8S2,"InChI=1S/C46H54F3N9O8S2/c1-28-39(67-27-53-28)31-12-10-29(11-13-31)22-51-42(61)37-21-34(59)25-58(37)43(62)40(45(2,3)4)55-38(60)26-65-18-19-66-35-16-14-32(15-17-35)54-44-52-24-36(46(47,48)49)41(56-44)50-23-30-8-7-9-33(20-30)57(5)68(6,63)64/h7-17,20,24,27,34,37,40,59H,18-19,21-23,25-26H2,1-6H3,(H,51,61)(H,55,60)(H2,50,52,54,56)/t34-,37+,40-/m1/s1",SSNVICBSSPQZQX-WPPCIPCFSA-N
266,7.6,99,7.6,99,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of Fak in PC3 cells after 24 h treatment,,,14.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,996.148,995.3645364,6.22,69,6,14,5,20,217.31,C47H56F3N9O8S2,"InChI=1S/C47H56F3N9O8S2/c1-29-40(68-28-54-29)32-13-11-30(12-14-32)23-52-43(62)38-22-35(60)26-59(38)44(63)41(46(2,3)4)56-39(61)27-66-19-8-20-67-36-17-15-33(16-18-36)55-45-53-25-37(47(48,49)50)42(57-45)51-24-31-9-7-10-34(21-31)58(5)69(6,64)65/h7,9-18,21,25,28,35,38,41,60H,8,19-20,22-24,26-27H2,1-6H3,(H,52,62)(H,56,61)(H2,51,53,55,57)/t35-,38+,41-/m1/s1",SHPXUUGJMCCMIO-LFHXYJAASA-N
267,3,99,3,99,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of Fak in PC3 cells after 24 h treatment,,,6.5,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,996.148,995.3645364,5.76,69,6,14,5,20,217.31,C47H56F3N9O8S2,"InChI=1S/C47H56F3N9O8S2/c1-29-40(68-28-54-29)32-12-10-30(11-13-32)24-52-43(62)38-23-35(60)27-59(38)44(63)41(46(2,3)4)56-39(61)18-19-66-20-21-67-36-16-14-33(15-17-36)55-45-53-26-37(47(48,49)50)42(57-45)51-25-31-8-7-9-34(22-31)58(5)69(6,64)65/h7-17,22,26,28,35,38,41,60H,18-21,23-25,27H2,1-6H3,(H,52,62)(H,56,61)(H2,51,53,55,57)/t35-,38+,41-/m1/s1",MVULIYLBRNHLEE-LFHXYJAASA-N
268,4,99,4,99,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of Fak in PC3 cells after 24 h treatment,,,14.5,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1010.175,1009.380186,6.12,70,6,14,5,21,217.31,C48H58F3N9O8S2,"InChI=1S/C48H58F3N9O8S2/c1-30-41(69-29-55-30)33-13-11-31(12-14-33)25-53-44(63)39-24-36(61)28-60(39)45(64)42(47(2,3)4)57-40(62)19-22-67-20-8-21-68-37-17-15-34(16-18-37)56-46-54-27-38(48(49,50)51)43(58-46)52-26-32-9-7-10-35(23-32)59(5)70(6,65)66/h7,9-18,23,27,29,36,39,42,61H,8,19-22,24-26,28H2,1-6H3,(H,53,63)(H,57,62)(H2,52,54,56,58)/t36-,39+,42-/m1/s1",WVWFJWJYLUTFRG-QLMCDVMBSA-N
269,20.8,99,20.8,99,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of Fak in PC3 cells after 24 h treatment,,,12.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1040.201,1039.390751,5.62,72,6,15,5,23,226.54,C49H60F3N9O9S2,"InChI=1S/C49H60F3N9O9S2/c1-31-42(71-30-56-31)34-12-10-32(11-13-34)26-54-45(64)40-25-37(62)29-61(40)46(65)43(48(2,3)4)58-41(63)18-19-68-20-21-69-22-23-70-38-16-14-35(15-17-38)57-47-55-28-39(49(50,51)52)44(59-47)53-27-33-8-7-9-36(24-33)60(5)72(6,66)67/h7-17,24,28,30,37,40,43,62H,18-23,25-27,29H2,1-6H3,(H,54,64)(H,58,63)(H2,53,55,57,59)/t37-,40+,43-/m1/s1",DRJLXMYTVYIROA-AKCINUCUSA-N
270,48.1,91,48.1,91,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of Fak in PC3 cells after 24 h treatment,,,6.1,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1128.307,1127.443181,5.32,78,6,17,5,29,245,C53H68F3N9O11S2,"InChI=1S/C53H68F3N9O11S2/c1-35-46(77-34-60-35)38-12-10-36(11-13-38)30-58-49(68)44-29-41(66)33-65(44)50(69)47(52(2,3)4)62-45(67)18-19-72-20-21-73-22-23-74-24-25-75-26-27-76-42-16-14-39(15-17-42)61-51-59-32-43(53(54,55)56)48(63-51)57-31-37-8-7-9-40(28-37)64(5)78(6,70)71/h7-17,28,32,34,41,44,47,66H,18-27,29-31,33H2,1-6H3,(H,58,68)(H,62,67)(H2,57,59,61,63)/t41-,44+,47-/m1/s1",CVMXJJVQILKJCT-IIWOMYBWSA-N
271,8.2,98,8.2,98,Q05397,FAK,CRBN,,,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(OCCCOCCC(=O)NCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,Degradation of Fak in PC3 cells after 24 h treatment,,,11.3,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,896.902,896.2774952,3.22,63,6,14,4,20,227.56,C41H43F3N8O10S,"InChI=1S/C41H43F3N8O10S/c1-51(63(2,58)59)27-7-3-6-25(22-27)23-46-36-30(41(42,43)44)24-47-40(50-36)48-26-10-12-28(13-11-26)61-19-5-18-60-20-16-33(53)45-17-21-62-32-9-4-8-29-35(32)39(57)52(38(29)56)31-14-15-34(54)49-37(31)55/h3-4,6-13,22,24,31H,5,14-21,23H2,1-2H3,(H,45,53)(H,49,54,55)(H2,46,47,48,50)",ATTMBNXPUWOYNQ-UHFFFAOYSA-N
272,26.7,99,26.7,99,Q05397,FAK,CRBN,,,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(OCCOCCOCCC(=O)NCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,Degradation of Fak in PC3 cells after 24 h treatment,,,4.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,926.928,926.2880599,2.72,65,6,15,4,22,236.79,C42H45F3N8O11S,"InChI=1S/C42H45F3N8O11S/c1-52(65(2,59)60)28-6-3-5-26(23-28)24-47-37-31(42(43,44)45)25-48-41(51-37)49-27-9-11-29(12-10-27)63-22-21-62-20-19-61-17-15-34(54)46-16-18-64-33-8-4-7-30-36(33)40(58)53(39(30)57)32-13-14-35(55)50-38(32)56/h3-12,23,25,32H,13-22,24H2,1-2H3,(H,46,54)(H,50,55,56)(H2,47,48,49,51)",RKQPBRYWQQLESB-UHFFFAOYSA-N
273,10,87,<10,87,Q05397,FAK,CRBN,,,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(OCCOCCOCCOCCOCCC(=O)NCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,Degradation of Fak in PC3 cells after 24 h treatment,,,9.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1015.034,1014.340489,2.42,71,6,17,4,28,255.25,C46H53F3N8O13S,"InChI=1S/C46H53F3N8O13S/c1-56(71(2,63)64)32-6-3-5-30(27-32)28-51-41-35(46(47,48)49)29-52-45(55-41)53-31-9-11-33(12-10-31)69-26-25-68-24-23-67-22-21-66-20-19-65-17-15-38(58)50-16-18-70-37-8-4-7-34-40(37)44(62)57(43(34)61)36-13-14-39(59)54-42(36)60/h3-12,27,29,36H,13-26,28H2,1-2H3,(H,50,58)(H,54,59,60)(H2,51,52,53,55)",QZQNVCJSORWNHR-UHFFFAOYSA-N
275,39.2,97.6,39.2/736.2,97.6/68.8,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOC3=CC=C(C4=CC=C5N=CN=C(NC6=CC=C(OCC7=CC=CC(F)=C7)C(Cl)=C6)C5=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WT/Exon 20 Ins EGFR in OVCAR8/HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,102,Inhibit proliferation of SKBr3 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.009,1030.62,1029.366189,9.03,73,8,13,4,21,186.36,C55H57ClFN7O8S,"InChI=1S/C55H57ClFN7O8S/c1-34-50(73-33-61-34)38-10-8-35(9-11-38)28-58-53(67)47-27-42(65)29-64(47)54(68)51(55(2,3)4)63-49(66)31-70-21-20-69-22-23-71-43-16-12-37(13-17-43)39-14-18-46-44(25-39)52(60-32-59-46)62-41-15-19-48(45(56)26-41)72-30-36-6-5-7-40(57)24-36/h5-19,24-26,32-33,42,47,51,65H,20-23,27-31H2,1-4H3,(H,58,67)(H,63,66)(H,59,60,62)/t42-,47+,51-/m1/s1",ZSCOIFSUFMYZEZ-YSWDPXALSA-N
276,11.7,98.9,11.7/22.3,98.9/96.6,P00533,EGFR,VHL,,,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of Exon 19 del/L858R EGFR in HCC827/H3255 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.009,934.532,933.3661887,6.88,65,6,13,4,22,186.36,C47H57ClFN7O8S,"InChI=1S/C47H57ClFN7O8S/c1-29-42(65-28-53-29)31-11-9-30(10-12-31)25-50-45(59)38-22-33(57)26-56(38)46(60)43(47(2,3)4)55-41(58)15-18-63-20-19-62-16-7-6-8-17-64-40-23-34-37(24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9-14,21,23-24,27-28,33,38,43,57H,6-8,15-20,22,25-26H2,1-5H3,(H,50,59)(H,55,58)(H,51,52,54)/t33-,38+,43-/m1/s1",NICKHWYZMNLEPJ-TZSMONEZSA-N
277,215.8,79.1,215.8,79.1,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCOCCCCOCCCCOC3=CC4=NC=NC(NC5=CC=C(F)C(Cl)=C5)=C4C=C3NC(=O)/C=C/CN(C)C)C(C)(C)C)C=C2)SC=N1,"Degradation of L858R, T790M EGFR in H1975 cells after 24 h treatment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.009,1086.773,1085.497537,7.81,76,6,14,5,29,209.47,C56H73ClFN9O8S,"InChI=1S/C56H73ClFN9O8S/c1-37-51(76-36-62-37)39-19-17-38(18-20-39)33-59-54(71)47-30-41(68)34-67(47)55(72)52(56(2,3)4)65-50(70)15-8-7-9-24-73-25-10-11-26-74-27-12-13-28-75-48-32-45-42(31-46(48)64-49(69)16-14-23-66(5)6)53(61-35-60-45)63-40-21-22-44(58)43(57)29-40/h14,16-22,29,31-32,35-36,41,47,52,68H,7-13,15,23-28,30,33-34H2,1-6H3,(H,59,71)(H,64,69)(H,65,70)(H,60,61,63)/b16-14+/t41-,47+,52-/m1/s1",BXHBYEPLXDQKAT-JYCNGAFSSA-N
280,80.6,96,80.6,96,Q06187,BTK,CRBN,,MT-540,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCCCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,843.942,843.3704095,4.31,62,8,14,3,18,213.2,C45H49N9O8,"InChI=1S/C45H49N9O8/c46-41-39-40(29-13-15-32(16-14-29)62-31-9-4-3-5-10-31)51-54(42(39)48-28-47-41)30-19-22-52(23-20-30)21-6-1-2-7-24-60-25-26-61-27-37(56)49-34-12-8-11-33-38(34)45(59)53(44(33)58)35-17-18-36(55)50-43(35)57/h3-5,8-16,28,30,35H,1-2,6-7,17-27H2,(H,49,56)(H2,46,47,48)(H,50,55,57)",YFWKTWXPNMNMSC-UHFFFAOYSA-N
281,90.1,93,90.1,93,Q06187,BTK,CRBN,,MT-541,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCCOCCCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,843.942,843.3704095,4.31,62,8,14,3,18,213.2,C45H49N9O8,"InChI=1S/C45H49N9O8/c46-41-39-40(29-13-15-32(16-14-29)62-31-9-2-1-3-10-31)51-54(42(39)48-28-47-41)30-19-22-52(23-20-30)21-4-5-24-60-25-6-7-26-61-27-37(56)49-34-12-8-11-33-38(34)45(59)53(44(33)58)35-17-18-36(55)50-43(35)57/h1-3,8-16,28,30,35H,4-7,17-27H2,(H,49,56)(H2,46,47,48)(H,50,55,57)",JJEBSGCXKQODDX-UHFFFAOYSA-N
282,68.3,95,68.3,95,Q06187,BTK,CRBN,,MT-781,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCOCCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,829.915,829.3547595,3.5,61,8,14,3,17,213.2,C44H47N9O8,"InChI=1S/C44H47N9O8/c45-40-38-39(28-11-13-31(14-12-28)61-30-7-2-1-3-8-30)50-53(41(38)47-27-46-40)29-17-21-51(22-18-29)20-5-23-59-24-6-25-60-26-19-36(55)48-33-10-4-9-32-37(33)44(58)52(43(32)57)34-15-16-35(54)49-42(34)56/h1-4,7-14,27,29,34H,5-6,15-26H2,(H,48,55)(H2,45,46,47)(H,49,54,56)",CESHFJRNQNNGLW-UHFFFAOYSA-N
283,6.2,99,6.2,99,Q06187,BTK,CRBN,,MT-802,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,787.834,787.3078093,2.33,58,8,14,3,14,213.2,C41H41N9O8,"InChI=1S/C41H41N9O8/c42-37-35-36(25-6-9-29(10-7-25)58-28-4-2-1-3-5-28)47-50(38(35)44-24-43-37)27-14-16-48(17-15-27)18-19-56-20-21-57-23-34(52)45-26-8-11-30-31(22-26)41(55)49(40(30)54)32-12-13-33(51)46-39(32)53/h1-11,22,24,27,32H,12-21,23H2,(H,45,52)(H2,42,43,44)(H,46,51,53)",AJTLGUJXIKEZCQ-UHFFFAOYSA-N
283,9.1,99,9.1/14.6,>99/(n/a),Q06187,BTK,CRBN,,MT-802,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of BTK in NAMALWA/XLA cells after 24 h treatment,,,46.9,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,787.834,787.3078093,2.33,58,8,14,3,14,213.2,C41H41N9O8,"InChI=1S/C41H41N9O8/c42-37-35-36(25-6-9-29(10-7-25)58-28-4-2-1-3-5-28)47-50(38(35)44-24-43-37)27-14-16-48(17-15-27)18-19-56-20-21-57-23-34(52)45-26-8-11-30-31(22-26)41(55)49(40(30)54)32-12-13-33(51)46-39(32)53/h1-11,22,24,27,32H,12-21,23H2,(H,45,52)(H2,42,43,44)(H,46,51,53)",AJTLGUJXIKEZCQ-UHFFFAOYSA-N
283,14.9,99,14.9,>99,Q06187,BTK C481S,CRBN,,MT-802,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of C481S BTK in XLA cells after 24 h treatment,,,20.9,Inhibition of C481S BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,787.834,787.3078093,2.33,58,8,14,3,14,213.2,C41H41N9O8,"InChI=1S/C41H41N9O8/c42-37-35-36(25-6-9-29(10-7-25)58-28-4-2-1-3-5-28)47-50(38(35)44-24-43-37)27-14-16-48(17-15-27)18-19-56-20-21-57-23-34(52)45-26-8-11-30-31(22-26)41(55)49(40(30)54)32-12-13-33(51)46-39(32)53/h1-11,22,24,27,32H,12-21,23H2,(H,45,52)(H2,42,43,44)(H,46,51,53)",AJTLGUJXIKEZCQ-UHFFFAOYSA-N
284,11.6,99,11.6,>99,Q06187,BTK,CRBN,,MT-809,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCCOCCCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,843.942,843.3704095,3.76,62,8,14,3,18,213.2,C45H49N9O8,"InChI=1S/C45H49N9O8/c46-41-39-40(29-10-13-33(14-11-29)62-32-8-2-1-3-9-32)51-54(42(39)48-28-47-41)31-18-21-52(22-19-31)20-4-5-23-60-24-6-7-25-61-27-38(56)49-30-12-15-34-35(26-30)45(59)53(44(34)58)36-16-17-37(55)50-43(36)57/h1-3,8-15,26,28,31,36H,4-7,16-25,27H2,(H,49,56)(H2,46,47,48)(H,50,55,57)",VPGHQPSPNUQPLG-UHFFFAOYSA-N
285,27,91,27,91,O15264,p38delta,CRBN,,SJF-8242,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)NCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of p38delta in MDA-MB-231 cells after 24 h treatment,,,,,,,2000,Kd was assessed by competition binding assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.010,992.986,992.3403921,5.03,72,8,14,4,24,239.12,C51H50F2N6O13,"InChI=1S/C51H50F2N6O13/c1-67-41-28-34-36(54-19-15-38(34)72-39-13-11-32(27-35(39)53)57-50(66)51(17-18-51)49(65)56-31-9-7-30(52)8-10-31)29-42(41)70-24-4-23-68-21-3-22-69-25-16-43(60)55-20-26-71-40-6-2-5-33-45(40)48(64)59(47(33)63)37-12-14-44(61)58-46(37)62/h2,5-11,13,15,19,27-29,37H,3-4,12,14,16-18,20-26H2,1H3,(H,55,60)(H,56,65)(H,57,66)(H,58,61,62)",ZAJXSUNUSHEGCB-UHFFFAOYSA-N
294,1.5,95,<1.5,,Q92831,PCAF,CRBN,,GSK699,CN1C[C@H](NC2=C(Br)C(=O)N(C)N=C2)C[C@H](C2=CC=C(C(=O)N(C)CCCN(C)C3=CC=C(CCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)C=C2)C1,Degradation of PCAF in THP1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.8b00705,895.856,894.3064081,4.67,61,7,12,2,15,166.49,C45H51BrN8O7,"InChI=1S/C45H51BrN8O7/c1-50-26-31(24-32(27-50)48-35-25-47-53(4)45(60)40(35)46)29-13-15-30(16-14-29)42(57)52(3)22-7-21-51(2)33-17-11-28(12-18-33)8-6-23-61-37-10-5-9-34-39(37)44(59)54(43(34)58)36-19-20-38(55)49-41(36)56/h5,9-18,25,31-32,36,48H,6-8,19-24,26-27H2,1-4H3,(H,49,55,56)/t31-,32+,36?/m0/s1",SARLMRHJAJBYBI-CIDUPMPKSA-N
294,,,<3,,Q92830,GCN5,CRBN,,GSK699,CN1C[C@H](NC2=C(Br)C(=O)N(C)N=C2)C[C@H](C2=CC=C(C(=O)N(C)CCCN(C)C3=CC=C(CCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)C=C2)C1,Degradation of GCN5 in THP1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.8b00705,895.856,894.3064081,4.67,61,7,12,2,15,166.49,C45H51BrN8O7,"InChI=1S/C45H51BrN8O7/c1-50-26-31(24-32(27-50)48-35-25-47-53(4)45(60)40(35)46)29-13-15-30(16-14-29)42(57)52(3)22-7-21-51(2)33-17-11-28(12-18-33)8-6-23-61-37-10-5-9-34-39(37)44(59)54(43(34)58)36-19-20-38(55)49-41(36)56/h5,9-18,25,31-32,36,48H,6-8,19-24,26-27H2,1-4H3,(H,49,55,56)/t31-,32+,36?/m0/s1",SARLMRHJAJBYBI-CIDUPMPKSA-N
328,5,95,<5/<5/<5,,P25440,BRD2,VHL,,ARV-771,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in 22Rv1/VCaP/LnCaP95 cells after 16 h treatment,,,,,,,34/4.7,Kd of BRD2 BD1/2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<1,Suppression of cellular c-MYC levels measured by ELISA,,,,,,,,,,,,,,,10.1073/pnas.1521738113,986.662,985.3745649,5.87,68,7,14,4,18,202.26,C49H60ClN9O7S2,"InChI=1S/C49H60ClN9O7S2/c1-27-30(4)68-48-41(27)42(33-14-16-35(50)17-15-33)54-37(45-57-56-31(5)59(45)48)23-39(61)51-18-21-65-19-9-20-66-25-40(62)55-44(49(6,7)8)47(64)58-24-36(60)22-38(58)46(63)53-28(2)32-10-12-34(13-11-32)43-29(3)52-26-67-43/h10-17,26,28,36-38,44,60H,9,18-25H2,1-8H3,(H,51,61)(H,53,63)(H,55,62)/t28-,36+,37-,38-,44+/m0/s1",PQOGZKGXGLHDGS-QQRWPDCKSA-N
328,,,<5/<5/<5,,Q15059,BRD3,VHL,,ARV-771,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in 22Rv1/VCaP/LnCaP95 cells after 16 h treatment,,,,,,,8.3/7.6,Kd of BRD3 BD1/2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<1,Suppression of cellular c-MYC levels measured by ELISA,,,,,,,,,,,,,,,10.1073/pnas.1521738113,986.662,985.3745649,5.87,68,7,14,4,18,202.26,C49H60ClN9O7S2,"InChI=1S/C49H60ClN9O7S2/c1-27-30(4)68-48-41(27)42(33-14-16-35(50)17-15-33)54-37(45-57-56-31(5)59(45)48)23-39(61)51-18-21-65-19-9-20-66-25-40(62)55-44(49(6,7)8)47(64)58-24-36(60)22-38(58)46(63)53-28(2)32-10-12-34(13-11-32)43-29(3)52-26-67-43/h10-17,26,28,36-38,44,60H,9,18-25H2,1-8H3,(H,51,61)(H,53,63)(H,55,62)/t28-,36+,37-,38-,44+/m0/s1",PQOGZKGXGLHDGS-QQRWPDCKSA-N
328,,,<5/<5/<5,,O60885,BRD4,VHL,,ARV-771,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in 22Rv1/VCaP/LnCaP95 cells after 16 h treatment,,,,,,,9.6/7.6,Kd of BRD4 BD1/2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<1,Suppression of cellular c-MYC levels measured by ELISA,,,,,,,,,0.2,PAMPA assay,,,,,10.1073/pnas.1521738113; 10.1021/acs.jmedchem.1c01496,986.662,985.3745649,5.87,68,7,14,4,18,202.26,C49H60ClN9O7S2,"InChI=1S/C49H60ClN9O7S2/c1-27-30(4)68-48-41(27)42(33-14-16-35(50)17-15-33)54-37(45-57-56-31(5)59(45)48)23-39(61)51-18-21-65-19-9-20-66-25-40(62)55-44(49(6,7)8)47(64)58-24-36(60)22-38(58)46(63)53-28(2)32-10-12-34(13-11-32)43-29(3)52-26-67-43/h10-17,26,28,36-38,44,60H,9,18-25H2,1-8H3,(H,51,61)(H,53,63)(H,55,62)/t28-,36+,37-,38-,44+/m0/s1",PQOGZKGXGLHDGS-QQRWPDCKSA-N
329,0.31,95,0.31,,O60885,BRD4,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in Namalwa cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cb00223j,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,0.57,95,0.57,,O60885,BRD4,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.01.023,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,0.6,97,0.6/1,97/100,O60885,BRD4,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/35,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,0.8,98,0.8,98,Q15059,BRD3,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/35,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,1,95,<1/<1,,O60885,BRD4,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in Namalwa/CA-46 cells after overnight treatment,,,,,,,90/28,Kd of BRD4 BD1/2 was determined with BROMOscan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2015.05.009,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,,,6,83,P25440,BRD2,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/35,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
330,2.9,95,5.27/2.9,,O60885,BRD4,CRBN,,dBET1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MV4-11 cells after 12/24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.6,Compounds were administered at 10000 nM and incubated for 2 h,,,10.1002/anie.202108848,785.283,784.2194442,3.22,55,7,12,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)40-15-4-5-16-41-30(50)18-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,49)(H,41,50)(H,43,48,51)/t25-,26?/m0/s1",LKEGXJXRNBALBV-PMCHYTPCSA-N
330,430,95,430,,O60885,BRD4,CRBN,,dBET1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in SUM149 cells after 18 h treatment,,,,,,,07�� 06��,Kd of BRD4 BD1/2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1126/science.aab1433,785.283,784.2194442,3.22,55,7,12,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)40-15-4-5-16-41-30(50)18-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,49)(H,41,50)(H,43,48,51)/t25-,26?/m0/s1",LKEGXJXRNBALBV-PMCHYTPCSA-N
330,,,500/1000,,O60885,BRD4,CRBN,,dBET1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 BD1/2 assessed by EGFP/mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-018-0055-y,785.283,784.2194442,3.22,55,7,12,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)40-15-4-5-16-41-30(50)18-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,49)(H,41,50)(H,43,48,51)/t25-,26?/m0/s1",LKEGXJXRNBALBV-PMCHYTPCSA-N
330,,,230,,O60885,BRD4,CRBN,,dBET1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HD-MB03 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202108848,785.283,784.2194442,3.22,55,7,12,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)40-15-4-5-16-41-30(50)18-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,49)(H,41,50)(H,43,48,51)/t25-,26?/m0/s1",LKEGXJXRNBALBV-PMCHYTPCSA-N
333,100,86,100,86,P11474,ERRalpha,VHL,,,COC1=CC(/C=C2\SC(=O)N(CCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C2=O)=CC=C1OC1=CC=C(C#N)C=C1C(F)(F)F,Degradation of ERRalpha in MCF-7 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/nchembio.1858,949.043,948.2798037,6.35,66,6,13,3,16,200.49,C46H47F3N6O9S2,"InChI=1S/C46H47F3N6O9S2/c1-26-39(65-25-52-26)30-10-6-27(7-11-30)23-51-41(58)33-21-31(56)24-55(33)43(60)40(45(2,3)4)53-38(57)14-16-63-17-15-54-42(59)37(66-44(54)61)20-28-8-13-35(36(19-28)62-5)64-34-12-9-29(22-50)18-32(34)46(47,48)49/h6-13,18-20,25,31,33,40,56H,14-17,21,23-24H2,1-5H3,(H,51,58)(H,53,57)/b37-20-/t31-,33+,40-/m1/s1",IIJORMBEWMYDEN-FRKKMCEPSA-N
334,1.4,95,1.4,95,O43353,RIPK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOC3=CC4=NC=CC(NC5=CC=C6SC=NC6=C5)=C4C=C3S(=O)(=O)C(C)(C)C)C(C)(C)C)C=C2)SC=N1,Degradation of RIPK2 in THP-1 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,656,Inhibition of VHL by competition binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/nchembio.1858,1060.331,1059.390419,5.91,73,7,17,4,24,229.73,C52H65N7O11S3,"InChI=1S/C52H65N7O11S3/c1-33-47(72-31-55-33)35-10-8-34(9-11-35)28-54-49(62)42-25-37(60)29-59(42)50(63)48(51(2,3)4)58-46(61)30-69-21-20-67-17-16-66-18-19-68-22-23-70-43-27-40-38(26-45(43)73(64,65)52(5,6)7)39(14-15-53-40)57-36-12-13-44-41(24-36)56-32-71-44/h8-15,24,26-27,31-32,37,42,48,60H,16-23,25,28-30H2,1-7H3,(H,53,57)(H,54,62)(H,58,61)/t37-,42+,48-/m1/s1",RIEGJNXDHULIKM-GPPJZCFZSA-N
334,,,2,,O43353,RIPK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOC3=CC4=NC=CC(NC5=CC=C6SC=NC6=C5)=C4C=C3S(=O)(=O)C(C)(C)C)C(C)(C)C)C=C2)SC=N1,Degradation of RIPK2 in THP-1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,1060.331,1059.390419,5.91,73,7,17,4,24,229.73,C52H65N7O11S3,"InChI=1S/C52H65N7O11S3/c1-33-47(72-31-55-33)35-10-8-34(9-11-35)28-54-49(62)42-25-37(60)29-59(42)50(63)48(51(2,3)4)58-46(61)30-69-21-20-67-17-16-66-18-19-68-22-23-70-43-27-40-38(26-45(43)73(64,65)52(5,6)7)39(14-15-53-40)57-36-12-13-44-41(24-36)56-32-71-44/h8-15,24,26-27,31-32,37,42,48,60H,16-23,25,28-30H2,1-7H3,(H,53,57)(H,54,62)(H,58,61)/t37-,42+,48-/m1/s1",RIEGJNXDHULIKM-GPPJZCFZSA-N
335,40,98,40,98,P25440,BRD2,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,69,ITC,,,-9.77,-7.76,-2.02,ITC,,,,,,,,,,,,,,,,,,,,,,,27/219,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,,,100,100,Q15059,BRD3,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,69,ITC,,,-9.77,-7.76,-2.02,ITC,,,,,,,,,,,,,,,,,,,,,,,27/219,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,,,45872,98/100,O60885,BRD4,VHL,5T35,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,26,ITC in BRD4 BD2,,,-10.3,-11.1,0.77,ITC in BRD4 BD2,,,,,,,,,69,ITC,,,-9.77,-7.76,-2.02,ITC,,,,,,,,,9,Kd between VHL and MZ1-BRD4 BD2 was tested by ITC,,,-11.1,-8.47,-2.59,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,27/219,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,,,40,98,O60885,BRD4,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9600000,0.015,54.8,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,,,250,100,O60885,BRD4,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95,ITC,,,,,,,,,,,,,,,,,,,,,,,0.11,Caco-2 A2B assay,9,Caco-2 B2A assay,10.1002/cmdc.202200615,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
336,200,97,200,97,P25440,BRD2,VHL,,MZ2,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,73,ITC,,,-9.75,-8.79,-0.96,ITC,,,,,,,,,,,,,,,,,,,,,,,123/1259,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912; 10.1021/acschembio.5b00216,1046.714,1045.395694,4.82,72,7,16,4,23,220.72,C51H64ClN9O9S2,"InChI=1S/C51H64ClN9O9S2/c1-30-32(3)72-50-43(30)44(35-12-14-37(52)15-13-35)56-39(47-59-58-33(4)61(47)50)25-41(63)53-16-17-67-18-19-68-20-21-69-22-23-70-28-42(64)57-46(51(5,6)7)49(66)60-27-38(62)24-40(60)48(65)54-26-34-8-10-36(11-9-34)45-31(2)55-29-71-45/h8-15,29,38-40,46,62H,16-28H2,1-7H3,(H,53,63)(H,54,65)(H,57,64)/t38-,39+,40+,46-/m1/s1",LSELSHXLKGXPPF-BOBBFQORSA-N
336,,,316,99,Q15059,BRD3,VHL,,MZ2,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,73,ITC,,,-9.75,-8.79,-0.96,ITC,,,,,,,,,,,,,,,,,,,,,,,123/1259,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912; 10.1021/acschembio.5b00216,1046.714,1045.395694,4.82,72,7,16,4,23,220.72,C51H64ClN9O9S2,"InChI=1S/C51H64ClN9O9S2/c1-30-32(3)72-50-43(30)44(35-12-14-37(52)15-13-35)56-39(47-59-58-33(4)61(47)50)25-41(63)53-16-17-67-18-19-68-20-21-69-22-23-70-28-42(64)57-46(51(5,6)7)49(66)60-27-38(62)24-40(60)48(65)54-26-34-8-10-36(11-9-34)45-31(2)55-29-71-45/h8-15,29,38-40,46,62H,16-28H2,1-7H3,(H,53,63)(H,54,65)(H,57,64)/t38-,39+,40+,46-/m1/s1",LSELSHXLKGXPPF-BOBBFQORSA-N
336,,,45757,99/100,O60885,BRD4,VHL,,MZ2,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,27,ITC in BRD4 BD2,,,-10.3,-10.6,0.31,ITC in BRD4 BD2,,,,,,,,,73,ITC,,,-9.75,-8.79,-0.96,ITC,,,,,,,,,15,Kd between VHL and MZ2-BRD4 BD2 was tested by ITC,,,-10.7,-10.6,-0.07,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,123/1259,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912; 10.1021/acschembio.5b00216,1046.714,1045.395694,4.82,72,7,16,4,23,220.72,C51H64ClN9O9S2,"InChI=1S/C51H64ClN9O9S2/c1-30-32(3)72-50-43(30)44(35-12-14-37(52)15-13-35)56-39(47-59-58-33(4)61(47)50)25-41(63)53-16-17-67-18-19-68-20-21-69-22-23-70-28-42(64)57-46(51(5,6)7)49(66)60-27-38(62)24-40(60)48(65)54-26-34-8-10-36(11-9-34)45-31(2)55-29-71-45/h8-15,29,38-40,46,62H,16-28H2,1-7H3,(H,53,63)(H,54,65)(H,57,64)/t38-,39+,40+,46-/m1/s1",LSELSHXLKGXPPF-BOBBFQORSA-N
339,6,97,6,97,O60885,BRD4,CRBN,6BOY,dBET6,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 3 h treatment,,,,,,,46,Kd of BRD4 BD1 was assessed by FP,,,,,,,,,,,,,,,264,FP,,,,,,,,,,,,,,,33,Kd was tested by AlphaLISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.1c00376,841.391,840.2820445,5.02,59,7,12,3,16,194.05,C42H45ClN8O7S,"InChI=1S/C42H45ClN8O7S/c1-23-24(2)59-42-35(23)37(26-13-15-27(43)16-14-26)46-29(38-49-48-25(3)50(38)42)21-33(53)44-19-8-6-4-5-7-9-20-45-34(54)22-58-31-12-10-11-28-36(31)41(57)51(40(28)56)30-17-18-32(52)47-39(30)55/h10-16,29-30H,4-9,17-22H2,1-3H3,(H,44,53)(H,45,54)(H,47,52,55)/t29-,30?/m0/s1",JGQPZPLJOBHHBK-UFXYQILXSA-N
339,10,95,10/50,,O60885,BRD4,CRBN,6BOY,dBET6,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 BD1/2 assessed by EGFP/mCherry reporter assay,,,,,,,,,,,,,,,,,,,800,Inhibition of CRBN by competition binding assay,,,,,,,,,,,,,,,1800/4100,Inhibition of CRBN in the presence of BRD4 BD1/2 by competition binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-018-0055-y,841.391,840.2820445,5.02,59,7,12,3,16,194.05,C42H45ClN8O7S,"InChI=1S/C42H45ClN8O7S/c1-23-24(2)59-42-35(23)37(26-13-15-27(43)16-14-26)46-29(38-49-48-25(3)50(38)42)21-33(53)44-19-8-6-4-5-7-9-20-45-34(54)22-58-31-12-10-11-28-36(31)41(57)51(40(28)56)30-17-18-32(52)47-39(30)55/h10-16,29-30H,4-9,17-22H2,1-3H3,(H,44,53)(H,45,54)(H,47,52,55)/t29-,30?/m0/s1",JGQPZPLJOBHHBK-UFXYQILXSA-N
340,50,95,50/>1000,,O60885,BRD4,CRBN,6BN7,dBET23,COC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(SC(C(=O)NCCCCCCCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C2C)N2C(C)=NN=C12,Degradation of BRD4 BD1/2 assessed by EGFP/mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-018-0055-y,885.4,884.2718737,4.81,62,7,14,3,17,220.35,C43H45ClN8O9S,"InChI=1S/C43H45ClN8O9S/c1-23-34-36(25-13-15-26(44)16-14-25)47-28(21-33(55)60-3)38-50-49-24(2)51(38)43(34)62-37(23)40(57)46-20-9-7-5-4-6-8-19-45-32(54)22-61-30-12-10-11-27-35(30)42(59)52(41(27)58)29-17-18-31(53)48-39(29)56/h10-16,28-29H,4-9,17-22H2,1-3H3,(H,45,54)(H,46,57)(H,48,53,56)/t28-,29?/m0/s1",ZIHIUFZFPMILIG-XLTVJXRZSA-N
342,500,99,500,,O60885,BRD4 BD1,CRBN,6BNB,dBET57,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCNC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 BD1 assessed by EGFP/mCherry reporter assay,,,,,95/298,EC50 of BRD4 BD1/2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-018-0055-y,699.193,698.1826648,3.73,49,7,11,3,8,167.75,C34H31ClN8O5S,"InChI=1S/C34H31ClN8O5S/c1-16-17(2)49-34-27(16)29(19-7-9-20(35)10-8-19)38-23(30-41-40-18(3)42(30)34)15-26(45)37-14-13-36-22-6-4-5-21-28(22)33(48)43(32(21)47)24-11-12-25(44)39-31(24)46/h4-10,23-24,36H,11-15H2,1-3H3,(H,37,45)(H,39,44,46)/t23-,24?/m0/s1",CZRLOIDJCMKJHE-UXMRNZNESA-N
343,5,95,05 05,,O60885,BRD4,CRBN,6BN9,dBET70,COC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(SC(C(=O)NCCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C2C)N2C(C)=NN=C12,Degradation of BRD4 BD1/2 assessed by EGFP/mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-018-0055-y,827.364,826.2663944,6.03,58,7,13,3,15,194.05,C41H43ClN8O7S,"InChI=1S/C41H43ClN8O7S/c1-22-32-34(24-13-15-25(42)16-14-24)45-28(21-31(52)57-3)36-48-47-23(2)49(36)41(32)58-35(22)38(54)44-20-9-7-5-4-6-8-19-43-27-12-10-11-26-33(27)40(56)50(39(26)55)29-17-18-30(51)46-37(29)53/h10-16,28-29,43H,4-9,17-21H2,1-3H3,(H,44,54)(H,46,51,53)/t28-,29?/m0/s1",VDRKZYYQEGSLIS-XLTVJXRZSA-N
350,5,95,5,,O60885,BRD4 BD1,CRBN,,ZXH-3-26,COC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(SC(C(=O)NCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C2C)N2C(C)=NN=C12,Degradation of BRD4 BD1 assessed by EGFP/mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-018-0055-y,785.283,784.2194442,4.58,55,7,13,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-29-31(21-10-12-22(39)13-11-21)42-25(18-28(49)54-3)33-45-44-20(2)46(33)38(29)55-32(19)35(51)41-17-6-4-5-16-40-24-9-7-8-23-30(24)37(53)47(36(23)52)26-14-15-27(48)43-34(26)50/h7-13,25-26,40H,4-6,14-18H2,1-3H3,(H,41,51)(H,43,48,50)/t25-,26?/m0/s1",OTKOFICOCDRNDA-PMCHYTPCSA-N
363,0.2,95,0.5/1/0.2,>99/>95/>95,P10275,AR,VHL,,ARD-266,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(C#CC3=CC=C(C(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)CC2)C2=CC=CC=C2)C(C)C)=C1,Degradation of AR in LNCaP/VCaP/22Rv1 cells after 6 h treatment,90/>95/>99,% AR degradation in LNCaP cells after 6 h treatment at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,02�� 06��,Inhibit growth of LNCaP/VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01393,915.532,914.4133759,7.63,66,7,9,3,12,178.1,C52H59ClN6O7,"InChI=1S/C52H59ClN6O7/c1-31(2)45(43-25-32(3)57-66-43)48(64)59-30-38(60)26-42(59)47(63)55-41(35-11-9-8-10-12-35)28-44(61)58-23-21-34(22-24-58)14-13-33-15-17-36(18-16-33)46(62)56-49-51(4,5)50(52(49,6)7)65-39-20-19-37(29-54)40(53)27-39/h8-12,15-20,25,27,31,34,38,41-42,45,49-50,60H,21-24,26,28,30H2,1-7H3,(H,55,63)(H,56,62)/t38-,41+,42+,45-,49-,50-/m1/s1",RTNONCBKGZNCJS-LJLQSONVSA-N
379,1.1,95,1.1,,Q00534,CDK6,CRBN,,CP-5,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,847.934,847.3765575,1.91,62,8,16,4,15,230.16,C43H49N11O8,"InChI=1S/C43H49N11O8/c1-25-30-23-47-43(50-38(30)53(27-6-3-4-7-27)41(60)36(25)26(2)55)48-33-12-10-28(22-46-33)52-18-16-51(17-19-52)24-35(57)45-15-21-62-20-14-44-31-9-5-8-29-37(31)42(61)54(40(29)59)32-11-13-34(56)49-39(32)58/h5,8-10,12,22-23,27,32,44H,3-4,6-7,11,13-21,24H2,1-2H3,(H,45,57)(H,49,56,58)(H,46,47,48,50)",UWSFJIBFTAHYOI-UHFFFAOYSA-N
379,,,>100,,P11802,CDK4,CRBN,,CP-5,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,847.934,847.3765575,1.91,62,8,16,4,15,230.16,C43H49N11O8,"InChI=1S/C43H49N11O8/c1-25-30-23-47-43(50-38(30)53(27-6-3-4-7-27)41(60)36(25)26(2)55)48-33-12-10-28(22-46-33)52-18-16-51(17-19-52)24-35(57)45-15-21-62-20-14-44-31-9-5-8-29-37(31)42(61)54(40(29)59)32-11-13-34(56)49-39(32)58/h5,8-10,12,22-23,27,32,44H,3-4,6-7,11,13-21,24H2,1-2H3,(H,45,57)(H,49,56,58)(H,46,47,48,50)",UWSFJIBFTAHYOI-UHFFFAOYSA-N
380,24.2,95,24.2,,Q00534,CDK6,CRBN,,CP-6,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,891.987,891.4027723,1.77,65,8,17,4,18,239.39,C45H53N11O9,"InChI=1S/C45H53N11O9/c1-27-32-25-49-45(52-40(32)55(29-6-3-4-7-29)43(62)38(27)28(2)57)50-35-12-10-30(24-48-35)54-18-16-53(17-19-54)26-37(59)47-15-21-65-23-22-64-20-14-46-33-9-5-8-31-39(33)44(63)56(42(31)61)34-11-13-36(58)51-41(34)60/h5,8-10,12,24-25,29,34,46H,3-4,6-7,11,13-23,26H2,1-2H3,(H,47,59)(H,51,58,60)(H,48,49,50,52)",SVMNWGPZVPEEIA-UHFFFAOYSA-N
380,,,>100,,P11802,CDK4,CRBN,,CP-6,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,891.987,891.4027723,1.77,65,8,17,4,18,239.39,C45H53N11O9,"InChI=1S/C45H53N11O9/c1-27-32-25-49-45(52-40(32)55(29-6-3-4-7-29)43(62)38(27)28(2)57)50-35-12-10-30(24-48-35)54-18-16-53(17-19-54)26-37(59)47-15-21-65-23-22-64-20-14-46-33-9-5-8-31-39(33)44(63)56(42(31)61)34-11-13-36(58)51-41(34)60/h5,8-10,12,24-25,29,34,46H,3-4,6-7,11,13-23,26H2,1-2H3,(H,47,59)(H,51,58,60)(H,48,49,50,52)",SVMNWGPZVPEEIA-UHFFFAOYSA-N
381,31,95,31,,Q00534,CDK6,CRBN,,CP-8,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,980.093,979.4552018,1.47,71,8,19,4,24,257.85,C49H61N11O11,"InChI=1S/C49H61N11O11/c1-31-36-29-53-49(56-44(36)59(33-6-3-4-7-33)47(66)42(31)32(2)61)54-39-12-10-34(28-52-39)58-18-16-57(17-19-58)30-41(63)51-15-21-69-23-25-71-27-26-70-24-22-68-20-14-50-37-9-5-8-35-43(37)48(67)60(46(35)65)38-11-13-40(62)55-45(38)64/h5,8-10,12,28-29,33,38,50H,3-4,6-7,11,13-27,30H2,1-2H3,(H,51,63)(H,55,62,64)(H,52,53,54,56)",VRUSWNHAEFVIGX-UHFFFAOYSA-N
381,,,>100,,P11802,CDK4,CRBN,,CP-8,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,980.093,979.4552018,1.47,71,8,19,4,24,257.85,C49H61N11O11,"InChI=1S/C49H61N11O11/c1-31-36-29-53-49(56-44(36)59(33-6-3-4-7-33)47(66)42(31)32(2)61)54-39-12-10-34(28-52-39)58-18-16-57(17-19-58)30-41(63)51-15-21-69-23-25-71-27-26-70-24-22-68-20-14-50-37-9-5-8-35-43(37)48(67)60(46(35)65)38-11-13-40(62)55-45(38)64/h5,8-10,12,28-29,33,38,50H,3-4,6-7,11,13-27,30H2,1-2H3,(H,51,63)(H,55,62,64)(H,52,53,54,56)",VRUSWNHAEFVIGX-UHFFFAOYSA-N
382,2.1,95,2.1,,Q00534,CDK6,CRBN,,CP-10,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCOCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,262,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10�� 08��,Inhibit proliferation of MM.1S/Mino cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,871.96,871.3877909,1.8,64,9,18,3,15,231.77,C44H49N13O7,"InChI=1S/C44H49N13O7/c1-26-32-23-47-44(50-39(32)56(29-6-3-4-7-29)42(62)37(26)27(2)58)48-35-12-10-30(22-46-35)54-17-15-53(16-18-54)24-28-25-55(52-51-28)19-21-64-20-14-45-33-9-5-8-31-38(33)43(63)57(41(31)61)34-11-13-36(59)49-40(34)60/h5,8-10,12,22-23,25,29,34,45H,3-4,6-7,11,13-21,24H2,1-2H3,(H,49,59,60)(H,46,47,48,50)",PACRWHUPEPCFHX-UHFFFAOYSA-N
382,,,>100,,P11802,CDK4,CRBN,,CP-10,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCOCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,30,Inhibition of CDK4-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10�� 08��,Inhibit proliferation of MM.1S/Mino cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,871.96,871.3877909,1.8,64,9,18,3,15,231.77,C44H49N13O7,"InChI=1S/C44H49N13O7/c1-26-32-23-47-44(50-39(32)56(29-6-3-4-7-29)42(62)37(26)27(2)58)48-35-12-10-30(22-46-35)54-17-15-53(16-18-54)24-28-25-55(52-51-28)19-21-64-20-14-45-33-9-5-8-31-38(33)43(63)57(41(31)61)34-11-13-36(59)49-40(34)60/h5,8-10,12,22-23,25,29,34,45H,3-4,6-7,11,13-21,24H2,1-2H3,(H,49,59,60)(H,46,47,48,50)",PACRWHUPEPCFHX-UHFFFAOYSA-N
384,5.3,95,5.3,,Q00534,CDK6,CRBN,,CP-13,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,869.988,869.4085264,3.02,64,9,17,3,15,222.54,C45H51N13O6,"InChI=1S/C45H51N13O6/c1-27-33-24-48-45(51-40(33)57(30-9-4-5-10-30)43(63)38(27)28(2)59)49-36-15-13-31(23-47-36)55-21-19-54(20-22-55)25-29-26-56(53-52-29)18-7-3-6-17-46-34-12-8-11-32-39(34)44(64)58(42(32)62)35-14-16-37(60)50-41(35)61/h8,11-13,15,23-24,26,30,35,46H,3-7,9-10,14,16-22,25H2,1-2H3,(H,50,60,61)(H,47,48,49,51)",PEBAOKOWNDTABR-UHFFFAOYSA-N
384,,,>100,,P11802,CDK4,CRBN,,CP-13,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,869.988,869.4085264,3.02,64,9,17,3,15,222.54,C45H51N13O6,"InChI=1S/C45H51N13O6/c1-27-33-24-48-45(51-40(33)57(30-9-4-5-10-30)43(63)38(27)28(2)59)49-36-15-13-31(23-47-36)55-21-19-54(20-22-55)25-29-26-56(53-52-29)18-7-3-6-17-46-34-12-8-11-32-39(34)44(64)58(42(32)62)35-14-16-37(60)50-41(35)61/h8,11-13,15,23-24,26,30,35,46H,3-7,9-10,14,16-22,25H2,1-2H3,(H,50,60,61)(H,47,48,49,51)",PEBAOKOWNDTABR-UHFFFAOYSA-N
385,10.6,95,10.6,,Q00534,CDK6,CRBN,,CP-14,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,884.015,883.4241764,3.38,65,9,17,3,16,222.54,C46H53N13O6,"InChI=1S/C46H53N13O6/c1-28-34-25-49-46(52-41(34)58(31-10-5-6-11-31)44(64)39(28)29(2)60)50-37-16-14-32(24-48-37)56-22-20-55(21-23-56)26-30-27-57(54-53-30)19-8-4-3-7-18-47-35-13-9-12-33-40(35)45(65)59(43(33)63)36-15-17-38(61)51-42(36)62/h9,12-14,16,24-25,27,31,36,47H,3-8,10-11,15,17-23,26H2,1-2H3,(H,51,61,62)(H,48,49,50,52)",VQBSDHOKKXEKJO-UHFFFAOYSA-N
385,,,>100,,P11802,CDK4,CRBN,,CP-14,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,884.015,883.4241764,3.38,65,9,17,3,16,222.54,C46H53N13O6,"InChI=1S/C46H53N13O6/c1-28-34-25-49-46(52-41(34)58(31-10-5-6-11-31)44(64)39(28)29(2)60)50-37-16-14-32(24-48-37)56-22-20-55(21-23-56)26-30-27-57(54-53-30)19-8-4-3-7-18-47-35-13-9-12-33-40(35)45(65)59(43(33)63)36-15-17-38(61)51-42(36)62/h9,12-14,16,24-25,27,31,36,47H,3-8,10-11,15,17-23,26H2,1-2H3,(H,51,61,62)(H,48,49,50,52)",VQBSDHOKKXEKJO-UHFFFAOYSA-N
386,1.6,95,1.6,,Q00534,CDK6,CRBN,,CP-15,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,834.935,834.3813086,2.42,61,8,16,3,16,210.29,C43H50N10O8,"InChI=1S/C43H50N10O8/c1-26-31-25-46-43(49-38(31)52(28-6-3-4-7-28)41(58)36(26)27(2)54)47-34-12-10-29(24-45-34)51-17-15-50(16-18-51)19-21-61-23-22-60-20-14-44-32-9-5-8-30-37(32)42(59)53(40(30)57)33-11-13-35(55)48-39(33)56/h5,8-10,12,24-25,28,33,44H,3-4,6-7,11,13-23H2,1-2H3,(H,48,55,56)(H,45,46,47,49)",PKIMSAWOOAAVNA-UHFFFAOYSA-N
386,,,>50,,P11802,CDK4,CRBN,,CP-15,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,834.935,834.3813086,2.42,61,8,16,3,16,210.29,C43H50N10O8,"InChI=1S/C43H50N10O8/c1-26-31-25-46-43(49-38(31)52(28-6-3-4-7-28)41(58)36(26)27(2)54)47-34-12-10-29(24-45-34)51-17-15-50(16-18-51)19-21-61-23-22-60-20-14-44-32-9-5-8-30-37(32)42(59)53(40(30)57)33-11-13-35(55)48-39(33)56/h5,8-10,12,24-25,28,33,44H,3-4,6-7,11,13-23H2,1-2H3,(H,48,55,56)(H,45,46,47,49)",PKIMSAWOOAAVNA-UHFFFAOYSA-N
387,1.7,95,1.7,,Q00534,CDK6,CRBN,,CP-16,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCCC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,855.017,854.4340128,3.52,63,9,15,2,15,193.44,C46H54N12O5,"InChI=1S/C46H54N12O5/c1-29-36-25-48-46(51-42(36)58(33-12-6-7-13-33)45(63)41(29)30(2)59)49-39-17-15-34(24-47-39)55-22-20-54(21-23-55)26-32-27-56(53-52-32)19-8-4-3-5-10-31-11-9-14-35-37(31)28-57(44(35)62)38-16-18-40(60)50-43(38)61/h9,11,14-15,17,24-25,27,33,38H,3-8,10,12-13,16,18-23,26,28H2,1-2H3,(H,50,60,61)(H,47,48,49,51)",YOIMKMXYGWEBJZ-UHFFFAOYSA-N
387,,,>50,,P11802,CDK4,CRBN,,CP-16,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCCC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,855.017,854.4340128,3.52,63,9,15,2,15,193.44,C46H54N12O5,"InChI=1S/C46H54N12O5/c1-29-36-25-48-46(51-42(36)58(33-12-6-7-13-33)45(63)41(29)30(2)59)49-39-17-15-34(24-47-39)55-22-20-54(21-23-55)26-32-27-56(53-52-32)19-8-4-3-5-10-31-11-9-14-35-37(31)28-57(44(35)62)38-16-18-40(60)50-43(38)61/h9,11,14-15,17,24-25,27,33,38H,3-8,10,12-13,16,18-23,26,28H2,1-2H3,(H,50,60,61)(H,47,48,49,51)",YOIMKMXYGWEBJZ-UHFFFAOYSA-N
392,81.6,99,81.6,,Q00534,CDK6,CRBN,,CP-21,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,864.968,864.3819773,2.78,64,9,16,2,12,210.51,C46H48N12O6,"InChI=1S/C46H48N12O6/c1-28-35-25-48-46(51-41(35)57(32-12-6-7-13-32)44(63)39(28)29(2)59)49-37-17-15-33(24-47-37)55-22-20-54(21-23-55)26-31-27-56(53-52-31)19-8-4-3-5-10-30-11-9-14-34-40(30)45(64)58(43(34)62)36-16-18-38(60)50-42(36)61/h9,11,14-15,17,24-25,27,32,36H,3-4,6-8,12-13,16,18-23,26H2,1-2H3,(H,50,60,61)(H,47,48,49,51)",AWGBHEYLROEJQR-UHFFFAOYSA-N
392,,,>100,,P11802,CDK4,CRBN,,CP-21,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,864.968,864.3819773,2.78,64,9,16,2,12,210.51,C46H48N12O6,"InChI=1S/C46H48N12O6/c1-28-35-25-48-46(51-41(35)57(32-12-6-7-13-32)44(63)39(28)29(2)59)49-37-17-15-33(24-47-37)55-22-20-54(21-23-55)26-31-27-56(53-52-31)19-8-4-3-5-10-30-11-9-14-34-40(30)45(64)58(43(34)62)36-16-18-38(60)50-42(36)61/h9,11,14-15,17,24-25,27,32,36H,3-4,6-8,12-13,16,18-23,26H2,1-2H3,(H,50,60,61)(H,47,48,49,51)",AWGBHEYLROEJQR-UHFFFAOYSA-N
393,86.8,99,86.8,,Q00534,CDK6,CRBN,,CP-22,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,878.995,878.3976273,3.32,65,9,16,2,13,210.51,C47H50N12O6,"InChI=1S/C47H50N12O6/c1-29-36-26-49-47(52-42(36)58(33-13-7-8-14-33)45(64)40(29)30(2)60)50-38-18-16-34(25-48-38)56-23-21-55(22-24-56)27-32-28-57(54-53-32)20-9-5-3-4-6-11-31-12-10-15-35-41(31)46(65)59(44(35)63)37-17-19-39(61)51-43(37)62/h10,12,15-16,18,25-26,28,33,37H,3-5,7-9,13-14,17,19-24,27H2,1-2H3,(H,51,61,62)(H,48,49,50,52)",GNAMPLNFELXMIO-UHFFFAOYSA-N
393,,,>100,,P11802,CDK4,CRBN,,CP-22,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,878.995,878.3976273,3.32,65,9,16,2,13,210.51,C47H50N12O6,"InChI=1S/C47H50N12O6/c1-29-36-26-49-47(52-42(36)58(33-13-7-8-14-33)45(64)40(29)30(2)60)50-38-18-16-34(25-48-38)56-23-21-55(22-24-56)27-32-28-57(54-53-32)20-9-5-3-4-6-11-31-12-10-15-35-41(31)46(65)59(44(35)63)37-17-19-39(61)51-43(37)62/h10,12,15-16,18,25-26,28,33,37H,3-5,7-9,13-14,17,19-24,27H2,1-2H3,(H,51,61,62)(H,48,49,50,52)",GNAMPLNFELXMIO-UHFFFAOYSA-N
394,8.6,99,8.6,,Q00534,CDK6,CRBN,,CP-A1,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,902.968,902.3900171,2.99,66,9,17,3,16,210.52,C45H48F2N14O5,"InChI=1S/C45H48F2N14O5/c1-26(2)60-27(3)51-41-32(46)19-29(20-36(41)60)40-33(47)22-50-45(54-40)52-37-9-7-28(21-49-37)23-57-12-14-58(15-13-57)24-30-25-59(56-55-30)16-18-66-17-11-48-34-6-4-5-31-39(34)44(65)61(43(31)64)35-8-10-38(62)53-42(35)63/h4-7,9,19-22,25-26,35,48H,8,10-18,23-24H2,1-3H3,(H,53,62,63)(H,49,50,52,54)",HYZNVNZFNOPQLO-UHFFFAOYSA-N
394,,,>500,,P11802,CDK4,CRBN,,CP-A1,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,902.968,902.3900171,2.99,66,9,17,3,16,210.52,C45H48F2N14O5,"InChI=1S/C45H48F2N14O5/c1-26(2)60-27(3)51-41-32(46)19-29(20-36(41)60)40-33(47)22-50-45(54-40)52-37-9-7-28(21-49-37)23-57-12-14-58(15-13-57)24-30-25-59(56-55-30)16-18-66-17-11-48-34-6-4-5-31-39(34)44(65)61(43(31)64)35-8-10-38(62)53-42(35)63/h4-7,9,19-22,25-26,35,48H,8,10-18,23-24H2,1-3H3,(H,53,62,63)(H,49,50,52,54)",HYZNVNZFNOPQLO-UHFFFAOYSA-N
395,129.7,99,129.7,,Q00534,CDK6,CRBN,,CP-A2,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,947.021,946.4162318,2.84,69,9,18,3,19,219.75,C47H52F2N14O6,"InChI=1S/C47H52F2N14O6/c1-28(2)62-29(3)53-43-34(48)21-31(22-38(43)62)42-35(49)24-52-47(56-42)54-39-9-7-30(23-51-39)25-59-12-14-60(15-13-59)26-32-27-61(58-57-32)16-18-69-20-19-68-17-11-50-36-6-4-5-33-41(36)46(67)63(45(33)66)37-8-10-40(64)55-44(37)65/h4-7,9,21-24,27-28,37,50H,8,10-20,25-26H2,1-3H3,(H,55,64,65)(H,51,52,54,56)",MMXACPGYKXVBCK-UHFFFAOYSA-N
395,,,>500,,P11802,CDK4,CRBN,,CP-A2,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,947.021,946.4162318,2.84,69,9,18,3,19,219.75,C47H52F2N14O6,"InChI=1S/C47H52F2N14O6/c1-28(2)62-29(3)53-43-34(48)21-31(22-38(43)62)42-35(49)24-52-47(56-42)54-39-9-7-30(23-51-39)25-59-12-14-60(15-13-59)26-32-27-61(58-57-32)16-18-69-20-19-68-17-11-50-36-6-4-5-33-41(36)46(67)63(45(33)66)37-8-10-40(64)55-44(37)65/h4-7,9,21-24,27-28,37,50H,8,10-20,25-26H2,1-3H3,(H,55,64,65)(H,51,52,54,56)",MMXACPGYKXVBCK-UHFFFAOYSA-N
396,271.9,99,271.9,,Q00534,CDK6,CRBN,,CP-A3,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCOCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,991.074,990.4424466,2.69,72,9,19,3,22,228.98,C49H56F2N14O7,"InChI=1S/C49H56F2N14O7/c1-30(2)64-31(3)55-45-36(50)23-33(24-40(45)64)44-37(51)26-54-49(58-44)56-41-9-7-32(25-53-41)27-61-12-14-62(15-13-61)28-34-29-63(60-59-34)16-18-71-20-22-72-21-19-70-17-11-52-38-6-4-5-35-43(38)48(69)65(47(35)68)39-8-10-42(66)57-46(39)67/h4-7,9,23-26,29-30,39,52H,8,10-22,27-28H2,1-3H3,(H,57,66,67)(H,53,54,56,58)",ODKBPNWNYDPLSX-UHFFFAOYSA-N
396,,,>500,,P11802,CDK4,CRBN,,CP-A3,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCOCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,991.074,990.4424466,2.69,72,9,19,3,22,228.98,C49H56F2N14O7,"InChI=1S/C49H56F2N14O7/c1-30(2)64-31(3)55-45-36(50)23-33(24-40(45)64)44-37(51)26-54-49(58-44)56-41-9-7-32(25-53-41)27-61-12-14-62(15-13-61)28-34-29-63(60-59-34)16-18-71-20-22-72-21-19-70-17-11-52-38-6-4-5-35-43(38)48(69)65(47(35)68)39-8-10-42(66)57-46(39)67/h4-7,9,23-26,29-30,39,52H,8,10-22,27-28H2,1-3H3,(H,57,66,67)(H,53,54,56,58)",ODKBPNWNYDPLSX-UHFFFAOYSA-N
397,145.5,99,145.5,,Q00534,CDK6,CRBN,,CP-A4,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCOCCOCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK6 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,1035.127,1034.468661,2.55,75,9,20,3,25,238.21,C51H60F2N14O8,"InChI=1S/C51H60F2N14O8/c1-32(2)66-33(3)57-47-38(52)25-35(26-42(47)66)46-39(53)28-56-51(60-46)58-43-9-7-34(27-55-43)29-63-12-14-64(15-13-63)30-36-31-65(62-61-36)16-18-73-20-22-75-24-23-74-21-19-72-17-11-54-40-6-4-5-37-45(40)50(71)67(49(37)70)41-8-10-44(68)59-48(41)69/h4-7,9,25-28,31-32,41,54H,8,10-24,29-30H2,1-3H3,(H,59,68,69)(H,55,56,58,60)",SXHHVSLMICYDHT-UHFFFAOYSA-N
397,,,>500,,P11802,CDK4,CRBN,,CP-A4,CC1=NC2=C(F)C=C(C3=NC(NC4=CC=C(CN5CCN(CC6=CN(CCOCCOCCOCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)C=N4)=NC=C3F)C=C2N1C(C)C,Degradation of CDK4 in U251 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00871,1035.127,1034.468661,2.55,75,9,20,3,25,238.21,C51H60F2N14O8,"InChI=1S/C51H60F2N14O8/c1-32(2)66-33(3)57-47-38(52)25-35(26-42(47)66)46-39(53)28-56-51(60-46)58-43-9-7-34(27-55-43)29-63-12-14-64(15-13-63)30-36-31-65(62-61-36)16-18-73-20-22-75-24-23-74-21-19-72-17-11-54-40-6-4-5-37-45(40)50(71)67(49(37)70)41-8-10-44(68)59-48(41)69/h4-7,9,25-28,31-32,41,54H,8,10-24,29-30H2,1-3H3,(H,59,68,69)(H,55,56,58,60)",SXHHVSLMICYDHT-UHFFFAOYSA-N
464,10.1,99,10.1,,,BCR-ABL,VHL,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14.3,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01264,1040.758,1039.432749,8.56,72,7,14,5,20,214.98,C52H66ClN11O6S2,"InChI=1S/C52H66ClN11O6S2/c1-32-14-13-15-38(53)45(32)61-49(69)40-29-55-51(72-40)59-41-27-42(58-34(3)57-41)62-22-24-63(25-23-62)44(67)17-12-10-8-7-9-11-16-43(66)60-47(52(4,5)6)50(70)64-30-37(65)26-39(64)48(68)54-28-35-18-20-36(21-19-35)46-33(2)56-31-71-46/h13-15,18-21,27,29,31,37,39,47,65H,7-12,16-17,22-26,28,30H2,1-6H3,(H,54,68)(H,60,66)(H,61,69)(H,55,57,58,59)/t37-,39+,47-/m1/s1",WATFMEVRKAKIPO-PHQHQIPESA-N
465,37.9,99,37.9,,,BCR-ABL,VHL,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22.4,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01264,1026.731,1025.417098,8.02,71,7,14,5,19,214.98,C51H64ClN11O6S2,"InChI=1S/C51H64ClN11O6S2/c1-31-13-12-14-37(52)44(31)60-48(68)39-28-54-50(71-39)58-40-26-41(57-33(3)56-40)61-21-23-62(24-22-61)43(66)16-11-9-7-8-10-15-42(65)59-46(51(4,5)6)49(69)63-29-36(64)25-38(63)47(67)53-27-34-17-19-35(20-18-34)45-32(2)55-30-70-45/h12-14,17-20,26,28,30,36,38,46,64H,7-11,15-16,21-25,27,29H2,1-6H3,(H,53,67)(H,59,65)(H,60,68)(H,54,56,57,58)/t36-,38+,46-/m1/s1",JHGSGIUENJDREJ-TZAPCMPKSA-N
466,8.5,99,8.5,,,BCR-ABL,VHL,,SIAIS178,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,0.35/0.14,Kd of non-phosphorylated/phosphorylated c-ABL was tested using the KinomeScan platform,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24,Inhibit growth of K562 cells,,,,,,,,,,,0.02,Compounds were administered at 10000 nM and incubated for 2 h,0.07,Compounds were administered at 10000 nM and incubated for 2 h,10.1021/acs.jmedchem.9b01264,1012.704,1011.401448,7.48,70,7,14,5,18,214.98,C50H62ClN11O6S2,"InChI=1S/C50H62ClN11O6S2/c1-30-12-11-13-36(51)43(30)59-47(67)38-27-53-49(70-38)57-39-25-40(56-32(3)55-39)60-20-22-61(23-21-60)42(65)15-10-8-7-9-14-41(64)58-45(50(4,5)6)48(68)62-28-35(63)24-37(62)46(66)52-26-33-16-18-34(19-17-33)44-31(2)54-29-69-44/h11-13,16-19,25,27,29,35,37,45,63H,7-10,14-15,20-24,26,28H2,1-6H3,(H,52,66)(H,58,64)(H,59,67)(H,53,55,56,57)/t35-,37+,45-/m1/s1",YGQREOJIRFCRKQ-ZIBKGDFVSA-N
467,17.9,99,17.9,,,BCR-ABL,VHL,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37.6,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01264,998.677,997.3857983,6.94,69,7,14,5,17,214.98,C49H60ClN11O6S2,"InChI=1S/C49H60ClN11O6S2/c1-29-11-10-12-35(50)42(29)58-46(66)37-26-52-48(69-37)56-38-24-39(55-31(3)54-38)59-19-21-60(22-20-59)41(64)14-9-7-8-13-40(63)57-44(49(4,5)6)47(67)61-27-34(62)23-36(61)45(65)51-25-32-15-17-33(18-16-32)43-30(2)53-28-68-43/h10-12,15-18,24,26,28,34,36,44,62H,7-9,13-14,19-23,25,27H2,1-6H3,(H,51,65)(H,57,63)(H,58,66)(H,52,54,55,56)/t34-,36+,44-/m1/s1",VOJOCZVLPUNKIS-GUXJVCHGSA-N
468,34.7,99,34.7,,,BCR-ABL,VHL,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01264,984.65,983.3701483,6.4,68,7,14,5,16,214.98,C48H58ClN11O6S2,"InChI=1S/C48H58ClN11O6S2/c1-28-10-9-11-34(49)41(28)57-45(65)36-25-51-47(68-36)55-37-23-38(54-30(3)53-37)58-18-20-59(21-19-58)40(63)13-8-7-12-39(62)56-43(48(4,5)6)46(66)60-26-33(61)22-35(60)44(64)50-24-31-14-16-32(17-15-31)42-29(2)52-27-67-42/h9-11,14-17,23,25,27,33,35,43,61H,7-8,12-13,18-22,24,26H2,1-6H3,(H,50,64)(H,56,62)(H,57,65)(H,51,53,54,55)/t33-,35+,43-/m1/s1",VWQBGMDEQXASJE-MXYPERTFSA-N
469,40.2,99,40.2,,,BCR-ABL,VHL,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01264,970.623,969.3544982,6.04,67,7,14,5,15,214.98,C47H56ClN11O6S2,"InChI=1S/C47H56ClN11O6S2/c1-27-9-7-10-33(48)40(27)56-44(64)35-24-50-46(67-35)54-36-22-37(53-29(3)52-36)57-17-19-58(20-18-57)39(62)12-8-11-38(61)55-42(47(4,5)6)45(65)59-25-32(60)21-34(59)43(63)49-23-30-13-15-31(16-14-30)41-28(2)51-26-66-41/h7,9-10,13-16,22,24,26,32,34,42,60H,8,11-12,17-21,23,25H2,1-6H3,(H,49,63)(H,55,61)(H,56,64)(H,50,52,53,54)/t32-,34+,42-/m1/s1",GBRSKPWVXGJTRM-SYVXFDQESA-N
470,611.4,99,611.4,,,BCR-ABL,VHL,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,78,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01264,956.596,955.3388481,5.68,66,7,14,5,14,214.98,C46H54ClN11O6S2,"InChI=1S/C46H54ClN11O6S2/c1-26-8-7-9-32(47)39(26)55-43(63)34-23-49-45(66-34)53-35-21-36(52-28(3)51-35)56-16-18-57(19-17-56)38(61)15-14-37(60)54-41(46(4,5)6)44(64)58-24-31(59)20-33(58)42(62)48-22-29-10-12-30(13-11-29)40-27(2)50-25-65-40/h7-13,21,23,25,31,33,41,59H,14-20,22,24H2,1-6H3,(H,48,62)(H,54,60)(H,55,63)(H,49,51,52,53)/t31-,33+,41-/m1/s1",BAMNKVFIYWQPKH-VYLGKBOWSA-N
475,2630,99,2630,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,950,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1130.112,1129.391061,2.17,81,9,10,8,17,310.81,C57H58F2N9O12P,"InChI=1S/C57H58F2N9O12P/c58-57(59,81(78,79)80)37-19-21-41-36(29-37)30-43(61-41)52(73)63-44-32-66(49(71)18-9-3-4-11-33-16-10-17-39-40(33)31-67(55(39)76)45-24-26-48(70)64-53(45)74)28-27-38-20-23-46(68(38)56(44)77)54(75)62-42(22-25-47(60)69)51(72)65-50(34-12-5-1-6-13-34)35-14-7-2-8-15-35/h1-2,5-8,10,12-17,19,21,29-30,38,42,44-46,50,61H,3,9,18,20,22-28,31-32H2,(H2,60,69)(H,62,75)(H,63,73)(H,65,72)(H,64,70,74)(H2,78,79,80)/t38-,42+,44+,45?,46+/m1/s1",JUVLSKPPPVWKIB-RZJNVLOKSA-N
476,260,99,260,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,78,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1144.139,1143.406711,2.71,82,9,10,8,18,310.81,C58H60F2N9O12P,"InChI=1S/C58H60F2N9O12P/c59-58(60,82(79,80)81)38-20-22-42-37(30-38)31-44(62-42)53(74)64-45-33-67(50(72)19-10-2-1-5-12-34-17-11-18-40-41(34)32-68(56(40)77)46-25-27-49(71)65-54(46)75)29-28-39-21-24-47(69(39)57(45)78)55(76)63-43(23-26-48(61)70)52(73)66-51(35-13-6-3-7-14-35)36-15-8-4-9-16-36/h3-4,6-9,11,13-18,20,22,30-31,39,43,45-47,51,62H,1-2,10,19,21,23-29,32-33H2,(H2,61,70)(H,63,76)(H,64,74)(H,66,73)(H,65,71,75)(H2,79,80,81)/t39-,43+,45+,46?,47+/m1/s1",BDYQRBRHLWXHSV-ALXJROBFSA-N
477,28,99,60/28,,P40763,STAT3,CRBN,,SD-36,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13/610,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1158.166,1157.422361,3.25,83,9,10,8,19,310.81,C59H62F2N9O12P,"InChI=1S/C59H62F2N9O12P/c60-59(61,83(80,81)82)39-21-23-43-38(31-39)32-45(63-43)54(75)65-46-34-68(51(73)20-11-3-1-2-6-13-35-18-12-19-41-42(35)33-69(57(41)78)47-26-28-50(72)66-55(47)76)30-29-40-22-25-48(70(40)58(46)79)56(77)64-44(24-27-49(62)71)53(74)67-52(36-14-7-4-8-15-36)37-16-9-5-10-17-37/h4-5,7-10,12,14-19,21,23,31-32,40,44,46-48,52,63H,1-3,11,20,22,24-30,33-34H2,(H2,62,71)(H,64,77)(H,65,75)(H,67,74)(H,66,72,76)(H2,80,81,82)/t40-,44+,46+,47?,48+/m1/s1",JKCSCHXVWPSGBG-OPKPGBGESA-N
478,90,99,90,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1172.193,1171.438012,3.8,84,9,10,8,20,310.81,C60H64F2N9O12P,"InChI=1S/C60H64F2N9O12P/c61-60(62,84(81,82)83)40-22-24-44-39(32-40)33-46(64-44)55(76)66-47-35-69(52(74)21-12-4-2-1-3-7-14-36-19-13-20-42-43(36)34-70(58(42)79)48-27-29-51(73)67-56(48)77)31-30-41-23-26-49(71(41)59(47)80)57(78)65-45(25-28-50(63)72)54(75)68-53(37-15-8-5-9-16-37)38-17-10-6-11-18-38/h5-6,8-11,13,15-20,22,24,32-33,41,45,47-49,53,64H,1-4,12,21,23,25-31,34-35H2,(H2,63,72)(H,65,78)(H,66,76)(H,68,75)(H,67,73,77)(H2,81,82,83)/t41-,45+,47+,48?,49+/m1/s1",PSOLZBBCSLPKNE-MCIGMSQYSA-N
479,150,99,150,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1200.247,1199.469312,4.88,86,9,10,8,22,310.81,C62H68F2N9O12P,"InChI=1S/C62H68F2N9O12P/c63-62(64,86(83,84)85)42-24-26-46-41(34-42)35-48(66-46)57(78)68-49-37-71(54(76)23-14-6-4-2-1-3-5-9-16-38-21-15-22-44-45(38)36-72(60(44)81)50-29-31-53(75)69-58(50)79)33-32-43-25-28-51(73(43)61(49)82)59(80)67-47(27-30-52(65)74)56(77)70-55(39-17-10-7-11-18-39)40-19-12-8-13-20-40/h7-8,10-13,15,17-22,24,26,34-35,43,47,49-51,55,66H,1-6,14,23,25,27-33,36-37H2,(H2,65,74)(H,67,80)(H,68,78)(H,70,77)(H,69,75,79)(H2,83,84,85)/t43-,47+,49+,50?,51+/m1/s1",MSFCNZZBAJYPCP-AACVIFBVSA-N
480,659,99,650/919,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(CCCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,147/>100000,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1144.183,1143.443097,1.94,82,9,10,8,20,293.74,C59H64F2N9O11P,"InChI=1S/C59H64F2N9O11P/c60-59(61,82(79,80)81)40-21-23-44-39(32-40)33-46(63-44)54(74)65-47-35-68(30-12-4-2-1-3-7-14-36-19-13-20-42-43(36)34-69(57(42)77)48-26-28-51(72)66-55(48)75)31-29-41-22-25-49(70(41)58(47)78)56(76)64-45(24-27-50(62)71)53(73)67-52(37-15-8-5-9-16-37)38-17-10-6-11-18-38/h5-6,8-11,13,15-21,23,32-33,41,45,47-49,52,63H,1-4,12,22,24-31,34-35H2,(H2,62,71)(H,64,76)(H,65,74)(H,67,73)(H,66,72,75)(H2,79,80,81)/t41-,45+,47+,48?,49+/m1/s1",STTINLOVDTUWIQ-MCIGMSQYSA-N
481,49,99,240/49,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)OCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,128/2370,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1160.138,1159.401626,3,83,9,11,8,18,320.04,C58H60F2N9O13P,"InChI=1S/C58H60F2N9O13P/c59-58(60,83(79,80)81)38-19-21-42-37(30-38)31-44(62-42)52(73)64-45-33-67(57(78)82-29-10-2-1-5-12-34-17-11-18-40-41(34)32-68(55(40)76)46-24-26-49(71)65-53(46)74)28-27-39-20-23-47(69(39)56(45)77)54(75)63-43(22-25-48(61)70)51(72)66-50(35-13-6-3-7-14-35)36-15-8-4-9-16-36/h3-4,6-9,11,13-19,21,30-31,39,43,45-47,50,62H,1-2,10,20,22-29,32-33H2,(H2,61,70)(H,63,75)(H,64,73)(H,66,72)(H,65,71,74)(H2,79,80,81)/t39-,43+,45+,46?,47+/m1/s1",AYDCOOQDCPYUIU-ALXJROBFSA-N
482,50,99,18568,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)NCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91/430,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1159.154,1158.41761,2.42,83,9,10,9,18,322.84,C58H61F2N10O12P,"InChI=1S/C58H61F2N10O12P/c59-58(60,83(80,81)82)38-19-21-42-37(30-38)31-44(63-42)52(74)65-45-33-68(57(79)62-28-10-2-1-5-12-34-17-11-18-40-41(34)32-69(55(40)77)46-24-26-49(72)66-53(46)75)29-27-39-20-23-47(70(39)56(45)78)54(76)64-43(22-25-48(61)71)51(73)67-50(35-13-6-3-7-14-35)36-15-8-4-9-16-36/h3-4,6-9,11,13-19,21,30-31,39,43,45-47,50,63H,1-2,10,20,22-29,32-33H2,(H2,61,71)(H,62,79)(H,64,76)(H,65,74)(H,67,73)(H,66,72,75)(H2,80,81,82)/t39-,43+,45+,46?,47+/m1/s1",ZNTHSJGRFSTPKW-ALXJROBFSA-N
483,180,99,180,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)C3=CN(CCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=C3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,241,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1196.175,1195.412859,2.14,86,10,12,8,18,328.63,C60H60F2N11O12P,"InChI=1S/C60H60F2N11O12P/c61-60(62,86(83,84)85)40-18-20-44-38(29-40)30-46(65-44)54(77)67-47-34-70(57(80)39-31-64-71(32-39)27-9-3-8-11-35-16-10-17-42-43(35)33-72(58(42)81)48-23-25-51(75)68-55(48)78)28-26-41-19-22-49(73(41)59(47)82)56(79)66-45(21-24-50(63)74)53(76)69-52(36-12-4-1-5-13-36)37-14-6-2-7-15-37/h1-2,4-7,10,12-18,20,29-32,41,45,47-49,52,65H,3,9,19,21-28,33-34H2,(H2,63,74)(H,66,79)(H,67,77)(H,69,76)(H,68,75,78)(H2,83,84,85)/t41-,45+,47+,48?,49+/m1/s1",GRFIIYLYEIAGDZ-MCIGMSQYSA-N
484,250,99,250,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCN3C=C(C#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)C=N3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,232,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1196.175,1195.412859,1.78,86,10,12,8,18,328.63,C60H60F2N11O12P,"InChI=1S/C60H60F2N11O12P/c61-60(62,86(83,84)85)40-18-20-44-39(29-40)30-46(65-44)55(78)67-47-34-70(52(76)15-8-27-71-32-35(31-64-71)16-17-36-13-7-14-42-43(36)33-72(58(42)81)48-23-25-51(75)68-56(48)79)28-26-41-19-22-49(73(41)59(47)82)57(80)66-45(21-24-50(63)74)54(77)69-53(37-9-3-1-4-10-37)38-11-5-2-6-12-38/h1-7,9-14,18,20,29-32,41,45,47-49,53,65H,8,15,19,21-28,33-34H2,(H2,63,74)(H,66,80)(H,67,78)(H,69,77)(H,68,75,79)(H2,83,84,85)/t41-,45+,47+,48?,49+/m1/s1",ITISWPJBZKPZQW-MCIGMSQYSA-N
485,180,99,180,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)N3CCC(CCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1199.219,1198.448911,3.18,86,10,10,8,16,314.05,C61H65F2N10O12P,"InChI=1S/C61H65F2N10O12P/c62-61(63,86(83,84)85)41-18-20-45-40(32-41)33-47(65-45)55(77)67-48-35-71(60(82)70-29-26-36(27-30-70)10-7-8-11-37-16-9-17-43-44(37)34-72(58(43)80)49-23-25-52(75)68-56(49)78)31-28-42-19-22-50(73(42)59(48)81)57(79)66-46(21-24-51(64)74)54(76)69-53(38-12-3-1-4-13-38)39-14-5-2-6-15-39/h1-6,9,12-18,20,32-33,36,42,46,48-50,53,65H,7,10,19,21-31,34-35H2,(H2,64,74)(H,66,79)(H,67,77)(H,69,76)(H,68,75,78)(H2,83,84,85)/t42-,46+,48+,49?,50+/m1/s1",DNUHNFLKEFZIJN-RNJJLJFWSA-N
486,2470,99,2470,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCN3CCC(C#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,360,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1199.219,1198.448911,-0.15,86,10,11,8,17,314.05,C61H65F2N10O12P,"InChI=1S/C61H65F2N10O12P/c62-61(63,86(83,84)85)41-16-18-45-40(32-41)33-47(65-45)56(78)67-48-35-71(53(76)27-30-70-28-24-36(25-29-70)14-15-37-12-7-13-43-44(37)34-72(59(43)81)49-21-23-52(75)68-57(49)79)31-26-42-17-20-50(73(42)60(48)82)58(80)66-46(19-22-51(64)74)55(77)69-54(38-8-3-1-4-9-38)39-10-5-2-6-11-39/h1-13,16,18,32-33,36,42,46,48-50,54,65H,17,19-31,34-35H2,(H2,64,74)(H,66,80)(H,67,78)(H,69,77)(H,68,75,79)(H2,83,84,85)/t42-,46+,48+,49?,50+/m1/s1",FDBBKBSMSHLUPL-RNJJLJFWSA-N
487,380,99,380,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CC(=O)N3CCC(C#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,67,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1213.202,1212.428175,1.79,87,10,11,8,16,331.12,C61H63F2N10O13P,"InChI=1S/C61H63F2N10O13P/c62-61(63,87(84,85)86)40-16-18-44-39(30-40)31-46(65-44)56(79)67-47-34-71(53(77)32-52(76)70-27-24-35(25-28-70)14-15-36-12-7-13-42-43(36)33-72(59(42)82)48-21-23-51(75)68-57(48)80)29-26-41-17-20-49(73(41)60(47)83)58(81)66-45(19-22-50(64)74)55(78)69-54(37-8-3-1-4-9-37)38-10-5-2-6-11-38/h1-13,16,18,30-31,35,41,45,47-49,54,65H,17,19-29,32-34H2,(H2,64,74)(H,66,81)(H,67,79)(H,69,78)(H,68,75,80)(H2,84,85,86)/t41-,45+,47+,48?,49+/m1/s1",DNVSITWTEKNBFF-MCIGMSQYSA-N
488,160,99,160,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1162.198,1161.453662,3.94,83,9,10,8,22,310.81,C59H66F2N9O12P,"InChI=1S/C59H66F2N9O12P/c60-59(61,83(80,81)82)39-21-23-43-38(31-39)32-45(63-43)54(75)65-46-34-68(51(73)20-11-3-1-2-6-13-35-18-12-19-41-42(35)33-69(57(41)78)47-26-28-50(72)66-55(47)76)30-29-40-22-25-48(70(40)58(46)79)56(77)64-44(24-27-49(62)71)53(74)67-52(36-14-7-4-8-15-36)37-16-9-5-10-17-37/h4-5,7-10,12,14-19,21,23,31-32,40,44,46-48,52,63H,1-3,6,11,13,20,22,24-30,33-34H2,(H2,62,71)(H,64,77)(H,65,75)(H,67,74)(H,66,72,76)(H2,80,81,82)/t40-,44+,46+,47?,48+/m1/s1",FXYCZGNLHMEDSW-OPKPGBGESA-N
489,90,99,90,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCCNC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,59,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1163.186,1162.448911,2.76,83,9,11,9,22,322.84,C58H65F2N10O12P,"InChI=1S/C58H65F2N10O12P/c59-58(60,83(80,81)82)37-19-21-41-36(30-37)31-44(63-41)53(75)65-45-33-68(50(73)18-9-1-2-10-28-62-42-17-11-16-39-40(42)32-69(56(39)78)46-24-26-49(72)66-54(46)76)29-27-38-20-23-47(70(38)57(45)79)55(77)64-43(22-25-48(61)71)52(74)67-51(34-12-5-3-6-13-34)35-14-7-4-8-15-35/h3-8,11-17,19,21,30-31,38,43,45-47,51,62-63H,1-2,9-10,18,20,22-29,32-33H2,(H2,61,71)(H,64,77)(H,65,75)(H,67,74)(H,66,72,76)(H2,80,81,82)/t38-,43+,45+,46?,47+/m1/s1",XPIZROMNDAHUBB-ZSAPAZMUSA-N
490,3540,99,3540/>10000,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582/>10000,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1172.149,1171.401626,3.2,84,9,11,8,19,327.88,C59H60F2N9O13P,"InChI=1S/C59H60F2N9O13P/c60-59(61,84(81,82)83)38-21-23-41-37(31-38)32-43(63-41)53(75)65-44-33-68(49(73)20-11-3-1-2-6-13-34-18-12-19-40-50(34)58(80)70(56(40)78)46-26-28-48(72)66-55(46)77)30-29-39-22-25-45(69(39)57(44)79)54(76)64-42(24-27-47(62)71)52(74)67-51(35-14-7-4-8-15-35)36-16-9-5-10-17-36/h4-5,7-10,12,14-19,21,23,31-32,39,42,44-46,51,63H,1-3,11,20,22,24-30,33H2,(H2,62,71)(H,64,76)(H,65,75)(H,67,74)(H,66,72,77)(H2,81,82,83)/t39-,42+,44+,45+,46?/m1/s1",ZMCYXBJXBBCEIP-DYGUMZBISA-N
491,410,99,410,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,104,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1158.166,1157.422361,3.25,83,9,10,8,19,310.81,C59H62F2N9O12P,"InChI=1S/C59H62F2N9O12P/c60-59(61,83(80,81)82)40-19-22-43-38(31-40)32-45(63-43)54(75)65-46-34-68(51(73)17-11-3-1-2-6-12-35-18-21-42-39(30-35)33-69(57(42)78)47-25-27-50(72)66-55(47)76)29-28-41-20-24-48(70(41)58(46)79)56(77)64-44(23-26-49(62)71)53(74)67-52(36-13-7-4-8-14-36)37-15-9-5-10-16-37/h4-5,7-10,13-16,18-19,21-22,30-32,41,44,46-48,52,63H,1-3,11,17,20,23-29,33-34H2,(H2,62,71)(H,64,77)(H,65,75)(H,67,74)(H,66,72,76)(H2,80,81,82)/t41-,44+,46+,47?,48+/m1/s1",FXZPXYVHFYRABL-VTOHLSPHSA-N
492,360,99,360,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=C4CN(C5CCC(=O)NC5=O)C(=O)C4=C3)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,711,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1158.166,1157.422361,3.25,83,9,10,8,19,310.81,C59H62F2N9O12P,"InChI=1S/C59H62F2N9O12P/c60-59(61,83(80,81)82)40-20-22-43-39(31-40)32-45(63-43)54(75)65-46-34-68(51(73)17-11-3-1-2-6-12-35-18-19-38-33-69(57(78)42(38)30-35)47-25-27-50(72)66-55(47)76)29-28-41-21-24-48(70(41)58(46)79)56(77)64-44(23-26-49(62)71)53(74)67-52(36-13-7-4-8-14-36)37-15-9-5-10-16-37/h4-5,7-10,13-16,18-20,22,30-32,41,44,46-48,52,63H,1-3,11,17,21,23-29,33-34H2,(H2,62,71)(H,64,77)(H,65,75)(H,67,74)(H,66,72,76)(H2,80,81,82)/t41-,44+,46+,47?,48+/m1/s1",PUAPFJPRVXBTRM-VTOHLSPHSA-N
493,55,99,220/55,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NCC1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,210/3240,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1082.068,1081.391061,1.56,77,8,10,8,18,310.81,C53H58F2N9O12P,"InChI=1S/C53H58F2N9O12P/c54-53(55,77(74,75)76)34-16-18-38-33(26-34)27-40(58-38)48(69)60-41-30-62(46(67)15-8-3-1-2-7-12-32-13-9-14-36-37(32)29-63(51(36)72)42-21-23-45(66)61-49(42)70)25-24-35-17-20-43(64(35)52(41)73)50(71)59-39(19-22-44(56)65)47(68)57-28-31-10-5-4-6-11-31/h4-6,9-11,13-14,16,18,26-27,35,39,41-43,58H,1-3,8,15,17,19-25,28-30H2,(H2,56,65)(H,57,68)(H,59,71)(H,60,69)(H,61,66,70)(H2,74,75,76)/t35-,39+,41+,42?,43+/m1/s1",JMUHWFNJLJLSLE-UCJSLEDASA-N
494,640,99,640/890,,P40763,STAT3,CRBN,,,CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(F)(F)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,226/>10000,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1005.97,1005.359761,0.07,71,7,10,8,16,310.81,C47H54F2N9O12P,"InChI=1S/C47H54F2N9O12P/c1-51-41(62)33(15-18-38(50)59)53-44(65)37-16-13-29-20-21-56(25-35(46(67)58(29)37)54-42(63)34-23-27-22-28(12-14-32(27)52-34)47(48,49)71(68,69)70)40(61)11-6-4-2-3-5-8-26-9-7-10-30-31(26)24-57(45(30)66)36-17-19-39(60)55-43(36)64/h7,9-10,12,14,22-23,29,33,35-37,52H,2-4,6,11,13,15-21,24-25H2,1H3,(H2,50,59)(H,51,62)(H,53,65)(H,54,63)(H,55,60,64)(H2,68,69,70)/t29-,33+,35+,36?,37+/m1/s1",YGMZLSZZQXJJGQ-BSGAXWGTSA-N
495,,,>10000,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(OP(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>2000,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1124.158,1123.42047,2.88,81,9,11,8,19,320.04,C58H62N9O13P,"InChI=1S/C58H62N9O13P/c59-49(68)27-24-44(53(71)64-52(36-14-7-4-8-15-36)37-16-9-5-10-17-37)61-56(74)48-25-21-39-29-30-65(34-46(58(76)67(39)48)62-54(72)45-32-38-31-40(80-81(77,78)79)22-23-43(38)60-45)51(70)20-11-3-1-2-6-13-35-18-12-19-41-42(35)33-66(57(41)75)47-26-28-50(69)63-55(47)73/h4-5,7-10,12,14-19,22-23,31-32,39,44,46-48,52,60H,1-3,11,20-21,24-30,33-34H2,(H2,59,68)(H,61,74)(H,62,72)(H,64,71)(H,63,69,73)(H2,77,78,79)/t39-,44+,46+,47?,48+/m1/s1",GHKKHWPDPXWQMX-MWHNVIERSA-N
496,,,>10000,,P40763,STAT3,CRBN,,,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(CP(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>2000,Inhibit growth of Molm-16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1122.186,1121.441205,2.51,81,9,10,8,19,310.81,C59H64N9O12P,"InChI=1S/C59H64N9O12P/c60-50(69)27-24-45(54(72)65-53(38-14-7-4-8-15-38)39-16-9-5-10-17-39)62-57(75)49-25-22-41-29-30-66(34-47(59(77)68(41)49)63-55(73)46-32-40-31-36(35-81(78,79)80)21-23-44(40)61-46)52(71)20-11-3-1-2-6-13-37-18-12-19-42-43(37)33-67(58(42)76)48-26-28-51(70)64-56(48)74/h4-5,7-10,12,14-19,21,23,31-32,41,45,47-49,53,61H,1-3,11,20,22,24-30,33-35H2,(H2,60,69)(H,62,75)(H,63,73)(H,65,72)(H,64,70,74)(H2,78,79,80)/t41-,45+,47+,48?,49+/m1/s1",JEIWTFIDHFVTPB-MCIGMSQYSA-N
497,4450,99,4450/>10000,,P40763,STAT3,CRBN,,,C/C(=C\C(=O)N[C@H]1CN(C(=O)CCCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC[C@H]2CC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NC(C3=CC=CC=C3)C3=CC=CC=C3)N2C1=O)C1=CC=C(C(F)(F)P(=O)(O)O)C=C1,Degradation of total STAT3 and p-STAT3Y705 proteins in Molm-16/SU-DHL-1 cells after 4/16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1250/>10000,Inhibit growth of Molm-16/SU-DHL-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01530,1159.194,1158.442763,3.84,83,8,10,7,20,295.02,C60H65F2N8O12P,"InChI=1S/C60H65F2N8O12P/c1-37(38-22-24-42(25-23-38)60(61,62)83(80,81)82)34-52(73)64-47-36-68(53(74)21-12-4-2-3-7-14-39-19-13-20-44-45(39)35-69(58(44)78)48-29-31-51(72)66-56(48)76)33-32-43-26-28-49(70(43)59(47)79)57(77)65-46(27-30-50(63)71)55(75)67-54(40-15-8-5-9-16-40)41-17-10-6-11-18-41/h5-6,8-11,13,15-20,22-25,34,43,46-49,54H,2-4,12,21,26-33,35-36H2,1H3,(H2,63,71)(H,64,73)(H,65,77)(H,67,75)(H,66,72,76)(H2,80,81,82)/b37-34+/t43-,46+,47+,48?,49+/m1/s1",BEYVGGZLHQFWMW-DOJNSZAGSA-N
500,700,99,700,,Q07820,MCL1,CRBN,,,O=C(CCCCC(=O)NCCN1C(=O)C2=CC=CC3=C(SC4=CC=C(Br)C=C4)C=CC(=C23)C1=O)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of MCL1 in HeLa cells after 12 h treatment,,,780,Inhibition of MCL1 by ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00919,909.86,908.2202955,5.98,61,7,10,4,19,191.16,C45H45BrN6O8S,"InChI=1S/C45H45BrN6O8S/c46-27-15-17-28(18-16-27)61-35-21-19-32-39-29(35)9-7-10-30(39)42(57)51(43(32)58)26-25-49-37(54)14-4-3-13-36(53)48-24-6-2-1-5-23-47-33-12-8-11-31-40(33)45(60)52(44(31)59)34-20-22-38(55)50-41(34)56/h7-12,15-19,21,34,47H,1-6,13-14,20,22-26H2,(H,48,53)(H,49,54)(H,50,55,56)",BORXNUWYWZOREQ-UHFFFAOYSA-N
502,3000,99,3000,,P10415,BCL2,CRBN,,,O=C(CCCCC(=O)NCCN1C(=O)C2=CC=CC3=C(SC4=CC=C(Br)C=C4)C=CC(=C23)C1=O)NCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BCL2 in HeLa cells after 12 h treatment,,,4940,Inhibition of BCL2 by ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00919,941.858,940.2101247,4.26,63,7,12,4,21,209.62,C45H45BrN6O10S,"InChI=1S/C45H45BrN6O10S/c46-27-11-13-28(14-12-27)63-35-17-15-32-39-29(35)5-3-6-30(39)42(57)51(43(32)58)22-19-48-36(53)9-1-2-10-37(54)49-21-24-62-26-25-61-23-20-47-33-8-4-7-31-40(33)45(60)52(44(31)59)34-16-18-38(55)50-41(34)56/h3-8,11-15,17,34,47H,1-2,9-10,16,18-26H2,(H,48,53)(H,49,54)(H,50,55,56)",IUSLKFLLLNNOGR-UHFFFAOYSA-N
513,,,>50,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1055.684,1054.44193,7.26,73,7,14,5,20,211.32,C53H68ClN10O7PS,"InChI=1S/C53H68ClN10O7PS/c1-34-47(73-33-57-34)36-20-18-35(19-21-36)30-55-50(68)42-29-38(65)32-64(42)51(69)48(53(2,3)4)60-45(66)16-10-8-9-11-17-46(67)63-26-24-62(25-27-63)37-22-23-40(43(28-37)71-5)59-52-56-31-39(54)49(61-52)58-41-14-12-13-15-44(41)72(6,7)70/h12-15,18-23,28,31,33,38,42,48,65H,8-11,16-17,24-27,29-30,32H2,1-7H3,(H,55,68)(H,60,66)(H2,56,58,59,61)/t38-,42+,48-/m1/s1",KVVNVQLVKFQXHX-AQHSYVBPSA-N
514,15,99,15,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCN(C(=O)CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1069.711,1068.45758,7.8,74,7,14,5,21,211.32,C54H70ClN10O7PS,"InChI=1S/C54H70ClN10O7PS/c1-35-48(74-34-58-35)37-21-19-36(20-22-37)31-56-51(69)43-30-39(66)33-65(43)52(70)49(54(2,3)4)61-46(67)17-11-9-8-10-12-18-47(68)64-27-25-63(26-28-64)38-23-24-41(44(29-38)72-5)60-53-57-32-40(55)50(62-53)59-42-15-13-14-16-45(42)73(6,7)71/h13-16,19-24,29,32,34,39,43,49,66H,8-12,17-18,25-28,30-31,33H2,1-7H3,(H,56,69)(H,61,67)(H2,57,59,60,62)/t39-,43+,49-/m1/s1",KHTOZEJDDODCIE-SHTJZPIOSA-N
515,,,>50,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCN(C(=O)CCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1083.738,1082.47323,8.35,75,7,14,5,22,211.32,C55H72ClN10O7PS,"InChI=1S/C55H72ClN10O7PS/c1-36-49(75-35-59-36)38-22-20-37(21-23-38)32-57-52(70)44-31-40(67)34-66(44)53(71)50(55(2,3)4)62-47(68)18-12-10-8-9-11-13-19-48(69)65-28-26-64(27-29-65)39-24-25-42(45(30-39)73-5)61-54-58-33-41(56)51(63-54)60-43-16-14-15-17-46(43)74(6,7)72/h14-17,20-25,30,33,35,40,44,50,67H,8-13,18-19,26-29,31-32,34H2,1-7H3,(H,57,70)(H,62,68)(H2,58,60,61,63)/t40-,44+,50-/m1/s1",HUMHJRIACKUHDX-PFPUJWRRSA-N
520,9.1,99,9.1,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCC(NC(=O)CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1069.711,1068.45758,7.86,74,7,14,6,21,220.11,C54H70ClN10O7PS,"InChI=1S/C54H70ClN10O7PS/c1-34-48(74-33-58-34)36-20-18-35(19-21-36)30-56-51(69)43-29-39(66)32-65(43)52(70)49(54(2,3)4)62-47(68)17-11-9-8-10-16-46(67)59-37-24-26-64(27-25-37)38-22-23-41(44(28-38)72-5)61-53-57-31-40(55)50(63-53)60-42-14-12-13-15-45(42)73(6,7)71/h12-15,18-23,28,31,33,37,39,43,49,66H,8-11,16-17,24-27,29-30,32H2,1-7H3,(H,56,69)(H,59,67)(H,62,68)(H2,57,60,61,63)/t39-,43+,49-/m1/s1",QKMSSVGJUBVJIO-SHTJZPIOSA-N
521,20.9,99,20.9,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCC(NC(=O)CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1083.738,1082.47323,8.4,75,7,14,6,22,220.11,C55H72ClN10O7PS,"InChI=1S/C55H72ClN10O7PS/c1-35-49(75-34-59-35)37-21-19-36(20-22-37)31-57-52(70)44-30-40(67)33-66(44)53(71)50(55(2,3)4)63-48(69)18-12-10-8-9-11-17-47(68)60-38-25-27-65(28-26-38)39-23-24-42(45(29-39)73-5)62-54-58-32-41(56)51(64-54)61-43-15-13-14-16-46(43)74(6,7)72/h13-16,19-24,29,32,34,38,40,44,50,67H,8-12,17-18,25-28,30-31,33H2,1-7H3,(H,57,70)(H,60,68)(H,63,69)(H2,58,61,62,64)/t40-,44+,50-/m1/s1",LMNCKEZYUHGAAW-PFPUJWRRSA-N
522,7.2,99,7.2,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCC(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1097.765,1096.48888,8.94,76,7,14,6,23,220.11,C56H74ClN10O7PS,"InChI=1S/C56H74ClN10O7PS/c1-36-50(76-35-60-36)38-22-20-37(21-23-38)32-58-53(71)45-31-41(68)34-67(45)54(72)51(56(2,3)4)64-49(70)19-13-11-9-8-10-12-18-48(69)61-39-26-28-66(29-27-39)40-24-25-43(46(30-40)74-5)63-55-59-33-42(57)52(65-55)62-44-16-14-15-17-47(44)75(6,7)73/h14-17,20-25,30,33,35,39,41,45,51,68H,8-13,18-19,26-29,31-32,34H2,1-7H3,(H,58,71)(H,61,69)(H,64,70)(H2,59,62,63,65)/t41-,45+,51-/m1/s1",YLHFCKVCYLEGIG-JSKJCRAUSA-N
523,7,99,7,,Q9UM73,ALK,VHL,,SIAIS117,COC1=CC(N2CCC(NC(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7/46/259,Inhibit growth of SR/H2228/NCI-H1688 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1111.792,1110.50453,9.49,77,7,14,6,24,220.11,C57H76ClN10O7PS,"InChI=1S/C57H76ClN10O7PS/c1-37-51(77-36-61-37)39-23-21-38(22-24-39)33-59-54(72)46-32-42(69)35-68(46)55(73)52(57(2,3)4)65-50(71)20-14-12-10-8-9-11-13-19-49(70)62-40-27-29-67(30-28-40)41-25-26-44(47(31-41)75-5)64-56-60-34-43(58)53(66-56)63-45-17-15-16-18-48(45)76(6,7)74/h15-18,21-26,31,34,36,40,42,46,52,69H,8-14,19-20,27-30,32-33,35H2,1-7H3,(H,59,72)(H,62,70)(H,65,71)(H2,60,63,64,66)/t42-,46+,52-/m1/s1",DYUJLNPTOOBZBB-CCXZOALNSA-N
523,,,<200,,Q9UM73,ALK G1202R,VHL,,SIAIS117,COC1=CC(N2CCC(NC(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of G1202R ALK in 293T cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,146.4,Inhibit growth of 293T cells expressing G1202R ALK,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1111.792,1110.50453,9.49,77,7,14,6,24,220.11,C57H76ClN10O7PS,"InChI=1S/C57H76ClN10O7PS/c1-37-51(77-36-61-37)39-23-21-38(22-24-39)33-59-54(72)46-32-42(69)35-68(46)55(73)52(57(2,3)4)65-50(71)20-14-12-10-8-9-11-13-19-49(70)62-40-27-29-67(30-28-40)41-25-26-44(47(31-41)75-5)64-56-60-34-43(58)53(66-56)63-45-17-15-16-18-48(45)76(6,7)74/h15-18,21-26,31,34,36,40,42,46,52,69H,8-14,19-20,27-30,32-33,35H2,1-7H3,(H,59,72)(H,62,70)(H,65,71)(H2,60,63,64,66)/t42-,46+,52-/m1/s1",DYUJLNPTOOBZBB-CCXZOALNSA-N
528,11.4,99,11.4,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCC(N3CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1138.818,1137.515429,7.85,79,8,15,5,21,214.56,C58H77ClN11O7PS,"InChI=1S/C58H77ClN11O7PS/c1-38-52(79-37-62-38)40-20-18-39(19-21-40)34-60-55(74)47-33-43(71)36-70(47)56(75)53(58(2,3)4)65-50(72)16-10-8-9-11-17-51(73)69-30-28-68(29-31-69)41-24-26-67(27-25-41)42-22-23-45(48(32-42)77-5)64-57-61-35-44(59)54(66-57)63-46-14-12-13-15-49(46)78(6,7)76/h12-15,18-23,32,35,37,41,43,47,53,71H,8-11,16-17,24-31,33-34,36H2,1-7H3,(H,60,74)(H,65,72)(H2,61,63,64,66)/t43-,47+,53-/m1/s1",LTPUWRULBUKGNI-LGIBPJQYSA-N
529,25.1,99,25.1,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCC(N3CCN(C(=O)CCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1152.845,1151.531079,8.4,80,8,15,5,22,214.56,C59H79ClN11O7PS,"InChI=1S/C59H79ClN11O7PS/c1-39-53(80-38-63-39)41-21-19-40(20-22-41)35-61-56(75)48-34-44(72)37-71(48)57(76)54(59(2,3)4)66-51(73)17-11-9-8-10-12-18-52(74)70-31-29-69(30-32-70)42-25-27-68(28-26-42)43-23-24-46(49(33-43)78-5)65-58-62-36-45(60)55(67-58)64-47-15-13-14-16-50(47)79(6,7)77/h13-16,19-24,33,36,38,42,44,48,54,72H,8-12,17-18,25-32,34-35,37H2,1-7H3,(H,61,75)(H,66,73)(H2,62,64,65,67)/t44-,48+,54-/m1/s1",GONDMTIOPVKJJM-IEUXFAQDSA-N
530,7.5,99,7.5,,Q9UM73,ALK,VHL,,,COC1=CC(N2CCC(N3CCN(C(=O)CCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112190,1166.872,1165.546729,8.94,81,8,15,5,23,214.56,C60H81ClN11O7PS,"InChI=1S/C60H81ClN11O7PS/c1-40-54(81-39-64-40)42-22-20-41(21-23-42)36-62-57(76)49-35-45(73)38-72(49)58(77)55(60(2,3)4)67-52(74)18-12-10-8-9-11-13-19-53(75)71-32-30-70(31-33-71)43-26-28-69(29-27-43)44-24-25-47(50(34-44)79-5)66-59-63-37-46(61)56(68-59)65-48-16-14-15-17-51(48)80(6,7)78/h14-17,20-25,34,37,39,43,45,49,55,73H,8-13,18-19,26-33,35-36,38H2,1-7H3,(H,62,76)(H,67,74)(H2,63,65,66,68)/t45-,49+,55-/m1/s1",ZRZMJGXWXYTWKE-JVPKQGNTSA-N
543,10,99,10/180/50,,Q9UM73,ALK,CRBN,,TL13-12,COC1=CC(N2CCN(CCOCCOCCNC(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of ALK in H3122/Karpas 299/Kelly cells 16 h treatment,,,0.69,Inhibition of ALK by TR-FRET ALK activity assay,,,,,,,,,,,,,,,1200,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21.3/2.6/95,Inhibit proliferation of H3122/Karpas 299/Kelly cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b01655,961.499,960.3355366,4.56,67,7,17,5,21,242.83,C45H53ClN10O10S,"InChI=1S/C45H53ClN10O10S/c1-28(2)67(62,63)37-10-5-4-8-33(37)50-41-31(46)26-49-45(53-41)51-32-12-11-29(25-36(32)64-3)55-18-16-54(17-19-55)20-22-66-24-23-65-21-15-47-39(58)27-48-34-9-6-7-30-40(34)44(61)56(43(30)60)35-13-14-38(57)52-42(35)59/h4-12,25-26,28,35,48H,13-24,27H2,1-3H3,(H,47,58)(H,52,57,59)(H2,49,50,51,53)",WXNUIPVZMJMPNM-UHFFFAOYSA-N
544,10,99,10/40/50,,Q9UM73,ALK,CRBN,,TL13-112,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CCOCCOCCNC(=O)CNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of ALK in H3122/Karpas 299/Kelly cells 16 h treatment,,,0.6,Inhibition of ALK by TR-FRET ALK activity assay,,,,,,,,,,,,,,,2400,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.4/9.2/374,Inhibit proliferation of H3122/Karpas 299/Kelly cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b01655,1002.592,1001.387238,6.37,70,7,16,5,22,239.59,C49H60ClN9O10S,"InChI=1S/C49H60ClN9O10S/c1-29(2)69-40-26-34(31(5)25-38(40)55-49-53-27-35(50)45(57-49)54-36-10-6-7-12-41(36)70(65,66)30(3)4)32-15-18-58(19-16-32)20-22-68-24-23-67-21-17-51-43(61)28-52-37-11-8-9-33-44(37)48(64)59(47(33)63)39-13-14-42(60)56-46(39)62/h6-12,25-27,29-30,32,39,52H,13-24,28H2,1-5H3,(H,51,61)(H,56,60,62)(H2,53,54,55,57)",XIRQUXILNXIWDI-UHFFFAOYSA-N
544,289,87,289,87,,EML4-ALK,CRBN,,TL13-112,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CCOCCOCCNC(=O)CNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EML4-ALK in Ba/F3 cells,,,971,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,1002.592,1001.387238,6.37,70,7,16,5,22,239.59,C49H60ClN9O10S,"InChI=1S/C49H60ClN9O10S/c1-29(2)69-40-26-34(31(5)25-38(40)55-49-53-27-35(50)45(57-49)54-36-10-6-7-12-41(36)70(65,66)30(3)4)32-15-18-58(19-16-32)20-22-68-24-23-67-21-17-51-43(61)28-52-37-11-8-9-33-44(37)48(64)59(47(33)63)39-13-14-42(60)56-46(39)62/h6-12,25-27,29-30,32,39,52H,13-24,28H2,1-5H3,(H,51,61)(H,56,60,62)(H2,53,54,55,57)",XIRQUXILNXIWDI-UHFFFAOYSA-N
556,23,90,23,90,Q00987,MDM2,CRBN,,,CCOC1=CC(C(C)(C)C)=CC=C1C1=N[C@@H](C2=CC=C(Cl)C=C2)[C@@H](C2=CC=C(Cl)C=C2)N1C(=O)N1CCN(CC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of MDM2 in RS4; 11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2,Inhibit proliferation of RS4; 11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.05.046,859.855,858.306324,7.3,61,8,7,1,7,114.86,C48H48Cl2N6O5,"InChI=1S/C48H48Cl2N6O5/c1-5-61-40-28-33(48(2,3)4)15-20-37(40)44-52-42(31-11-16-34(49)17-12-31)43(32-13-18-35(50)19-14-32)56(44)47(60)54-26-24-53(25-27-54)23-7-9-30-8-6-10-36-38(30)29-55(46(36)59)39-21-22-41(57)51-45(39)58/h6,8,10-20,28,39,42-43H,5,21-27,29H2,1-4H3,(H,51,57,58)/t39?,42-,43+/m0/s1",SXPSRFOBNYZXKH-UZLVNVLGSA-N
559,45.2,87,45.2,87,P00533,EGFR,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)CCCCCCCN4CCN(C5=CC=C(NC6=CC7=C(N8CCC(CO)CC8)N=C(NC8=CC=C(F)C=C8)N=C7C=N6)N=C5)CC4)C=CC=C3C2=O)C(=O)N1,Degradation of EGFR in HCC827 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,180,Inhibit proliferation of HCC827 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112061,913.072,912.4558911,5.26,67,9,14,5,17,201.15,C49H57FN12O5,"InChI=1S/C49H57FN12O5/c50-33-10-12-34(13-11-33)53-49-55-40-29-52-43(27-37(40)46(58-49)61-21-18-32(31-63)19-22-61)56-42-16-14-35(28-51-42)60-25-23-59(24-26-60)20-5-3-1-2-4-9-44(64)54-39-8-6-7-36-38(39)30-62(48(36)67)41-15-17-45(65)57-47(41)66/h6-8,10-14,16,27-29,32,41,63H,1-5,9,15,17-26,30-31H2,(H,54,64)(H,51,52,56)(H,53,55,58)(H,57,65,66)",ZWLPWTDAYPOQGR-UHFFFAOYSA-N
567,34.8,98,34.8,98,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(C4=CC=C(NC5=CC6=C(N7CCC(CO)CC7)N=C(NC7=CC=C(F)C=C7)N=C6C=N5)N=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR in HCC827 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,220,Inhibit proliferation of HCC827 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112061,1070.354,1069.548412,7.67,77,9,16,6,20,217.2,C57H72FN13O5S,"InChI=1S/C57H72FN13O5S/c1-37-51(77-36-62-37)40-12-10-38(11-13-40)31-61-54(75)47-29-44(73)34-71(47)55(76)52(57(2,3)4)66-50(74)9-7-5-6-8-22-68-25-27-69(28-26-68)43-18-19-48(59-32-43)65-49-30-45-46(33-60-49)64-56(63-42-16-14-41(58)15-17-42)67-53(45)70-23-20-39(35-72)21-24-70/h10-19,30,32-33,36,39,44,47,52,72-73H,5-9,20-29,31,34-35H2,1-4H3,(H,61,75)(H,66,74)(H,59,60,65)(H,63,64,67)/t44-,47+,52-/m1/s1",LCTCXOPSLJEXKE-FEDPBZRBSA-N
572,,,>2000,,P00533,EGFR L858R/T790M,CRBN,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,979.108,978.4388234,6.07,72,8,14,4,20,234.34,C53H58N10O9,"InChI=1S/C53H58N10O9/c1-4-43(64)55-34-15-13-16-36(30-34)62-47(68)29-33(2)38-32-54-53(59-49(38)62)57-39-22-21-35(31-42(39)72-3)60-25-27-61(28-26-60)46(67)20-12-10-8-6-5-7-9-11-19-44(65)56-40-18-14-17-37-48(40)52(71)63(51(37)70)41-23-24-45(66)58-50(41)69/h4,13-18,21-22,29-32,41H,1,5-12,19-20,23-28H2,2-3H3,(H,55,64)(H,56,65)(H,54,57,59)(H,58,66,69)",JYBLMIXCGVMISV-UHFFFAOYSA-N
572,,,>2000,,P00533,EGFR,CRBN,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,979.108,978.4388234,6.07,72,8,14,4,20,234.34,C53H58N10O9,"InChI=1S/C53H58N10O9/c1-4-43(64)55-34-15-13-16-36(30-34)62-47(68)29-33(2)38-32-54-53(59-49(38)62)57-39-22-21-35(31-42(39)72-3)60-25-27-61(28-26-60)46(67)20-12-10-8-6-5-7-9-11-19-44(65)56-40-18-14-17-37-48(40)52(71)63(51(37)70)41-23-24-45(66)58-50(41)69/h4,13-18,21-22,29-32,41H,1,5-12,19-20,23-28H2,2-3H3,(H,55,64)(H,56,65)(H,54,57,59)(H,58,66,69)",JYBLMIXCGVMISV-UHFFFAOYSA-N
573,,,>2000,,P00533,EGFR L858R/T790M,cIAP1,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC6=CC=CC=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,999.271,998.5741947,7.71,73,6,13,6,27,226.14,C56H74N10O7,"InChI=1S/C56H74N10O7/c1-6-49(67)60-41-22-19-23-43(35-41)66-51(69)33-39(4)44-37-59-56(63-53(44)66)62-46-26-25-42(36-48(46)73-5)64-28-30-65(31-29-64)50(68)24-17-12-10-8-7-9-11-13-18-27-58-54(71)47(32-38(2)3)61-55(72)52(70)45(57)34-40-20-15-14-16-21-40/h6,14-16,19-23,25-26,33,35-38,45,47,52,70H,1,7-13,17-18,24,27-32,34,57H2,2-5H3,(H,58,71)(H,60,67)(H,61,72)(H,59,62,63)/t45-,47+,52+/m1/s1",DOEISPNISSZUOZ-KTBSTWIUSA-N
573,,,>2000,,P00533,EGFR,cIAP1,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC6=CC=CC=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,999.271,998.5741947,7.71,73,6,13,6,27,226.14,C56H74N10O7,"InChI=1S/C56H74N10O7/c1-6-49(67)60-41-22-19-23-43(35-41)66-51(69)33-39(4)44-37-59-56(63-53(44)66)62-46-26-25-42(36-48(46)73-5)64-28-30-65(31-29-64)50(68)24-17-12-10-8-7-9-11-13-18-27-58-54(71)47(32-38(2)3)61-55(72)52(70)45(57)34-40-20-15-14-16-21-40/h6,14-16,19-23,25-26,33,35-38,45,47,52,70H,1,7-13,17-18,24,27-32,34,57H2,2-5H3,(H,58,71)(H,60,67)(H,61,72)(H,59,62,63)/t45-,47+,52+/m1/s1",DOEISPNISSZUOZ-KTBSTWIUSA-N
574,263.8,99,263.8,,P00533,EGFR L858R/T790M,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1307.385,1305.550906,12.96,93,9,14,5,26,224.94,C71H79Cl2F2N11O7,"InChI=1S/C71H79Cl2F2N11O7/c1-8-60(87)79-47-20-18-21-49(39-47)86-62(89)36-44(2)51-42-78-69(83-66(51)86)81-56-30-27-48(40-58(56)93-7)84-32-34-85(35-33-84)61(88)24-16-14-12-10-9-11-13-15-17-31-77-67(90)45-25-29-55(57(37-45)92-6)80-68(91)65-63(50-22-19-23-53(73)64(50)75)71(43-76,59(82-65)41-70(3,4)5)52-28-26-46(72)38-54(52)74/h8,18-23,25-30,36-40,42,59,63,65,82H,1,9-17,24,31-35,41H2,2-7H3,(H,77,90)(H,79,87)(H,80,91)(H,78,81,83)/t59-,63-,65+,71-/m0/s1",DCPNWQZQYCVVJX-UYDHSDFFSA-N
574,,,>2000,,P00533,EGFR,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1307.385,1305.550906,12.96,93,9,14,5,26,224.94,C71H79Cl2F2N11O7,"InChI=1S/C71H79Cl2F2N11O7/c1-8-60(87)79-47-20-18-21-49(39-47)86-62(89)36-44(2)51-42-78-69(83-66(51)86)81-56-30-27-48(40-58(56)93-7)84-32-34-85(35-33-84)61(88)24-16-14-12-10-9-11-13-15-17-31-77-67(90)45-25-29-55(57(37-45)92-6)80-68(91)65-63(50-22-19-23-53(73)64(50)75)71(43-76,59(82-65)41-70(3,4)5)52-28-26-46(72)38-54(52)74/h8,18-23,25-30,36-40,42,59,63,65,82H,1,9-17,24,31-35,41H2,2-7H3,(H,77,90)(H,79,87)(H,80,91)(H,78,81,83)/t59-,63-,65+,71-/m0/s1",DCPNWQZQYCVVJX-UYDHSDFFSA-N
575,,,>2000,,P00533,EGFR L858R/T790M,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1293.402,1291.571641,13.92,92,9,14,5,27,207.87,C71H81Cl2F2N11O6,"InChI=1S/C71H81Cl2F2N11O6/c1-8-61(87)79-48-21-19-22-50(40-48)86-62(88)37-45(2)52-43-78-69(83-66(52)86)81-57-30-27-49(41-59(57)92-7)85-35-33-84(34-36-85)32-18-16-14-12-10-9-11-13-15-17-31-77-67(89)46-25-29-56(58(38-46)91-6)80-68(90)65-63(51-23-20-24-54(73)64(51)75)71(44-76,60(82-65)42-70(3,4)5)53-28-26-47(72)39-55(53)74/h8,19-30,37-41,43,60,63,65,82H,1,9-18,31-36,42H2,2-7H3,(H,77,89)(H,79,87)(H,80,90)(H,78,81,83)/t60-,63-,65+,71-/m0/s1",UPZKEHBNYUDGOC-AFJHDGOUSA-N
575,,,>2000,,P00533,EGFR,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1293.402,1291.571641,13.92,92,9,14,5,27,207.87,C71H81Cl2F2N11O6,"InChI=1S/C71H81Cl2F2N11O6/c1-8-61(87)79-48-21-19-22-50(40-48)86-62(88)37-45(2)52-43-78-69(83-66(52)86)81-57-30-27-49(41-59(57)92-7)85-35-33-84(34-36-85)32-18-16-14-12-10-9-11-13-15-17-31-77-67(89)46-25-29-56(58(38-46)91-6)80-68(90)65-63(51-23-20-24-54(73)64(51)75)71(44-76,60(82-65)42-70(3,4)5)53-28-26-47(72)39-55(53)74/h8,19-30,37-41,43,60,63,65,82H,1,9-18,31-36,42H2,2-7H3,(H,77,89)(H,79,87)(H,80,90)(H,78,81,83)/t60-,63-,65+,71-/m0/s1",UPZKEHBNYUDGOC-AFJHDGOUSA-N
576,312.9,99,312.9,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1136.434,1135.567729,8.53,82,8,15,5,24,233.32,C62H77N11O8S,"InChI=1S/C62H77N11O8S/c1-8-52(75)66-44-18-17-19-46(33-44)73-55(78)32-40(2)48-37-64-61(69-58(48)73)67-49-27-26-45(34-51(49)81-7)70-28-30-71(31-29-70)54(77)21-16-14-12-10-9-11-13-15-20-53(76)68-57(62(4,5)6)60(80)72-38-47(74)35-50(72)59(79)63-36-42-22-24-43(25-23-42)56-41(3)65-39-82-56/h8,17-19,22-27,32-34,37,39,47,50,57,74H,1,9-16,20-21,28-31,35-36,38H2,2-7H3,(H,63,79)(H,66,75)(H,68,76)(H,64,67,69)/t47-,50+,57-/m1/s1",GSUQPNOGNRJJQO-YTFMVYPUSA-N
576,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1136.434,1135.567729,8.53,82,8,15,5,24,233.32,C62H77N11O8S,"InChI=1S/C62H77N11O8S/c1-8-52(75)66-44-18-17-19-46(33-44)73-55(78)32-40(2)48-37-64-61(69-58(48)73)67-49-27-26-45(34-51(49)81-7)70-28-30-71(31-29-70)54(77)21-16-14-12-10-9-11-13-15-20-53(76)68-57(62(4,5)6)60(80)72-38-47(74)35-50(72)59(79)63-36-42-22-24-43(25-23-42)56-41(3)65-39-82-56/h8,17-19,22-27,32-34,37,39,47,50,57,74H,1,9-16,20-21,28-31,35-36,38H2,2-7H3,(H,63,79)(H,66,75)(H,68,76)(H,64,67,69)/t47-,50+,57-/m1/s1",GSUQPNOGNRJJQO-YTFMVYPUSA-N
577,25.3,99,25.3,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1122.451,1121.588465,9.49,81,8,15,5,25,216.25,C62H79N11O7S,"InChI=1S/C62H79N11O7S/c1-8-53(75)66-45-19-18-20-47(34-45)73-55(77)33-41(2)49-38-64-61(69-58(49)73)67-50-27-26-46(35-52(50)80-7)71-31-29-70(30-32-71)28-17-15-13-11-9-10-12-14-16-21-54(76)68-57(62(4,5)6)60(79)72-39-48(74)36-51(72)59(78)63-37-43-22-24-44(25-23-43)56-42(3)65-40-81-56/h8,18-20,22-27,33-35,38,40,48,51,57,74H,1,9-17,21,28-32,36-37,39H2,2-7H3,(H,63,78)(H,66,75)(H,68,76)(H,64,67,69)/t48-,51+,57-/m1/s1",HQGHIKHHXKBFOJ-OIQPADLRSA-N
577,50.3,99,50.3,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1122.451,1121.588465,9.49,81,8,15,5,25,216.25,C62H79N11O7S,"InChI=1S/C62H79N11O7S/c1-8-53(75)66-45-19-18-20-47(34-45)73-55(77)33-41(2)49-38-64-61(69-58(49)73)67-50-27-26-46(35-52(50)80-7)71-31-29-70(30-32-71)28-17-15-13-11-9-10-12-14-16-21-54(76)68-57(62(4,5)6)60(79)72-39-48(74)36-51(72)59(78)63-37-43-22-24-44(25-23-43)56-42(3)65-40-81-56/h8,18-20,22-27,33-35,38,40,48,51,57,74H,1,9-17,21,28-32,36-37,39H2,2-7H3,(H,63,78)(H,66,75)(H,68,76)(H,64,67,69)/t48-,51+,57-/m1/s1",HQGHIKHHXKBFOJ-OIQPADLRSA-N
578,77,99,77,,P00533,EGFR L858R/T790M,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1279.331,1277.519606,11.88,91,9,14,5,24,224.94,C69H75Cl2F2N11O7,"InChI=1S/C69H75Cl2F2N11O7/c1-8-58(85)77-45-18-16-19-47(37-45)84-60(87)34-42(2)49-40-76-67(81-64(49)84)79-54-28-25-46(38-56(54)91-7)82-30-32-83(33-31-82)59(86)22-14-12-10-9-11-13-15-29-75-65(88)43-23-27-53(55(35-43)90-6)78-66(89)63-61(48-20-17-21-51(71)62(48)73)69(41-74,57(80-63)39-68(3,4)5)50-26-24-44(70)36-52(50)72/h8,16-21,23-28,34-38,40,57,61,63,80H,1,9-15,22,29-33,39H2,2-7H3,(H,75,88)(H,77,85)(H,78,89)(H,76,79,81)/t57-,61-,63+,69-/m0/s1",GDBFIWQFEZVSAL-RBRUZKMXSA-N
578,,,>2000,,P00533,EGFR,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1279.331,1277.519606,11.88,91,9,14,5,24,224.94,C69H75Cl2F2N11O7,"InChI=1S/C69H75Cl2F2N11O7/c1-8-58(85)77-45-18-16-19-47(37-45)84-60(87)34-42(2)49-40-76-67(81-64(49)84)79-54-28-25-46(38-56(54)91-7)82-30-32-83(33-31-82)59(86)22-14-12-10-9-11-13-15-29-75-65(88)43-23-27-53(55(35-43)90-6)78-66(89)63-61(48-20-17-21-51(71)62(48)73)69(41-74,57(80-63)39-68(3,4)5)50-26-24-44(70)36-52(50)72/h8,16-21,23-28,34-38,40,57,61,63,80H,1,9-15,22,29-33,39H2,2-7H3,(H,75,88)(H,77,85)(H,78,89)(H,76,79,81)/t57-,61-,63+,69-/m0/s1",GDBFIWQFEZVSAL-RBRUZKMXSA-N
579,,,>2000,,P00533,EGFR L858R/T790M,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1251.277,1249.488305,10.79,89,9,14,5,22,224.94,C67H71Cl2F2N11O7,"InChI=1S/C67H71Cl2F2N11O7/c1-8-56(83)75-43-16-14-17-45(35-43)82-58(85)32-40(2)47-38-74-65(79-62(47)82)77-52-26-23-44(36-54(52)89-7)80-28-30-81(31-29-80)57(84)20-12-10-9-11-13-27-73-63(86)41-21-25-51(53(33-41)88-6)76-64(87)61-59(46-18-15-19-49(69)60(46)71)67(39-72,55(78-61)37-66(3,4)5)48-24-22-42(68)34-50(48)70/h8,14-19,21-26,32-36,38,55,59,61,78H,1,9-13,20,27-31,37H2,2-7H3,(H,73,86)(H,75,83)(H,76,87)(H,74,77,79)/t55-,59-,61+,67-/m0/s1",GGZIIUYEYTZDCD-ASJDMNHUSA-N
579,,,>2000,,P00533,EGFR,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1251.277,1249.488305,10.79,89,9,14,5,22,224.94,C67H71Cl2F2N11O7,"InChI=1S/C67H71Cl2F2N11O7/c1-8-56(83)75-43-16-14-17-45(35-43)82-58(85)32-40(2)47-38-74-65(79-62(47)82)77-52-26-23-44(36-54(52)89-7)80-28-30-81(31-29-80)57(84)20-12-10-9-11-13-27-73-63(86)41-21-25-51(53(33-41)88-6)76-64(87)61-59(46-18-15-19-49(69)60(46)71)67(39-72,55(78-61)37-66(3,4)5)48-24-22-42(68)34-50(48)70/h8,14-19,21-26,32-36,38,55,59,61,78H,1,9-13,20,27-31,37H2,2-7H3,(H,73,86)(H,75,83)(H,76,87)(H,74,77,79)/t55-,59-,61+,67-/m0/s1",GGZIIUYEYTZDCD-ASJDMNHUSA-N
580,,,>2000,,P00533,EGFR L858R/T790M,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1223.223,1221.457005,9.71,87,9,14,5,20,224.94,C65H67Cl2F2N11O7,"InChI=1S/C65H67Cl2F2N11O7/c1-8-54(81)73-41-14-12-15-43(33-41)80-56(83)30-38(2)45-36-72-63(77-60(45)80)75-50-24-21-42(34-52(50)87-7)78-26-28-79(29-27-78)55(82)18-10-9-11-25-71-61(84)39-19-23-49(51(31-39)86-6)74-62(85)59-57(44-16-13-17-47(67)58(44)69)65(37-70,53(76-59)35-64(3,4)5)46-22-20-40(66)32-48(46)68/h8,12-17,19-24,30-34,36,53,57,59,76H,1,9-11,18,25-29,35H2,2-7H3,(H,71,84)(H,73,81)(H,74,85)(H,72,75,77)/t53-,57-,59+,65-/m0/s1",KFRDCTCOKBRAAL-OIUJZHHCSA-N
580,,,>2000,,P00533,EGFR,MDM2,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCNC(=O)C6=CC=C(NC(=O)[C@@H]7N[C@@H](CC(C)(C)C)[C@](C#N)(C8=CC=C(Cl)C=C8F)[C@H]7C7=CC=CC(Cl)=C7F)C(OC)=C6)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1223.223,1221.457005,9.71,87,9,14,5,20,224.94,C65H67Cl2F2N11O7,"InChI=1S/C65H67Cl2F2N11O7/c1-8-54(81)73-41-14-12-15-43(33-41)80-56(83)30-38(2)45-36-72-63(77-60(45)80)75-50-24-21-42(34-52(50)87-7)78-26-28-79(29-27-78)55(82)18-10-9-11-25-71-61(84)39-19-23-49(51(31-39)86-6)74-62(85)59-57(44-16-13-17-47(67)58(44)69)65(37-70,53(76-59)35-64(3,4)5)46-22-20-40(66)32-48(46)68/h8,12-17,19-24,30-34,36,53,57,59,76H,1,9-11,18,25-29,35H2,2-7H3,(H,71,84)(H,73,81)(H,74,85)(H,72,75,77)/t53-,57-,59+,65-/m0/s1",KFRDCTCOKBRAAL-OIUJZHHCSA-N
581,69,99,69,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1108.38,1107.536429,7.44,80,8,15,5,22,233.32,C60H73N11O8S,"InChI=1S/C60H73N11O8S/c1-8-50(73)64-42-16-15-17-44(31-42)71-53(76)30-38(2)46-35-62-59(67-56(46)71)65-47-25-24-43(32-49(47)79-7)68-26-28-69(29-27-68)52(75)19-14-12-10-9-11-13-18-51(74)66-55(60(4,5)6)58(78)70-36-45(72)33-48(70)57(77)61-34-40-20-22-41(23-21-40)54-39(3)63-37-80-54/h8,15-17,20-25,30-32,35,37,45,48,55,72H,1,9-14,18-19,26-29,33-34,36H2,2-7H3,(H,61,77)(H,64,73)(H,66,74)(H,62,65,67)/t45-,48+,55-/m1/s1",NXHJICMMHCOKPI-ZRJZPVMUSA-N
581,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1108.38,1107.536429,7.44,80,8,15,5,22,233.32,C60H73N11O8S,"InChI=1S/C60H73N11O8S/c1-8-50(73)64-42-16-15-17-44(31-42)71-53(76)30-38(2)46-35-62-59(67-56(46)71)65-47-25-24-43(32-49(47)79-7)68-26-28-69(29-27-68)52(75)19-14-12-10-9-11-13-18-51(74)66-55(60(4,5)6)58(78)70-36-45(72)33-48(70)57(77)61-34-40-20-22-41(23-21-40)54-39(3)63-37-80-54/h8,15-17,20-25,30-32,35,37,45,48,55,72H,1,9-14,18-19,26-29,33-34,36H2,2-7H3,(H,61,77)(H,64,73)(H,66,74)(H,62,65,67)/t45-,48+,55-/m1/s1",NXHJICMMHCOKPI-ZRJZPVMUSA-N
582,235,99,235,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1080.326,1079.505129,6.36,78,8,15,5,20,233.32,C58H69N11O8S,"InChI=1S/C58H69N11O8S/c1-8-48(71)62-40-14-13-15-42(29-40)69-51(74)28-36(2)44-33-60-57(65-54(44)69)63-45-23-22-41(30-47(45)77-7)66-24-26-67(27-25-66)50(73)17-12-10-9-11-16-49(72)64-53(58(4,5)6)56(76)68-34-43(70)31-46(68)55(75)59-32-38-18-20-39(21-19-38)52-37(3)61-35-78-52/h8,13-15,18-23,28-30,33,35,43,46,53,70H,1,9-12,16-17,24-27,31-32,34H2,2-7H3,(H,59,75)(H,62,71)(H,64,72)(H,60,63,65)/t43-,46+,53-/m1/s1",HQDMTJMOYXRLMD-BSDSDUADSA-N
582,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1080.326,1079.505129,6.36,78,8,15,5,20,233.32,C58H69N11O8S,"InChI=1S/C58H69N11O8S/c1-8-48(71)62-40-14-13-15-42(29-40)69-51(74)28-36(2)44-33-60-57(65-54(44)69)63-45-23-22-41(30-47(45)77-7)66-24-26-67(27-25-66)50(73)17-12-10-9-11-16-49(72)64-53(58(4,5)6)56(76)68-34-43(70)31-46(68)55(75)59-32-38-18-20-39(21-19-38)52-37(3)61-35-78-52/h8,13-15,18-23,28-30,33,35,43,46,53,70H,1,9-12,16-17,24-27,31-32,34H2,2-7H3,(H,59,75)(H,62,71)(H,64,72)(H,60,63,65)/t43-,46+,53-/m1/s1",HQDMTJMOYXRLMD-BSDSDUADSA-N
583,,,>2000,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1052.272,1051.473829,5.28,76,8,15,5,18,233.32,C56H65N11O8S,"InChI=1S/C56H65N11O8S/c1-8-46(69)60-38-12-11-13-40(27-38)67-49(72)26-34(2)42-31-58-55(63-52(42)67)61-43-21-20-39(28-45(43)75-7)64-22-24-65(25-23-64)48(71)15-10-9-14-47(70)62-51(56(4,5)6)54(74)66-32-41(68)29-44(66)53(73)57-30-36-16-18-37(19-17-36)50-35(3)59-33-76-50/h8,11-13,16-21,26-28,31,33,41,44,51,68H,1,9-10,14-15,22-25,29-30,32H2,2-7H3,(H,57,73)(H,60,69)(H,62,70)(H,58,61,63)/t41-,44+,51-/m1/s1",SUWGYDIQBJOKHS-MSYDQUDQSA-N
583,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1052.272,1051.473829,5.28,76,8,15,5,18,233.32,C56H65N11O8S,"InChI=1S/C56H65N11O8S/c1-8-46(69)60-38-12-11-13-40(27-38)67-49(72)26-34(2)42-31-58-55(63-52(42)67)61-43-21-20-39(28-45(43)75-7)64-22-24-65(25-23-64)48(71)15-10-9-14-47(70)62-51(56(4,5)6)54(74)66-32-41(68)29-44(66)53(73)57-30-36-16-18-37(19-17-36)50-35(3)59-33-76-50/h8,11-13,16-21,26-28,31,33,41,44,51,68H,1,9-10,14-15,22-25,29-30,32H2,2-7H3,(H,57,73)(H,60,69)(H,62,70)(H,58,61,63)/t41-,44+,51-/m1/s1",SUWGYDIQBJOKHS-MSYDQUDQSA-N
584,132,99,132,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1094.397,1093.557165,8.41,79,8,15,5,23,216.25,C60H75N11O7S,"InChI=1S/C60H75N11O7S/c1-8-51(73)64-43-17-16-18-45(32-43)71-53(75)31-39(2)47-36-62-59(67-56(47)71)65-48-25-24-44(33-50(48)78-7)69-29-27-68(28-30-69)26-15-13-11-9-10-12-14-19-52(74)66-55(60(4,5)6)58(77)70-37-46(72)34-49(70)57(76)61-35-41-20-22-42(23-21-41)54-40(3)63-38-79-54/h8,16-18,20-25,31-33,36,38,46,49,55,72H,1,9-15,19,26-30,34-35,37H2,2-7H3,(H,61,76)(H,64,73)(H,66,74)(H,62,65,67)/t46-,49+,55-/m1/s1",WWVCWKWNVMYOAL-CKCQHBCRSA-N
584,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1094.397,1093.557165,8.41,79,8,15,5,23,216.25,C60H75N11O7S,"InChI=1S/C60H75N11O7S/c1-8-51(73)64-43-17-16-18-45(32-43)71-53(75)31-39(2)47-36-62-59(67-56(47)71)65-48-25-24-44(33-50(48)78-7)69-29-27-68(28-30-69)26-15-13-11-9-10-12-14-19-52(74)66-55(60(4,5)6)58(77)70-37-46(72)34-49(70)57(76)61-35-41-20-22-42(23-21-41)54-40(3)63-38-79-54/h8,16-18,20-25,31-33,36,38,46,49,55,72H,1,9-15,19,26-30,34-35,37H2,2-7H3,(H,61,76)(H,64,73)(H,66,74)(H,62,65,67)/t46-,49+,55-/m1/s1",WWVCWKWNVMYOAL-CKCQHBCRSA-N
585,466,99,466,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1066.343,1065.525865,7.32,77,8,15,5,21,216.25,C58H71N11O7S,"InChI=1S/C58H71N11O7S/c1-8-49(71)62-41-15-14-16-43(30-41)69-51(73)29-37(2)45-34-60-57(65-54(45)69)63-46-23-22-42(31-48(46)76-7)67-27-25-66(26-28-67)24-13-11-9-10-12-17-50(72)64-53(58(4,5)6)56(75)68-35-44(70)32-47(68)55(74)59-33-39-18-20-40(21-19-39)52-38(3)61-36-77-52/h8,14-16,18-23,29-31,34,36,44,47,53,70H,1,9-13,17,24-28,32-33,35H2,2-7H3,(H,59,74)(H,62,71)(H,64,72)(H,60,63,65)/t44-,47+,53-/m1/s1",UKICTJWYEJNYHR-JSYKSQSDSA-N
585,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1066.343,1065.525865,7.32,77,8,15,5,21,216.25,C58H71N11O7S,"InChI=1S/C58H71N11O7S/c1-8-49(71)62-41-15-14-16-43(30-41)69-51(73)29-37(2)45-34-60-57(65-54(45)69)63-46-23-22-42(31-48(46)76-7)67-27-25-66(26-28-67)24-13-11-9-10-12-17-50(72)64-53(58(4,5)6)56(75)68-35-44(70)32-47(68)55(74)59-33-39-18-20-40(21-19-39)52-38(3)61-36-77-52/h8,14-16,18-23,29-31,34,36,44,47,53,70H,1,9-13,17,24-28,32-33,35H2,2-7H3,(H,59,74)(H,62,71)(H,64,72)(H,60,63,65)/t44-,47+,53-/m1/s1",UKICTJWYEJNYHR-JSYKSQSDSA-N
586,5.9,99,5.9,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,19.3,Inhibition of EGFR L858R/T790M by ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,506,Inhibit proliferation of H1975 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1038.289,1037.494564,6.24,75,8,15,5,19,216.25,C56H67N11O7S,"InChI=1S/C56H67N11O7S/c1-8-47(69)60-39-13-12-14-41(28-39)67-49(71)27-35(2)43-32-58-55(63-52(43)67)61-44-21-20-40(29-46(44)74-7)65-25-23-64(24-26-65)22-11-9-10-15-48(70)62-51(56(4,5)6)54(73)66-33-42(68)30-45(66)53(72)57-31-37-16-18-38(19-17-37)50-36(3)59-34-75-50/h8,12-14,16-21,27-29,32,34,42,45,51,68H,1,9-11,15,22-26,30-31,33H2,2-7H3,(H,57,72)(H,60,69)(H,62,70)(H,58,61,63)/t42-,45+,51-/m1/s1",CBWIPIZLLNOTMZ-PDMHGPQCSA-N
586,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,>1000,Inhibition of EGFR by ELISA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,506,Inhibit proliferation of H1975 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1038.289,1037.494564,6.24,75,8,15,5,19,216.25,C56H67N11O7S,"InChI=1S/C56H67N11O7S/c1-8-47(69)60-39-13-12-14-41(28-39)67-49(71)27-35(2)43-32-58-55(63-52(43)67)61-44-21-20-40(29-46(44)74-7)65-25-23-64(24-26-65)22-11-9-10-15-48(70)62-51(56(4,5)6)54(73)66-33-42(68)30-45(66)53(72)57-31-37-16-18-38(19-17-37)50-36(3)59-34-75-50/h8,12-14,16-21,27-29,32,34,42,45,51,68H,1,9-11,15,22-26,30-31,33H2,2-7H3,(H,57,72)(H,60,69)(H,62,70)(H,58,61,63)/t42-,45+,51-/m1/s1",CBWIPIZLLNOTMZ-PDMHGPQCSA-N
587,,,>2000,,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1010.235,1009.463264,5.53,73,8,15,5,17,216.25,C54H63N11O7S,"InChI=1S/C54H63N11O7S/c1-8-45(67)58-37-11-9-12-39(26-37)65-47(69)25-33(2)41-30-56-53(61-50(41)65)59-42-19-18-38(27-44(42)72-7)63-23-21-62(22-24-63)20-10-13-46(68)60-49(54(4,5)6)52(71)64-31-40(66)28-43(64)51(70)55-29-35-14-16-36(17-15-35)48-34(3)57-32-73-48/h8-9,11-12,14-19,25-27,30,32,40,43,49,66H,1,10,13,20-24,28-29,31H2,2-7H3,(H,55,70)(H,58,67)(H,60,68)(H,56,59,61)/t40-,43+,49-/m1/s1",GHHZCEDRWNWCTG-PCGSYBQZSA-N
587,,,>2000,,P00533,EGFR,VHL,,,C=CC(=O)NC1=CC=CC(N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)=C1,Degradation of EGFR in A431 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112199,1010.235,1009.463264,5.53,73,8,15,5,17,216.25,C54H63N11O7S,"InChI=1S/C54H63N11O7S/c1-8-45(67)58-37-11-9-12-39(26-37)65-47(69)25-33(2)41-30-56-53(61-50(41)65)59-42-19-18-38(27-44(42)72-7)63-23-21-62(22-24-63)20-10-13-46(68)60-49(54(4,5)6)52(71)64-31-40(66)28-43(64)51(70)55-29-35-14-16-36(17-15-35)48-34(3)57-32-73-48/h8-9,11-12,14-19,25-27,30,32,40,43,49,66H,1,10,13,20-24,28-29,31H2,2-7H3,(H,55,70)(H,58,67)(H,60,68)(H,56,59,61)/t40-,43+,49-/m1/s1",GHHZCEDRWNWCTG-PCGSYBQZSA-N
593,3.3,99,3.3,,P00533,EGFR L858R,VHL,,MS39,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCN(C(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,Degradation of EGFR L858R in H3255 cells after 16 h treatment,,,,,,,12,Kd of EGFR L858R was assessed by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01566,1056.747,1055.486973,9.13,74,7,13,4,24,191.45,C55H71ClFN9O7S,"InChI=1S/C55H71ClFN9O7S/c1-36-50(74-35-61-36)38-18-16-37(17-19-38)32-58-53(70)45-29-40(67)33-66(45)54(71)51(55(2,3)4)63-48(68)14-11-9-7-6-8-10-12-15-49(69)65-25-23-64(24-26-65)22-13-27-73-47-30-41-44(31-46(47)72-5)59-34-60-52(41)62-39-20-21-43(57)42(56)28-39/h16-21,28,30-31,34-35,40,45,51,67H,6-15,22-27,29,32-33H2,1-5H3,(H,58,70)(H,63,68)(H,59,60,62)/t40-,45+,51-/m1/s1",HLFLODKZIGYHNR-LTEFSYCBSA-N
593,5,99,5,,P00533,EGFR e19d,VHL,,MS39,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCN(C(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,Degradation of EGFR e19d in HCC-827 cells after 16 h treatment,,,,,,,11,Kd of EGFR WT was assessed by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01566,1056.747,1055.486973,9.13,74,7,13,4,24,191.45,C55H71ClFN9O7S,"InChI=1S/C55H71ClFN9O7S/c1-36-50(74-35-61-36)38-18-16-37(17-19-38)32-58-53(70)45-29-40(67)33-66(45)54(71)51(55(2,3)4)63-48(68)14-11-9-7-6-8-10-12-15-49(69)65-25-23-64(24-26-65)22-13-27-73-47-30-41-44(31-46(47)72-5)59-34-60-52(41)62-39-20-21-43(57)42(56)28-39/h16-21,28,30-31,34-35,40,45,51,67H,6-15,22-27,29,32-33H2,1-5H3,(H,58,70)(H,63,68)(H,59,60,62)/t40-,45+,51-/m1/s1",HLFLODKZIGYHNR-LTEFSYCBSA-N
597,11,99,11,,P00533,EGFR e19d,CRBN,,MS154,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCN(CCC(=O)NCCCCCCCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EGFR e19d in HCC-827 cells after 16 h treatment,,,,,,,1.8,Kd of EGFR WT was assessed by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01566,901.437,900.3737166,5.92,64,7,13,3,22,184.63,C46H54ClFN8O8,"InChI=1S/C46H54ClFN8O8/c1-62-38-28-35-32(43(51-29-50-35)52-30-12-13-34(48)33(47)26-30)27-39(38)64-25-9-18-54-20-22-55(23-21-54)19-16-40(57)49-17-6-4-2-3-5-7-24-63-37-11-8-10-31-42(37)46(61)56(45(31)60)36-14-15-41(58)53-44(36)59/h8,10-13,26-29,36H,2-7,9,14-25H2,1H3,(H,49,57)(H,50,51,52)(H,53,58,59)",ALKKWBPMCDDKKA-UHFFFAOYSA-N
597,25,99,25,,P00533,EGFR L858R,CRBN,,MS154,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCN(CCC(=O)NCCCCCCCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EGFR L858R in H3255 cells after 16 h treatment,,,,,,,3.8,Kd of EGFR L858R was assessed by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01566,901.437,900.3737166,5.92,64,7,13,3,22,184.63,C46H54ClFN8O8,"InChI=1S/C46H54ClFN8O8/c1-62-38-28-35-32(43(51-29-50-35)52-30-12-13-34(48)33(47)26-30)27-39(38)64-25-9-18-54-20-22-55(23-21-54)19-16-40(57)49-17-6-4-2-3-5-7-24-63-37-11-8-10-31-42(37)46(61)56(45(31)60)36-14-15-41(58)53-44(36)59/h8,10-13,26-29,36H,2-7,9,14-25H2,1H3,(H,49,57)(H,50,51,52)(H,53,58,59)",ALKKWBPMCDDKKA-UHFFFAOYSA-N
610,33,99,33,,P50750,CDK9,CRBN,,,O=C(CCC(=O)N1CCN(CC2=CC=C(NC(=O)C3=C(NC4=NC=NC5=C4C=C[NH]5)C=N[NH]3)C=C2)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of CDK9 in PC-3 cells after 24 h treatment,,,14.5,Inhibition of CDK9/cyclin T1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120,Inhibit proliferation of PC-3 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.111952,815.852,815.3251907,1.28,60,8,13,7,14,259.61,C40H41N13O7,"InChI=1S/C40H41N13O7/c54-30(42-15-14-41-27-3-1-2-25-33(27)40(60)53(39(25)59)29-8-9-31(55)49-37(29)57)10-11-32(56)52-18-16-51(17-19-52)21-23-4-6-24(7-5-23)47-38(58)34-28(20-46-50-34)48-36-26-12-13-43-35(26)44-22-45-36/h1-7,12-13,20,22,29,41H,8-11,14-19,21H2,(H,42,54)(H,46,50)(H,47,58)(H,49,55,57)(H2,43,44,45,48)",BRYMZSSAIDEFEM-UHFFFAOYSA-N
610,62,99,62,,P24941,CDK2,CRBN,,,O=C(CCC(=O)N1CCN(CC2=CC=C(NC(=O)C3=C(NC4=NC=NC5=C4C=C[NH]5)C=N[NH]3)C=C2)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of CDK2 in PC-3 cells after 24 h treatment,,,7.42,Inhibition of CDK2/cyclin A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120,Inhibit proliferation of PC-3 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.111952,815.852,815.3251907,1.28,60,8,13,7,14,259.61,C40H41N13O7,"InChI=1S/C40H41N13O7/c54-30(42-15-14-41-27-3-1-2-25-33(27)40(60)53(39(25)59)29-8-9-31(55)49-37(29)57)10-11-32(56)52-18-16-51(17-19-52)21-23-4-6-24(7-5-23)47-38(58)34-28(20-46-50-34)48-36-26-12-13-43-35(26)44-22-45-36/h1-7,12-13,20,22,29,41H,8-11,14-19,21H2,(H,42,54)(H,46,50)(H,47,58)(H,49,55,57)(H2,43,44,45,48)",BRYMZSSAIDEFEM-UHFFFAOYSA-N
624,93,99,93,,Q07817,BCL-xL,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCN(CC[C@H](CSC4=CC=CC=C4)NC4=CC=C(S(=O)(=O)NC(=O)C5=CC=C(N6CCN(CC7=C(C8=CC=C(Cl)C=C8)CCC(C)(C)C7)CC6)C=C5)C=C4S(=O)(=O)C(F)(F)F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,82/76/203,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1514.38,1512.588521,13.25,103,10,17,5,28,234,C76H96ClF3N10O9S4,"InChI=1S/C76H96ClF3N10O9S4/c1-51(53-17-19-55(20-18-53)69-52(2)81-50-101-69)82-72(94)66-44-61(91)48-90(66)73(95)70(74(3,4)5)84-68(92)16-12-9-13-34-86-36-38-87(39-37-86)35-32-59(49-100-62-14-10-8-11-15-62)83-65-30-29-63(45-67(65)102(96,97)76(78,79)80)103(98,99)85-71(93)56-23-27-60(28-24-56)89-42-40-88(41-43-89)47-57-46-75(6,7)33-31-64(57)54-21-25-58(77)26-22-54/h8,10-11,14-15,17-30,45,50-51,59,61,66,70,83,91H,9,12-13,16,31-44,46-49H2,1-7H3,(H,82,94)(H,84,92)(H,85,93)/t51-,59+,61+,66-,70+/m0/s1",FQLHSKINBMZPFV-WTFVIAODSA-N
635,71,99,71,,Q07817,BCL-xL,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN(C)CC[C@H](CSC3=CC=CC=C3)NC3=CC=C(S(=O)(=O)NC(=O)C4=CC=C(N5CCN(CC6=C(C7=CC=C(Cl)C=C7)CCC(C)(C)C6)CC5)C=C4)C=C3S(=O)(=O)C(F)(F)F)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,81.3/189/265,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1473.327,1471.561972,13.98,100,9,16,5,29,230.76,C74H93ClF3N9O9S4,"InChI=1S/C74H93ClF3N9O9S4/c1-49(51-19-21-53(22-20-51)67-50(2)79-48-98-67)80-70(91)64-42-59(88)46-87(64)71(92)68(72(3,4)5)82-66(89)18-14-9-10-15-36-84(8)37-34-57(47-97-60-16-12-11-13-17-60)81-63-32-31-61(43-65(63)99(93,94)74(76,77)78)100(95,96)83-69(90)54-25-29-58(30-26-54)86-40-38-85(39-41-86)45-55-44-73(6,7)35-33-62(55)52-23-27-56(75)28-24-52/h11-13,16-17,19-32,43,48-49,57,59,64,68,81,88H,9-10,14-15,18,33-42,44-47H2,1-8H3,(H,80,91)(H,82,89)(H,83,90)/t49-,57+,59+,64-,68+/m0/s1",CZOKQVGGYUWHCE-OIWNBYFASA-N
657,4.5,99,4.5,,Q07817,BCL-xL,CRBN,,,CC1(C)CCC(C2=CC=C(Cl)C=C2)=C(CN2CCN(C3=CC=C(C(=O)NS(=O)(=O)C4=CC=C(N[C@H](CCN5CCN(CCOCCOCCOCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CSC5=CC=CC=C5)C(S(=O)(=O)C(F)(F)F)=C4)C=C3)CC2)C1,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17.3/38.5/24.6,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1405.095,1403.480744,9.75,96,10,19,4,30,245.64,C68H81ClF3N9O12S3,"InChI=1S/C68H81ClF3N9O12S3/c1-67(2)25-23-55(47-11-15-50(69)16-12-47)49(44-67)45-79-32-34-80(35-33-79)52-17-13-48(14-18-52)63(83)76-96(89,90)54-19-20-57(60(43-54)95(87,88)68(70,71)72)74-51(46-94-53-7-4-3-5-8-53)24-27-77-28-30-78(31-29-77)36-38-92-40-42-93-41-39-91-37-26-73-58-10-6-9-56-62(58)66(86)81(65(56)85)59-21-22-61(82)75-64(59)84/h3-20,43,51,59,73-74H,21-42,44-46H2,1-2H3,(H,76,83)(H,75,82,84)/t51-,59?/m1/s1",NCWWDSSVLZQYKO-HTEBOMBNSA-N
662,6.3,99,6.3,,Q07817,BCL-xL,CRBN,,,CN(CCCCCCCN1C=C(COCCOCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)N=N1)CC[C@H](CSC1=CC=CC=C1)NC1=CC=C(S(=O)(=O)NC(=O)C2=CC=C(N3CCN(CC4=C(C5=CC=C(Cl)C=C5)CCC(C)(C)C4)CC3)C=C2)C=C1S(=O)(=O)C(F)(F)F,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,29.2/62.2/61.7,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1457.175,1455.523278,11.29,100,10,20,4,34,263.88,C71H85ClF3N11O11S3,"InChI=1S/C71H85ClF3N11O11S3/c1-70(2)31-29-58(49-17-21-52(72)22-18-49)51(44-70)45-83-36-38-84(39-37-83)55-23-19-50(20-24-55)66(88)80-100(94,95)57-25-26-60(63(43-57)99(92,93)71(73,74)75)77-53(48-98-56-13-8-7-9-14-56)30-35-82(3)33-10-5-4-6-11-34-85-46-54(79-81-85)47-97-42-41-96-40-32-76-61-16-12-15-59-65(61)69(91)86(68(59)90)62-27-28-64(87)78-67(62)89/h7-9,12-26,43,46,53,62,76-77H,4-6,10-11,27-42,44-45,47-48H2,1-3H3,(H,80,88)(H,78,87,89)/t53-,62?/m1/s1",ZFKTXHMPLCYQMU-YOHLDDLQSA-N
664,10.6,99,10.6,,Q07817,BCL-xL,CRBN,,,CN(CCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@H](CSC1=CC=CC=C1)NC1=CC=C(S(=O)(=O)NC(=O)C2=CC=C(N3CCN(CC4=C(C5=CC=C(Cl)C=C5)CCC(C)(C)C4)CC3)C=C2)C=C1S(=O)(=O)C(F)(F)F,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.5/129/70.2,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1231.883,1230.375551,10.74,84,9,15,4,22,214.71,C60H66ClF3N8O9S3,"InChI=1S/C60H66ClF3N8O9S3/c1-59(2)27-25-47(39-13-17-42(61)18-14-39)41(36-59)37-70-31-33-71(34-32-70)44-19-15-40(16-20-44)55(74)68-84(80,81)46-21-22-49(52(35-46)83(78,79)60(62,63)64)66-43(38-82-45-9-5-4-6-10-45)26-30-69(3)29-8-28-65-50-12-7-11-48-54(50)58(77)72(57(48)76)51-23-24-53(73)67-56(51)75/h4-7,9-22,35,43,51,65-66H,8,23-34,36-38H2,1-3H3,(H,68,74)(H,67,73,75)/t43-,51?/m1/s1",HUFMCQSCXIKKGP-KYNVYPTLSA-N
670,2.5,99,2.5,,Q07817,BCL-xL,CRBN,,XZ739,CN(CCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@H](CSC1=CC=CC=C1)NC1=CC=C(S(=O)(=O)NC(=O)C2=CC=C(N3CCN(CC4=C(C5=CC=C(Cl)C=C5)CCC(C)(C)C4)CC3)C=C2)C=C1S(=O)(=O)C(F)(F)F,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1/41.8/25.3,Inhibit viability of MOLT-4 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1350.015,1348.438545,9.94,92,9,18,4,30,242.4,C65H76ClF3N8O12S3,"InChI=1S/C65H76ClF3N8O12S3/c1-64(2)26-24-52(44-12-16-47(66)17-13-44)46(41-64)42-75-29-31-76(32-30-75)49-18-14-45(15-19-49)60(79)73-92(85,86)51-20-21-54(57(40-51)91(83,84)65(67,68)69)71-48(43-90-50-8-5-4-6-9-50)25-28-74(3)33-35-88-37-39-89-38-36-87-34-27-70-55-11-7-10-53-59(55)63(82)77(62(53)81)56-22-23-58(78)72-61(56)80/h4-21,40,48,56,70-71H,22-39,41-43H2,1-3H3,(H,73,79)(H,72,78,80)/t48-,56?/m1/s1",RTASGZOITGGVPZ-YJUSKGKKSA-N
697,53,99,53,,Q07817,BCL-xL,VHL,,DT2216,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC[C@H](CSC4=CC=CC=C4)NC4=CC=C(S(=O)(=O)NC(=O)C5=CC=C(N6CCN(CC7=C(C8=CC=C(Cl)C=C8)CCC(C)(C)C7)CC6)C=C5)C=C4S(=O)(=O)C(F)(F)F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77.1/213/278,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112186,1542.39,1540.583436,12.83,105,10,17,5,28,251.07,C77H96ClF3N10O10S4,"InChI=1S/C77H96ClF3N10O10S4/c1-51(53-18-20-55(21-19-53)70-52(2)82-50-103-70)83-73(96)66-44-61(92)48-91(66)74(97)71(75(3,4)5)85-68(93)16-12-9-13-17-69(94)90-42-36-87(37-43-90)35-33-59(49-102-62-14-10-8-11-15-62)84-65-31-30-63(45-67(65)104(98,99)77(79,80)81)105(100,101)86-72(95)56-24-28-60(29-25-56)89-40-38-88(39-41-89)47-57-46-76(6,7)34-32-64(57)54-22-26-58(78)27-23-54/h8,10-11,14-15,18-31,45,50-51,59,61,66,71,84,92H,9,12-13,16-17,32-44,46-49H2,1-7H3,(H,83,96)(H,85,93)(H,86,95)/t51-,59+,61+,66-,71+/m0/s1",PXVFFBGSTYQHRO-REQIQPEASA-N
697,63,90.8,63/>3000,90.8/26,Q07817,BCL-xL,VHL,,DT2216,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC[C@H](CSC4=CC=CC=C4)NC4=CC=C(S(=O)(=O)NC(=O)C5=CC=C(N6CCN(CC7=C(C8=CC=C(Cl)C=C8)CCC(C)(C)C7)CC6)C=C5)C=C4S(=O)(=O)C(F)(F)F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4/platelets cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,52/23/160,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,10.1038/s41591-019-0668-z,1542.39,1540.583436,12.83,105,10,17,5,28,251.07,C77H96ClF3N10O10S4,"InChI=1S/C77H96ClF3N10O10S4/c1-51(53-18-20-55(21-19-53)70-52(2)82-50-103-70)83-73(96)66-44-61(92)48-91(66)74(97)71(75(3,4)5)85-68(93)16-12-9-13-17-69(94)90-42-36-87(37-43-90)35-33-59(49-102-62-14-10-8-11-15-62)84-65-31-30-63(45-67(65)104(98,99)77(79,80)81)105(100,101)86-72(95)56-24-28-60(29-25-56)89-40-38-88(39-41-89)47-57-46-76(6,7)34-32-64(57)54-22-26-58(78)27-23-54/h8,10-11,14-15,18-31,45,50-51,59,61,66,71,84,92H,9,12-13,16-17,32-44,46-49H2,1-7H3,(H,83,96)(H,85,93)(H,86,95)/t51-,59+,61+,66-,71+/m0/s1",PXVFFBGSTYQHRO-REQIQPEASA-N
701,0.8,99,0.8,,Q00534,CDK6,CRBN,,BSJ-02-162,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,8,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,831.935,831.3816429,2.78,61,8,15,4,14,220.93,C43H49N11O7,"InChI=1S/C43H49N11O7/c1-25-30-23-47-43(50-38(30)53(27-8-3-4-9-27)41(60)36(25)26(2)55)48-33-14-12-28(22-46-33)52-20-18-51(19-21-52)17-6-5-16-44-35(57)24-45-31-11-7-10-29-37(31)42(61)54(40(29)59)32-13-15-34(56)49-39(32)58/h7,10-12,14,22-23,27,32,45H,3-6,8-9,13,15-21,24H2,1-2H3,(H,44,57)(H,49,56,58)(H,46,47,48,50)",AWPNCYPNCSCZFL-UHFFFAOYSA-N
701,10,99,10,,P11802,CDK4,CRBN,,BSJ-02-162,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,3,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,831.935,831.3816429,2.78,61,8,15,4,14,220.93,C43H49N11O7,"InChI=1S/C43H49N11O7/c1-25-30-23-47-43(50-38(30)53(27-8-3-4-9-27)41(60)36(25)26(2)55)48-33-14-12-28(22-46-33)52-20-18-51(19-21-52)17-6-5-16-44-35(57)24-45-31-11-7-10-29-37(31)42(61)54(40(29)59)32-13-15-34(56)49-39(32)58/h7,10-12,14,22-23,27,32,45H,3-6,8-9,13,15-21,24H2,1-2H3,(H,44,57)(H,49,56,58)(H,46,47,48,50)",AWPNCYPNCSCZFL-UHFFFAOYSA-N
714,48,83.4,48,83.4,O43924,PDEdelta,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCNC(=O)C4=CC=C(CN(CC5CCNCC5)S(=O)(=O)C5=CC=C(S(=O)(=O)N(CC6=CC=C(Cl)C=C6)C6CCCC6)C=C5)C=C4)=C3C2=O)C(=O)N1,Degradation of PDEdelta in Panc Tu-I cells after 24 h treatment,,,,,,,64.3,Kd was determined by competitive fluorescent polarization analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.9,Kd between CRBN and the complex of protac and PDEdelta was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.201913904,1134.772,1133.400505,4.54,78,8,15,4,29,248.39,C55H68ClN7O13S2,"InChI=1S/C55H68ClN7O13S2/c56-43-14-10-40(11-15-43)38-62(44-4-1-2-5-44)78(71,72)46-18-16-45(17-19-46)77(69,70)61(37-41-22-24-57-25-23-41)36-39-8-12-42(13-9-39)52(65)59-27-29-74-31-33-76-35-34-75-32-30-73-28-26-58-48-7-3-6-47-51(48)55(68)63(54(47)67)49-20-21-50(64)60-53(49)66/h3,6-19,41,44,49,57-58H,1-2,4-5,20-38H2,(H,59,65)(H,60,64,66)",OWYXKRGXEAHYMU-UHFFFAOYSA-N
717,50,99,50,,Q07817,BCL-xL,CRBN,,XZ424,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCC4=CN(CCCC(=O)N5CCN(CC#CC6=CC=C(OCCCC7=C(C(=O)O)N=C(N8CCC9=CC=CC(C(=O)NC%10=NC%11=CC=CC=C%11S%10)=C9C8)S7)C(F)=C6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of BCL-xL in MOLT-4 cells after 16 h treatment,,,,,,,,,0.009,Ki was determined by AlphaScreen competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,Inhibit viability of MOLT-4 cells,,,,,,,,,,,,,10.1039/c9cc07217a,1221.364,1220.400821,3.73,87,11,20,4,24,272.95,C61H61FN12O11S2,"InChI=1S/C61H61FN12O11S2/c62-44-34-38(17-19-48(44)85-30-7-15-50-54(59(81)82)66-61(87-50)72-25-21-39-9-3-10-41(43(39)36-72)55(77)67-60-64-45-12-1-2-14-49(45)86-60)8-5-23-70-26-28-71(29-27-70)52(76)16-6-24-73-35-40(68-69-73)37-84-33-32-83-31-22-63-46-13-4-11-42-53(46)58(80)74(57(42)79)47-18-20-51(75)65-56(47)78/h1-4,9-14,17,19,34-35,47,63H,6-7,15-16,18,20-33,36-37H2,(H,81,82)(H,64,67,77)(H,65,75,78)",KDSYVLYKZZKENZ-UHFFFAOYSA-N
719,12.9,99,12.9,,P11802,CDK4,CRBN,,pal-pom,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in MDA-MB-231 cells after 18 h treatment,,,,,,,900,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc00163h,897.998,897.403441,2.14,66,9,17,3,15,239.61,C46H51N13O7,"InChI=1S/C46H51N13O7/c1-27-33-24-48-46(52-41(33)58(30-9-5-6-10-30)44(65)39(27)28(2)60)50-36-16-14-31(23-47-36)56-21-19-55(20-22-56)25-29-26-57(54-53-29)18-7-3-4-13-37(61)49-34-12-8-11-32-40(34)45(66)59(43(32)64)35-15-17-38(62)51-42(35)63/h8,11-12,14,16,23-24,26,30,35H,3-7,9-10,13,15,17-22,25H2,1-2H3,(H,49,61)(H,51,62,63)(H,47,48,50,52)",JSJGLYIYFOFJTA-UHFFFAOYSA-N
719,34.1,99,34.1,,Q00534,CDK6,CRBN,,pal-pom,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in MDA-MB-231 cells after 18 h treatment,,,,,,,235,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc00163h,897.998,897.403441,2.14,66,9,17,3,15,239.61,C46H51N13O7,"InChI=1S/C46H51N13O7/c1-27-33-24-48-46(52-41(33)58(30-9-5-6-10-30)44(65)39(27)28(2)60)50-36-16-14-31(23-47-36)56-21-19-55(20-22-56)25-29-26-57(54-53-29)18-7-3-4-13-37(61)49-34-12-8-11-32-40(34)45(66)59(43(32)64)35-15-17-38(62)51-42(35)63/h8,11-12,14,16,23-24,26,30,35H,3-7,9-10,13,15,17-22,25H2,1-2H3,(H,49,61)(H,51,62,63)(H,47,48,50,52)",JSJGLYIYFOFJTA-UHFFFAOYSA-N
721,97,99,97,,P11802,CDK4,CRBN,,rib-pom,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N1C1CCCC1,Degradation of CDK4 in MDA-MB-231 cells after 18 h treatment,,,,,,,1650,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc00163h,885.003,884.4194254,2.52,65,9,16,3,15,225.78,C45H52N14O6,"InChI=1S/C45H52N14O6/c1-54(2)43(64)35-23-28-24-47-45(51-40(28)58(35)30-9-5-6-10-30)49-36-16-14-31(25-46-36)56-21-19-55(20-22-56)26-29-27-57(53-52-29)18-7-3-4-13-37(60)48-33-12-8-11-32-39(33)44(65)59(42(32)63)34-15-17-38(61)50-41(34)62/h8,11-12,14,16,23-25,27,30,34H,3-7,9-10,13,15,17-22,26H2,1-2H3,(H,48,60)(H,50,61,62)(H,46,47,49,51)",JYILVSNNISWWAT-UHFFFAOYSA-N
721,300,99,300,,Q00534,CDK6,CRBN,,rib-pom,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(N4CCN(CC5=CN(CCCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)C=N3)N=C2N1C1CCCC1,Degradation of CDK6 in MDA-MB-231 cells after 18 h treatment,,,,,,,6100,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc00163h,885.003,884.4194254,2.52,65,9,16,3,15,225.78,C45H52N14O6,"InChI=1S/C45H52N14O6/c1-54(2)43(64)35-23-28-24-47-45(51-40(28)58(35)30-9-5-6-10-30)49-36-16-14-31(25-46-36)56-21-19-55(20-22-56)26-29-27-57(53-52-29)18-7-3-4-13-37(60)48-33-12-8-11-32-39(33)44(65)59(42(32)63)34-15-17-38(61)50-41(34)62/h8,11-12,14,16,23-25,27,30,34H,3-7,9-10,13,15,17-22,26H2,1-2H3,(H,48,60)(H,50,61,62)(H,46,47,49,51)",JYILVSNNISWWAT-UHFFFAOYSA-N
723,3.2,99,3.2,,Q9UBN7,HDAC6,CRBN,,NH2,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(NC(=O)CCCC2=CN(CCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,Degradation of HDAC6 in MM.1S cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc08509b,836.907,836.3605731,2.09,61,6,13,6,20,246.29,C42H48N10O9,"InChI=1S/C42H48N10O9/c1-2-3-21-50(25-27-10-12-28(13-11-27)38(55)48-60)42(59)45-30-16-14-29(15-17-30)44-35(53)9-4-6-31-26-51(49-47-31)22-24-61-23-20-43-33-8-5-7-32-37(33)41(58)52(40(32)57)34-18-19-36(54)46-39(34)56/h5,7-8,10-17,26,34,43,60H,2-4,6,9,18-25H2,1H3,(H,44,53)(H,45,59)(H,48,55)(H,46,54,56)",ASTBYSZIHNGCIB-UHFFFAOYSA-N
740,4,99,4,,Q00534,CDK6,VHL,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,200,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1016.327,1015.5466,6.85,73,8,15,4,19,207.88,C55H73N11O6S,"InChI=1S/C55H73N11O6S/c1-34-43-31-57-54(62-50(43)66(40-15-12-13-16-40)52(71)47(34)37(4)67)60-45-23-22-41(30-56-45)64-27-25-63(26-28-64)24-14-10-8-9-11-17-46(69)61-49(55(5,6)7)53(72)65-32-42(68)29-44(65)51(70)59-35(2)38-18-20-39(21-19-38)48-36(3)58-33-73-48/h18-23,30-31,33,35,40,42,44,49,68H,8-17,24-29,32H2,1-7H3,(H,59,70)(H,61,69)(H,56,57,60,62)/t35-,42+,44-,49+/m0/s1",ORKAKWRVOOOMDD-GUQASDBOSA-N
740,25,99,25,,P11802,CDK4,VHL,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,32,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1016.327,1015.5466,6.85,73,8,15,4,19,207.88,C55H73N11O6S,"InChI=1S/C55H73N11O6S/c1-34-43-31-57-54(62-50(43)66(40-15-12-13-16-40)52(71)47(34)37(4)67)60-45-23-22-41(30-56-45)64-27-25-63(26-28-64)24-14-10-8-9-11-17-46(69)61-49(55(5,6)7)53(72)65-32-42(68)29-44(65)51(70)59-35(2)38-18-20-39(21-19-38)48-36(3)58-33-73-48/h18-23,30-31,33,35,40,42,44,49,68H,8-17,24-29,32H2,1-7H3,(H,59,70)(H,61,69)(H,56,57,60,62)/t35-,42+,44-,49+/m0/s1",ORKAKWRVOOOMDD-GUQASDBOSA-N
741,1.7,99,1.7,,Q00534,CDK6,VHL,,CST620,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in MM.1S cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1540,Inhibit viability of HEL cells,,,,,,,,,,,,,,,10.1039/d0sc00167h,1064.324,1063.531344,4.35,76,8,18,4,22,235.57,C55H73N11O9S,"InChI=1S/C55H73N11O9S/c1-34-43-30-57-54(62-50(43)66(40-10-8-9-11-40)52(71)47(34)37(4)67)60-45-17-16-41(29-56-45)64-20-18-63(19-21-64)22-23-73-24-25-74-26-27-75-32-46(69)61-49(55(5,6)7)53(72)65-31-42(68)28-44(65)51(70)59-35(2)38-12-14-39(15-13-38)48-36(3)58-33-76-48/h12-17,29-30,33,35,40,42,44,49,68H,8-11,18-28,31-32H2,1-7H3,(H,59,70)(H,61,69)(H,56,57,60,62)/t35-,42+,44-,49+/m0/s1",RSMLEVNIFFMOJA-GUQASDBOSA-N
741,20,99,20,,Q00534,CDK6,VHL,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,158,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1064.324,1063.531344,4.35,76,8,18,4,22,235.57,C55H73N11O9S,"InChI=1S/C55H73N11O9S/c1-34-43-30-57-54(62-50(43)66(40-10-8-9-11-40)52(71)47(34)37(4)67)60-45-17-16-41(29-56-45)64-20-18-63(19-21-64)22-23-73-24-25-74-26-27-75-32-46(69)61-49(55(5,6)7)53(72)65-31-42(68)28-44(65)51(70)59-35(2)38-12-14-39(15-13-38)48-36(3)58-33-76-48/h12-17,29-30,33,35,40,42,44,49,68H,8-11,18-28,31-32H2,1-7H3,(H,59,70)(H,61,69)(H,56,57,60,62)/t35-,42+,44-,49+/m0/s1",RSMLEVNIFFMOJA-GUQASDBOSA-N
741,32,99,32,,P11802,CDK4,VHL,,CST620,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in MM.1S cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1540,Inhibit viability of HEL cells,,,,,,,,,,,,,,,10.1039/d0sc00167h,1064.324,1063.531344,4.35,76,8,18,4,22,235.57,C55H73N11O9S,"InChI=1S/C55H73N11O9S/c1-34-43-30-57-54(62-50(43)66(40-10-8-9-11-40)52(71)47(34)37(4)67)60-45-17-16-41(29-56-45)64-20-18-63(19-21-64)22-23-73-24-25-74-26-27-75-32-46(69)61-49(55(5,6)7)53(72)65-31-42(68)28-44(65)51(70)59-35(2)38-12-14-39(15-13-38)48-36(3)58-33-76-48/h12-17,29-30,33,35,40,42,44,49,68H,8-11,18-28,31-32H2,1-7H3,(H,59,70)(H,61,69)(H,56,57,60,62)/t35-,42+,44-,49+/m0/s1",RSMLEVNIFFMOJA-GUQASDBOSA-N
741,631,99,631,,P11802,CDK4,VHL,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,40,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1064.324,1063.531344,4.35,76,8,18,4,22,235.57,C55H73N11O9S,"InChI=1S/C55H73N11O9S/c1-34-43-30-57-54(62-50(43)66(40-10-8-9-11-40)52(71)47(34)37(4)67)60-45-17-16-41(29-56-45)64-20-18-63(19-21-64)22-23-73-24-25-74-26-27-75-32-46(69)61-49(55(5,6)7)53(72)65-31-42(68)28-44(65)51(70)59-35(2)38-12-14-39(15-13-38)48-36(3)58-33-76-48/h12-17,29-30,33,35,40,42,44,49,68H,8-11,18-28,31-32H2,1-7H3,(H,59,70)(H,61,69)(H,56,57,60,62)/t35-,42+,44-,49+/m0/s1",RSMLEVNIFFMOJA-GUQASDBOSA-N
742,200,99,200,,Q00534,CDK6,VHL,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,126,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1135.403,1134.568458,3.6,81,8,19,5,25,264.67,C58H78N12O10S,"InChI=1S/C58H78N12O10S/c1-36-45-32-61-57(66-53(45)70(42-10-8-9-11-42)55(76)50(36)39(4)71)64-47-17-16-43(31-60-47)68-22-20-67(21-23-68)34-49(74)59-19-25-79-27-29-80-28-26-78-24-18-48(73)65-52(58(5,6)7)56(77)69-33-44(72)30-46(69)54(75)63-37(2)40-12-14-41(15-13-40)51-38(3)62-35-81-51/h12-17,31-32,35,37,42,44,46,52,72H,8-11,18-30,33-34H2,1-7H3,(H,59,74)(H,63,75)(H,65,73)(H,60,61,64,66)/t37-,44+,46-,52+/m0/s1",CTPCMILSWFJJJB-HANZASPOSA-N
742,2512,99,2512,,P11802,CDK4,VHL,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCOCCOCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,32,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1135.403,1134.568458,3.6,81,8,19,5,25,264.67,C58H78N12O10S,"InChI=1S/C58H78N12O10S/c1-36-45-32-61-57(66-53(45)70(42-10-8-9-11-42)55(76)50(36)39(4)71)64-47-17-16-43(31-60-47)68-22-20-67(21-23-68)34-49(74)59-19-25-79-27-29-80-28-26-78-24-18-48(73)65-52(58(5,6)7)56(77)69-33-44(72)30-46(69)54(75)63-37(2)40-12-14-41(15-13-40)51-38(3)62-35-81-51/h12-17,31-32,35,37,42,44,46,52,72H,8-11,18-30,33-34H2,1-7H3,(H,59,74)(H,63,75)(H,65,73)(H,60,61,64,66)/t37-,44+,46-,52+/m0/s1",CTPCMILSWFJJJB-HANZASPOSA-N
743,5,99,5,,Q00534,CDK6,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCCCCCCN2CCN(C3=CC=C(NC4=NC=C5C(C)=C(C(C)=O)C(=O)N(C6CCCC6)C5=N4)N=C3)CC2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,13,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1011.233,1010.566584,5.63,73,7,14,5,20,215.89,C53H72F2N12O6,"InChI=1S/C53H72F2N12O6/c1-32-38-30-58-52(63-47(38)67(36-16-12-13-17-36)50(72)44(32)34(3)68)60-42-22-21-37(29-57-42)65-26-24-64(25-27-65)23-14-10-8-9-11-20-43(69)59-35-28-41(49(71)61-45-39(54)18-15-19-40(45)55)66(31-35)51(73)46(53(4,5)6)62-48(70)33(2)56-7/h15,18-19,21-22,29-30,33,35-36,41,46,56H,8-14,16-17,20,23-28,31H2,1-7H3,(H,59,69)(H,61,71)(H,62,70)(H,57,58,60,63)/t33-,35-,41-,46+/m0/s1",OUTLYXINOACMSY-OYTRKBTESA-N
743,20,99,20,,P11802,CDK4,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCCCCCCN2CCN(C3=CC=C(NC4=NC=C5C(C)=C(C(C)=O)C(=O)N(C6CCCC6)C5=N4)N=C3)CC2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,5,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1011.233,1010.566584,5.63,73,7,14,5,20,215.89,C53H72F2N12O6,"InChI=1S/C53H72F2N12O6/c1-32-38-30-58-52(63-47(38)67(36-16-12-13-17-36)50(72)44(32)34(3)68)60-42-22-21-37(29-57-42)65-26-24-64(25-27-65)23-14-10-8-9-11-20-43(69)59-35-28-41(49(71)61-45-39(54)18-15-19-40(45)55)66(31-35)51(73)46(53(4,5)6)62-48(70)33(2)56-7/h15,18-19,21-22,29-30,33,35-36,41,46,56H,8-14,16-17,20,23-28,31H2,1-7H3,(H,59,69)(H,61,71)(H,62,70)(H,57,58,60,63)/t33-,35-,41-,46+/m0/s1",OUTLYXINOACMSY-OYTRKBTESA-N
744,16,99,16,,Q00534,CDK6,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)COCCOCCOCCN2CCN(C3=CC=C(NC4=NC=C5C(C)=C(C(C)=O)C(=O)N(C6CCCC6)C5=N4)N=C3)CC2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,16,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1059.23,1058.551328,3.13,76,7,17,5,23,243.58,C53H72F2N12O9,"InChI=1S/C53H72F2N12O9/c1-32-38-29-58-52(63-47(38)67(36-11-8-9-12-36)50(72)44(32)34(3)68)60-42-16-15-37(28-57-42)65-19-17-64(18-20-65)21-22-74-23-24-75-25-26-76-31-43(69)59-35-27-41(49(71)61-45-39(54)13-10-14-40(45)55)66(30-35)51(73)46(53(4,5)6)62-48(70)33(2)56-7/h10,13-16,28-29,33,35-36,41,46,56H,8-9,11-12,17-27,30-31H2,1-7H3,(H,59,69)(H,61,71)(H,62,70)(H,57,58,60,63)/t33-,35-,41-,46+/m0/s1",MFTRNYPINLZRSO-OYTRKBTESA-N
744,79,99,79,,P11802,CDK4,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)COCCOCCOCCN2CCN(C3=CC=C(NC4=NC=C5C(C)=C(C(C)=O)C(=O)N(C6CCCC6)C5=N4)N=C3)CC2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,6,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1059.23,1058.551328,3.13,76,7,17,5,23,243.58,C53H72F2N12O9,"InChI=1S/C53H72F2N12O9/c1-32-38-29-58-52(63-47(38)67(36-11-8-9-12-36)50(72)44(32)34(3)68)60-42-16-15-37(28-57-42)65-19-17-64(18-20-65)21-22-74-23-24-75-25-26-76-31-43(69)59-35-27-41(49(71)61-45-39(54)13-10-14-40(45)55)66(30-35)51(73)46(53(4,5)6)62-48(70)33(2)56-7/h10,13-16,28-29,33,35-36,41,46,56H,8-9,11-12,17-27,30-31H2,1-7H3,(H,59,69)(H,61,71)(H,62,70)(H,57,58,60,63)/t33-,35-,41-,46+/m0/s1",MFTRNYPINLZRSO-OYTRKBTESA-N
745,1585,99,1585,,Q00534,CDK6,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCOCCOCCOCCNC(=O)CN2CCN(C3=CC=C(NC4=NC=C5C(C)=C(C(C)=O)C(=O)N(C6CCCC6)C5=N4)N=C3)CC2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,40,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1130.309,1129.588442,2.37,81,7,18,6,26,272.68,C56H77F2N13O10,"InChI=1S/C56H77F2N13O10/c1-34-40-31-62-55(67-50(40)71(38-11-8-9-12-38)53(77)47(34)36(3)72)64-44-16-15-39(30-61-44)69-21-19-68(20-22-69)33-46(74)60-18-24-80-26-28-81-27-25-79-23-17-45(73)63-37-29-43(52(76)65-48-41(57)13-10-14-42(48)58)70(32-37)54(78)49(56(4,5)6)66-51(75)35(2)59-7/h10,13-16,30-31,35,37-38,43,49,59H,8-9,11-12,17-29,32-33H2,1-7H3,(H,60,74)(H,63,73)(H,65,76)(H,66,75)(H,61,62,64,67)/t35-,37-,43-,49+/m0/s1",DNVODRITWXGBQB-TXCNDJKGSA-N
745,5012,99,5012,,P11802,CDK4,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCOCCOCCOCCNC(=O)CN2CCN(C3=CC=C(NC4=NC=C5C(C)=C(C(C)=O)C(=O)N(C6CCCC6)C5=N4)N=C3)CC2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,16,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,1130.309,1129.588442,2.37,81,7,18,6,26,272.68,C56H77F2N13O10,"InChI=1S/C56H77F2N13O10/c1-34-40-31-62-55(67-50(40)71(38-11-8-9-12-38)53(77)47(34)36(3)72)64-44-16-15-39(30-61-44)69-21-19-68(20-22-69)33-46(74)60-18-24-80-26-28-81-27-25-79-23-17-45(73)63-37-29-43(52(76)65-48-41(57)13-10-14-42(48)58)70(32-37)54(78)49(56(4,5)6)66-51(75)35(2)59-7/h10,13-16,30-31,35,37-38,43,49,59H,8-9,11-12,17-29,32-33H2,1-7H3,(H,60,74)(H,63,73)(H,65,76)(H,66,75)(H,61,62,64,67)/t35-,37-,43-,49+/m0/s1",DNVODRITWXGBQB-TXCNDJKGSA-N
746,5,99,5,,Q00534,CDK6,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 24 h treatment,,,16,Inhibition of CDK6-cyclin D3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,891.987,891.4027723,1.77,65,8,17,4,18,239.39,C45H53N11O9,"InChI=1S/C45H53N11O9/c1-27-32-25-49-45(52-40(32)55(29-6-3-4-7-29)43(62)38(27)28(2)57)50-35-12-10-30(24-48-35)54-17-15-53(16-18-54)19-21-65-23-22-64-20-14-46-37(59)26-47-33-9-5-8-31-39(33)44(63)56(42(31)61)34-11-13-36(58)51-41(34)60/h5,8-10,12,24-25,29,34,47H,3-4,6-7,11,13-23,26H2,1-2H3,(H,46,59)(H,51,58,60)(H,48,49,50,52)",JWNZXWGMBRXMPK-UHFFFAOYSA-N
746,50,99,50,,P11802,CDK4,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 24 h treatment,,,6,Inhibition of CDK4-cyclin D1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127106,891.987,891.4027723,1.77,65,8,17,4,18,239.39,C45H53N11O9,"InChI=1S/C45H53N11O9/c1-27-32-25-49-45(52-40(32)55(29-6-3-4-7-29)43(62)38(27)28(2)57)50-35-12-10-30(24-48-35)54-17-15-53(16-18-54)19-21-65-23-22-64-20-14-46-37(59)26-47-33-9-5-8-31-39(33)44(63)56(42(31)61)34-11-13-36(58)51-41(34)60/h5,8-10,12,24-25,29,34,47H,3-4,6-7,11,13-23,26H2,1-2H3,(H,46,59)(H,51,58,60)(H,48,49,50,52)",JWNZXWGMBRXMPK-UHFFFAOYSA-N
750,374,49,374,49,Q06187,BTK,VHL,,SJF638,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,945.16,944.4367153,5.34,68,8,15,4,18,212.18,C50H60N10O7S,"InChI=1S/C50H60N10O7S/c1-32-44(68-31-55-32)35-12-10-33(11-13-35)27-52-48(63)40-26-37(61)28-59(40)49(64)45(50(2,3)4)56-41(62)29-66-25-24-65-23-22-58-20-18-36(19-21-58)60-47-42(46(51)53-30-54-47)43(57-60)34-14-16-39(17-15-34)67-38-8-6-5-7-9-38/h5-17,30-31,36-37,40,45,61H,18-29H2,1-4H3,(H,52,63)(H,56,62)(H2,51,53,54)/t37-,40+,45-/m1/s1",RIOHYDUGYNZWPD-DIKPJKDTSA-N
751,162,50,162,50,Q06187,BTK,VHL,,SJF678,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCCCOCCCCN3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)=C2)SC=N1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,1061.323,1060.499316,7.88,77,10,15,3,22,203.39,C59H68N10O7S,"InChI=1S/C59H68N10O7S/c1-38(2)53(68-34-43-13-7-8-16-48(43)58(68)72)59(73)67-35-45(70)32-49(67)57(71)61-33-42-18-17-41(54-39(3)64-37-77-54)31-50(42)75-30-12-11-29-74-28-10-9-25-66-26-23-44(24-27-66)69-56-51(55(60)62-36-63-56)52(65-69)40-19-21-47(22-20-40)76-46-14-5-4-6-15-46/h4-8,13-22,31,36-38,44-45,49,53,70H,9-12,23-30,32-35H2,1-3H3,(H,61,71)(H2,60,62,63)/t45-,49+,53+/m1/s1",VFRJYHIRKCDWOQ-ABZCTAHRSA-N
752,,,>1000,,Q06187,BTK,VHL,,SJF690,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCCOCCC(=O)N3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)=C2)SC=N1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,1047.252,1046.44728,6.2,76,10,15,3,19,220.46,C57H62N10O8S,"InChI=1S/C57H62N10O8S/c1-35(2)51(66-31-40-10-7-8-13-45(40)56(66)71)57(72)65-32-42(68)29-46(65)55(70)59-30-39-15-14-38(52-36(3)62-34-76-52)28-47(39)74-26-9-25-73-27-22-48(69)64-23-20-41(21-24-64)67-54-49(53(58)60-33-61-54)50(63-67)37-16-18-44(19-17-37)75-43-11-5-4-6-12-43/h4-8,10-19,28,33-35,41-42,46,51,68H,9,20-27,29-32H2,1-3H3,(H,59,70)(H2,58,60,61)/t42-,46+,51+/m1/s1",YAKBRBQHMAONAH-QSDOZQHJSA-N
753,8.3,91,8.3,91,Q06187,BTK,CRBN,,SJF608,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCCOC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,774.835,774.3125603,3.1,57,8,14,2,15,193.33,C41H42N8O8,"InChI=1S/C41H42N8O8/c42-37-35-36(26-6-8-29(9-7-26)57-28-4-2-1-3-5-28)46-49(38(35)44-25-43-37)27-14-16-47(17-15-27)18-19-54-20-21-55-22-23-56-30-10-11-31-32(24-30)41(53)48(40(31)52)33-12-13-34(50)45-39(33)51/h1-11,24-25,27,33H,12-23H2,(H2,42,43,44)(H,45,50,51)",KCRCMDOSXFUJPF-UHFFFAOYSA-N
754,7.9,95,7.9,95,Q06187,BTK,CRBN,,SJF620,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCCOC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)CC3=C2)CC1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,760.852,760.3332957,3.15,56,8,13,2,15,176.26,C41H44N8O7,"InChI=1S/C41H44N8O7/c42-38-36-37(27-6-8-31(9-7-27)56-30-4-2-1-3-5-30)46-49(39(36)44-26-43-38)29-14-16-47(17-15-29)18-19-53-20-21-54-22-23-55-32-10-11-33-28(24-32)25-48(41(33)52)34-12-13-35(50)45-40(34)51/h1-11,24,26,29,34H,12-23,25H2,(H2,42,43,44)(H,45,50,51)",UJJYPBWMGIPXOE-UHFFFAOYSA-N
796,250,70,250,70,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOCCOCCN3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)=C2)SC=N1,Degradation of SMARCA4 in MV-4-11 cells after 18 h treatment,,,3000/1300,IC50 of SMARCA4 BD was tested by TR-FRET/AlphaLISA,,,4800,SPR in SMARCA4 BD,,,,,,,,,,,,,,,234/98,ITC/SPR,210,FP,-37.9,-21,-17,ITC,,,,,230/330,TR-FRET/AlphaLISA,,,,,26,FP,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,918.106,917.4269591,3.22,65,7,15,5,19,217.83,C46H60FN9O8S,"InChI=1S/C46H60FN9O8S/c1-29-39(65-28-50-29)30-9-10-31(26-49-42(59)36-24-32(57)27-56(36)43(60)40(45(2,3)4)51-44(61)46(47)11-12-46)38(23-30)64-22-21-63-20-19-62-18-17-54-13-15-55(16-14-54)35-25-34(52-53-41(35)48)33-7-5-6-8-37(33)58/h5-10,23,25,28,32,36,40,57-58H,11-22,24,26-27H2,1-4H3,(H2,48,53)(H,49,59)(H,51,61)/t32-,36+,40-/m1/s1",QCULBRPVCWJUKY-OUMVKTTMSA-N
796,300,65,300,65,P51531,SMARCA2,VHL,6HAY,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOCCOCCN3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)=C2)SC=N1,Degradation of SMARCA2 in MV-4-11 cells after 18 h treatment,,,2400/600,IC50 of SMARCA2 BD was tested by TR-FRET/AlphaLISA,,,4500,SPR in SMARCA2 BD,,,,,,,,,,,,,,,234/98,ITC/SPR,210,FP,-37.9,-21,-17,ITC,,,,,205/120,TR-FRET/AlphaLISA,,,49,ITC,48,FP,-41.8,-27,-15,ITC between VHL and PROTAC:SMARCA2,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,918.106,917.4269591,3.22,65,7,15,5,19,217.83,C46H60FN9O8S,"InChI=1S/C46H60FN9O8S/c1-29-39(65-28-50-29)30-9-10-31(26-49-42(59)36-24-32(57)27-56(36)43(60)40(45(2,3)4)51-44(61)46(47)11-12-46)38(23-30)64-22-21-63-20-19-62-18-17-54-13-15-55(16-14-54)35-25-34(52-53-41(35)48)33-7-5-6-8-37(33)58/h5-10,23,25,28,32,36,40,57-58H,11-22,24,26-27H2,1-4H3,(H2,48,53)(H,49,59)(H,51,61)/t32-,36+,40-/m1/s1",QCULBRPVCWJUKY-OUMVKTTMSA-N
797,221,53,221,53,P51531,SMARCA2,VHL,8G1P,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1130000,0.12,5.9,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,920.125,919.4214798,5.27,66,8,13,5,15,199.37,C49H58FN9O6S,"InChI=1S/C49H58FN9O6S/c1-30-42(66-29-53-30)33-13-14-34(26-52-45(62)39-24-35(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)16-17-49)41(23-33)65-22-15-31-9-11-32(12-10-31)27-57-18-20-58(21-19-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,35,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t35-,39+,43-/m1/s1",UTZVLJZPTDCKCT-XBPZXCMESA-N
798,3.3,99,6/3.3,,P51531,SMARCA2,VHL,,ACBI1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA2 in MV-4-11/NCI-H1568 cells after 18 h treatment,,,770/700,IC50 of SMARCA2 BD was tested by TR-FRET/AlphaLISA,,,1800,SPR in SMARCA2 BD,,,,,,,,,,,,,,,250,SPR,450,FP,,,,,,,,,26/730,TR-FRET/AlphaLISA,,,,,16,FP,,,,,,,,,28/68,Inhibit proliferation of MV-4-11/NCI-H1568 cells,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,936.124,935.4163944,4.98,67,8,14,5,16,208.6,C49H58FN9O7S,"InChI=1S/C49H58FN9O7S/c1-30-42(67-29-53-30)32-11-12-33(26-52-45(62)39-24-34(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)15-16-49)41(23-32)66-22-21-65-35-13-9-31(10-14-35)27-57-17-19-58(20-18-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,34,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t34-,39+,43-/m1/s1",IVARZBJJMMUJHI-SQKKEFIPSA-N
798,11,99,11,,P51532,SMARCA4,VHL,,ACBI1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA2 in MV-4-11 cells after 18 h treatment,,,560/670,IC50 of SMARCA4 BD was tested by TR-FRET/AlphaLISA,,,2600,SPR in SMARCA4 BD,,,,,,,,,,,,,,,250,SPR,450,FP,,,,,,,,,51/720,TR-FRET/AlphaLISA,,,,,,,,,,,,,,,28/68,Inhibit proliferation of MV-4-11/NCI-H1568 cells,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,936.124,935.4163944,4.98,67,8,14,5,16,208.6,C49H58FN9O7S,"InChI=1S/C49H58FN9O7S/c1-30-42(67-29-53-30)32-11-12-33(26-52-45(62)39-24-34(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)15-16-49)41(23-32)66-22-21-65-35-13-9-31(10-14-35)27-57-17-19-58(20-18-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,34,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t34-,39+,43-/m1/s1",IVARZBJJMMUJHI-SQKKEFIPSA-N
798,15.6,99,32/15.6,,Q86U86,PBRM1,VHL,,ACBI1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of PBRM1 in MV-4-11/NCI-H1568 cells after 18 h treatment,,,504,IC50 of PBRM1 BD5 was tested by TR-FRET,,,830,SPR in PBRM1 BD5,,,,,,,,,,,,,,,250,SPR,450,FP,,,,,,,,,42,TR-FRET,,,,,,,,,,,,,,,28/68,Inhibit proliferation of MV-4-11/NCI-H1568 cells,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,936.124,935.4163944,4.98,67,8,14,5,16,208.6,C49H58FN9O7S,"InChI=1S/C49H58FN9O7S/c1-30-42(67-29-53-30)32-11-12-33(26-52-45(62)39-24-34(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)15-16-49)41(23-32)66-22-21-65-35-13-9-31(10-14-35)27-57-17-19-58(20-18-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,34,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t34-,39+,43-/m1/s1",IVARZBJJMMUJHI-SQKKEFIPSA-N
815,259,99,259,,Q9NWZ3,IRAK4,VHL,,,CC[C@H]1[C@@H](COC2=NC=C(C#CCCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C3=CC(C(N)=O)=C(OC)C=C23)NC(=O)[C@H]1F,Degradation of IRAK4 in PBMC cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00219,982.233,981.4834114,8.79,70,6,11,5,22,215.17,C53H68FN7O8S,"InChI=1S/C53H68FN7O8S/c1-7-37-41(59-50(66)45(37)54)30-69-51-39-26-43(68-6)40(48(55)64)25-38(39)35(28-57-51)18-16-14-12-10-8-9-11-13-15-17-19-44(63)60-47(53(3,4)5)52(67)61-29-36(62)24-42(61)49(65)56-27-33-20-22-34(23-21-33)46-32(2)58-31-70-46/h20-23,25-26,28,31,36-37,41-42,45,47,62H,7-15,17,19,24,27,29-30H2,1-6H3,(H2,55,64)(H,56,65)(H,59,66)(H,60,63)/t36-,37+,41-,42+,45+,47-/m1/s1",OMTXYNZVPBTRTI-LWWCJIENSA-N
816,36,99,151/36,,Q9NWZ3,IRAK4,VHL,,,CC[C@H]1[C@@H](COC2=NC=C(C#CCN3CCC4(CC3)CCN(C3=NC=C(C(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C=N3)CC4)C3=CC(C(N)=O)=C(OC)C=C23)NC(=O)[C@H]1F,Degradation of IRAK4 in PBMC cells/dermal fibroblast after 24/24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00219,1086.305,1085.495707,5.77,78,9,15,5,15,247.43,C57H68FN11O8S,"InChI=1S/C57H68FN11O8S/c1-7-39-43(65-52(74)46(39)58)31-77-53-41-25-45(76-6)42(49(59)71)24-40(41)36(27-61-53)9-8-18-67-19-14-57(15-20-67)16-21-68(22-17-57)55-62-28-37(29-63-55)50(72)66-48(56(3,4)5)54(75)69-30-38(70)23-44(69)51(73)60-26-34-10-12-35(13-11-34)47-33(2)64-32-78-47/h10-13,24-25,27-29,32,38-39,43-44,46,48,70H,7,14-23,26,30-31H2,1-6H3,(H2,59,71)(H,60,73)(H,65,74)(H,66,72)/t38-,39+,43-,44+,46+,48-/m1/s1",VCCDOPPWOSIMCD-LLCFZETMSA-N
817,5,99,<5,,O60885,BRD4,CRBN,,HBL-4,CC[C@@H]1C(=O)N(C)C2=CN=C(NC3=CC=C(C(=O)NCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3OC)N=C2N1C1CCCC1,Degradation of BRD4 in MV4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.48/6.21/6.94,Inhibit viability of MV4-11/MOLM-13/KG1 cells,,,,,,,,,,,,,,,10.1016/j.bbrc.2019.11.007,811.897,811.3653241,3.28,59,7,14,4,17,213.73,C41H49N9O9,"InChI=1S/C41H49N9O9/c1-4-29-39(55)48(2)31-23-44-41(47-35(31)49(29)25-8-5-6-9-25)45-27-13-12-24(22-32(27)57-3)36(52)43-17-19-59-21-20-58-18-16-42-28-11-7-10-26-34(28)40(56)50(38(26)54)30-14-15-33(51)46-37(30)53/h7,10-13,22-23,25,29-30,42H,4-6,8-9,14-21H2,1-3H3,(H,43,52)(H,44,45,47)(H,46,51,53)/t29-,30?/m1/s1",QSDZWQSDYJSGFC-IDCGIGBZSA-N
817,10,99,10 20,,P53350,PLK1,CRBN,,HBL-4,CC[C@@H]1C(=O)N(C)C2=CN=C(NC3=CC=C(C(=O)NCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3OC)N=C2N1C1CCCC1,Degradation of PLK1 in MV4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.48/6.21/6.94,Inhibit viability of MV4-11/MOLM-13/KG1 cells,,,,,,,,,,,,,,,10.1016/j.bbrc.2019.11.007,811.897,811.3653241,3.28,59,7,14,4,17,213.73,C41H49N9O9,"InChI=1S/C41H49N9O9/c1-4-29-39(55)48(2)31-23-44-41(47-35(31)49(29)25-8-5-6-9-25)45-27-13-12-24(22-32(27)57-3)36(52)43-17-19-59-21-20-58-18-16-42-28-11-7-10-26-34(28)40(56)50(38(26)54)30-14-15-33(51)46-37(30)53/h7,10-13,22-23,25,29-30,42H,4-6,8-9,14-21H2,1-3H3,(H,43,52)(H,44,45,47)(H,46,51,53)/t29-,30?/m1/s1",QSDZWQSDYJSGFC-IDCGIGBZSA-N
825,7.7,95,7.7/10.3,95/98,P03372,ER,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(/C=N/NC(=O)C4=CC=C(C(=O)C5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF-7/T47D cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,69.1/65.2,Inhibit proliferation of MCF-7/T47D cells,,,,,,,,,,,,,,,10.1021/acschembio.0c00140,1035.258,1034.370669,9.25,74,8,13,6,18,219.85,C57H58N6O9S2,"InChI=1S/C57H58N6O9S2/c1-33(36-11-15-38(16-12-36)51-34(2)58-32-73-51)60-55(70)46-28-43(66)31-63(46)56(71)53(57(3,4)5)61-48(67)8-6-7-27-72-44-24-9-35(10-25-44)30-59-62-54(69)40-17-13-37(14-18-40)50(68)49-45-26-23-42(65)29-47(45)74-52(49)39-19-21-41(64)22-20-39/h9-26,29-30,32-33,43,46,53,64-66H,6-8,27-28,31H2,1-5H3,(H,60,70)(H,61,67)(H,62,69)/b59-30+/t33-,43+,46-,53+/m0/s1",VVAVIHDLCKOZJR-WFZPVKHBSA-N
860,5.2,75,5.2,75,P03372,ER,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCOC3=CC=C(/C=N/NC(=O)C4=CC=C(OC5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF-7 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.0c00140,1009.22,1008.355019,9.08,72,8,13,6,17,212.01,C55H56N6O9S2,"InChI=1S/C55H56N6O9S2/c1-32(35-10-12-36(13-11-35)49-33(2)56-31-71-49)58-53(67)45-27-41(64)30-61(45)54(68)51(55(3,4)5)59-47(65)7-6-26-69-42-21-8-34(9-22-42)29-57-60-52(66)38-16-23-43(24-17-38)70-48-44-25-20-40(63)28-46(44)72-50(48)37-14-18-39(62)19-15-37/h8-25,28-29,31-32,41,45,51,62-64H,6-7,26-27,30H2,1-5H3,(H,58,67)(H,59,65)(H,60,66)/b57-29+/t32-,41+,45-,51+/m0/s1",QCDUJVGYYULYRO-INUWBVJXSA-N
920,1.1,98,1.1,98,P03372,ER,VHL,,AM-A3,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(CCNC(=O)C4=CC=C(C(=O)C5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF-7 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13.2/17,Inhibit proliferation of MCF-7/T47D cells,,,,,,,,,,,,,,,10.1021/acschembio.0c00140,1036.286,1035.391071,9.57,74,8,12,6,19,207.49,C58H61N5O9S2,"InChI=1S/C58H61N5O9S2/c1-34(37-11-15-39(16-12-37)52-35(2)60-33-73-52)61-56(70)47-30-44(66)32-63(47)57(71)54(58(3,4)5)62-49(67)8-6-7-29-72-45-24-9-36(10-25-45)27-28-59-55(69)41-17-13-38(14-18-41)51(68)50-46-26-23-43(65)31-48(46)74-53(50)40-19-21-42(64)22-20-40/h9-26,31,33-34,44,47,54,64-66H,6-8,27-30,32H2,1-5H3,(H,59,69)(H,61,70)(H,62,67)/t34-,44+,47-,54+/m0/s1",VXEYUCNJDJXFGM-BMAAPKIPSA-N
937,300,75,300/670,75/96,Q15910,EZH2,VHL,,UNC6852,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of EZH2 in HeLa/DB cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3400/410,Inhibit proliferation of DB/Pfeiffer cells,,,,,,,,,,,,,10.1016/j.chembiol.2019.11.006,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,590,82,(n/a)/590,22/82,Q15022,SUZ12,VHL,,UNC6852,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SUZ12 in HeLa/DB cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3400/410,Inhibit proliferation of DB/Pfeiffer cells,,,,,,,,,,,,,10.1016/j.chembiol.2019.11.006,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,610,94,610,94,O75530,EED,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of EED in DB cells after 24h treatment,90,% EED protein degradation in DB cells at 3000 nM for 24h treatment,49.3,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,610,94,790/610,92/94,O75530,EED,VHL,,UNC6852,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of EED in HeLa/DB cells after 24 h treatment,,,247,IC50 of EED was tested by the TR-FRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3400/410,Inhibit proliferation of DB/Pfeiffer cells,,,,,,,,,,,,,10.1016/j.chembiol.2019.11.006,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,670,96,670,96,Q15910,EZH2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of EZH2 in DB cells after 24h treatment,53,% EZH2 protein degradation in DB cells at 3000 nM for 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
959,2000,85,2000,85,,BCR-ABL,VHL,,GMB-101,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCNC(=O)C3=CC=CC(C4=CC(NC5=CC=C(OC(F)(F)F)C=C5)=NC=N4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BCR-ABL in K562 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1158/0008-5472.CAN-19-1236,888.97,888.3240515,6.17,63,6,12,5,16,197,C44H47F3N8O7S,"InChI=1S/C44H47F3N8O7S/c1-26-38(63-25-52-26)28-10-8-27(9-11-28)21-49-41(59)35-19-32(56)22-55(35)42(60)39(43(2,3)4)54-37(57)23-61-17-16-48-40(58)30-7-5-6-29(18-30)34-20-36(51-24-50-34)53-31-12-14-33(15-13-31)62-44(45,46)47/h5-15,18,20,24-25,32,35,39,56H,16-17,19,21-23H2,1-4H3,(H,48,58)(H,49,59)(H,54,57)(H,50,51,53)/t32-,35+,39-/m1/s1",DTXGFSWBHDABPE-MNYREFGISA-N
961,340,95,340,95,,BCR-ABL,VHL,,GMB-475,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOC3=CC=C(C4=CC(NC5=CC=C(OC(F)(F)F)C=C5)=NC=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BCR-ABL in K562 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1000/1110,Inhibit proliferation of K562/BCR-ABL1 transformed Ba/F3 cells,,,,,,,,,,,,,,,10.1158/0008-5472.CAN-19-1236,861.944,861.3131525,6.86,61,6,12,4,16,177.13,C43H46F3N7O7S,"InChI=1S/C43H46F3N7O7S/c1-26-38(61-25-50-26)29-7-5-27(6-8-29)21-47-40(56)35-19-31(54)22-53(35)41(57)39(42(2,3)4)52-37(55)23-58-17-18-59-32-13-9-28(10-14-32)34-20-36(49-24-48-34)51-30-11-15-33(16-12-30)60-43(44,45)46/h5-16,20,24-25,31,35,39,54H,17-19,21-23H2,1-4H3,(H,47,56)(H,52,55)(H,48,49,51)/t31-,35+,39-/m1/s1",ONDVWISBMHHLGZ-SBJIGXGQSA-N
968,200,75,200/230,75/98,Q96SW2,CRBN,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCOCCCCCOCC(=O)NCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HeLa/HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmc.2019.02.048,1061.269,1060.493955,3.67,75,6,16,6,30,273.23,C53H72N8O13S,"InChI=1S/C53H72N8O13S/c1-34-46(75-33-57-34)36-16-14-35(15-17-36)29-56-48(66)41-28-37(62)30-60(41)52(70)47(53(2,3)4)58-44(65)32-74-25-10-6-8-23-72-27-26-71-22-7-5-9-24-73-31-43(64)55-21-20-54-39-13-11-12-38-45(39)51(69)61(50(38)68)40-18-19-42(63)59-49(40)67/h11-17,33,37,40-41,47,54,62H,5-10,18-32H2,1-4H3,(H,55,64)(H,56,66)(H,58,65)(H,59,63,67)/t37-,40?,41+,47-/m1/s1",PEZCAXDTKNFUCR-CTMFSBKBSA-N
975,0.27,99,0.27,,P62942,FKBP12,CRBN,,RC32,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCOCC3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Degradation of FKBP12 in Jurkat cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41421-018-0079-1,1426.71,1425.757089,5.78,102,8,24,4,23,338.41,C75H107N7O20,"InChI=1S/C75H107N7O20/c1-45-17-12-11-13-18-46(2)61(94-8)41-54-24-22-51(7)75(93,102-54)69(87)73(91)81-29-15-14-21-58(81)74(92)101-62(42-59(83)47(3)38-50(6)67(86)68(96-10)66(85)49(5)37-45)48(4)39-52-23-26-60(63(40-52)95-9)100-36-35-99-44-53-43-80(79-78-53)30-32-98-34-33-97-31-28-76-56-20-16-19-55-65(56)72(90)82(71(55)89)57-25-27-64(84)77-70(57)88/h11-13,16-20,38,43,45,47-49,51-52,54,57-58,60-63,67-68,76,86,93H,14-15,21-37,39-42,44H2,1-10H3,(H,77,84,88)/b13-11+,17-12+,46-18+,50-38+/t45-,47-,48-,49-,51-,52+,54+,57?,58+,60-,61+,62+,63-,67-,68+,75-/m1/s1",XCSUEITWRRFFMN-SJQMKIJVSA-N
977,0.4,99,0.4,,O43353,RIPK2,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC2=CC(OCCOCCOCCOCCOC3=CC4=NC=CC(NC5=CC=C6SC=NC6=C5)=C4C=C3S(=O)(=O)C(C)(C)C)=CC=C2C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C(C)(C)C,Degradation of RIPK2 in THP-1 cells after 18 h treatment,,,10,IC50 of RIPK2 was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,1092.395,1091.486034,7.7,77,8,15,4,23,208.64,C58H73N7O10S2,"InChI=1S/C58H73N7O10S2/c1-37(59-8)54(66)64-53(57(2,3)4)56(68)65-35-40-30-42(18-16-39(40)31-49(65)55(67)63-45-15-11-13-38-12-9-10-14-43(38)45)74-28-26-72-24-22-71-23-25-73-27-29-75-50-34-47-44(33-52(50)77(69,70)58(5,6)7)46(20-21-60-47)62-41-17-19-51-48(32-41)61-36-76-51/h9-10,12,14,16-21,30,32-34,36-37,45,49,53,59H,11,13,15,22-29,31,35H2,1-8H3,(H,60,62)(H,63,67)(H,64,66)/t37-,45+,49-,53+/m0/s1",QEZBEUBDCKYYAV-ORFCTVBLSA-N
978,2.5,99,2.5,,O43353,RIPK2,CRBN,,,CC(C)(C)S(=O)(=O)C1=CC2=C(NC3=CC=C4SC=NC4=C3)C=CN=C2C=C1OCCOCCOCCOCCOCC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,Degradation of RIPK2 in THP-1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,889.022,888.2822484,2.95,62,7,15,3,20,213.68,C43H48N6O11S2,"InChI=1S/C43H48N6O11S2/c1-43(2,3)62(54,55)38-22-29-32(46-27-7-9-37-34(21-27)45-26-61-37)11-12-44-33(29)23-36(38)60-20-19-58-16-15-56-13-14-57-17-18-59-25-40(51)47-31-6-4-5-28-30(31)24-49(42(28)53)35-8-10-39(50)48-41(35)52/h4-7,9,11-12,21-23,26,35H,8,10,13-20,24-25H2,1-3H3,(H,44,46)(H,47,51)(H,48,50,52)",BRZGXSNAXRPPFI-UHFFFAOYSA-N
979,12.6,69.2,12.6,69.2,O43353,RIPK2,IAP,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=C(F)C=C2)=CS1)C1CCN(C(=O)C2=CN=C(N3CCN(CCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)N=C2)CC1,Degradation of RIPK2 in hPBMC cells after 24 h treatment,,,251.2,IC50 of RIPK2 was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,1093.326,1092.458611,5.19,77,9,18,4,17,253.83,C53H65FN14O7S2,"InChI=1S/C53H65FN14O7S2/c1-31-32(2)63-64-46(31)62-47-38-25-43(77(73,74)53(4,5)6)42(26-39(38)58-30-59-47)75-24-23-65-19-21-67(22-20-65)52-56-27-36(28-57-52)50(71)66-17-14-34(15-18-66)44(61-48(70)33(3)55-7)51(72)68-16-8-9-41(68)49-60-40(29-76-49)45(69)35-10-12-37(54)13-11-35/h10-13,25-30,33-34,41,44,55H,8-9,14-24H2,1-7H3,(H,61,70)(H2,58,59,62,63,64)/t33-,41-,44-/m0/s1",HZMQXNZSFFXKMT-LCPJFFRWSA-N
980,0.4,94.3,0.4,94.3,O43353,RIPK2,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of RIPK2 in hPBMC cells after 24 h treatment,,,10,IC50 of RIPK2 was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,1045.232,1044.492768,4.73,74,7,16,6,17,261.76,C50H66F2N14O7S,"InChI=1S/C50H66F2N14O7S/c1-28-29(2)62-63-43(28)61-44-32-22-39(74(71,72)50(7,8)9)38(23-35(32)56-27-57-44)73-20-12-15-64-16-18-65(19-17-64)40-25-54-36(24-55-40)46(68)58-31-21-37(47(69)59-41-33(51)13-11-14-34(41)52)66(26-31)48(70)42(49(4,5)6)60-45(67)30(3)53-10/h11,13-14,22-25,27,30-31,37,42,53H,12,15-21,26H2,1-10H3,(H,58,68)(H,59,69)(H,60,67)(H2,56,57,61,62,63)/t30-,31-,37-,42+/m0/s1",CHNBEZLJAQUZEX-LFRONEFISA-N
980,0.79,99,0.79,,O43353,RIPK2,IAP,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,Degradation of RIPK2 in THP1 cells after 18 h treatment,,,10,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.16,Inhibition of MDP-stimulated TNFalpha release in human whole blood,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01118,1045.232,1044.492768,4.73,74,7,16,6,17,261.76,C50H66F2N14O7S,"InChI=1S/C50H66F2N14O7S/c1-28-29(2)62-63-43(28)61-44-32-22-39(74(71,72)50(7,8)9)38(23-35(32)56-27-57-44)73-20-12-15-64-16-18-65(19-17-64)40-25-54-36(24-55-40)46(68)58-31-21-37(47(69)59-41-33(51)13-11-14-34(41)52)66(26-31)48(70)42(49(4,5)6)60-45(67)30(3)53-10/h11,13-14,22-25,27,30-31,37,42,53H,12,15-21,26H2,1-10H3,(H,58,68)(H,59,69)(H,60,67)(H2,56,57,61,62,63)/t30-,31-,37-,42+/m0/s1",CHNBEZLJAQUZEX-LFRONEFISA-N
984,1600,99,1600/1600,,Q12834,Cdc20,VHL,,CP5V,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCC(=O)NCCCOC(=O)NC(NC3=NC=CC=N3)C(Cl)(Cl)Cl)C(C)(C)C)C=C2)SC=N1,Degradation of Cdc20 in MCF7/MDA-MB-231 cells after 10 h treatment,,,,,,,12400,Kd of His-tagged Cdc20 was assessed by SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2600/1990,Inhibit growth of MDA-MB-231/MDA-MB-435 cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2019.10.013,1075.511,1073.361723,3.69,71,4,17,6,31,263.02,C46H66Cl3N9O12S,"InChI=1S/C46H66Cl3N9O12S/c1-31-38(71-30-54-31)33-9-7-32(8-10-33)28-53-40(62)35-27-34(59)29-58(35)41(63)39(45(2,3)4)55-37(61)12-18-66-20-22-68-24-26-69-25-23-67-21-19-65-17-11-36(60)50-15-6-16-70-44(64)57-42(46(47,48)49)56-43-51-13-5-14-52-43/h5,7-10,13-14,30,34-35,39,42,59H,6,11-12,15-29H2,1-4H3,(H,50,60)(H,53,62)(H,55,61)(H,57,64)(H,51,52,56)/t34-,35+,39-,42?/m1/s1",BQQILUVLGKHSNJ-NWRQRLFSSA-N
998,10,99,10-100,,P40337,VHL,VHL,,CM11,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C(C)(C)C)C=C2)SC=N1,Degradation of pVHL30 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11�� 25��,ITC in pVHL19/pVHL30,,,0.96460177,1.182692308,1.4/-0.9,ITC in pVHL19/pVHL30,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-017-00954-1,1179.47,1178.539191,3.57,82,6,18,6,31,278.64,C58H82N8O14S2,"InChI=1S/C58H82N8O14S2/c1-37-49(81-35-61-37)41-13-9-39(10-14-41)29-59-53(71)45-27-43(67)31-65(45)55(73)51(57(3,4)5)63-47(69)33-79-25-23-77-21-19-75-17-18-76-20-22-78-24-26-80-34-48(70)64-52(58(6,7)8)56(74)66-32-44(68)28-46(66)54(72)60-30-40-11-15-42(16-12-40)50-38(2)62-36-82-50/h9-16,35-36,43-46,51-52,67-68H,17-34H2,1-8H3,(H,59,71)(H,60,72)(H,63,69)(H,64,70)/t43-,44-,45+,46+,51-,52-/m1/s1",WGJCHHJGGFCCRS-DEYDLUNASA-N
1003,100,99,100-1000,,Q16288,TRKC,CRBN,,IY-IY-pom,CC[C@H](C)[C@H](N)C1=CN([C@@H](CC2=CC=C(O)C=C2)C(=O)N2CCN(C3=NC(NCCOCCOCCOCC4=CN(CCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)=NC(N4CCN(C(=O)[C@H](CC5=CC=C(O)C=C5)N5C=C([C@@H](N)[C@@H](C)CC)N=N5)CC4)=N3)CC2)N=N1,Degradation of TrkC in Hs578t cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.molpharmaceut.9b00673,1447.675,1446.742156,2.86,105,11,29,7,36,422.77,C71H94N22O12,"InChI=1S/C71H94N22O12/c1-5-45(3)62(72)54-42-91(84-81-54)57(39-47-14-18-50(94)19-15-47)66(100)86-26-30-88(31-27-86)70-77-69(78-71(79-70)89-32-28-87(29-33-89)67(101)58(40-48-16-20-51(95)21-17-48)92-43-55(82-85-92)63(73)46(4)6-2)74-24-34-103-35-36-104-37-38-105-44-49-41-90(83-80-49)25-9-7-8-13-59(96)75-53-12-10-11-52-61(53)68(102)93(65(52)99)56-22-23-60(97)76-64(56)98/h10-12,14-21,41-43,45-46,56-58,62-63,94-95H,5-9,13,22-40,44,72-73H2,1-4H3,(H,75,96)(H,76,97,98)(H,74,77,78,79)/t45-,46-,56?,57-,58-,62-,63-/m0/s1",IFUNICMRISUORK-AHAKWFMWSA-N
1008,3.8,99,3.8,,Q9UBN7,HDAC6,CRBN,,NP8,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCN4C=C(CCCCN(CC5=CC=C(C(=O)NO)C=C5)C(=O)NC5=CC=CC=C5)N=N4)=C3C2=O)C(=O)N1,Degradation of HADC6 in MM.1S cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1210,Inhibit viability of MM.1S cells,,,,,,,,,,,10.1007/s13238-018-0602-z,795.854,795.334024,1.94,58,6,13,5,20,226.42,C40H45N9O9,"InChI=1S/C40H45N9O9/c50-34-17-16-33(37(52)43-34)49-38(53)31-10-6-11-32(35(31)39(49)54)41-18-21-57-23-24-58-22-20-48-26-30(44-46-48)9-4-5-19-47(40(55)42-29-7-2-1-3-8-29)25-27-12-14-28(15-13-27)36(51)45-56/h1-3,6-8,10-15,26,33,41,56H,4-5,9,16-25H2,(H,42,55)(H,45,51)(H,43,50,52)",NLVMRCQAKUCFIA-UHFFFAOYSA-N
1011,44.5,97.1,44.5,97.1,Q96SW2,CRBN,VHL,,TD-158,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,842.032,841.3832827,5.37,60,6,11,5,17,207.21,C44H55N7O8S,"InChI=1S/C44H55N7O8S/c1-26-37(60-25-47-26)28-17-15-27(16-18-28)23-46-39(55)33-22-29(52)24-50(33)43(59)38(44(2,3)4)48-34(53)14-9-7-5-6-8-10-21-45-31-13-11-12-30-36(31)42(58)51(41(30)57)32-19-20-35(54)49-40(32)56/h11-13,15-18,25,29,32-33,38,45,52H,5-10,14,19-24H2,1-4H3,(H,46,55)(H,48,53)(H,49,54,56)/t29-,32?,33+,38-/m1/s1",UQJOJHWASBETAR-PHPCURKRSA-N
1012,20.4,99.6,20.4,99.6,Q96SW2,CRBN,VHL,,TD-165,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,870.086,869.4145828,6.46,62,6,11,5,19,207.21,C46H59N7O8S,"InChI=1S/C46H59N7O8S/c1-28-39(62-27-49-28)30-19-17-29(18-20-30)25-48-41(57)35-24-31(54)26-52(35)45(61)40(46(2,3)4)50-36(55)16-11-9-7-5-6-8-10-12-23-47-33-15-13-14-32-38(33)44(60)53(43(32)59)34-21-22-37(56)51-42(34)58/h13-15,17-20,27,31,34-35,40,47,54H,5-12,16,21-26H2,1-4H3,(H,48,57)(H,50,55)(H,51,56,58)/t31-,34?,35+,40-/m1/s1",KSXVXTSIDVRZBR-IINAPWRYSA-N
1013,100.6,96.9,100.6,96.9,Q96SW2,CRBN,VHL,,TD-156,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,813.978,813.3519826,4.29,58,6,11,5,15,207.21,C42H51N7O8S,"InChI=1S/C42H51N7O8S/c1-24-35(58-23-45-24)26-15-13-25(14-16-26)21-44-37(53)31-20-27(50)22-48(31)41(57)36(42(2,3)4)46-32(51)12-7-5-6-8-19-43-29-11-9-10-28-34(29)40(56)49(39(28)55)30-17-18-33(52)47-38(30)54/h9-11,13-16,23,27,30-31,36,43,50H,5-8,12,17-22H2,1-4H3,(H,44,53)(H,46,51)(H,47,52,54)/t27-,30?,31+,36-/m1/s1",NONAQRYFKJIZQD-AEXNMDALSA-N
1014,28.8,98.4,28.8,98.4,Q96SW2,CRBN,VHL,,TD-759,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,927.138,926.4360466,5.8,66,6,12,6,21,236.31,C48H62N8O9S,"InChI=1S/C48H62N8O9S/c1-29-41(66-28-52-29)31-19-17-30(18-20-31)25-51-43(61)36-24-32(57)27-55(36)47(65)42(48(2,3)4)53-37(58)16-11-9-7-5-6-8-10-12-23-49-39(60)26-50-34-15-13-14-33-40(34)46(64)56(45(33)63)35-21-22-38(59)54-44(35)62/h13-15,17-20,28,32,35-36,42,50,57H,5-12,16,21-27H2,1-4H3,(H,49,60)(H,51,61)(H,53,58)(H,54,59,62)/t32-,35?,36+,42-/m1/s1",FWZROUMFDYURRM-FYESNEIGSA-N
1015,367.7,82,367.7,82,Q96SW2,CRBN,VHL,,TD-760,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,928.122,927.4200622,5.24,66,6,12,5,21,233.51,C48H61N7O10S,"InChI=1S/C48H61N7O10S/c1-29-41(66-28-51-29)31-19-17-30(18-20-31)25-50-43(60)35-24-32(56)26-54(35)47(64)42(48(2,3)4)52-37(57)16-11-9-7-5-6-8-10-12-23-49-39(59)27-65-36-15-13-14-33-40(36)46(63)55(45(33)62)34-21-22-38(58)53-44(34)61/h13-15,17-20,28,32,34-35,42,56H,5-12,16,21-27H2,1-4H3,(H,49,59)(H,50,60)(H,52,57)(H,53,58,61)/t32-,34?,35+,42-/m1/s1",NANCWGWHLCCPLL-MSVILSSVSA-N
1016,2546.1,77.9,2546.1,77.9,Q96SW2,CRBN,VHL,,TD-033,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,827.961,827.3312471,3.06,59,6,11,5,14,224.28,C42H49N7O9S,"InChI=1S/C42H49N7O9S/c1-23-35(59-22-44-23)25-15-13-24(14-16-25)20-43-37(54)30-19-26(50)21-48(30)41(58)36(42(2,3)4)46-32(52)12-7-5-6-11-31(51)45-28-10-8-9-27-34(28)40(57)49(39(27)56)29-17-18-33(53)47-38(29)55/h8-10,13-16,22,26,29-30,36,50H,5-7,11-12,17-21H2,1-4H3,(H,43,54)(H,45,51)(H,46,52)(H,47,53,55)/t26-,29?,30+,36-/m1/s1",ZBCXOELGHROVDK-FOLICCEFSA-N
1017,100000,99,100000,,,BCR-ABL,IAP,,SNIPER(ABL)-49,CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C(=O)COCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC4=CC=CC=C4)CC3)C=C2)C=C1NC1=NC=CC(C2=CC=CN=C2)=N1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,959.162,958.5065091,3.41,70,6,14,6,26,235.49,C52H66N10O8,"InChI=1S/C52H66N10O8/c1-36(2)30-46(58-51(67)48(64)43(53)31-38-8-5-4-6-9-38)50(66)55-20-25-68-26-27-69-28-29-70-35-47(63)62-23-21-61(22-24-62)34-39-12-14-40(15-13-39)49(65)57-42-16-11-37(3)45(32-42)60-52-56-19-17-44(59-52)41-10-7-18-54-33-41/h4-19,32-33,36,43,46,48,64H,20-31,34-35,53H2,1-3H3,(H,55,66)(H,57,65)(H,58,67)(H,56,59,60)/t43-,46+,48+/m1/s1",JBCHWUPJETZFEN-RGTBTGBSSA-N
1018,20000,99,20000,,,BCR-ABL,IAP,,SNIPER(ABL)-13,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(=O)NCCOCCOCCOCCNC(=O)C1=CC=CC(C2=CC(NC3=CC=C(OC(F)(F)F)C=C3)=NC=N2)=C1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,839.913,839.3829463,4.6,60,4,12,6,25,208.28,C42H52F3N7O8,"InChI=1S/C42H52F3N7O8/c1-28(2)23-36(52-41(56)38(53)34(46)24-29-7-4-3-5-8-29)40(55)48-16-18-58-20-22-59-21-19-57-17-15-47-39(54)31-10-6-9-30(25-31)35-26-37(50-27-49-35)51-32-11-13-33(14-12-32)60-42(43,44)45/h3-14,25-28,34,36,38,53H,15-24,46H2,1-2H3,(H,47,54)(H,48,55)(H,52,56)(H,49,50,51)/t34-,36+,38+/m1/s1",QPZIGDUURVIUPV-IJDZGJQBSA-N
1019,10000,99,10000,,,BCR-ABL,IAP,,SNIPER(ABL)-44,CCN1CCN(CC2=CC=C(NC(=O)C3=CC=CC(C4=CC=C5N=C(NC(=O)COCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC6=CC=CC=C6)SC5=N4)=C3)C=C2C(F)(F)F)CC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1020.189,1019.455066,4.98,72,6,14,6,26,222.6,C51H64F3N9O8S,"InChI=1S/C51H64F3N9O8S/c1-4-62-18-20-63(21-19-62)31-37-13-14-38(30-39(37)51(52,53)54)57-46(66)36-12-8-11-35(29-36)41-15-16-42-49(59-41)72-50(60-42)61-44(64)32-71-26-25-70-24-23-69-22-17-56-47(67)43(27-33(2)3)58-48(68)45(65)40(55)28-34-9-6-5-7-10-34/h5-16,29-30,33,40,43,45,65H,4,17-28,31-32,55H2,1-3H3,(H,56,67)(H,57,66)(H,58,68)(H,60,61,64)/t40-,43+,45+/m1/s1",QRGLWQMXPLDUPI-XMNZJGRJSA-N
1020,,,>100000,,,BCR-ABL,IAP,,SNIPER(ABL)-20,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)COCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC3=CC=CC=C3)CC2)=N1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,923.538,922.3926575,4.16,64,5,15,6,24,235.49,C44H59ClN10O8S,"InChI=1S/C44H59ClN10O8S/c1-28(2)23-34(51-43(60)40(57)33(46)24-31-10-6-5-7-11-31)41(58)47-13-18-61-19-20-62-21-22-63-27-38(56)55-16-14-54(15-17-55)37-25-36(49-30(4)50-37)52-44-48-26-35(64-44)42(59)53-39-29(3)9-8-12-32(39)45/h5-12,25-26,28,33-34,40,57H,13-24,27,46H2,1-4H3,(H,47,58)(H,51,60)(H,53,59)(H,48,49,50,52)/t33-,34+,40+/m1/s1",YYNXYOVXFJJJHD-OCIHUODESA-N
1021,,,>100000,,,BCR-ABL,IAP,,SNIPER(ABL)-50,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCOCCOCCOCC(=O)N1CCN(CC2=CC=C(C(=O)NC3=CC=C(C)C(NC4=NC=CC(C5=CC=CN=C5)=N4)=C3)C=C2)CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)C1CCCCC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1213.495,1212.648422,6.47,89,9,15,6,29,250.68,C68H84N12O9,"InChI=1S/C68H84N12O9/c1-47-23-28-55(43-57(47)75-68-72-31-29-56(74-68)54-21-13-30-70-44-54)73-64(83)53-26-24-49(25-27-53)45-78-34-36-79(37-35-78)59(81)46-89-42-41-88-40-39-87-38-32-71-66(85)62(60(50-15-7-4-8-16-50)51-17-9-5-10-18-51)77-65(84)58-22-14-33-80(58)67(86)61(52-19-11-6-12-20-52)76-63(82)48(2)69-3/h4-5,7-10,13,15-18,21,23-31,43-44,48,52,58,60-62,69H,6,11-12,14,19-20,22,32-42,45-46H2,1-3H3,(H,71,85)(H,73,83)(H,76,82)(H,77,84)(H,72,74,75)/t48-,58-,61-,62-/m0/s1",PBMLWDMSBSZGHC-KOMGJWJNSA-N
1022,5000,99,5000,,,BCR-ABL,IAP,,SNIPER(ABL)-15,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCOCCOCCOCCNC(=O)C1=CC=CC(C2=CC(NC3=CC=C(OC(F)(F)F)C=C3)=NC=N2)=C1)C(C1=CC=CC=C1)C1=CC=CC=C1)C1CCCCC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1094.246,1093.524859,7.66,79,7,13,6,28,223.47,C58H70F3N9O9,"InChI=1S/C58H70F3N9O9/c1-39(62-2)53(71)68-51(42-18-10-5-11-19-42)57(75)70-29-13-22-48(70)55(73)69-52(50(40-14-6-3-7-15-40)41-16-8-4-9-17-41)56(74)64-28-31-77-33-35-78-34-32-76-30-27-63-54(72)44-21-12-20-43(36-44)47-37-49(66-38-65-47)67-45-23-25-46(26-24-45)79-58(59,60)61/h3-4,6-9,12,14-17,20-21,23-26,36-39,42,48,50-52,62H,5,10-11,13,18-19,22,27-35H2,1-2H3,(H,63,72)(H,64,74)(H,68,71)(H,69,73)(H,65,66,67)/t39-,48-,51-,52-/m0/s1",CYNNYMZGPVIXHI-ZUDXTMBRSA-N
1023,2000,99,2000,,,BCR-ABL,IAP,,SNIPER(ABL)-47,CCN1CCN(CC2=CC=C(NC(=O)C3=CC=CC(C4=CC=C5N=C(NC(=O)COCCOCCOCCNC(=O)[C@@H](NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)[C@H](C)NC)C6CCCCC6)C(C6=CC=CC=C6)C6=CC=CC=C6)SC5=N4)=C3)C=C2C(F)(F)F)CC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1274.522,1273.596979,8.04,91,9,15,6,29,237.79,C67H82F3N11O9S,"InChI=1S/C67H82F3N11O9S/c1-4-79-31-33-80(34-32-79)42-50-25-26-51(41-52(50)67(68,69)70)73-61(84)49-23-14-22-48(40-49)53-27-28-54-64(74-53)91-66(75-54)76-56(82)43-90-39-38-89-37-36-88-35-29-72-63(86)59(57(45-16-8-5-9-17-45)46-18-10-6-11-19-46)78-62(85)55-24-15-30-81(55)65(87)58(47-20-12-7-13-21-47)77-60(83)44(2)71-3/h5-6,8-11,14,16-19,22-23,25-28,40-41,44,47,55,57-59,71H,4,7,12-13,15,20-21,24,29-39,42-43H2,1-3H3,(H,72,86)(H,73,84)(H,77,83)(H,78,85)(H,75,76,82)/t44-,55-,58-,59-/m0/s1",NGXYXIVUCDETCQ-LXFUJSLCSA-N
1024,300,99,300,,,BCR-ABL,IAP,,SNIPER(ABL)-19,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCOCCOCCOCC(=O)N1CCN(C2=CC(NC3=NC=C(C(=O)NC4=C(C)C=CC=C4Cl)S3)=NC(C)=N2)CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)C1CCCCC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1177.871,1176.534571,7.23,83,8,16,6,27,250.68,C60H77ClN12O9S,"InChI=1S/C60H77ClN12O9S/c1-39-16-14-23-45(61)52(39)68-57(77)47-37-64-60(83-47)67-48-36-49(66-41(3)65-48)71-27-29-72(30-28-71)50(74)38-82-35-34-81-33-32-80-31-25-63-58(78)54(51(42-17-8-5-9-18-42)43-19-10-6-11-20-43)70-56(76)46-24-15-26-73(46)59(79)53(44-21-12-7-13-22-44)69-55(75)40(2)62-4/h5-6,8-11,14,16-20,23,36-37,40,44,46,51,53-54,62H,7,12-13,15,21-22,24-35,38H2,1-4H3,(H,63,78)(H,68,77)(H,69,75)(H,70,76)(H,64,65,66,67)/t40-,46-,53-,54-/m0/s1",SKXVPICURZPVJG-YKQCETGNSA-N
1025,,,10000,,,BCR-ABL,IAP,,SNIPER(ABL)-58,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=CC(OCCOCCOCCOCC(=O)N3CCN(CC4=CC=C(C(=O)NC5=CC=C(C)C(NC6=NC=CC(C7=CC=CN=C7)=N6)=C5)C=C4)CC3)=C2)=CS1)C1CCCCC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1150.417,1149.546994,6.55,83,9,17,4,27,231.67,C62H75N11O9S,"InChI=1S/C62H75N11O9S/c1-42-16-21-49(37-52(42)69-62-65-24-22-51(68-62)48-13-8-23-64-38-48)66-59(77)46-19-17-44(18-20-46)39-71-26-28-72(29-27-71)55(74)40-81-33-32-79-30-31-80-34-35-82-50-14-7-12-47(36-50)57(75)53-41-83-60(67-53)54-15-9-25-73(54)61(78)56(45-10-5-4-6-11-45)70-58(76)43(2)63-3/h7-8,12-14,16-24,36-38,41,43,45,54,56,63H,4-6,9-11,15,25-35,39-40H2,1-3H3,(H,66,77)(H,70,76)(H,65,68,69)/t43-,54-,56-/m0/s1",TVHMRPZDSBFQBQ-INNJKCEPSA-N
1026,5000,99,5000,,,BCR-ABL,IAP,,SNIPER(ABL)-24,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=CC(OCCOCCOCCOCCNC(=O)C3=CC=CC(C4=CC(NC5=CC=C(OC(F)(F)F)C=C5)=NC=N4)=C3)=C2)=CS1)C1CCCCC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1031.168,1030.423431,7.74,73,7,15,4,26,204.46,C52H61F3N8O9S,"InChI=1S/C52H61F3N8O9S/c1-34(56-2)48(65)62-46(35-9-4-3-5-10-35)51(67)63-21-8-15-44(63)50-61-43(32-73-50)47(64)37-12-7-14-41(30-37)71-28-27-70-26-25-69-24-23-68-22-20-57-49(66)38-13-6-11-36(29-38)42-31-45(59-33-58-42)60-39-16-18-40(19-17-39)72-52(53,54)55/h6-7,11-14,16-19,29-35,44,46,56H,3-5,8-10,15,20-28H2,1-2H3,(H,57,66)(H,62,65)(H,58,59,60)/t34-,44-,46-/m0/s1",WDQUTOHXUGVTJQ-WUSNILEASA-N
1027,300,99,300,,,BCR-ABL,IAP,,SNIPER(ABL)-33,CCN1CCN(CC2=CC=C(NC(=O)C3=CC=CC(C4=CC=C5N=C(NC(=O)COCCOCCOCCOC6=CC=CC(C(=O)C7=CSC([C@@H]8CCCN8C(=O)[C@@H](NC(=O)[C@H](C)NC)C8CCCCC8)=N7)=C6)SC5=N4)=C3)C=C2C(F)(F)F)CC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1111/cas.13284,1211.444,1210.495551,8.12,85,9,17,4,27,218.78,C61H73F3N10O9S2,"InChI=1S/C61H73F3N10O9S2/c1-4-72-23-25-73(26-24-72)36-44-18-19-45(35-47(44)61(62,63)64)66-56(78)43-15-8-13-41(33-43)48-20-21-49-57(67-48)85-60(69-49)70-52(75)37-82-30-29-80-27-28-81-31-32-83-46-16-9-14-42(34-46)54(76)50-38-84-58(68-50)51-17-10-22-74(51)59(79)53(40-11-6-5-7-12-40)71-55(77)39(2)65-3/h8-9,13-16,18-21,33-35,38-40,51,53,65H,4-7,10-12,17,22-32,36-37H2,1-3H3,(H,66,78)(H,71,77)(H,69,70,75)/t39-,51-,53-/m0/s1",NJCPVTOZWPVLBE-XOIMNWENSA-N
1028,10,99,10,,,BCR-ABL,IAP,,SNIPER(ABL)-39,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=CC(OCCOCCOCCOCC(=O)N3CCN(C4=CC(NC5=NC=C(C(=O)NC6=C(C)C=CC=C6Cl)S5)=NC(C)=N4)CC3)=C2)=CS1)C1CCCCC1,Degradation of BCR-ABL in K562 cells after 6 h treatment,,,0.54,IC50 of BCR-ABL was tested by TR-FRET,,,,,,,,,,,,,,,10/12/50,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8.92/8.06/6.72,Inhibit growth of K562/KCL22/KU812 cells,,,,,,,,,,,,,,,10.1111/cas.13284,1114.793,1113.433142,7.3,77,8,18,4,25,231.67,C54H68ClN11O9S2,"InChI=1S/C54H68ClN11O9S2/c1-34-11-8-16-40(55)47(34)62-51(70)43-31-57-54(77-43)61-44-30-45(59-36(3)58-44)64-19-21-65(22-20-64)46(67)32-74-26-25-72-23-24-73-27-28-75-39-15-9-14-38(29-39)49(68)41-33-76-52(60-41)42-17-10-18-66(42)53(71)48(37-12-6-5-7-13-37)63-50(69)35(2)56-4/h8-9,11,14-16,29-31,33,35,37,42,48,56H,5-7,10,12-13,17-28,32H2,1-4H3,(H,62,70)(H,63,69)(H,57,58,59,61)/t35-,42-,48-/m0/s1",PLCDNLSIFCGNNG-GFKCZKLESA-N
1038,3,99,3,,P03372,ER,XIAP,,SNIPER(ER)-87,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC(C(=O)C3=CSC([C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)=N3)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 6 h treatment,,,97,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,400/2100/3900,IC50 of cIAP1/cIAP2/XIAP was tested by HTRF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.6/9.6,Inhibit growth of MCF-7/T47D cells,,,,,,,,,,,,,,,10.1074/jbc.M116.768853,1044.325,1043.507815,9.81,75,7,13,3,28,178.09,C59H73N5O10S,"InChI=1S/C59H73N5O10S/c1-5-50(42-14-8-6-9-15-42)54(43-21-25-47(65)26-22-43)44-23-27-48(28-24-44)73-31-30-63(4)53(66)39-72-35-34-70-32-33-71-36-37-74-49-19-12-18-46(38-49)56(67)51-40-75-58(61-51)52-20-13-29-64(52)59(69)55(45-16-10-7-11-17-45)62-57(68)41(2)60-3/h6,8-9,12,14-15,18-19,21-28,38,40-41,45,52,55,60,65H,5,7,10-11,13,16-17,20,29-37,39H2,1-4H3,(H,62,68)/b54-50-/t41-,52-,55-/m0/s1",ILLYWIKUEZHTSD-RJFLEHBVSA-N
1038,3,99,<3/83,,P03372,ER,XIAP,,SNIPER(ER)-87,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC(C(=O)C3=CSC([C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)=N3)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4/48 h treatment,,,110,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,450/960/700,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1044.325,1043.507815,9.81,75,7,13,3,28,178.09,C59H73N5O10S,"InChI=1S/C59H73N5O10S/c1-5-50(42-14-8-6-9-15-42)54(43-21-25-47(65)26-22-43)44-23-27-48(28-24-44)73-31-30-63(4)53(66)39-72-35-34-70-32-33-71-36-37-74-49-19-12-18-46(38-49)56(67)51-40-75-58(61-51)52-20-13-29-64(52)59(69)55(45-16-10-7-11-17-45)62-57(68)41(2)60-3/h6,8-9,12,14-15,18-19,21-28,38,40-41,45,52,55,60,65H,5,7,10-11,13,16-17,20,29-37,39H2,1-4H3,(H,62,68)/b54-50-/t41-,52-,55-/m0/s1",ILLYWIKUEZHTSD-RJFLEHBVSA-N
1051,,,>100,,P03372,ER,XIAP,,SNIPER(ER)-104,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCNC(=O)C2=CC(C3=CN=CC([C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)=C3)=CC=C2F)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,61,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,>1000/>1000/>1000,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1055.302,1054.557956,9.03,77,7,11,4,27,180.89,C61H75FN6O9,"InChI=1S/C61H75FN6O9/c1-5-52(43-13-8-6-9-14-43)57(44-18-23-50(69)24-19-44)45-20-25-51(26-21-45)77-32-30-67(4)56(70)41-76-36-35-75-34-33-74-31-28-65-60(72)53-38-47(22-27-54(53)62)48-37-49(40-64-39-48)55-17-12-29-68(55)61(73)58(46-15-10-7-11-16-46)66-59(71)42(2)63-3/h6,8-9,13-14,18-27,37-40,42,46,55,58,63,69H,5,7,10-12,15-17,28-36,41H2,1-4H3,(H,65,72)(H,66,71)/b57-52-/t42-,55-,58-/m0/s1",TYEBWQBTRDRKSI-QLCHOWBWSA-N
1052,3,99,<3/<3,,P03372,ER,XIAP,,SNIPER(ER)-105,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCNC(=O)C2=CC=CC3=C2C=CN3C2=CN=CC([C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)C)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4/48h treatment,,,69,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,5.3/7.2/55,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1036.284,1035.546977,8.01,76,7,12,4,27,185.82,C60H73N7O9,"InChI=1S/C60H73N7O9/c1-7-50(43-13-9-8-10-14-43)56(44-18-22-48(68)23-19-44)45-20-24-49(25-21-45)76-32-30-65(6)55(69)40-75-36-35-74-34-33-73-31-27-63-59(71)52-15-11-16-54-51(52)26-29-66(54)47-37-46(38-62-39-47)53-17-12-28-67(53)60(72)57(41(2)3)64-58(70)42(4)61-5/h8-11,13-16,18-26,29,37-39,41-42,53,57,61,68H,7,12,17,27-28,30-36,40H2,1-6H3,(H,63,71)(H,64,70)/b56-50-/t42-,53-,57-/m0/s1",CEZKEOAAJBCWLN-GYLRPOFSSA-N
1053,3,99,<3/7.7,,P03372,ER,XIAP,,SNIPER(ER)-110,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC(O[C@H]3C[C@@H](C(=O)N[C@@H]4CCCC5=CC=CC=C54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)C3)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4/48h treatment,,,120,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,74/73/330,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1122.414,1121.608908,10.58,82,8,12,4,29,186.46,C66H83N5O11,"InChI=1S/C66H83N5O11/c1-5-57(47-16-8-6-9-17-47)62(49-26-30-52(72)31-27-49)50-28-32-53(33-29-50)80-35-34-70(4)61(73)45-79-39-38-77-36-37-78-40-41-81-54-22-15-23-55(42-54)82-56-43-60(65(75)68-59-25-14-21-48-18-12-13-24-58(48)59)71(44-56)66(76)63(51-19-10-7-11-20-51)69-64(74)46(2)67-3/h6,8-9,12-13,15-18,22-24,26-33,42,46,51,56,59-60,63,67,72H,5,7,10-11,14,19-21,25,34-41,43-45H2,1-4H3,(H,68,75)(H,69,74)/b62-57-/t46-,56-,59+,60-,63-/m0/s1",DXLPZZKVYXMXOP-UXACQRMVSA-N
1054,3,99,<3/13.3,,P03372,ER,XIAP,,SNIPER(ER)-113,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=C(O[C@H]3C[C@@H](C(=O)N[C@@H]4CCCC5=CC=CC=C54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)C3)C=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4/48h treatment,,,150,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,85/99/810,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1122.414,1121.608908,10.58,82,8,12,4,29,186.46,C66H83N5O11,"InChI=1S/C66H83N5O11/c1-5-57(47-15-8-6-9-16-47)62(49-23-27-52(72)28-24-49)50-25-29-53(30-26-50)80-36-35-70(4)61(73)45-79-40-39-77-37-38-78-41-42-81-54-31-33-55(34-32-54)82-56-43-60(65(75)68-59-22-14-20-48-17-12-13-21-58(48)59)71(44-56)66(76)63(51-18-10-7-11-19-51)69-64(74)46(2)67-3/h6,8-9,12-13,15-17,21,23-34,46,51,56,59-60,63,67,72H,5,7,10-11,14,18-20,22,35-45H2,1-4H3,(H,68,75)(H,69,74)/b62-57-/t46-,56-,59+,60-,63-/m0/s1",MVGYQGKJHVJHEF-UXACQRMVSA-N
1055,,,>100,,P03372,ER,XIAP,,SNIPER(ER)-118,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC(CCN3C[C@@H]4CC[C@H]3[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC)C3CCCCC3)C4)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,230,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,140/900/>1000,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1016.334,1015.603429,9.87,74,8,11,4,29,160.16,C60H81N5O9,"InChI=1S/C60H81N5O9/c1-5-53(46-14-8-6-9-15-46)57(47-20-24-50(66)25-21-47)48-22-26-51(27-23-48)73-32-31-64(4)56(67)42-72-36-35-70-33-34-71-37-38-74-52-18-12-13-44(39-52)29-30-65-41-45-19-28-55(65)54(40-45)62-60(69)58(49-16-10-7-11-17-49)63-59(68)43(2)61-3/h6,8-9,12-15,18,20-27,39,43,45,49,54-55,58,61,66H,5,7,10-11,16-17,19,28-38,40-42H2,1-4H3,(H,62,69)(H,63,68)/b57-53-/t43-,45+,54-,55-,58-/m0/s1",IMRBKDGQLBEWCO-RYGGPLERSA-N
1056,4,99,4/15.7,,P03372,ER,XIAP,,SNIPER(ER)-119,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC=C2O[C@H]2C[C@@H](C(=O)N[C@@H]3CCCC4=CC=CC=C43)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C3CCCCC3)C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4/48h treatment,,,200,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,80/48/700,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1122.414,1121.608908,10.58,82,8,12,4,29,186.46,C66H83N5O11,"InChI=1S/C66H83N5O11/c1-5-55(47-17-8-6-9-18-47)62(49-27-31-52(72)32-28-49)50-29-33-53(34-30-50)80-36-35-70(4)61(73)45-79-40-39-77-37-38-78-41-42-81-59-25-14-15-26-60(59)82-54-43-58(65(75)68-57-24-16-22-48-19-12-13-23-56(48)57)71(44-54)66(76)63(51-20-10-7-11-21-51)69-64(74)46(2)67-3/h6,8-9,12-15,17-19,23,25-34,46,51,54,57-58,63,67,72H,5,7,10-11,16,20-22,24,35-45H2,1-4H3,(H,68,75)(H,69,74)/b62-55-/t46-,54-,57+,58-,63-/m0/s1",NTGZVUKHLCPLPK-RDILSQNJSA-N
1057,,,>100,,P03372,ER,XIAP,,SNIPER(ER)-121,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=C(CCN3C[C@@H]4CC[C@H]3[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC)C3CCCCC3)C4)C=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,,,,,,,,,,,,,,,,,650/>1000/>1000,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1016.334,1015.603429,9.87,74,8,11,4,29,160.16,C60H81N5O9,"InChI=1S/C60H81N5O9/c1-5-53(46-12-8-6-9-13-46)57(47-19-23-50(66)24-20-47)48-21-27-52(28-22-48)73-33-32-64(4)56(67)42-72-37-36-70-34-35-71-38-39-74-51-25-16-44(17-26-51)30-31-65-41-45-18-29-55(65)54(40-45)62-60(69)58(49-14-10-7-11-15-49)63-59(68)43(2)61-3/h6,8-9,12-13,16-17,19-28,43,45,49,54-55,58,61,66H,5,7,10-11,14-15,18,29-42H2,1-4H3,(H,62,69)(H,63,68)/b57-53-/t43-,45+,54-,55-,58-/m0/s1",RLQDLUGWXIZLOW-RYGGPLERSA-N
1058,3,99,<3/3.7,,P03372,ER,XIAP,,SNIPER(ER)-126,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC(C(=O)C3=CN=CC([C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)=C3)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4/48h treatment,,,83,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,68/200/490,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1038.296,1037.551394,9.34,76,7,12,3,28,178.09,C61H75N5O10,"InChI=1S/C61H75N5O10/c1-5-54(44-14-8-6-9-15-44)57(45-21-25-51(67)26-22-45)46-23-27-52(28-24-46)75-31-30-65(4)56(68)42-74-35-34-72-32-33-73-36-37-76-53-19-12-18-48(39-53)59(69)50-38-49(40-63-41-50)55-20-13-29-66(55)61(71)58(47-16-10-7-11-17-47)64-60(70)43(2)62-3/h6,8-9,12,14-15,18-19,21-28,38-41,43,47,55,58,62,67H,5,7,10-11,13,16-17,20,29-37,42H2,1-4H3,(H,64,70)/b57-54-/t43-,55-,58-/m0/s1",QLVUUHMLPDRYAZ-FYNWWMGYSA-N
1059,36.9,99,36.9,,P03372,ER,XIAP,,SNIPER(ER)-130,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOCC(=O)N2CCC([C@H](NC(=O)[C@H](C)NC)C(=O)N3CCC[C@H]3C3=NC4=C(C5=CC=CC=C5)N=CC=C4S3)CC2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,41,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,68/28/25,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1110.388,1109.529613,7.94,80,8,14,3,28,194.22,C62H75N7O10S,"InChI=1S/C62H75N7O10S/c1-5-51(44-13-8-6-9-14-44)56(45-18-22-49(70)23-19-45)46-20-24-50(25-21-46)79-34-33-67(4)54(71)41-77-39-37-75-35-36-76-38-40-78-42-55(72)68-31-27-48(28-32-68)58(65-60(73)43(2)63-3)62(74)69-30-12-17-52(69)61-66-59-53(80-61)26-29-64-57(59)47-15-10-7-11-16-47/h6-11,13-16,18-26,29,43,48,52,58,63,70H,5,12,17,27-28,30-42H2,1-4H3,(H,65,73)/b56-51-/t43-,52-,58-/m0/s1",BTEFBUSBBSDOGF-DWWKJPFSSA-N
1060,33.8,99,33.8,,P03372,ER,XIAP,,SNIPER(ER)-131,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N2CCC[C@H]2C(=O)NC2=C(C3=CC=CC=C3)N=NS2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,80,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,25/24/140,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1091.342,1090.519776,6.92,78,6,15,5,33,232.11,C58H74N8O11S,"InChI=1S/C58H74N8O11S/c1-5-48(42-15-8-6-9-16-42)53(43-21-25-46(67)26-22-43)44-23-27-47(28-24-44)77-32-31-65(4)52(69)40-76-38-36-74-34-33-73-35-37-75-39-51(68)60-29-13-12-19-49(61-55(70)41(2)59-3)58(72)66-30-14-20-50(66)56(71)62-57-54(63-64-78-57)45-17-10-7-11-18-45/h6-11,15-18,21-28,41,49-50,59,67H,5,12-14,19-20,29-40H2,1-4H3,(H,60,68)(H,61,70)(H,62,71)/b53-48-/t41-,49-,50-/m0/s1",MADKLDOJBWDGSR-GKQIOZEKSA-N
1061,,,>100,,P03372,ER,XIAP,,SNIPER(ER)-134,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=CC(O[C@@H]3C[C@@H](C(=O)N[C@@H]4CCCC5=CC=CC=C54)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)C3)=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,47,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,550/360/>1000,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1122.414,1121.608908,10.58,82,8,12,4,29,186.46,C66H83N5O11,"InChI=1S/C66H83N5O11/c1-5-57(47-16-8-6-9-17-47)62(49-26-30-52(72)31-27-49)50-28-32-53(33-29-50)80-35-34-70(4)61(73)45-79-39-38-77-36-37-78-40-41-81-54-22-15-23-55(42-54)82-56-43-60(65(75)68-59-25-14-21-48-18-12-13-24-58(48)59)71(44-56)66(76)63(51-19-10-7-11-20-51)69-64(74)46(2)67-3/h6,8-9,12-13,15-18,22-24,26-33,42,46,51,56,59-60,63,67,72H,5,7,10-11,14,19-21,25,34-41,43-45H2,1-4H3,(H,68,75)(H,69,74)/b62-57-/t46-,56+,59+,60-,63-/m0/s1",DXLPZZKVYXMXOP-TWILRSJCSA-N
1062,,,>100,,P03372,ER,XIAP,,SNIPER(ER)-136,CC/C(=C(\C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)COCCOCCOCCOC2=CC=C(O[C@H]3C[C@@H](C4=NC(C5=CC=C(F)C6=CC=CC=C56)=CS4)N(C(=O)[C@@H](NC(=O)[C@H](C)NC)C4CCCCC4)C3)C=C2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 4h treatment,,,47,IC50 of ERalpha was tested using the PolarScreen ERalpha Competitor Assay Green,,,,,,,,,,,,,,,890/>1000/>1000,IC50 of cIAP1/cIAP2/XIAP was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1074/jbc.RA117.001091,1176.462,1175.545343,12.53,85,9,13,3,29,170.25,C68H78FN5O10S,"InChI=1S/C68H78FN5O10S/c1-5-56(47-14-8-6-9-15-47)64(48-20-24-51(75)25-21-48)49-22-26-52(27-23-49)82-35-34-73(4)63(76)44-81-39-38-79-36-37-80-40-41-83-53-28-30-54(31-29-53)84-55-42-62(67-71-61(45-85-67)59-32-33-60(69)58-19-13-12-18-57(58)59)74(43-55)68(78)65(50-16-10-7-11-17-50)72-66(77)46(2)70-3/h6,8-9,12-15,18-33,45-46,50,55,62,65,70,75H,5,7,10-11,16-17,34-44H2,1-4H3,(H,72,77)/b64-56-/t46-,55-,62-,65-/m0/s1",RTFPXJSTAFUILP-FIBILLHVSA-N
1063,21600,99,21600,,P10275,AR,cIAP1,,SNIPER(AR)-2,CC1=C(C#N)C(C2=CC=C(C#N)C=C2)=C(C)N1CC1=CC=C(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC2=CC=CC=C2)C=C1,Degradation of AR in 22Rv1 cells after 6 h treatment,,,27,IC50 of AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b00168,820.004,819.4319472,3.8,60,4,11,5,24,213.75,C46H57N7O7,"InChI=1S/C46H57N7O7/c1-31(2)26-41(52-46(57)43(54)40(49)27-34-8-6-5-7-9-34)45(56)51-19-21-59-23-25-60-24-22-58-20-18-50-44(55)38-16-12-36(13-17-38)30-53-32(3)39(29-48)42(33(53)4)37-14-10-35(28-47)11-15-37/h5-17,31,40-41,43,54H,18-27,30,49H2,1-4H3,(H,50,55)(H,51,56)(H,52,57)/t40-,41+,43+/m1/s1",NHMJRWPSMORJLM-JWZYOJHJSA-N
1064,,,>30000,,P10275,AR,cIAP1,,SNIPER(AR)-8,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(=O)NCCOCCOCCOCCNC(=O)C1=CC=C(S(=O)(=O)CC(C)(O)C(=O)NC2=CC=C(C#N)C(C(F)(F)F)=C2)C=C1,Degradation of AR in 22Rv1 cells after 6 h treatment,,,1100,IC50 of AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b00168,921.005,920.3601622,1.89,64,3,13,7,26,268.5,C43H55F3N6O11S,"InChI=1S/C43H55F3N6O11S/c1-28(2)23-36(52-40(56)37(53)35(48)24-29-7-5-4-6-8-29)39(55)50-16-18-62-20-22-63-21-19-61-17-15-49-38(54)30-10-13-33(14-11-30)64(59,60)27-42(3,58)41(57)51-32-12-9-31(26-47)34(25-32)43(44,45)46/h4-14,25,28,35-37,53,58H,15-24,27,48H2,1-3H3,(H,49,54)(H,50,55)(H,51,57)(H,52,56)/t35-,36+,37+,42?/m1/s1",PIRRWGXSGGCAEW-OGBWKRBHSA-N
1065,11700,99,11700,,P10275,AR,cIAP1,,SNIPER(AR)-23,CC1=NN(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(C)=C1CC1=CC=C(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC2=CC=CC=C2)C=C1,Degradation of AR in 22Rv1 cells after 6 h treatment,,,190,IC50 of AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b00168,863.979,863.4193318,4.9,62,4,11,5,24,202.85,C45H56F3N7O7,"InChI=1S/C45H56F3N7O7/c1-29(2)24-40(53-44(59)41(56)39(50)26-32-8-6-5-7-9-32)43(58)52-17-19-61-21-23-62-22-20-60-18-16-51-42(57)34-12-10-33(11-13-34)25-37-30(3)54-55(31(37)4)36-15-14-35(28-49)38(27-36)45(46,47)48/h5-15,27,29,39-41,56H,16-26,50H2,1-4H3,(H,51,57)(H,52,58)(H,53,59)/t39-,40+,41+/m1/s1",ZTVZRLVVINGLIZ-AEKUSUEZSA-N
1066,20500,99,20500,,P10275,AR,cIAP1,,SNIPER(AR)-26,CC1=NN(C2=CC=C(C#N)C(Cl)=C2)C(C)=C1CCC1=CC=C(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC2=CC=CC=C2)C=C1,Degradation of AR in 22Rv1 cells after 6 h treatment,,,190,IC50 of AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b00168,844.454,843.4086249,4.94,60,4,11,5,25,202.85,C45H58ClN7O7,"InChI=1S/C45H58ClN7O7/c1-30(2)26-41(51-45(57)42(54)40(48)27-34-8-6-5-7-9-34)44(56)50-19-21-59-23-25-60-24-22-58-20-18-49-43(55)35-13-10-33(11-14-35)12-17-38-31(3)52-53(32(38)4)37-16-15-36(29-47)39(46)28-37/h5-11,13-16,28,30,40-42,54H,12,17-27,48H2,1-4H3,(H,49,55)(H,50,56)(H,51,57)/t40-,41+,42+/m1/s1",LMIAQQBKBLWQGJ-IWSHAHEXSA-N
1067,,,>30000,,P10275,AR,cIAP1,,SNIPER(AR)-27,CC1=NN(C2=CC=C(C#N)C=C2Cl)C(C)=C1CC1=CC=C(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC2=CC=CC=C2)C=C1,Degradation of AR in 22Rv1 cells after 6 h treatment,,,>10000,IC50 of AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.7b00168,830.427,829.3929748,4.64,59,4,11,5,24,202.85,C44H56ClN7O7,"InChI=1S/C44H56ClN7O7/c1-29(2)24-39(50-44(56)41(53)38(47)27-32-8-6-5-7-9-32)43(55)49-17-19-58-21-23-59-22-20-57-18-16-48-42(54)35-13-10-33(11-14-35)25-36-30(3)51-52(31(36)4)40-15-12-34(28-46)26-37(40)45/h5-15,26,29,38-39,41,53H,16-25,27,47H2,1-4H3,(H,48,54)(H,49,55)(H,50,56)/t38-,39+,41+/m1/s1",ITBLIPSXEWWMSK-QAOPUTECSA-N
1081,100,65,100,65,P15056,BRAF V600E,CRBN,,Pmd-PEG3-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,65,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1520,FP,,,,,,,,,,,,,,,3750,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1001.083,1000.371315,3.08,71,8,16,3,22,236.59,C48H54F2N10O10S,"InChI=1S/C48H54F2N10O10S/c1-3-25-71(66,67)56-36-8-7-34(49)45(43(36)50)59-28-33(30-26-51-29-52-27-30)44-37(59)9-11-39(54-44)57(2)31-13-17-58(18-14-31)41(62)15-19-68-21-23-70-24-22-69-20-16-53-35-6-4-5-32-42(35)48(65)60(47(32)64)38-10-12-40(61)55-46(38)63/h4-9,11,26-29,31,38,53,56H,3,10,12-25H2,1-2H3,(H,55,61,63)",FMUGAZVOOIUFAT-UHFFFAOYSA-N
1098,15,82,15,82,P15056,BRAF V600E,CRBN,,P4B,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,12,Inhibition of BRAF V600E,,,5.6,SPR,,,,,,,1.4,0.77,,,900,FP,,,,,,,,,,,,,,,2570,FP,,,,,,,,,,,,,,,71/75/147,Inhibit proliferation of A375/WM266-4/RKO cells,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1045.136,1044.39753,2.93,74,8,17,3,25,245.82,C50H58F2N10O11S,"InChI=1S/C50H58F2N10O11S/c1-3-27-74(68,69)58-38-8-7-36(51)47(45(38)52)61-30-35(32-28-53-31-54-29-32)46-39(61)9-11-41(56-46)59(2)33-13-17-60(18-14-33)43(64)15-19-70-21-23-72-25-26-73-24-22-71-20-16-55-37-6-4-5-34-44(37)50(67)62(49(34)66)40-10-12-42(63)57-48(40)65/h4-9,11,28-31,33,40,55,58H,3,10,12-27H2,1-2H3,(H,57,63,65)",GJCIYFAPQUEGNE-UHFFFAOYSA-N
1099,70,82,70,82,P15056,BRAF V600E,CRBN,,P5B,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,25,Inhibition of BRAF V600E,,,,,,,,,,,,,,,850,FP,,,,,,,,,,,,,,,2170,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1089.189,1088.423745,2.78,77,8,18,3,28,255.05,C52H62F2N10O12S,"InChI=1S/C52H62F2N10O12S/c1-3-29-77(70,71)60-40-8-7-38(53)49(47(40)54)63-32-37(34-30-55-33-56-31-34)48-41(63)9-11-43(58-48)61(2)35-13-17-62(18-14-35)45(66)15-19-72-21-23-74-25-27-76-28-26-75-24-22-73-20-16-57-39-6-4-5-36-46(39)52(69)64(51(36)68)42-10-12-44(65)59-50(42)67/h4-9,11,30-33,35,42,57,60H,3,10,12-29H2,1-2H3,(H,59,65,67)",RQROXFBXOKHLAH-UHFFFAOYSA-N
1106,100,40,100,40,P15056,BRAF V600E,VHL,,VH-PEG4-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,67,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1230.472,1229.521351,4.51,86,8,18,4,29,261.87,C60H77F2N11O11S2,"InChI=1S/C60H77F2N11O11S2/c1-7-30-86(79,80)69-47-13-12-46(61)55(53(47)62)72-36-45(42-33-63-37-64-34-42)54-48(72)14-15-50(67-54)70(6)43-16-20-71(21-17-43)52(76)19-23-82-25-27-84-29-28-83-26-24-81-22-18-51(75)68-57(60(3,4)5)59(78)73-35-44(74)31-49(73)58(77)65-32-40-8-10-41(11-9-40)56-39(2)66-38-85-56/h8-15,33-34,36-38,43-44,49,57,69,74H,7,16-32,35H2,1-6H3,(H,65,77)(H,68,75)/t44-,49+,57-/m1/s1",FFRMYNSJXNXLED-ZPPJDHJYSA-N
1108,,,>3000,,P04035,HMGCR,CRBN,,P13A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1027.12,1026.428733,5.27,75,8,15,6,25,256.54,C55H59FN8O11,"InChI=1S/C55H59FN8O11/c1-33(2)50-49(53(71)58-37-10-4-3-5-11-37)47(51(34-16-18-36(56)19-17-34)63(50)24-22-39(65)30-40(66)31-46(68)69)35-9-6-13-41(29-35)75-26-8-12-38-32-62(61-60-38)25-28-74-27-23-57-43-15-7-14-42-48(43)55(73)64(54(42)72)44-20-21-45(67)59-52(44)70/h3-7,9-11,13-19,29,32-33,39-40,44,57,65-66H,8,12,20-28,30-31H2,1-2H3,(H,58,71)(H,68,69)(H,59,67,70)/t39-,40-,44?/m1/s1",KOPPBUIQHDCVSF-FPWGYEBVSA-N
1109,,,>3000,,P04035,HMGCR,CRBN,,P14A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1041.147,1040.444383,5.62,76,8,15,6,26,256.54,C56H61FN8O11,"InChI=1S/C56H61FN8O11/c1-34(2)51-50(54(72)59-38-11-4-3-5-12-38)48(52(35-17-19-37(57)20-18-35)64(51)25-23-40(66)31-41(67)32-47(69)70)36-10-8-14-42(30-36)76-27-7-6-13-39-33-63(62-61-39)26-29-75-28-24-58-44-16-9-15-43-49(44)56(74)65(55(43)73)45-21-22-46(68)60-53(45)71/h3-5,8-12,14-20,30,33-34,40-41,45,58,66-67H,6-7,13,21-29,31-32H2,1-2H3,(H,59,72)(H,69,70)(H,60,68,71)/t40-,41-,45?/m1/s1",LYZQONNTSQMVGJ-WGFAKLPBSA-N
1110,3000,99,3000,,P04035,HMGCR,CRBN,,P15A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1055.174,1054.460033,5.98,77,8,15,6,27,256.54,C57H63FN8O11,"InChI=1S/C57H63FN8O11/c1-35(2)52-51(55(73)60-39-12-5-3-6-13-39)49(53(36-18-20-38(58)21-19-36)65(52)26-24-41(67)32-42(68)33-48(70)71)37-11-9-15-43(31-37)77-28-8-4-7-14-40-34-64(63-62-40)27-30-76-29-25-59-45-17-10-16-44-50(45)57(75)66(56(44)74)46-22-23-47(69)61-54(46)72/h3,5-6,9-13,15-21,31,34-35,41-42,46,59,67-68H,4,7-8,14,22-30,32-33H2,1-2H3,(H,60,73)(H,70,71)(H,61,69,72)/t41-,42-,46?/m1/s1",JMLYHOMYNWELEV-RFIMGWBHSA-N
1111,,,>3000,,P04035,HMGCR,CRBN,,P16A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1071.173,1070.454948,5.12,78,8,16,6,28,265.77,C57H63FN8O12,"InChI=1S/C57H63FN8O12/c1-35(2)52-51(55(73)60-39-10-4-3-5-11-39)49(53(36-16-18-38(58)19-17-36)65(52)24-22-41(67)32-42(68)33-48(70)71)37-9-6-13-43(31-37)78-26-8-12-40-34-64(63-62-40)25-28-77-30-29-76-27-23-59-45-15-7-14-44-50(45)57(75)66(56(44)74)46-20-21-47(69)61-54(46)72/h3-7,9-11,13-19,31,34-35,41-42,46,59,67-68H,8,12,20-30,32-33H2,1-2H3,(H,60,73)(H,70,71)(H,61,69,72)/t41-,42-,46?/m1/s1",PAYQRGVUYUNIDJ-RFIMGWBHSA-N
1112,,,>3000,,P04035,HMGCR,CRBN,,P17A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1085.2,1084.470598,5.48,79,8,16,6,29,265.77,C58H65FN8O12,"InChI=1S/C58H65FN8O12/c1-36(2)53-52(56(74)61-40-11-4-3-5-12-40)50(54(37-17-19-39(59)20-18-37)66(53)25-23-42(68)33-43(69)34-49(71)72)38-10-8-14-44(32-38)79-27-7-6-13-41-35-65(64-63-41)26-29-78-31-30-77-28-24-60-46-16-9-15-45-51(46)58(76)67(57(45)75)47-21-22-48(70)62-55(47)73/h3-5,8-12,14-20,32,35-36,42-43,47,60,68-69H,6-7,13,21-31,33-34H2,1-2H3,(H,61,74)(H,71,72)(H,62,70,73)/t42-,43-,47?/m1/s1",LFNFPNZCEJIEOS-VDKNZPKNSA-N
1113,,,>3000,,P04035,HMGCR,CRBN,,P18A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1099.227,1098.486248,5.83,80,8,16,6,30,265.77,C59H67FN8O12,"InChI=1S/C59H67FN8O12/c1-37(2)54-53(57(75)62-41-12-5-3-6-13-41)51(55(38-18-20-40(60)21-19-38)67(54)26-24-43(69)34-44(70)35-50(72)73)39-11-9-15-45(33-39)80-28-8-4-7-14-42-36-66(65-64-42)27-30-79-32-31-78-29-25-61-47-17-10-16-46-52(47)59(77)68(58(46)76)48-22-23-49(71)63-56(48)74/h3,5-6,9-13,15-21,33,36-37,43-44,48,61,69-70H,4,7-8,14,22-32,34-35H2,1-2H3,(H,62,75)(H,72,73)(H,63,71,74)/t43-,44-,48?/m1/s1",BCTTUKOMPZRYHS-OGVMARDASA-N
1114,,,>3000,,P04035,HMGCR,CRBN,,P19A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1115.226,1114.481162,4.97,81,8,17,6,31,275,C59H67FN8O13,"InChI=1S/C59H67FN8O13/c1-37(2)54-53(57(75)62-41-10-4-3-5-11-41)51(55(38-16-18-40(60)19-17-38)67(54)24-22-43(69)34-44(70)35-50(72)73)39-9-6-13-45(33-39)81-26-8-12-42-36-66(65-64-42)25-28-79-30-32-80-31-29-78-27-23-61-47-15-7-14-46-52(47)59(77)68(58(46)76)48-20-21-49(71)63-56(48)74/h3-7,9-11,13-19,33,36-37,43-44,48,61,69-70H,8,12,20-32,34-35H2,1-2H3,(H,62,75)(H,72,73)(H,63,71,74)/t43-,44-,48?/m1/s1",YHXVDJNFXLNLSO-OGVMARDASA-N
1115,,,>3000,,P04035,HMGCR,CRBN,,P20A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1129.253,1128.496812,5.33,82,8,17,6,32,275,C60H69FN8O13,"InChI=1S/C60H69FN8O13/c1-38(2)55-54(58(76)63-42-11-4-3-5-12-42)52(56(39-17-19-41(61)20-18-39)68(55)25-23-44(70)35-45(71)36-51(73)74)40-10-8-14-46(34-40)82-27-7-6-13-43-37-67(66-65-43)26-29-80-31-33-81-32-30-79-28-24-62-48-16-9-15-47-53(48)60(78)69(59(47)77)49-21-22-50(72)64-57(49)75/h3-5,8-12,14-20,34,37-38,44-45,49,62,70-71H,6-7,13,21-33,35-36H2,1-2H3,(H,63,76)(H,73,74)(H,64,72,75)/t44-,45-,49?/m1/s1",UHFHFZUJWIFRPV-OEUTXLNUSA-N
1116,1800,99,1800,,P04035,HMGCR,CRBN,,P21A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1143.28,1142.512463,5.68,83,8,17,6,33,275,C61H71FN8O13,"InChI=1S/C61H71FN8O13/c1-39(2)56-55(59(77)64-43-12-5-3-6-13-43)53(57(40-18-20-42(62)21-19-40)69(56)26-24-45(71)36-46(72)37-52(74)75)41-11-9-15-47(35-41)83-28-8-4-7-14-44-38-68(67-66-44)27-30-81-32-34-82-33-31-80-29-25-63-49-17-10-16-48-54(49)61(79)70(60(48)78)50-22-23-51(73)65-58(50)76/h3,5-6,9-13,15-21,35,38-39,45-46,50,63,71-72H,4,7-8,14,22-34,36-37H2,1-2H3,(H,64,77)(H,74,75)(H,65,73,76)/t45-,46-,50?/m1/s1",VQPHUFKUCJQDDO-SRQCOUMPSA-N
1117,100,99,100,,P04035,HMGCR,CRBN,,P22A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1159.279,1158.507377,4.82,84,8,18,6,34,284.23,C61H71FN8O14,"InChI=1S/C61H71FN8O14/c1-39(2)56-55(59(77)64-43-10-4-3-5-11-43)53(57(40-16-18-42(62)19-17-40)69(56)24-22-45(71)36-46(72)37-52(74)75)41-9-6-13-47(35-41)84-26-8-12-44-38-68(67-66-44)25-28-81-30-32-83-34-33-82-31-29-80-27-23-63-49-15-7-14-48-54(49)61(79)70(60(48)78)50-20-21-51(73)65-58(50)76/h3-7,9-11,13-19,35,38-39,45-46,50,63,71-72H,8,12,20-34,36-37H2,1-2H3,(H,64,77)(H,74,75)(H,65,73,76)/t45-,46-,50?/m1/s1",JGEJZAWLMMDNEZ-SRQCOUMPSA-N
1118,400,99,400,,P04035,HMGCR,CRBN,,P23A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1173.306,1172.523027,5.18,85,8,18,6,35,284.23,C62H73FN8O14,"InChI=1S/C62H73FN8O14/c1-40(2)57-56(60(78)65-44-11-4-3-5-12-44)54(58(41-17-19-43(63)20-18-41)70(57)25-23-46(72)37-47(73)38-53(75)76)42-10-8-14-48(36-42)85-27-7-6-13-45-39-69(68-67-45)26-29-82-31-33-84-35-34-83-32-30-81-28-24-64-50-16-9-15-49-55(50)62(80)71(61(49)79)51-21-22-52(74)66-59(51)77/h3-5,8-12,14-20,36,39-40,46-47,51,64,72-73H,6-7,13,21-35,37-38H2,1-2H3,(H,65,78)(H,75,76)(H,66,74,77)/t46-,47-,51?/m1/s1",FGHBFYYPECSTEQ-CFQHIMGQSA-N
1119,500,99,500,,P04035,HMGCR,CRBN,,P24A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1187.333,1186.538677,5.54,86,8,18,6,36,284.23,C63H75FN8O14,"InChI=1S/C63H75FN8O14/c1-41(2)58-57(61(79)66-45-12-5-3-6-13-45)55(59(42-18-20-44(64)21-19-42)71(58)26-24-47(73)38-48(74)39-54(76)77)43-11-9-15-49(37-43)86-28-8-4-7-14-46-40-70(69-68-46)27-30-83-32-34-85-36-35-84-33-31-82-29-25-65-51-17-10-16-50-56(51)63(81)72(62(50)80)52-22-23-53(75)67-60(52)78/h3,5-6,9-13,15-21,37,40-41,47-48,52,65,73-74H,4,7-8,14,22-36,38-39H2,1-2H3,(H,66,79)(H,76,77)(H,67,75,78)/t47-,48-,52?/m1/s1",IIAPDULZKPEHMU-FPALUEFMSA-N
1120,200,99,200,,P04035,HMGCR,CRBN,,P25A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1203.332,1202.533592,4.68,87,8,19,6,37,293.46,C63H75FN8O15,"InChI=1S/C63H75FN8O15/c1-41(2)58-57(61(79)66-45-10-4-3-5-11-45)55(59(42-16-18-44(64)19-17-42)71(58)24-22-47(73)38-48(74)39-54(76)77)43-9-6-13-49(37-43)87-26-8-12-46-40-70(69-68-46)25-28-83-30-32-85-34-36-86-35-33-84-31-29-82-27-23-65-51-15-7-14-50-56(51)63(81)72(62(50)80)52-20-21-53(75)67-60(52)78/h3-7,9-11,13-19,37,40-41,47-48,52,65,73-74H,8,12,20-36,38-39H2,1-2H3,(H,66,79)(H,76,77)(H,67,75,78)/t47-,48-,52?/m1/s1",JLBAXXGSFOPYED-FPALUEFMSA-N
1121,,,>3000,,P04035,HMGCR,CRBN,,P26A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1217.359,1216.549242,5.03,88,8,19,6,38,293.46,C64H77FN8O15,"InChI=1S/C64H77FN8O15/c1-42(2)59-58(62(80)67-46-11-4-3-5-12-46)56(60(43-17-19-45(65)20-18-43)72(59)25-23-48(74)39-49(75)40-55(77)78)44-10-8-14-50(38-44)88-27-7-6-13-47-41-71(70-69-47)26-29-84-31-33-86-35-37-87-36-34-85-32-30-83-28-24-66-52-16-9-15-51-57(52)64(82)73(63(51)81)53-21-22-54(76)68-61(53)79/h3-5,8-12,14-20,38,41-42,48-49,53,66,74-75H,6-7,13,21-37,39-40H2,1-2H3,(H,67,80)(H,77,78)(H,68,76,79)/t48-,49-,53?/m1/s1",UVFPGFDLMAJEOI-MOHJDXDLSA-N
1122,600,99,600,,P04035,HMGCR,CRBN,,P27A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1231.386,1230.564892,5.39,89,8,19,6,39,293.46,C65H79FN8O15,"InChI=1S/C65H79FN8O15/c1-43(2)60-59(63(81)68-47-12-5-3-6-13-47)57(61(44-18-20-46(66)21-19-44)73(60)26-24-49(75)40-50(76)41-56(78)79)45-11-9-15-51(39-45)89-28-8-4-7-14-48-42-72(71-70-48)27-30-85-32-34-87-36-38-88-37-35-86-33-31-84-29-25-67-53-17-10-16-52-58(53)65(83)74(64(52)82)54-22-23-55(77)69-62(54)80/h3,5-6,9-13,15-21,39,42-43,49-50,54,67,75-76H,4,7-8,14,22-38,40-41H2,1-2H3,(H,68,81)(H,78,79)(H,69,77,80)/t49-,50-,54?/m1/s1",TWQUUKPKPBHTJN-VTRKPICJSA-N
1124,400,99,400,,P04035,HMGCR,CRBN,,P14A1,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1039.175,1038.465118,6.84,76,8,14,6,26,247.31,C57H63FN8O10,"InChI=1S/C57H63FN8O10/c1-35(2)52-51(55(73)60-39-14-6-5-7-15-39)49(53(36-20-22-38(58)23-21-36)65(52)29-26-41(67)32-42(68)33-48(70)71)37-13-10-17-43(31-37)76-30-12-16-40-34-64(63-62-40)28-9-4-3-8-27-59-45-19-11-18-44-50(45)57(75)66(56(44)74)46-24-25-47(69)61-54(46)72/h5-7,10-11,13-15,17-23,31,34-35,41-42,46,59,67-68H,3-4,8-9,12,16,24-30,32-33H2,1-2H3,(H,60,73)(H,70,71)(H,61,69,72)/t41-,42-,46?/m1/s1",ZSYCSQSVLORGPQ-RFIMGWBHSA-N
1125,200,99,200,,P04035,HMGCR,CRBN,,P15A1,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1053.202,1052.480769,7.38,77,8,14,6,27,247.31,C58H65FN8O10,"InChI=1S/C58H65FN8O10/c1-36(2)53-52(56(74)61-40-15-7-6-8-16-40)50(54(37-21-23-39(59)24-22-37)66(53)30-27-42(68)33-43(69)34-49(71)72)38-14-11-18-44(32-38)77-31-13-17-41-35-65(64-63-41)29-10-5-3-4-9-28-60-46-20-12-19-45-51(46)58(76)67(57(45)75)47-25-26-48(70)62-55(47)73/h6-8,11-12,14-16,18-24,32,35-36,42-43,47,60,68-69H,3-5,9-10,13,17,25-31,33-34H2,1-2H3,(H,61,74)(H,71,72)(H,62,70,73)/t42-,43-,47?/m1/s1",SSIVFTARUYZQRR-VDKNZPKNSA-N
1126,300,99,300,,P04035,HMGCR,CRBN,,P16A1,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1067.229,1066.496419,7.74,78,8,14,6,28,247.31,C59H67FN8O10,"InChI=1S/C59H67FN8O10/c1-37(2)54-53(57(75)62-41-16-7-6-8-17-41)51(55(38-22-24-40(60)25-23-38)67(54)31-28-43(69)34-44(70)35-50(72)73)39-15-13-19-45(33-39)78-32-12-9-18-42-36-66(65-64-42)30-11-5-3-4-10-29-61-47-21-14-20-46-52(47)59(77)68(58(46)76)48-26-27-49(71)63-56(48)74/h6-8,13-17,19-25,33,36-37,43-44,48,61,69-70H,3-5,9-12,18,26-32,34-35H2,1-2H3,(H,62,75)(H,72,73)(H,63,71,74)/t43-,44-,48?/m1/s1",QSIGDMGYYLASQS-OGVMARDASA-N
1127,400,99,400,,P04035,HMGCR,CRBN,,P17A1,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1081.256,1080.512069,8.1,79,8,14,6,29,247.31,C60H69FN8O10,"InChI=1S/C60H69FN8O10/c1-38(2)55-54(58(76)63-42-17-8-6-9-18-42)52(56(39-23-25-41(61)26-24-39)68(55)32-29-44(70)35-45(71)36-51(73)74)40-16-14-20-46(34-40)79-33-13-7-10-19-43-37-67(66-65-43)31-12-5-3-4-11-30-62-48-22-15-21-47-53(48)60(78)69(59(47)77)49-27-28-50(72)64-57(49)75/h6,8-9,14-18,20-26,34,37-38,44-45,49,62,70-71H,3-5,7,10-13,19,27-33,35-36H2,1-2H3,(H,63,76)(H,73,74)(H,64,72,75)/t44-,45-,49?/m1/s1",LYZGJWGMLFFWSX-OEUTXLNUSA-N
1128,300,99,300,,P04035,HMGCR,CRBN,,P18A1,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCCC3=CN(CCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1095.283,1094.527719,8.64,80,8,14,6,30,247.31,C61H71FN8O10,"InChI=1S/C61H71FN8O10/c1-39(2)56-55(59(77)64-43-18-10-8-11-19-43)53(57(40-24-26-42(62)27-25-40)69(56)33-30-45(71)36-46(72)37-52(74)75)41-17-15-21-47(35-41)80-34-14-7-4-9-20-44-38-68(67-66-44)32-13-6-3-5-12-31-63-49-23-16-22-48-54(49)61(79)70(60(48)78)50-28-29-51(73)65-58(50)76/h8,10-11,15-19,21-27,35,38-39,45-46,50,63,71-72H,3-7,9,12-14,20,28-34,36-37H2,1-2H3,(H,64,77)(H,74,75)(H,65,73,76)/t45-,46-,50?/m1/s1",YLSNBWKVPICJNZ-SRQCOUMPSA-N
1129,500,99,500,,P04035,HMGCR,CRBN,,P19A1,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCCCC3=CN(CCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1109.31,1108.543369,9.18,81,8,14,6,31,247.31,C62H73FN8O10,"InChI=1S/C62H73FN8O10/c1-40(2)57-56(60(78)65-44-19-11-9-12-20-44)54(58(41-25-27-43(63)28-26-41)70(57)34-31-46(72)37-47(73)38-53(75)76)42-18-16-22-48(36-42)81-35-15-8-3-5-10-21-45-39-69(68-67-45)33-14-7-4-6-13-32-64-50-24-17-23-49-55(50)62(80)71(61(49)79)51-29-30-52(74)66-59(51)77/h9,11-12,16-20,22-28,36,39-40,46-47,51,64,72-73H,3-8,10,13-15,21,29-35,37-38H2,1-2H3,(H,65,78)(H,75,76)(H,66,74,77)/t46-,47-,51?/m1/s1",CIOOKQVNPLZLAN-CFQHIMGQSA-N
1130,,,>3000,,P04035,HMGCR,CRBN,,P19AM,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCOCCOCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1115.226,1114.481162,4.42,81,8,17,6,31,275,C59H67FN8O13,"InChI=1S/C59H67FN8O13/c1-37(2)54-53(57(75)62-41-9-4-3-5-10-41)52(55(38-13-15-40(60)16-14-38)67(54)23-21-44(69)34-45(70)35-51(72)73)39-8-6-12-46(32-39)81-25-7-11-43-36-66(65-64-43)24-27-79-29-31-80-30-28-78-26-22-61-42-17-18-47-48(33-42)59(77)68(58(47)76)49-19-20-50(71)63-56(49)74/h3-6,8-10,12-18,32-33,36-37,44-45,49,61,69-70H,7,11,19-31,34-35H2,1-2H3,(H,62,75)(H,72,73)(H,63,71,74)/t44-,45-,49?/m1/s1",FLZOWPIEHOMVRX-OEUTXLNUSA-N
1131,,,>3000,,P04035,HMGCR,CRBN,,P20AM,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCOCCOCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1129.253,1128.496812,4.78,82,8,17,6,32,275,C60H69FN8O13,"InChI=1S/C60H69FN8O13/c1-38(2)55-54(58(76)63-42-10-4-3-5-11-42)53(56(39-14-16-41(61)17-15-39)68(55)24-22-45(70)35-46(71)36-52(73)74)40-9-8-13-47(33-40)82-26-7-6-12-44-37-67(66-65-44)25-28-80-30-32-81-31-29-79-27-23-62-43-18-19-48-49(34-43)60(78)69(59(48)77)50-20-21-51(72)64-57(50)75/h3-5,8-11,13-19,33-34,37-38,45-46,50,62,70-71H,6-7,12,20-32,35-36H2,1-2H3,(H,63,76)(H,73,74)(H,64,72,75)/t45-,46-,50?/m1/s1",SGYUWZDXRBHEKP-SRQCOUMPSA-N
1132,,,>3000,,P04035,HMGCR,CRBN,,P21AM,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCOCCOCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1143.28,1142.512463,5.13,83,8,17,6,33,275,C61H71FN8O13,"InChI=1S/C61H71FN8O13/c1-39(2)56-55(59(77)64-43-11-5-3-6-12-43)54(57(40-15-17-42(62)18-16-40)69(56)25-23-46(71)36-47(72)37-53(74)75)41-10-9-14-48(34-41)83-27-8-4-7-13-45-38-68(67-66-45)26-29-81-31-33-82-32-30-80-28-24-63-44-19-20-49-50(35-44)61(79)70(60(49)78)51-21-22-52(73)65-58(51)76/h3,5-6,9-12,14-20,34-35,38-39,46-47,51,63,71-72H,4,7-8,13,21-33,36-37H2,1-2H3,(H,64,77)(H,74,75)(H,65,73,76)/t46-,47-,51?/m1/s1",XSBGEHVFSGCQMH-CFQHIMGQSA-N
1133,300,99,300,,P04035,HMGCR,CRBN,,P22AM,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCOCCOCCOCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1159.279,1158.507377,4.27,84,8,18,6,34,284.23,C61H71FN8O14,"InChI=1S/C61H71FN8O14/c1-39(2)56-55(59(77)64-43-9-4-3-5-10-43)54(57(40-13-15-42(62)16-14-40)69(56)23-21-46(71)36-47(72)37-53(74)75)41-8-6-12-48(34-41)84-25-7-11-45-38-68(67-66-45)24-27-81-29-31-83-33-32-82-30-28-80-26-22-63-44-17-18-49-50(35-44)61(79)70(60(49)78)51-19-20-52(73)65-58(51)76/h3-6,8-10,12-18,34-35,38-39,46-47,51,63,71-72H,7,11,19-33,36-37H2,1-2H3,(H,64,77)(H,74,75)(H,65,73,76)/t46-,47-,51?/m1/s1",FEPLBHREWCSACK-CFQHIMGQSA-N
1134,,,>3000,,P04035,HMGCR,CRBN,,P23AM,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCC3=CN(CCOCCOCCOCCOCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1173.306,1172.523027,4.63,85,8,18,6,35,284.23,C62H73FN8O14,"InChI=1S/C62H73FN8O14/c1-40(2)57-56(60(78)65-44-10-4-3-5-11-44)55(58(41-14-16-43(63)17-15-41)70(57)24-22-47(72)37-48(73)38-54(75)76)42-9-8-13-49(35-42)85-26-7-6-12-46-39-69(68-67-46)25-28-82-30-32-84-34-33-83-31-29-81-27-23-64-45-18-19-50-51(36-45)62(80)71(61(50)79)52-20-21-53(74)66-59(52)77/h3-5,8-11,13-19,35-36,39-40,47-48,52,64,72-73H,6-7,12,20-34,37-38H2,1-2H3,(H,65,78)(H,75,76)(H,66,74,77)/t47-,48-,52?/m1/s1",LKXPCVSVQQEPRK-FPALUEFMSA-N
1135,,,>3000,,P04035,HMGCR,CRBN,,P24AM,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCCCC3=CN(CCOCCOCCOCCOCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1187.333,1186.538677,4.99,86,8,18,6,36,284.23,C63H75FN8O14,"InChI=1S/C63H75FN8O14/c1-41(2)58-57(61(79)66-45-11-5-3-6-12-45)56(59(42-15-17-44(64)18-16-42)71(58)25-23-48(73)38-49(74)39-55(76)77)43-10-9-14-50(36-43)86-27-8-4-7-13-47-40-70(69-68-47)26-29-83-31-33-85-35-34-84-32-30-82-28-24-65-46-19-20-51-52(37-46)63(81)72(62(51)80)53-21-22-54(75)67-60(53)78/h3,5-6,9-12,14-20,36-37,40-41,48-49,53,65,73-74H,4,7-8,13,21-35,38-39H2,1-2H3,(H,66,79)(H,76,77)(H,67,75,78)/t48-,49-,53?/m1/s1",METKOBDLEKDPEQ-MOHJDXDLSA-N
1136,,,>3000,,P04035,HMGCR,CRBN,,L13A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1008.117,1007.422919,4.98,74,8,13,5,22,227.44,C56H58FN7O10,"InChI=1S/C56H58FN7O10/c1-35(2)52-51(55(71)58-40-13-4-3-5-14-40)50(53(37-18-20-39(57)21-19-37)63(52)25-24-42(65)31-43(66)32-49(68)69)38-11-6-16-44(30-38)74-28-9-15-41-33-62(61-60-41)26-29-73-27-8-12-36-10-7-17-45-46(36)34-64(56(45)72)47-22-23-48(67)59-54(47)70/h3-7,10-11,13-14,16-21,30,33,35,42-43,47,65-66H,9,15,22-29,31-32,34H2,1-2H3,(H,58,71)(H,68,69)(H,59,67,70)/t42-,43-,47?/m1/s1",ICDOXFOPMPLNMJ-VDKNZPKNSA-N
1137,,,>3000,,P04035,HMGCR,CRBN,,L14A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCOCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1022.144,1021.438569,5.33,75,8,13,5,23,227.44,C57H60FN7O10,"InChI=1S/C57H60FN7O10/c1-36(2)53-52(56(72)59-41-14-4-3-5-15-41)51(54(38-19-21-40(58)22-20-38)64(53)27-25-43(66)32-44(67)33-50(69)70)39-12-6-17-45(31-39)75-30-9-16-42-34-63(62-61-42)26-10-29-74-28-8-13-37-11-7-18-46-47(37)35-65(57(46)73)48-23-24-49(68)60-55(48)71/h3-7,11-12,14-15,17-22,31,34,36,43-44,48,66-67H,9-10,16,23-30,32-33,35H2,1-2H3,(H,59,72)(H,69,70)(H,60,68,71)/t43-,44-,48?/m1/s1",DVLGRXKVQLBKEM-OGVMARDASA-N
1138,,,>3000,,P04035,HMGCR,CRBN,,L15A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCOCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1036.171,1035.454219,5.69,76,8,13,5,24,227.44,C58H62FN7O10,"InChI=1S/C58H62FN7O10/c1-37(2)54-53(57(73)60-42-15-4-3-5-16-42)52(55(39-20-22-41(59)23-21-39)65(54)28-26-44(67)33-45(68)34-51(70)71)40-13-8-18-46(32-40)76-31-11-17-43-35-64(63-62-43)27-6-7-29-75-30-10-14-38-12-9-19-47-48(38)36-66(58(47)74)49-24-25-50(69)61-56(49)72/h3-5,8-9,12-13,15-16,18-23,32,35,37,44-45,49,67-68H,6-7,11,17,24-31,33-34,36H2,1-2H3,(H,60,73)(H,70,71)(H,61,69,72)/t44-,45-,49?/m1/s1",USDKDQYXGONXDX-OEUTXLNUSA-N
1139,300,99,300,,P04035,HMGCR,CRBN,,L16A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCOCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1050.198,1049.469869,6.05,77,8,13,5,25,227.44,C59H64FN7O10,"InChI=1S/C59H64FN7O10/c1-38(2)55-54(58(74)61-43-16-5-3-6-17-43)53(56(40-21-23-42(60)24-22-40)66(55)29-27-45(68)34-46(69)35-52(71)72)41-14-9-19-47(33-41)77-32-12-18-44-36-65(64-63-44)28-7-4-8-30-76-31-11-15-39-13-10-20-48-49(39)37-67(59(48)75)50-25-26-51(70)62-57(50)73/h3,5-6,9-10,13-14,16-17,19-24,33,36,38,45-46,50,68-69H,4,7-8,12,18,25-32,34-35,37H2,1-2H3,(H,61,74)(H,71,72)(H,62,70,73)/t45-,46-,50?/m1/s1",RXFBLQWZSSSQDX-SRQCOUMPSA-N
1140,200,99,200,,P04035,HMGCR,CRBN,,L17A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCCOCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1064.225,1063.48552,6.41,78,8,13,5,26,227.44,C60H66FN7O10,"InChI=1S/C60H66FN7O10/c1-39(2)56-55(59(75)62-44-17-6-5-7-18-44)54(57(41-22-24-43(61)25-23-41)67(56)30-28-46(69)35-47(70)36-53(72)73)42-15-10-20-48(34-42)78-33-13-19-45-37-66(65-64-45)29-8-3-4-9-31-77-32-12-16-40-14-11-21-49-50(40)38-68(60(49)76)51-26-27-52(71)63-58(51)74/h5-7,10-11,14-15,17-18,20-25,34,37,39,46-47,51,69-70H,3-4,8-9,13,19,26-33,35-36,38H2,1-2H3,(H,62,75)(H,72,73)(H,63,71,74)/t46-,47-,51?/m1/s1",XENQODBRMXLGFU-CFQHIMGQSA-N
1141,700,99,700,,P04035,HMGCR,CRBN,,L18A,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCCCOCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1078.252,1077.50117,6.95,79,8,13,5,27,227.44,C61H68FN7O10,"InChI=1S/C61H68FN7O10/c1-40(2)57-56(60(76)63-45-18-7-6-8-19-45)55(58(42-23-25-44(62)26-24-42)68(57)31-29-47(70)36-48(71)37-54(73)74)43-16-11-21-49(35-43)79-34-14-20-46-38-67(66-65-46)30-9-4-3-5-10-32-78-33-13-17-41-15-12-22-50-51(41)39-69(61(50)77)52-27-28-53(72)64-59(52)75/h6-8,11-12,15-16,18-19,21-26,35,38,40,47-48,52,70-71H,3-5,9-10,14,20,27-34,36-37,39H2,1-2H3,(H,63,76)(H,73,74)(H,64,72,75)/t47-,48-,52?/m1/s1",UOMHGMSXAWPEFB-FPALUEFMSA-N
1142,,,>3000,,P04035,HMGCR,CRBN,,L13AR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCOCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1012.149,1011.454219,5.4,74,8,13,5,25,227.44,C56H62FN7O10,"InChI=1S/C56H62FN7O10/c1-35(2)52-51(55(71)58-40-13-4-3-5-14-40)50(53(37-18-20-39(57)21-19-37)63(52)25-24-42(65)31-43(66)32-49(68)69)38-11-6-16-44(30-38)74-28-9-15-41-33-62(61-60-41)26-29-73-27-8-12-36-10-7-17-45-46(36)34-64(56(45)72)47-22-23-48(67)59-54(47)70/h3-7,10-11,13-14,16-21,30,33,35,42-43,47,65-66H,8-9,12,15,22-29,31-32,34H2,1-2H3,(H,58,71)(H,68,69)(H,59,67,70)/t42-,43-,47?/m1/s1",DMTQJVYKMUNQSL-VDKNZPKNSA-N
1143,,,>3000,,P04035,HMGCR,CRBN,,L14AR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCOCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1026.176,1025.469869,5.76,75,8,13,5,26,227.44,C57H64FN7O10,"InChI=1S/C57H64FN7O10/c1-36(2)53-52(56(72)59-41-14-4-3-5-15-41)51(54(38-19-21-40(58)22-20-38)64(53)27-25-43(66)32-44(67)33-50(69)70)39-12-6-17-45(31-39)75-30-9-16-42-34-63(62-61-42)26-10-29-74-28-8-13-37-11-7-18-46-47(37)35-65(57(46)73)48-23-24-49(68)60-55(48)71/h3-7,11-12,14-15,17-22,31,34,36,43-44,48,66-67H,8-10,13,16,23-30,32-33,35H2,1-2H3,(H,59,72)(H,69,70)(H,60,68,71)/t43-,44-,48?/m1/s1",LVXGILNVGOQASY-OGVMARDASA-N
1144,,,>3000,,P04035,HMGCR,CRBN,,L15AR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCOCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1040.203,1039.48552,6.12,76,8,13,5,27,227.44,C58H66FN7O10,"InChI=1S/C58H66FN7O10/c1-37(2)54-53(57(73)60-42-15-4-3-5-16-42)52(55(39-20-22-41(59)23-21-39)65(54)28-26-44(67)33-45(68)34-51(70)71)40-13-8-18-46(32-40)76-31-11-17-43-35-64(63-62-43)27-6-7-29-75-30-10-14-38-12-9-19-47-48(38)36-66(58(47)74)49-24-25-50(69)61-56(49)72/h3-5,8-9,12-13,15-16,18-23,32,35,37,44-45,49,67-68H,6-7,10-11,14,17,24-31,33-34,36H2,1-2H3,(H,60,73)(H,70,71)(H,61,69,72)/t44-,45-,49?/m1/s1",RABCENWFZGJGLY-OEUTXLNUSA-N
1145,2300,99,2300,,P04035,HMGCR,CRBN,,L16AR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCOCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1054.23,1053.50117,6.47,77,8,13,5,28,227.44,C59H68FN7O10,"InChI=1S/C59H68FN7O10/c1-38(2)55-54(58(74)61-43-16-5-3-6-17-43)53(56(40-21-23-42(60)24-22-40)66(55)29-27-45(68)34-46(69)35-52(71)72)41-14-9-19-47(33-41)77-32-12-18-44-36-65(64-63-44)28-7-4-8-30-76-31-11-15-39-13-10-20-48-49(39)37-67(59(48)75)50-25-26-51(70)62-57(50)73/h3,5-6,9-10,13-14,16-17,19-24,33,36,38,45-46,50,68-69H,4,7-8,11-12,15,18,25-32,34-35,37H2,1-2H3,(H,61,74)(H,71,72)(H,62,70,73)/t45-,46-,50?/m1/s1",NRJXEKVOWNZICO-SRQCOUMPSA-N
1146,500,99,500,,P04035,HMGCR,CRBN,,L17AR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCCOCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1068.257,1067.51682,6.83,78,8,13,5,29,227.44,C60H70FN7O10,"InChI=1S/C60H70FN7O10/c1-39(2)56-55(59(75)62-44-17-6-5-7-18-44)54(57(41-22-24-43(61)25-23-41)67(56)30-28-46(69)35-47(70)36-53(72)73)42-15-10-20-48(34-42)78-33-13-19-45-37-66(65-64-45)29-8-3-4-9-31-77-32-12-16-40-14-11-21-49-50(40)38-68(60(49)76)51-26-27-52(71)63-58(51)74/h5-7,10-11,14-15,17-18,20-25,34,37,39,46-47,51,69-70H,3-4,8-9,12-13,16,19,26-33,35-36,38H2,1-2H3,(H,62,75)(H,72,73)(H,63,71,74)/t46-,47-,51?/m1/s1",VFNKLBHQQQAJLL-CFQHIMGQSA-N
1147,600,99,600,,P04035,HMGCR,CRBN,,L18AR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC(OCCCC3=CN(CCCCCCCOCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)N=N3)=C2)=C(C2=CC=C(F)C=C2)N1CC[C@@H](O)C[C@@H](O)CC(=O)O,Degradation of HMGCR in SRD15 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00339,1082.284,1081.53247,7.37,79,8,13,5,30,227.44,C61H72FN7O10,"InChI=1S/C61H72FN7O10/c1-40(2)57-56(60(76)63-45-18-7-6-8-19-45)55(58(42-23-25-44(62)26-24-42)68(57)31-29-47(70)36-48(71)37-54(73)74)43-16-11-21-49(35-43)79-34-14-20-46-38-67(66-65-46)30-9-4-3-5-10-32-78-33-13-17-41-15-12-22-50-51(41)39-69(61(50)77)52-27-28-53(72)64-59(52)75/h6-8,11-12,15-16,18-19,21-26,35,38,40,47-48,52,70-71H,3-5,9-10,13-14,17,20,27-34,36-37,39H2,1-2H3,(H,63,76)(H,73,74)(H,64,72,75)/t47-,48-,52?/m1/s1",OMYIRPXMDXBYEZ-FPALUEFMSA-N
1153,9.3,99,17/9.3/11,,P36507,MEK2,VHL,,MS432,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNCCCONC(=O)C3=CC=C(F)C(F)=C3NC3=CC=C(I)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK2 in HT-29/SK-MEL-28/COLO 205 cells after 24 h treatment,,,590,IC50 of MEK2 was tested using the HotSpot kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,130/83/34,Inhibit proliferation of HT-29/SK-MEL-28/COLO 205 cells,,,,,,,,,,,10.1021/acs.jmedchem.9b01528,1076.078,1075.371386,10.42,68,5,10,6,25,174.02,C50H65F3IN7O6S,"InChI=1S/C50H65F3IN7O6S/c1-31(33-16-18-34(19-17-33)45-32(2)56-30-68-45)57-48(65)41-28-36(62)29-61(41)49(66)46(50(3,4)5)59-42(63)15-12-10-8-6-7-9-11-13-24-55-25-14-26-67-60-47(64)37-21-22-38(51)43(53)44(37)58-40-23-20-35(54)27-39(40)52/h16-23,27,30-31,36,41,46,55,58,62H,6-15,24-26,28-29H2,1-5H3,(H,57,65)(H,59,63)(H,60,64)/t31-,36+,41-,46+/m0/s1",KCBAMQOKOLXLOX-BSZYMOERSA-N
1153,18,99,31/31/18,,Q02750,MEK1,VHL,,MS432,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNCCCONC(=O)C3=CC=C(F)C(F)=C3NC3=CC=C(I)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK1 in HT-29/SK-MEL-28/COLO 205 cells after 24 h treatment,,,1500,IC50 of MEK1 was tested using the HotSpot kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,130/83/34,Inhibit proliferation of HT-29/SK-MEL-28/COLO 205 cells,,,,,,,,,,,10.1021/acs.jmedchem.9b01528,1076.078,1075.371386,10.42,68,5,10,6,25,174.02,C50H65F3IN7O6S,"InChI=1S/C50H65F3IN7O6S/c1-31(33-16-18-34(19-17-33)45-32(2)56-30-68-45)57-48(65)41-28-36(62)29-61(41)49(66)46(50(3,4)5)59-42(63)15-12-10-8-6-7-9-11-13-24-55-25-14-26-67-60-47(64)37-21-22-38(51)43(53)44(37)58-40-23-20-35(54)27-39(40)52/h16-23,27,30-31,36,41,46,55,58,62H,6-15,24-26,28-29H2,1-5H3,(H,57,65)(H,59,63)(H,60,64)/t31-,36+,41-,46+/m0/s1",KCBAMQOKOLXLOX-BSZYMOERSA-N
1154,3.41,88.01,3.41,88.01,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,Degradation of HDAC6 in MM1S cells after 6 h treatment,62.1/81.3,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,737.774,737.2921592,2.28,54,6,12,5,15,217.19,C37H39N9O8,"InChI=1S/C37H39N9O8/c1-2-3-17-44(21-23-7-9-24(10-8-23)33(48)42-53)37(52)39-25-11-13-27(14-12-25)54-19-18-45-22-26(41-43-45)20-38-29-6-4-5-28-32(29)36(51)46(35(28)50)30-15-16-31(47)40-34(30)49/h4-14,22,30,38,53H,2-3,15-21H2,1H3,(H,39,52)(H,42,48)(H,40,47,49)",YVMSHPWOPPUCHZ-UHFFFAOYSA-N
1157,1.64,86.26,1.64,86.26,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,Degradation of HDAC6 in MM1S cells after 6 h treatment,74.9/82.7,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,8.7,IC50 of HDAC6 was determined using a fluorescence-based assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74.9,Inhibit proliferation of MM1S cells,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,779.855,779.3391094,3.35,57,6,12,5,18,217.19,C40H45N9O8,"InChI=1S/C40H45N9O8/c1-2-3-20-47(24-26-10-12-27(13-11-26)36(51)45-56)40(55)42-28-14-16-30(17-15-28)57-22-6-4-5-21-48-25-29(44-46-48)23-41-32-9-7-8-31-35(32)39(54)49(38(31)53)33-18-19-34(50)43-37(33)52/h7-17,25,33,41,56H,2-6,18-24H2,1H3,(H,42,55)(H,45,51)(H,43,50,52)",DQGQXFRCIYCGOE-UHFFFAOYSA-N
1157,2.2,86,2.2/18,86/45,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,Degradation of HDAC6 in MM1S/Mouse 4935 cells after 4/6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74.9,Inhibit proliferation of MM1S cells,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00046,779.855,779.3391094,3.35,57,6,12,5,18,217.19,C40H45N9O8,"InChI=1S/C40H45N9O8/c1-2-3-20-47(24-26-10-12-27(13-11-26)36(51)45-56)40(55)42-28-14-16-30(17-15-28)57-22-6-4-5-21-48-25-29(44-46-48)23-41-32-9-7-8-31-35(32)39(54)49(38(31)53)33-18-19-34(50)43-37(33)52/h7-17,25,33,41,56H,2-6,18-24H2,1H3,(H,42,55)(H,45,51)(H,43,50,52)",DQGQXFRCIYCGOE-UHFFFAOYSA-N
1162,2.54,86.3,2.54,86.3,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCN2C=C(CCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,Degradation of HDAC6 in MM1S cells after 6 h treatment,70.6/83.1,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,765.828,765.3234593,3.1,56,6,12,5,17,217.19,C39H43N9O8,"InChI=1S/C39H43N9O8/c1-2-3-20-46(23-25-9-11-26(12-10-25)35(50)44-55)39(54)41-27-13-15-29(16-14-27)56-22-21-47-24-28(43-45-47)6-5-19-40-31-8-4-7-30-34(31)38(53)48(37(30)52)32-17-18-33(49)42-36(32)51/h4,7-16,24,32,40,55H,2-3,5-6,17-23H2,1H3,(H,41,54)(H,44,50)(H,42,49,51)",HKHMBOOYLKOYAW-UHFFFAOYSA-N
1181,4.3,57,7.1/4.3,90/57,Q9UBN7,HDAC6,VHL,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCCCCCCCN2C=C(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1,Degradation of HDAC6 in MM1S/Mouse 4935 cells after 4/6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00046,1091.434,1090.603781,9.17,78,6,13,6,31,233.24,C59H82N10O8S,"InChI=1S/C59H82N10O8S/c1-6-7-33-67(38-44-23-27-46(28-24-44)55(72)65-76)58(75)62-47-29-31-50(32-30-47)77-35-18-14-12-10-8-9-11-13-17-34-68-39-48(64-66-68)19-15-16-20-52(71)63-54(59(3,4)5)57(74)69-40-49(70)36-51(69)56(73)60-37-43-21-25-45(26-22-43)53-42(2)61-41-78-53/h21-32,39,41,49,51,54,70,76H,6-20,33-38,40H2,1-5H3,(H,60,73)(H,62,75)(H,63,71)(H,65,72)/t49-,51+,54-/m1/s1",QLLXPSZTCLBVQY-UFUXGVROSA-N
1182,11,89,11,89,Q9UBN7,HDAC6,VHL,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCCCCCCCCN2C=C(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1,Degradation of HDAC6 in MM1S cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00046,1105.461,1104.619431,9.72,79,6,13,6,32,233.24,C60H84N10O8S,"InChI=1S/C60H84N10O8S/c1-6-7-34-68(39-45-24-28-47(29-25-45)56(73)66-77)59(76)63-48-30-32-51(33-31-48)78-36-19-15-13-11-9-8-10-12-14-18-35-69-40-49(65-67-69)20-16-17-21-53(72)64-55(60(3,4)5)58(75)70-41-50(71)37-52(70)57(74)61-38-44-22-26-46(27-23-44)54-43(2)62-42-79-54/h22-33,40,42,50,52,55,71,77H,6-21,34-39,41H2,1-5H3,(H,61,74)(H,63,76)(H,64,72)(H,66,73)/t50-,52+,55-/m1/s1",TXQZPPRNSVBETP-MXXGPWJYSA-N
1220,161,68,161,68,P00533,EGFR,CRBN,,,C=CC(=O)NC1=CC(NC2=NC=CC(C3=CN(C)C4=CC=CC=C34)=N2)=C(OC)C=C1N(C)CCN(C)CCOCCOCCOCCOCC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,Degradation of EGFR in PC9 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,413/1344/657,Inhibit proliferation of PC9/HCC827/H1975 cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127167,961.09,960.4493881,2.29,70,7,16,4,26,220.05,C50H60N10O10,"InChI=1S/C50H60N10O10/c1-6-45(61)53-39-28-40(55-50-51-17-16-38(54-50)35-30-59(4)41-13-8-7-10-33(35)41)44(66-5)29-43(39)58(3)19-18-57(2)20-21-67-22-23-68-24-25-69-26-27-70-32-47(63)52-37-12-9-11-34-36(37)31-60(49(34)65)42-14-15-46(62)56-48(42)64/h6-13,16-17,28-30,42H,1,14-15,18-27,31-32H2,2-5H3,(H,52,63)(H,53,61)(H,51,54,55)(H,56,62,64)",MVXHKLZUALKPTB-UHFFFAOYSA-N
1223,0.9,99,0.9,99,Q06187,BTK,CRBN,,DD-03-171,CC1=C(NC(=O)C2=CC=C(C(C)(C)C)C=C2)C=CC=C1C1=CN(C)C(=O)C(NC2=CC=C(C(=O)N3CCN(CCCCCCNC(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)=N1,Degradation of BTK in Mino cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.crchbi.2022.100029,991.163,990.4752089,5.83,73,8,13,5,17,224.25,C55H62N10O8,"InChI=1S/C55H62N10O8/c1-34-39(12-10-14-41(34)60-49(68)35-16-20-37(21-17-35)55(2,3)4)43-33-62(5)54(73)48(59-43)58-38-22-18-36(19-23-38)51(70)64-30-28-63(29-31-64)27-9-7-6-8-26-56-46(67)32-57-42-15-11-13-40-47(42)53(72)65(52(40)71)44-24-25-45(66)61-50(44)69/h10-23,33,44,57H,6-9,24-32H2,1-5H3,(H,56,67)(H,58,59)(H,60,68)(H,61,66,69)",QBPVFCNYKUENHU-UHFFFAOYSA-N
1299,35.7,90,35.7,90,P09874,PARP1,CRBN,,iRucaparib-AP5,CN(CCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1=CC=C(C2=C3CCNC(=O)C4=C3C(=CC(F)=C4)[NH]2)C=C1,Degradation of PARP1 in Primary Cardiomyocytes after 24 h treatment,,,24.6,IC50 was tested by using a PARP universal chemiluminescent assay kit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0379-2,842.922,842.3650701,2.66,61,7,12,4,23,189.86,C44H51FN6O10,"InChI=1S/C44H51FN6O10/c1-50(27-28-5-7-29(8-6-28)40-31-11-12-47-41(53)33-25-30(45)26-35(48-40)38(31)33)14-16-58-18-20-60-22-24-61-23-21-59-19-17-57-15-13-46-34-4-2-3-32-39(34)44(56)51(43(32)55)36-9-10-37(52)49-42(36)54/h2-8,25-26,36,46,48H,9-24,27H2,1H3,(H,47,53)(H,49,52,54)",CDKSZVJXSCKNQN-UHFFFAOYSA-N
1300,81.8,92,81.8,92,P09874,PARP1,CRBN,,iRucaparib-AP6,CN(CCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1=CC=C(C2=C3CCNC(=O)C4=C3C(=CC(F)=C4)[NH]2)C=C1,Degradation of PARP1 in Primary Cardiomyocytes after 24 h treatment,,,28.5,IC50 was tested by using a PARP universal chemiluminescent assay kit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0379-2,886.975,886.3912848,2.51,64,7,13,4,26,199.09,C46H55FN6O11,"InChI=1S/C46H55FN6O11/c1-52(29-30-5-7-31(8-6-30)42-33-11-12-49-43(55)35-27-32(47)28-37(50-42)40(33)35)14-16-60-18-20-62-22-24-64-26-25-63-23-21-61-19-17-59-15-13-48-36-4-2-3-34-41(36)46(58)53(45(34)57)38-9-10-39(54)51-44(38)56/h2-8,27-28,38,48,50H,9-26,29H2,1H3,(H,49,55)(H,51,54,56)",YHMDCINUVWULST-UHFFFAOYSA-N
1306,62.8,99,62.8,,Q9UGN5,PARP2,CRBN,,iVeliparib-AP6,C[C@]1(C2=NC3=C(C(N)=O)C=CC=C3[NH]2)CCCN1CCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of PARP2 in HeLa cells after 24 h treatment,,,21.1,IC50 was tested by using a PARP2 chemiluminescent assay kit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0379-2,807.902,807.3803055,0.5,58,6,14,4,25,225.97,C40H53N7O11,"InChI=1S/C40H53N7O11/c1-40(39-43-30-8-3-6-28(35(41)49)34(30)45-39)11-4-13-46(40)14-16-54-18-20-56-22-24-58-26-25-57-23-21-55-19-17-53-15-12-42-29-7-2-5-27-33(29)38(52)47(37(27)51)31-9-10-32(48)44-36(31)50/h2-3,5-8,31,42H,4,9-26H2,1H3,(H2,41,49)(H,43,45)(H,44,48,50)/t31?,40-/m1/s1",XLGCZZCLPNSQNH-YMURELKOSA-N
1323,1.94,99,1.94,,Q9UBN7,HDAC6,CRBN,,YZ167,O=C(CCCCCCC(=O)N/N=C/C1=CC=C(OCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C=C1)NO,Degradation of HDAC6 in MM1S after 6 h treatment by in-cell ELISA analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.04.008,615.687,615.2692985,2.6,45,4,8,4,14,166.5,C33H37N5O7,"InChI=1S/C33H37N5O7/c39-29-19-18-28(32(42)35-29)38-22-27-24(10-8-11-26(27)33(38)43)9-4-3-7-20-45-25-16-14-23(15-17-25)21-34-36-30(40)12-5-1-2-6-13-31(41)37-44/h8,10-11,14-17,21,28,44H,1-3,5-7,12-13,18-20,22H2,(H,36,40)(H,37,41)(H,35,39,42)/b34-21+",BNOFYYKLSQEOFU-KEIPNQJHSA-N
1357,669,99,669,,,NS3,CRBN,,DGY-03-081,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=C(C(=O)NCCCCCCNC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C=N1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,Degradation of NS3 in Huh7.5 cells after 4 h treatment,,,385,Inhibition of NS3,,,,,,,,,,,,,,,,,576,EC50 was tested using a BRD4 BRD2-eGFP-mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3069,IC50 of antiviral activity against HCV in Huh7.5 cells,,,,,,,,,,,,,,,10.1038/s41467-019-11429-w,1064.299,1063.585488,5.17,77,8,13,7,23,287.17,C56H77N11O10,"InChI=1S/C56H77N11O10/c1-5-15-39(46(69)53(75)61-34-22-23-34)62-52(74)45-35-19-13-18-33(35)30-67(45)55(77)47(56(2,3)4)65-51(73)44(32-16-9-8-10-17-32)64-49(71)41-29-59-40(28-60-41)48(70)58-27-12-7-6-11-26-57-38-21-14-20-36-37(38)31-66(54(36)76)42-24-25-43(68)63-50(42)72/h14,20-21,28-29,32-35,39,42,44-45,47,57H,5-13,15-19,22-27,30-31H2,1-4H3,(H,58,70)(H,61,75)(H,62,74)(H,64,71)(H,65,73)(H,63,68,72)/t33-,35-,39-,42?,44-,45-,47+/m0/s1",KJEYLCKKOBCAHO-KSESKIPOSA-N
1358,489,99,489,,,NS3,CRBN,,DGY-04-035,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=C(C(=O)NCCOCCOCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=N1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,Degradation of NS3 in Huh7.5 cells after 4 h treatment,,,296,Inhibition of NS3,,,,,,,,,,,,,,,,,641,EC50 was tested using a BRD4 BRD2-eGFP-mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2920,IC50 of antiviral activity against HCV in Huh7.5 cells,,,,,,,,,,,,,,,10.1038/s41467-019-11429-w,1110.28,1109.554581,3.95,80,8,16,7,25,322.7,C56H75N11O13,"InChI=1S/C56H75N11O13/c1-5-11-37(45(69)52(75)61-33-18-19-33)62-51(74)44-34-15-9-14-32(34)30-66(44)55(78)46(56(2,3)4)65-50(73)43(31-12-7-6-8-13-31)64-48(71)39-29-59-38(28-60-39)47(70)58-23-25-80-27-26-79-24-22-57-36-17-10-16-35-42(36)54(77)67(53(35)76)40-20-21-41(68)63-49(40)72/h10,16-17,28-29,31-34,37,40,43-44,46,57H,5-9,11-15,18-27,30H2,1-4H3,(H,58,70)(H,61,75)(H,62,74)(H,64,71)(H,65,73)(H,63,68,72)/t32-,34-,37-,40?,43-,44-,46+/m0/s1",UPQQGQPPFLHEMM-PDWPTQNYSA-N
1359,50,99,50,,,NS3,CRBN,,DGY-08-097,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=C(C(=O)NCCOCCOCCOC2=CC3=C4C(=CC=CC4=C2)C(=O)N(C2CCC(=O)NC2=O)C3=O)C=N1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,Degradation of NS3 in Huh7.5 cells after 4 h treatment,,,247,Inhibition of NS3,,,,,,,,,,,,,,,,,703,EC50 was tested using a BRD4 BRD2-eGFP-mCherry reporter assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,748,IC50 of antiviral activity against HCV in Huh7.5 cells,,,,,,,,,,,,,,,10.1038/s41467-019-11429-w,1161.324,1160.554247,4.63,84,9,16,6,25,319.9,C60H76N10O14,"InChI=1S/C60H76N10O14/c1-5-11-41(49(72)56(78)64-36-18-19-36)65-55(77)48-38-16-10-15-35(38)32-69(48)59(81)50(60(2,3)4)68-54(76)47(33-12-7-6-8-13-33)67-52(74)43-31-62-42(30-63-43)51(73)61-22-23-82-24-25-83-26-27-84-37-28-34-14-9-17-39-46(34)40(29-37)58(80)70(57(39)79)44-20-21-45(71)66-53(44)75/h9,14,17,28-31,33,35-36,38,41,44,47-48,50H,5-8,10-13,15-16,18-27,32H2,1-4H3,(H,61,73)(H,64,78)(H,65,77)(H,67,74)(H,68,76)(H,66,71,75)/t35-,38-,41-,44?,47-,48-,50+/m0/s1",YZNSNVPSBDWZBQ-LNWDVATRSA-N
1360,46,96.2,46,96.2,Q07817,BCL-xL,CRBN,,PZ15227,CC1(C)CCC(C2=CC=C(Cl)C=C2)=C(CN2CCN(C3=CC=C(C(=O)NS(=O)(=O)C4=CC=C(N[C@H](CCN5CCN(C(=O)CCCN6C=C(COCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)CSC5=CC=CC=C5)C(S(=O)(=O)C(F)(F)F)=C4)C=C3)CC2)C1,Degradation of BCL-xL in WI38 cells after 16 h treatment,,,,,,,,,1.9,Ki was tested by the AlphaScreen competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,290/>10000/>3000,Inhibit viability of IR-SC/WI38/platelets cells,,,,,,,,,,,,,10.1038/s41467-020-15838-0,1484.157,1482.497791,8.88,102,11,21,4,30,284.19,C71H82ClF3N12O12S3,"InChI=1S/C71H82ClF3N12O12S3/c1-70(2)27-25-57(48-13-17-51(72)18-14-48)50(43-70)44-83-33-35-84(36-34-83)54-19-15-49(16-20-54)66(90)80-102(96,97)56-21-22-59(62(42-56)101(94,95)71(73,74)75)77-52(47-100-55-8-4-3-5-9-55)26-30-82-31-37-85(38-32-82)64(89)12-7-29-86-45-53(79-81-86)46-99-41-40-98-39-28-76-60-11-6-10-58-65(60)69(93)87(68(58)92)61-23-24-63(88)78-67(61)91/h3-6,8-11,13-22,42,45,52,61,76-77H,7,12,23-41,43-44,46-47H2,1-2H3,(H,80,90)(H,78,88,91)/t52-,61?/m1/s1",OWEARFNXBBNNKR-ADXOFTSBSA-N
1373,136,88,136,88,Q06187,BTK,VHL,,,C=CC(=O)N1C[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C[C@H]1C(=O)OCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of BTK in K562 cells after 18 h treatment,,,39,IC50 was tested by the HTRF KinEase assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc08238g,1029.19,1028.421459,4.99,74,8,17,4,20,255.55,C53H60N10O10S,"InChI=1S/C53H60N10O10S/c1-6-43(66)61-27-36(63-49-44(48(54)56-30-57-49)45(60-63)34-16-18-39(19-17-34)73-38-10-8-7-9-11-38)24-41(61)52(69)72-23-22-70-20-21-71-29-42(65)59-47(53(3,4)5)51(68)62-28-37(64)25-40(62)50(67)55-26-33-12-14-35(15-13-33)46-32(2)58-31-74-46/h6-19,30-31,36-37,40-41,47,64H,1,20-29H2,2-5H3,(H,55,67)(H,59,65)(H2,54,56,57)/t36-,37+,40-,41-,47+/m0/s1",JQIURFOHEWHROK-WNKYWPOYSA-N
1373,220,75,220,75,P51451,BLK,VHL,,,C=CC(=O)N1C[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C[C@H]1C(=O)OCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,Degradation of BLK in Ramos cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc08238g,1029.19,1028.421459,4.99,74,8,17,4,20,255.55,C53H60N10O10S,"InChI=1S/C53H60N10O10S/c1-6-43(66)61-27-36(63-49-44(48(54)56-30-57-49)45(60-63)34-16-18-39(19-17-34)73-38-10-8-7-9-11-38)24-41(61)52(69)72-23-22-70-20-21-71-29-42(65)59-47(53(3,4)5)51(68)62-28-37(64)25-40(62)50(67)55-26-33-12-14-35(15-13-33)46-32(2)58-31-74-46/h6-19,30-31,36-37,40-41,47,64H,1,20-29H2,2-5H3,(H,55,67)(H,59,65)(H2,54,56,57)/t36-,37+,40-,41-,47+/m0/s1",JQIURFOHEWHROK-WNKYWPOYSA-N
1380,2.2,97,2.2,97,Q06187,BTK,CRBN,,NC-1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)CCCCCCOCCOCCOCCOCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,Degradation of BTK in Mino cells after 24 h treatment,,,16,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,947.059,946.4225047,3.81,69,8,16,2,25,228.86,C50H58N8O11,"InChI=1S/C50H58N8O11/c51-46-44-45(34-16-18-37(19-17-34)69-36-11-4-3-5-12-36)55-58(47(44)53-33-52-46)35-10-9-22-56(32-35)42(60)15-6-1-2-7-23-64-24-25-65-26-27-66-28-29-67-30-31-68-40-14-8-13-38-43(40)50(63)57(49(38)62)39-20-21-41(59)54-48(39)61/h3-5,8,11-14,16-19,33,35,39H,1-2,6-7,9-10,15,20-32H2,(H2,51,52,53)(H,54,59,61)/t35-,39?/m1/s1",QSLUWEWRUWTRBT-QQKHLPPFSA-N
1381,8.6,91,8.6,91,Q06187,BTK,CRBN,,IR-1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)/C=C/COCCOCCOCCOCCOCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,Degradation of BTK in Mino cells after 24 h treatment,,,2,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,947.015,946.3861192,2.37,69,8,17,2,24,238.09,C49H54N8O12,"InChI=1S/C49H54N8O12/c50-45-43-44(33-13-15-36(16-14-33)69-35-8-2-1-3-9-35)54-57(46(43)52-32-51-45)34-7-5-19-55(31-34)41(59)12-6-20-63-21-22-64-23-24-65-25-26-66-27-28-67-29-30-68-39-11-4-10-37-42(39)49(62)56(48(37)61)38-17-18-40(58)53-47(38)60/h1-4,6,8-16,32,34,38H,5,7,17-31H2,(H2,50,51,52)(H,53,58,60)/b12-6+/t34-,38?/m1/s1",AWOLTJZICWTLFS-AHDGVXFFSA-N
1382,1.9,88,1.9,88,Q06187,BTK,CRBN,,IR-2,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)/C=C/CCCCOCCOCCOCCOCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,Degradation of BTK in Mino cells after 24 h treatment,,,14,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,945.043,944.4068546,3.69,69,8,16,2,24,228.86,C50H56N8O11,"InChI=1S/C50H56N8O11/c51-46-44-45(34-16-18-37(19-17-34)69-36-11-4-3-5-12-36)55-58(47(44)53-33-52-46)35-10-9-22-56(32-35)42(60)15-6-1-2-7-23-64-24-25-65-26-27-66-28-29-67-30-31-68-40-14-8-13-38-43(40)50(63)57(49(38)62)39-20-21-41(59)54-48(39)61/h3-6,8,11-19,33,35,39H,1-2,7,9-10,20-32H2,(H2,51,52,53)(H,54,59,61)/b15-6+/t35-,39?/m1/s1",ZJJZBBBSQKVNHL-BYBNZYMESA-N
1383,10,68,10,68,Q06187,BTK,CRBN,,,N#C/C(=C/COCCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,Degradation of BTK in Mino cells after 24 h treatment,,,12,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,972.025,971.3813681,2.3,71,8,18,2,24,261.88,C50H53N9O12,"InChI=1S/C50H53N9O12/c51-30-34(48(62)57-18-5-6-35(31-57)59-46-43(45(52)53-32-54-46)44(56-59)33-11-13-37(14-12-33)71-36-7-2-1-3-8-36)17-19-65-20-21-66-22-23-67-24-25-68-26-27-69-28-29-70-40-10-4-9-38-42(40)50(64)58(49(38)63)39-15-16-41(60)55-47(39)61/h1-4,7-14,17,32,35,39H,5-6,15-16,18-29,31H2,(H2,52,53,54)(H,55,60,61)/b34-17-/t35-,39?/m1/s1",PVBBNEIMTQFCAP-YFDXCGLRSA-N
1384,35,66,35,66,Q06187,BTK,CRBN,,,N#C/C(=C/CCCCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,Degradation of BTK in Mino cells after 24 h treatment,,,1,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,970.053,969.4021036,3.62,71,8,17,2,24,252.65,C51H55N9O11,"InChI=1S/C51H55N9O11/c52-31-35(49(63)58-21-8-10-36(32-58)60-47-44(46(53)54-33-55-47)45(57-60)34-15-17-38(18-16-34)71-37-11-4-1-5-12-37)9-3-2-6-22-66-23-24-67-25-26-68-27-28-69-29-30-70-41-14-7-13-39-43(41)51(65)59(50(39)64)40-19-20-42(61)56-48(40)62/h1,4-5,7,9,11-18,33,36,40H,2-3,6,8,10,19-30,32H2,(H2,53,54,55)(H,56,61,62)/b35-9-/t36-,40?/m1/s1",JLHRNNVFNFHLTO-BYLADGCCSA-N
1385,6,85,6,85,Q06187,BTK,CRBN,,,CC(C)(/C=C(/C#N)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1)CCCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK in Mino cells after 24 h treatment,,,0.4,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,998.107,997.4334037,4.5,73,8,17,2,24,252.65,C53H59N9O11,"InChI=1S/C53H59N9O11/c1-53(2,20-8-22-68-23-24-69-25-26-70-27-28-71-29-30-72-42-13-6-12-40-44(42)52(67)61(51(40)66)41-18-19-43(63)58-49(41)64)31-36(32-54)50(65)60-21-7-9-37(33-60)62-48-45(47(55)56-34-57-48)46(59-62)35-14-16-39(17-15-35)73-38-10-4-3-5-11-38/h3-6,10-17,31,34,37,41H,7-9,18-30,33H2,1-2H3,(H2,55,56,57)(H,58,63,64)/b36-31-/t37-,41?/m1/s1",DEABZGHTSXTNRF-DTNILNBBSA-N
1429,50,71,<=50/<=50,>=71/51-70,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=O)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP/VCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,1004.142,1003.412532,6.85,71,6,12,3,21,203.73,C51H60F3N7O9S,"InChI=1S/C51H60F3N7O9S/c1-32-43(71-31-57-32)34-13-11-33(12-14-34)28-56-45(64)41-26-38(62)29-59(41)46(65)44(49(2,3)4)58-42(63)30-69-23-10-22-68-21-8-7-9-24-70-39-19-17-36(18-20-39)61-48(67)60(47(66)50(61,5)6)37-16-15-35(27-55)40(25-37)51(52,53)54/h11-20,25,31,38,41,44,62H,7-10,21-24,26,28-30H2,1-6H3,(H,56,64)(H,58,63)/t38-,41+,44-/m1/s1",JAJUSXSEHHKCEK-UMWCMSNQSA-N
1430,501,70,<=501,51-70,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCN3CCC(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,1045.264,1044.421323,6.98,73,7,12,3,18,180.67,C53H63F3N8O7S2,"InChI=1S/C53H63F3N8O7S2/c1-33-45(73-32-59-33)37-10-8-34(9-11-37)29-58-47(67)43-27-41(65)30-62(43)48(68)46(51(2,3)4)60-44(66)31-71-24-7-23-70-25-22-61-20-18-36(19-21-61)35-12-15-39(16-13-35)64-50(72)63(49(69)52(64,5)6)40-17-14-38(28-57)42(26-40)53(54,55)56/h8-17,26,32,36,41,43,46,65H,7,18-25,27,29-31H2,1-6H3,(H,58,67)(H,60,66)/t41-,43+,46-/m1/s1",FDBSHOXCSNLRGD-LASKKICZSA-N
1431,50,71,<=50,>=71,P10275,AR,VHL,,,CC(C)(C)[C@H](NC(=O)COCCCCCOC1=CC=C(C(=O)N[C@H]2C(C)(C)[C@H](OC3=CC=C(C#N)C(Cl)=C3)C2(C)C)C=C1)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=CN=CS2)C=C1,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,941.592,940.3960116,8.11,66,6,11,4,19,192.21,C50H61ClN6O8S,"InChI=1S/C50H61ClN6O8S/c1-48(2,3)42(45(62)57-28-35(58)23-39(57)44(61)54-26-31-11-13-32(14-12-31)40-27-53-30-66-40)55-41(59)29-63-21-9-8-10-22-64-36-18-15-33(16-19-36)43(60)56-46-49(4,5)47(50(46,6)7)65-37-20-17-34(25-52)38(51)24-37/h11-20,24,27,30,35,39,42,46-47,58H,8-10,21-23,26,28-29H2,1-7H3,(H,54,61)(H,55,59)(H,56,60)/t35-,39+,42-,46-,47-/m1/s1",AMPBLCGZRAITTM-RRMXYVBQSA-N
1432,50,71,<=50,>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCNC3=CC=C(C(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,968.662,967.4432961,8.92,68,6,11,5,19,195.01,C52H66ClN7O7S,"InChI=1S/C52H66ClN7O7S/c1-31(33-13-15-34(16-14-33)43-32(2)56-30-68-43)57-46(64)41-25-38(61)28-60(41)47(65)44(50(3,4)5)58-42(62)29-66-24-12-10-11-23-55-37-20-17-35(18-21-37)45(63)59-48-51(6,7)49(52(48,8)9)67-39-22-19-36(27-54)40(53)26-39/h13-22,26,30-31,38,41,44,48-49,55,61H,10-12,23-25,28-29H2,1-9H3,(H,57,64)(H,58,62)(H,59,63)/t31-,38+,41-,44+,48-,49-/m0/s1",JQTRUKZGCBXQDD-IWHLCMBKSA-N
1433,50,71,<=50,>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC=C(C4=CC=C(C(=O)N[C@H]5C(C)(C)[C@H](OC6=CC=C(C#N)C(Cl)=C6)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,973.637,972.401097,9.35,69,7,10,4,16,182.98,C54H61ClN6O7S,"InChI=1S/C54H61ClN6O7S/c1-32-45(69-31-58-32)37-15-11-34(12-16-37)28-57-48(65)43-25-40(62)29-61(43)49(66)46(52(2,3)4)59-44(63)30-67-24-23-33-9-13-35(14-10-33)36-17-19-38(20-18-36)47(64)60-50-53(5,6)51(54(50,7)8)68-41-22-21-39(27-56)42(55)26-41/h9-22,26,31,40,43,46,50-51,62H,23-25,28-30H2,1-8H3,(H,57,65)(H,59,63)(H,60,64)/t40-,43+,46-,50-,51-/m1/s1",GPLDNHBAUYMIMT-XUDCYVGASA-N
1434,50,71,<=50,>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC3=CC=C(OC(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)C(C)(C)C)C=C2)OC=N1,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,883.443,882.371905,6.95,63,6,11,4,14,205.35,C47H55ClN6O9,"InChI=1S/C47H55ClN6O9/c1-27-38(61-26-51-27)30-13-9-28(10-14-30)22-50-40(57)36-19-32(55)23-54(36)41(58)39(45(2,3)4)52-37(56)25-60-24-29-11-16-33(17-12-29)63-44(59)53-42-46(5,6)43(47(42,7)8)62-34-18-15-31(21-49)35(48)20-34/h9-18,20,26,32,36,39,42-43,55H,19,22-25H2,1-8H3,(H,50,57)(H,52,56)(H,53,59)/t32-,36+,39-,42-,43-/m1/s1",VEFDAFDSPLDCMS-RCOCDALESA-N
1461,30,70,<30,>70,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(OCCOCCOCCN4CCN(CC5=CC=C6N=C(NC(=O)C7=CC=CC(C(F)(F)F)=C7)N([C@H]7CC[C@@H](CO)CC7)C6=C5)CC4)C=C3C2=O)C(=O)N1,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,903.956,903.3778609,3.46,65,8,13,3,17,184.87,C46H52F3N7O9,"InChI=1S/C46H52F3N7O9/c47-46(48,49)32-3-1-2-31(25-32)41(59)52-45-50-37-11-6-30(24-39(37)55(45)33-7-4-29(28-57)5-8-33)27-54-16-14-53(15-17-54)18-19-63-20-21-64-22-23-65-34-9-10-35-36(26-34)44(62)56(43(35)61)38-12-13-40(58)51-42(38)60/h1-3,6,9-11,24-26,29,33,38,57H,4-5,7-8,12-23,27-28H2,(H,50,52,59)(H,51,58,60)/t29-,33+,38?",DRSGINHARUFRQE-CDUPFHCPSA-N
1462,30,70,<30,>70,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(OCCOCCOCCOCCN4CCN(CC5=CC=C6N=C(NC(=O)C7=CC=CC(C(F)(F)F)=C7)N([C@H]7CC[C@@H](CO)CC7)C6=C5)CC4)C=C3C2=O)C(=O)N1,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,948.009,947.4040757,3.31,68,8,14,3,20,194.1,C48H56F3N7O10,"InChI=1S/C48H56F3N7O10/c49-48(50,51)34-3-1-2-33(27-34)43(61)54-47-52-39-11-6-32(26-41(39)57(47)35-7-4-31(30-59)5-8-35)29-56-16-14-55(15-17-56)18-19-65-20-21-66-22-23-67-24-25-68-36-9-10-37-38(28-36)46(64)58(45(37)63)40-12-13-42(60)53-44(40)62/h1-3,6,9-11,26-28,31,35,40,59H,4-5,7-8,12-25,29-30H2,(H,52,54,61)(H,53,60,62)/t31-,35+,40?",ADNQFJRANZZPKY-RGDYMFDWSA-N
1463,30,70,<30,>70,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CN5CCN(CC6=CC=C7N=C(NC(=O)C8=CC=CC(C(F)(F)F)=C8)N([C@H]8CC[C@@H](CO)CC8)C7=C6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,868.958,868.388366,4.65,63,9,11,3,10,160.42,C46H51F3N8O6,"InChI=1S/C46H51F3N8O6/c47-46(48,49)32-3-1-2-31(23-32)41(60)52-45-50-37-11-6-30(22-39(37)56(45)33-7-4-29(27-58)5-8-33)26-54-20-18-53(19-21-54)25-28-14-16-55(17-15-28)34-9-10-35-36(24-34)44(63)57(43(35)62)38-12-13-40(59)51-42(38)61/h1-3,6,9-11,22-24,28-29,33,38,58H,4-5,7-8,12-21,25-27H2,(H,50,52,60)(H,51,59,61)/t29-,33+,38?",RJDRFOSUZYUZBV-CDUPFHCPSA-N
1464,30,70,<30,50-70,Q9NWZ3,IRAK4,CRBN,,,COC1=CC2=NN(C3CCN(CCOCCOC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)C=C2C=C1NC(=O)C1=CC=CC(C(F)(F)F)=N1,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,763.73,763.2577458,2.78,55,7,12,2,12,174.29,C37H36F3N7O8,"InChI=1S/C37H36F3N7O8/c1-53-30-19-27-21(17-28(30)42-33(49)26-3-2-4-31(41-26)37(38,39)40)20-46(44-27)22-9-11-45(12-10-22)13-14-54-15-16-55-23-5-6-24-25(18-23)36(52)47(35(24)51)29-7-8-32(48)43-34(29)50/h2-6,17-20,22,29H,7-16H2,1H3,(H,42,49)(H,43,48,50)",XXKSDGIIEAJWCB-UHFFFAOYSA-N
1465,30,70,<30,50-70,Q9NWZ3,IRAK4,CRBN,,,COC1=CC2=NN(C3CCN(CCOCCOC4=CC=C5CN(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)C=C2C=C1NC(=O)C1=CC=CC(C(F)(F)F)=N1,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,749.747,749.2784812,2.83,54,7,11,2,12,157.22,C37H38F3N7O7,"InChI=1S/C37H38F3N7O7/c1-52-31-19-28-23(17-29(31)42-34(49)27-3-2-4-32(41-27)37(38,39)40)21-47(44-28)24-9-11-45(12-10-24)13-14-53-15-16-54-25-6-5-22-20-46(36(51)26(22)18-25)30-7-8-33(48)43-35(30)50/h2-6,17-19,21,24,30H,7-16,20H2,1H3,(H,42,49)(H,43,48,50)",KSDCGXPRMXBENQ-UHFFFAOYSA-N
1466,30,70,30-100,>70,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(OC4CCC(CN5CCN(CC6=CC=C7N=C(NC(=O)C8=CC=CC(C(F)(F)F)=C8)N([C@H]8CC[C@@H](CO)CC8)C7=C6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,883.969,883.3880317,5.28,64,9,11,3,11,166.41,C47H52F3N7O7,"InChI=1S/C47H52F3N7O7/c48-47(49,50)32-3-1-2-31(23-32)42(60)53-46-51-38-15-8-30(22-40(38)56(46)33-9-4-29(27-58)5-10-33)26-55-20-18-54(19-21-55)25-28-6-11-34(12-7-28)64-35-13-14-36-37(24-35)45(63)57(44(36)62)39-16-17-41(59)52-43(39)61/h1-3,8,13-15,22-24,28-29,33-34,39,58H,4-7,9-12,16-21,25-27H2,(H,51,53,60)(H,52,59,61)/t28?,29-,33+,34?,39?",LGAMKMQUDXCHFO-RIOIAMSCSA-N
1467,0.3,99,0.3,,P03372,ER,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC3=CC(F)=C([C@@H]4C5=C(C[C@@H](C)N4CC(C)(C)F)C4=CC=CC=C4[NH]5)C(F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF7 cells,,,0.8,IC50 of ERalpha was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00397,1005.214,1004.469319,7.29,71,7,11,4,21,167.58,C53H67F3N6O8S,"InChI=1S/C53H67F3N6O8S/c1-31-23-39-38-11-9-10-12-42(38)59-46(39)47(62(31)29-53(7,8)56)45-40(54)25-37(26-41(45)55)70-22-21-68-18-17-67-19-20-69-28-44(64)60-49(52(4,5)6)51(66)61-27-36(63)24-43(61)50(65)58-32(2)34-13-15-35(16-14-34)48-33(3)57-30-71-48/h9-16,25-26,30-32,36,43,47,49,59,63H,17-24,27-29H2,1-8H3,(H,58,65)(H,60,64)/t31-,32+,36-,43+,47-,49-/m1/s1",WNWBHGDKGOSOKU-QIINAUKOSA-N
1468,0.4,99,0.4,,P03372,ER,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC3=CC(F)=C([C@@H]4C5=C(C[C@@H](C)N4CC(C)(C)F)C4=CC=CC=C4[NH]5)C(F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF7 cells,,,0.5,IC50 of ERalpha was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00397,961.161,960.443104,7.39,68,7,10,4,19,158.35,C51H63F3N6O7S,"InChI=1S/C51H63F3N6O7S/c1-30-21-37-36-11-8-9-12-40(36)57-44(37)45(60(30)28-51(6,7)54)43-38(52)23-35(24-39(43)53)67-20-19-65-17-10-18-66-27-42(62)58-47(50(3,4)5)49(64)59-26-34(61)22-41(59)48(63)55-25-32-13-15-33(16-14-32)46-31(2)56-29-68-46/h8-9,11-16,23-24,29-30,34,41,45,47,57,61H,10,17-22,25-28H2,1-7H3,(H,55,63)(H,58,62)/t30-,34-,41+,45-,47-/m1/s1",WNJYGPJDJPCRJH-GSXDKGEZSA-N
1469,0.3,99,0.3,,P03372,ER,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC3=CC(F)=C([C@@H]4C5=C(C[C@@H](C)N4CC(C)(C)F)C4=CC=CC=C4[NH]5)C(F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF7 cells,,,0.7,IC50 of ERalpha was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00397,991.187,990.4536687,6.89,70,7,11,4,21,167.58,C52H65F3N6O8S,"InChI=1S/C52H65F3N6O8S/c1-31-22-38-37-10-8-9-11-41(37)58-45(38)46(61(31)29-52(6,7)55)44-39(53)24-36(25-40(44)54)69-21-20-67-17-16-66-18-19-68-28-43(63)59-48(51(3,4)5)50(65)60-27-35(62)23-42(60)49(64)56-26-33-12-14-34(15-13-33)47-32(2)57-30-70-47/h8-15,24-25,30-31,35,42,46,48,58,62H,16-23,26-29H2,1-7H3,(H,56,64)(H,59,63)/t31-,35-,42+,46-,48-/m1/s1",WWSBSFVKXFRDJO-DXALMRNBSA-N
1470,0.4,99,0.4,,P03372,ER,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCOC3=CC(F)=C([C@@H]4C5=C(C[C@@H](C)N4CC(C)(C)F)C4=CC=CC=C4[NH]5)C(F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF7 cells,,,0.6,IC50 of ERalpha was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00397,975.188,974.4587541,7.75,69,7,10,4,20,158.35,C52H65F3N6O7S,"InChI=1S/C52H65F3N6O7S/c1-31-22-38-37-12-8-9-13-41(37)58-45(38)46(61(31)29-52(6,7)55)44-39(53)24-36(25-40(44)54)68-21-11-19-66-18-10-20-67-28-43(63)59-48(51(3,4)5)50(65)60-27-35(62)23-42(60)49(64)56-26-33-14-16-34(17-15-33)47-32(2)57-30-69-47/h8-9,12-17,24-25,30-31,35,42,46,48,58,62H,10-11,18-23,26-29H2,1-7H3,(H,56,64)(H,59,63)/t31-,35-,42+,46-,48-/m1/s1",PMXVLCRRMGVGJX-DXALMRNBSA-N
1471,0.8,99,0.8,,P03372,ER,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCC(F)(F)CCOC3=CC(F)=C([C@@H]4C5=C(C[C@@H](C)N4CC(C)(C)F)C4=CC=CC=C4[NH]5)C(F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF7 cells,,,0.5,IC50 of ERalpha was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00397,1025.195,1024.455561,8.42,72,7,10,4,21,158.35,C53H65F5N6O7S,"InChI=1S/C53H65F5N6O7S/c1-31-22-38-37-10-8-9-11-41(37)61-45(38)46(64(31)29-52(6,7)56)44-39(54)24-36(25-40(44)55)71-19-17-53(57,58)16-18-69-20-21-70-28-43(66)62-48(51(3,4)5)50(68)63-27-35(65)23-42(63)49(67)59-26-33-12-14-34(15-13-33)47-32(2)60-30-72-47/h8-15,24-25,30-31,35,42,46,48,61,65H,16-23,26-29H2,1-7H3,(H,59,67)(H,62,66)/t31-,35-,42+,46-,48-/m1/s1",KEOMTDRIBPAOQE-DXALMRNBSA-N
1472,0.6,99,0.6,,P03372,ER,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCCCCOC3=CC(F)=C([C@@H]4C5=C(C[C@@H](C)N4CC(C)(C)F)C4=CC=CC=C4[NH]5)C(F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF7 cells,,,0.5,IC50 of ERalpha was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00397,1003.242,1002.490054,8.51,71,7,10,4,21,158.35,C54H69F3N6O7S,"InChI=1S/C54H69F3N6O7S/c1-32-24-40-39-14-10-11-15-43(39)60-47(40)48(63(32)30-54(7,8)57)46-41(55)26-38(27-42(46)56)70-21-13-9-12-20-68-22-23-69-29-45(65)61-50(53(4,5)6)52(67)62-28-37(64)25-44(62)51(66)59-33(2)35-16-18-36(19-17-35)49-34(3)58-31-71-49/h10-11,14-19,26-27,31-33,37,44,48,50,60,64H,9,12-13,20-25,28-30H2,1-8H3,(H,59,66)(H,61,65)/t32-,33+,37-,44+,48-,50-/m1/s1",KCIXKNDPNDCWMB-GXXILBQTSA-N
1505,2.6,99,6/2.6,,Q06124,SHP2,VHL,,SHP2-D26,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3CCN(C(=O)CCC(=O)NC4=CC=CC(SC5=NC=C(N6CCC(C)(N)CC6)N=C5N)=C4Cl)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SHP2 in KYSE520/MV4;11 cells after 12 h treatment,>95/>95,% SHP2 degradation in KYSE520 cells after 6 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,660/9.9,Inhibit growth of KYSE520/MV4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00471,1115.913,1114.537548,6.19,77,7,15,6,22,245.34,C56H79ClN12O6S2,"InChI=1S/C56H79ClN12O6S2/c1-36(38-17-19-39(20-18-38)49-37(2)61-35-76-49)62-52(74)42-32-40(70)34-69(42)54(75)50(55(3,4)5)65-45(71)16-11-9-7-8-10-12-25-66-28-30-68(31-29-66)47(73)22-21-46(72)63-41-14-13-15-43(48(41)57)77-53-51(58)64-44(33-60-53)67-26-23-56(6,59)24-27-67/h13-15,17-20,33,35-36,40,42,50,70H,7-12,16,21-32,34,59H2,1-6H3,(H2,58,64)(H,62,74)(H,63,72)(H,65,71)/t36-,40+,42-,50+/m0/s1",XJSPAQRZSJUBLB-WQFCSRJTSA-N
1509,0.04,99,0.37/0.04,,Q05397,FAK,CRBN,,FC-11,CN(C1=NC=CC=C1CNC1=NC(NC2=CC=C(NC(=O)C3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)C=C2)=NC=C1C(F)(F)F)S(C)(=O)=O,Degradation of FAK in LNCaP/Ramos cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00372,949.93,949.2901256,2.19,67,7,18,5,20,273.96,C41H42F3N13O9S,"InChI=1S/C41H42F3N13O9S/c1-55(67(2,63)64)35-24(5-4-14-46-35)21-47-34-28(41(42,43)44)22-48-40(52-34)50-26-10-8-25(9-11-26)49-36(59)30-23-56(54-53-30)16-18-66-20-19-65-17-15-45-29-7-3-6-27-33(29)39(62)57(38(27)61)31-12-13-32(58)51-37(31)60/h3-11,14,22-23,31,45H,12-13,15-21H2,1-2H3,(H,49,59)(H,51,58,60)(H2,47,48,50,52)",RZKZQCHSKWKOAJ-UHFFFAOYSA-N
1509,0.08,99,0.31/0.08/0.33,,Q05397,FAK,CRBN,,FC-11,CN(C1=NC=CC=C1CNC1=NC(NC2=CC=C(NC(=O)C3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)C=C2)=NC=C1C(F)(F)F)S(C)(=O)=O,Degradation of FAK in TM3/PA1/MDA-MB-436 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00372,949.93,949.2901256,2.19,67,7,18,5,20,273.96,C41H42F3N13O9S,"InChI=1S/C41H42F3N13O9S/c1-55(67(2,63)64)35-24(5-4-14-46-35)21-47-34-28(41(42,43)44)22-48-40(52-34)50-26-10-8-25(9-11-26)49-36(59)30-23-56(54-53-30)16-18-66-20-19-65-17-15-45-29-7-3-6-27-33(29)39(62)57(38(27)61)31-12-13-32(58)51-37(31)60/h3-11,14,22-23,31,45H,12-13,15-21H2,1-2H3,(H,49,59)(H,51,58,60)(H2,47,48,50,52)",RZKZQCHSKWKOAJ-UHFFFAOYSA-N
1509,0.4,99,1.3/0.4,,Q05397,FAK,CRBN,,FC-11,CN(C1=NC=CC=C1CNC1=NC(NC2=CC=C(NC(=O)C3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)C=C2)=NC=C1C(F)(F)F)S(C)(=O)=O,Degradation of Fak in primary Sertoli/germ cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s13238-020-00732-8,949.93,949.2901256,2.19,67,7,18,5,20,273.96,C41H42F3N13O9S,"InChI=1S/C41H42F3N13O9S/c1-55(67(2,63)64)35-24(5-4-14-46-35)21-47-34-28(41(42,43)44)22-48-40(52-34)50-26-10-8-25(9-11-26)49-36(59)30-23-56(54-53-30)16-18-66-20-19-65-17-15-45-29-7-3-6-27-33(29)39(62)57(38(27)61)31-12-13-32(58)51-37(31)60/h3-11,14,22-23,31,45H,12-13,15-21H2,1-2H3,(H,49,59)(H,51,58,60)(H2,47,48,50,52)",RZKZQCHSKWKOAJ-UHFFFAOYSA-N
1510,391,99,391,,,BCR-ABL,CRBN,,Azo-PROTAC-2C,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCOC3=CC=C(/N=N/C4=CC=C(C(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)C=C4)C=C3)CC2)=N1,Degradation of BCR-ABL in K562 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b02058,953.486,952.2994258,6.81,68,9,15,4,14,215.81,C48H45ClN12O6S,"InChI=1S/C48H45ClN12O6S/c1-28-5-3-7-36(49)43(28)56-46(65)39-26-50-48(68-39)54-40-25-41(52-29(2)51-40)60-21-19-59(20-22-60)23-24-67-33-15-13-32(14-16-33)58-57-31-11-9-30(10-12-31)44(63)53-37-8-4-6-34-35(37)27-61(47(34)66)38-17-18-42(62)55-45(38)64/h3-16,25-26,38H,17-24,27H2,1-2H3,(H,53,63)(H,56,65)(H,55,62,64)(H,50,51,52,54)/b58-57+",QYPFNLRIBGXFNO-UPRQXYPZSA-N
1511,114,99,114,,,BCR-ABL,CRBN,,Azo-PROTAC-3C,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCOC3=CC=C(/N=N/C4=CC=C(C(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)C=C4)C=C3)CC2)=N1,Degradation of BCR-ABL in K562 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b02058,967.513,966.3150759,7.16,69,9,15,4,15,215.81,C49H47ClN12O6S,"InChI=1S/C49H47ClN12O6S/c1-29-6-3-8-37(50)44(29)57-47(66)40-27-51-49(69-40)55-41-26-42(53-30(2)52-41)61-23-21-60(22-24-61)20-5-25-68-34-16-14-33(15-17-34)59-58-32-12-10-31(11-13-32)45(64)54-38-9-4-7-35-36(38)28-62(48(35)67)39-18-19-43(63)56-46(39)65/h3-4,6-17,26-27,39H,5,18-25,28H2,1-2H3,(H,54,64)(H,57,66)(H,56,63,65)(H,51,52,53,55)/b59-58+",QTQHNLIFWIPLAX-NTDNRIHLSA-N
1512,62,99,62,,,BCR-ABL,CRBN,,Azo-PROTAC-4C,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCCOC3=CC=C(/N=N/C4=CC=C(C(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)C=C4)C=C3)CC2)=N1,Degradation of BCR-ABL in K562 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68,Inhibit proliferation of K562 cells,28,Inhibit viability of K562 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.9b02058,981.54,980.330726,7.52,70,9,15,4,16,215.81,C50H49ClN12O6S,"InChI=1S/C50H49ClN12O6S/c1-30-7-5-9-38(51)45(30)58-48(67)41-28-52-50(70-41)56-42-27-43(54-31(2)53-42)62-24-22-61(23-25-62)21-3-4-26-69-35-17-15-34(16-18-35)60-59-33-13-11-32(12-14-33)46(65)55-39-10-6-8-36-37(39)29-63(49(36)68)40-19-20-44(64)57-47(40)66/h5-18,27-28,40H,3-4,19-26,29H2,1-2H3,(H,55,65)(H,58,67)(H,57,64,66)(H,52,53,54,56)/b60-59+",DYBUXZNKVNIICM-BCLHHTJESA-N
1513,,,>500,,,BCR-ABL,CRBN,,Azo-PROTAC-5C,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCCCOC3=CC=C(/N=N/C4=CC=C(C(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)C=C4)C=C3)CC2)=N1,Degradation of BCR-ABL in K562 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b02058,995.567,994.346376,7.88,71,9,15,4,17,215.81,C51H51ClN12O6S,"InChI=1S/C51H51ClN12O6S/c1-31-8-6-10-39(52)46(31)59-49(68)42-29-53-51(71-42)57-43-28-44(55-32(2)54-43)63-25-23-62(24-26-63)22-4-3-5-27-70-36-18-16-35(17-19-36)61-60-34-14-12-33(13-15-34)47(66)56-40-11-7-9-37-38(40)30-64(50(37)69)41-20-21-45(65)58-48(41)67/h6-19,28-29,41H,3-5,20-27,30H2,1-2H3,(H,56,66)(H,59,68)(H,58,65,67)(H,53,54,55,57)/b61-60+",OGTSSFRBYDKZEX-OGAWRBAASA-N
1514,,,>500,,,BCR-ABL,CRBN,,Azo-PROTAC-6C,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCCCCOC3=CC=C(/N=N/C4=CC=C(C(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)C=C4)C=C3)CC2)=N1,Degradation of BCR-ABL in K562 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b02058,1009.594,1008.362026,8.24,72,9,15,4,18,215.81,C52H53ClN12O6S,"InChI=1S/C52H53ClN12O6S/c1-32-9-7-11-40(53)47(32)60-50(69)43-30-54-52(72-43)58-44-29-45(56-33(2)55-44)64-26-24-63(25-27-64)23-5-3-4-6-28-71-37-19-17-36(18-20-37)62-61-35-15-13-34(14-16-35)48(67)57-41-12-8-10-38-39(41)31-65(51(38)70)42-21-22-46(66)59-49(42)68/h7-20,29-30,42H,3-6,21-28,31H2,1-2H3,(H,57,67)(H,60,69)(H,59,66,68)(H,54,55,56,58)/b62-61+",FRVLEPNINKRXPD-AIDPXTNXSA-N
1535,25,99,25-125,,O60885,BRD4,VHL,6SIS,macroPROTAC-1,CC1=C(C2=CC=C3CNC(=O)[C@@H]4C[C@@H](O)CN4C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOC[C@H](NC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)COCCOCCOC3=C2)SC=N1,Degradation of BRD4 in HeLa cells after 4/18 h treatment,,,,,,,180,Kd of BRD4 BD2 was tested by ITC,,,-9.2,-6.25,-2.7,ITC in BRD4 BD2,,,,,,,,,47,ITC,33,FP,-10,-6.7,-3.3,ITC,,,,,,,,,2,Kd between VHL and the complex of protac and BRD4 BD2 was tested by ITC,,,-11.9,-10.9,-1,ITC between VHL and PROTAC:BRD4 BD2,,,,,,,640/300,Inhibit proliferation of 22RV1/MV4;11 cells,,,,,,,,,,,,,10.1002/anie.201914396,1118.777,1117.416824,4.48,77,8,18,4,5,239.18,C54H68ClN9O11S2,"InChI=1S/C54H68ClN9O11S2/c1-31-33(3)77-53-46(31)47(35-10-12-38(55)13-11-35)59-41(50-62-61-34(4)64(50)53)24-44(66)58-39-27-72-17-14-70-16-19-74-29-45(67)60-49(54(5,6)7)52(69)63-26-40(65)23-42(63)51(68)56-25-37-9-8-36(48-32(2)57-30-76-48)22-43(37)75-21-20-71-15-18-73-28-39/h8-13,22,30,39-42,49,65H,14-21,23-29H2,1-7H3,(H,56,68)(H,58,66)(H,60,67)/t39-,40+,41-,42-,49+/m0/s1",GMEHQGWGMMKWAX-NIQMDXQVSA-N
1535,,,>125,,P25440,BRD2,VHL,,macroPROTAC-1,CC1=C(C2=CC=C3CNC(=O)[C@@H]4C[C@@H](O)CN4C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOC[C@H](NC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)COCCOCCOC3=C2)SC=N1,Degradation of BRD2 in HeLa cells after 4/18 h treatment,,,,,,,743,Kd of BRD2 BD1 was tested by ITC,,,-8.4,-9.6,1.2,ITC in BRD2 BD1,,,,,,,,,47,ITC,33,FP,-10,-6.7,-3.3,ITC,,,,,,,,,70,Kd between VHL and the complex of protac and BRD2 BD1 was tested by ITC,,,-9.9,-4.8,-5,ITC between VHL and PROTAC:BRD2 BD1,,,,,,,640/300,Inhibit proliferation of 22RV1/MV4;11 cells,,,,,,,,,,,,,10.1002/anie.201914396,1118.777,1117.416824,4.48,77,8,18,4,5,239.18,C54H68ClN9O11S2,"InChI=1S/C54H68ClN9O11S2/c1-31-33(3)77-53-46(31)47(35-10-12-38(55)13-11-35)59-41(50-62-61-34(4)64(50)53)24-44(66)58-39-27-72-17-14-70-16-19-74-29-45(67)60-49(54(5,6)7)52(69)63-26-40(65)23-42(63)51(68)56-25-37-9-8-36(48-32(2)57-30-76-48)22-43(37)75-21-20-71-15-18-73-28-39/h8-13,22,30,39-42,49,65H,14-21,23-29H2,1-7H3,(H,56,68)(H,58,66)(H,60,67)/t39-,40+,41-,42-,49+/m0/s1",GMEHQGWGMMKWAX-NIQMDXQVSA-N
1535,,,>125,,Q15059,BRD3,VHL,,macroPROTAC-1,CC1=C(C2=CC=C3CNC(=O)[C@@H]4C[C@@H](O)CN4C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOC[C@H](NC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)COCCOCCOC3=C2)SC=N1,Degradation of BRD3 in HeLa cells after 4/18 h treatment,,,,,,,,,,,,,,,,,,,,,,,47,ITC,33,FP,-10,-6.7,-3.3,ITC,,,,,,,,,,,,,,,,,,,,,,,640/300,Inhibit proliferation of 22RV1/MV4;11 cells,,,,,,,,,,,,,10.1002/anie.201914396,1118.777,1117.416824,4.48,77,8,18,4,5,239.18,C54H68ClN9O11S2,"InChI=1S/C54H68ClN9O11S2/c1-31-33(3)77-53-46(31)47(35-10-12-38(55)13-11-35)59-41(50-62-61-34(4)64(50)53)24-44(66)58-39-27-72-17-14-70-16-19-74-29-45(67)60-49(54(5,6)7)52(69)63-26-40(65)23-42(63)51(68)56-25-37-9-8-36(48-32(2)57-30-76-48)22-43(37)75-21-20-71-15-18-73-28-39/h8-13,22,30,39-42,49,65H,14-21,23-29H2,1-7H3,(H,56,68)(H,58,66)(H,60,67)/t39-,40+,41-,42-,49+/m0/s1",GMEHQGWGMMKWAX-NIQMDXQVSA-N
1561,10,33,10,33,P10275,AR,CRBN,,,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(OCCOCCOCCOCCOC2=CC=CC3=C2CN([C@H]2CCC(=O)NC2=O)C3=O)C=C1,Degradation of AR in LNCaP cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00194,823.847,823.2498835,3.68,58,6,11,1,17,159.97,C40H40F3N5O9S,"InChI=1S/C40H40F3N5O9S/c1-39(2)37(52)47(27-7-6-25(23-44)31(22-27)40(41,42)43)38(58)48(39)26-8-10-28(11-9-26)56-20-18-54-16-14-53-15-17-55-19-21-57-33-5-3-4-29-30(33)24-46(36(29)51)32-12-13-34(49)45-35(32)50/h3-11,22,32H,12-21,24H2,1-2H3,(H,45,49,50)/t32-/m0/s1",OHIHMSVOYVOFIW-YTTGMZPUSA-N
1584,50,71,<=50/<=50,>=71/51-70,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=S)N(C5=CN=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1021.198,1020.384938,6.71,71,6,13,3,21,199.55,C50H59F3N8O8S2,"InChI=1S/C50H59F3N8O8S2/c1-31-42(71-30-57-31)33-13-11-32(12-14-33)26-56-44(64)40-24-36(62)28-59(40)45(65)43(48(2,3)4)58-41(63)29-68-21-10-20-67-19-8-7-9-22-69-37-17-15-34(16-18-37)61-47(70)60(46(66)49(61,5)6)35-23-38(50(51,52)53)39(25-54)55-27-35/h11-18,23,27,30,36,40,43,62H,7-10,19-22,24,26,28-29H2,1-6H3,(H,56,64)(H,58,63)/t36-,40+,43-/m1/s1",SGTVGCRQPJCKNZ-QIWIAYTASA-N
1585,50,71,<=50/<=50,>=71/51-70,P10275,AR,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1052.227,1051.395917,7.95,73,6,12,3,21,186.66,C52H61F4N7O8S2,"InChI=1S/C52H61F4N7O8S2/c1-31(33-12-14-34(15-13-33)44-32(2)58-30-73-44)59-46(66)41-26-38(64)28-61(41)47(67)45(50(3,4)5)60-43(65)29-70-22-11-21-69-20-9-8-10-23-71-42-19-18-37(25-40(42)53)63-49(72)62(48(68)51(63,6)7)36-17-16-35(27-57)39(24-36)52(54,55)56/h12-19,24-25,30-31,38,41,45,64H,8-11,20-23,26,28-29H2,1-7H3,(H,59,66)(H,60,65)/t31-,38+,41-,45+/m0/s1",FLLKKIZFEMVEEL-OZSPHOIVSA-N
1586,50,71,<=50/<=50,>=71/51-70,P10275,AR,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=C(F)C=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1070.217,1069.386495,8.05,74,6,12,3,21,186.66,C52H60F5N7O8S2,"InChI=1S/C52H60F5N7O8S2/c1-30(32-12-14-33(15-13-32)44-31(2)59-29-74-44)60-46(67)41-25-37(65)27-62(41)47(68)45(50(3,4)5)61-42(66)28-71-20-11-19-70-18-9-8-10-21-72-43-39(53)23-36(24-40(43)54)64-49(73)63(48(69)51(64,6)7)35-17-16-34(26-58)38(22-35)52(55,56)57/h12-17,22-24,29-30,37,41,45,65H,8-11,18-21,25,27-28H2,1-7H3,(H,60,67)(H,61,66)/t30-,37+,41-,45+/m0/s1",DKNBVZGJLBYCQJ-YCDRFOERSA-N
1587,50,71,<=50/<=50,>=71/>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1024.173,1023.364617,7.19,71,6,12,3,20,186.66,C50H57F4N7O8S2,"InChI=1S/C50H57F4N7O8S2/c1-30-42(71-29-57-30)32-12-10-31(11-13-32)26-56-44(64)39-24-36(62)27-59(39)45(65)43(48(2,3)4)58-41(63)28-68-20-9-19-67-18-7-8-21-69-40-17-16-35(23-38(40)51)61-47(70)60(46(66)49(61,5)6)34-15-14-33(25-55)37(22-34)50(52,53)54/h10-17,22-23,29,36,39,43,62H,7-9,18-21,24,26-28H2,1-6H3,(H,56,64)(H,58,63)/t36-,39+,43-/m1/s1",HVIFXYXSTAVNJM-IPQHXDNUSA-N
1588,50,71,<=50/<=50,>=71/>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(N4C(=S)N(C5=CN=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1007.171,1006.369287,6.35,70,6,13,3,20,199.55,C49H57F3N8O8S2,"InChI=1S/C49H57F3N8O8S2/c1-30-41(70-29-56-30)32-12-10-31(11-13-32)25-55-43(63)39-23-35(61)27-58(39)44(64)42(47(2,3)4)57-40(62)28-67-20-9-19-66-18-7-8-21-68-36-16-14-33(15-17-36)60-46(69)59(45(65)48(60,5)6)34-22-37(49(50,51)52)38(24-53)54-26-34/h10-17,22,26,29,35,39,42,61H,7-9,18-21,23,25,27-28H2,1-6H3,(H,55,63)(H,57,62)/t35-,39+,42-/m1/s1",QRYUVTSBJUTMOL-DCFQOXSYSA-N
1589,50,71,<=50/<=50,>=71/>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(Cl)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,972.631,971.3476815,6.83,67,6,12,3,20,186.66,C49H58ClN7O8S2,"InChI=1S/C49H58ClN7O8S2/c1-31-42(67-30-53-31)33-12-10-32(11-13-33)27-52-44(60)40-25-37(58)28-55(40)45(61)43(48(2,3)4)54-41(59)29-64-22-9-21-63-20-7-8-23-65-38-18-16-35(17-19-38)57-47(66)56(46(62)49(57,5)6)36-15-14-34(26-51)39(50)24-36/h10-19,24,30,37,40,43,58H,7-9,20-23,25,27-29H2,1-6H3,(H,52,60)(H,54,59)/t37-,40+,43-/m1/s1",HTGWWWOBPGTSLC-AKCINUCUSA-N
1590,50,71,<=50/<=50,>=71/>=71,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1082.281,1081.405339,8.72,76,7,12,3,21,186.66,C56H62F3N7O8S2,"InChI=1S/C56H62F3N7O8S2/c1-35-48(76-34-62-35)39-12-10-36(11-13-39)31-61-50(69)46-29-43(67)32-64(46)51(70)49(54(2,3)4)63-47(68)33-73-26-9-25-72-24-7-8-27-74-44-22-17-38(18-23-44)37-14-19-41(20-15-37)66-53(75)65(52(71)55(66,5)6)42-21-16-40(30-60)45(28-42)56(57,58)59/h10-23,28,34,43,46,49,67H,7-9,24-27,29,31-33H2,1-6H3,(H,61,69)(H,63,68)/t43-,46+,49-/m1/s1",IACCNUDTPQOEHL-YWIAGSDQSA-N
1593,30000,99,30000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,216,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,81000/68000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,652.712,652.2757809,2.67,48,6,11,3,11,177.39,C34H36N8O6,"InChI=1S/C34H36N8O6/c1-19-10-12-22(13-11-19)42-21(3)28-20(2)38-40(34(48)30(28)39-42)18-5-9-26(43)36-17-6-16-35-24-8-4-7-23-29(24)33(47)41(32(23)46)25-14-15-27(44)37-31(25)45/h4,7-8,10-13,25,35H,5-6,9,14-18H2,1-3H3,(H,36,43)(H,37,44,45)",JEEWMQSGYNEVAR-UHFFFAOYSA-N
1594,25000,99,25000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,30,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,76000/51000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,666.739,666.2914309,3.02,49,6,11,3,12,177.39,C35H38N8O6,"InChI=1S/C35H38N8O6/c1-20-11-13-23(14-12-20)43-22(3)29-21(2)39-41(35(49)31(29)40-43)19-7-10-27(44)37-18-5-4-17-36-25-9-6-8-24-30(25)34(48)42(33(24)47)26-15-16-28(45)38-32(26)46/h6,8-9,11-14,26,36H,4-5,7,10,15-19H2,1-3H3,(H,37,44)(H,38,45,46)",QAIXUYJWVALFLV-UHFFFAOYSA-N
1595,22000,99,22000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,29,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17000/32000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,680.766,680.307081,3.38,50,6,11,3,13,177.39,C36H40N8O6,"InChI=1S/C36H40N8O6/c1-21-12-14-24(15-13-21)44-23(3)30-22(2)40-42(36(50)32(30)41-44)20-8-11-28(45)38-19-6-4-5-18-37-26-10-7-9-25-31(26)35(49)43(34(25)48)27-16-17-29(46)39-33(27)47/h7,9-10,12-15,27,37H,4-6,8,11,16-20H2,1-3H3,(H,38,45)(H,39,46,47)",JJAOWBPHOQZIJX-UHFFFAOYSA-N
1596,15000,99,15000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,17,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15000/19000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,694.793,694.3227311,3.74,51,6,11,3,14,177.39,C37H42N8O6,"InChI=1S/C37H42N8O6/c1-22-13-15-25(16-14-22)45-24(3)31-23(2)41-43(37(51)33(31)42-45)21-9-12-29(46)39-20-7-5-4-6-19-38-27-11-8-10-26-32(27)36(50)44(35(26)49)28-17-18-30(47)40-34(28)48/h8,10-11,13-16,28,38H,4-7,9,12,17-21H2,1-3H3,(H,39,46)(H,40,47,48)",KVPIXXSMHHXIPO-UHFFFAOYSA-N
1597,14000,99,14000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,14,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12000/20000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,708.82,708.3383811,4.28,52,6,11,3,15,177.39,C38H44N8O6,"InChI=1S/C38H44N8O6/c1-23-14-16-26(17-15-23)46-25(3)32-24(2)42-44(38(52)34(32)43-46)22-10-13-30(47)40-21-8-6-4-5-7-20-39-28-12-9-11-27-33(28)37(51)45(36(27)50)29-18-19-31(48)41-35(29)49/h9,11-12,14-17,29,39H,4-8,10,13,18-22H2,1-3H3,(H,40,47)(H,41,48,49)",ASYJUBLYCMRVHZ-UHFFFAOYSA-N
1598,3600,99,3600,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,9,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8000/8000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,0.37,Compounds were administered at 10000 nM and incubated for 2 h,12.84,Compounds were administered at 10000 nM and incubated for 2 h,10.1021/acs.jmedchem.0c00929,722.847,722.3540312,4.82,53,6,11,3,16,177.39,C39H46N8O6,"InChI=1S/C39H46N8O6/c1-24-15-17-27(18-16-24)47-26(3)33-25(2)43-45(39(53)35(33)44-47)23-11-14-31(48)41-22-9-7-5-4-6-8-21-40-29-13-10-12-28-34(29)38(52)46(37(28)51)30-19-20-32(49)42-36(30)50/h10,12-13,15-18,30,40H,4-9,11,14,19-23H2,1-3H3,(H,41,48)(H,42,49,50)",UETAXZPCBATLJC-UHFFFAOYSA-N
1599,30000,99,30000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,160,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58000/25000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,726.791,726.3125603,2.01,53,6,13,3,16,195.85,C37H42N8O8,"InChI=1S/C37H42N8O8/c1-22-9-11-25(12-10-22)45-24(3)31-23(2)41-43(37(51)33(31)42-45)17-5-8-29(46)39-16-19-53-21-20-52-18-15-38-27-7-4-6-26-32(27)36(50)44(35(26)49)28-13-14-30(47)40-34(28)48/h4,6-7,9-12,28,38H,5,8,13-21H2,1-3H3,(H,39,46)(H,40,47,48)",CSOBFSQKJUVRAA-UHFFFAOYSA-N
1600,10000,99,10000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCOCCOCCOCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,70,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26000/23000,Inhibit growth of SW480/HCT116 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,798.898,798.3700752,2.58,58,6,14,3,21,205.08,C41H50N8O9,"InChI=1S/C41H50N8O9/c1-26-11-13-29(14-12-26)49-28(3)35-27(2)45-47(41(55)37(35)46-49)19-5-10-33(50)43-18-7-21-57-23-25-58-24-22-56-20-6-17-42-31-9-4-8-30-36(31)40(54)48(39(30)53)32-15-16-34(51)44-38(32)52/h4,8-9,11-14,32,42H,5-7,10,15-25H2,1-3H3,(H,43,50)(H,44,51,52)",GIFCUWIWLNHZIP-UHFFFAOYSA-N
1601,5000,99,5000,,O43924,PDEdelta,CRBN,,,CC1=CC=C(N2N=C3C(=O)N(CCCC(=O)NCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)N=C(C)C3=C2C)C=C1,Degradation of PDEdelta in SW480 cells after 24 h treatment,,,,,,,8,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7000,Inhibit growth of SW480 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00929,722.847,722.3540312,4.27,53,6,11,3,16,177.39,C39H46N8O6,"InChI=1S/C39H46N8O6/c1-24-12-15-28(16-13-24)47-26(3)34-25(2)43-45(39(53)35(34)44-47)22-10-11-32(48)41-21-9-7-5-4-6-8-20-40-27-14-17-29-30(23-27)38(52)46(37(29)51)31-18-19-33(49)42-36(31)50/h12-17,23,31,40H,4-11,18-22H2,1-3H3,(H,41,48)(H,42,49,50)",OBUJFXGGFPXSOS-UHFFFAOYSA-N
1602,,,>10000,,,BCR-ABL,CRBN,,P10lm,CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)C=C1NC1=NC=CC(C2=CC=CN=C2)=N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,916.016,915.3928763,3.39,68,9,15,4,16,229.64,C49H49N13O6,"InChI=1S/C49H49N13O6/c1-31-10-15-35(27-40(31)55-49-52-20-18-38(54-49)34-5-4-19-50-28-34)53-45(65)33-13-11-32(12-14-33)29-59-23-25-60(26-24-59)43(64)9-2-6-36-30-61(58-57-36)22-21-51-39-8-3-7-37-44(39)48(68)62(47(37)67)41-16-17-42(63)56-46(41)66/h3-5,7-8,10-15,18-20,27-28,30,41,51H,2,6,9,16-17,21-26,29H2,1H3,(H,53,65)(H,52,54,55)(H,56,63,66)",SNRWLRVLHXFKNR-UHFFFAOYSA-N
1603,,,>10000,,,BCR-ABL,CRBN,,P13lm,CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)C=C1NC1=NC=CC(C2=CC=CN=C2)=N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,960.069,959.419091,3.25,71,9,16,4,19,238.87,C51H53N13O7,"InChI=1S/C51H53N13O7/c1-33-10-15-37(29-42(33)57-51-54-20-18-40(56-51)36-5-4-19-52-30-36)55-47(67)35-13-11-34(12-14-35)31-61-22-24-62(25-23-61)45(66)9-2-6-38-32-63(60-59-38)26-28-71-27-21-53-41-8-3-7-39-46(41)50(70)64(49(39)69)43-16-17-44(65)58-48(43)68/h3-5,7-8,10-15,18-20,29-30,32,43,53H,2,6,9,16-17,21-28,31H2,1H3,(H,55,67)(H,54,56,57)(H,58,65,68)",WEVFCVSACWLJHM-UHFFFAOYSA-N
1604,,,>10000,,,BCR-ABL,CRBN,,P16lm,CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)C=C1NC1=NC=CC(C2=CC=CN=C2)=N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1004.122,1003.445306,3.1,74,9,17,4,22,248.1,C53H57N13O8,"InChI=1S/C53H57N13O8/c1-35-10-15-39(31-44(35)59-53-56-20-18-42(58-53)38-5-4-19-54-32-38)57-49(69)37-13-11-36(12-14-37)33-63-22-24-64(25-23-63)47(68)9-2-6-40-34-65(62-61-40)26-28-74-30-29-73-27-21-55-43-8-3-7-41-48(43)52(72)66(51(41)71)45-16-17-46(67)60-50(45)70/h3-5,7-8,10-15,18-20,31-32,34,45,55H,2,6,9,16-17,21-30,33H2,1H3,(H,57,69)(H,56,58,59)(H,60,67,70)",BCRKJNDKDHEKKG-UHFFFAOYSA-N
1605,,,>10000,,,BCR-ABL,CRBN,,P19lm,CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)C=C1NC1=NC=CC(C2=CC=CN=C2)=N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1048.175,1047.471521,2.95,77,9,18,4,25,257.33,C55H61N13O9,"InChI=1S/C55H61N13O9/c1-37-10-15-41(33-46(37)61-55-58-20-18-44(60-55)40-5-4-19-56-34-40)59-51(71)39-13-11-38(12-14-39)35-65-22-24-66(25-23-65)49(70)9-2-6-42-36-67(64-63-42)26-28-76-30-32-77-31-29-75-27-21-57-45-8-3-7-43-50(45)54(74)68(53(43)73)47-16-17-48(69)62-52(47)72/h3-5,7-8,10-15,18-20,33-34,36,47,57H,2,6,9,16-17,21-32,35H2,1H3,(H,59,71)(H,58,60,61)(H,62,69,72)",VUQOGXGCYSGFPE-UHFFFAOYSA-N
1606,,,>10000,,,BCR-ABL,CRBN,,P20lm,CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)C=C1NC1=NC=CC(C2=CC=CN=C2)=N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1092.228,1091.497735,2.8,80,9,19,4,28,266.56,C57H65N13O10,"InChI=1S/C57H65N13O10/c1-39-10-15-43(35-48(39)63-57-60-20-18-46(62-57)42-5-4-19-58-36-42)61-53(73)41-13-11-40(12-14-41)37-67-22-24-68(25-23-67)51(72)9-2-6-44-38-69(66-65-44)26-28-78-30-32-80-34-33-79-31-29-77-27-21-59-47-8-3-7-45-52(47)56(76)70(55(45)75)49-16-17-50(71)64-54(49)74/h3-5,7-8,10-15,18-20,35-36,38,49,59H,2,6,9,16-17,21-34,37H2,1H3,(H,61,73)(H,60,62,63)(H,64,71,74)",FVRDYNQXLKNCEW-UHFFFAOYSA-N
1607,56,99,56,,,BCR-ABL,CRBN,,P10D,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC3=CN(CCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)CC2)=N1,Degradation of BCR-ABL in K562 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,880.392,879.2790247,4.15,62,8,16,4,14,229.64,C41H42ClN13O6S,"InChI=1S/C41H42ClN13O6S/c1-23-6-3-9-27(42)36(23)49-38(59)30-21-44-41(62-30)47-31-20-32(46-24(2)45-31)52-16-18-53(19-17-52)34(57)11-4-7-25-22-54(51-50-25)15-14-43-28-10-5-8-26-35(28)40(61)55(39(26)60)29-12-13-33(56)48-37(29)58/h3,5-6,8-10,20-22,29,43H,4,7,11-19H2,1-2H3,(H,49,59)(H,48,56,58)(H,44,45,46,47)",UDYKDIVYTSSTMR-UHFFFAOYSA-N
1608,56,99,56,,,BCR-ABL,CRBN,,P13D,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)CC2)=N1,Degradation of BCR-ABL in K562 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,924.445,923.3052395,4,65,8,17,4,17,238.87,C43H46ClN13O7S,"InChI=1S/C43H46ClN13O7S/c1-25-6-3-9-29(44)38(25)51-40(61)32-23-46-43(65-32)49-33-22-34(48-26(2)47-33)54-15-17-55(18-16-54)36(59)11-4-7-27-24-56(53-52-27)19-21-64-20-14-45-30-10-5-8-28-37(30)42(63)57(41(28)62)31-12-13-35(58)50-39(31)60/h3,5-6,8-10,22-24,31,45H,4,7,11-21H2,1-2H3,(H,51,61)(H,50,58,60)(H,46,47,48,49)",VCNRYEXPDDIZFJ-UHFFFAOYSA-N
1609,20,99,20,,,BCR-ABL,CRBN,,P16D,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC3=CN(CCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)CC2)=N1,Degradation of BCR-ABL in K562 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,968.498,967.3314542,3.85,68,8,18,4,20,248.1,C45H50ClN13O8S,"InChI=1S/C45H50ClN13O8S/c1-27-6-3-9-31(46)40(27)53-42(63)34-25-48-45(68-34)51-35-24-36(50-28(2)49-35)56-15-17-57(18-16-56)38(61)11-4-7-29-26-58(55-54-29)19-21-67-23-22-66-20-14-47-32-10-5-8-30-39(32)44(65)59(43(30)64)33-12-13-37(60)52-41(33)62/h3,5-6,8-10,24-26,33,47H,4,7,11-23H2,1-2H3,(H,53,63)(H,52,60,62)(H,48,49,50,51)",POLFXDZCPIISDB-UHFFFAOYSA-N
1610,56,99,56,,,BCR-ABL,CRBN,,P19D,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC3=CN(CCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)CC2)=N1,Degradation of BCR-ABL in K562 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1012.551,1011.357669,3.71,71,8,19,4,23,257.33,C47H54ClN13O9S,"InChI=1S/C47H54ClN13O9S/c1-29-6-3-9-33(48)42(29)55-44(65)36-27-50-47(71-36)53-37-26-38(52-30(2)51-37)58-15-17-59(18-16-58)40(63)11-4-7-31-28-60(57-56-31)19-21-69-23-25-70-24-22-68-20-14-49-34-10-5-8-32-41(34)46(67)61(45(32)66)35-12-13-39(62)54-43(35)64/h3,5-6,8-10,26-28,35,49H,4,7,11-25H2,1-2H3,(H,55,65)(H,54,62,64)(H,50,51,52,53)",HBLQGFOSQLTPDJ-UHFFFAOYSA-N
1611,10,99,10,,,BCR-ABL,CRBN,,P22D,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC3=CN(CCOCCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)CC2)=N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.2,Inhibit viability of K562 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1056.604,1055.383884,3.56,74,8,20,4,26,266.56,C49H58ClN13O10S,"InChI=1S/C49H58ClN13O10S/c1-31-6-3-9-35(50)44(31)57-46(67)38-29-52-49(74-38)55-39-28-40(54-32(2)53-39)60-15-17-61(18-16-60)42(65)11-4-7-33-30-62(59-58-33)19-21-71-23-25-73-27-26-72-24-22-70-20-14-51-36-10-5-8-34-43(36)48(69)63(47(34)68)37-12-13-41(64)56-45(37)66/h3,5-6,8-10,28-30,37,51H,4,7,11-27H2,1-2H3,(H,57,67)(H,56,64,66)(H,52,53,54,55)",BCHARVWLDCVBSQ-UHFFFAOYSA-N
1612,,,>625,,,BCR-ABL,CRBN,,P10As,O=C1CCC(N2C(=O)C3=CC=CC(NCCN4C=C(CCCC(=O)N[C@@H]5CCN(C6=NC=C(C(=O)NC7=CC=C(OC(F)(F)Cl)C=C7)C=C6C6=N[NH]C=C6)C5)N=N4)=C3C2=O)C(=O)N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,885.289,884.2721257,3.46,63,8,14,5,16,238.53,C41H39ClF2N12O7,"InChI=1S/C41H39ClF2N12O7/c42-41(43,44)63-27-9-7-24(8-10-27)49-37(59)23-19-29(30-13-15-47-52-30)36(46-20-23)54-17-14-25(21-54)48-33(57)6-1-3-26-22-55(53-51-26)18-16-45-31-5-2-4-28-35(31)40(62)56(39(28)61)32-11-12-34(58)50-38(32)60/h2,4-5,7-10,13,15,19-20,22,25,32,45H,1,3,6,11-12,14,16-18,21H2,(H,47,52)(H,48,57)(H,49,59)(H,50,58,60)/t25-,32?/m1/s1",KHHQVHBDTLVQLY-LYYPKXFYSA-N
1613,400,99,400,,,BCR-ABL,CRBN,,P13As,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCN4C=C(CCCC(=O)N[C@@H]5CCN(C6=NC=C(C(=O)NC7=CC=C(OC(F)(F)Cl)C=C7)C=C6C6=N[NH]C=C6)C5)N=N4)=C3C2=O)C(=O)N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,929.342,928.2983405,3.31,66,8,15,5,19,247.76,C43H43ClF2N12O8,"InChI=1S/C43H43ClF2N12O8/c44-43(45,46)66-29-9-7-26(8-10-29)51-39(61)25-21-31(32-13-15-49-54-32)38(48-22-25)56-17-14-27(23-56)50-35(59)6-1-3-28-24-57(55-53-28)18-20-65-19-16-47-33-5-2-4-30-37(33)42(64)58(41(30)63)34-11-12-36(60)52-40(34)62/h2,4-5,7-10,13,15,21-22,24,27,34,47H,1,3,6,11-12,14,16-20,23H2,(H,49,54)(H,50,59)(H,51,61)(H,52,60,62)/t27-,34?/m1/s1",NIHYSKAIKSWAKC-RVLHTLCESA-N
1614,300,99,300,,,BCR-ABL,CRBN,,P16As,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCN4C=C(CCCC(=O)N[C@@H]5CCN(C6=NC=C(C(=O)NC7=CC=C(OC(F)(F)Cl)C=C7)C=C6C6=N[NH]C=C6)C5)N=N4)=C3C2=O)C(=O)N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,973.395,972.3245552,3.16,69,8,16,5,22,256.99,C45H47ClF2N12O9,"InChI=1S/C45H47ClF2N12O9/c46-45(47,48)69-31-9-7-28(8-10-31)53-41(63)27-23-33(34-13-15-51-56-34)40(50-24-27)58-17-14-29(25-58)52-37(61)6-1-3-30-26-59(57-55-30)18-20-68-22-21-67-19-16-49-35-5-2-4-32-39(35)44(66)60(43(32)65)36-11-12-38(62)54-42(36)64/h2,4-5,7-10,13,15,23-24,26,29,36,49H,1,3,6,11-12,14,16-22,25H2,(H,51,56)(H,52,61)(H,53,63)(H,54,62,64)/t29-,36?/m1/s1",STRPXCHXMXBMQI-NDPHRHSWSA-N
1615,200,99,200,,,BCR-ABL,CRBN,,P19As,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCN4C=C(CCCC(=O)N[C@@H]5CCN(C6=NC=C(C(=O)NC7=CC=C(OC(F)(F)Cl)C=C7)C=C6C6=N[NH]C=C6)C5)N=N4)=C3C2=O)C(=O)N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,121,Inhibit viability of K562 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1017.448,1016.35077,3.01,72,8,17,5,25,266.22,C47H51ClF2N12O10,"InChI=1S/C47H51ClF2N12O10/c48-47(49,50)72-33-9-7-30(8-10-33)55-43(65)29-25-35(36-13-15-53-58-36)42(52-26-29)60-17-14-31(27-60)54-39(63)6-1-3-32-28-61(59-57-32)18-20-70-22-24-71-23-21-69-19-16-51-37-5-2-4-34-41(37)46(68)62(45(34)67)38-11-12-40(64)56-44(38)66/h2,4-5,7-10,13,15,25-26,28,31,38,51H,1,3,6,11-12,14,16-24,27H2,(H,53,58)(H,54,63)(H,55,65)(H,56,64,66)/t31-,38?/m1/s1",LUCAXHCIOIVJQP-LERZKORDSA-N
1616,500,99,500,,,BCR-ABL,CRBN,,P22As,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCN4C=C(CCCC(=O)N[C@@H]5CCN(C6=NC=C(C(=O)NC7=CC=C(OC(F)(F)Cl)C=C7)C=C6C6=N[NH]C=C6)C5)N=N4)=C3C2=O)C(=O)N1,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1061.501,1060.376985,2.87,75,8,18,5,28,275.45,C49H55ClF2N12O11,"InChI=1S/C49H55ClF2N12O11/c50-49(51,52)75-35-9-7-32(8-10-35)57-45(67)31-27-37(38-13-15-55-60-38)44(54-28-31)62-17-14-33(29-62)56-41(65)6-1-3-34-30-63(61-59-34)18-20-72-22-24-74-26-25-73-23-21-71-19-16-53-39-5-2-4-36-43(39)48(70)64(47(36)69)40-11-12-42(66)58-46(40)68/h2,4-5,7-10,13,15,27-28,30,33,40,53H,1,3,6,11-12,14,16-26,29H2,(H,55,60)(H,56,65)(H,57,67)(H,58,66,68)/t33-,40?/m1/s1",PSIJYAOLNAWKKI-DGRXGLRRSA-N
1617,625,99,625,,,BCR-ABL,CRBN,,P10P,CC1=CC=C(C(=O)NC2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C(C(F)(F)F)=C2)C=C1C#CC1=CN=C2C=CC=NN12,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,954.971,954.3537118,3.99,70,9,14,3,13,209.13,C49H45F3N12O6,"InChI=1S/C49H45F3N12O6/c1-30-10-11-32(25-31(30)13-15-36-27-54-41-8-4-18-55-64(36)41)45(67)56-34-14-12-33(38(26-34)49(50,51)52)28-60-21-23-61(24-22-60)43(66)9-2-5-35-29-62(59-58-35)20-19-53-39-7-3-6-37-44(39)48(70)63(47(37)69)40-16-17-42(65)57-46(40)68/h3-4,6-8,10-12,14,18,25-27,29,40,53H,2,5,9,16-17,19-24,28H2,1H3,(H,56,67)(H,57,65,68)",VKWNMNNQSSMQIS-UHFFFAOYSA-N
1618,70,99,70,,,BCR-ABL,CRBN,,P13P,CC1=CC=C(C(=O)NC2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C(C(F)(F)F)=C2)C=C1C#CC1=CN=C2C=CC=NN12,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,999.024,998.3799266,3.84,73,9,15,3,16,218.36,C51H49F3N12O7,"InChI=1S/C51H49F3N12O7/c1-32-10-11-34(27-33(32)13-15-38-29-56-43-8-4-18-57-66(38)43)47(69)58-36-14-12-35(40(28-36)51(52,53)54)30-62-20-22-63(23-21-62)45(68)9-2-5-37-31-64(61-60-37)24-26-73-25-19-55-41-7-3-6-39-46(41)50(72)65(49(39)71)42-16-17-44(67)59-48(42)70/h3-4,6-8,10-12,14,18,27-29,31,42,55H,2,5,9,16-17,19-26,30H2,1H3,(H,58,69)(H,59,67,70)",VCIZNIVXZWDIOC-UHFFFAOYSA-N
1619,70,99,70,,,BCR-ABL,CRBN,,P16P,CC1=CC=C(C(=O)NC2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C(C(F)(F)F)=C2)C=C1C#CC1=CN=C2C=CC=NN12,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1043.077,1042.406141,3.7,76,9,16,3,19,227.59,C53H53F3N12O8,"InChI=1S/C53H53F3N12O8/c1-34-10-11-36(29-35(34)13-15-40-31-58-45-8-4-18-59-68(40)45)49(71)60-38-14-12-37(42(30-38)53(54,55)56)32-64-20-22-65(23-21-64)47(70)9-2-5-39-33-66(63-62-39)24-26-76-28-27-75-25-19-57-43-7-3-6-41-48(43)52(74)67(51(41)73)44-16-17-46(69)61-50(44)72/h3-4,6-8,10-12,14,18,29-31,33,44,57H,2,5,9,16-17,19-28,32H2,1H3,(H,60,71)(H,61,69,72)",ZFZXSTQIIIMNAX-UHFFFAOYSA-N
1620,20,99,20,,,BCR-ABL,CRBN,,P19P,CC1=CC=C(C(=O)NC2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C(C(F)(F)F)=C2)C=C1C#CC1=CN=C2C=CC=NN12,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.5,Inhibit viability of K562 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1087.13,1086.432356,3.55,79,9,17,3,22,236.82,C55H57F3N12O9,"InChI=1S/C55H57F3N12O9/c1-36-10-11-38(31-37(36)13-15-42-33-60-47-8-4-18-61-70(42)47)51(73)62-40-14-12-39(44(32-40)55(56,57)58)34-66-20-22-67(23-21-66)49(72)9-2-5-41-35-68(65-64-41)24-26-78-28-30-79-29-27-77-25-19-59-45-7-3-6-43-50(45)54(76)69(53(43)75)46-16-17-48(71)63-52(46)74/h3-4,6-8,10-12,14,18,31-33,35,46,59H,2,5,9,16-17,19-30,34H2,1H3,(H,62,73)(H,63,71,74)",SVYYVGZMWJYFIE-UHFFFAOYSA-N
1621,70,99,70,,,BCR-ABL,CRBN,,P22P,CC1=CC=C(C(=O)NC2=CC=C(CN3CCN(C(=O)CCCC4=CN(CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C(C(F)(F)F)=C2)C=C1C#CC1=CN=C2C=CC=NN12,Degradation of BCR-ABL in K562 cells after 32 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00967,1131.183,1130.458571,3.4,82,9,18,3,25,246.05,C57H61F3N12O10,"InChI=1S/C57H61F3N12O10/c1-38-10-11-40(33-39(38)13-15-44-35-62-49-8-4-18-63-72(44)49)53(75)64-42-14-12-41(46(34-42)57(58,59)60)36-68-20-22-69(23-21-68)51(74)9-2-5-43-37-70(67-66-43)24-26-80-28-30-82-32-31-81-29-27-79-25-19-61-47-7-3-6-45-52(47)56(78)71(55(45)77)48-16-17-50(73)65-54(48)76/h3-4,6-8,10-12,14,18,33-35,37,48,61H,2,5,9,16-17,19-32,36H2,1H3,(H,64,75)(H,65,73,76)",OCHJOGLRDDWDLC-UHFFFAOYSA-N
1636,2.9,99,2.9/18.4,,Q16539,p38alpha,CRBN,,NR-6a,CC1=CC=C(C(=O)NCCCCC2=CN(CCCC(=O)NCCCCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1N1C(C)=CC(OCC2=CC=C(F)C=C2F)=C(Br)C1=O,Degradation of p38alpha in T47D/MB-MDA-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112451,997.939,996.3345146,6.27,68,7,11,3,22,186.62,C50H55BrF2N8O7,"InChI=1S/C50H55BrF2N8O7/c1-31-16-17-34(26-42(31)61-32(2)25-43(46(51)50(61)67)68-30-35-18-19-36(52)27-40(35)53)47(64)55-23-8-6-13-37-28-59(58-57-37)24-10-15-44(62)54-22-7-4-3-5-11-33-12-9-14-38-39(33)29-60(49(38)66)41-20-21-45(63)56-48(41)65/h9,12,14,16-19,25-28,41H,3-8,10-11,13,15,20-24,29-30H2,1-2H3,(H,54,62)(H,55,64)(H,56,63,65)",DYERNVOWSSIIQF-UHFFFAOYSA-N
1636,19.1,99,35.19/19.1,,Q15759,p38beta,CRBN,,NR-6a,CC1=CC=C(C(=O)NCCCCC2=CN(CCCC(=O)NCCCCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1N1C(C)=CC(OCC2=CC=C(F)C=C2F)=C(Br)C1=O,Degradation of p38beta in T47D/MB-MDA-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112451,997.939,996.3345146,6.27,68,7,11,3,22,186.62,C50H55BrF2N8O7,"InChI=1S/C50H55BrF2N8O7/c1-31-16-17-34(26-42(31)61-32(2)25-43(46(51)50(61)67)68-30-35-18-19-36(52)27-40(35)53)47(64)55-23-8-6-13-37-28-59(58-57-37)24-10-15-44(62)54-22-7-4-3-5-11-33-12-9-14-38-39(33)29-60(49(38)66)41-20-21-45(63)56-48(41)65/h9,12,14,16-19,25-28,41H,3-8,10-11,13,15,20-24,29-30H2,1-2H3,(H,54,62)(H,55,64)(H,56,63,65)",DYERNVOWSSIIQF-UHFFFAOYSA-N
1645,24,99,24/27.2,,Q16539,p38alpha,CRBN,,NR-7h,CC1=CC=C(C(=O)NCCCCC2=CN(CCCC(=O)NCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1N1C(C)=CC(OCC2=CC=C(F)C=C2F)=C(Br)C1=O,Degradation of p38alpha in T47D/MB-MDA-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112451,998.883,997.2933781,5.41,68,7,13,4,21,215.72,C48H50BrF2N9O8,"InChI=1S/C48H50BrF2N9O8/c1-28-13-14-30(24-38(28)59-29(2)23-39(43(49)48(59)67)68-27-31-15-16-32(50)25-35(31)51)44(63)54-21-4-3-9-33-26-58(57-56-33)22-8-12-40(61)53-20-6-5-19-52-36-11-7-10-34-42(36)47(66)60(46(34)65)37-17-18-41(62)55-45(37)64/h7,10-11,13-16,23-26,37,52H,3-6,8-9,12,17-22,27H2,1-2H3,(H,53,61)(H,54,63)(H,55,62,64)",BEMLUUUHZPFCBS-UHFFFAOYSA-N
1645,48.47,99,48.47/48.9,,Q15759,p38beta,CRBN,,NR-7h,CC1=CC=C(C(=O)NCCCCC2=CN(CCCC(=O)NCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1N1C(C)=CC(OCC2=CC=C(F)C=C2F)=C(Br)C1=O,Degradation of p38beta in T47D/MB-MDA-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112451,998.883,997.2933781,5.41,68,7,13,4,21,215.72,C48H50BrF2N9O8,"InChI=1S/C48H50BrF2N9O8/c1-28-13-14-30(24-38(28)59-29(2)23-39(43(49)48(59)67)68-27-31-15-16-32(50)25-35(31)51)44(63)54-21-4-3-9-33-26-58(57-56-33)22-8-12-40(61)53-20-6-5-19-52-36-11-7-10-34-42(36)47(66)60(46(34)65)37-17-18-41(62)55-45(37)64/h7,10-11,13-16,23-26,37,52H,3-6,8-9,12,17-22,27H2,1-2H3,(H,53,61)(H,54,63)(H,55,62,64)",BEMLUUUHZPFCBS-UHFFFAOYSA-N
1648,30,99,30,,,BCR-ABL,VHL,,GMB-805,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCNC3=NC=C(C(=O)NC4=CC=C(OC(F)(F)Cl)C=C4)C=C3C3=CC=N[NH]3)C(C)(C)C)C=C2)SC=N1,Degradation of BCR-ABL in K562 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,169,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1039/d0cc02201b,894.402,893.2897499,5.35,62,6,12,6,17,212.79,C42H46ClF2N9O7S,"InChI=1S/C42H46ClF2N9O7S/c1-24-35(62-23-49-24)26-7-5-25(6-8-26)19-48-39(58)33-18-29(55)21-54(33)40(59)36(41(2,3)4)52-34(56)22-60-16-15-46-37-31(32-13-14-50-53-32)17-27(20-47-37)38(57)51-28-9-11-30(12-10-28)61-42(43,44)45/h5-14,17,20,23,29,33,36,55H,15-16,18-19,21-22H2,1-4H3,(H,46,47)(H,48,58)(H,50,53)(H,51,57)(H,52,56)/t29-,33+,36-/m1/s1",ZZAMCOWPQNSLBF-CPIPLPSASA-N
1649,4.8,76,4.8,76,Q07817,BCL-xL,VHL,6ZHC,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCOCC#CC3=CC=C(OCCCC4=C(C(=O)O)N=C(N5CCC6=CC=CC(C(=O)NC7=NC8=CC=CC=C8S7)=C6C5)S4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in THP-1 cells after 24 h treatment,,,0.6,IC50 was tested by HTRF assay,,,,,,,,,,,,,,,190,SPR,,,,,,,,,,,,,,,290,Titrations of PROTAC over an immobilised VCB surface in the presence of BCL-xL (SPR),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.0c00266,1329.631,1328.495612,8.07,93,9,20,5,34,271.66,C68H80N8O14S3,"InChI=1S/C68H80N8O14S3/c1-45-60(91-44-70-45)49-20-16-47(17-21-49)41-69-63(80)55-40-50(77)42-76(55)64(81)61(68(2,3)4)72-58(78)25-29-85-31-33-87-35-37-89-39-38-88-36-34-86-32-30-84-27-8-10-46-18-22-51(23-19-46)90-28-9-15-57-59(65(82)83)73-67(93-57)75-26-24-48-11-7-12-52(53(48)43-75)62(79)74-66-71-54-13-5-6-14-56(54)92-66/h5-7,11-14,16-23,44,50,55,61,77H,9,15,24-43H2,1-4H3,(H,69,80)(H,72,78)(H,82,83)(H,71,74,79)/t50-,55+,61-/m1/s1",LOJJAKUNUJJOKC-MXEISZGISA-N
1650,9.6,99,9.6,,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,Degradation of BTK in Ramos cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,1109.147,1108.456484,2.32,79,7,20,4,34,295.12,C53H66F2N8O16,"InChI=1S/C53H66F2N8O16/c54-36-8-12-43(40(55)33-36)79-38-9-6-35(7-10-38)47-46(49(57)65)48(56)63(60-47)37-3-2-15-61(34-37)53(69)78-32-31-77-30-29-76-28-27-75-26-25-74-24-23-73-22-21-72-20-19-71-18-17-70-16-14-58-41-5-1-4-39-45(41)52(68)62(51(39)67)42-11-13-44(64)59-50(42)66/h1,4-10,12,33,37,42,58H,2-3,11,13-32,34,56H2,(H2,57,65)(H,59,64,66)/t37-,42?/m1/s1",YOXZTCCVXQIAMP-SZUYGLCUSA-N
1651,126,94,126/200,94/78,O60885,BRD4,VHL,,MZP-61,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,3,Kd of BRD4 BD2 was tested by ITC,,,-11.7,-10,-1.71,ITC in BRD4 BD2,,,,,,,,,116,ITC,,,-9.46,-4.07,-5.39,ITC,,,,,,,,,781,Kd between VHL and the complex of protac and BRD4 BD2 was tested by ITC,,,-8.33,-7.02,-1.31,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,575/676,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,992.64,991.4069106,6.71,70,7,11,5,18,191.53,C53H62ClN7O8S,"InChI=1S/C53H62ClN7O8S/c1-32-25-44(58-41-18-16-40(54)17-19-41)43-26-39(15-20-45(43)61(32)34(3)62)36-11-13-38(14-12-36)50(65)55-21-22-68-23-24-69-30-47(64)59-49(53(4,5)6)52(67)60-29-42(63)27-46(60)51(66)56-28-35-7-9-37(10-8-35)48-33(2)57-31-70-48/h7-20,26,31-32,42,44,46,49,58,63H,21-25,27-30H2,1-6H3,(H,55,65)(H,56,66)(H,59,64)/t32-,42+,44+,46-,49+/m0/s1",AIFXAXRMMBWMAG-OVLUFEKXSA-N
1651,158,74,158,74,Q15059,BRD3,VHL,,MZP-61,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,116,ITC,,,-9.46,-4.07,-5.39,ITC,,,,,,,,,,,,,,,,,,,,,,,575/676,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,992.64,991.4069106,6.71,70,7,11,5,18,191.53,C53H62ClN7O8S,"InChI=1S/C53H62ClN7O8S/c1-32-25-44(58-41-18-16-40(54)17-19-41)43-26-39(15-20-45(43)61(32)34(3)62)36-11-13-38(14-12-36)50(65)55-21-22-68-23-24-69-30-47(64)59-49(53(4,5)6)52(67)60-29-42(63)27-46(60)51(66)56-28-35-7-9-37(10-8-35)48-33(2)57-31-70-48/h7-20,26,31-32,42,44,46,49,58,63H,21-25,27-30H2,1-6H3,(H,55,65)(H,56,66)(H,59,64)/t32-,42+,44+,46-,49+/m0/s1",AIFXAXRMMBWMAG-OVLUFEKXSA-N
1652,8,98,08 25,98/95,O60885,BRD4,VHL,,MZP-54,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,4,Kd of BRD4 BD2 was tested by ITC,,,-11.5,-9.74,-1.73,ITC in BRD4 BD2,,,,,,,,,105,ITC,,,-9.52,-6.18,-3.34,ITC,,,,,,,,,228,Kd between VHL and the complex of protac and BRD4 BD2 was tested by ITC,,,-9.06,-6.9,-2.16,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,49/269,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1036.693,1035.433125,6.56,73,7,12,5,21,200.76,C55H66ClN7O9S,"InChI=1S/C55H66ClN7O9S/c1-34-27-46(60-43-18-16-42(56)17-19-43)45-28-41(15-20-47(45)63(34)36(3)64)38-11-13-40(14-12-38)52(67)57-21-22-70-23-24-71-25-26-72-32-49(66)61-51(55(4,5)6)54(69)62-31-44(65)29-48(62)53(68)58-30-37-7-9-39(10-8-37)50-35(2)59-33-73-50/h7-20,28,33-34,44,46,48,51,60,65H,21-27,29-32H2,1-6H3,(H,57,67)(H,58,68)(H,61,66)/t34-,44+,46+,48-,51+/m0/s1",FYSWLIFIYIVHPI-DDWISSAJSA-N
1652,50,91,50,91,Q15059,BRD3,VHL,,MZP-54,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,105,ITC,,,-9.52,-6.18,-3.34,ITC,,,,,,,,,,,,,,,,,,,,,,,49/269,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1036.693,1035.433125,6.56,73,7,12,5,21,200.76,C55H66ClN7O9S,"InChI=1S/C55H66ClN7O9S/c1-34-27-46(60-43-18-16-42(56)17-19-43)45-28-41(15-20-47(45)63(34)36(3)64)38-11-13-40(14-12-38)52(67)57-21-22-70-23-24-71-25-26-72-32-49(66)61-51(55(4,5)6)54(69)62-31-44(65)29-48(62)53(68)58-30-37-7-9-39(10-8-37)50-35(2)59-33-73-50/h7-20,28,33-34,44,46,48,51,60,65H,21-27,29-32H2,1-6H3,(H,57,67)(H,58,68)(H,61,66)/t34-,44+,46+,48-,51+/m0/s1",FYSWLIFIYIVHPI-DDWISSAJSA-N
1653,8,95,8/32,95/93,O60885,BRD4,VHL,,MZP-55,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,Aug-39,Kd of BRD4 BD1/2 was tested by ITC,,,0.927927928,1.101851852,1.6/-0.33,ITC in BRD4 BD1/2,,,,,,,,,109,ITC,,,-9.5,-8.01,-1.5,ITC,,,,,,,,,221/183,Kd between VHL and the complex of protac and BRD4 BD1/2 was tested by ITC,,,0.990217391,0.32585752,4.092592593,ITC between VHL and BRD4 BD1/2:PROTAC,,,,,,,83/427,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1080.746,1079.45934,6.41,76,7,13,5,24,209.99,C57H70ClN7O10S,"InChI=1S/C57H70ClN7O10S/c1-36-29-48(62-45-18-16-44(58)17-19-45)47-30-43(15-20-49(47)65(36)38(3)66)40-11-13-42(14-12-40)54(69)59-21-22-72-23-24-73-25-26-74-27-28-75-34-51(68)63-53(57(4,5)6)56(71)64-33-46(67)31-50(64)55(70)60-32-39-7-9-41(10-8-39)52-37(2)61-35-76-52/h7-20,30,35-36,46,48,50,53,62,67H,21-29,31-34H2,1-6H3,(H,59,69)(H,60,70)(H,63,68)/t36-,46+,48+,50-,53+/m0/s1",UHWNJFZTYJNBAN-HYXXSBGTSA-N
1653,20,92,20,92,Q15059,BRD3,VHL,,MZP-55,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,Nov-39,Kd of BRD3 BD1/2 was tested by ITC,,,0.926605505,0.956834532,3.2/3,ITC in BRD3 BD1/2,,,,,,,,,109,ITC,,,-9.5,-8.01,-1.5,ITC,,,,,,,,,152/434,Kd between VHL and the complex of protac and BRD3 BD1/2 was tested by ITC,,,1.068886338,0.563437926,3.781021898,ITC between VHL and BRD3 BD1/2:PROTAC,,,,,,,83/427,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1080.746,1079.45934,6.41,76,7,13,5,24,209.99,C57H70ClN7O10S,"InChI=1S/C57H70ClN7O10S/c1-36-29-48(62-45-18-16-44(58)17-19-45)47-30-43(15-20-49(47)65(36)38(3)66)40-11-13-42(14-12-40)54(69)59-21-22-72-23-24-73-25-26-74-27-28-75-34-51(68)63-53(57(4,5)6)56(71)64-33-46(67)31-50(64)55(70)60-32-39-7-9-41(10-8-39)52-37(2)61-35-76-52/h7-20,30,35-36,46,48,50,53,62,67H,21-29,31-34H2,1-6H3,(H,59,69)(H,60,70)(H,63,68)/t36-,46+,48+,50-,53+/m0/s1",UHWNJFZTYJNBAN-HYXXSBGTSA-N
1654,100,96,100/100,96/97,O60885,BRD4,VHL,,MZ4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,17,ITC in BRD4 BD2,,,-10.6,-11.2,-0.65,ITC in BRD4 BD2,,,,,,,,,147,ITC,,,-9.34,-5.72,-3.61,ITC,,,,,,,,,26,Kd between VHL and MZ4-BRD4 BD2 was tested by ITC,,,-10.4,-5.36,-5.05,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,178/1445,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,958.608,957.3432648,5.11,66,7,14,4,17,202.26,C47H56ClN9O7S2,"InChI=1S/C47H56ClN9O7S2/c1-26-28(3)66-46-39(26)40(31-12-14-33(48)15-13-31)52-35(43-55-54-29(4)57(43)46)21-37(59)49-16-17-63-18-19-64-24-38(60)53-42(47(5,6)7)45(62)56-23-34(58)20-36(56)44(61)50-22-30-8-10-32(11-9-30)41-27(2)51-25-65-41/h8-15,25,34-36,42,58H,16-24H2,1-7H3,(H,49,59)(H,50,61)(H,53,60)/t34-,35+,36+,42-/m1/s1",UAQDCZFGBBSHLT-PBSGCNNPSA-N
1654,316,97,316,97,Q15059,BRD3,VHL,,MZ4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,147,ITC,,,-9.34,-5.72,-3.61,ITC,,,,,,,,,,,,,,,,,,,,,,,178/1445,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,958.608,957.3432648,5.11,66,7,14,4,17,202.26,C47H56ClN9O7S2,"InChI=1S/C47H56ClN9O7S2/c1-26-28(3)66-46-39(26)40(31-12-14-33(48)15-13-31)52-35(43-55-54-29(4)57(43)46)21-37(59)49-16-17-63-18-19-64-24-38(60)53-42(47(5,6)7)45(62)56-23-34(58)20-36(56)44(61)50-22-30-8-10-32(11-9-30)41-27(2)51-25-65-41/h8-15,25,34-36,42,58H,16-24H2,1-7H3,(H,49,59)(H,50,61)(H,53,60)/t34-,35+,36+,42-/m1/s1",UAQDCZFGBBSHLT-PBSGCNNPSA-N
1654,631,93,631,93,P25440,BRD2,VHL,,MZ4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,147,ITC,,,-9.34,-5.72,-3.61,ITC,,,,,,,,,,,,,,,,,,,,,,,178/1445,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,958.608,957.3432648,5.11,66,7,14,4,17,202.26,C47H56ClN9O7S2,"InChI=1S/C47H56ClN9O7S2/c1-26-28(3)66-46-39(26)40(31-12-14-33(48)15-13-31)52-35(43-55-54-29(4)57(43)46)21-37(59)49-16-17-63-18-19-64-24-38(60)53-42(47(5,6)7)45(62)56-23-34(58)20-36(56)44(61)50-22-30-8-10-32(11-9-30)41-27(2)51-25-65-41/h8-15,25,34-36,42,58H,16-24H2,1-7H3,(H,49,59)(H,50,61)(H,53,60)/t34-,35+,36+,42-/m1/s1",UAQDCZFGBBSHLT-PBSGCNNPSA-N
1655,3,95,398/3/13,30/95/90,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in HLF/SNU-398/HUCCT1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/>25119/>25119,Inhibit proliferation of HLF/SNU-398/HUCCT1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1655,13,96,27/13/25,95/96/90,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in A549/Hep3B2.1-7/SNU-387 cells after 18 h treatment,,,18,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/25119,Inhibit proliferation of SNU-387/Hep3B2.1-7 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1655,13,93,158/50/13,79/93/93,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in HLE/HuH-7/SNU-423 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/>25119/19953,Inhibit proliferation of HLE/HuH-7/SNU-423 cells,,,,,,,,,,,1,Compounds were administered at 10000 nM and incubated for 2 h,17,Compounds were administered at 10000 nM and incubated for 2 h,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1655,32,89,251/32/32,50/89/89,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in HUH-1/HepG2/SK-Hep-1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25119/>25119/1585,Inhibit proliferation of HUH-1/HepG2/SK-Hep-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1656,10,99,40/10/126,66/99/86,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in HLF/SNU-398/HUCCT1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/7943/6310,Inhibit proliferation of HLF/SNU-398/HUCCT1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1656,25,85,25/100/79,85/79/87,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in HLE/HuH-7/SNU-423 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10000/3981/6310,Inhibit proliferation of HLE/HuH-7/SNU-423 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1656,32,98,243/631/32,80/59/98,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in A549/Hep3B2.1-7/SNU-387 cells after 18 h treatment,,,19,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5012/6310,Inhibit proliferation of SNU-387/Hep3B2.1-7 cells,,,,,,,,,,,<1,Compounds were administered at 10000 nM and incubated for 2 h,11,Compounds were administered at 10000 nM and incubated for 2 h,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1656,79,79,79/631/126,79/65/87,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,Degradation of Fak in HUH-1/HepG2/SK-Hep-1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19953/>25119/7943,Inhibit proliferation of HUH-1/HepG2/SK-Hep-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1658,250,90,250/520,90/40,P01116,KRAS G12C,VHL,,LC-2,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,Degradation of KRAS G12C in NCI-H23/NCI-H358 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1132.805,1131.493121,7.27,80,9,15,3,20,209.69,C59H71ClFN11O7S,"InChI=1S/C59H71ClFN11O7S/c1-37(61)56(76)71-27-26-70(32-42(71)19-22-62)54-45-20-25-69(48-14-7-11-40-10-6-13-46(60)51(40)48)34-47(45)65-58(67-54)79-35-43-12-8-23-68(43)24-9-28-78-29-21-50(74)66-53(59(3,4)5)57(77)72-33-44(73)30-49(72)55(75)63-31-39-15-17-41(18-16-39)52-38(2)64-36-80-52/h6-7,10-11,13-18,36,42-44,49,53,73H,1,8-9,12,19-21,23-35H2,2-5H3,(H,63,75)(H,66,74)/t42-,43-,44+,49-,53+/m0/s1",ZCGQZLKPUVGCBQ-HLMPTVQRSA-N
1658,320,75,590/320/760,80/75/90,P01116,KRAS G12C,VHL,,LC-2,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,Degradation of KRAS G12C in NCI-H2030/MIA PaCa-2/SW1573 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3800/2900,Inhibit viability of NCI-H2030/NCI-H23 cells,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1132.805,1131.493121,7.27,80,9,15,3,20,209.69,C59H71ClFN11O7S,"InChI=1S/C59H71ClFN11O7S/c1-37(61)56(76)71-27-26-70(32-42(71)19-22-62)54-45-20-25-69(48-14-7-11-40-10-6-13-46(60)51(40)48)34-47(45)65-58(67-54)79-35-43-12-8-23-68(43)24-9-28-78-29-21-50(74)66-53(59(3,4)5)57(77)72-33-44(73)30-49(72)55(75)63-31-39-15-17-41(18-16-39)52-38(2)64-36-80-52/h6-7,10-11,13-18,36,42-44,49,53,73H,1,8-9,12,19-21,23-35H2,2-5H3,(H,63,75)(H,66,74)/t42-,43-,44+,49-,53+/m0/s1",ZCGQZLKPUVGCBQ-HLMPTVQRSA-N
1659,640,85,640,85,P01116,KRAS G12C,VHL,,LC-3,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCC(=O)NCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,Degradation of KRAS G12C in NCI-H2030 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1145.804,1144.488369,6.31,81,9,15,4,19,229.56,C59H70ClFN12O7S,"InChI=1S/C59H70ClFN12O7S/c1-36(61)56(78)72-28-27-71(31-41(72)18-22-62)54-44-20-25-70(47-13-7-10-39-9-6-12-45(60)51(39)47)33-46(44)66-58(68-54)80-34-42-11-8-24-69(42)26-21-49(75)63-23-19-50(76)67-53(59(3,4)5)57(79)73-32-43(74)29-48(73)55(77)64-30-38-14-16-40(17-15-38)52-37(2)65-35-81-52/h6-7,9-10,12-17,35,41-43,48,53,74H,1,8,11,18-21,23-34H2,2-5H3,(H,63,75)(H,64,77)(H,67,76)/t41-,42-,43+,48-,53+/m0/s1",QSJKPPVXARILLJ-GYUTUTRISA-N
1660,880,90,880,90,P01116,KRAS G12C,VHL,,LC-4,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,Degradation of KRAS G12C in SW1573 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1146.832,1145.508771,7.63,81,9,15,3,21,209.69,C60H73ClFN11O7S,"InChI=1S/C60H73ClFN11O7S/c1-38(62)57(77)72-28-27-71(33-43(72)20-23-63)55-46-21-26-70(49-15-9-12-41-11-8-14-47(61)52(41)49)35-48(46)66-59(68-55)80-36-44-13-10-25-69(44)24-6-7-29-79-30-22-51(75)67-54(60(3,4)5)58(78)73-34-45(74)31-50(73)56(76)64-32-40-16-18-42(19-17-40)53-39(2)65-37-81-53/h8-9,11-12,14-19,37,43-45,50,54,74H,1,6-7,10,13,20-22,24-36H2,2-5H3,(H,64,76)(H,67,75)/t43-,44-,45+,50-,54+/m0/s1",ZTFKFELOBVAACZ-JCKBJUPWSA-N
1661,,,>10000,50,P01116,KRAS G12C,VHL,,LC-5,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,Degradation of KRAS G12C in SW1573 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1162.831,1161.503685,6.77,82,9,16,3,22,218.92,C60H73ClFN11O8S,"InChI=1S/C60H73ClFN11O8S/c1-38(62)57(77)72-25-24-71(33-43(72)18-21-63)55-46-19-23-70(49-13-7-10-41-9-6-12-47(61)52(41)49)35-48(46)66-59(68-55)81-36-44-11-8-22-69(44)26-28-80-30-29-79-27-20-51(75)67-54(60(3,4)5)58(78)73-34-45(74)31-50(73)56(76)64-32-40-14-16-42(17-15-40)53-39(2)65-37-82-53/h6-7,9-10,12-17,37,43-45,50,54,74H,1,8,11,18-20,22-36H2,2-5H3,(H,64,76)(H,67,75)/t43-,44-,45+,50-,54+/m0/s1",LHQBPRGJSOSPMT-JCKBJUPWSA-N
1675,0.228,99,0.578/1.08/0.228,>99/>99/>99,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of PARP1 in PC-3/LNCaP/MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5140/1440/4790,Inhibit growth of PC-3/LNCaP/MDA-MB-231 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00821,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1675,0.263,99,0.384/0.512/0.263,>99/>99/>99,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of PARP1 in HCC1937/22RV1/MDA-MB-468 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8410/12300/4360,Inhibit growth of HCC1937/22RV1/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00821,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1675,0.509,99,1.26/6.72/0.509,>99/>99/>99,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of PARP1 in MDA-MB-436/Capan-1/SW620 cells after 24 h treatment,,,2.3,IC50 was tested using a PARP1 activity assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19/56/5130,Inhibit growth of MDA-MB-436/Capan-1/SW620 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00821,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1675,2.89,99,2.89,,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of PARP1 in L-O2 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmc.2022.116908,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1693,0.48,99,0.48/1.26,,P04629,TRKA,CRBN,,CG416,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCC(=O)N4CCN(C5=CC=CC(C6=CN=C7C=CC(N8CCC[C@@H]8C8=CC=CC(F)=C8)=NN67)=N5)CC4)=C3C2=O)C(=O)N1,Degradation of TPM3-TRKA/TRKA in KM12/HEL cells after 6 h treatment,18/65/96,% TPM3-TRKA degradation in KM12 cells after 6 h treatment at 0.1/1/10 nM,,,,,2.1,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4,Inhibit growth of KM12 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01342,812.907,812.3558428,4.69,60,9,12,2,12,165.45,C44H45FN10O5,"InChI=1S/C44H45FN10O5/c45-29-9-4-8-28(26-29)33-13-7-21-53(33)38-18-17-36-47-27-35(55(36)50-38)31-11-6-14-37(48-31)51-22-24-52(25-23-51)40(57)15-2-1-3-20-46-32-12-5-10-30-41(32)44(60)54(43(30)59)34-16-19-39(56)49-42(34)58/h4-6,8-12,14,17-18,26-27,33-34,46H,1-3,7,13,15-16,19-25H2,(H,49,56,58)/t33-,34?/m1/s1",YTPXNCADDOOFPA-BONSOQDYSA-N
1696,0.36,99,0.36/2.23,,P04629,TRKA,CRBN,,CG428,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCC(=O)N4CCN(C5=CC=CC(C6=CN=C7C=CC(N8CCC[C@@H]8C8=CC=CC(F)=C8)=NN67)=N5)CC4)=C3C2=O)C(=O)N1,Degradation of TPM3-TRKA/TRKA in KM12/HEL cells after 6 h treatment,46/82/96,% TPM3-TRKA degradation in KM12 cells after 6 h treatment at 0.1/1/10 nM,,,,,1,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.9,Inhibit growth of KM12 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01342,814.879,814.3351073,3.48,60,9,13,2,12,174.68,C43H43FN10O6,"InChI=1S/C43H43FN10O6/c44-28-6-1-5-27(25-28)32-10-4-18-52(32)37-14-13-35-46-26-34(54(35)49-37)30-8-3-11-36(47-30)50-19-21-51(22-20-50)39(56)16-23-60-24-17-45-31-9-2-7-29-40(31)43(59)53(42(29)58)33-12-15-38(55)48-41(33)57/h1-3,5-9,11,13-14,25-26,32-33,45H,4,10,12,15-24H2,(H,48,55,57)/t32-,33?/m1/s1",FWANKJAOTQAHHR-KWRHIPAJSA-N
1716,52,74,52,74,Q9Y616,IRAK3,CRBN,,,CC(C)C1=C2C(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CN6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)CC4)CC3)=NC=NN2C=C1,Degradation of IRAK3 in THP1 cells after 16 h treatment,,,6.3,LanthaScreen Eu IRAK3 binding displacement assay using an Alexa Fluor conjugate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01125,864.065,863.4806287,2.44,63,9,13,2,11,176.11,C46H61N11O6,"InChI=1S/C46H61N11O6/c1-30(2)35-15-18-56-42(35)43(47-29-48-56)49-32-3-5-33(6-4-32)52-23-25-55(26-24-52)41(60)12-11-40(59)54-16-13-31(14-17-54)28-51-19-21-53(22-20-51)34-7-8-36-37(27-34)46(63)57(45(36)62)38-9-10-39(58)50-44(38)61/h7-8,15,18,27,29-33,38H,3-6,9-14,16-17,19-26,28H2,1-2H3,(H,47,48,49)(H,50,58,61)/t32-,33+,38?",PVLXFMAKABZOPF-YVLRYLSESA-N
1717,2,98,2,98,Q9Y616,IRAK3,CRBN,,,CC(C)C1=C2C(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)CC4)CC3)=NC=NN2C=C1,Degradation of IRAK3 in THP1 cells after 16 h treatment,,,4.9,LanthaScreen Eu IRAK3 binding displacement assay using an Alexa Fluor conjugate,,,34,Kd apparent of IRAK3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01125,878.092,877.4962787,2.8,64,9,13,2,12,176.11,C47H63N11O6,"InChI=1S/C47H63N11O6/c1-31(2)36-16-20-57-43(36)44(48-30-49-57)50-33-3-5-34(6-4-33)53-25-27-56(28-26-53)42(61)12-11-41(60)55-18-14-32(15-19-55)13-17-52-21-23-54(24-22-52)35-7-8-37-38(29-35)47(64)58(46(37)63)39-9-10-40(59)51-45(39)62/h7-8,16,20,29-34,39H,3-6,9-15,17-19,21-28H2,1-2H3,(H,48,49,50)(H,51,59,62)/t33-,34+,39?",ZUODKONSNNHSAJ-AMLBMYBGSA-N
1734,6,99,08 06,,P36507,MEK2,VHL,,MS928,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)C3=CC=C(F)C(F)=C3NC3=CC=C(I)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK2 in HT-29/SK-MEL-28 cells after 24 h treatment,,,,,,,1400,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32/56/360,Inhibit proliferation of HT-29/SK-MEL-28/SUDHL1 cells,,,,,,,,,,,10.1021/acs.jmedchem.0c01609,1090.105,1089.387037,10.88,69,5,10,5,25,165.23,C51H67F3IN7O6S,"InChI=1S/C51H67F3IN7O6S/c1-32(34-17-19-35(20-18-34)46-33(2)56-31-69-46)57-49(66)42-29-37(63)30-62(42)50(67)47(51(3,4)5)59-43(64)16-13-11-9-7-8-10-12-14-25-61(6)26-15-27-68-60-48(65)38-22-23-39(52)44(54)45(38)58-41-24-21-36(55)28-40(41)53/h17-24,28,31-32,37,42,47,58,63H,7-16,25-27,29-30H2,1-6H3,(H,57,66)(H,59,64)(H,60,65)/t32-,37+,42-,47+/m0/s1",DXMOVGRUXPNRRX-IJSQUPEFSA-N
1734,16,99,18/16,,Q02750,MEK1,VHL,,MS928,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)C3=CC=C(F)C(F)=C3NC3=CC=C(I)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK1 in HT-29/SK-MEL-28 cells after 24 h treatment,,,,,,,400,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32/56/360,Inhibit proliferation of HT-29/SK-MEL-28/SUDHL1 cells,,,,,,,,,,,10.1021/acs.jmedchem.0c01609,1090.105,1089.387037,10.88,69,5,10,5,25,165.23,C51H67F3IN7O6S,"InChI=1S/C51H67F3IN7O6S/c1-32(34-17-19-35(20-18-34)46-33(2)56-31-69-46)57-49(66)42-29-37(63)30-62(42)50(67)47(51(3,4)5)59-43(64)16-13-11-9-7-8-10-12-14-25-61(6)26-15-27-68-60-48(65)38-22-23-39(52)44(54)45(38)58-41-24-21-36(55)28-40(41)53/h17-24,28,31-32,37,42,47,58,63H,7-16,25-27,29-30H2,1-6H3,(H,57,66)(H,59,64)(H,60,65)/t32-,37+,42-,47+/m0/s1",DXMOVGRUXPNRRX-IJSQUPEFSA-N
1737,4,99,4,,P36507,MEK2,VHL,,MS934,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)C3=CC=C(F)C(F)=C3NC3=CC=C(I)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK2 in HT-29/SK-MEL-28 cells after 24 h treatment,,,,,,,2000,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23/40/330,Inhibit proliferation of HT-29/SK-MEL-28/SUDHL1 cells,,,,,,,,,,,10.1021/acs.jmedchem.0c01609,1104.132,1103.402687,11.31,70,5,10,6,27,174.02,C52H69F3IN7O6S,"InChI=1S/C52H69F3IN7O6S/c1-33(35-18-20-36(21-19-35)47-34(2)58-32-70-47)59-50(67)43-30-38(64)31-63(43)51(68)48(52(3,4)5)61-44(65)17-13-11-9-7-6-8-10-12-14-26-57-27-15-16-28-69-62-49(66)39-23-24-40(53)45(55)46(39)60-42-25-22-37(56)29-41(42)54/h18-25,29,32-33,38,43,48,57,60,64H,6-17,26-28,30-31H2,1-5H3,(H,59,67)(H,61,65)(H,62,66)/t33-,38+,43-,48+/m0/s1",DYLGPTDXXUWFMK-ARFQKLFXSA-N
1737,10,99,"	18/10",,Q02750,MEK1,VHL,,MS934,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)C3=CC=C(F)C(F)=C3NC3=CC=C(I)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK1 in HT-29/SK-MEL-28 cells after 24 h treatment,,,,,,,400,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23/40/330,Inhibit proliferation of HT-29/SK-MEL-28/SUDHL1 cells,,,,,,,,,,,10.1021/acs.jmedchem.0c01609,1104.132,1103.402687,11.31,70,5,10,6,27,174.02,C52H69F3IN7O6S,"InChI=1S/C52H69F3IN7O6S/c1-33(35-18-20-36(21-19-35)47-34(2)58-32-70-47)59-50(67)43-30-38(64)31-63(43)51(68)48(52(3,4)5)61-44(65)17-13-11-9-7-6-8-10-12-14-26-57-27-15-16-28-69-62-49(66)39-23-24-40(53)45(55)46(39)60-42-25-22-37(56)29-41(42)54/h18-25,29,32-33,38,43,48,57,60,64H,6-17,26-28,30-31H2,1-5H3,(H,59,67)(H,61,65)(H,62,66)/t33-,38+,43-,48+/m0/s1",DYLGPTDXXUWFMK-ARFQKLFXSA-N
1758,38,99,55/38,,P36507,MEK2,CRBN,,MS910,O=C1CCC(N2C(=O)C3=CC=C(NCCOCCOCCOCCOCCOCCNCCCONC(=O)C4=CC=C(F)C(F)=C4NC4=CC=C(I)C=C4F)C=C3C2=O)C(=O)N1,Degradation of MEK2 in HT-29/SK-MEL-28 cells after 24 h treatment,,,,,,,2400,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,300/780,Inhibit proliferation of HT-29/SK-MEL-28 cells,,,,,,,,,,,10.1021/acs.jmedchem.0c01609,984.764,984.237789,3.36,62,5,14,5,28,204.12,C41H48F3IN6O11,"InChI=1S/C41H48F3IN6O11/c42-31-6-5-29(37(36(31)44)48-33-7-2-26(45)24-32(33)43)38(53)50-62-13-1-10-46-11-14-57-16-18-59-20-22-61-23-21-60-19-17-58-15-12-47-27-3-4-28-30(25-27)41(56)51(40(28)55)34-8-9-35(52)49-39(34)54/h2-7,24-25,34,46-48H,1,8-23H2,(H,50,53)(H,49,52,54)",OWWBODSADLTRAR-UHFFFAOYSA-N
1758,94,99,118/94,,Q02750,MEK1,CRBN,,MS910,O=C1CCC(N2C(=O)C3=CC=C(NCCOCCOCCOCCOCCOCCNCCCONC(=O)C4=CC=C(F)C(F)=C4NC4=CC=C(I)C=C4F)C=C3C2=O)C(=O)N1,Degradation of MEK1 in HT-29/SK-MEL-28 cells after 24 h treatment,,,,,,,660,Kd was assessed using the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,300/780,Inhibit proliferation of HT-29/SK-MEL-28 cells,,,,,,,,,,,10.1021/acs.jmedchem.0c01609,984.764,984.237789,3.36,62,5,14,5,28,204.12,C41H48F3IN6O11,"InChI=1S/C41H48F3IN6O11/c42-31-6-5-29(37(36(31)44)48-33-7-2-26(45)24-32(33)43)38(53)50-62-13-1-10-46-11-14-57-16-18-59-20-22-61-23-21-60-19-17-58-15-12-47-27-3-4-28-30(25-27)41(56)51(40(28)55)34-8-9-35(52)49-39(34)54/h2-7,24-25,34,46-48H,1,8-23H2,(H,50,53)(H,49,52,54)",OWWBODSADLTRAR-UHFFFAOYSA-N
1782,1100,74,1100,74,O14744,PRMT5,VHL,,MS4322,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC(=O)N3CC(NC4=CC(C(=O)NC[C@H](O)CN5CCC6=CC=CC=C6C5)=NC=N4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of PRMT5 in MCF-7 cells after 6 d treatment,,,18,IC50 was assessed by a human PRMT5/MEP50 radioactive biochemical assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01111,1101.338,1100.536489,2.22,78,7,18,6,29,268.47,C55H76N10O12S,"InChI=1S/C55H76N10O12S/c1-36(38-10-12-40(13-11-38)50-37(2)59-35-78-50)60-53(71)46-24-43(66)31-65(46)54(72)51(55(3,4)5)62-48(68)32-76-22-20-74-18-16-73-17-19-75-21-23-77-33-49(69)64-28-42(29-64)61-47-25-45(57-34-58-47)52(70)56-26-44(67)30-63-15-14-39-8-6-7-9-41(39)27-63/h6-13,25,34-36,42-44,46,51,66-67H,14-24,26-33H2,1-5H3,(H,56,70)(H,60,71)(H,62,68)(H,57,58,61)/t36-,43+,44-,46-,51+/m0/s1",XUJMNOQMXWVXQE-STHBVIMFSA-N
1783,7.5,98,7.5,98,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,1.1/1.4,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1102.253,1101.390002,2.66,77,8,16,5,21,256.48,C53H61F2N9O11S2,"InChI=1S/C53H61F2N9O11S2/c1-30-46(76-29-60-30)32-9-7-31(8-10-32)21-59-50(68)42-19-36(65)25-64(42)52(70)47(53(2,3)4)61-43(66)27-75-16-15-74-14-13-73-12-11-56-49(67)37-20-41-38(17-33(37)28-77(6,71)72)39-26-62(5)51(69)45-44(39)34(22-57-45)24-63(41)48-40(55)18-35(54)23-58-48/h7-10,17-18,20,22-23,26,29,36,42,47,57,65H,11-16,19,21,24-25,27-28H2,1-6H3,(H,56,67)(H,59,68)(H,61,66)/t36-,42+,47-/m1/s1",GPZQCKOJSPAJES-KFRCLFBHSA-N
1784,0.095,96,0.095,96,O60885,BRD4,VHL,7KHH,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,4.7/4.3,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,613,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.63,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1096.337,1095.452209,6.78,77,8,13,5,21,228.79,C56H67F2N9O8S2,"InChI=1S/C56H67F2N9O8S2/c1-33-49(76-32-63-33)35-18-16-34(17-19-35)25-62-53(71)45-23-39(68)29-67(45)55(73)50(56(2,3)4)64-46(69)15-13-11-9-7-8-10-12-14-20-59-52(70)40-24-44-41(21-36(40)31-77(6,74)75)42-30-65(5)54(72)48-47(42)37(26-60-48)28-66(44)51-43(58)22-38(57)27-61-51/h16-19,21-22,24,26-27,30,32,39,45,50,60,68H,7-15,20,23,25,28-29,31H2,1-6H3,(H,59,70)(H,62,71)(H,64,69)/t39-,45+,50-/m1/s1",VTPSYVSGGUUAFN-GDNJTPAESA-N
1785,180,99,180,99,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,1.2/1.6,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,383,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,220,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1201.386,1200.458416,2.75,84,9,18,6,23,277.74,C58H70F2N10O12S2,"InChI=1S/C58H70F2N10O12S2/c1-33-51(83-32-66-33)34-7-8-35(47(20-34)82-40-9-11-61-12-10-40)24-65-55(74)46-22-39(71)28-70(46)57(76)52(58(2,3)4)67-48(72)30-81-18-17-80-16-15-79-14-13-62-54(73)41-23-45-42(19-36(41)31-84(6,77)78)43-29-68(5)56(75)50-49(43)37(25-63-50)27-69(45)53-44(60)21-38(59)26-64-53/h7-8,19-21,23,25-26,29,32,39-40,46,52,61,63,71H,9-18,22,24,27-28,30-31H2,1-6H3,(H,62,73)(H,65,74)(H,67,72)/t39-,46+,52-/m1/s1",QZSIUKWWOMOSBP-MHQZIYKSSA-N
1786,3.4,98,3.4,98,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,2/2.7,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1195.47,1194.520622,6.88,84,9,15,6,23,250.05,C61H76F2N10O9S2,"InChI=1S/C61H76F2N10O9S2/c1-36-54(83-35-69-36)37-16-17-38(50(24-37)82-43-18-21-64-22-19-43)28-68-58(77)49-26-42(74)32-73(49)60(79)55(61(2,3)4)70-51(75)15-13-11-9-7-8-10-12-14-20-65-57(76)44-27-48-45(23-39(44)34-84(6,80)81)46-33-71(5)59(78)53-52(46)40(29-66-53)31-72(48)56-47(63)25-41(62)30-67-56/h16-17,23-25,27,29-30,33,35,42-43,49,55,64,66,74H,7-15,18-22,26,28,31-32,34H2,1-6H3,(H,65,76)(H,68,77)(H,70,75)/t42-,49+,55-/m1/s1",QJBZJBJONOIDIV-GSTUPHOUSA-N
1787,2.1,98,2.1,98,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC(N)=CC(OCCNC(=O)C4=CC5=C(C=C4CS(C)(=O)=O)C4=CN(C)C(=O)C6=C4C(=C[NH]6)CN5C4=NC=C(F)C=C4F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in EOL-1 cells 4 h treatment,,,7.2/8.1,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1149.313,1148.405987,4.2,81,9,16,6,19,273.27,C57H62F2N10O10S2,"InChI=1S/C57H62F2N10O10S2/c1-31-50(80-30-65-31)34-9-7-32(8-10-34)22-64-54(73)46-20-39(70)26-69(46)56(75)51(57(2,3)4)66-47(71)28-78-13-11-33-15-38(60)19-40(16-33)79-14-12-61-53(72)41-21-45-42(17-35(41)29-81(6,76)77)43-27-67(5)55(74)49-48(43)36(23-62-49)25-68(45)52-44(59)18-37(58)24-63-52/h7-10,15-19,21,23-24,27,30,39,46,51,62,70H,11-14,20,22,25-26,28-29,60H2,1-6H3,(H,61,72)(H,64,73)(H,66,71)/t39-,46+,51-/m1/s1",UNADZUGJDDCVKE-RVLLIKLQSA-N
1788,1.4,99.9,1.4,100,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC(O)=CC(OCCNC(=O)C4=CC5=C(C=C4CS(C)(=O)=O)C4=CN(C)C(=O)C6=C4C(=C[NH]6)CN5C4=NC=C(F)C=C4F)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,1.8/1.7,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,229,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1150.297,1149.390002,4.52,81,9,16,6,19,267.48,C57H61F2N9O11S2,"InChI=1S/C57H61F2N9O11S2/c1-31-50(80-30-64-31)34-9-7-32(8-10-34)22-63-54(73)46-20-39(70)26-68(46)56(75)51(57(2,3)4)65-47(71)28-78-13-11-33-15-38(69)19-40(16-33)79-14-12-60-53(72)41-21-45-42(17-35(41)29-81(6,76)77)43-27-66(5)55(74)49-48(43)36(23-61-49)25-67(45)52-44(59)18-37(58)24-62-52/h7-10,15-19,21,23-24,27,30,39,46,51,61,69-70H,11-14,20,22,25-26,28-29H2,1-6H3,(H,60,72)(H,63,73)(H,65,71)/t39-,46+,51-/m1/s1",JQHNOZDZLLPAJF-RVLLIKLQSA-N
1789,,,>20000,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(N)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,180/56,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5000,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,983.231,982.4193509,3.66,69,7,16,5,20,237.51,C49H62N10O8S2,"InChI=1S/C49H62N10O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26,50H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",XCXZOGOAQQLALD-PYNGZGNASA-N
1790,930,79,930,79,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(C#CCN)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,60/22,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,610,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2600,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1021.28,1020.435001,3.59,72,7,16,5,20,237.51,C52H64N10O8S2,"InChI=1S/C52H64N10O8S2/c1-31-33(3)72-51-44(31)45(37-14-10-35(11-15-37)9-8-18-53)57-40(48-60-59-34(4)62(48)51)26-42(64)54-19-20-68-21-22-69-23-24-70-29-43(65)58-47(52(5,6)7)50(67)61-28-39(63)25-41(61)49(66)55-27-36-12-16-38(17-13-36)46-32(2)56-30-71-46/h10-17,30,39-41,47,63H,18-29,53H2,1-7H3,(H,54,64)(H,55,66)(H,58,65)/t39-,40+,41+,47-/m1/s1",RJYPXJLNNMXFMD-XRFVFAKVSA-N
1791,780,99,780,99,O60885,BRD4,VHL,,,CNCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(SC(C)=C2C)N2C(C)=NN=C12)C(C)(C)C,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,Oct-34,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,720,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2800,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1075.756,1074.422243,4.51,74,7,17,5,24,232.75,C52H67ClN10O9S2,"InChI=1S/C52H67ClN10O9S2/c1-30-32(3)74-51-44(30)45(34-11-13-37(53)14-12-34)58-39(48-61-60-33(4)63(48)51)25-42(65)55-16-17-69-19-20-70-21-22-71-28-43(66)59-47(52(5,6)7)50(68)62-27-38(64)24-40(62)49(67)56-26-36-10-9-35(46-31(2)57-29-73-46)23-41(36)72-18-15-54-8/h9-14,23,29,38-40,47,54,64H,15-22,24-28H2,1-8H3,(H,55,65)(H,56,67)(H,59,66)/t38-,39+,40+,47-/m1/s1",AFQYUHBTQNKWIU-KVLVHDNBSA-N
1792,350,99.9,350,100,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,Nov-35,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,520,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2700,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1101.794,1100.437893,5.06,76,8,17,5,22,232.75,C54H69ClN10O9S2,"InChI=1S/C54H69ClN10O9S2/c1-31-33(3)76-53-46(31)47(35-10-12-38(55)13-11-35)60-41(50-63-62-34(4)65(50)53)26-44(67)57-18-19-71-20-21-72-22-23-73-29-45(68)61-49(54(5,6)7)52(70)64-28-39(66)25-42(64)51(69)58-27-37-9-8-36(48-32(2)59-30-75-48)24-43(37)74-40-14-16-56-17-15-40/h8-13,24,30,39-42,49,56,66H,14-23,25-29H2,1-7H3,(H,57,67)(H,58,69)(H,61,68)/t39-,41+,42+,49-/m1/s1",FOJOYRKGPBBUCX-BCSSRTCSSA-N
1793,85,98,85,98,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC(N)=CC(OCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,208/69,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,135,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1300,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1049.721,1048.385464,6.51,73,8,15,5,18,228.28,C53H61ClN10O7S2,"InChI=1S/C53H61ClN10O7S2/c1-29-31(3)73-52-45(29)46(35-12-14-37(54)15-13-35)59-41(49-62-61-32(4)64(49)52)24-43(66)56-17-19-71-40-21-34(20-38(55)22-40)16-18-70-27-44(67)60-48(53(5,6)7)51(69)63-26-39(65)23-42(63)50(68)57-25-33-8-10-36(11-9-33)47-30(2)58-28-72-47/h8-15,20-22,28,39,41-42,48,65H,16-19,23-27,55H2,1-7H3,(H,56,66)(H,57,68)(H,60,67)/t39-,41+,42+,48-/m1/s1",BVEMTZIKXNJFIM-NMNKMPBPSA-N
1794,280,88,280,88,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COC[C@@H]3CNC[C@H](COCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,12/6.4,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,570,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3800,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1041.742,1040.416764,5.33,72,8,15,5,18,214.29,C52H65ClN10O7S2,"InChI=1S/C52H65ClN10O7S2/c1-29-31(3)72-51-44(29)45(36-12-14-38(53)15-13-36)58-40(48-61-60-32(4)63(48)51)20-42(65)55-16-17-69-25-34-18-35(22-54-21-34)26-70-27-43(66)59-47(52(5,6)7)50(68)62-24-39(64)19-41(62)49(67)56-23-33-8-10-37(11-9-33)46-30(2)57-28-71-46/h8-15,28,34-35,39-41,47,54,64H,16-27H2,1-7H3,(H,55,65)(H,56,67)(H,59,66)/t34-,35+,39-,40+,41+,47-/m1/s1",XYRCFJBQFAIJBP-MFCIJMLGSA-N
1795,87,99.9,87,100,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC(N)=CC(CCOCCOCC#CC4=CC=C(C5=N[C@@H](CC6=NC=CS6)C6=NN=C(C)N6C6=C5C(C)=C(C)S6)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,55/40,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,440,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,480,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1107.442,1106.432893,7.89,78,9,16,4,19,212.07,C59H66N10O6S3,"InChI=1S/C59H66N10O6S3/c1-35-37(3)78-58-51(35)52(64-47(31-50-61-21-26-76-50)55-67-66-38(4)69(55)58)43-15-10-39(11-16-43)9-8-22-74-24-25-75-23-20-42-27-41(28-45(60)29-42)14-19-49(71)65-54(59(5,6)7)57(73)68-33-46(70)30-48(68)56(72)62-32-40-12-17-44(18-13-40)53-36(2)63-34-77-53/h10-13,15-18,21,26-29,34,46-48,54,70H,14,19-20,22-25,30-33,60H2,1-7H3,(H,62,72)(H,65,71)/t46-,47+,48+,54-/m1/s1",MXYBZGJJYHQKSU-OSCONUCQSA-N
1796,6500,99.9,6500,100,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC(N)=CC(CCOCCOCC#CC4=CC=C(C5=N[C@@H](CC(=O)NCCS(=O)(=O)O)C6=NN=C(C)N6C6=C5C(C)=C(C)S6)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,18/13,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11000,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1175.47,1174.443851,5,82,8,17,6,22,282.65,C59H70N10O10S3,"InChI=1S/C59H70N10O10S3/c1-35-37(3)81-58-51(35)52(64-47(55-67-66-38(4)69(55)58)31-50(72)61-21-26-82(75,76)77)43-15-10-39(11-16-43)9-8-22-78-24-25-79-23-20-42-27-41(28-45(60)29-42)14-19-49(71)65-54(59(5,6)7)57(74)68-33-46(70)30-48(68)56(73)62-32-40-12-17-44(18-13-40)53-36(2)63-34-80-53/h10-13,15-18,27-29,34,46-48,54,70H,14,19-26,30-33,60H2,1-7H3,(H,61,72)(H,62,73)(H,65,71)(H,75,76,77)/t46-,47+,48+,54-/m1/s1",JSCBAQVBPQZYHJ-OSCONUCQSA-N
1797,7.2,99,7.2,99,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC#CC#CCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,62/24,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,470,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,67,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,962.599,961.3170501,5.71,67,7,13,4,13,193.03,C49H52ClN9O6S2,"InChI=1S/C49H52ClN9O6S2/c1-28-30(3)67-48-41(28)42(33-16-18-35(50)19-17-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-20-10-8-9-11-21-65-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-12-14-34(15-13-32)43-29(2)53-27-66-43/h12-19,27,36-38,44,60H,20-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",FXEIENSZGMCCEE-PYNGZGNASA-N
1834,2840,93,2840,93,P14902,IDO1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCOCCOCCNCCNC4=NON=C4/C(=N\O)NC4=CC=C(F)C(Br)=C4)=C3C2=O)C(=O)N1,Degradation of IDO1 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35380,Inhibit viability of HeLa cells,,,,,,,,,,,,,,,10.1016/j.apsb.2020.02.010,966.816,965.2930231,1.26,64,5,19,6,32,267.79,C40H53BrFN9O13,"InChI=1S/C40H53BrFN9O13/c41-29-26-27(4-5-30(29)42)46-37(48-56)35-36(50-64-49-35)45-9-8-43-10-12-57-14-16-59-18-20-61-22-24-63-25-23-62-21-19-60-17-15-58-13-11-44-31-3-1-2-28-34(31)40(55)51(39(28)54)32-6-7-33(52)47-38(32)53/h1-5,26,32,43-44,56H,6-25H2,(H,45,50)(H,46,48)(H,47,52,53)",BVQZWOPTIZSOAW-UHFFFAOYSA-N
1840,4320,99,4320,,P35348,ADRA1A,CRBN,,,COC1=CC2=NC(N3CCN(C(=O)C4=CN(CCOCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)=NC(N)=C2C=C1OC,Degradation of ADRA1A in HEK293 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.apsb.2020.01.014,741.722,741.2619217,0.07,54,7,16,3,11,246.4,C34H35N11O9,"InChI=1S/C34H35N11O9/c1-52-24-14-19-21(15-25(24)53-2)37-34(39-29(19)35)43-10-8-42(9-11-43)32(50)22-16-44(41-40-22)12-13-54-17-27(47)36-20-5-3-4-18-28(20)33(51)45(31(18)49)23-6-7-26(46)38-30(23)48/h3-5,14-16,23H,6-13,17H2,1-2H3,(H,36,47)(H2,35,37,39)(H,38,46,48)",BMEBWCUDRJFZGZ-UHFFFAOYSA-N
1842,2860,94,2860,94,P35348,ADRA1A,CRBN,,,COC1=CC2=NC(N3CCN(C(=O)C4=CN(CCOCCOCCOCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)=NC(N)=C2C=C1OC,Degradation of ADRA1A in HEK293 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6120,Inhibit proliferation of PC-3 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2020.01.014,829.828,829.3143512,-0.23,60,7,18,3,17,264.86,C38H43N11O11,"InChI=1S/C38H43N11O11/c1-56-28-18-23-25(19-29(28)57-2)41-38(43-33(23)39)47-10-8-46(9-11-47)36(54)26-20-48(45-44-26)12-13-58-14-15-59-16-17-60-21-31(51)40-24-5-3-4-22-32(24)37(55)49(35(22)53)27-6-7-30(50)42-34(27)52/h3-5,18-20,27H,6-17,21H2,1-2H3,(H,40,51)(H2,39,41,43)(H,42,50,52)",SFODRSARUJDQSA-UHFFFAOYSA-N
1844,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6840,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,688.686,688.2268246,2.43,50,6,12,1,7,188.75,C36H36N2O12,"InChI=1S/C36H36N2O12/c1-19(31(44)48-24-9-5-8-22-27(24)30(43)38(29(22)42)23-10-11-26(40)37-28(23)41)7-6-15-34(3)25-14-17-35(33(46)50-34)16-12-21(32(45)47-4)13-18-36(25,35)49-20(2)39/h5-9,12,15,23,25H,10-11,13-14,16-18H2,1-4H3,(H,37,40,41)/b15-6+,19-7+/t23?,25-,34-,35-,36+/m1/s1",UGAAQMHZRGBKQI-YMRORBOUSA-N
1845,13850,99,13850,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12450,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,718.712,718.2373893,2.64,52,6,13,1,9,197.98,C37H38N2O13,"InChI=1S/C37H38N2O13/c1-20(32(45)50-19-49-25-9-5-8-23-28(25)31(44)39(30(23)43)24-10-11-27(41)38-29(24)42)7-6-15-35(3)26-14-17-36(34(47)52-35)16-12-22(33(46)48-4)13-18-37(26,36)51-21(2)40/h5-9,12,15,24,26H,10-11,13-14,16-19H2,1-4H3,(H,38,41,42)/b15-6+,20-7+/t24?,26-,35-,36-,37+/m1/s1",LACKEONNEGURRH-UEKFTLLPSA-N
1846,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12100,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,732.739,732.2530393,2.54,53,6,13,1,10,197.98,C38H40N2O13,"InChI=1S/C38H40N2O13/c1-21(33(46)51-20-19-50-26-9-5-8-24-29(26)32(45)40(31(24)44)25-10-11-28(42)39-30(25)43)7-6-15-36(3)27-14-17-37(35(48)53-36)16-12-23(34(47)49-4)13-18-38(27,37)52-22(2)41/h5-9,12,15,25,27H,10-11,13-14,16-20H2,1-4H3,(H,39,42,43)/b15-6+,21-7+/t25?,27-,36-,37-,38+/m1/s1",WHUXRYAADPSZDQ-AVBJXDJUSA-N
1847,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14140,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,746.766,746.2686894,2.9,54,6,13,1,11,197.98,C39H42N2O13,"InChI=1S/C39H42N2O13/c1-22(8-6-16-37(3)28-15-18-38(36(49)54-37)17-13-24(35(48)50-4)14-19-39(28,38)53-23(2)42)34(47)52-21-7-20-51-27-10-5-9-25-30(27)33(46)41(32(25)45)26-11-12-29(43)40-31(26)44/h5-6,8-10,13,16,26,28H,7,11-12,14-15,17-21H2,1-4H3,(H,40,43,44)/b16-6+,22-8+/t26?,28-,37-,38-,39+/m1/s1",YPWCKSJHFDZUNO-XAWXCVTDSA-N
1848,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCCCCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>40000,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,774.82,774.2999895,3.61,56,6,13,1,13,197.98,C41H46N2O13,"InChI=1S/C41H46N2O13/c1-24(10-9-18-39(3)30-17-20-40(38(51)56-39)19-15-26(37(50)52-4)16-21-41(30,40)55-25(2)44)36(49)54-23-7-5-6-22-53-29-12-8-11-27-32(29)35(48)43(34(27)47)28-13-14-31(45)42-33(28)46/h8-12,15,18,28,30H,5-7,13-14,16-17,19-23H2,1-4H3,(H,42,45,46)/b18-9+,24-10+/t28?,30-,39-,40-,41+/m1/s1",NPCDHHICMMZLER-JEIKEVFSSA-N
1849,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCCCCCCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>40000,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,802.874,802.3312897,4.51,58,6,13,1,15,197.98,C43H50N2O13,"InChI=1S/C43H50N2O13/c1-26(12-11-20-41(3)32-19-22-42(40(53)58-41)21-17-28(39(52)54-4)18-23-43(32,42)57-27(2)46)38(51)56-25-9-7-5-6-8-24-55-31-14-10-13-29-34(31)37(50)45(36(29)49)30-15-16-33(47)44-35(30)48/h10-14,17,20,30,32H,5-9,15-16,18-19,21-25H2,1-4H3,(H,44,47,48)/b20-11+,26-12+/t30?,32-,41-,42-,43+/m1/s1",DHWXVGHEJBGGBG-RKRJGGBXSA-N
1850,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4030,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,820.845,820.3054688,2.25,59,6,15,1,16,216.44,C42H48N2O15,"InChI=1S/C42H48N2O15/c1-25(7-6-15-40(3)31-14-17-41(39(52)59-40)16-12-27(38(51)53-4)13-18-42(31,41)58-26(2)45)37(50)57-24-22-55-20-19-54-21-23-56-30-9-5-8-28-33(30)36(49)44(35(28)48)29-10-11-32(46)43-34(29)47/h5-9,12,15,29,31H,10-11,13-14,16-24H2,1-4H3,(H,43,46,47)/b15-6+,25-7+/t29?,31-,40-,41-,42+/m1/s1",LIIPDGRRJYPSAT-CUULVINISA-N
1851,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)OCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4460,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,864.898,864.3316836,2.1,62,6,16,1,19,225.67,C44H52N2O16,"InChI=1S/C44H52N2O16/c1-27(7-6-15-42(3)33-14-17-43(41(54)62-42)16-12-29(40(53)55-4)13-18-44(33,43)61-28(2)47)39(52)60-26-24-58-22-20-56-19-21-57-23-25-59-32-9-5-8-30-35(32)38(51)46(37(30)50)31-10-11-34(48)45-36(31)49/h5-9,12,15,31,33H,10-11,13-14,16-26H2,1-4H3,(H,45,48,49)/b15-6+,27-7+/t31?,33-,42-,43-,44+/m1/s1",KIKGYQSXBONTRB-SLICWOFJSA-N
1852,6720,99,6720,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6230,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,730.771,730.2850082,2.53,53,6,12,3,10,203.58,C38H42N4O11,"InChI=1S/C38H42N4O11/c1-21(30(45)40-20-19-39-25-9-5-8-24-29(25)33(48)42(32(24)47)26-10-11-28(44)41-31(26)46)7-6-15-36(3)27-14-17-37(35(50)53-36)16-12-23(34(49)51-4)13-18-38(27,37)52-22(2)43/h5-9,12,15,26-27,39H,10-11,13-14,16-20H2,1-4H3,(H,40,45)(H,41,44,46)/b15-6+,21-7+/t26?,27-,36-,37-,38+/m1/s1",HXOYUWKUTDAHIM-CIDUFYDMSA-N
1853,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)NCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7090,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,744.798,744.3006582,2.89,54,6,12,3,11,203.58,C39H44N4O11,"InChI=1S/C39H44N4O11/c1-22(8-6-16-37(3)28-15-18-38(36(51)54-37)17-13-24(35(50)52-4)14-19-39(28,38)53-23(2)44)31(46)41-21-7-20-40-26-10-5-9-25-30(26)34(49)43(33(25)48)27-11-12-29(45)42-32(27)47/h5-6,8-10,13,16,27-28,40H,7,11-12,14-15,17-21H2,1-4H3,(H,41,46)(H,42,45,47)/b16-6+,22-8+/t27?,28-,37-,38-,39+/m1/s1",FINCIBVFPLIQGI-IRTJMNHGSA-N
1854,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)NCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5430,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,758.825,758.3163083,3.24,55,6,12,3,12,203.58,C40H46N4O11,"InChI=1S/C40H46N4O11/c1-23(9-8-17-38(3)29-16-19-39(37(52)55-38)18-14-25(36(51)53-4)15-20-40(29,39)54-24(2)45)32(47)42-22-6-5-21-41-27-11-7-10-26-31(27)35(50)44(34(26)49)28-12-13-30(46)43-33(28)48/h7-11,14,17,28-29,41H,5-6,12-13,15-16,18-22H2,1-4H3,(H,42,47)(H,43,46,48)/b17-8+,23-9+/t28?,29-,38-,39-,40+/m1/s1",MBFRJWUVWQWPIJ-IFHYTNTRSA-N
1855,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6230,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,786.879,786.3476084,3.96,57,6,12,3,14,203.58,C42H50N4O11,"InChI=1S/C42H50N4O11/c1-25(11-10-19-40(3)31-18-21-41(39(54)57-40)20-16-27(38(53)55-4)17-22-42(31,41)56-26(2)47)34(49)44-24-8-6-5-7-23-43-29-13-9-12-28-33(29)37(52)46(36(28)51)30-14-15-32(48)45-35(30)50/h9-13,16,19,30-31,43H,5-8,14-15,17-18,20-24H2,1-4H3,(H,44,49)(H,45,48,50)/b19-10+,25-11+/t30?,31-,40-,41-,42+/m1/s1",JGEQPCIHUWDGBZ-FDGMJWISSA-N
1856,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)N1CCN(C2=CC=CC4=C2C(=O)N(C2CCC(=O)NC2=O)C4=O)CC1)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24970,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,756.809,756.3006582,2.07,55,7,12,1,7,186,C40H44N4O11,"InChI=1S/C40H44N4O11/c1-23(7-6-15-38(3)29-14-17-39(37(52)55-38)16-12-25(36(51)53-4)13-18-40(29,39)54-24(2)45)33(48)43-21-19-42(20-22-43)27-9-5-8-26-31(27)35(50)44(34(26)49)28-10-11-30(46)41-32(28)47/h5-9,12,15,28-29H,10-11,13-14,16-22H2,1-4H3,(H,41,46,47)/b15-6+,23-7+/t28?,29-,38-,39-,40+/m1/s1",UGEBDJFVWGYGBO-DKBIAIPGSA-N
1857,16840,99,16840,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)NC1CCN(C2=CC=CC4=C2C(=O)N(C2CCC(=O)NC2=O)C4=O)CC1)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4770,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,770.836,770.3163083,2.67,56,7,12,2,8,194.79,C41H46N4O11,"InChI=1S/C41H46N4O11/c1-23(7-6-17-39(3)30-14-19-40(38(53)56-39)18-12-25(37(52)54-4)13-20-41(30,40)55-24(2)46)33(48)42-26-15-21-44(22-16-26)28-9-5-8-27-32(28)36(51)45(35(27)50)29-10-11-31(47)43-34(29)49/h5-9,12,17,26,29-30H,10-11,13-16,18-22H2,1-4H3,(H,42,48)(H,43,47,49)/b17-6+,23-7+/t29?,30-,39-,40-,41+/m1/s1",LMIYKUREKRMWNT-ZQUWOFLKSA-N
1858,,,>40000,,P35613,CD147,CRBN,,,COC(=O)C1=CC[C@]23CC[C@@H]([C@@]2(OC(C)=O)CC1)[C@@](C)(/C=C/C=C(\C)C(=O)N1CCC(NC2=CC=CC4=C2C(=O)N(C2CCC(=O)NC2=O)C4=O)CC1)OC3=O,Degradation of CD147 in Sk-Mel-28 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28860,Inhibit proliferation of Sk-Mel-28 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2020.104453,770.836,770.3163083,2.71,56,7,12,2,8,194.79,C41H46N4O11,"InChI=1S/C41H46N4O11/c1-23(7-6-17-39(3)30-14-19-40(38(53)56-39)18-12-25(37(52)54-4)13-20-41(30,40)55-24(2)46)34(49)44-21-15-26(16-22-44)42-28-9-5-8-27-32(28)36(51)45(35(27)50)29-10-11-31(47)43-33(29)48/h5-9,12,17,26,29-30,42H,10-11,13-16,18-22H2,1-4H3,(H,43,47,48)/b17-6+,23-7+/t29?,30-,39-,40-,41+/m1/s1",JRWNCELYFXURRI-ZQUWOFLKSA-N
1865,320,99,320,,O15379,HDAC3,CRBN,,HD-TAC7,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(NC(=O)CCCCNC(=O)CNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC3 in RAW 264.7 cells after 24 h treatment,,,1100,Inhibition of HDAC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112800,657.659,657.2347246,1.78,48,5,9,6,12,208.9,C33H32FN7O7,"InChI=1S/C33H32FN7O7/c34-19-9-12-23(22(35)16-19)39-30(45)18-7-10-20(11-8-18)38-26(42)6-1-2-15-36-28(44)17-37-24-5-3-4-21-29(24)33(48)41(32(21)47)25-13-14-27(43)40-31(25)46/h3-5,7-12,16,25,37H,1-2,6,13-15,17,35H2,(H,36,44)(H,38,42)(H,39,45)(H,40,43,46)",AMBNMDIPGZXRRW-UHFFFAOYSA-N
1995,0.51,80.4,0.51,80.4,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR del19 in HCC827 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.83,Inhibit proliferation of HCC827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,995.312,994.5363697,8.54,72,9,14,5,19,185.77,C55H70N12O4S,"InChI=1S/C55H70N12O4S/c1-37-48(72-36-58-37)39-21-19-38(20-22-39)33-56-51(70)46-32-44(68)35-66(46)52(71)49(55(2,3)4)62-47(69)18-10-5-6-13-27-64-28-30-65(31-29-64)42-25-23-41(24-26-42)59-53-57-34-45-50(63-53)67(43-16-11-12-17-43)54(61-45)60-40-14-8-7-9-15-40/h7-9,14-15,19-26,34,36,43-44,46,49,68H,5-6,10-13,16-18,27-33,35H2,1-4H3,(H,56,70)(H,60,61)(H,62,69)(H,57,59,63)/t44-,46+,49-/m1/s1",MCPFQJKJCFMAIH-CRHSMECVSA-N
1995,126.2,90.3,126.2,90.3,P00533,EGFR L858R/T790M,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR L858R/T790M in H1975 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,203,Inhibit proliferation of H1975 (EGFR L858R/T790M) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,995.312,994.5363697,8.54,72,9,14,5,19,185.77,C55H70N12O4S,"InChI=1S/C55H70N12O4S/c1-37-48(72-36-58-37)39-21-19-38(20-22-39)33-56-51(70)46-32-44(68)35-66(46)52(71)49(55(2,3)4)62-47(69)18-10-5-6-13-27-64-28-30-65(31-29-64)42-25-23-41(24-26-42)59-53-57-34-45-50(63-53)67(43-16-11-12-17-43)54(61-45)60-40-14-8-7-9-15-40/h7-9,14-15,19-26,34,36,43-44,46,49,68H,5-6,10-13,16-18,27-33,35H2,1-4H3,(H,56,70)(H,60,61)(H,62,69)(H,57,59,63)/t44-,46+,49-/m1/s1",MCPFQJKJCFMAIH-CRHSMECVSA-N
1996,3.54,74.8,3.54,74.8,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR del19 in HCC827 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.76,Inhibit proliferation of HCC827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,1009.339,1008.55202,9.08,73,9,14,5,20,185.77,C56H72N12O4S,"InChI=1S/C56H72N12O4S/c1-38-49(73-37-59-38)40-22-20-39(21-23-40)34-57-52(71)47-33-45(69)36-67(47)53(72)50(56(2,3)4)63-48(70)19-11-6-5-7-14-28-65-29-31-66(32-30-65)43-26-24-42(25-27-43)60-54-58-35-46-51(64-54)68(44-17-12-13-18-44)55(62-46)61-41-15-9-8-10-16-41/h8-10,15-16,20-27,35,37,44-45,47,50,69H,5-7,11-14,17-19,28-34,36H2,1-4H3,(H,57,71)(H,61,62)(H,63,70)(H,58,60,64)/t45-,47+,50-/m1/s1",OAEOAAWVWTZNON-KHDRDAPVSA-N
1996,151.2,80.3,151.2,80.3,P00533,EGFR L858R/T790M,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR L858R/T790M in H1975 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,970,Inhibit proliferation of H1975 (EGFR L858R/T790M) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,1009.339,1008.55202,9.08,73,9,14,5,20,185.77,C56H72N12O4S,"InChI=1S/C56H72N12O4S/c1-38-49(73-37-59-38)40-22-20-39(21-23-40)34-57-52(71)47-33-45(69)36-67(47)53(72)50(56(2,3)4)63-48(70)19-11-6-5-7-14-28-65-29-31-66(32-30-65)43-26-24-42(25-27-43)60-54-58-35-46-51(64-54)68(44-17-12-13-18-44)55(62-46)61-41-15-9-8-10-16-41/h8-10,15-16,20-27,35,37,44-45,47,50,69H,5-7,11-14,17-19,28-34,36H2,1-4H3,(H,57,71)(H,61,62)(H,63,70)(H,58,60,64)/t45-,47+,50-/m1/s1",OAEOAAWVWTZNON-KHDRDAPVSA-N
1998,1.91,82,1.91,82,P00533,EGFR e19d,CRBN,,,CN(CCOCCOCCOCCN1CCN(C2=CC=C(NC3=NC=C4N=C(NC5=CC=CC=C5)N(C5CCCC5)C4=N3)C=C2)CC1)CC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,Degradation of EGFR del19 in HCC827 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of HCC827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,943.123,942.4864423,3.67,69,9,16,4,22,200.65,C50H62N12O7,"InChI=1S/C50H62N12O7/c1-58(34-45(64)54-41-13-7-12-39-40(41)33-61(48(39)66)43-18-19-44(63)56-47(43)65)24-26-67-28-30-69-31-29-68-27-25-59-20-22-60(23-21-59)37-16-14-36(15-17-37)52-49-51-32-42-46(57-49)62(38-10-5-6-11-38)50(55-42)53-35-8-3-2-4-9-35/h2-4,7-9,12-17,32,38,43H,5-6,10-11,18-31,33-34H2,1H3,(H,53,55)(H,54,64)(H,51,52,57)(H,56,63,65)",YTBOHZLAPNSENZ-UHFFFAOYSA-N
2003,0.75,96,0.75,96,Q92793,CBP,CRBN,,dCBP-1,CNC(=O)N1CCC2=C(C1)C(N1CCCC3=CC(C4=CN(C)N=C4)=C(C(F)F)C=C31)=NN2C1CCN(C(=O)CCOCCOCCOCCOCCNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.8,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,1028.128,1027.472744,1.57,74,9,16,3,21,224.03,C51H63F2N11O10,"InChI=1S/C51H63F2N11O10/c1-54-51(70)61-17-11-41-40(31-61)47(62-14-3-4-32-26-37(33-29-56-59(2)30-33)38(46(52)53)28-43(32)62)58-64(41)35-9-15-60(16-10-35)45(66)12-18-71-20-22-73-24-25-74-23-21-72-19-13-55-34-5-6-36-39(27-34)50(69)63(49(36)68)42-7-8-44(65)57-48(42)67/h5-6,26-30,35,42,46,55H,3-4,7-25,31H2,1-2H3,(H,54,70)(H,57,65,67)",ILVRLRGBSSFKIE-UHFFFAOYSA-N
2003,1.85,90,1.85,90,Q09472,EP300,CRBN,,dCBP-1,CNC(=O)N1CCC2=C(C1)C(N1CCCC3=CC(C4=CN(C)N=C4)=C(C(F)F)C=C31)=NN2C1CCN(C(=O)CCOCCOCCOCCOCCNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,1028.128,1027.472744,1.57,74,9,16,3,21,224.03,C51H63F2N11O10,"InChI=1S/C51H63F2N11O10/c1-54-51(70)61-17-11-41-40(31-61)47(62-14-3-4-32-26-37(33-29-56-59(2)30-33)38(46(52)53)28-43(32)62)58-64(41)35-9-15-60(16-10-35)45(66)12-18-71-20-22-73-24-25-74-23-21-72-19-13-55-34-5-6-36-39(27-34)50(69)63(49(36)68)42-7-8-44(65)57-48(42)67/h5-6,26-30,35,42,46,55H,3-4,7-25,31H2,1-2H3,(H,54,70)(H,57,65,67)",ILVRLRGBSSFKIE-UHFFFAOYSA-N
2005,485,92,485,92,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,5,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,490,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,816.876,816.3343584,2.64,60,7,13,5,14,246.61,C42H44N10O8,"InChI=1S/C42H44N10O8/c1-23(2)48-30-18-33(51-16-13-26-17-24(19-43)20-47-37(26)51)46-21-29(30)39(56)49-27-9-7-25(8-10-27)38(55)45-15-4-14-44-35(54)22-60-32-6-3-5-28-36(32)42(59)52(41(28)58)31-11-12-34(53)50-40(31)57/h3,5-6,13,16-18,20-21,23,25,27,31H,4,7-12,14-15,22H2,1-2H3,(H,44,54)(H,45,55)(H,46,48)(H,49,56)(H,50,53,57)/t25-,27-,31?",DHVQDOJINANBTP-NYHQYBDOSA-N
2006,190,93,190,93,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,7,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,768,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,830.903,830.3500084,3,61,7,13,5,15,246.61,C43H46N10O8,"InChI=1S/C43H46N10O8/c1-24(2)49-31-19-34(52-17-14-27-18-25(20-44)21-48-38(27)52)47-22-30(31)40(57)50-28-10-8-26(9-11-28)39(56)46-16-4-3-15-45-36(55)23-61-33-7-5-6-29-37(33)43(60)53(42(29)59)32-12-13-35(54)51-41(32)58/h5-7,14,17-19,21-22,24,26,28,32H,3-4,8-13,15-16,23H2,1-2H3,(H,45,55)(H,46,56)(H,47,49)(H,50,57)(H,51,54,58)/t26-,28-,32?",HTWBTPRKNVRYHW-OAMJFVEXSA-N
2007,293,97,293,97,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,26,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,1030,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,844.93,844.3656585,3.36,62,7,13,5,16,246.61,C44H48N10O8,"InChI=1S/C44H48N10O8/c1-25(2)50-32-20-35(53-18-15-28-19-26(21-45)22-49-39(28)53)48-23-31(32)41(58)51-29-11-9-27(10-12-29)40(57)47-17-5-3-4-16-46-37(56)24-62-34-8-6-7-30-38(34)44(61)54(43(30)60)33-13-14-36(55)52-42(33)59/h6-8,15,18-20,22-23,25,27,29,33H,3-5,9-14,16-17,24H2,1-2H3,(H,46,56)(H,47,57)(H,48,50)(H,51,58)(H,52,55,59)/t27-,29-,33?",NOGGUZVPDPKPMG-SNOFGSQBSA-N
2008,405,90,405,90,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCOCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,7,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,609,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,846.902,846.3449231,2.14,62,7,14,5,16,255.84,C43H46N10O9,"InChI=1S/C43H46N10O9/c1-24(2)49-31-19-34(52-15-12-27-18-25(20-44)21-48-38(27)52)47-22-30(31)40(57)50-28-8-6-26(7-9-28)39(56)46-14-17-61-16-13-45-36(55)23-62-33-5-3-4-29-37(33)43(60)53(42(29)59)32-10-11-35(54)51-41(32)58/h3-5,12,15,18-19,21-22,24,26,28,32H,6-11,13-14,16-17,23H2,1-2H3,(H,45,55)(H,46,56)(H,47,49)(H,50,57)(H,51,54,58)/t26-,28-,32?",YNNBDJQWDDDBRU-OAMJFVEXSA-N
2009,7420,71,7420,71,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCOCCOCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,12,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,680,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,890.955,890.3711378,1.99,65,7,15,5,19,265.07,C45H50N10O10,"InChI=1S/C45H50N10O10/c1-26(2)51-33-21-36(54-15-12-29-20-27(22-46)23-50-40(29)54)49-24-32(33)42(59)52-30-8-6-28(7-9-30)41(58)48-14-17-64-19-18-63-16-13-47-38(57)25-65-35-5-3-4-31-39(35)45(62)55(44(31)61)34-10-11-37(56)53-43(34)60/h3-5,12,15,20-21,23-24,26,28,30,34H,6-11,13-14,16-19,25H2,1-2H3,(H,47,57)(H,48,58)(H,49,51)(H,52,59)(H,53,56,60)/t28-,30-,34?",OLRLOHZCSMMOCS-BVRPOGDGSA-N
2017,42,99,42,,O15379,HDAC3,VHL,,XZ9002,CCCNNC(=O)C1=CC=C(C2=CC=C(NC(=O)CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=C2)C=C1,Degradation of HDAC3 in MDA-MB-468 cells after 14 h treatment,,,350,IC50 was assessed by HDAC-Glot I/II Assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2570/3690/6140,Inhibit viability of MDA-MB-468/MDA-MB-231/T47D cells,,,,,,,,,,,,,,,10.1039/d0cc03243c,852.115,851.4404037,6.81,61,5,9,6,19,181.86,C47H61N7O6S,"InChI=1S/C47H61N7O6S/c1-7-26-49-53-44(58)36-20-16-33(17-21-36)34-22-24-37(25-23-34)51-40(56)12-10-8-9-11-13-41(57)52-43(47(4,5)6)46(60)54-28-38(55)27-39(54)45(59)50-30(2)32-14-18-35(19-15-32)42-31(3)48-29-61-42/h14-25,29-30,38-39,43,49,55H,7-13,26-28H2,1-6H3,(H,50,59)(H,51,56)(H,52,57)(H,53,58)/t30-,38+,39-,43+/m0/s1",INXGMIWEZJNJOA-NVZKIFIHSA-N
2038,5.1,95,5.1,>95,Q00534,CDK6,VHL,,CST651,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOC5=CC(C6=C(C)N=CS6)=CC=C5CNC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@@H](NC(=O)C5(F)CC5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in MM.1S cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,450,Inhibit viability of HEL cells,,,,,,,,,,,,,,,10.1039/d0sc00167h,1094.325,1093.521922,4.76,78,9,18,4,22,235.57,C56H72FN11O9S,"InChI=1S/C56H72FN11O9S/c1-34-42-31-60-54(64-49(42)68(39-9-7-8-10-39)51(72)46(34)36(3)69)62-45-14-13-40(30-58-45)66-19-17-65(18-20-66)21-22-75-23-24-76-25-26-77-44-27-37(47-35(2)61-33-78-47)11-12-38(44)29-59-50(71)43-28-41(70)32-67(43)52(73)48(55(4,5)6)63-53(74)56(57)15-16-56/h11-14,27,30-31,33,39,41,43,48,70H,7-10,15-26,28-29,32H2,1-6H3,(H,59,71)(H,63,74)(H,58,60,62,64)/t41-,43+,48-/m1/s1",WYPMPGWHIPETEB-VZUPZQALSA-N
2038,20,99,20,,P11802,CDK4,VHL,,CST651,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOC5=CC(C6=C(C)N=CS6)=CC=C5CNC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@@H](NC(=O)C5(F)CC5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in MM.1S cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,450,Inhibit viability of HEL cells,,,,,,,,,,,,,,,10.1039/d0sc00167h,1094.325,1093.521922,4.76,78,9,18,4,22,235.57,C56H72FN11O9S,"InChI=1S/C56H72FN11O9S/c1-34-42-31-60-54(64-49(42)68(39-9-7-8-10-39)51(72)46(34)36(3)69)62-45-14-13-40(30-58-45)66-19-17-65(18-20-66)21-22-75-23-24-76-25-26-77-44-27-37(47-35(2)61-33-78-47)11-12-38(44)29-59-50(71)43-28-41(70)32-67(43)52(73)48(55(4,5)6)63-53(74)56(57)15-16-56/h11-14,27,30-31,33,39,41,43,48,70H,7-10,15-26,28-29,32H2,1-6H3,(H,59,71)(H,63,74)(H,58,60,62,64)/t41-,43+,48-/m1/s1",WYPMPGWHIPETEB-VZUPZQALSA-N
2044,28,99,28,,O14965,AURKA,CRBN,,JB170,COC1=CC(NC2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)=CC=C1C(=O)NCCOCCOCCNC(=O)COC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of AURKA in MV4-11 cells after 6 h treatment,,,,,,,375,ITC,,,,,,,,,,,,,,,6880,ITC,,,,,,,,,,,,,,,183,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-00652-y,963.376,962.2802101,3.69,69,8,15,4,19,238.07,C48H44ClFN8O11,"InChI=1S/C48H44ClFN8O11/c1-65-35-7-4-6-33(50)41(35)43-32-21-27(49)9-11-29(32)42-26(23-53-43)24-54-48(57-42)55-28-10-12-30(37(22-28)66-2)44(61)52-16-18-68-20-19-67-17-15-51-39(60)25-69-36-8-3-5-31-40(36)47(64)58(46(31)63)34-13-14-38(59)56-45(34)62/h3-12,21-22,24,34H,13-20,23,25H2,1-2H3,(H,51,60)(H,52,61)(H,54,55,57)(H,56,59,62)",GYKNPXCQINZRLL-UHFFFAOYSA-N
2048,90,84,90,84,P15056,BRAF V600E,CRBN,,Pmd-PEG6-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,83,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1180,FP,,,,,,,,,,,,,,,3040,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1133.242,1132.44996,2.63,80,8,19,3,31,264.28,C54H66F2N10O13S,"InChI=1S/C54H66F2N10O13S/c1-3-31-80(72,73)62-42-8-7-40(55)51(49(42)56)65-34-39(36-32-57-35-58-33-36)50-43(65)9-11-45(60-50)63(2)37-13-17-64(18-14-37)47(68)15-19-74-21-23-76-25-27-78-29-30-79-28-26-77-24-22-75-20-16-59-41-6-4-5-38-48(41)54(71)66(53(38)70)44-10-12-46(67)61-52(44)69/h4-9,11,32-35,37,44,59,62H,3,10,12-31H2,1-2H3,(H,61,67,69)",PHBHADRVFSMQAN-UHFFFAOYSA-N
2049,45,65,45,65,P15056,BRAF V600E,CRBN,,Pmd-PEG8-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,85,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1070,FP,,,,,,,,,,,,,,,2980,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1221.348,1220.502389,2.34,86,8,21,3,37,282.74,C58H74F2N10O15S,"InChI=1S/C58H74F2N10O15S/c1-3-35-86(76,77)66-46-8-7-44(59)55(53(46)60)69-38-43(40-36-61-39-62-37-40)54-47(69)9-11-49(64-54)67(2)41-13-17-68(18-14-41)51(72)15-19-78-21-23-80-25-27-82-29-31-84-33-34-85-32-30-83-28-26-81-24-22-79-20-16-63-45-6-4-5-42-52(45)58(75)70(57(42)74)48-10-12-50(71)65-56(48)73/h4-9,11,36-39,41,48,63,66H,3,10,12-35H2,1-2H3,(H,65,71,73)",UGQUDUNSDGAZIO-UHFFFAOYSA-N
2050,100,51,100,51,P15056,BRAF V600E,CRBN,,Pmd-1C-PEG3-1C-2C-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCC(=O)NCCCOCCOCCOCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,82,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1010,FP,,,,,,,,,,,,,,,2460,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1100.216,1099.439729,3.04,78,8,17,4,27,265.69,C53H63F2N11O11S,"InChI=1S/C53H63F2N11O11S/c1-3-29-78(73,74)62-40-10-9-38(54)50(48(40)55)65-32-37(34-30-56-33-57-31-34)49-41(65)11-13-43(60-49)63(2)35-17-21-64(22-18-35)46(69)16-15-44(67)59-20-6-24-76-26-28-77-27-25-75-23-5-19-58-39-8-4-7-36-47(39)53(72)66(52(36)71)42-12-14-45(68)61-51(42)70/h4,7-11,13,30-33,35,42,58,62H,3,5-6,12,14-29H2,1-2H3,(H,59,67)(H,61,68,70)",GVOFKFUVWFBDKE-UHFFFAOYSA-N
2059,500,50,500,50,P15056,BRAF V600E,CRBN,,Pmd-PEG3-Dab#2,NC1=NC=CC(C2=C(C3=CC=CC(NS(=O)(=O)C4=C(F)C=CC=C4F)=C3F)N=C(C3CCN(C(=O)CCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)S2)=N1,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,26,Inhibition of BRAF V600E,,,2.6,SPR,,,,,,,1.8,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1006.055,1005.276115,3.07,70,8,16,4,20,254.44,C46H46F3N9O10S2,"InChI=1S/C46H46F3N9O10S2/c47-29-6-3-7-30(48)41(29)70(64,65)56-32-9-2-5-28(38(32)49)39-40(33-12-16-52-46(50)53-33)69-43(55-39)26-13-18-57(19-14-26)36(60)15-20-66-22-24-68-25-23-67-21-17-51-31-8-1-4-27-37(31)45(63)58(44(27)62)34-10-11-35(59)54-42(34)61/h1-9,12,16,26,34,51,56H,10-11,13-15,17-25H2,(H2,50,52,53)(H,54,59,61)",TTXCLAHYGSGCRI-UHFFFAOYSA-N
2063,25,71,25,71,P15056,BRAF V600E,CRBN,,Pmd-DODA-C1-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(CC(=O)NCCCOCCCCOCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,25,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1042.18,1041.43425,4.61,74,8,16,4,25,239.39,C51H61F2N11O9S,"InChI=1S/C51H61F2N11O9S/c1-3-27-74(70,71)60-39-12-11-37(52)48(46(39)53)63-30-36(33-28-54-32-55-29-33)47-40(63)13-15-42(58-47)61(2)34-17-21-62(22-18-34)31-44(66)57-20-8-26-73-24-5-4-23-72-25-7-19-56-38-10-6-9-35-45(38)51(69)64(50(35)68)41-14-16-43(65)59-49(41)67/h6,9-13,15,28-30,32,34,41,56,60H,3-5,7-8,14,16-27,31H2,1-2H3,(H,57,66)(H,59,65,67)",DAQQIWJQNSGFLU-UHFFFAOYSA-N
2064,80,72,80,72,P15056,BRAF V600E,CRBN,,Pmd-PEG1-Trz-PEG2-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCN5C=C(COCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,15,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1082.161,1081.404012,2.31,77,9,19,3,24,267.3,C51H57F2N13O10S,"InChI=1S/C51H57F2N13O10S/c1-3-25-77(72,73)60-39-8-7-37(52)48(46(39)53)65-29-36(32-26-54-31-55-27-32)47-40(65)9-11-42(57-47)62(2)34-13-17-63(18-14-34)44(68)15-20-74-23-24-75-22-19-64-28-33(59-61-64)30-76-21-16-56-38-6-4-5-35-45(38)51(71)66(50(35)70)41-10-12-43(67)58-49(41)69/h4-9,11,26-29,31,34,41,56,60H,3,10,12-25,30H2,1-2H3,(H,58,67,69)",VFSRJJPNEQKSQQ-UHFFFAOYSA-N
2065,50,74,50,74,P15056,BRAF V600E,CRBN,,Len(C)PEG4-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCC#CC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,90,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1026.133,1025.391716,2.64,73,8,15,2,22,216.72,C51H57F2N9O10S,"InChI=1S/C51H57F2N9O10S/c1-3-28-73(67,68)58-41-10-9-40(52)49(47(41)53)61-32-39(35-29-54-33-55-30-35)48-42(61)11-13-44(56-48)59(2)36-15-18-60(19-16-36)46(64)17-21-70-23-25-72-27-26-71-24-22-69-20-5-7-34-6-4-8-37-38(34)31-62(51(37)66)43-12-14-45(63)57-50(43)65/h4,6,8-11,13,29-30,32-33,36,43,58H,3,12,14-28,31H2,1-2H3,(H,57,63,65)",OURGGRRMESLKOS-UHFFFAOYSA-N
2067,800,99,800,,Q06187,BTK,cIAP1,6W7O,BCPyr,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC2=CC(OCC3=CN=C(COC(=O)N4CCC[C@@H](N5N=C(C6=CC=C(OC7=CC=C(F)C=C7F)C=C6)C(C(N)=O)=C5N)C4)C=N3)=CC=C2C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C(C)(C)C,Degradation of BTK in THP-1 cells,,,,,,,692,BLI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,262,BLI,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-00686-2,1082.223,1081.498564,6.05,79,9,14,5,16,251.25,C58H65F2N11O8,"InChI=1S/C58H65F2N11O8/c1-33(63-5)54(73)67-51(58(2,3)4)56(75)70-29-37-24-43(21-17-36(37)25-47(70)55(74)66-46-14-8-11-34-10-6-7-13-44(34)46)77-31-39-27-65-40(28-64-39)32-78-57(76)69-23-9-12-41(30-69)71-52(61)49(53(62)72)50(68-71)35-15-19-42(20-16-35)79-48-22-18-38(59)26-45(48)60/h6-7,10,13,15-22,24,26-28,33,41,46-47,51,63H,8-9,11-12,14,23,25,29-32,61H2,1-5H3,(H2,62,72)(H,66,74)(H,67,73)/t33-,41+,46+,47-,51+/m0/s1",PTEVOZUKHQQUNI-DLUJOBAXSA-N
2068,4700,99,4700,,Q06187,BTK,IAP,,BCPip,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=C(F)C=C2)=CS1)C1CCN(CCCC(=O)N2CCC[C@@H](N3N=C(C4=CC=C(OC5=CC=C(F)C=C5F)C=C4)C(C(N)=O)=C3N)C2)CC1,Degradation of BTK in THP-1 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13750,BLI,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-00686-2,983.131,982.4135352,5.47,70,8,13,4,17,211.11,C50H57F3N10O6S,"InChI=1S/C50H57F3N10O6S/c1-29(56-2)48(67)58-44(50(68)62-23-4-7-39(62)49-57-38(28-70-49)45(65)32-9-13-33(51)14-10-32)31-19-24-60(25-20-31)21-5-8-41(64)61-22-3-6-35(27-61)63-46(54)42(47(55)66)43(59-63)30-11-16-36(17-12-30)69-40-18-15-34(52)26-37(40)53/h9-18,26,28-29,31,35,39,44,56H,3-8,19-25,27,54H2,1-2H3,(H2,55,66)(H,58,67)/t29-,35+,39-,44-/m0/s1",AAKFJWJWMSEXFZ-MKGGXPFMSA-N
2071,1,99,22616,,P24941,CDK2,CRBN,,CPS2,CC1=C(C(=O)N2N=C(NC3=CC=C(S(=O)(=O)NCCOCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)C=C3)N=C2N)SC=C1,Degradation of CDK2 in Kasumi-1/NB4/MV-4-11 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-021-00742-5,890.962,890.2588275,2.19,62,7,20,5,21,285.98,C38H42N12O10S2,"InChI=1S/C38H42N12O10S2/c1-23-11-20-61-32(23)36(55)50-37(39)44-38(46-50)42-24-5-7-26(8-6-24)62(56,57)41-13-16-60-22-25-21-48(47-45-25)14-17-59-19-18-58-15-12-40-28-4-2-3-27-31(28)35(54)49(34(27)53)29-9-10-30(51)43-33(29)52/h2-8,11,20-21,29,40-41H,9-10,12-19,22H2,1H3,(H,43,51,52)(H3,39,42,44,46)",BXCPYBFBMAWDDY-UHFFFAOYSA-N
2071,4,99,160/4/9,,P24941,CDK2,CRBN,,CPS2,CC1=C(C(=O)N2N=C(NC3=CC=C(S(=O)(=O)NCCOCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)C=C3)N=C2N)SC=C1,Degradation of CDK2 in Pfeiffer/DOHH2/K562 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-021-00742-5,890.962,890.2588275,2.19,62,7,20,5,21,285.98,C38H42N12O10S2,"InChI=1S/C38H42N12O10S2/c1-23-11-20-61-32(23)36(55)50-37(39)44-38(46-50)42-24-5-7-26(8-6-24)62(56,57)41-13-16-60-22-25-21-48(47-45-25)14-17-59-19-18-58-15-12-40-28-4-2-3-27-31(28)35(54)49(34(27)53)29-9-10-30(51)43-33(29)52/h2-8,11,20-21,29,40-41H,9-10,12-19,22H2,1H3,(H,43,51,52)(H3,39,42,44,46)",BXCPYBFBMAWDDY-UHFFFAOYSA-N
2071,8,99,08 22,,P24941,CDK2,CRBN,,CPS2,CC1=C(C(=O)N2N=C(NC3=CC=C(S(=O)(=O)NCCOCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)C=C3)N=C2N)SC=C1,Degradation of CDK2 in MM.1S/MDA-MB-231 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-021-00742-5,890.962,890.2588275,2.19,62,7,20,5,21,285.98,C38H42N12O10S2,"InChI=1S/C38H42N12O10S2/c1-23-11-20-61-32(23)36(55)50-37(39)44-38(46-50)42-24-5-7-26(8-6-24)62(56,57)41-13-16-60-22-25-21-48(47-45-25)14-17-59-19-18-58-15-12-40-28-4-2-3-27-31(28)35(54)49(34(27)53)29-9-10-30(51)43-33(29)52/h2-8,11,20-21,29,40-41H,9-10,12-19,22H2,1H3,(H,43,51,52)(H3,39,42,44,46)",BXCPYBFBMAWDDY-UHFFFAOYSA-N
2071,11,99,38/53/11,,P24941,CDK2,CRBN,,CPS2,CC1=C(C(=O)N2N=C(NC3=CC=C(S(=O)(=O)NCCOCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)C=C3)N=C2N)SC=C1,Degradation of CDK2 in Jurkat/MOLT-4/U937 cells after 48 h treatment,,,24,Inhibition of CDK2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-021-00742-5,890.962,890.2588275,2.19,62,7,20,5,21,285.98,C38H42N12O10S2,"InChI=1S/C38H42N12O10S2/c1-23-11-20-61-32(23)36(55)50-37(39)44-38(46-50)42-24-5-7-26(8-6-24)62(56,57)41-13-16-60-22-25-21-48(47-45-25)14-17-59-19-18-58-15-12-40-28-4-2-3-27-31(28)35(54)49(34(27)53)29-9-10-30(51)43-33(29)52/h2-8,11,20-21,29,40-41H,9-10,12-19,22H2,1H3,(H,43,51,52)(H3,39,42,44,46)",BXCPYBFBMAWDDY-UHFFFAOYSA-N
2071,13,99,56/13/18,,P24941,CDK2,CRBN,,CPS2,CC1=C(C(=O)N2N=C(NC3=CC=C(S(=O)(=O)NCCOCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)C=C3)N=C2N)SC=C1,Degradation of CDK2 in OCI-AML2/OCI-AML3/Ramos cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-021-00742-5,890.962,890.2588275,2.19,62,7,20,5,21,285.98,C38H42N12O10S2,"InChI=1S/C38H42N12O10S2/c1-23-11-20-61-32(23)36(55)50-37(39)44-38(46-50)42-24-5-7-26(8-6-24)62(56,57)41-13-16-60-22-25-21-48(47-45-25)14-17-59-19-18-58-15-12-40-28-4-2-3-27-31(28)35(54)49(34(27)53)29-9-10-30(51)43-33(29)52/h2-8,11,20-21,29,40-41H,9-10,12-19,22H2,1H3,(H,43,51,52)(H3,39,42,44,46)",BXCPYBFBMAWDDY-UHFFFAOYSA-N
2071,29,99,43/33/29,,P24941,CDK2,CRBN,,CPS2,CC1=C(C(=O)N2N=C(NC3=CC=C(S(=O)(=O)NCCOCC4=CN(CCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)C=C3)N=C2N)SC=C1,Degradation of CDK2 in Z138/HBL-1/Mino cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-021-00742-5,890.962,890.2588275,2.19,62,7,20,5,21,285.98,C38H42N12O10S2,"InChI=1S/C38H42N12O10S2/c1-23-11-20-61-32(23)36(55)50-37(39)44-38(46-50)42-24-5-7-26(8-6-24)62(56,57)41-13-16-60-22-25-21-48(47-45-25)14-17-59-19-18-58-15-12-40-28-4-2-3-27-31(28)35(54)49(34(27)53)29-9-10-30(51)43-33(29)52/h2-8,11,20-21,29,40-41H,9-10,12-19,22H2,1H3,(H,43,51,52)(H3,39,42,44,46)",BXCPYBFBMAWDDY-UHFFFAOYSA-N
2073,6.8,95,6.8,95,P15056,BRAF V600E,VHL,,SJF-0628,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,Degradation of BRAF V600E in SK-MEL-28 cells,,,1.87/24.4,IC50 was assessed by radio labeled kinase assay/Elisa Kinase inhibition Assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37/218,Inhibit growth of SK-MEL-28/SK-MEL-239 C4 cells,,,,,,,,,,,,,10.1038/s41467-021-21159-7,1010.203,1009.379044,6.39,71,8,12,5,16,210.03,C51H57F2N9O7S2,"InChI=1S/C51H57F2N9O7S2/c1-6-21-71(68,69)59-40-16-15-39(52)43(44(40)53)45(65)38-26-55-48-37(38)22-34(25-54-48)32-11-13-35(14-12-32)61-19-17-60(18-20-61)28-42(64)58-47(51(3,4)5)50(67)62-27-36(63)23-41(62)49(66)56-24-31-7-9-33(10-8-31)46-30(2)57-29-70-46/h7-16,22,25-26,29,36,41,47,59,63H,6,17-21,23-24,27-28H2,1-5H3,(H,54,55)(H,56,66)(H,58,64)/t36-,41+,47-/m1/s1",MBCAVOCJJAQHHT-FGUOTCRGSA-N
2073,15,95,15,95,P15056,BRAF G469A,VHL,,SJF-0628,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,Degradation of BRAF G469A in SK-MEL-246 cells,,,0.98,IC50 was assessed by radio labeled kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45,Inhibit growth of SK-MEL-246 cells,,,,,,,,,,,,,10.1038/s41467-021-21159-7,1010.203,1009.379044,6.39,71,8,12,5,16,210.03,C51H57F2N9O7S2,"InChI=1S/C51H57F2N9O7S2/c1-6-21-71(68,69)59-40-16-15-39(52)43(44(40)53)45(65)38-26-55-48-37(38)22-34(25-54-48)32-11-13-35(14-12-32)61-19-17-60(18-20-61)28-42(64)58-47(51(3,4)5)50(67)62-27-36(63)23-41(62)49(66)56-24-31-7-9-33(10-8-31)46-30(2)57-29-70-46/h7-16,22,25-26,29,36,41,47,59,63H,6,17-21,23-24,27-28H2,1-5H3,(H,54,55)(H,56,66)(H,58,64)/t36-,41+,47-/m1/s1",MBCAVOCJJAQHHT-FGUOTCRGSA-N
2073,23,80,29/23,80/90,P15056,BRAF G466V,VHL,,SJF-0628,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,Degradation of BRAF G466V in H1666/CAL-12T cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-21159-7,1010.203,1009.379044,6.39,71,8,12,5,16,210.03,C51H57F2N9O7S2,"InChI=1S/C51H57F2N9O7S2/c1-6-21-71(68,69)59-40-16-15-39(52)43(44(40)53)45(65)38-26-55-48-37(38)22-34(25-54-48)32-11-13-35(14-12-32)61-19-17-60(18-20-61)28-42(64)58-47(51(3,4)5)50(67)62-27-36(63)23-41(62)49(66)56-24-31-7-9-33(10-8-31)46-30(2)57-29-70-46/h7-16,22,25-26,29,36,41,47,59,63H,6,17-21,23-24,27-28H2,1-5H3,(H,54,55)(H,56,66)(H,58,64)/t36-,41+,47-/m1/s1",MBCAVOCJJAQHHT-FGUOTCRGSA-N
2076,6.6,99,6.6,,Q06187,BTK,CRBN,,,CN(CCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,Degradation of BTK in MOLM-14 cells after 24 h treatment,,,43,Target Engagement IC50 was assessed by NanoBRET assay,,,6.4,Kd was assessed by Eurofins DiscoverX,,,,,,,,,,,250,Target Engagement IC50 was assessed by NanoBRET assay,,,4214,Kd was assessed based on fluorescence quenching after compounds binding to CRBN,,,,,,,,,,,,,,,,,,,,,,,,,,,309/82,Inhibit viability of MOLM-14/Mino cells,,,,,,,,,,,,,,,10.1038/s41467-020-17997-6,907.005,906.3925419,3.93,67,8,15,4,15,250.87,C48H50N12O7,"InChI=1S/C48H50N12O7/c1-48(2,57(3)22-9-21-51-38(62)26-52-35-14-7-13-34-39(35)47(66)59(46(34)65)36-19-20-37(61)55-44(36)63)24-30(25-49)45(64)58-23-8-10-31(27-58)60-43-40(42(50)53-28-54-43)41(56-60)29-15-17-33(18-16-29)67-32-11-5-4-6-12-32/h4-7,11-18,24,28,31,36,52H,8-10,19-23,26-27H2,1-3H3,(H,51,62)(H2,50,53,54)(H,55,61,63)/b30-24+/t31-,36?/m1/s1",TXZDWTVEZQSZKM-ZLCUCVQPSA-N
2100,5400,99,5400,,P09874,PARP1,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)CCCCCCCCCCNC(=O)C4=CC(CC5=N[NH]C(=O)C6=CC=CC=C56)=CC=C4F)C=CC=C3C2=O)C(=O)N1,Degradation of PARP1 in SW620 cells after 24 h treatment,,,54.7,Inhibition of PARP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2900,Inhibit proliferation of SW620 cells,,,,,,,,,,,,,,,10.1080/14756366.2020.1804382,722.818,722.3228113,4.83,53,6,7,4,16,170.43,C40H43FN6O6,"InChI=1S/C40H43FN6O6/c41-31-18-17-25(23-33-26-12-8-9-13-27(26)38(51)46-45-33)22-29(31)37(50)42-21-10-6-4-2-1-3-5-7-16-35(48)43-32-15-11-14-28-30(32)24-47(40(28)53)34-19-20-36(49)44-39(34)52/h8-9,11-15,17-18,22,34H,1-7,10,16,19-21,23-24H2,(H,42,50)(H,43,48)(H,46,51)(H,44,49,52)",QFFHUSYJWPTYGI-UHFFFAOYSA-N
2101,6200,99,6200,,P09874,PARP1,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)CCCCCCCCCCCNC(=O)C4=CC(CC5=N[NH]C(=O)C6=CC=CC=C56)=CC=C4F)C=CC=C3C2=O)C(=O)N1,Degradation of PARP1 in SW620 cells after 24 h treatment,,,20.7,Inhibition of PARP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1080/14756366.2020.1804382,736.845,736.3384614,5.38,54,6,7,4,17,170.43,C41H45FN6O6,"InChI=1S/C41H45FN6O6/c42-32-19-18-26(24-34-27-13-9-10-14-28(27)39(52)47-46-34)23-30(32)38(51)43-22-11-7-5-3-1-2-4-6-8-17-36(49)44-33-16-12-15-29-31(33)25-48(41(29)54)35-20-21-37(50)45-40(35)53/h9-10,12-16,18-19,23,35H,1-8,11,17,20-22,24-25H2,(H,43,51)(H,44,49)(H,47,52)(H,45,50,53)",ILGXZNUUIJTUAT-UHFFFAOYSA-N
2102,370,99,370,,P10275,AR-V7,VHL,,MTX-23,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCNC(=O)COC3=C(F)C(F)=CC=C3C3=CSC(N4CCOCC4)=N3)C(C)(C)C)C=C2)SC=N1,Degradation of AR-V7 in 22Rv1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1158/1535-7163.MCT-20-0417,882.069,881.3415955,5.35,61,6,12,4,16,175.32,C43H53F2N7O7S2,"InChI=1S/C43H53F2N7O7S2/c1-25(27-9-11-28(12-10-27)38-26(2)47-24-61-38)48-40(56)33-20-29(53)21-52(33)41(57)39(43(3,4)5)50-34(54)8-6-7-15-46-35(55)22-59-37-30(13-14-31(44)36(37)45)32-23-60-42(49-32)51-16-18-58-19-17-51/h9-14,23-25,29,33,39,53H,6-8,15-22H2,1-5H3,(H,46,55)(H,48,56)(H,50,54)/t25-,29+,33-,39+/m0/s1",JOZGICGAZBMCJF-JMSDHYLISA-N
2102,2000,99,2000,,P10275,AR,VHL,,MTX-23,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCNC(=O)COC3=C(F)C(F)=CC=C3C3=CSC(N4CCOCC4)=N3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in 22Rv1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1158/1535-7163.MCT-20-0417,882.069,881.3415955,5.35,61,6,12,4,16,175.32,C43H53F2N7O7S2,"InChI=1S/C43H53F2N7O7S2/c1-25(27-9-11-28(12-10-27)38-26(2)47-24-61-38)48-40(56)33-20-29(53)21-52(33)41(57)39(43(3,4)5)50-34(54)8-6-7-15-46-35(55)22-59-37-30(13-14-31(44)36(37)45)32-23-60-42(49-32)51-16-18-58-19-17-51/h9-14,23-25,29,33,39,53H,6-8,15-22H2,1-5H3,(H,46,55)(H,48,56)(H,50,54)/t25-,29+,33-,39+/m0/s1",JOZGICGAZBMCJF-JMSDHYLISA-N
2119,0.5,99,0.5,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC(CCN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)CC4)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,3.3,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,775.974,775.4333648,4.77,57,9,9,2,9,121.01,C44H54FN9O3,"InChI=1S/C44H54FN9O3/c1-28-22-35-34-6-4-5-7-36(34)48-39(35)40(54(28)27-44(2,3)45)31-24-46-43(47-25-31)52-16-13-29(14-17-52)12-15-50-18-20-51(21-19-50)32-8-9-33-30(23-32)26-53(42(33)57)37-10-11-38(55)49-41(37)56/h4-9,23-25,28-29,37,40,48H,10-22,26-27H2,1-3H3,(H,49,55,56)/t28-,37?,40-/m1/s1",IJEJPRVUJLKGAE-PBHRBXGSSA-N
2120,0.5,99,0.5,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC(OCCN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)CC4)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,2.1,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,791.973,791.4282794,4.08,58,9,10,2,10,130.24,C44H54FN9O4,"InChI=1S/C44H54FN9O4/c1-28-22-35-34-6-4-5-7-36(34)48-39(35)40(54(28)27-44(2,3)45)30-24-46-43(47-25-30)52-14-12-32(13-15-52)58-21-20-50-16-18-51(19-17-50)31-8-9-33-29(23-31)26-53(42(33)57)37-10-11-38(55)49-41(37)56/h4-9,23-25,28,32,37,40,48H,10-22,26-27H2,1-3H3,(H,49,55,56)/t28-,37?,40-/m1/s1",BHDSLVZMGDLJHY-PBHRBXGSSA-N
2121,0.6,99,0.6,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(OCCCCCN3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C=C2F)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,3.7,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,784.924,784.3923888,6.18,57,8,7,2,12,101.22,C44H51F3N6O4,"InChI=1S/C44H51F3N6O4/c1-27-21-33-32-9-5-6-10-36(32)48-40(33)41(53(27)26-44(2,3)47)39-34(45)23-30(24-35(39)46)57-20-8-4-7-15-50-16-18-51(19-17-50)29-11-12-31-28(22-29)25-52(43(31)56)37-13-14-38(54)49-42(37)55/h5-6,9-12,22-24,27,37,41,48H,4,7-8,13-21,25-26H2,1-3H3,(H,49,54,55)/t27-,37?,41-/m1/s1",WORXJAUBQRKOSP-RAEIRWBESA-N
2122,0.6,99,0.6,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC(CN4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)CC4)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,5.6,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,859.108,858.5068641,5.2,63,10,10,2,10,124.25,C49H63FN10O3,"InChI=1S/C49H63FN10O3/c1-32-24-40-39-6-4-5-7-41(39)53-44(40)45(60(32)31-49(2,3)50)36-26-51-48(52-27-36)58-18-14-34(15-19-58)29-56-22-20-55(21-23-56)28-33-12-16-57(17-13-33)37-8-9-38-35(25-37)30-59(47(38)63)42-10-11-43(61)54-46(42)62/h4-9,25-27,32-34,42,45,53H,10-24,28-31H2,1-3H3,(H,54,61,62)/t32-,42?,45-/m1/s1",YPOGTJVZKIJFOH-OOAKFHKVSA-N
2123,0.8,99,0.8,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC4(CCN(CCC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)CC4)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,22.3,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,844.093,843.4959651,6.09,62,10,9,2,9,121.01,C49H62FN9O3,"InChI=1S/C49H62FN9O3/c1-32-26-39-38-6-4-5-7-40(38)53-43(39)44(59(32)31-48(2,3)50)35-28-51-47(52-29-35)57-24-17-49(18-25-57)15-22-55(23-16-49)19-12-33-13-20-56(21-14-33)36-8-9-37-34(27-36)30-58(46(37)62)41-10-11-42(60)54-45(41)61/h4-9,27-29,32-33,41,44,53H,10-26,30-31H2,1-3H3,(H,54,60,61)/t32-,41?,44-/m1/s1",KTYXNZWFRVLYAQ-GNDFOHGCSA-N
2124,0.4,99,0.4,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC(CCN4CCC5(CC4)CCN(C4=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C4)CC5)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,1.2,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,844.093,843.4959651,6.09,62,10,9,2,9,121.01,C49H62FN9O3,"InChI=1S/C49H62FN9O3/c1-32-26-39-38-6-4-5-7-40(38)53-43(39)44(59(32)31-48(2,3)50)35-28-51-47(52-29-35)57-20-13-33(14-21-57)12-19-55-22-15-49(16-23-55)17-24-56(25-18-49)36-8-9-37-34(27-36)30-58(46(37)62)41-10-11-42(60)54-45(41)61/h4-9,27-29,32-33,41,44,53H,10-26,30-31H2,1-3H3,(H,54,60,61)/t32-,41?,44-/m1/s1",VYWJZVLGTNXMPM-GNDFOHGCSA-N
2125,0.4,99,0.4,,P03372,ER,CRBN,,,COC1=CC(N2CCN(CCC3CCN(C4=NC=C([C@@H]5C6=C(C[C@@H](C)N5CC(C)(C)F)C5=CC=CC=C5[NH]6)C=N4)CC3)CC2)=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2,Degradation of ERalpha in MCF-7 cells,,,1.5,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,806,805.4439295,4.74,59,9,10,2,10,130.24,C45H56FN9O4,"InChI=1S/C45H56FN9O4/c1-28-21-34-33-7-5-6-8-35(33)49-40(34)41(55(28)27-45(2,3)46)31-24-47-44(48-25-31)53-15-12-29(13-16-53)11-14-51-17-19-52(20-18-51)32-22-30-26-54(36-9-10-38(56)50-42(36)57)43(58)39(30)37(23-32)59-4/h5-8,22-25,28-29,36,41,49H,9-21,26-27H2,1-4H3,(H,50,56,57)/t28-,36?,41-/m1/s1",UVOLQWHYZGQCTM-DKTPKOOQSA-N
2126,0.4,99,0.4,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC(CN4CCOC5(CC4)CCN(C4=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C4)CC5)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,5.3,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,846.065,845.4752296,5,62,10,10,2,8,130.24,C48H60FN9O4,"InChI=1S/C48H60FN9O4/c1-31-24-38-37-6-4-5-7-39(37)52-42(38)43(58(31)30-47(2,3)49)34-26-50-46(51-27-34)56-17-12-32(13-18-56)28-54-19-14-48(62-23-22-54)15-20-55(21-16-48)35-8-9-36-33(25-35)29-57(45(36)61)40-10-11-41(59)53-44(40)60/h4-9,25-27,31-32,40,43,52H,10-24,28-30H2,1-3H3,(H,53,59,60)/t31-,40?,43-/m1/s1",ZDKSTADPBFKRTK-VZGKAOHESA-N
2127,0.5,99,0.5,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC(CCN4CCOC5(CC4)CCN(C4=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C4)CC5)CC3)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,2,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,860.092,859.4908797,5.35,63,10,10,2,9,130.24,C49H62FN9O4,"InChI=1S/C49H62FN9O4/c1-32-26-39-38-6-4-5-7-40(38)53-43(39)44(59(32)31-48(2,3)50)35-28-51-47(52-29-35)57-19-13-33(14-20-57)12-18-55-21-15-49(63-25-24-55)16-22-56(23-17-49)36-8-9-37-34(27-36)30-58(46(37)62)41-10-11-42(60)54-45(41)61/h4-9,27-29,32-33,41,44,53H,10-26,30-31H2,1-3H3,(H,54,60,61)/t32-,41?,44-/m1/s1",LRCKXZMRGJWXQI-GNDFOHGCSA-N
2128,0.4,99,0.4,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(N3CCC4(CC3)CC(CN3CC5(CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C3)C4)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,1.9,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,842.077,841.480315,5.62,62,11,9,2,8,121.01,C49H60FN9O3,"InChI=1S/C49H60FN9O3/c1-31-20-38-37-6-4-5-7-39(37)53-42(38)43(59(31)28-47(2,3)50)34-24-51-46(52-25-34)57-18-12-48(13-19-57)22-32(23-48)26-55-29-49(30-55)14-16-56(17-15-49)35-8-9-36-33(21-35)27-58(45(36)62)40-10-11-41(60)54-44(40)61/h4-9,21,24-25,31-32,40,43,53H,10-20,22-23,26-30H2,1-3H3,(H,54,60,61)/t31-,40?,43-/m1/s1",QFRXPTNFPOHCTQ-VZGKAOHESA-N
2129,0.7,99,0.7,,P03372,ER,CRBN,,,COC1=CC(N2CCN(CC3CCN(C4=NC=C([C@@H]5C6=C(C[C@@H](C)N5CC(C)(C)F)C5=CC=CC=C5[NH]6)C=N4)CC3)CC2)=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2,Degradation of ERalpha in MCF-7 cells,,,3.2,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,791.973,791.4282794,4.39,58,9,10,2,9,130.24,C44H54FN9O4,"InChI=1S/C44H54FN9O4/c1-27-19-33-32-7-5-6-8-34(32)48-39(33)40(54(27)26-44(2,3)45)30-22-46-43(47-23-30)52-13-11-28(12-14-52)24-50-15-17-51(18-16-50)31-20-29-25-53(35-9-10-37(55)49-41(35)56)42(57)38(29)36(21-31)58-4/h5-8,20-23,27-28,35,40,48H,9-19,24-26H2,1-4H3,(H,49,55,56)/t27-,35?,40-/m1/s1",HWCUOPSCISMUJK-IXGPZBLMSA-N
2130,0.4,99,0.4,,P03372,ER,CRBN,,,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CN=C(OC3CCC4(CC3)CCN(CC3CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)CC3)CC4)N=C2)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 cells,,,2.2,IC50 of ERalpha was assessed by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00589,845.077,844.4799807,6.36,62,10,9,2,9,127,C49H61FN8O4,"InChI=1S/C49H61FN8O4/c1-31-24-39-38-6-4-5-7-40(38)53-43(39)44(58(31)30-48(2,3)50)34-26-51-47(52-27-34)62-36-12-16-49(17-13-36)18-22-55(23-19-49)28-32-14-20-56(21-15-32)35-8-9-37-33(25-35)29-57(46(37)61)41-10-11-42(59)54-45(41)60/h4-9,25-27,31-32,36,41,44,53H,10-24,28-30H2,1-3H3,(H,54,59,60)/t31-,41?,44-/m1/s1",YVQDCQVRYNZDBP-MPNICMQISA-N
2131,26,99,26,99,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(OCCN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.44,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-11-12-34(28-53-46(63)40-26-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(25-33)67-23-15-32-9-13-36(14-10-32)66-24-22-58-18-20-59(21-19-58)39-27-38(56-57-45(39)52)37-7-5-6-8-41(37)62/h5-14,25,27,30,35,40,44,61-62H,15-24,26,28-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",CVBRBVVZZZJXQO-HOPMZIQWSA-N
2131,41,99,41,99,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(OCCN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.44,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-11-12-34(28-53-46(63)40-26-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(25-33)67-23-15-32-9-13-36(14-10-32)66-24-22-58-18-20-59(21-19-58)39-27-38(56-57-45(39)52)37-7-5-6-8-41(37)62/h5-14,25,27,30,35,40,44,61-62H,15-24,26,28-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",CVBRBVVZZZJXQO-HOPMZIQWSA-N
2132,16,99.9,16,100,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.34,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-12-13-34(27-53-46(63)40-25-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(24-33)67-23-7-22-66-36-14-10-32(11-15-36)28-58-18-20-59(21-19-58)39-26-38(56-57-45(39)52)37-8-5-6-9-41(37)62/h5-6,8-15,24,26,30,35,40,44,61-62H,7,16-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",LPYXXDVKMQAWIP-HOPMZIQWSA-N
2132,26,99,26,99,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.34,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-12-13-34(27-53-46(63)40-25-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(24-33)67-23-7-22-66-36-14-10-32(11-15-36)28-58-18-20-59(21-19-58)39-26-38(56-57-45(39)52)37-8-5-6-9-41(37)62/h5-6,8-15,24,26,30,35,40,44,61-62H,7,16-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",LPYXXDVKMQAWIP-HOPMZIQWSA-N
2133,25,92,25,92,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,934.152,933.4371299,5.63,67,8,13,5,16,199.37,C50H60FN9O6S,"InChI=1S/C50H60FN9O6S/c1-31-43(67-30-54-31)34-15-16-35(27-53-46(63)40-25-36(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)17-18-50)42(24-34)66-23-7-8-32-11-13-33(14-12-32)28-58-19-21-59(22-20-58)39-26-38(56-57-45(39)52)37-9-5-6-10-41(37)62/h5-6,9-16,24,26,30,36,40,44,61-62H,7-8,17-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t36-,40+,44-/m1/s1",KKFAKGWHXAANIL-OTIWGHMISA-N
2133,58,90,58,90,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,934.152,933.4371299,5.63,67,8,13,5,16,199.37,C50H60FN9O6S,"InChI=1S/C50H60FN9O6S/c1-31-43(67-30-54-31)34-15-16-35(27-53-46(63)40-25-36(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)17-18-50)42(24-34)66-23-7-8-32-11-13-33(14-12-32)28-58-19-21-59(22-20-58)39-26-38(56-57-45(39)52)37-9-5-6-10-41(37)62/h5-6,9-16,24,26,30,36,40,44,61-62H,7-8,17-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t36-,40+,44-/m1/s1",KKFAKGWHXAANIL-OTIWGHMISA-N
2134,33,95,33,95,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C(F)=C3)=C2)SC=N1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,938.115,937.412058,5.37,67,8,13,5,15,199.37,C49H57F2N9O6S,"InChI=1S/C49H57F2N9O6S/c1-29-42(67-28-54-29)31-11-12-32(25-53-45(63)39-23-34(61)27-60(39)46(64)43(48(2,3)4)55-47(65)49(51)14-15-49)41(22-31)66-20-13-30-9-10-33(36(50)21-30)26-58-16-18-59(19-17-58)38-24-37(56-57-44(38)52)35-7-5-6-8-40(35)62/h5-12,21-22,24,28,34,39,43,61-62H,13-20,23,25-27H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t34-,39+,43-/m1/s1",TWFCHBNLUUPMHG-SQKKEFIPSA-N
2134,55,95,55,95,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C(F)=C3)=C2)SC=N1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,938.115,937.412058,5.37,67,8,13,5,15,199.37,C49H57F2N9O6S,"InChI=1S/C49H57F2N9O6S/c1-29-42(67-28-54-29)31-11-12-32(25-53-45(63)39-23-34(61)27-60(39)46(64)43(48(2,3)4)55-47(65)49(51)14-15-49)41(22-31)66-20-13-30-9-10-33(36(50)21-30)26-58-16-18-59(19-17-58)38-24-37(56-57-44(38)52)35-7-5-6-8-40(35)62/h5-12,21-22,24,28,34,39,43,61-62H,13-20,23,25-27H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t34-,39+,43-/m1/s1",TWFCHBNLUUPMHG-SQKKEFIPSA-N
2209,27.4,99,27.4/116.5,,Q9UM73,ALK,CRBN,,,CCC1=CC2=C(C=C1N1CCN(C(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of ALK in H3122/Karpas 299 cells after 16/48 h treatment,,,13.63,IC50 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,62/42,Inhibit proliferation of H3122/Karpas 299 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00270,711.779,711.2805319,4.77,53,8,9,3,6,175.78,C40H37N7O6,"InChI=1S/C40H37N7O6/c1-4-22-17-25-26(40(2,3)36-34(35(25)50)23-9-8-21(19-41)16-28(23)43-36)18-30(22)45-12-14-46(15-13-45)32(49)20-42-27-7-5-6-24-33(27)39(53)47(38(24)52)29-10-11-31(48)44-37(29)51/h5-9,16-18,29,42-43H,4,10-15,20H2,1-3H3,(H,44,48,51)",UMEMOEKJTJMMJN-UHFFFAOYSA-N
2217,6.1,87.7,6.1,87.7,Q9UM73,ALK,CRBN,,SIAIS091,CCC1=CC2=C(C=C1N1CCC(N3CCN(C(=O)CNC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of ALK in SR cells,,,4.7,Inhibition of ALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.5,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113335,780.93,780.3747666,4.86,58,9,9,3,7,161.95,C45H48N8O5,"InChI=1S/C45H48N8O5/c1-4-27-21-31-33(45(2,3)42-40(41(31)56)30-9-8-26(23-46)20-35(30)48-42)22-37(27)51-14-12-28(13-15-51)50-16-18-52(19-17-50)39(55)24-47-34-7-5-6-29-32(34)25-53(44(29)58)36-10-11-38(54)49-43(36)57/h5-9,20-22,28,36,47-48H,4,10-19,24-25H2,1-3H3,(H,49,54,57)",BWJIJVUAQRLZRJ-UHFFFAOYSA-N
2222,3.9,70.3,3.9,70.3,Q9UM73,ALK,CRBN,,SIAIS001,CCC1=CC2=C(C=C1N1CCC(N3CCN(CCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of ALK in SR cells,,,3.3,Inhibition of ALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.9,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113335,789.981,789.4002531,6.4,59,9,8,2,7,132.85,C48H51N7O4,"InChI=1S/C48H51N7O4/c1-4-31-26-36-38(48(2,3)45-43(44(36)57)35-13-12-30(28-49)25-39(35)50-45)27-41(31)54-19-16-33(17-20-54)53-23-21-52(22-24-53)18-7-5-6-9-32-10-8-11-34-37(32)29-55(47(34)59)40-14-15-42(56)51-46(40)58/h8,10-13,25-27,33,40,50H,4-5,7,14-24,29H2,1-3H3,(H,51,56,58)",OGAOHACYLUBWJQ-UHFFFAOYSA-N
2222,200,99,200,,Q9UM73,ALK G1202R,CRBN,,SIAIS001,CCC1=CC2=C(C=C1N1CCC(N3CCN(CCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of ALK G1202R in 293T cells,,,94.6,Inhibition of ALK G1202R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.9,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113335,789.981,789.4002531,6.4,59,9,8,2,7,132.85,C48H51N7O4,"InChI=1S/C48H51N7O4/c1-4-31-26-36-38(48(2,3)45-43(44(36)57)35-13-12-30(28-49)25-39(35)50-45)27-41(31)54-19-16-33(17-20-54)53-23-21-52(22-24-53)18-7-5-6-9-32-10-8-11-34-37(32)29-55(47(34)59)40-14-15-42(56)51-46(40)58/h8,10-13,25-27,33,40,50H,4-5,7,14-24,29H2,1-3H3,(H,51,56,58)",OGAOHACYLUBWJQ-UHFFFAOYSA-N
2231,30,99,30-50/100,,P00533,EGFR L858R/T790M,CRBN,,SIAIS125,C=CC(=O)NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCN(C(=O)CCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EGFR L858R/T790M in H1975/(Ba/F3) cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22.1/71.27,Inhibit proliferation of H1975/(Ba/F3) cells expressing EGFR L858R/T790M,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113328,854.34,853.3114507,4.99,61,7,12,4,17,195.27,C43H45ClFN9O7,"InChI=1S/C43H45ClFN9O7/c1-2-36(55)50-33-23-28-32(47-25-48-40(28)49-26-11-12-30(45)29(44)22-26)24-35(33)61-21-7-16-52-17-19-53(20-18-52)38(57)10-4-3-5-15-46-31-9-6-8-27-39(31)43(60)54(42(27)59)34-13-14-37(56)51-41(34)58/h2,6,8-9,11-12,22-25,34,46H,1,3-5,7,10,13-21H2,(H,50,55)(H,47,48,49)(H,51,56,58)",UFVWZVUFBJDPFK-UHFFFAOYSA-N
2231,100,40,100,40,P00533,EGFR e19d,CRBN,,SIAIS125,C=CC(=O)NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCN(C(=O)CCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EGFR e19d in PC9 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.603/2.123,Inhibit proliferation of PC9/HCC827 cells expressing EGFR e19d,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113328,854.34,853.3114507,4.99,61,7,12,4,17,195.27,C43H45ClFN9O7,"InChI=1S/C43H45ClFN9O7/c1-2-36(55)50-33-23-28-32(47-25-48-40(28)49-26-11-12-30(45)29(44)22-26)24-35(33)61-21-7-16-52-17-19-53(20-18-52)38(57)10-4-3-5-15-46-31-9-6-8-27-39(31)43(60)54(42(27)59)34-13-14-37(56)51-41(34)58/h2,6,8-9,11-12,22-25,34,46H,1,3-5,7,10,13-21H2,(H,50,55)(H,47,48,49)(H,51,56,58)",UFVWZVUFBJDPFK-UHFFFAOYSA-N
2232,30,99,<30/100,,P00533,EGFR L858R/T790M,CRBN,,SIAIS126,C=CC(=O)NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCN(C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EGFR L858R/T790M in H1975/(Ba/F3) cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.52/51.28,Inhibit proliferation of H1975/(Ba/F3) cells expressing EGFR L858R/T790M,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113328,868.367,867.3271007,5.53,62,7,12,4,18,195.27,C44H47ClFN9O7,"InChI=1S/C44H47ClFN9O7/c1-2-37(56)51-34-24-29-33(48-26-49-41(29)50-27-12-13-31(46)30(45)23-27)25-36(34)62-22-8-17-53-18-20-54(21-19-53)39(58)11-5-3-4-6-16-47-32-10-7-9-28-40(32)44(61)55(43(28)60)35-14-15-38(57)52-42(35)59/h2,7,9-10,12-13,23-26,35,47H,1,3-6,8,11,14-22H2,(H,51,56)(H,48,49,50)(H,52,57,59)",YTNYTUGBAXJPBN-UHFFFAOYSA-N
2232,30,99,30-100,,P00533,EGFR e19d,CRBN,,SIAIS126,C=CC(=O)NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCN(C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EGFR e19d in PC9 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.942/1.154,Inhibit proliferation of PC9/HCC827 cells expressing EGFR e19d,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113328,868.367,867.3271007,5.53,62,7,12,4,18,195.27,C44H47ClFN9O7,"InChI=1S/C44H47ClFN9O7/c1-2-37(56)51-34-24-29-33(48-26-49-41(29)50-27-12-13-31(46)30(45)23-27)25-36(34)62-22-8-17-53-18-20-54(21-19-53)39(58)11-5-3-4-6-16-47-32-10-7-9-28-40(32)44(61)55(43(28)60)35-14-15-38(57)52-42(35)59/h2,7,9-10,12-13,23-26,35,47H,1,3-6,8,11,14-22H2,(H,51,56)(H,48,49,50)(H,52,57,59)",YTNYTUGBAXJPBN-UHFFFAOYSA-N
2236,6.02,99,6.02,,Q06124,SHP2,CRBN,,ZB-S-29,C[C@@H]1OCC2(CCN(C3=CN=C(SC4=CC=CC(NC(=O)CCC(=O)NCCCOCCOCCOCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C4Cl)C(N)=N3)CC2)[C@@H]1N,Degradation of SHP2 in MV4;11 cells after 12 h treatment,,,202,Inhibition of SHP2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,207,Inhibit growth of MV4;11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113341,979.558,978.3824868,1.77,68,7,17,6,23,271.76,C46H59ClN10O10S,"InChI=1S/C46H59ClN10O10S/c1-28-40(48)46(27-67-28)14-18-56(19-15-46)34-26-52-43(41(49)54-34)68-33-9-3-8-31(39(33)47)53-36(59)13-12-35(58)51-17-5-21-65-23-25-66-24-22-64-20-4-16-50-30-7-2-6-29-38(30)45(63)57(44(29)62)32-10-11-37(60)55-42(32)61/h2-3,6-9,26,28,32,40,50H,4-5,10-25,27,48H2,1H3,(H2,49,54)(H,51,58)(H,53,59)(H,55,60,61)/t28-,32?,40+/m0/s1",GOEFYTZABOPTQD-PXUBBKKOSA-N
2247,5,99,5,,Q460N5,PARP14,CRBN,,RBN012811,O=C(CN1CCC(SCC2=NC3=CC(NC4CCCC4)=CC(F)=C3C(=O)[NH]2)CC1)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of PARP14 in KYSE-270 cells after 24 h treatment,,,12,IC50 was assessed by probe displacement assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202100047,788.947,788.3479805,4.53,56,7,11,5,16,185.7,C40H49FN8O6S,"InChI=1S/C40H49FN8O6S/c41-28-20-25(44-24-8-3-4-9-24)21-30-36(28)38(53)46-32(45-30)23-56-26-14-18-48(19-15-26)22-34(51)43-17-6-2-1-5-16-42-29-11-7-10-27-35(29)40(55)49(39(27)54)31-12-13-33(50)47-37(31)52/h7,10-11,20-21,24,26,31,42,44H,1-6,8-9,12-19,22-23H2,(H,43,51)(H,45,46,53)(H,47,50,52)",HTRNIXWEXIRUMI-UHFFFAOYSA-N
2255,57,99,57/83,,Q9NYV4,CDK12,CRBN,,BSJ-4-116,CC(C)S(=O)(=O)C1=CC=CC=C1NC1=NC(N[C@@H]2CCCN(CCCCCCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)=NC=C1Cl,Degradation of CDK12 in HeLa cells after 24h treatment (cytoblot/westernblot),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115248,837.4,836.3082592,5.39,58,6,13,4,18,209.1,C40H49ClN8O8S,"InChI=1S/C40H49ClN8O8S/c1-25(2)58(55,56)32-16-7-6-14-29(32)45-36-28(41)22-43-40(47-36)44-26-12-11-21-48(23-26)20-9-5-3-4-8-19-42-34(51)24-57-31-15-10-13-27-35(31)39(54)49(38(27)53)30-17-18-33(50)46-37(30)52/h6-7,10,13-16,22,25-26,30H,3-5,8-9,11-12,17-21,23-24H2,1-2H3,(H,42,51)(H,46,50,52)(H2,43,44,45,47)/t26-,30?/m1/s1",YJOJMGTVKMABKQ-FIQOPJFZSA-N
2259,6.9,99,8/6.9,,P36888,FLT3-ITD,CRBN,,,NC1=C(C2=NC3=CC(N4CCN(C(=O)CCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C3[NH]2)C(=O)[NH]C2=CC=CC(F)=C12,Degradation of FLT3-ITD in MOLM-13/MV-4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1/18.7,Inhibit proliferation of MOLM-13/MV-4-11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00996,733.761,733.2772581,2.19,54,8,10,5,9,206.69,C38H36FN9O6,"InChI=1S/C38H36FN9O6/c39-22-6-4-8-25-31(22)33(40)32(36(52)44-25)34-42-23-11-10-20(19-26(23)43-34)46-15-17-47(18-16-46)29(50)9-1-2-14-41-24-7-3-5-21-30(24)38(54)48(37(21)53)27-12-13-28(49)45-35(27)51/h3-8,10-11,19,27,41H,1-2,9,12-18H2,(H,42,43)(H3,40,44,52)(H,45,49,51)",MSGCDHXTWFWAJI-UHFFFAOYSA-N
2260,7.4,99,7.4/9.1,,P36888,FLT3-ITD,CRBN,,,NC1=C(C2=NC3=CC(N4CCN(C(=O)CCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C3[NH]2)C(=O)[NH]C2=CC=CC(F)=C12,Degradation of FLT3-ITD in MOLM-13/MV-4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.5/9.2,Inhibit proliferation of MOLM-13/MV-4-11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00996,747.788,747.2929082,2.54,55,8,10,5,10,206.69,C39H38FN9O6,"InChI=1S/C39H38FN9O6/c40-23-7-5-9-26-32(23)34(41)33(37(53)45-26)35-43-24-12-11-21(20-27(24)44-35)47-16-18-48(19-17-47)30(51)10-2-1-3-15-42-25-8-4-6-22-31(25)39(55)49(38(22)54)28-13-14-29(50)46-36(28)52/h4-9,11-12,20,28,42H,1-3,10,13-19H2,(H,43,44)(H3,41,45,53)(H,46,50,52)",LOZMISVXTOAAHE-UHFFFAOYSA-N
2284,625,99,625,,P61964,WDR5,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCNC(=O)C3=CC=C(C4=CC=C(N5CCN(C)CC5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5-HiBiT in MV4-11 (WDR5-HiBiT) cells after 24 h treatment,,,,,,,9,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00146,984.115,983.3975508,4.05,70,7,11,6,14,209.17,C50H56F3N9O7S,"InChI=1S/C50H56F3N9O7S/c1-29-43(70-28-57-29)32-8-6-30(7-9-32)25-56-47(68)40-23-35(63)27-62(40)48(69)44(49(2,3)4)59-41(64)16-17-54-45(66)33-12-10-31(11-13-33)34-14-15-39(61-20-18-60(5)19-21-61)38(22-34)58-46(67)36-26-55-42(65)24-37(36)50(51,52)53/h6-15,22,24,26,28,35,40,44,63H,16-21,23,25,27H2,1-5H3,(H,54,66)(H,55,65)(H,56,68)(H,58,67)(H,59,64)/t35-,40+,44-/m1/s1",YOILXXMNXUOXLA-HOPMZIQWSA-N
2285,116,99,116,,P61964,WDR5,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CC=C(N5CCN(C)CC5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5-HiBiT in MV4-11 (WDR5-HiBiT) cells after 24 h treatment,,,,,,,6,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00146,998.142,997.4132009,4.41,71,7,11,6,15,209.17,C51H58F3N9O7S,"InChI=1S/C51H58F3N9O7S/c1-30-44(71-29-58-30)33-10-8-31(9-11-33)26-57-48(69)41-24-36(64)28-63(41)49(70)45(50(2,3)4)60-42(65)7-6-18-55-46(67)34-14-12-32(13-15-34)35-16-17-40(62-21-19-61(5)20-22-62)39(23-35)59-47(68)37-27-56-43(66)25-38(37)51(52,53)54/h8-17,23,25,27,29,36,41,45,64H,6-7,18-22,24,26,28H2,1-5H3,(H,55,67)(H,56,66)(H,57,69)(H,59,68)(H,60,65)/t36-,41+,45-/m1/s1",KFCLTULBYCCZBG-LTJJNQLXSA-N
2286,53,99,53,,P61964,WDR5,VHL,7Q2J,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCNC(=O)C3=CC=C(C4=CC=C(N5CCN(C)CC5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5-HiBiT in MV4-11 (WDR5-HiBiT) cells after 24 h treatment,,,,,,,18,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00146,1012.169,1011.428851,4.77,72,7,11,6,16,209.17,C52H60F3N9O7S,"InChI=1S/C52H60F3N9O7S/c1-31-45(72-30-59-31)34-11-9-32(10-12-34)27-58-49(70)42-25-37(65)29-64(42)50(71)46(51(2,3)4)61-43(66)8-6-7-19-56-47(68)35-15-13-33(14-16-35)36-17-18-41(63-22-20-62(5)21-23-63)40(24-36)60-48(69)38-28-57-44(67)26-39(38)52(53,54)55/h9-18,24,26,28,30,37,42,46,65H,6-8,19-23,25,27,29H2,1-5H3,(H,56,68)(H,57,67)(H,58,70)(H,60,69)(H,61,66)/t37-,42+,46-/m1/s1",OFNZESNEBSQKSE-BQGOKDIQSA-N
2287,920,99,920,,P61964,WDR5,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCNC(=O)C3=CC=C(C4=CC=C(N5CCN(C)CC5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5-HiBiT in MV4-11 (WDR5-HiBiT) cells after 24 h treatment,,,,,,,12,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00146,1026.196,1025.444501,5.12,73,7,11,6,17,209.17,C53H62F3N9O7S,"InChI=1S/C53H62F3N9O7S/c1-32-46(73-31-60-32)35-12-10-33(11-13-35)28-59-50(71)43-26-38(66)30-65(43)51(72)47(52(2,3)4)62-44(67)9-7-6-8-20-57-48(69)36-16-14-34(15-17-36)37-18-19-42(64-23-21-63(5)22-24-64)41(25-37)61-49(70)39-29-58-45(68)27-40(39)53(54,55)56/h10-19,25,27,29,31,38,43,47,66H,6-9,20-24,26,28,30H2,1-5H3,(H,57,69)(H,58,68)(H,59,71)(H,61,70)(H,62,67)/t38-,43+,47-/m1/s1",UPLJFUHLGRAYID-MXPJCAPISA-N
2288,915,99,915,,P61964,WDR5,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC(=O)C3=CC=C(C4=CC=C(N5CCN(C)CC5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5-HiBiT in MV4-11 (WDR5-HiBiT) cells after 24 h treatment,,,,,,,11,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00146,1040.223,1039.460151,5.66,74,7,11,6,18,209.17,C54H64F3N9O7S,"InChI=1S/C54H64F3N9O7S/c1-33-47(74-32-61-33)36-13-11-34(12-14-36)29-60-51(72)44-27-39(67)31-66(44)52(73)48(53(2,3)4)63-45(68)10-8-6-7-9-21-58-49(70)37-17-15-35(16-18-37)38-19-20-43(65-24-22-64(5)23-25-65)42(26-38)62-50(71)40-30-59-46(69)28-41(40)54(55,56)57/h11-20,26,28,30,32,39,44,48,67H,6-10,21-25,27,29,31H2,1-5H3,(H,58,70)(H,59,69)(H,60,72)(H,62,71)(H,63,68)/t39-,44+,48-/m1/s1",BXKFHYMDHAHJSX-UOHLUGTHSA-N
2294,1240,99,1240,,P61964,WDR5,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOC3=CC=C(C4=CN5CCCC5=N4)C=C3CNC(=O)CC3=CC=C(Cl)C(Cl)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5-HiBiT in MV4-11 (WDR5-HiBiT) cells after 24 h treatment,,,,,,,97,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00146,989.036,987.3522882,5.69,68,7,12,4,21,186.24,C50H59Cl2N7O8S,"InChI=1S/C50H59Cl2N7O8S/c1-31-46(68-30-55-31)34-10-7-32(8-11-34)26-54-48(63)41-25-37(60)28-59(41)49(64)47(50(2,3)4)57-44(61)15-17-65-18-19-66-20-21-67-42-14-12-35(40-29-58-16-5-6-43(58)56-40)24-36(42)27-53-45(62)23-33-9-13-38(51)39(52)22-33/h7-14,22,24,29-30,37,41,47,60H,5-6,15-21,23,25-28H2,1-4H3,(H,53,62)(H,54,63)(H,57,61)/t37-,41+,47-/m1/s1",KUOHKJIOVPXKOP-AWWHSMTCSA-N
2316,0.15,99,0.15/5.08,,P10275,AR,CRBN,,,CC1(C)[C@H](NC(=O)C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)C(C)(C)[C@H]1OC1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,64/96/98/90,% AR degradation in VCaP cells after 6 h treatment at 1/10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,07�� 10��,Inhibit growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00882,792.337,791.3198099,5.48,57,8,10,2,9,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c1-42(2)40(43(3,4)41(42)57-30-11-7-27(21-45)33(44)20-30)47-36(53)26-5-8-28(9-6-26)49-17-15-48(16-18-49)22-25-23-50(24-25)29-10-12-31-32(19-29)39(56)51(38(31)55)34-13-14-35(52)46-37(34)54/h5-12,19-20,25,34,40-41H,13-18,22-24H2,1-4H3,(H,47,53)(H,46,52,54)/t34?,40-,41-",NYTQWRHXSYHGSP-RPINAMIVSA-N
2317,0.76,99,0.76/1.41,,P10275,AR,CRBN,,,CC1(C)[C@H](NC(=O)C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)C(C)(C)[C@H]1OC1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,79/93/85/55,% AR degradation in VCaP cells after 6 h treatment at 1/10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,08�� 11��,Inhibit growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00882,806.364,805.3354599,6.01,58,8,10,2,8,155.39,C44H48ClN7O6,"InChI=1S/C44H48ClN7O6/c1-43(2)41(44(3,4)42(43)58-31-11-7-27(25-46)34(45)24-31)48-37(54)26-5-8-28(9-6-26)50-19-21-51(22-20-50)29-15-17-49(18-16-29)30-10-12-32-33(23-30)40(57)52(39(32)56)35-13-14-36(53)47-38(35)55/h5-12,23-24,29,35,41-42H,13-22H2,1-4H3,(H,48,54)(H,47,53,55)/t35?,41-,42-",GOJVIZZNCNOPSJ-ZOVDNBRGSA-N
2318,0.28,99,0.28/8.3,,P10275,AR,CRBN,,ARD-2128,CC1(C)[C@H](NC(=O)C2=CC=C(N3CCN(CC4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)C(C)(C)[C@H]1OC1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,62/94/98/96,% AR degradation in VCaP cells after 6 h treatment at 1/10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,04�� 05��,Inhibit growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00882,820.391,819.35111,6.2,59,8,10,2,9,155.39,C45H50ClN7O6,"InChI=1S/C45H50ClN7O6/c1-44(2)42(45(3,4)43(44)59-32-11-7-29(25-47)35(46)24-32)49-38(55)28-5-8-30(9-6-28)52-21-19-50(20-22-52)26-27-15-17-51(18-16-27)31-10-12-33-34(23-31)41(58)53(40(33)57)36-13-14-37(54)48-39(36)56/h5-12,23-24,27,36,42-43H,13-22,26H2,1-4H3,(H,49,55)(H,48,54,56)/t36?,42-,43-",BWDWHHAZFQBJQL-JABICJEXSA-N
2323,0.12,99,0.12/1.43,,P10275,AR,CRBN,,,CC1(C)[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)C(C)(C)[C@H]1OC1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,57/93/96/85,% AR degradation in VCaP cells after 6 h treatment at 1/10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,04�� 14��,Inhibit growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00882,806.364,805.3354599,6.01,58,8,10,2,8,155.39,C44H48ClN7O6,"InChI=1S/C44H48ClN7O6/c1-43(2)41(44(3,4)42(43)58-31-11-7-27(25-46)34(45)24-31)48-37(54)26-5-8-28(9-6-26)49-17-15-29(16-18-49)50-19-21-51(22-20-50)30-10-12-32-33(23-30)40(57)52(39(32)56)35-13-14-36(53)47-38(35)55/h5-12,23-24,29,35,41-42H,13-22H2,1-4H3,(H,48,54)(H,47,53,55)/t35?,41-,42-",IBPGCZDPTQXMHO-ZOVDNBRGSA-N
2324,0.38,99,0.38/3.38,,P10275,AR,CRBN,,,CC1(C)[C@H](NC(=O)C2=CC=C(N3CCC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)C(C)(C)[C@H]1OC1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,40/96/99/99,% AR degradation in VCaP cells after 6 h treatment at 1/10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,05�� 13��,Inhibit growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00882,820.391,819.35111,6.2,59,8,10,2,9,155.39,C45H50ClN7O6,"InChI=1S/C45H50ClN7O6/c1-44(2)42(45(3,4)43(44)59-32-11-7-29(25-47)35(46)24-32)49-38(55)28-5-8-30(9-6-28)51-17-15-27(16-18-51)26-50-19-21-52(22-20-50)31-10-12-33-34(23-31)41(58)53(40(33)57)36-13-14-37(54)48-39(36)56/h5-12,23-24,27,36,42-43H,13-22,26H2,1-4H3,(H,49,55)(H,48,54,56)/t36?,42-,43-",ARVBJCZQRUZZDE-JABICJEXSA-N
2338,125.89,99,125.89,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 long in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,98,FP,,,,,,,,,,,,,,,3.7,Kd between VHL and the complex of protac and BRD4 BD2 was tested by FP,,,,,,,,,,,100/398.1,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,1000.689,999.390215,6.18,69,7,14,4,20,202.26,C50H62ClN9O7S2,"InChI=1S/C50H62ClN9O7S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)55-38(46-58-57-32(4)60(46)49)24-40(62)52-19-22-66-20-9-8-10-21-67-27-41(63)56-45(50(5,6)7)48(65)59-26-37(61)23-39(59)47(64)53-25-33-11-13-35(14-12-33)44-30(2)54-28-68-44/h11-18,28,37-39,45,61H,8-10,19-27H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t37-,38+,39+,45-/m1/s1",PWFGHENEZLVBOP-DPSJZEHMSA-N
2338,158.5,99,158.5,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,98,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,100/398.1,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,0.5,PAMPA assay,,,,,10.1021/acs.jmedchem.1c01496,1000.689,999.390215,6.18,69,7,14,4,20,202.26,C50H62ClN9O7S2,"InChI=1S/C50H62ClN9O7S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)55-38(46-58-57-32(4)60(46)49)24-40(62)52-19-22-66-20-9-8-10-21-67-27-41(63)56-45(50(5,6)7)48(65)59-26-37(61)23-39(59)47(64)53-25-33-11-13-35(14-12-33)44-30(2)54-28-68-44/h11-18,28,37-39,45,61H,8-10,19-27H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t37-,38+,39+,45-/m1/s1",PWFGHENEZLVBOP-DPSJZEHMSA-N
2338,158.5,99,158.5,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,98,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,100/398.1,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,1000.689,999.390215,6.18,69,7,14,4,20,202.26,C50H62ClN9O7S2,"InChI=1S/C50H62ClN9O7S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)55-38(46-58-57-32(4)60(46)49)24-40(62)52-19-22-66-20-9-8-10-21-67-27-41(63)56-45(50(5,6)7)48(65)59-26-37(61)23-39(59)47(64)53-25-33-11-13-35(14-12-33)44-30(2)54-28-68-44/h11-18,28,37-39,45,61H,8-10,19-27H2,1-7H3,(H,52,62)(H,53,64)(H,56,63)/t37-,38+,39+,45-/m1/s1",PWFGHENEZLVBOP-DPSJZEHMSA-N
2339,125.89,99,125.89,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 long in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,66,FP,,,,,,,,,,,,,,,3,Kd between VHL and the complex of protac and BRD4 BD2 was tested by FP,,,,,,,,,,,199.5/631,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,972.635,971.3589149,5.47,67,7,14,4,18,202.26,C48H58ClN9O7S2,"InChI=1S/C48H58ClN9O7S2/c1-27-29(3)67-47-40(27)41(32-13-15-34(49)16-14-32)53-36(44-56-55-30(4)58(44)47)22-38(60)50-17-20-64-18-8-19-65-25-39(61)54-43(48(5,6)7)46(63)57-24-35(59)21-37(57)45(62)51-23-31-9-11-33(12-10-31)42-28(2)52-26-66-42/h9-16,26,35-37,43,59H,8,17-25H2,1-7H3,(H,50,60)(H,51,62)(H,54,61)/t35-,36+,37+,43-/m1/s1",MJCKFIWZHNIKPQ-AYWQWSHZSA-N
2339,199.5,99,199.5,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,66,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,199.5/631,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,972.635,971.3589149,5.47,67,7,14,4,18,202.26,C48H58ClN9O7S2,"InChI=1S/C48H58ClN9O7S2/c1-27-29(3)67-47-40(27)41(32-13-15-34(49)16-14-32)53-36(44-56-55-30(4)58(44)47)22-38(60)50-17-20-64-18-8-19-65-25-39(61)54-43(48(5,6)7)46(63)57-24-35(59)21-37(57)45(62)51-23-31-9-11-33(12-10-31)42-28(2)52-26-66-42/h9-16,26,35-37,43,59H,8,17-25H2,1-7H3,(H,50,60)(H,51,62)(H,54,61)/t35-,36+,37+,43-/m1/s1",MJCKFIWZHNIKPQ-AYWQWSHZSA-N
2339,251.2,99,251.2,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,66,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,199.5/631,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,0.08,PAMPA assay,,,,,10.1021/acs.jmedchem.1c01496,972.635,971.3589149,5.47,67,7,14,4,18,202.26,C48H58ClN9O7S2,"InChI=1S/C48H58ClN9O7S2/c1-27-29(3)67-47-40(27)41(32-13-15-34(49)16-14-32)53-36(44-56-55-30(4)58(44)47)22-38(60)50-17-20-64-18-8-19-65-25-39(61)54-43(48(5,6)7)46(63)57-24-35(59)21-37(57)45(62)51-23-31-9-11-33(12-10-31)42-28(2)52-26-66-42/h9-16,26,35-37,43,59H,8,17-25H2,1-7H3,(H,50,60)(H,51,62)(H,54,61)/t35-,36+,37+,43-/m1/s1",MJCKFIWZHNIKPQ-AYWQWSHZSA-N
2340,39.81,99,39.81,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 long in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,248,FP,,,,,,,,,,,,,,,6.4,Kd between VHL and the complex of protac and BRD4 BD2 was tested by FP,,,,,,,,,,,199.5/794.3,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,1003.645,1002.353495,5.54,69,7,16,3,20,208.69,C49H59ClN8O9S2,"InChI=1S/C49H59ClN8O9S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)53-37(45-56-55-31(4)58(45)48)23-40(61)67-21-20-65-17-16-64-18-19-66-26-39(60)54-44(49(5,6)7)47(63)57-25-36(59)22-38(57)46(62)51-24-32-8-10-34(11-9-32)43-29(2)52-27-68-43/h8-15,27,36-38,44,59H,16-26H2,1-7H3,(H,51,62)(H,54,60)/t36-,37+,38+,44-/m1/s1",HZTRWCKQNKXISW-PYNGZGNASA-N
2340,125.9,99,125.9,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,248,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,199.5/794.3,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,0.1,PAMPA assay,,,,,10.1021/acs.jmedchem.1c01496,1003.645,1002.353495,5.54,69,7,16,3,20,208.69,C49H59ClN8O9S2,"InChI=1S/C49H59ClN8O9S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)53-37(45-56-55-31(4)58(45)48)23-40(61)67-21-20-65-17-16-64-18-19-66-26-39(60)54-44(49(5,6)7)47(63)57-25-36(59)22-38(57)46(62)51-24-32-8-10-34(11-9-32)43-29(2)52-27-68-43/h8-15,27,36-38,44,59H,16-26H2,1-7H3,(H,51,62)(H,54,60)/t36-,37+,38+,44-/m1/s1",HZTRWCKQNKXISW-PYNGZGNASA-N
2340,199.5,99,199.5,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,248,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,199.5/794.3,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,1003.645,1002.353495,5.54,69,7,16,3,20,208.69,C49H59ClN8O9S2,"InChI=1S/C49H59ClN8O9S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)53-37(45-56-55-31(4)58(45)48)23-40(61)67-21-20-65-17-16-64-18-19-66-26-39(60)54-44(49(5,6)7)47(63)57-25-36(59)22-38(57)46(62)51-24-32-8-10-34(11-9-32)43-29(2)52-27-68-43/h8-15,27,36-38,44,59H,16-26H2,1-7H3,(H,51,62)(H,54,60)/t36-,37+,38+,44-/m1/s1",HZTRWCKQNKXISW-PYNGZGNASA-N
2341,1.3,99,1.3,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,63,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,4/63.1,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,0.3,PAMPA assay,,,,,10.1021/acs.jmedchem.1c01496,987.646,986.3585805,6.45,68,7,15,3,18,199.46,C49H59ClN8O8S2,"InChI=1S/C49H59ClN8O8S2/c1-27-30(4)68-48-41(27)42(33-14-16-35(50)17-15-33)53-37(45-56-55-31(5)58(45)48)23-40(61)66-21-20-64-18-9-19-65-25-39(60)54-44(49(6,7)8)47(63)57-24-36(59)22-38(57)46(62)52-28(2)32-10-12-34(13-11-32)43-29(3)51-26-67-43/h10-17,26,28,36-38,44,59H,9,18-25H2,1-8H3,(H,52,62)(H,54,60)/t28-,36+,37-,38-,44+/m0/s1",CWTFXHWWWKKEQI-QQRWPDCKSA-N
2341,4,99,4,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,63,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,4/63.1,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,987.646,986.3585805,6.45,68,7,15,3,18,199.46,C49H59ClN8O8S2,"InChI=1S/C49H59ClN8O8S2/c1-27-30(4)68-48-41(27)42(33-14-16-35(50)17-15-33)53-37(45-56-55-31(5)58(45)48)23-40(61)66-21-20-64-18-9-19-65-25-39(60)54-44(49(6,7)8)47(63)57-24-36(59)22-38(57)46(62)52-28(2)32-10-12-34(13-11-32)43-29(3)51-26-67-43/h10-17,26,28,36-38,44,59H,9,18-25H2,1-8H3,(H,52,62)(H,54,60)/t28-,36+,37-,38-,44+/m0/s1",CWTFXHWWWKKEQI-QQRWPDCKSA-N
2341,6.31,99,6.31,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 long in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,63,FP,,,,,,,,,,,,,,,7.3,Kd between VHL and the complex of protac and BRD4 BD2 was tested by FP,,,,,,,,,,,4/63.1,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,987.646,986.3585805,6.45,68,7,15,3,18,199.46,C49H59ClN8O8S2,"InChI=1S/C49H59ClN8O8S2/c1-27-30(4)68-48-41(27)42(33-14-16-35(50)17-15-33)53-37(45-56-55-31(5)58(45)48)23-40(61)66-21-20-64-18-9-19-65-25-39(60)54-44(49(6,7)8)47(63)57-24-36(59)22-38(57)46(62)52-28(2)32-10-12-34(13-11-32)43-29(3)51-26-67-43/h10-17,26,28,36-38,44,59H,9,18-25H2,1-8H3,(H,52,62)(H,54,60)/t28-,36+,37-,38-,44+/m0/s1",CWTFXHWWWKKEQI-QQRWPDCKSA-N
2342,63.1,99,63.1,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 long in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,236,FP,,,,,,,,,,,,,,,18,Kd between VHL and the complex of protac and BRD4 BD2 was tested by FP,,,,,,,,,,,125.9/316.2,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,1001.673,1000.374231,6.76,69,7,15,3,20,199.46,C50H61ClN8O8S2,"InChI=1S/C50H61ClN8O8S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)54-38(46-57-56-32(4)59(46)49)24-41(62)67-22-21-65-19-9-8-10-20-66-27-40(61)55-45(50(5,6)7)48(64)58-26-37(60)23-39(58)47(63)52-25-33-11-13-35(14-12-33)44-30(2)53-28-68-44/h11-18,28,37-39,45,60H,8-10,19-27H2,1-7H3,(H,52,63)(H,55,61)/t37-,38+,39+,45-/m1/s1",VRVWHAZIBGEPEK-DPSJZEHMSA-N
2342,79.4,99,79.4,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,236,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,125.9/316.2,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,0.2,PAMPA assay,,,,,10.1021/acs.jmedchem.1c01496,1001.673,1000.374231,6.76,69,7,15,3,20,199.46,C50H61ClN8O8S2,"InChI=1S/C50H61ClN8O8S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)54-38(46-57-56-32(4)59(46)49)24-41(62)67-22-21-65-19-9-8-10-20-66-27-40(61)55-45(50(5,6)7)48(64)58-26-37(60)23-39(58)47(63)52-25-33-11-13-35(14-12-33)44-30(2)53-28-68-44/h11-18,28,37-39,45,60H,8-10,19-27H2,1-7H3,(H,52,63)(H,55,61)/t37-,38+,39+,45-/m1/s1",VRVWHAZIBGEPEK-DPSJZEHMSA-N
2342,100,99,100,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,236,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,125.9/316.2,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,1001.673,1000.374231,6.76,69,7,15,3,20,199.46,C50H61ClN8O8S2,"InChI=1S/C50H61ClN8O8S2/c1-29-31(3)69-49-42(29)43(34-15-17-36(51)18-16-34)54-38(46-57-56-32(4)59(46)49)24-41(62)67-22-21-65-19-9-8-10-20-66-27-40(61)55-45(50(5,6)7)48(64)58-26-37(60)23-39(58)47(63)52-25-33-11-13-35(14-12-33)44-30(2)53-28-68-44/h11-18,28,37-39,45,60H,8-10,19-27H2,1-7H3,(H,52,63)(H,55,61)/t37-,38+,39+,45-/m1/s1",VRVWHAZIBGEPEK-DPSJZEHMSA-N
2343,31.62,99,31.62,,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 long in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,143,FP,,,,,,,,,,,,,,,21,Kd between VHL and the complex of protac and BRD4 BD2 was tested by FP,,,,,,,,,,,50.1/251.2,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,973.619,972.3429305,6.04,67,7,15,3,18,199.46,C48H57ClN8O8S2,"InChI=1S/C48H57ClN8O8S2/c1-27-29(3)67-47-40(27)41(32-13-15-34(49)16-14-32)52-36(44-55-54-30(4)57(44)47)22-39(60)65-20-19-63-17-8-18-64-25-38(59)53-43(48(5,6)7)46(62)56-24-35(58)21-37(56)45(61)50-23-31-9-11-33(12-10-31)42-28(2)51-26-66-42/h9-16,26,35-37,43,58H,8,17-25H2,1-7H3,(H,50,61)(H,53,59)/t35-,36+,37+,43-/m1/s1",SZLZPTHXIDWXLS-AYWQWSHZSA-N
2343,63.1,99,63.1,,P25440,BRD2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD2 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,143,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,50.1/251.2,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,0.6,PAMPA assay,,,,,10.1021/acs.jmedchem.1c01496,973.619,972.3429305,6.04,67,7,15,3,18,199.46,C48H57ClN8O8S2,"InChI=1S/C48H57ClN8O8S2/c1-27-29(3)67-47-40(27)41(32-13-15-34(49)16-14-32)52-36(44-55-54-30(4)57(44)47)22-39(60)65-20-19-63-17-8-18-64-25-38(59)53-43(48(5,6)7)46(62)56-24-35(58)21-37(56)45(61)50-23-31-9-11-33(12-10-31)42-28(2)51-26-66-42/h9-16,26,35-37,43,58H,8,17-25H2,1-7H3,(H,50,61)(H,53,59)/t35-,36+,37+,43-/m1/s1",SZLZPTHXIDWXLS-AYWQWSHZSA-N
2343,63.1,99,63.1,,Q15059,BRD3,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCOC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD3 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,143,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,50.1/251.2,Inhibit proliferation of MV4;11/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01496,973.619,972.3429305,6.04,67,7,15,3,18,199.46,C48H57ClN8O8S2,"InChI=1S/C48H57ClN8O8S2/c1-27-29(3)67-47-40(27)41(32-13-15-34(49)16-14-32)52-36(44-55-54-30(4)57(44)47)22-39(60)65-20-19-63-17-8-18-64-25-38(59)53-43(48(5,6)7)46(62)56-24-35(58)21-37(56)45(61)50-23-31-9-11-33(12-10-31)42-28(2)51-26-66-42/h9-16,26,35-37,43,58H,8,17-25H2,1-7H3,(H,50,61)(H,53,59)/t35-,36+,37+,43-/m1/s1",SZLZPTHXIDWXLS-AYWQWSHZSA-N
2344,,,>1000,,P33981,TTK,VHL,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCOCCC(=O)N[C@@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,1048.325,1047.536429,4.82,75,8,16,5,19,225.48,C55H73N11O8S,"InChI=1S/C55H73N11O8S/c1-8-46(68)59-38-13-15-39(16-14-38)66-48(70)27-34(2)42-31-57-54(62-51(42)66)60-43-18-17-40(28-45(43)73-7)64-22-20-63(21-23-64)24-26-74-25-19-47(69)61-50(55(4,5)6)53(72)65-32-41(67)29-44(65)52(71)56-30-36-9-11-37(12-10-36)49-35(3)58-33-75-49/h9-12,17-18,27-28,31,33,38-39,41,44,50,67H,8,13-16,19-26,29-30,32H2,1-7H3,(H,56,71)(H,59,68)(H,61,69)(H,57,60,62)/t38-,39+,41-,44+,50+/m1/s1",SUUSSNMSFOIMTM-QWALSHNLSA-N
2345,,,>1000,,P33981,TTK,VHL,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCOCCC(=O)N[C@@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,1076.379,1075.567729,5.53,77,8,16,5,21,225.48,C57H77N11O8S,"InChI=1S/C57H77N11O8S/c1-8-48(70)61-40-15-17-41(18-16-40)68-50(72)29-36(2)44-33-59-56(64-53(44)68)62-45-20-19-42(30-47(45)75-7)66-25-23-65(24-26-66)22-9-10-27-76-28-21-49(71)63-52(57(4,5)6)55(74)67-34-43(69)31-46(67)54(73)58-32-38-11-13-39(14-12-38)51-37(3)60-35-77-51/h11-14,19-20,29-30,33,35,40-41,43,46,52,69H,8-10,15-18,21-28,31-32,34H2,1-7H3,(H,58,73)(H,61,70)(H,63,71)(H,59,62,64)/t40-,41+,43-,46+,52+/m1/s1",MPXCMWJVCZZWNP-NWFHPFIOSA-N
2346,,,>1000,,P33981,TTK,VHL,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCOCCC(=O)N[C@@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,1104.433,1103.59903,6.25,79,8,16,5,23,225.48,C59H81N11O8S,"InChI=1S/C59H81N11O8S/c1-8-50(72)63-42-17-19-43(20-18-42)70-52(74)31-38(2)46-35-61-58(66-55(46)70)64-47-22-21-44(32-49(47)77-7)68-27-25-67(26-28-68)24-11-9-10-12-29-78-30-23-51(73)65-54(59(4,5)6)57(76)69-36-45(71)33-48(69)56(75)60-34-40-13-15-41(16-14-40)53-39(3)62-37-79-53/h13-16,21-22,31-32,35,37,42-43,45,48,54,71H,8-12,17-20,23-30,33-34,36H2,1-7H3,(H,60,75)(H,63,72)(H,65,73)(H,61,64,66)/t42-,43+,45-,48+,54+/m1/s1",MKPDBPCFJYIBSR-RUIVAHQKSA-N
2347,,,>1000,,P33981,TTK,VHL,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(CCCCCCCCOCCC(=O)N[C@@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,1132.487,1131.63033,7.33,81,8,16,5,25,225.48,C61H85N11O8S,"InChI=1S/C61H85N11O8S/c1-8-52(74)65-44-19-21-45(22-20-44)72-54(76)33-40(2)48-37-63-60(68-57(48)72)66-49-24-23-46(34-51(49)79-7)70-29-27-69(28-30-70)26-13-11-9-10-12-14-31-80-32-25-53(75)67-56(61(4,5)6)59(78)71-38-47(73)35-50(71)58(77)62-36-42-15-17-43(18-16-42)55-41(3)64-39-81-55/h15-18,23-24,33-34,37,39,44-45,47,50,56,73H,8-14,19-22,25-32,35-36,38H2,1-7H3,(H,62,77)(H,65,74)(H,67,75)(H,63,66,68)/t44-,45+,47-,50+,56+/m1/s1",HGGXUMRGGKLPIH-BLKJDWLZSA-N
2348,598.7,28,598.7/>1000,28/43,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-40(57)49-31-13-15-32(16-14-31)56-43(60)25-29(2)35-27-48-47(52-44(35)56)50-37-18-17-33(26-39(37)63-3)53-21-23-54(24-22-53)42(59)12-7-5-6-9-30-10-8-11-34-36(30)28-55(46(34)62)38-19-20-41(58)51-45(38)61/h8,10-11,17-18,25-27,31-32,38H,4-5,7,12-16,19-24,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t31-,32+,38?",ILIHAEQFLUWMRH-HSWALOBVSA-N
2349,4.97,76,4.97/20.3,76/50,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-42(59)51-33-15-17-34(18-16-33)58-45(62)27-31(2)37-29-50-49(54-46(37)58)52-39-20-19-35(28-41(39)65-3)55-23-25-56(26-24-55)44(61)14-9-7-5-6-8-11-32-12-10-13-36-38(32)30-57(48(36)64)40-21-22-43(60)53-47(40)63/h10,12-13,19-20,27-29,33-34,40H,4-7,9,14-18,21-26,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t33-,34+,40?",QEDFXQXPBXHVGU-RMDMJGLRSA-N
2350,7.05,84,7.05/58.1,84/53,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-44(61)53-35-17-19-36(20-18-35)60-47(64)29-33(2)39-31-52-51(56-48(39)60)54-41-22-21-37(30-43(41)67-3)57-25-27-58(28-26-57)46(63)16-11-9-7-5-6-8-10-13-34-14-12-15-38-40(34)32-59(50(38)66)42-23-24-45(62)55-49(42)65/h12,14-15,21-22,29-31,35-36,42H,4-9,11,16-20,23-28,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t35-,36+,42?",OEMAZTSGRNBCPF-HUPKRMINSA-N
2351,2.25,87,2.25/49.6,87/66,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-46(63)55-37-19-21-38(22-20-37)62-49(66)31-35(2)41-33-54-53(58-50(41)62)56-43-24-23-39(32-45(43)69-3)59-27-29-60(30-28-59)48(65)18-13-11-9-7-5-6-8-10-12-15-36-16-14-17-40-42(36)34-61(52(40)68)44-25-26-47(64)57-51(44)67/h14,16-17,23-24,31-33,37-38,44H,4-11,13,18-22,25-30,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t37-,38+,44?",LUPSPQQYVRGZLI-FPDSPUJPSA-N
2352,1.75,88,1.75/5.8,88/80,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,1.6,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,110,Inhibit growth of COLO-205 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-40(57)49-32-11-13-33(14-12-32)56-43(60)24-29(2)36-27-48-47(52-44(36)56)50-37-17-15-34(26-39(37)63-3)53-20-22-54(23-21-53)42(59)9-7-5-6-8-30-10-16-35-31(25-30)28-55(46(35)62)38-18-19-41(58)51-45(38)61/h10,15-17,24-27,32-33,38H,4-5,7,9,11-14,18-23,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t32-,33+,38?",LWHJKWAUKAHIGC-YVLRYLSESA-N
2353,1.55,86,1.55/35,86/61,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-42(59)51-34-13-15-35(16-14-34)58-45(62)26-31(2)38-29-50-49(54-46(38)58)52-39-19-17-36(28-41(39)65-3)55-22-24-56(25-23-55)44(61)11-9-7-5-6-8-10-32-12-18-37-33(27-32)30-57(48(37)64)40-20-21-43(60)53-47(40)63/h12,17-19,26-29,34-35,40H,4-7,9,11,13-16,20-25,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t34-,35+,40?",WLMZSJVDMUNOHX-UKMVIOKASA-N
2354,3.04,85,3.04/663,85/50,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-44(61)53-36-15-17-37(18-16-36)60-47(64)28-33(2)40-31-52-51(56-48(40)60)54-41-21-19-38(30-43(41)67-3)57-24-26-58(27-25-57)46(63)13-11-9-7-5-6-8-10-12-34-14-20-39-35(29-34)32-59(50(39)66)42-22-23-45(62)55-49(42)65/h14,19-21,28-31,36-37,42H,4-9,11,13,15-18,22-27,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t36-,37+,42?",VGMBSGNGVRXDBY-ILWCGICZSA-N
2355,5.6,85,5.6/30.2,85/83,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-46(63)55-38-17-19-39(20-18-38)62-49(66)30-35(2)42-33-54-53(58-50(42)62)56-43-23-21-40(32-45(43)69-3)59-26-28-60(29-27-59)48(65)15-13-11-9-7-5-6-8-10-12-14-36-16-22-41-37(31-36)34-61(52(41)68)44-24-25-47(64)57-51(44)67/h16,21-23,30-33,38-39,44H,4-11,13,15,17-20,24-29,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t38-,39+,44?",WNBZJWHJHXEDEO-GTFGDMOZSA-N
2356,3.31,77,3.31/25.4,77/57,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-40(57)49-32-12-14-33(15-13-32)56-43(60)24-29(2)36-27-48-47(52-44(36)56)50-37-17-16-34(26-39(37)63-3)53-20-22-54(23-21-53)42(59)9-7-5-6-8-30-10-11-31-28-55(46(62)35(31)25-30)38-18-19-41(58)51-45(38)61/h10-11,16-17,24-27,32-33,38H,4-5,7,9,12-15,18-23,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t32-,33+,38?",IJOXNAXACYQBRL-YVLRYLSESA-N
2357,3.15,82,3.15/12.4,82/77,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,6.5,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,250,Inhibit growth of COLO-205 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-42(59)51-34-14-16-35(17-15-34)58-45(62)26-31(2)38-29-50-49(54-46(38)58)52-39-19-18-36(28-41(39)65-3)55-22-24-56(25-23-55)44(61)11-9-7-5-6-8-10-32-12-13-33-30-57(48(64)37(33)27-32)40-20-21-43(60)53-47(40)63/h12-13,18-19,26-29,34-35,40H,4-7,9,11,14-17,20-25,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t34-,35+,40?",XWOZFCIASHOPCP-UKMVIOKASA-N
2358,7.03,84,7.03/161,84/43,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-44(61)53-36-16-18-37(19-17-36)60-47(64)28-33(2)40-31-52-51(56-48(40)60)54-41-21-20-38(30-43(41)67-3)57-24-26-58(27-25-57)46(63)13-11-9-7-5-6-8-10-12-34-14-15-35-32-59(50(66)39(35)29-34)42-22-23-45(62)55-49(42)65/h14-15,20-21,28-31,36-37,42H,4-9,11,13,16-19,22-27,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t36-,37+,42?",ILQRGGWQVGLOSJ-ILWCGICZSA-N
2359,19.09,87,19.09/74.5,87/66,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-46(63)55-38-18-20-39(21-19-38)62-49(66)30-35(2)42-33-54-53(58-50(42)62)56-43-23-22-40(32-45(43)69-3)59-26-28-60(29-27-59)48(65)15-13-11-9-7-5-6-8-10-12-14-36-16-17-37-34-61(52(68)41(37)31-36)44-24-25-47(64)57-51(44)67/h16-17,22-23,30-33,38-39,44H,4-11,13,15,18-21,24-29,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t38-,39+,44?",DTEBXQFNWWUSPH-GTFGDMOZSA-N
2360,30.28,64,30.28/>1000,64/28,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-39(57)49-32-13-15-33(16-14-32)56-42(60)25-29(2)35-27-48-47(52-44(35)56)50-36-18-17-34(26-38(36)63-3)53-21-23-54(24-22-53)41(59)12-7-5-6-9-30-10-8-11-31-28-55(46(62)43(30)31)37-19-20-40(58)51-45(37)61/h8,10-11,17-18,25-27,32-33,37H,4-5,7,12-16,19-24,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t32-,33+,37?",RPGBSIRPMJGXHN-MBSVEICTSA-N
2361,31.35,72,31.35/>1000,72/41,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-41(59)51-34-15-17-35(18-16-34)58-44(62)27-31(2)37-29-50-49(54-46(37)58)52-38-20-19-36(28-40(38)65-3)55-23-25-56(26-24-55)43(61)14-9-7-5-6-8-11-32-12-10-13-33-30-57(48(64)45(32)33)39-21-22-42(60)53-47(39)63/h10,12-13,19-20,27-29,34-35,39H,4-7,9,14-18,21-26,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t34-,35+,39?",QKBCJYTUWJPJPK-DMBNOJOPSA-N
2362,46,73,46/496,73/37,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-43(61)53-36-17-19-37(20-18-36)60-46(64)29-33(2)39-31-52-51(56-48(39)60)54-40-22-21-38(30-42(40)67-3)57-25-27-58(28-26-57)45(63)16-11-9-7-5-6-8-10-13-34-14-12-15-35-32-59(50(66)47(34)35)41-23-24-44(62)55-49(41)65/h12,14-15,21-22,29-31,36-37,41H,4-9,11,16-20,23-28,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t36-,37+,41?",ZPUBDTHTIYULJM-WFMPFVDOSA-N
2363,21.71,88,21.71/>1000,88/13,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-45(63)55-38-19-21-39(22-20-38)62-48(66)31-35(2)41-33-54-53(58-50(41)62)56-42-24-23-40(32-44(42)69-3)59-27-29-60(30-28-59)47(65)18-13-11-9-7-5-6-8-10-12-15-36-16-14-17-37-34-61(52(68)49(36)37)43-25-26-46(64)57-51(43)67/h14,16-17,23-24,31-33,38-39,43H,4-11,13,18-22,25-30,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t38-,39+,43?",RFDZITCLUUJECZ-FRBFHYLZSA-N
2376,0.13,99,0.13,,O43353,RIPK2,IAP,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=C(F)C=C2)=CS1)C1CCN(C(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)CC1,Degradation of RIPK2 in THP1 cells after 18 h treatment,,,12.59,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.58,Inhibition of MDP-stimulated TNFalpha release in human whole blood,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01118,1107.353,1106.474261,5.46,78,9,18,4,18,253.83,C54H67FN14O7S2,"InChI=1S/C54H67FN14O7S2/c1-32-33(2)64-65-48(32)63-49-38-26-44(78(74,75)54(4,5)6)43(27-39(38)59-31-60-49)76-25-9-17-66-21-23-67(24-22-66)45-29-57-40(28-58-45)52(72)68-19-15-35(16-20-68)46(62-50(71)34(3)56-7)53(73)69-18-8-10-42(69)51-61-41(30-77-51)47(70)36-11-13-37(55)14-12-36/h11-14,26-31,34-35,42,46,56H,8-10,15-25H2,1-7H3,(H,62,71)(H2,59,60,63,64,65)/t34-,42-,46-/m0/s1",VXCZVPTVGMPYKY-RTBFYXABSA-N
2377,0.16,99,0.16,,O43353,RIPK2,IAP,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C(C)(C)C,Degradation of RIPK2 in THP1 cells after 18 h treatment,,,12.59,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.51,Inhibition of MDP-stimulated TNFalpha release in human whole blood,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01118,1063.344,1062.558562,5.25,76,8,16,6,17,261.76,C54H74N14O7S,"InChI=1S/C54H74N14O7S/c1-32-33(2)64-65-47(32)63-48-38-26-44(76(73,74)54(7,8)9)43(27-40(38)58-31-59-48)75-24-14-19-66-20-22-67(23-21-66)45-29-56-41(28-57-45)50(70)60-36-25-42(51(71)61-39-18-13-16-35-15-11-12-17-37(35)39)68(30-36)52(72)46(53(4,5)6)62-49(69)34(3)55-10/h11-12,15,17,26-29,31,34,36,39,42,46,55H,13-14,16,18-25,30H2,1-10H3,(H,60,70)(H,61,71)(H,62,69)(H2,58,59,63,64,65)/t34-,36-,39+,42-,46+/m0/s1",LOTKOBYQNYXXQX-YJHYPDGLSA-N
2378,0.1,99,0.1,,O43353,RIPK2,IAP,,,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)CC[C@H]2CC[C@@H](C(=O)N[C@@H]3CCCC4=CC=CC=C43)N2C1=O,Degradation of RIPK2 in THP1 cells after 18 h treatment,,,6.31,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.16,Inhibition of MDP-stimulated TNFalpha release in human whole blood,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01118,1047.301,1046.527262,4.2,75,9,16,5,15,252.97,C53H70N14O7S,"InChI=1S/C53H70N14O7S/c1-32-33(2)62-63-47(32)61-48-38-26-45(75(72,73)53(4,5)6)44(27-40(38)57-31-58-48)74-25-11-19-64-21-23-65(24-22-64)46-29-55-41(28-56-46)51(70)66-20-18-36-16-17-43(67(36)52(71)42(30-66)60-49(68)34(3)54-7)50(69)59-39-15-10-13-35-12-8-9-14-37(35)39/h8-9,12,14,26-29,31,34,36,39,42-43,54H,10-11,13,15-25,30H2,1-7H3,(H,59,69)(H,60,68)(H2,57,58,61,62,63)/t34-,36+,39+,42-,43-/m0/s1",LYHKPGCMTCWLDN-XLJSIVTLSA-N
2379,0.05,99,0.05,,O43353,RIPK2,IAP,,,CC1=N[NH]C(NC2=NC=NC3=CC(OCCCN4CCN(C(=O)C5=CN=C(N6CCN(C[C@H]7CN[C@H](C)CN7CC(=O)N7CC(C)(C)C8=C7C=C(CC7=CC=C(F)C=C7)C(=O)N8C)[C@H](C)C6)N=C5)CC4)=C(S(=O)(=O)C(C)(C)C)C=C23)=C1C,Degradation of RIPK2 in THP1 cells after 18 h treatment,,,7.94,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.51,Inhibition of MDP-stimulated TNFalpha release in human whole blood,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01118,1144.437,1143.596424,5.41,82,10,18,3,16,223.25,C59H78FN15O6S,"InChI=1S/C59H78FN15O6S/c1-37-31-74(34-51(76)75-35-59(8,9)52-48(75)25-42(55(77)69(52)10)24-41-12-14-44(60)15-13-41)45(30-61-37)33-72-21-22-73(32-38(72)2)57-62-28-43(29-63-57)56(78)71-19-17-70(18-20-71)16-11-23-81-49-27-47-46(26-50(49)82(79,80)58(5,6)7)54(65-36-64-47)66-53-39(3)40(4)67-68-53/h12-15,25-29,36-38,45,61H,11,16-24,30-35H2,1-10H3,(H2,64,65,66,67,68)/t37-,38-,45-/m1/s1",UBVFSVDGHDABFK-KENLXIIISA-N
2380,0.16,99,0.16,,O43353,RIPK2,IAP,,,CC1=N[NH]C(NC2=NC=NC3=CC(OCCCN4CCN(C(=O)C5=CN=C(N6CCN(C[C@H]7CN[C@H](C)CN7CC(=O)N7CC(C)(C)C8=NC=C(CC9=CC=C(F)C=C9)C=C87)[C@H](C)C6)N=C5)CC4)=C(S(=O)(=O)C(C)(C)C)C=C23)=C1C,Degradation of RIPK2 in THP1 cells after 18 h treatment,,,25.12,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3,Inhibition of MDP-stimulated TNFalpha release in human whole blood,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01118,1114.411,1113.58586,6.17,80,10,17,3,16,214.14,C58H76FN15O5S,"InChI=1S/C58H76FN15O5S/c1-37-31-73(34-51(75)74-35-58(8,9)52-48(74)24-42(27-61-52)23-41-11-13-44(59)14-12-41)45(30-60-37)33-71-20-21-72(32-38(71)2)56-62-28-43(29-63-56)55(76)70-18-16-69(17-19-70)15-10-22-79-49-26-47-46(25-50(49)80(77,78)57(5,6)7)54(65-36-64-47)66-53-39(3)40(4)67-68-53/h11-14,24-29,36-38,45,60H,10,15-23,30-35H2,1-9H3,(H2,64,65,66,67,68)/t37-,38-,45-/m1/s1",IODBOTCCGBUXBQ-KENLXIIISA-N
2385,22.6,99,31.6/22.6,,Q07817,BCL-xL,VHL,,PP5,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)NCC3(C)CCC(C4=CC=C(Cl)C=C4)=C(CN4CCN(C5=CC=C(C(=O)NS(=O)(=O)C6=CC=C(N[C@H](CCN7CCOCC7)CSC7=CC=CC=C7)C(S(=O)(=O)C(F)(F)F)=C6)C=C5)CC4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4/RS4;11 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.1/23.3,Inhibit viability of MOLT-4/RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00517,1600.47,1598.6253,13.4,109,10,18,6,33,269.09,C80H102ClF3N10O11S4,"InChI=1S/C80H102ClF3N10O11S4/c1-54(56-20-22-58(23-21-56)73-55(2)86-53-107-73)87-76(99)69-46-64(95)50-94(69)77(100)74(78(3,4)5)89-72(97)19-15-10-8-7-9-14-18-71(96)85-52-79(6)36-34-67(57-24-28-61(81)29-25-57)60(48-79)49-92-38-40-93(41-39-92)63-30-26-59(27-31-63)75(98)90-109(103,104)66-32-33-68(70(47-66)108(101,102)80(82,83)84)88-62(35-37-91-42-44-105-45-43-91)51-106-65-16-12-11-13-17-65/h11-13,16-17,20-33,47,53-54,62,64,69,74,88,95H,7-10,14-15,18-19,34-46,48-52H2,1-6H3,(H,85,96)(H,87,99)(H,89,97)(H,90,98)/t54-,62+,64+,69-,74+,79?/m0/s1",CWIUDSZQDVZITQ-AAWIYDMSSA-N
2389,75.2,99,127.4/75.2,,Q07817,BCL-xL,VHL,,PZ703a,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)NC[C@@]3(C)CCC(C4=CC=C(Cl)C=C4)=C(CN4CCN(C5=CC=C(C(=O)NS(=O)(=O)C6=CC=C(N[C@H](CCN7CCOCC7)CSC7=CC=CC=C7)C(S(=O)(=O)C(F)(F)F)=C6)C=C5)CC4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4/RS4;11 cells after 16 h treatment,,,,,,,2.75,Kd was assessed by the AlphaScreen displacement binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.64,Kd between VHL and the complex of protac and BCL-xL was assessed by the AlphaScreen displacement binding assay,,,,,,,,,,,170.4/418.3,Inhibit viability of MOLT-4/RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00517,1600.47,1598.6253,13.4,109,10,18,6,33,269.09,C80H102ClF3N10O11S4,"InChI=1S/C80H102ClF3N10O11S4/c1-54(56-20-22-58(23-21-56)73-55(2)86-53-107-73)87-76(99)69-46-64(95)50-94(69)77(100)74(78(3,4)5)89-72(97)19-15-10-8-7-9-14-18-71(96)85-52-79(6)36-34-67(57-24-28-61(81)29-25-57)60(48-79)49-92-38-40-93(41-39-92)63-30-26-59(27-31-63)75(98)90-109(103,104)66-32-33-68(70(47-66)108(101,102)80(82,83)84)88-62(35-37-91-42-44-105-45-43-91)51-106-65-16-12-11-13-17-65/h11-13,16-17,20-33,47,53-54,62,64,69,74,88,95H,7-10,14-15,18-19,34-46,48-52H2,1-6H3,(H,85,96)(H,87,99)(H,89,97)(H,90,98)/t54-,62+,64+,69-,74+,79-/m0/s1",CWIUDSZQDVZITQ-OCIVTJSKSA-N
2390,11.6,99,14.3/11.6,,Q07817,BCL-xL,VHL,,PZ703b,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)NC[C@]3(C)CCC(C4=CC=C(Cl)C=C4)=C(CN4CCN(C5=CC=C(C(=O)NS(=O)(=O)C6=CC=C(N[C@H](CCN7CCOCC7)CSC7=CC=CC=C7)C(S(=O)(=O)C(F)(F)F)=C6)C=C5)CC4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in MOLT-4/RS4;11 cells after 16 h treatment,,,,,,,2.59,Kd was assessed by the AlphaScreen displacement binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.65,Kd between VHL and the complex of protac and BCL-xL was assessed by the AlphaScreen displacement binding assay,,,,,,,,,,,15.9/11.3,Inhibit viability of MOLT-4/RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00517,1600.47,1598.6253,13.4,109,10,18,6,33,269.09,C80H102ClF3N10O11S4,"InChI=1S/C80H102ClF3N10O11S4/c1-54(56-20-22-58(23-21-56)73-55(2)86-53-107-73)87-76(99)69-46-64(95)50-94(69)77(100)74(78(3,4)5)89-72(97)19-15-10-8-7-9-14-18-71(96)85-52-79(6)36-34-67(57-24-28-61(81)29-25-57)60(48-79)49-92-38-40-93(41-39-92)63-30-26-59(27-31-63)75(98)90-109(103,104)66-32-33-68(70(47-66)108(101,102)80(82,83)84)88-62(35-37-91-42-44-105-45-43-91)51-106-65-16-12-11-13-17-65/h11-13,16-17,20-33,47,53-54,62,64,69,74,88,95H,7-10,14-15,18-19,34-46,48-52H2,1-6H3,(H,85,96)(H,87,99)(H,89,97)(H,90,98)/t54-,62+,64+,69-,74+,79+/m0/s1",CWIUDSZQDVZITQ-QFNMACOTSA-N
2396,1,99,<1,,Q14289,PTK2B,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of PYK2 in SR cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,1,99,<1,,Q13882,PTK6,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of PTK6 in MDA-MB-231 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,1,99,<1/<1/<1,,Q05397,FAK,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of FAK in NCI-H2228/A549/Calu-1 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,10,99,<10,,Q9UM73,ALK,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK in SR cells after 24 h treatment,,,2.5,IC50 was tested using the KinomeScan platform,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,10,99,<10,,P16591,FER,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of FER in SR cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,100,99,<100,,Q9UM73,ALK G1202R,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of ALK G1202R in 293T cells after 72 h treatment,,,6.6,IC50 was tested using the KinomeScan platform,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21,Inhibit proliferation of 293T (ALK G1202R) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,100,99,<100,,P00533,EGFR L858R/T790M,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of EGFR L858R/T790M in H1975 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42,Inhibit proliferation of H1975 (EGFR L858R/T790M) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2396,100,99,<100/<100/<100,,Q15418,RPS6KA1,CRBN,,SIAIS164018,COC1=CC(N2CCC(N3CCN(C(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of RSK1 in NCI-H2228/A549/Calu-1 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00373,883.347,882.3133582,4.57,62,8,14,4,12,198.51,C43H48ClN10O7P,"InChI=1S/C43H48ClN10O7P/c1-61-34-23-27(11-12-30(34)48-43-46-24-29(44)39(50-43)47-31-8-4-5-10-35(31)62(2,3)60)51-17-15-26(16-18-51)52-19-21-53(22-20-52)37(56)25-45-32-9-6-7-28-38(32)42(59)54(41(28)58)33-13-14-36(55)49-40(33)57/h4-12,23-24,26,33,45H,13-22,25H2,1-3H3,(H,49,55,57)(H2,46,47,48,50)",AQGLXXCBEXDRNS-UHFFFAOYSA-N
2411,7.95,98,7.95,98,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3C=C(COC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR del19 in HCC-827 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,36,Inhibit proliferation of HCC-827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2022.105605,1091.756,1090.477805,7.83,77,8,15,5,23,221.72,C56H68ClFN12O6S,"InChI=1S/C56H68ClFN12O6S/c1-36-51(77-35-62-36)38-18-16-37(17-19-38)30-59-54(74)47-27-41(71)32-70(47)55(75)52(56(2,3)4)65-50(73)14-9-6-5-7-12-25-69-31-40(66-67-69)33-76-48-29-45-42(53(61-34-60-45)63-39-20-21-44(58)43(57)26-39)28-46(48)64-49(72)15-13-24-68-22-10-8-11-23-68/h13,15-21,26,28-29,31,34-35,41,47,52,71H,5-12,14,22-25,27,30,32-33H2,1-4H3,(H,59,74)(H,64,72)(H,65,73)(H,60,61,63)/b15-13+/t41-,47+,52-/m1/s1",BUDQKNIUFHYJQZ-ABSCMPNGSA-N
2414,3.57,91,3.57,91,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3C=C(COC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR del19 in HCC-827 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,Inhibit proliferation of HCC-827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2022.105605,1133.837,1132.524755,9.46,80,8,15,5,26,221.72,C59H74ClFN12O6S,"InChI=1S/C59H74ClFN12O6S/c1-39-54(80-38-65-39)41-21-19-40(20-22-41)33-62-57(77)50-30-44(74)35-73(50)58(78)55(59(2,3)4)68-53(76)17-12-9-7-5-6-8-10-15-28-72-34-43(69-70-72)36-79-51-32-48-45(56(64-37-63-48)66-42-23-24-47(61)46(60)29-42)31-49(51)67-52(75)18-16-27-71-25-13-11-14-26-71/h16,18-24,29,31-32,34,37-38,44,50,55,74H,5-15,17,25-28,30,33,35-36H2,1-4H3,(H,62,77)(H,67,75)(H,68,76)(H,63,64,66)/b18-16+/t44-,50+,55-/m1/s1",RBUUUIFZYMVDPT-DLMBMICPSA-N
2418,36.51,99,36.51,,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3C=C(CCCCCOC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of EGFR in HCC-827 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4,Inhibit proliferation of HCC-827 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02221,1151.808,1150.498934,7.01,81,8,17,5,27,240.18,C58H72ClFN12O8S,"InChI=1S/C58H72ClFN12O8S/c1-38-53(81-37-64-38)40-16-14-39(15-17-40)32-61-56(76)49-29-43(73)34-72(49)57(77)54(58(2,3)4)67-52(75)35-79-27-26-78-25-23-71-33-42(68-69-71)12-7-5-10-24-80-50-31-47-44(55(63-36-62-47)65-41-18-19-46(60)45(59)28-41)30-48(50)66-51(74)13-11-22-70-20-8-6-9-21-70/h11,13-19,28,30-31,33,36-37,43,49,54,73H,5-10,12,20-27,29,32,34-35H2,1-4H3,(H,61,76)(H,66,74)(H,67,75)(H,62,63,65)/b13-11+/t43-,49+,54-/m1/s1",PXQHEFZTJMGFAP-QLJGRUAOSA-N
2424,640,59,640,59,O15379,HDAC3,VHL,,JPS014,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,140,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,854.087,853.4196682,5.85,61,5,10,6,20,205.08,C46H59N7O7S,"InChI=1S/C46H59N7O7S/c1-30-41(61-29-49-30)32-18-16-31(17-19-32)26-48-44(58)38-25-35(54)27-53(38)45(59)42(46(2,3)4)52-39(55)15-9-7-5-6-8-12-24-60-28-40(56)50-34-22-20-33(21-23-34)43(57)51-37-14-11-10-13-36(37)47/h10-11,13-14,16-23,29,35,38,42,54H,5-9,12,15,24-28,47H2,1-4H3,(H,48,58)(H,50,56)(H,51,57)(H,52,55)/t35-,38+,42-/m1/s1",QANLZMZKZIPVPD-DRTKLYQKSA-N
2424,910,74,910,74,Q13547,HDAC1,VHL,,JPS014,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC1 in HCT116 cells after 24 h treatment,,,220,IC50 of HDAC1-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,854.087,853.4196682,5.85,61,5,10,6,20,205.08,C46H59N7O7S,"InChI=1S/C46H59N7O7S/c1-30-41(61-29-49-30)32-18-16-31(17-19-32)26-48-44(58)38-25-35(54)27-53(38)45(59)42(46(2,3)4)52-39(55)15-9-7-5-6-8-12-24-60-28-40(56)50-34-22-20-33(21-23-34)43(57)51-37-14-11-10-13-36(37)47/h10-11,13-14,16-23,29,35,38,42,54H,5-9,12,15,24-28,47H2,1-4H3,(H,48,58)(H,50,56)(H,51,57)(H,52,55)/t35-,38+,42-/m1/s1",QANLZMZKZIPVPD-DRTKLYQKSA-N
2424,4190,56,4190,56,Q92769,HDAC2,VHL,,JPS014,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC2 in HCT116 cells after 24 h treatment,,,360,IC50 of HDAC2-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,854.087,853.4196682,5.85,61,5,10,6,20,205.08,C46H59N7O7S,"InChI=1S/C46H59N7O7S/c1-30-41(61-29-49-30)32-18-16-31(17-19-32)26-48-44(58)38-25-35(54)27-53(38)45(59)42(46(2,3)4)52-39(55)15-9-7-5-6-8-12-24-60-28-40(56)50-34-22-20-33(21-23-34)43(57)51-37-14-11-10-13-36(37)47/h10-11,13-14,16-23,29,35,38,42,54H,5-9,12,15,24-28,47H2,1-4H3,(H,48,58)(H,50,56)(H,51,57)(H,52,55)/t35-,38+,42-/m1/s1",QANLZMZKZIPVPD-DRTKLYQKSA-N
2426,530,66,530,66,O15379,HDAC3,VHL,,JPS016,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,380,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,898.14,897.445883,6.16,64,5,11,6,23,214.31,C48H63N7O8S,"InChI=1S/C48H63N7O8S/c1-32-43(64-31-51-32)34-18-16-33(17-19-34)27-50-46(60)40-26-37(56)28-55(40)47(61)44(48(2,3)4)54-42(58)30-63-25-13-9-7-5-6-8-12-24-62-29-41(57)52-36-22-20-35(21-23-36)45(59)53-39-15-11-10-14-38(39)49/h10-11,14-23,31,37,40,44,56H,5-9,12-13,24-30,49H2,1-4H3,(H,50,60)(H,52,57)(H,53,59)(H,54,58)/t37-,40+,44-/m1/s1",BOXZMOCGSKLDAH-OUZJXKGJSA-N
2426,550,77,550,77,Q13547,HDAC1,VHL,,JPS016,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC1 in HCT116 cells after 24 h treatment,,,570,IC50 of HDAC1-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,898.14,897.445883,6.16,64,5,11,6,23,214.31,C48H63N7O8S,"InChI=1S/C48H63N7O8S/c1-32-43(64-31-51-32)34-18-16-33(17-19-34)27-50-46(60)40-26-37(56)28-55(40)47(61)44(48(2,3)4)54-42(58)30-63-25-13-9-7-5-6-8-12-24-62-29-41(57)52-36-22-20-35(21-23-36)45(59)53-39-15-11-10-14-38(39)49/h10-11,14-23,31,37,40,44,56H,5-9,12-13,24-30,49H2,1-4H3,(H,50,60)(H,52,57)(H,53,59)(H,54,58)/t37-,40+,44-/m1/s1",BOXZMOCGSKLDAH-OUZJXKGJSA-N
2438,1380,76,1380,76,O15379,HDAC3,VHL,,JPS035,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1OCCCCCCCCCCCC(=O)NC1=CC=C(C(=O)NC2=CC=CC=C2N)C=C1)C(C)(C)C,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,3810,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,896.168,895.4666184,7.56,64,5,10,6,22,205.08,C49H65N7O7S,"InChI=1S/C49H65N7O7S/c1-32-44(64-31-52-32)35-20-21-36(29-51-47(61)41-28-38(58)30-56(41)48(62)45(49(3,4)5)53-33(2)57)42(27-35)63-26-16-12-10-8-6-7-9-11-13-19-43(59)54-37-24-22-34(23-25-37)46(60)55-40-18-15-14-17-39(40)50/h14-15,17-18,20-25,27,31,38,41,45,58H,6-13,16,19,26,28-30,50H2,1-5H3,(H,51,61)(H,53,57)(H,54,59)(H,55,60)/t38-,41+,45-/m1/s1",XPJGKIYHVFVWKJ-XVYMMXEDSA-N
2438,3580,68,3580,68,Q13547,HDAC1,VHL,,JPS035,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1OCCCCCCCCCCCC(=O)NC1=CC=C(C(=O)NC2=CC=CC=C2N)C=C1)C(C)(C)C,Degradation of HDAC1 in HCT116 cells after 24 h treatment,,,1810,IC50 of HDAC1-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,896.168,895.4666184,7.56,64,5,10,6,22,205.08,C49H65N7O7S,"InChI=1S/C49H65N7O7S/c1-32-44(64-31-52-32)35-20-21-36(29-51-47(61)41-28-38(58)30-56(41)48(62)45(49(3,4)5)53-33(2)57)42(27-35)63-26-16-12-10-8-6-7-9-11-13-19-43(59)54-37-24-22-34(23-25-37)46(60)55-40-18-15-14-17-39(40)50/h14-15,17-18,20-25,27,31,38,41,45,58H,6-13,16,19,26,28-30,50H2,1-5H3,(H,51,61)(H,53,57)(H,54,59)(H,55,60)/t38-,41+,45-/m1/s1",XPJGKIYHVFVWKJ-XVYMMXEDSA-N
2439,440,77,440,77,O15379,HDAC3,VHL,,JPS036,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCCCCCCCCCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)=C2)SC=N1,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,9670,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,940.196,939.4728467,8.28,67,6,10,6,23,205.08,C51H66FN7O7S,"InChI=1S/C51H66FN7O7S/c1-33-44(67-32-55-33)35-19-20-36(30-54-47(63)41-29-38(60)31-59(41)48(64)45(50(2,3)4)58-49(65)51(52)25-26-51)42(28-35)66-27-15-11-9-7-5-6-8-10-12-18-43(61)56-37-23-21-34(22-24-37)46(62)57-40-17-14-13-16-39(40)53/h13-14,16-17,19-24,28,32,38,41,45,60H,5-12,15,18,25-27,29-31,53H2,1-4H3,(H,54,63)(H,56,61)(H,57,62)(H,58,65)/t38-,41+,45-/m1/s1",NAADBQUVFJWCFU-XVYMMXEDSA-N
2495,1,85,1,85,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,683.165,682.2306605,4.77,49,6,9,4,11,169.73,C36H35ClN6O6,"InChI=1S/C36H35ClN6O6/c37-30-19-27(10-4-22(30)20-38)49-26-11-7-24(8-12-26)41-33(45)21-2-5-23(6-3-21)39-16-1-17-40-25-9-13-28-29(18-25)36(48)43(35(28)47)31-14-15-32(44)42-34(31)46/h2-6,9-10,13,18-19,24,26,31,39-40H,1,7-8,11-12,14-17H2,(H,41,45)(H,42,44,46)/t24-,26-,31?",XLWFMSWFAKUJON-QYYYJOFJSA-N
2496,1.1,89,1.1,89,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,697.192,696.2463106,5.13,50,6,9,4,12,169.73,C37H37ClN6O6,"InChI=1S/C37H37ClN6O6/c38-31-20-28(11-5-23(31)21-39)50-27-12-8-25(9-13-27)42-34(46)22-3-6-24(7-4-22)40-17-1-2-18-41-26-10-14-29-30(19-26)37(49)44(36(29)48)32-15-16-33(45)43-35(32)47/h3-7,10-11,14,19-20,25,27,32,40-41H,1-2,8-9,12-13,15-18H2,(H,42,46)(H,43,45,47)/t25-,27-,32?",SEKBVYVWYRALIG-COJZMJFXSA-N
2497,0.2,95,0.2,95,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,711.219,710.2619606,5.49,51,6,9,4,13,169.73,C38H39ClN6O6,"InChI=1S/C38H39ClN6O6/c39-32-21-29(12-6-24(32)22-40)51-28-13-9-26(10-14-28)43-35(47)23-4-7-25(8-5-23)41-18-2-1-3-19-42-27-11-15-30-31(20-27)38(50)45(37(30)49)33-16-17-34(46)44-36(33)48/h4-8,11-12,15,20-21,26,28,33,41-42H,1-3,9-10,13-14,16-19H2,(H,43,47)(H,44,46,48)/t26-,28-,33?",FZVBQSWNRMPEHR-NBAFNCFLSA-N
2498,0.6,99,0.6,99,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,725.246,724.2776107,5.84,52,6,9,4,14,169.73,C39H41ClN6O6,"InChI=1S/C39H41ClN6O6/c40-33-22-30(13-7-25(33)23-41)52-29-14-10-27(11-15-29)44-36(48)24-5-8-26(9-6-24)42-19-3-1-2-4-20-43-28-12-16-31-32(21-28)39(51)46(38(31)50)34-17-18-35(47)45-37(34)49/h5-9,12-13,16,21-22,27,29,34,42-43H,1-4,10-11,14-15,17-20H2,(H,44,48)(H,45,47,49)/t27-,29-,34?",SLYLTYLJUFVQPH-BKPPXGSPSA-N
2499,0.7,99,0.7,99,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,739.273,738.2932608,6.38,53,6,9,4,15,169.73,C40H43ClN6O6,"InChI=1S/C40H43ClN6O6/c41-34-23-31(14-8-26(34)24-42)53-30-15-11-28(12-16-30)45-37(49)25-6-9-27(10-7-25)43-20-4-2-1-3-5-21-44-29-13-17-32-33(22-29)40(52)47(39(32)51)35-18-19-36(48)46-38(35)50/h6-10,13-14,17,22-23,28,30,35,43-44H,1-5,11-12,15-16,18-21H2,(H,45,49)(H,46,48,50)/t28-,30-,35?",KLUHWCISGKYNHH-KGNGEQPNSA-N
2500,1.5,97,1.5,97,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,753.3,752.3089108,6.93,54,6,9,4,16,169.73,C41H45ClN6O6,"InChI=1S/C41H45ClN6O6/c42-35-24-32(15-9-27(35)25-43)54-31-16-12-29(13-17-31)46-38(50)26-7-10-28(11-8-26)44-21-5-3-1-2-4-6-22-45-30-14-18-33-34(23-30)41(53)48(40(33)52)36-19-20-37(49)47-39(36)51/h7-11,14-15,18,23-24,29,31,36,44-45H,1-6,12-13,16-17,19-22H2,(H,46,50)(H,47,49,51)/t29-,31-,36?",LIAPRZHHMHGLCS-NSGDDVBOSA-N
2501,3.2,96,3.2,96,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,767.327,766.3245609,7.47,55,6,9,4,17,169.73,C42H47ClN6O6,"InChI=1S/C42H47ClN6O6/c43-36-25-33(16-10-28(36)26-44)55-32-17-13-30(14-18-32)47-39(51)27-8-11-29(12-9-27)45-22-6-4-2-1-3-5-7-23-46-31-15-19-34-35(24-31)42(54)49(41(34)53)37-20-21-38(50)48-40(37)52/h8-12,15-16,19,24-25,30,32,37,45-46H,1-7,13-14,17-18,20-23H2,(H,47,51)(H,48,50,52)/t30-,32-,37?",VSYZSMLAOKWORE-GUJMKDNBSA-N
2502,,,>1000,25,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,781.354,780.340211,8.01,56,6,9,4,18,169.73,C43H49ClN6O6,"InChI=1S/C43H49ClN6O6/c44-37-26-34(17-11-29(37)27-45)56-33-18-14-31(15-19-33)48-40(52)28-9-12-30(13-10-28)46-23-7-5-3-1-2-4-6-8-24-47-32-16-20-35-36(25-32)43(55)50(42(35)54)38-21-22-39(51)49-41(38)53/h9-13,16-17,20,25-26,31,33,38,46-47H,1-8,14-15,18-19,21-24H2,(H,48,52)(H,49,51,53)/t31-,33-,38?",RJFFRTWDHINENB-GCVZDEPESA-N
2503,,,>1000,42,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,795.381,794.355861,8.55,57,6,9,4,19,169.73,C44H51ClN6O6,"InChI=1S/C44H51ClN6O6/c45-38-27-35(18-12-30(38)28-46)57-34-19-15-32(16-20-34)49-41(53)29-10-13-31(14-11-29)47-24-8-6-4-2-1-3-5-7-9-25-48-33-17-21-36-37(26-33)44(56)51(43(36)55)39-22-23-40(52)50-42(39)54/h10-14,17-18,21,26-27,32,34,39,47-48H,1-9,15-16,19-20,22-25H2,(H,49,53)(H,50,52,54)/t32-,34-,39?",KPYLNSRIYNAOJF-RIZDTZEESA-N
2504,0.8,77,0.8,77,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,738.245,737.2728597,4.36,53,7,10,3,10,164.18,C39H40ClN7O6,"InChI=1S/C39H40ClN7O6/c40-33-22-30(9-3-25(33)23-41)53-29-10-4-26(5-11-29)43-36(49)24-1-7-28(8-2-24)46-19-17-45(18-20-46)16-15-42-27-6-12-31-32(21-27)39(52)47(38(31)51)34-13-14-35(48)44-37(34)50/h1-3,6-9,12,21-22,26,29,34,42H,4-5,10-11,13-20H2,(H,43,49)(H,44,48,50)/t26-,29-,34?",KUCKATJPXILIRH-BPHARUEYSA-N
2505,2.7,82,2.7,82,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,752.272,751.2885097,4.72,54,7,10,3,11,164.18,C40H42ClN7O6,"InChI=1S/C40H42ClN7O6/c41-34-23-31(10-4-26(34)24-42)54-30-11-5-27(6-12-30)44-37(50)25-2-8-29(9-3-25)47-20-18-46(19-21-47)17-1-16-43-28-7-13-32-33(22-28)40(53)48(39(32)52)35-14-15-36(49)45-38(35)51/h2-4,7-10,13,22-23,27,30,35,43H,1,5-6,11-12,14-21H2,(H,44,50)(H,45,49,51)/t27-,30-,35?",IOIPLMHHWKGICH-LFUVDIOQSA-N
2506,16.2,67,16.2,67,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,766.299,765.3041598,5.08,55,7,10,3,12,164.18,C41H44ClN7O6,"InChI=1S/C41H44ClN7O6/c42-35-24-32(11-5-27(35)25-43)55-31-12-6-28(7-13-31)45-38(51)26-3-9-30(10-4-26)48-21-19-47(20-22-48)18-2-1-17-44-29-8-14-33-34(23-29)41(54)49(40(33)53)36-15-16-37(50)46-39(36)52/h3-5,8-11,14,23-24,28,31,36,44H,1-2,6-7,12-13,15-22H2,(H,45,51)(H,46,50,52)/t28-,31-,36?",QFBDIBRAVHTJHW-HDGSNFBOSA-N
2507,0.9,85,0.9,85,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,780.326,779.3198099,5.44,56,7,10,3,13,164.18,C42H46ClN7O6,"InChI=1S/C42H46ClN7O6/c43-36-25-33(12-6-28(36)26-44)56-32-13-7-29(8-14-32)46-39(52)27-4-10-31(11-5-27)49-22-20-48(21-23-49)19-3-1-2-18-45-30-9-15-34-35(24-30)42(55)50(41(34)54)37-16-17-38(51)47-40(37)53/h4-6,9-12,15,24-25,29,32,37,45H,1-3,7-8,13-14,16-23H2,(H,46,52)(H,47,51,53)/t29-,32-,37?",RIBBYHBSLKRREX-MLUZTVPMSA-N
2508,0.2,97,0.2,97,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,792.337,791.3198099,5.25,57,8,10,2,9,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c44-37-24-34(9-3-29(37)25-45)57-33-10-4-30(5-11-33)46-40(53)28-1-6-31(7-2-28)50-21-19-48(20-22-50)26-27-15-17-49(18-16-27)32-8-12-35-36(23-32)43(56)51(42(35)55)38-13-14-39(52)47-41(38)54/h1-3,6-9,12,23-24,27,30,33,38H,4-5,10-11,13-22,26H2,(H,46,53)(H,47,52,54)/t30-,33-,38?",QJZUVOHJKPMREF-SIOTYANSSA-N
2508,155.3,90,155.3,>90,P10275,AR,CRBN,,TJA-107,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in human dermal papilla cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/smtd.202201293,792.337,791.3198099,5.25,57,8,10,2,9,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c44-37-24-34(9-3-29(37)25-45)57-33-10-4-30(5-11-33)46-40(53)28-1-6-31(7-2-28)50-21-19-48(20-22-50)26-27-15-17-49(18-16-27)32-8-12-35-36(23-32)43(56)51(42(35)55)38-13-14-39(52)47-41(38)54/h1-3,6-9,12,23-24,27,30,33,38H,4-5,10-11,13-22,26H2,(H,46,53)(H,47,52,54)/t30-,33-,38?",QJZUVOHJKPMREF-SIOTYANSSA-N
2509,0.3,88,0.3,88,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.9,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,778.31,777.3041598,5.06,56,8,10,2,8,155.39,C42H44ClN7O6,"InChI=1S/C42H44ClN7O6/c43-36-24-33(9-3-27(36)25-44)56-32-10-4-28(5-11-32)45-39(52)26-1-6-29(7-2-26)48-19-21-49(22-20-48)30-15-17-47(18-16-30)31-8-12-34-35(23-31)42(55)50(41(34)54)37-13-14-38(51)46-40(37)53/h1-3,6-9,12,23-24,28,30,32,37H,4-5,10-11,13-22H2,(H,45,52)(H,46,51,53)/t28-,32-,37?",SRMKEEIRTHASLG-MVHOYPFPSA-N
2510,0.2,95,0.2,95,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.7,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,778.31,777.3041598,5.06,56,8,10,2,8,155.39,C42H44ClN7O6,"InChI=1S/C42H44ClN7O6/c43-36-24-33(9-3-27(36)25-44)56-32-10-4-28(5-11-32)45-39(52)26-1-6-29(7-2-26)47-17-15-30(16-18-47)48-19-21-49(22-20-48)31-8-12-34-35(23-31)42(55)50(41(34)54)37-13-14-38(51)46-40(37)53/h1-3,6-9,12,23-24,28,30,32,37H,4-5,10-11,13-22H2,(H,45,52)(H,46,51,53)/t28-,32-,37?",ZEEFAZNIKLZENT-MVHOYPFPSA-N
2511,0.3,92,0.3,92,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CC5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.7,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,764.283,763.2885097,4.53,55,8,10,2,9,155.39,C41H42ClN7O6,"InChI=1S/C41H42ClN7O6/c42-35-20-32(9-3-27(35)21-43)55-31-10-4-28(5-11-31)44-38(51)26-1-6-29(7-2-26)47-17-15-46(16-18-47)22-25-23-48(24-25)30-8-12-33-34(19-30)41(54)49(40(33)53)36-13-14-37(50)45-39(36)52/h1-3,6-9,12,19-20,25,28,31,36H,4-5,10-11,13-18,22-24H2,(H,44,51)(H,45,50,52)/t28-,31-,36?",ZXOIALMBAAMQKG-HDGSNFBOSA-N
2512,0.1,76,0.1,76,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,750.256,749.2728597,4.34,54,8,10,2,8,155.39,C40H40ClN7O6,"InChI=1S/C40H40ClN7O6/c41-34-20-31(9-3-25(34)21-42)54-30-10-4-26(5-11-30)43-37(50)24-1-6-27(7-2-24)45-15-17-46(18-16-45)29-22-47(23-29)28-8-12-32-33(19-28)40(53)48(39(32)52)35-13-14-36(49)44-38(35)51/h1-3,6-9,12,19-20,26,29-30,35H,4-5,10-11,13-18,22-23H2,(H,43,50)(H,44,49,51)/t26-,30-,35?",IFCKDGNCNVHZTM-KEQPVMAKSA-N
2513,,,>1000,20,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,764.283,763.2885097,4.7,55,8,10,2,8,155.39,C41H42ClN7O6,"InChI=1S/C41H42ClN7O6/c42-35-23-32(8-3-26(35)24-43)55-31-9-4-27(21-31)44-38(51)25-1-5-28(6-2-25)46-15-13-29(14-16-46)47-17-19-48(20-18-47)30-7-10-33-34(22-30)41(54)49(40(33)53)36-11-12-37(50)45-39(36)52/h1-3,5-8,10,22-23,27,29,31,36H,4,9,11-21H2,(H,44,51)(H,45,50,52)/t27-,31-,36?/m0/s1",GXUBCAYGWJGCKT-SVYXOXRISA-N
2514,,,>1000,45,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@@H]2CCC[C@@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,792.337,791.3198099,5.42,57,8,10,2,8,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c44-37-25-34(11-6-28(37)26-45)57-33-3-1-2-29(7-12-33)46-40(53)27-4-8-30(9-5-27)48-18-16-31(17-19-48)49-20-22-50(23-21-49)32-10-13-35-36(24-32)43(56)51(42(35)55)38-14-15-39(52)47-41(38)54/h4-6,8-11,13,24-25,29,31,33,38H,1-3,7,12,14-23H2,(H,46,53)(H,47,52,54)/t29-,33-,38?/m1/s1",VGXZUMFEKIFIQW-UCRZJGTBSA-N
2515,,,>1000,54,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CCC[C@@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CCC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,806.364,805.3354599,5.77,58,8,10,2,8,155.39,C44H48ClN7O6,"InChI=1S/C44H48ClN7O6/c45-38-26-35(13-9-29(38)27-46)58-34-5-1-3-30(4-2-6-34)47-41(54)28-7-10-31(11-8-28)49-19-17-32(18-20-49)50-21-23-51(24-22-50)33-12-14-36-37(25-33)44(57)52(43(36)56)39-15-16-40(53)48-42(39)55/h7-14,25-26,30,32,34,39H,1-6,15-24H2,(H,47,54)(H,48,53,55)/t30-,34+,39?",LOWACICYXXELEY-GDMVNCDBSA-N
2516,,,>1000,19,P10275,AR,CRBN,,,N#CC1=CC=C(OC2CCN(C(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,764.283,763.2885097,4.46,55,8,10,1,7,146.6,C41H42ClN7O6,"InChI=1S/C41H42ClN7O6/c42-35-24-32(7-3-27(35)25-43)55-31-13-17-48(18-14-31)39(52)26-1-4-28(5-2-26)45-15-11-29(12-16-45)46-19-21-47(22-20-46)30-6-8-33-34(23-30)41(54)49(40(33)53)36-9-10-37(50)44-38(36)51/h1-8,23-24,29,31,36H,9-22H2,(H,44,50,51)",RACWFSYZHXHUJV-UHFFFAOYSA-N
2517,,,>1000,35,P10275,AR,CRBN,,,N#CC1=CC=C(OC2CCCN(C(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,778.31,777.3041598,4.82,56,8,10,1,7,146.6,C42H44ClN7O6,"InChI=1S/C42H44ClN7O6/c43-36-25-33(9-5-28(36)26-44)56-32-2-1-16-49(19-15-32)40(53)27-3-6-29(7-4-27)46-17-13-30(14-18-46)47-20-22-48(23-21-47)31-8-10-34-35(24-31)42(55)50(41(34)54)37-11-12-38(51)45-39(37)52/h3-10,24-25,30,32,37H,1-2,11-23H2,(H,45,51,52)",SWYBGHSSRFVKQG-UHFFFAOYSA-N
2518,0.3,78,0.3,78,P10275,AR,CRBN,,,N#CC1=CC=C(N[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.6,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,5.07,56,8,10,3,8,158.19,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c43-36-23-30(4-1-27(36)25-44)45-28-5-7-29(8-6-28)46-39(53)26-2-9-31(10-3-26)48-17-15-32(16-18-48)49-19-21-50(22-20-49)33-11-12-34-35(24-33)42(56)51(41(34)55)37-13-14-38(52)47-40(37)54/h1-4,9-12,23-24,28-29,32,37,45H,5-8,13-22H2,(H,46,53)(H,47,52,54)/t28-,29-,37?",IRDHCECVXOCRLY-QZHRDHLUSA-N
2519,0.09,99,0.09,99,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)49-18-16-32(17-19-49)50-20-22-51(23-21-50)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",BEEAHZAQHFFDHP-KIIACXQNSA-N
2519,0.3,95,0.3,95,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.3,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)49-18-16-32(17-19-49)50-20-22-51(23-21-50)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",BEEAHZAQHFFDHP-KIIACXQNSA-N
2520,0.1,99,0.1,99,P10275,AR,CRBN,,,CCN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,805.38,804.3514443,5.58,58,8,10,2,9,149.4,C44H49ClN8O5,"InChI=1S/C44H49ClN8O5/c1-2-52(35-10-5-29(27-46)38(45)26-35)33-11-6-30(7-12-33)47-41(55)28-3-8-31(9-4-28)49-19-17-32(18-20-49)50-21-23-51(24-22-50)34-13-14-36-37(25-34)44(58)53(43(36)57)39-15-16-40(54)48-42(39)56/h3-5,8-10,13-14,25-26,30,32-33,39H,2,6-7,11-12,15-24H2,1H3,(H,47,55)(H,48,54,56)/t30-,33-,39?",VZVAWYNZTBXESG-BULKPCKOSA-N
2521,1.4,88,1.4,88,P10275,AR,CRBN,,,CCCN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.5,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,819.407,818.3670944,6.1,59,8,10,2,10,149.4,C45H51ClN8O5,"InChI=1S/C45H51ClN8O5/c1-2-19-53(36-10-5-30(28-47)39(46)27-36)34-11-6-31(7-12-34)48-42(56)29-3-8-32(9-4-29)50-20-17-33(18-21-50)51-22-24-52(25-23-51)35-13-14-37-38(26-35)45(59)54(44(37)58)40-15-16-41(55)49-43(40)57/h3-5,8-10,13-14,26-27,31,33-34,40H,2,6-7,11-12,15-25H2,1H3,(H,48,56)(H,49,55,57)/t31-,34-,40?",FVEFTVCRDXCSLR-MLTFQQHKSA-N
2522,1.4,93,1.4,93,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(CC4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,805.38,804.3514443,5.4,58,8,10,2,9,149.4,C44H49ClN8O5,"InChI=1S/C44H49ClN8O5/c1-49(34-9-4-30(26-46)38(45)25-34)32-10-5-31(6-11-32)47-41(55)29-2-7-33(8-3-29)52-22-20-50(21-23-52)27-28-16-18-51(19-17-28)35-12-13-36-37(24-35)44(58)53(43(36)57)39-14-15-40(54)48-42(39)56/h2-4,7-9,12-13,24-25,28,31-32,39H,5-6,10-11,14-23,27H2,1H3,(H,47,55)(H,48,54,56)/t31-,32-,39?",FSMCKEYFGVIYBM-WIDQNFKDSA-N
2523,0.5,96,0.5,96,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,805.38,804.3514443,5.4,58,8,10,2,9,149.4,C44H49ClN8O5,"InChI=1S/C44H49ClN8O5/c1-49(34-9-4-30(26-46)38(45)25-34)32-10-5-31(6-11-32)47-41(55)29-2-7-33(8-3-29)51-18-16-28(17-19-51)27-50-20-22-52(23-21-50)35-12-13-36-37(24-35)44(58)53(43(36)57)39-14-15-40(54)48-42(39)56/h2-4,7-9,12-13,24-25,28,31-32,39H,5-6,10-11,14-23,27H2,1H3,(H,47,55)(H,48,54,56)/t31-,32-,39?",XLQOXOVXCNIRJP-WIDQNFKDSA-N
2524,0.1,96,0.1,96,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.8,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)50-20-22-51(23-21-50)32-16-18-49(19-17-32)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",WHJVBMNCPUFBSX-KIIACXQNSA-N
2524,0.4,95,0.4,95,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22.3,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)50-20-22-51(23-21-50)32-16-18-49(19-17-32)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",WHJVBMNCPUFBSX-KIIACXQNSA-N
2525,0.01,99,0.01,99,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)49-18-16-48(17-19-49)23-26-24-50(25-26)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",YYULHFDWXXZSRM-VZASAIHWSA-N
2525,0.9,99,0.9,99,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.4,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)49-18-16-48(17-19-49)23-26-24-50(25-26)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",YYULHFDWXXZSRM-VZASAIHWSA-N
2526,0.04,99,0.04,99,P10275,AR,CRBN,,ARD-2585,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)47-16-18-48(19-17-47)32-23-49(24-32)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",LUCHABJUYSYJAT-RVWRWSNSSA-N
2526,0.1,98,0.1,98,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.2,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)47-16-18-48(19-17-47)32-23-49(24-32)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",LUCHABJUYSYJAT-RVWRWSNSSA-N
2527,0.1,99.9,0.1,100,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)50-24-26(25-50)23-48-16-18-49(19-17-48)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",LOFIFWMXRZZLIL-VZASAIHWSA-N
2527,1.9,99,1.9,99,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.6,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)50-24-26(25-50)23-48-16-18-49(19-17-48)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",LOFIFWMXRZZLIL-VZASAIHWSA-N
2528,0.2,96,0.2,96,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)49-23-32(24-49)48-18-16-47(17-19-48)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",RNZSZCNUPQYOIX-RVWRWSNSSA-N
2528,1.3,64,1.3,64,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21.7,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)49-23-32(24-49)48-18-16-47(17-19-48)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",RNZSZCNUPQYOIX-RVWRWSNSSA-N
2529,,,>1000,32,P10275,AR,CRBN,,,CC(O)(CS(=O)(=O)C1=CC=C(N2CCN(C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C=C1)C(=O)NC1=CC=C(C#N)C(C(F)(F)F)=C1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,835.862,835.2611169,2.72,59,7,12,3,9,200.53,C40H40F3N7O8S,"InChI=1S/C40H40F3N7O8S/c1-39(56,38(55)45-25-3-2-24(22-44)32(20-25)40(41,42)43)23-59(57,58)29-7-4-26(5-8-29)48-16-18-49(19-17-48)27-12-14-47(15-13-27)28-6-9-30-31(21-28)37(54)50(36(30)53)33-10-11-34(51)46-35(33)52/h2-9,20-21,27,33,56H,10-19,23H2,1H3,(H,45,55)(H,46,51,52)",RDTWXYREPJFRLJ-UHFFFAOYSA-N
2530,,,>1000,14,P10275,AR,CRBN,,,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(C(=O)N2CCN(C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C(F)=C1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,858.875,858.2571148,4.18,61,8,10,1,6,157.68,C42H38F4N8O6S,"InChI=1S/C42H38F4N8O6S/c1-41(2)39(60)52(26-4-3-23(22-47)31(20-26)42(44,45)46)40(61)54(41)27-6-8-29(32(43)21-27)36(57)51-17-15-50(16-18-51)24-11-13-49(14-12-24)25-5-7-28-30(19-25)38(59)53(37(28)58)33-9-10-34(55)48-35(33)56/h3-8,19-21,24,33H,9-18H2,1-2H3,(H,48,55,56)",GPZDKLVDAYMWLZ-UHFFFAOYSA-N
2531,,,>1000,27,P10275,AR,CRBN,,,N#CC1=NC=C(N2C(=O)C3(CCC3)N(C3=CC=C(C(=O)N4CCN(C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C(F)=C3)C2=S)C=C1C(F)(F)F,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,871.874,871.2523638,3.55,62,9,11,1,6,170.57,C42H37F4N9O6S,"InChI=1S/C42H37F4N9O6S/c43-31-20-25(55-40(62)53(39(61)41(55)10-1-11-41)26-19-30(42(44,45)46)32(21-47)48-22-26)3-5-28(31)36(58)52-16-14-51(15-17-52)23-8-12-50(13-9-23)24-2-4-27-29(18-24)38(60)54(37(27)59)33-6-7-34(56)49-35(33)57/h2-5,18-20,22-23,33H,1,6-17H2,(H,49,56,57)",DTFBEQQOOYQAKH-UHFFFAOYSA-N
2544,0.0173,99,0.0263/0.0173,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-7,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5CCN(C6=CC=C(NC(=O)C7=CN=C(OC8=CC=CC=C8)N=C7)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,Degradation of HPGDS in KU812 cells after 6/24 h treatment,,,170,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01206,742.793,742.2863456,2.77,55,8,11,2,8,174.45,C40H38N8O7,"InChI=1S/C40H38N8O7/c49-33-14-13-32(36(51)44-33)48-38(53)30-7-4-8-31(34(30)39(48)54)46-19-21-47(22-20-46)37(52)25-15-17-45(18-16-25)28-11-9-27(10-12-28)43-35(50)26-23-41-40(42-24-26)55-29-5-2-1-3-6-29/h1-12,23-25,32H,13-22H2,(H,43,50)(H,44,49,51)",KQNXUQJGOJWQGL-UHFFFAOYSA-N
2544,0.0187,99,0.0187,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-7,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5CCN(C6=CC=C(NC(=O)C7=CN=C(OC8=CC=CC=C8)N=C7)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,Degradation of H-PGDS in KU182 cells after 24h treatment,,,116.5,Inhibit of H-PGDS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2md00284a,742.793,742.2863456,2.77,55,8,11,2,8,174.45,C40H38N8O7,"InChI=1S/C40H38N8O7/c49-33-14-13-32(36(51)44-33)48-38(53)30-7-4-8-31(34(30)39(48)54)46-19-21-47(22-20-46)37(52)25-15-17-45(18-16-25)28-11-9-27(10-12-28)43-35(50)26-23-41-40(42-24-26)55-29-5-2-1-3-6-29/h1-12,23-25,32H,13-22H2,(H,43,50)(H,44,49,51)",KQNXUQJGOJWQGL-UHFFFAOYSA-N
2544,0.036,99,0.036,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-4-TFC,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5CCN(C6=CC=C(NC(=O)C7=CN=C(OC8=CC=CC=C8)N=C7)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,Degradation of H-PGDS in KU812 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.07,PAMPA assay,,,,,10.1016/j.bmc.2023.117259,742.793,742.2863456,2.77,55,8,11,2,8,174.45,C40H38N8O7,"InChI=1S/C40H38N8O7/c49-33-14-13-32(36(51)44-33)48-38(53)30-7-4-8-31(34(30)39(48)54)46-19-21-47(22-20-46)37(52)25-15-17-45(18-16-25)28-11-9-27(10-12-28)43-35(50)26-23-41-40(42-24-26)55-29-5-2-1-3-6-29/h1-12,23-25,32H,13-22H2,(H,43,50)(H,44,49,51)",KQNXUQJGOJWQGL-UHFFFAOYSA-N
2558,78,99,78,,P31751,AKT2,VHL,,MS98,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCC(=O)NCCNC[C@@H](C(=O)N3CCN(C4=NC=NC5=C4[C@H](C)C[C@H]5O)CC3)C3=CC=C(Cl)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of total AKT in BT474 cells after 24 h treatment,,,,,,,140,Kd was assessed by a competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1300/9200/3800,Inhibit proliferation of BT474/PC3/MDA-MB-468 cells,,,,,,,,,,,10.1021/acs.jmedchem.1c01476,1097.869,1096.569894,7.29,77,7,13,6,25,222.32,C58H81ClN10O7S,"InChI=1S/C58H81ClN10O7S/c1-37-31-47(71)51-50(37)54(63-35-62-51)67-27-29-68(30-28-67)56(75)45(41-21-23-43(59)24-22-41)33-60-25-26-61-48(72)15-13-11-9-7-8-10-12-14-16-49(73)66-53(58(4,5)6)57(76)69-34-44(70)32-46(69)55(74)65-38(2)40-17-19-42(20-18-40)52-39(3)64-36-77-52/h17-24,35-38,44-47,53,60,70-71H,7-16,25-34H2,1-6H3,(H,61,72)(H,65,74)(H,66,73)/t37-,38+,44-,45-,46+,47-,53-/m1/s1",QUWWUNJGSUEYJK-PYSDWBMZSA-N
2558,78,99,78,,P31749,AKT1,VHL,,MS98,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCC(=O)NCCNC[C@@H](C(=O)N3CCN(C4=NC=NC5=C4[C@H](C)C[C@H]5O)CC3)C3=CC=C(Cl)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of total AKT in BT474 cells after 24 h treatment,,,,,,,4,Kd was assessed by a competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1300/9200/3800,Inhibit proliferation of BT474/PC3/MDA-MB-468 cells,,,,,,,,,,,10.1021/acs.jmedchem.1c01476,1097.869,1096.569894,7.29,77,7,13,6,25,222.32,C58H81ClN10O7S,"InChI=1S/C58H81ClN10O7S/c1-37-31-47(71)51-50(37)54(63-35-62-51)67-27-29-68(30-28-67)56(75)45(41-21-23-43(59)24-22-41)33-60-25-26-61-48(72)15-13-11-9-7-8-10-12-14-16-49(73)66-53(58(4,5)6)57(76)69-34-44(70)32-46(69)55(74)65-38(2)40-17-19-42(20-18-40)52-39(3)64-36-77-52/h17-24,35-38,44-47,53,60,70-71H,7-16,25-34H2,1-6H3,(H,61,72)(H,65,74)(H,66,73)/t37-,38+,44-,45-,46+,47-,53-/m1/s1",QUWWUNJGSUEYJK-PYSDWBMZSA-N
2558,78,99,78,,Q9Y243,AKT3,VHL,,MS98,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCC(=O)NCCNC[C@@H](C(=O)N3CCN(C4=NC=NC5=C4[C@H](C)C[C@H]5O)CC3)C3=CC=C(Cl)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of total AKT in BT474 cells after 24 h treatment,,,,,,,8.1,Kd was assessed by a competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1300/9200/3800,Inhibit proliferation of BT474/PC3/MDA-MB-468 cells,,,,,,,,,,,10.1021/acs.jmedchem.1c01476,1097.869,1096.569894,7.29,77,7,13,6,25,222.32,C58H81ClN10O7S,"InChI=1S/C58H81ClN10O7S/c1-37-31-47(71)51-50(37)54(63-35-62-51)67-27-29-68(30-28-67)56(75)45(41-21-23-43(59)24-22-41)33-60-25-26-61-48(72)15-13-11-9-7-8-10-12-14-16-49(73)66-53(58(4,5)6)57(76)69-34-44(70)32-46(69)55(74)65-38(2)40-17-19-42(20-18-40)52-39(3)64-36-77-52/h17-24,35-38,44-47,53,60,70-71H,7-16,25-34H2,1-6H3,(H,61,72)(H,65,74)(H,66,73)/t37-,38+,44-,45-,46+,47-,53-/m1/s1",QUWWUNJGSUEYJK-PYSDWBMZSA-N
2570,32,99,32,,P31751,AKT2,CRBN,,MS170,C[C@@H]1C[C@@H](O)C2=NC=NC(N3CCN(C(=O)[C@H](CNCCC(=O)NCCCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C4=CC=C(Cl)C=C4)CC3)=C21,Degradation of total AKT in BT474 cells after 24 h treatment,,,,,,,77,Kd was assessed by a competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,700/7400/5700,Inhibit proliferation of BT474/PC3/MDA-MB-468 cells,,,,,,,,,,,10.1021/acs.jmedchem.1c01476,870.452,869.3991228,3.86,62,7,12,5,19,206.27,C45H56ClN9O7,"InChI=1S/C45H56ClN9O7/c1-28-25-35(56)40-38(28)41(51-27-50-40)53-21-23-54(24-22-53)43(60)32(29-11-13-30(46)14-12-29)26-47-20-17-36(57)49-19-7-5-3-2-4-6-18-48-33-10-8-9-31-39(33)45(62)55(44(31)61)34-15-16-37(58)52-42(34)59/h8-14,27-28,32,34-35,47-48,56H,2-7,15-26H2,1H3,(H,49,57)(H,52,58,59)/t28-,32-,34?,35-/m1/s1",QMLFGZYEQAMKRK-SCQVZNLVSA-N
2570,32,99,32,,P31749,AKT1,CRBN,,MS170,C[C@@H]1C[C@@H](O)C2=NC=NC(N3CCN(C(=O)[C@H](CNCCC(=O)NCCCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C4=CC=C(Cl)C=C4)CC3)=C21,Degradation of total AKT in BT474 cells after 24 h treatment,,,,,,,1.3,Kd was assessed by a competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,700/7400/5700,Inhibit proliferation of BT474/PC3/MDA-MB-468 cells,,,,,,,,,,,10.1021/acs.jmedchem.1c01476,870.452,869.3991228,3.86,62,7,12,5,19,206.27,C45H56ClN9O7,"InChI=1S/C45H56ClN9O7/c1-28-25-35(56)40-38(28)41(51-27-50-40)53-21-23-54(24-22-53)43(60)32(29-11-13-30(46)14-12-29)26-47-20-17-36(57)49-19-7-5-3-2-4-6-18-48-33-10-8-9-31-39(33)45(62)55(44(31)61)34-15-16-37(58)52-42(34)59/h8-14,27-28,32,34-35,47-48,56H,2-7,15-26H2,1H3,(H,49,57)(H,52,58,59)/t28-,32-,34?,35-/m1/s1",QMLFGZYEQAMKRK-SCQVZNLVSA-N
2570,32,99,32,,Q9Y243,AKT3,CRBN,,MS170,C[C@@H]1C[C@@H](O)C2=NC=NC(N3CCN(C(=O)[C@H](CNCCC(=O)NCCCCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C4=CC=C(Cl)C=C4)CC3)=C21,Degradation of total AKT in BT474 cells after 24 h treatment,,,,,,,6.5,Kd was assessed by a competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,700/7400/5700,Inhibit proliferation of BT474/PC3/MDA-MB-468 cells,,,,,,,,,,,10.1021/acs.jmedchem.1c01476,870.452,869.3991228,3.86,62,7,12,5,19,206.27,C45H56ClN9O7,"InChI=1S/C45H56ClN9O7/c1-28-25-35(56)40-38(28)41(51-27-50-40)53-21-23-54(24-22-53)43(60)32(29-11-13-30(46)14-12-29)26-47-20-17-36(57)49-19-7-5-3-2-4-6-18-48-33-10-8-9-31-39(33)45(62)55(44(31)61)34-15-16-37(58)52-42(34)59/h8-14,27-28,32,34-35,47-48,56H,2-7,15-26H2,1H3,(H,49,57)(H,52,58,59)/t28-,32-,34?,35-/m1/s1",QMLFGZYEQAMKRK-SCQVZNLVSA-N
2625,0.49,82,0.49,82,P00533,EGFR e19d,VHL,,,C=CC(=O)N1CCC[C@H](N2C(NC3=CC=CC=C3)=NC3=CN=C(NC4=CC=C(N5CCN(CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)N=C32)C1,Degradation of EGFR e19d in HCC827 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6/298/105,Inhibit proliferation of HCC827 (EGFR del19)/HCT116/SU-DHL-6 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01827,1092.429,1091.589134,8.86,79,9,15,5,21,206.08,C60H77N13O5S,"InChI=1S/C60H77N13O5S/c1-7-52(76)71-30-16-19-47(37-71)73-55-49(66-59(73)65-44-17-12-11-13-18-44)36-61-58(68-55)64-45-25-27-46(28-26-45)70-33-31-69(32-34-70)29-15-10-8-9-14-20-51(75)67-54(60(4,5)6)57(78)72-38-48(74)35-50(72)56(77)63-40(2)42-21-23-43(24-22-42)53-41(3)62-39-79-53/h7,11-13,17-18,21-28,36,39-40,47-48,50,54,74H,1,8-10,14-16,19-20,29-35,37-38H2,2-6H3,(H,63,77)(H,65,66)(H,67,75)(H,61,64,68)/t40-,47-,48+,50-,54+/m0/s1",RYXQXEGTLNBKEC-DKQRTKIFSA-N
2625,1.56,86,1.56,86,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)N1CCC[C@H](N2C(NC3=CC=CC=C3)=NC3=CN=C(NC4=CC=C(N5CCN(CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)N=C32)C1,Degradation of EGFR L858R/T790M in H1975 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32/298/105,Inhibit proliferation of H1975 (EGFR L858R/T790M)/HCT116/SU-DHL-6 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01827,1092.429,1091.589134,8.86,79,9,15,5,21,206.08,C60H77N13O5S,"InChI=1S/C60H77N13O5S/c1-7-52(76)71-30-16-19-47(37-71)73-55-49(66-59(73)65-44-17-12-11-13-18-44)36-61-58(68-55)64-45-25-27-46(28-26-45)70-33-31-69(32-34-70)29-15-10-8-9-14-20-51(75)67-54(60(4,5)6)57(78)72-38-48(74)35-50(72)56(77)63-40(2)42-21-23-43(24-22-42)53-41(3)62-39-79-53/h7,11-13,17-18,21-28,36,39-40,47-48,50,54,74H,1,8-10,14-16,19-20,29-35,37-38H2,2-6H3,(H,63,77)(H,65,66)(H,67,75)(H,61,64,68)/t40-,47-,48+,50-,54+/m0/s1",RYXQXEGTLNBKEC-DKQRTKIFSA-N
2628,216.4,99,216.4,,Q07889,SOS1,VHL,,,CC1=CC(CN2C(N3CC4(CNC4)C3)=NC3=C(N4CCN(CCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C(Cl)C=C32)=CC(C)=C1F,Degradation of SOS1 in NCI-H358 cells after 24 h treatment,30.7/79.9,% SOS1 degradation in NCI-H358 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01774,1023.765,1022.513128,8.15,72,9,12,4,17,151.2,C55H72ClFN10O4S,"InChI=1S/C55H72ClFN10O4S/c1-34-22-38(23-35(2)47(34)57)27-67-44-25-41(56)24-43(48(44)62-53(67)65-31-55(32-65)29-58-30-55)64-20-18-63(19-21-64)17-11-9-8-10-12-46(69)61-50(54(5,6)7)52(71)66-28-42(68)26-45(66)51(70)60-36(3)39-13-15-40(16-14-39)49-37(4)59-33-72-49/h13-16,22-25,33,36,42,45,50,58,68H,8-12,17-21,26-32H2,1-7H3,(H,60,70)(H,61,69)/t36-,42+,45-,50+/m0/s1",RWXRMOUTGNDVRG-UEFBMBKASA-N
2629,150.3,99,150.3,,Q07889,SOS1,VHL,,,CC1=CC(CN2C(N3CC4(CNC4)C3)=NC3=C(N4CCN(CCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C(Cl)C=C32)=CC(C)=C1F,Degradation of SOS1 in NCI-H358 cells after 24 h treatment,27.6/80.9,% SOS1 degradation in NCI-H358 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01774,1037.792,1036.528778,8.69,73,9,12,4,18,151.2,C56H74ClFN10O4S,"InChI=1S/C56H74ClFN10O4S/c1-35-23-39(24-36(2)48(35)58)28-68-45-26-42(57)25-44(49(45)63-54(68)66-32-56(33-66)30-59-31-56)65-21-19-64(20-22-65)18-12-10-8-9-11-13-47(70)62-51(55(5,6)7)53(72)67-29-43(69)27-46(67)52(71)61-37(3)40-14-16-41(17-15-40)50-38(4)60-34-73-50/h14-17,23-26,34,37,43,46,51,59,69H,8-13,18-22,27-33H2,1-7H3,(H,61,71)(H,62,70)/t37-,43+,46-,51+/m0/s1",BQACEOFNSGFSPA-FIOHTOFWSA-N
2630,22,99,104/125/22,,Q07889,SOS1,VHL,,,CC1=CC(CN2C(N3CC4(CNC4)C3)=NC3=C(N4CCN(CCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C(Cl)C=C32)=CC(C)=C1F,Degradation of SOS1 in SK-LU-1/SW620/A549 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,115/199/232,Inhibit growth of SK-LU-1/SW620/A549 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01774,1051.819,1050.544428,9.23,74,9,12,4,19,151.2,C57H76ClFN10O4S,"InChI=1S/C57H76ClFN10O4S/c1-36-24-40(25-37(2)49(36)59)29-69-46-27-43(58)26-45(50(46)64-55(69)67-33-57(34-67)31-60-32-57)66-22-20-65(21-23-66)19-13-11-9-8-10-12-14-48(71)63-52(56(5,6)7)54(73)68-30-44(70)28-47(68)53(72)62-38(3)41-15-17-42(18-16-41)51-39(4)61-35-74-51/h15-18,24-27,35,38,44,47,52,60,70H,8-14,19-23,28-34H2,1-7H3,(H,62,72)(H,63,71)/t38-,44+,47-,52+/m0/s1",AZBRWXRYNYEDKG-VWELVXIZSA-N
2630,98.4,99,98.4/255/119,,Q07889,SOS1,VHL,,,CC1=CC(CN2C(N3CC4(CNC4)C3)=NC3=C(N4CCN(CCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C(Cl)C=C32)=CC(C)=C1F,Degradation of SOS1 in NCI-H358/MIA PaCa2/AsPC-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,56,SPR,,,,,,,,,,,,,,,3.7,Kd between VHL and the complex of protac and SOS1 was tested by SPR,,,,,,,,,,,525/218/307,Inhibit growth of NCI-H358/MIA PaCa2/AsPC-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01774,1051.819,1050.544428,9.23,74,9,12,4,19,151.2,C57H76ClFN10O4S,"InChI=1S/C57H76ClFN10O4S/c1-36-24-40(25-37(2)49(36)59)29-69-46-27-43(58)26-45(50(46)64-55(69)67-33-57(34-67)31-60-32-57)66-22-20-65(21-23-66)19-13-11-9-8-10-12-14-48(71)63-52(56(5,6)7)54(73)68-30-44(70)28-47(68)53(72)62-38(3)41-15-17-42(18-16-41)51-39(4)61-35-74-51/h15-18,24-27,35,38,44,47,52,60,70H,8-14,19-23,28-34H2,1-7H3,(H,62,72)(H,63,71)/t38-,44+,47-,52+/m0/s1",AZBRWXRYNYEDKG-VWELVXIZSA-N
2631,182.1,99,182.1,,Q07889,SOS1,VHL,,,CC1=CC(CN2C(N3CC4(CNC4)C3)=NC3=C(N4CCN(CCCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C(Cl)C=C32)=CC(C)=C1F,Degradation of SOS1 in NCI-H358 cells after 24 h treatment,38.5/82,% SOS1 degradation in NCI-H358 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01774,1065.846,1064.560078,9.77,75,9,12,4,20,151.2,C58H78ClFN10O4S,"InChI=1S/C58H78ClFN10O4S/c1-37-25-41(26-38(2)50(37)60)30-70-47-28-44(59)27-46(51(47)65-56(70)68-34-58(35-68)32-61-33-58)67-23-21-66(22-24-67)20-14-12-10-8-9-11-13-15-49(72)64-53(57(5,6)7)55(74)69-31-45(71)29-48(69)54(73)63-39(3)42-16-18-43(19-17-42)52-40(4)62-36-75-52/h16-19,25-28,36,39,45,48,53,61,71H,8-15,20-24,29-35H2,1-7H3,(H,63,73)(H,64,72)/t39-,45+,48-,53+/m0/s1",BKHFNIAHQPHQNG-NFPWTNQKSA-N
2672,50000,61,50000,61,P14679,TYR,CRBN,,,N[C@@H](CC1=CC=C(O)C(O)=C1)C(=O)NCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of TYR in A375 cells after 24 h treatment,,,112700,Inhibition of TYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113850,537.573,537.2223483,1.42,39,4,9,6,11,191.16,C27H31N5O7,"InChI=1S/C27H31N5O7/c28-17(13-15-7-9-20(33)21(34)14-15)24(36)30-12-3-1-2-11-29-18-6-4-5-16-23(18)27(39)32(26(16)38)19-8-10-22(35)31-25(19)37/h4-7,9,14,17,19,29,33-34H,1-3,8,10-13,28H2,(H,30,36)(H,31,35,37)/t17-,19?/m0/s1",GTUJRUVNUQLCDT-KKFHFHRHSA-N
2679,100,99,100,,P24941,CDK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCN3C=C(CCCS(=O)(=O)C4=CC=C(NC5=NC=CC(C6=CN=C(C)N6C(C)C)=N5)C=C4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of CDK2 in HEI-OC1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113849,981.219,980.4149343,4.22,69,7,17,4,20,241.34,C48H60N12O7S2,"InChI=1S/C48H60N12O7S2/c1-30(2)60-32(4)50-25-41(60)39-18-19-49-47(54-39)53-35-14-16-38(17-15-35)69(65,66)22-8-9-36-26-58(57-56-36)20-21-67-28-42(62)55-44(48(5,6)7)46(64)59-27-37(61)23-40(59)45(63)51-24-33-10-12-34(13-11-33)43-31(3)52-29-68-43/h10-19,25-26,29-30,37,40,44,61H,8-9,20-24,27-28H2,1-7H3,(H,51,63)(H,55,62)(H,49,53,54)/t37-,40+,44-/m1/s1",XVCGNRHPFMMQTF-OUZJXKGJSA-N
2690,1,99,<1/<1,>99/>99,O60885,BRD4,CRBN,,WWL0245,CC[C@@H]1C2=NN=C(C)N2C2=CN=C(NC3=CC=C(C(=O)NC4CCN(C(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3OC)N=C2N1CC1CCCCC1,Degradation of BRD4 in 22Rv1/VCaP cells after 24 h treatment,,,254,IC50 was assessed by a radiometric ATP-competitive kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/20.8/52.9,Inhibit proliferation of MV4-11/LNCaP/22Rv1 cells,,,,,,,,12a(WWL0245),,,,,,,10.1016/j.ejmech.2021.113922,873.972,873.3922076,4.21,64,9,15,3,12,223.18,C45H51N11O8,"InChI=1S/C45H51N11O8/c1-4-31-40-52-51-25(2)55(40)33-22-46-45(50-39(33)54(31)23-26-9-6-5-7-10-26)48-30-14-13-27(21-35(30)63-3)41(59)47-28-17-19-53(20-18-28)37(58)24-64-34-12-8-11-29-38(34)44(62)56(43(29)61)32-15-16-36(57)49-42(32)60/h8,11-14,21-22,26,28,31-32H,4-7,9-10,15-20,23-24H2,1-3H3,(H,47,59)(H,46,48,50)(H,49,57,60)/t31-,32?/m1/s1",AORZPRLVKUMTOJ-XGDNGBMYSA-N
2699,8.7,99,8.7,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18.42,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,815.313,814.2412423,3.95,57,7,14,4,13,208.16,C38H39ClN10O7S,"InChI=1S/C38H39ClN10O7S/c1-21-5-3-7-24(39)33(21)46-35(53)27-20-41-38(57-27)44-28-19-29(43-22(2)42-28)47-13-15-48(16-14-47)31(51)11-17-56-18-12-40-25-8-4-6-23-32(25)37(55)49(36(23)54)26-9-10-30(50)45-34(26)52/h3-8,19-20,26,40H,9-18H2,1-2H3,(H,46,53)(H,45,50,52)(H,41,42,43,44)",SZIZYLBRFVQQMV-UHFFFAOYSA-N
2700,17.5,99,17.5,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8.05,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,859.366,858.267457,3.8,60,7,15,4,16,217.39,C40H43ClN10O8S,"InChI=1S/C40H43ClN10O8S/c1-23-5-3-7-26(41)35(23)48-37(55)29-22-43-40(60-29)46-30-21-31(45-24(2)44-30)49-13-15-50(16-14-49)33(53)11-17-58-19-20-59-18-12-42-27-8-4-6-25-34(27)39(57)51(38(25)56)28-9-10-32(52)47-36(28)54/h3-8,21-22,28,42H,9-20H2,1-2H3,(H,48,55)(H,47,52,54)(H,43,44,45,46)",PWEJVOFOTMSQSC-UHFFFAOYSA-N
2701,18.4,99,18.4,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14.75,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,903.419,902.2936718,3.66,63,7,16,4,19,226.62,C42H47ClN10O9S,"InChI=1S/C42H47ClN10O9S/c1-25-5-3-7-28(43)37(25)50-39(57)31-24-45-42(63-31)48-32-23-33(47-26(2)46-32)51-13-15-52(16-14-51)35(55)11-17-60-19-21-62-22-20-61-18-12-44-29-8-4-6-27-36(29)41(59)53(40(27)58)30-9-10-34(54)49-38(30)56/h3-8,23-24,30,44H,9-22H2,1-2H3,(H,50,57)(H,49,54,56)(H,45,46,47,48)",KMYACHYBDVUSCP-UHFFFAOYSA-N
2702,26.1,99,26.1,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40.4,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,947.472,946.3198865,3.51,66,7,17,4,22,235.85,C44H51ClN10O10S,"InChI=1S/C44H51ClN10O10S/c1-27-5-3-7-30(45)39(27)52-41(59)33-26-47-44(66-33)50-34-25-35(49-28(2)48-34)53-13-15-54(16-14-53)37(57)11-17-62-19-21-64-23-24-65-22-20-63-18-12-46-31-8-4-6-29-38(31)43(61)55(42(29)60)32-9-10-36(56)51-40(32)58/h3-8,25-26,32,46H,9-24H2,1-2H3,(H,52,59)(H,51,56,58)(H,47,48,49,50)",UWFYRMKSZBLWRI-UHFFFAOYSA-N
2703,10.8,99,10.8,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCOCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31.9,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,991.525,990.3461013,3.36,69,7,18,4,25,245.08,C46H55ClN10O11S,"InChI=1S/C46H55ClN10O11S/c1-29-5-3-7-32(47)41(29)54-43(61)35-28-49-46(69-35)52-36-27-37(51-30(2)50-36)55-13-15-56(16-14-55)39(59)11-17-64-19-21-66-23-25-68-26-24-67-22-20-65-18-12-48-33-8-4-6-31-40(33)45(63)57(44(31)62)34-9-10-38(58)53-42(34)60/h3-8,27-28,34,48H,9-26H2,1-2H3,(H,54,61)(H,53,58,60)(H,49,50,51,52)",SILFGWIHHRCURU-UHFFFAOYSA-N
2704,7.8,99,7.8,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.5,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,785.287,784.2306776,4.46,55,7,13,4,11,198.93,C37H37ClN10O6S,"InChI=1S/C37H37ClN10O6S/c1-20-6-3-8-23(38)32(20)45-34(52)26-19-40-37(55-26)43-27-18-28(42-21(2)41-27)46-14-16-47(17-15-46)30(50)10-5-13-39-24-9-4-7-22-31(24)36(54)48(35(22)53)25-11-12-29(49)44-33(25)51/h3-4,6-9,18-19,25,39H,5,10-17H2,1-2H3,(H,45,52)(H,44,49,51)(H,40,41,42,43)",ULQMXQMXNOMYGN-UHFFFAOYSA-N
2705,11,99,11,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.55,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,799.314,798.2463276,4.81,56,7,13,4,12,198.93,C38H39ClN10O6S,"InChI=1S/C38H39ClN10O6S/c1-21-7-5-9-24(39)33(21)46-35(53)27-20-41-38(56-27)44-28-19-29(43-22(2)42-28)47-15-17-48(18-16-47)31(51)11-3-4-14-40-25-10-6-8-23-32(25)37(55)49(36(23)54)26-12-13-30(50)45-34(26)52/h5-10,19-20,26,40H,3-4,11-18H2,1-2H3,(H,46,53)(H,45,50,52)(H,41,42,43,44)",AMMLOEMUGDHWEL-UHFFFAOYSA-N
2706,9,99,9,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.47,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,827.368,826.2776278,5.71,58,7,13,4,14,198.93,C40H43ClN10O6S,"InChI=1S/C40H43ClN10O6S/c1-23-9-7-11-26(41)35(23)48-37(55)29-22-43-40(58-29)46-30-21-31(45-24(2)44-30)49-17-19-50(20-18-49)33(53)13-5-3-4-6-16-42-27-12-8-10-25-34(27)39(57)51(38(25)56)28-14-15-32(52)47-36(28)54/h7-12,21-22,28,42H,3-6,13-20H2,1-2H3,(H,48,55)(H,47,52,54)(H,43,44,45,46)",NUMLKLUMDIDGLZ-UHFFFAOYSA-N
2707,5.6,99,5.6,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CSC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,774.285,773.1605494,4.17,53,7,13,3,9,186.9,C35H32ClN9O6S2,"InChI=1S/C35H32ClN9O6S2/c1-18-5-3-7-21(36)30(18)42-32(49)24-16-37-35(53-24)40-25-15-26(39-19(2)38-25)43-11-13-44(14-12-43)28(47)17-52-23-8-4-6-20-29(23)34(51)45(33(20)50)22-9-10-27(46)41-31(22)48/h3-8,15-16,22H,9-14,17H2,1-2H3,(H,42,49)(H,41,46,48)(H,37,38,39,40)",OJLCJVMCSVZIQZ-UHFFFAOYSA-N
2708,10,99,10,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.22,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,757.233,756.1993775,4.2,53,7,13,4,9,198.93,C35H33ClN10O6S,"InChI=1S/C35H33ClN10O6S/c1-18-5-3-7-21(36)30(18)43-32(50)24-16-38-35(53-24)41-25-15-26(40-19(2)39-25)44-11-13-45(14-12-44)28(48)17-37-22-8-4-6-20-29(22)34(52)46(33(20)51)23-9-10-27(47)42-31(23)49/h3-8,15-16,23,37H,9-14,17H2,1-2H3,(H,43,50)(H,42,47,49)(H,38,39,40,41)",MFRLCRUPMVPIMD-UHFFFAOYSA-N
2709,11.1,99,11.1,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,758.217,757.183393,3.63,53,7,13,3,9,196.13,C35H32ClN9O7S,"InChI=1S/C35H32ClN9O7S/c1-18-5-3-7-21(36)30(18)42-32(49)24-16-37-35(53-24)40-25-15-26(39-19(2)38-25)43-11-13-44(14-12-43)28(47)17-52-23-8-4-6-20-29(23)34(51)45(33(20)50)22-9-10-27(46)41-31(22)48/h3-8,15-16,22H,9-14,17H2,1-2H3,(H,42,49)(H,41,46,48)(H,37,38,39,40)",NJRHGBYRTRXLKB-UHFFFAOYSA-N
2710,95.4,99,95.4,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.84,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,756.245,755.2041285,3.82,53,7,12,3,9,186.9,C36H34ClN9O6S,"InChI=1S/C36H34ClN9O6S/c1-19-5-3-8-23(37)31(19)43-33(50)25-18-38-36(53-25)41-26-17-27(40-20(2)39-26)44-13-15-45(16-14-44)29(48)12-9-21-6-4-7-22-30(21)35(52)46(34(22)51)24-10-11-28(47)42-32(24)49/h3-8,17-18,24H,9-16H2,1-2H3,(H,43,50)(H,42,47,49)(H,38,39,40,41)",SXKYAXKGNXJHBH-UHFFFAOYSA-N
2711,245.1,99,245.1,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CS(=O)(=O)C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,206,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,806.283,805.1503787,2.9,55,7,14,3,9,221.04,C35H32ClN9O8S2,"InChI=1S/C35H32ClN9O8S2/c1-18-5-3-7-21(36)30(18)42-32(49)23-16-37-35(54-23)40-25-15-26(39-19(2)38-25)43-11-13-44(14-12-43)28(47)17-55(52,53)24-8-4-6-20-29(24)34(51)45(33(20)50)22-9-10-27(46)41-31(22)48/h3-8,15-16,22H,9-14,17H2,1-2H3,(H,42,49)(H,41,46,48)(H,37,38,39,40)",NMCQXYSUJSZTPX-UHFFFAOYSA-N
2712,0.18,99,0.18,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCSC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.49,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,760.302,759.1812849,4.68,52,7,13,3,10,169.83,C35H34ClN9O5S2,"InChI=1S/C35H34ClN9O5S2/c1-19-5-3-7-22(36)30(19)42-32(48)25-18-37-35(52-25)40-26-17-27(39-20(2)38-26)44-13-11-43(12-14-44)15-16-51-24-8-4-6-21-29(24)34(50)45(33(21)49)23-9-10-28(46)41-31(23)47/h3-8,17-18,23H,9-16H2,1-2H3,(H,42,48)(H,41,46,47)(H,37,38,39,40)",QOGZTNFOSUHSAL-UHFFFAOYSA-N
2713,8.9,99,8.9,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CSC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.7,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,760.302,759.1812849,4.23,52,7,12,3,9,169.83,C35H34ClN9O5S2,"InChI=1S/C35H34ClN9O5S2/c1-19-5-3-7-23(36)31(19)42-33(49)26-16-37-35(52-26)40-27-15-28(39-20(2)38-27)43-11-13-44(14-12-43)30(47)18-51-25-8-4-6-21-22(25)17-45(34(21)50)24-9-10-29(46)41-32(24)48/h3-8,15-16,24H,9-14,17-18H2,1-2H3,(H,42,49)(H,41,46,48)(H,37,38,39,40)",YPUFMWKOTXCGRO-UHFFFAOYSA-N
2714,2.7,99,2.7,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCSC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.51,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,746.319,745.2020203,4.74,51,7,12,3,10,152.76,C35H36ClN9O4S2,"InChI=1S/C35H36ClN9O4S2/c1-20-5-3-7-24(36)31(20)42-33(48)27-18-37-35(51-27)40-28-17-29(39-21(2)38-28)44-13-11-43(12-14-44)15-16-50-26-8-4-6-22-23(26)19-45(34(22)49)25-9-10-30(46)41-32(25)47/h3-8,17-18,25H,9-16,19H2,1-2H3,(H,42,48)(H,41,46,47)(H,37,38,39,40)",TWBLQEUPMCWVSA-UHFFFAOYSA-N
2715,2.7,99,2.7,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.28,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,771.304,770.251413,5.42,54,7,13,4,12,181.86,C37H39ClN10O5S,"InChI=1S/C37H39ClN10O5S/c1-21-7-5-9-24(38)32(21)45-34(51)27-20-40-37(54-27)43-28-19-29(42-22(2)41-28)47-17-15-46(16-18-47)14-4-3-13-39-25-10-6-8-23-31(25)36(53)48(35(23)52)26-11-12-30(49)44-33(26)50/h5-10,19-20,26,39H,3-4,11-18H2,1-2H3,(H,45,51)(H,44,49,50)(H,40,41,42,43)",WXBNWDRYXKZBKS-UHFFFAOYSA-N
2716,10.1,99,10.1,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCCC(=O)NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,799.314,798.2463276,4.55,56,7,13,4,12,198.93,C38H39ClN10O6S,"InChI=1S/C38H39ClN10O6S/c1-21-7-5-9-24(39)33(21)46-35(53)27-20-40-38(56-27)44-28-19-29(42-22(2)41-28)48-17-15-47(16-18-48)14-4-3-11-30(50)43-25-10-6-8-23-32(25)37(55)49(36(23)54)26-12-13-31(51)45-34(26)52/h5-10,19-20,26H,3-4,11-18H2,1-2H3,(H,43,50)(H,46,53)(H,45,51,52)(H,40,41,42,44)",ZHOVUHAPZWSGIE-UHFFFAOYSA-N
2717,11.1,99,11.1,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCCNC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,785.331,784.2670631,4.32,55,7,12,4,12,181.86,C38H41ClN10O5S,"InChI=1S/C38H41ClN10O5S/c1-22-7-5-9-26(39)34(22)46-36(53)29-20-41-38(55-29)44-30-19-31(43-23(2)42-30)47-15-17-48(18-16-47)33(51)11-3-4-14-40-27-10-6-8-24-25(27)21-49(37(24)54)28-12-13-32(50)45-35(28)52/h5-10,19-20,28,40H,3-4,11-18,21H2,1-2H3,(H,46,53)(H,45,50,52)(H,41,42,43,44)",TYAXRGVMSNZDCH-UHFFFAOYSA-N
2718,125,99,125,,,BCR-ABL,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(C(=O)CCCC(=O)NC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BCR-ABL in K562 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.03,Inhibit proliferation of K562 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113645,799.314,798.2463276,3.09,56,7,12,4,11,198.93,C38H39ClN10O6S,"InChI=1S/C38H39ClN10O6S/c1-21-6-3-8-25(39)34(21)46-36(54)28-19-40-38(56-28)44-29-18-30(42-22(2)41-29)47-14-16-48(17-15-47)33(52)11-5-10-31(50)43-26-9-4-7-23-24(26)20-49(37(23)55)27-12-13-32(51)45-35(27)53/h3-4,6-9,18-19,27H,5,10-17,20H2,1-2H3,(H,43,50)(H,46,54)(H,45,51,53)(H,40,41,42,44)",XEXXSHKPXLLHJH-UHFFFAOYSA-N
2720,990,83.43,990,83.43,,HSP90,CRBN,,BP3,COC1=C(C)C=NC(CN2C=C(C#CCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C3=C(Cl)N=C(N)N=C32)=C1C,Degradation of HSP90 in MCF-7 cells after 6 h treatment,,,,,,,118000,BLI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,630/3530,Inhibit growth of MCF-7/MDA-MB-231 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.114013,641.088,640.1949437,3.58,46,6,11,3,7,174.43,C32H29ClN8O5,"InChI=1S/C32H29ClN8O5/c1-16-13-36-21(17(2)26(16)46-3)15-40-14-18(24-27(33)38-32(34)39-28(24)40)7-4-5-12-35-20-9-6-8-19-25(20)31(45)41(30(19)44)22-10-11-23(42)37-29(22)43/h6,8-9,13-14,22,35H,5,10-12,15H2,1-3H3,(H2,34,38,39)(H,37,42,43)",ZSERQSKFLSKTGE-UHFFFAOYSA-N
2740,412,99,416/412,,Q9NYV4,CDK12,CRBN,,PP-C8,CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4[NH]3)N=C(N3CCOCC3)N=C21,Degradation of CDK12 in Bel-7402/MDA-MB-231 cells after 24 h treatment,,,645.4,Inhibition of CDK12/cyclinK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.114012,866.956,866.3987702,4.06,63,8,15,5,19,230.69,C43H51FN12O7,"InChI=1S/C43H51FN12O7/c1-25(2)55-24-48-37-38(52-43(53-39(37)55)54-16-18-62-19-17-54)47-22-33-49-29-20-27(44)28(21-30(29)50-33)45-14-7-5-3-4-6-8-15-46-35(58)23-63-32-11-9-10-26-36(32)42(61)56(41(26)60)31-12-13-34(57)51-40(31)59/h9-11,20-21,24-25,31,45H,3-8,12-19,22-23H2,1-2H3,(H,46,58)(H,49,50)(H,47,52,53)(H,51,57,59)",XZMGOWQHLJWQJN-UHFFFAOYSA-N
2760,38.2,99,38.2,,P49840,GSK3A,CRBN,,,NC1=NC=C(C2=CC=C(S(=O)(=O)N3CCN(CCCCC4=CN(CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)N=C1C(=O)NC1=CC=CN=C1,Degradation of GSK3A in SH-SY5Y cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113889,1038.158,1037.417771,0.96,74,8,20,4,27,297.62,C49H59N13O11S,"InChI=1S/C49H59N13O11S/c50-45-44(47(65)54-35-6-4-15-51-31-35)55-40(32-53-45)34-9-11-37(12-10-34)74(68,69)61-20-18-59(19-21-61)17-2-1-5-36-33-60(58-57-36)22-24-71-26-28-73-30-29-72-27-25-70-23-16-52-39-8-3-7-38-43(39)49(67)62(48(38)66)41-13-14-42(63)56-46(41)64/h3-4,6-12,15,31-33,41,52H,1-2,5,13-14,16-30H2,(H2,50,53)(H,54,65)(H,56,63,64)",MMDZUELMJKLTTR-UHFFFAOYSA-N
2760,110.1,99,110.1,,P49841,GSK-3beta,CRBN,,,NC1=NC=C(C2=CC=C(S(=O)(=O)N3CCN(CCCCC4=CN(CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)N=C1C(=O)NC1=CC=CN=C1,Degradation of GSK3B in SH-SY5Y cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113889,1038.158,1037.417771,0.96,74,8,20,4,27,297.62,C49H59N13O11S,"InChI=1S/C49H59N13O11S/c50-45-44(47(65)54-35-6-4-15-51-31-35)55-40(32-53-45)34-9-11-37(12-10-34)74(68,69)61-20-18-59(19-21-61)17-2-1-5-36-33-60(58-57-36)22-24-71-26-28-73-30-29-72-27-25-70-23-16-52-39-8-3-7-38-43(39)49(67)62(48(38)66)41-13-14-42(63)56-46(41)64/h3-4,6-12,15,31-33,41,52H,1-2,5,13-14,16-30H2,(H2,50,53)(H,54,65)(H,56,63,64)",MMDZUELMJKLTTR-UHFFFAOYSA-N
2761,28.3,99,28.3,,P49840,GSK3A,CRBN,,PT-65,NC1=NC=C(C2=CC=C(S(=O)(=O)N3CCN(CCCCC4=CN(CCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)N=C1C(=O)NC1=CC=CN=C1,Degradation of GSK3A in SH-SY5Y cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113889,1082.211,1081.443985,0.81,77,8,21,4,30,306.85,C51H63N13O12S,"InChI=1S/C51H63N13O12S/c52-47-46(49(67)56-37-6-4-15-53-33-37)57-42(34-55-47)36-9-11-39(12-10-36)77(70,71)63-20-18-61(19-21-63)17-2-1-5-38-35-62(60-59-38)22-24-73-26-28-75-30-32-76-31-29-74-27-25-72-23-16-54-41-8-3-7-40-45(41)51(69)64(50(40)68)43-13-14-44(65)58-48(43)66/h3-4,6-12,15,33-35,43,54H,1-2,5,13-14,16-32H2,(H2,52,55)(H,56,67)(H,58,65,66)",QJSFLEBIQZMJQF-UHFFFAOYSA-N
2761,34.2,99,34.2,,P49841,GSK-3beta,CRBN,,PT-65,NC1=NC=C(C2=CC=C(S(=O)(=O)N3CCN(CCCCC4=CN(CCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)N=C1C(=O)NC1=CC=CN=C1,Degradation of GSK3B in SH-SY5Y cells after 24 h treatment,,,,,,,12.41,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113889,1082.211,1081.443985,0.81,77,8,21,4,30,306.85,C51H63N13O12S,"InChI=1S/C51H63N13O12S/c52-47-46(49(67)56-37-6-4-15-53-33-37)57-42(34-55-47)36-9-11-39(12-10-36)77(70,71)63-20-18-61(19-21-63)17-2-1-5-38-35-62(60-59-38)22-24-73-26-28-75-30-32-76-31-29-74-27-25-72-23-16-54-41-8-3-7-40-45(41)51(69)64(50(40)68)43-13-14-44(65)58-48(43)66/h3-4,6-12,15,33-35,43,54H,1-2,5,13-14,16-32H2,(H2,52,55)(H,56,67)(H,58,65,66)",QJSFLEBIQZMJQF-UHFFFAOYSA-N
2762,40.4,99,40.4,,P49840,GSK3A,CRBN,,,NC1=NC=C(C2=CC=C(S(=O)(=O)N3CCN(CCCCC4=CN(CCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)N=C1C(=O)NC1=CC=CN=C1,Degradation of GSK3A in SH-SY5Y cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113889,1126.264,1125.4702,0.66,80,8,22,4,33,316.08,C53H67N13O13S,"InChI=1S/C53H67N13O13S/c54-49-48(51(69)58-39-6-4-15-55-35-39)59-44(36-57-49)38-9-11-41(12-10-38)80(72,73)65-20-18-63(19-21-65)17-2-1-5-40-37-64(62-61-40)22-24-75-26-28-77-30-32-79-34-33-78-31-29-76-27-25-74-23-16-56-43-8-3-7-42-47(43)53(71)66(52(42)70)45-13-14-46(67)60-50(45)68/h3-4,6-12,15,35-37,45,56H,1-2,5,13-14,16-34H2,(H2,54,57)(H,58,69)(H,60,67,68)",ZHGGZYWCROVTRI-UHFFFAOYSA-N
2762,66.6,99,66.6,,P49841,GSK-3beta,CRBN,,,NC1=NC=C(C2=CC=C(S(=O)(=O)N3CCN(CCCCC4=CN(CCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)C=C2)N=C1C(=O)NC1=CC=CN=C1,Degradation of GSK3B in SH-SY5Y cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113889,1126.264,1125.4702,0.66,80,8,22,4,33,316.08,C53H67N13O13S,"InChI=1S/C53H67N13O13S/c54-49-48(51(69)58-39-6-4-15-55-35-39)59-44(36-57-49)38-9-11-41(12-10-38)80(72,73)65-20-18-63(19-21-65)17-2-1-5-40-37-64(62-61-40)22-24-75-26-28-77-30-32-79-34-33-78-31-29-76-27-25-74-23-16-56-43-8-3-7-42-47(43)53(71)66(52(42)70)45-13-14-46(67)60-50(45)68/h3-4,6-12,15,35-37,45,56H,1-2,5,13-14,16-34H2,(H2,54,57)(H,58,69)(H,60,67,68)",ZHGGZYWCROVTRI-UHFFFAOYSA-N
2801,4.1,99,4.1,,Q00987,MDM2,CRBN,,WB214,CCOC(=O)C1=C(C(C(=O)NC(C)(C)C)N(CC2=CC(F)=C(F)C(F)=C2)C(=O)CCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C2=CC=C(Cl)C=C2[NH]1,Degradation of MDM2 in RS4;11 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2,Inhibit growth of RS4;11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113425,846.303,845.2803111,6.29,60,6,7,3,12,157.98,C44H43ClF3N5O7,"InChI=1S/C44H43ClF3N5O7/c1-5-60-43(59)38-36(28-16-15-26(45)21-32(28)49-38)39(41(57)51-44(2,3)4)53(22-24-19-30(46)37(48)31(47)20-24)35(55)14-9-7-6-8-11-25-12-10-13-27-29(25)23-52(42(27)58)33-17-18-34(54)50-40(33)56/h10,12-13,15-16,19-21,33,39,49H,5-7,9,14,17-18,22-23H2,1-4H3,(H,51,57)(H,50,54,56)",WGGGBWUFPMJXRU-UHFFFAOYSA-N
2829,3610,99,3610/4530,,P01116,KRAS G12C,VHL,,YF135,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCCN3CCC[C@H]3COC3=NC4=C(CCN(C5=CC=CC6=CC=CC(Cl)=C56)C4)C(N4CCN(C(=O)/C(C#N)=C\C5CC5)[C@@H](CC#N)C4)=N3)C(C)(C)C)C=C2)SC=N1,Degradation of KRAS G12C in H358/H23 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,153.9/243.9,Inhibit proliferation of H358/H23 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.114088,1179.89,1178.529091,7.67,84,10,16,3,21,233.48,C63H75ClN12O7S,"InChI=1S/C63H75ClN12O7S/c1-40-56(84-39-68-40)44-18-16-42(17-19-44)34-67-59(79)53-32-48(77)36-76(53)61(81)57(63(2,3)4)70-54(78)22-30-82-29-8-25-72-24-7-11-47(72)38-83-62-69-51-37-73(52-13-6-10-43-9-5-12-50(64)55(43)52)26-21-49(51)58(71-62)74-27-28-75(46(35-74)20-23-65)60(80)45(33-66)31-41-14-15-41/h5-6,9-10,12-13,16-19,31,39,41,46-48,53,57,77H,7-8,11,14-15,20-22,24-30,32,34-38H2,1-4H3,(H,67,79)(H,70,78)/b45-31-/t46-,47-,48+,53-,57+/m0/s1",VJEBOMJUVXOGQI-OAHWIDGASA-N
2833,28.5,67.1,28.5,67.1,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,1931.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,853.289,852.2634172,3.82,61,7,14,5,21,232.27,C42H41ClN8O10,"InChI=1S/C42H41ClN8O10/c43-30-21-26(61-25-5-2-1-3-6-25)9-10-27(30)37(54)29-22-46-38-36(29)39(49-24-48-38)47-23-34(53)45-14-16-59-18-20-60-19-17-58-15-13-44-31-8-4-7-28-35(31)42(57)51(41(28)56)32-11-12-33(52)50-40(32)55/h1-10,21-22,24,32,44H,11-20,23H2,(H,45,53)(H,50,52,55)(H2,46,47,48,49)",YUNXARYSBTUJHY-UHFFFAOYSA-N
2834,9.4,66.5,9.4,66.5,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,2203.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,897.342,896.2896319,3.67,64,7,15,5,24,241.5,C44H45ClN8O11,"InChI=1S/C44H45ClN8O11/c45-32-23-28(64-27-5-2-1-3-6-27)9-10-29(32)39(56)31-24-48-40-38(31)41(51-26-50-40)49-25-36(55)47-14-16-61-18-20-63-22-21-62-19-17-60-15-13-46-33-8-4-7-30-37(33)44(59)53(43(30)58)34-11-12-35(54)52-42(34)57/h1-10,23-24,26,34,46H,11-22,25H2,(H,47,55)(H,52,54,57)(H2,48,49,50,51)",IVICRPGKKOLGDE-UHFFFAOYSA-N
2834,52.7,68.6,52.7,68.6,Q06187,BTK C481S,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,897.342,896.2896319,3.67,64,7,15,5,24,241.5,C44H45ClN8O11,"InChI=1S/C44H45ClN8O11/c45-32-23-28(64-27-5-2-1-3-6-27)9-10-29(32)39(56)31-24-48-40-38(31)41(51-26-50-40)49-25-36(55)47-14-16-61-18-20-63-22-21-62-19-17-60-15-13-46-33-8-4-7-30-37(33)44(59)53(43(30)58)34-11-12-35(54)52-42(34)57/h1-10,23-24,26,34,46H,11-22,25H2,(H,47,55)(H,52,54,57)(H2,48,49,50,51)",IVICRPGKKOLGDE-UHFFFAOYSA-N
2835,8.1,72.4,8.1,72.4,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,1209.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63.3,Inhibit proliferation of TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,941.395,940.3158467,3.52,67,7,16,5,27,250.73,C46H49ClN8O12,"InChI=1S/C46H49ClN8O12/c47-34-25-30(67-29-5-2-1-3-6-29)9-10-31(34)41(58)33-26-50-42-40(33)43(53-28-52-42)51-27-38(57)49-14-16-63-18-20-65-22-24-66-23-21-64-19-17-62-15-13-48-35-8-4-7-32-39(35)46(61)55(45(32)60)36-11-12-37(56)54-44(36)59/h1-10,25-26,28,36,48H,11-24,27H2,(H,49,57)(H,54,56,59)(H2,50,51,52,53)",SVBNVWQRLLLMHI-UHFFFAOYSA-N
2835,80.4,88.4,80.4,88.4,Q06187,BTK C481S,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1689.3,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,941.395,940.3158467,3.52,67,7,16,5,27,250.73,C46H49ClN8O12,"InChI=1S/C46H49ClN8O12/c47-34-25-30(67-29-5-2-1-3-6-29)9-10-31(34)41(58)33-26-50-42-40(33)43(53-28-52-42)51-27-38(57)49-14-16-63-18-20-65-22-24-66-23-21-64-19-17-62-15-13-48-35-8-4-7-32-39(35)46(61)55(45(32)60)36-11-12-37(56)54-44(36)59/h1-10,25-26,28,36,48H,11-24,27H2,(H,49,57)(H,54,56,59)(H2,50,51,52,53)",SVBNVWQRLLLMHI-UHFFFAOYSA-N
2836,8.3,92.4,8.3,92.4,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,1390.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,104.5,Inhibit proliferation of TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,985.448,984.3420614,3.37,70,7,17,5,30,259.96,C48H53ClN8O13,"InChI=1S/C48H53ClN8O13/c49-36-27-32(70-31-5-2-1-3-6-31)9-10-33(36)43(60)35-28-52-44-42(35)45(55-30-54-44)53-29-40(59)51-14-16-65-18-20-67-22-24-69-26-25-68-23-21-66-19-17-64-15-13-50-37-8-4-7-34-41(37)48(63)57(47(34)62)38-11-12-39(58)56-46(38)61/h1-10,27-28,30,38,50H,11-26,29H2,(H,51,59)(H,56,58,61)(H2,52,53,54,55)",WJQKJTMVUALADJ-UHFFFAOYSA-N
2836,52.3,84.8,52.3,84.8,Q06187,BTK C481S,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,750,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,985.448,984.3420614,3.37,70,7,17,5,30,259.96,C48H53ClN8O13,"InChI=1S/C48H53ClN8O13/c49-36-27-32(70-31-5-2-1-3-6-31)9-10-33(36)43(60)35-28-52-44-42(35)45(55-30-54-44)53-29-40(59)51-14-16-65-18-20-67-22-24-69-26-25-68-23-21-66-19-17-64-15-13-50-37-8-4-7-34-41(37)48(63)57(47(34)62)38-11-12-39(58)56-46(38)61/h1-10,27-28,30,38,50H,11-26,29H2,(H,51,59)(H,56,58,61)(H2,52,53,54,55)",WJQKJTMVUALADJ-UHFFFAOYSA-N
2840,30.1,84.3,30.1,84.3,Q06187,BTK C481S,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,936.423,935.3369165,4.95,67,8,14,6,21,244.3,C47H50ClN9O10,"InChI=1S/C47H50ClN9O10/c48-35-25-31(67-30-5-2-1-3-6-30)13-14-32(35)41(59)34-26-51-42-40(34)43(53-27-52-42)54-28-9-11-29(12-10-28)55-47(63)50-18-20-65-22-24-66-23-21-64-19-17-49-36-8-4-7-33-39(36)46(62)57(45(33)61)37-15-16-38(58)56-44(37)60/h1-8,13-14,25-29,37,49H,9-12,15-24H2,(H2,50,55,63)(H,56,58,60)(H2,51,52,53,54)/t28-,29+,37?",HTWXOMYINZDUGN-JNLNXYSYSA-N
2840,32.3,76.9,32.3,76.9,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,22.3,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,936.423,935.3369165,4.95,67,8,14,6,21,244.3,C47H50ClN9O10,"InChI=1S/C47H50ClN9O10/c48-35-25-31(67-30-5-2-1-3-6-30)13-14-32(35)41(59)34-26-51-42-40(34)43(53-27-52-42)54-28-9-11-29(12-10-28)55-47(63)50-18-20-65-22-24-66-23-21-64-19-17-49-36-8-4-7-33-39(36)46(62)57(45(33)61)37-15-16-38(58)56-44(37)60/h1-8,13-14,25-29,37,49H,9-12,15-24H2,(H2,50,55,63)(H,56,58,60)(H2,51,52,53,54)/t28-,29+,37?",HTWXOMYINZDUGN-JNLNXYSYSA-N
2841,12.1,78,12.1,78,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,6.9,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,39.5,Inhibit proliferation of TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,980.476,979.3631312,4.8,70,8,15,6,24,253.53,C49H54ClN9O11,"InChI=1S/C49H54ClN9O11/c50-37-27-33(70-32-5-2-1-3-6-32)13-14-34(37)43(61)36-28-53-44-42(36)45(55-29-54-44)56-30-9-11-31(12-10-30)57-49(65)52-18-20-67-22-24-69-26-25-68-23-21-66-19-17-51-38-8-4-7-35-41(38)48(64)59(47(35)63)39-15-16-40(60)58-46(39)62/h1-8,13-14,27-31,39,51H,9-12,15-26H2,(H2,52,57,65)(H,58,60,62)(H2,53,54,55,56)/t30-,31+,39?",QJZSKXPDZKWNIF-ZMZOSUEXSA-N
2841,37.9,83.5,37.9,83.5,Q06187,BTK C481S,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,290.1,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,980.476,979.3631312,4.8,70,8,15,6,24,253.53,C49H54ClN9O11,"InChI=1S/C49H54ClN9O11/c50-37-27-33(70-32-5-2-1-3-6-32)13-14-34(37)43(61)36-28-53-44-42(36)45(55-29-54-44)56-30-9-11-31(12-10-30)57-49(65)52-18-20-67-22-24-69-26-25-68-23-21-66-19-17-51-38-8-4-7-35-41(38)48(64)59(47(35)63)39-15-16-40(60)58-46(39)62/h1-8,13-14,27-31,39,51H,9-12,15-26H2,(H2,52,57,65)(H,58,60,62)(H2,53,54,55,56)/t30-,31+,39?",QJZSKXPDZKWNIF-ZMZOSUEXSA-N
2842,20,93.8,20,93.8,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,86.5/88.6,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45.7/1760.0,Inhibition of cell proliferation in JeKo-1/BTK C481S Ba/F3 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,1024.529,1023.389346,4.65,73,8,16,6,27,262.76,C51H58ClN9O12,"InChI=1S/C51H58ClN9O12/c52-39-29-35(73-34-5-2-1-3-6-34)13-14-36(39)45(63)38-30-55-46-44(38)47(57-31-56-46)58-32-9-11-33(12-10-32)59-51(67)54-18-20-69-22-24-71-26-28-72-27-25-70-23-21-68-19-17-53-40-8-4-7-37-43(40)50(66)61(49(37)65)41-15-16-42(62)60-48(41)64/h1-8,13-14,29-33,41,53H,9-12,15-28H2,(H2,54,59,67)(H,60,62,64)(H2,55,56,57,58)/t32-,33+,41?",OIAOFDRZXBDDRR-HYKUANOISA-N
2842,41.9,93,41.9,93,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,56.4,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45.7,Inhibit proliferation of TMD8 cells,,,,,,,,,,,<0.53,Caco-2 A2B assay,7.5,Caco-2 B2A assay,10.1016/j.ejmech.2021.113820,1024.529,1023.389346,4.65,73,8,16,6,27,262.76,C51H58ClN9O12,"InChI=1S/C51H58ClN9O12/c52-39-29-35(73-34-5-2-1-3-6-34)13-14-36(39)45(63)38-30-55-46-44(38)47(57-31-56-46)58-32-9-11-33(12-10-32)59-51(67)54-18-20-69-22-24-71-26-28-72-27-25-70-23-21-68-19-17-53-40-8-4-7-37-43(40)50(66)61(49(37)65)41-15-16-42(62)60-48(41)64/h1-8,13-14,29-33,41,53H,9-12,15-28H2,(H2,54,59,67)(H,60,62,64)(H2,55,56,57,58)/t32-,33+,41?",OIAOFDRZXBDDRR-HYKUANOISA-N
2842,42.9,90.7,42.9,90.7,Q06187,BTK C481S,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,253.5,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,1024.529,1023.389346,4.65,73,8,16,6,27,262.76,C51H58ClN9O12,"InChI=1S/C51H58ClN9O12/c52-39-29-35(73-34-5-2-1-3-6-34)13-14-36(39)45(63)38-30-55-46-44(38)47(57-31-56-46)58-32-9-11-33(12-10-32)59-51(67)54-18-20-69-22-24-71-26-28-72-27-25-70-23-21-68-19-17-53-40-8-4-7-37-43(40)50(66)61(49(37)65)41-15-16-42(62)60-48(41)64/h1-8,13-14,29-33,41,53H,9-12,15-28H2,(H2,54,59,67)(H,60,62,64)(H2,55,56,57,58)/t32-,33+,41?",OIAOFDRZXBDDRR-HYKUANOISA-N
2843,108.9,88,108.9,88,Q9UBN7,HDAC6,CRBN,,,O=C(CCCO/N=C1C(=C2/C(=O)N(CC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)C3=CC=CC=C23)/NC2=CC=CC=C/12)NO,Degradation of HDAC6 in K562 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.1c00681,802.805,802.2823228,1.71,59,8,15,5,15,238.78,C40H38N10O9,"InChI=1S/C40H38N10O9/c51-31-15-14-30(37(53)43-31)50-38(54)26-9-5-11-28(33(26)40(50)56)41-16-19-58-20-17-48-21-23(44-47-48)22-49-29-12-4-2-8-25(29)34(39(49)55)36-35(24-7-1-3-10-27(24)42-36)46-59-18-6-13-32(52)45-57/h1-5,7-12,21,30,41-42,57H,6,13-20,22H2,(H,45,52)(H,43,51,53)/b36-34-,46-35+",DLBCMVGHLAVPJQ-ZQEKUULESA-N
2850,21,99,21,,O60674,JAK2,CRBN,,,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK2 in MHH-CALL-4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,20.2,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<0.2,Inhibit viability of MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,844.915,844.2863626,1.27,61,9,14,4,11,248.48,C41H40N12O7S,"InChI=1S/C41H40N12O7S/c1-2-61(59,60)51-22-41(23-51,14-15-42)52-21-25(20-44-52)34-30-11-16-43-35(30)49-40(48-34)46-26-5-3-24(4-6-26)36(55)45-27-12-17-50(18-13-27)28-7-8-29-31(19-28)39(58)53(38(29)57)32-9-10-33(54)47-37(32)56/h3-8,11,16,19-21,27,32H,2,9-10,12-14,17-18,22-23H2,1H3,(H,45,55)(H,47,54,56)(H2,43,46,48,49)",QENXNFNQQOSOIZ-UHFFFAOYSA-N
2852,14,99,14,,O60674,JAK2,CRBN,,,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCCNC5=CC=CC(C6CCC(=O)NC6=O)=C5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK2 in MHH-CALL-4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,1.13,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.43,Inhibit viability of MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,763.885,763.3012844,2.18,55,7,12,5,15,219.89,C38H41N11O5S,"InChI=1S/C38H41N11O5S/c1-2-55(53,54)48-23-38(24-48,15-16-39)49-22-27(21-43-49)33-31-14-19-41-34(31)47-37(46-33)44-28-10-8-25(9-11-28)35(51)42-18-4-3-17-40-29-7-5-6-26(20-29)30-12-13-32(50)45-36(30)52/h5-11,14,19-22,30,40H,2-4,12-13,15,17-18,23-24H2,1H3,(H,42,51)(H,45,50,52)(H2,41,44,46,47)",YMDKCHNRIDZCIK-UHFFFAOYSA-N
2853,17,99,17,,O60674,JAK2,CRBN,,,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCCOC5=CC=C(C6CCC(=O)NC6=O)C=C5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK2 in MHH-CALL-4 cells after 24 h treatment,,,,,,,0.14,Kd was assessed by KINOMEscan Assay,,,,,,,,,,,19.6,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.03,Inhibit viability of MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,764.869,764.2853,2.17,55,7,12,4,15,217.09,C38H40N10O6S,"InChI=1S/C38H40N10O6S/c1-2-55(52,53)47-23-38(24-47,16-17-39)48-22-27(21-42-48)33-31-15-19-40-34(31)46-37(45-33)43-28-9-5-26(6-10-28)35(50)41-18-3-4-20-54-29-11-7-25(8-12-29)30-13-14-32(49)44-36(30)51/h5-12,15,19,21-22,30H,2-4,13-14,16,18,20,23-24H2,1H3,(H,41,50)(H,44,49,51)(H2,40,43,45,46)",JQXUGPKGNONGRJ-UHFFFAOYSA-N
2855,26,99,26,,O60674,JAK2,CRBN,,,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NC5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK2 in MHH-CALL-4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,1045,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.25,Inhibit viability of MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,775.896,775.3012844,2.16,56,8,12,4,11,211.1,C39H41N11O5S,"InChI=1S/C39H41N11O5S/c1-2-56(54,55)49-23-39(24-49,16-17-40)50-22-27(21-42-50)34-32-13-18-41-35(32)47-38(46-34)44-28-7-3-26(4-8-28)36(52)43-29-14-19-48(20-15-29)30-9-5-25(6-10-30)31-11-12-33(51)45-37(31)53/h3-10,13,18,21-22,29,31H,2,11-12,14-16,19-20,23-24H2,1H3,(H,43,52)(H,45,51,53)(H2,41,44,46,47)",XKYDUBODDYBCNZ-UHFFFAOYSA-N
2857,11,92,11,92,P52333,JAK3,CRBN,,SJ10542,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCN5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK3 in PDX SJBALL020589 cells after 24 h treatment,,,,,,,0.056,Kd was assessed by KINOMEscan Assay,,,,,,,,,,,0.02,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24/86.4,Inhibit viability of PDX SJBALL020589/MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,818.965,818.3434836,1.78,59,8,13,4,14,214.34,C41H46N12O5S,"InChI=1S/C41H46N12O5S/c1-2-59(57,58)52-26-41(27-52,15-16-42)53-25-30(24-45-53)36-34-14-18-43-37(34)49-40(48-36)46-31-8-4-29(5-9-31)38(55)44-17-3-19-50-20-22-51(23-21-50)32-10-6-28(7-11-32)33-12-13-35(54)47-39(33)56/h4-11,14,18,24-25,33H,2-3,12-13,15,17,19-23,26-27H2,1H3,(H,44,55)(H,47,54,56)(H2,43,46,48,49)",WBEBZVDAHMXWJN-UHFFFAOYSA-N
2857,14,90,14/24,90/82,O60674,JAK2,CRBN,,SJ10542,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCN5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK2 in PDX SJBALL020589/MHH-CALL-4 cells after 24 h treatment,,,,,,,0.022,Kd was assessed by KINOMEscan Assay,,,,,,,,,,,0.02,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24/86.4,Inhibit viability of PDX SJBALL020589/MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,818.965,818.3434836,1.78,59,8,13,4,14,214.34,C41H46N12O5S,"InChI=1S/C41H46N12O5S/c1-2-59(57,58)52-26-41(27-52,15-16-42)53-25-30(24-45-53)36-34-14-18-43-37(34)49-40(48-36)46-31-8-4-29(5-9-31)38(55)44-17-3-19-50-20-22-51(23-21-50)32-10-6-28(7-11-32)33-12-13-35(54)47-39(33)56/h4-11,14,18,24-25,33H,2-3,12-13,15,17,19-23,26-27H2,1H3,(H,44,55)(H,47,54,56)(H2,43,46,48,49)",WBEBZVDAHMXWJN-UHFFFAOYSA-N
2857,74,99,74,,O60674,JAK2 R683G,CRBN,,SJ10542,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCN5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,Degradation of JAK2 R683G in KOPN49 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,0.02,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1029,Inhibit viability of KOPN49 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,818.965,818.3434836,1.78,59,8,13,4,14,214.34,C41H46N12O5S,"InChI=1S/C41H46N12O5S/c1-2-59(57,58)52-26-41(27-52,15-16-42)53-25-30(24-45-53)36-34-14-18-43-37(34)49-40(48-36)46-31-8-4-29(5-9-31)38(55)44-17-3-19-50-20-22-51(23-21-50)32-10-6-28(7-11-32)33-12-13-35(54)47-39(33)56/h4-11,14,18,24-25,33H,2-3,12-13,15,17,19-23,26-27H2,1H3,(H,44,55)(H,47,54,56)(H2,43,46,48,49)",WBEBZVDAHMXWJN-UHFFFAOYSA-N
2867,8,99,8,,P00533,EGFR del19/T790M/C797S,VHL,,,COC1=CC(N2CCN(CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of EGFR del19/T790M/C797S in Ba/F3 cells after 3 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20,Inhibit growth of Ba/F3 EGFR del19/T790M/C797S cells,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00645,1055.728,1054.478315,8.63,73,7,14,5,21,194.25,C54H72ClN10O6PS,"InChI=1S/C54H72ClN10O6PS/c1-35(37-19-21-38(22-20-37)48-36(2)57-34-73-48)58-51(68)44-31-40(66)33-65(44)52(69)49(54(3,4)5)61-47(67)18-12-10-9-11-15-25-63-26-28-64(29-27-63)39-23-24-42(45(30-39)71-6)60-53-56-32-41(55)50(62-53)59-43-16-13-14-17-46(43)72(7,8)70/h13-14,16-17,19-24,30,32,34-35,40,44,49,66H,9-12,15,18,25-29,31,33H2,1-8H3,(H,58,68)(H,61,67)(H2,56,59,60,62)/t35-,40+,44-,49+/m0/s1",KSHZFKVXGRVRTM-XJLLBULKSA-N
2869,17,99,120/17/1200,,P40763,STAT3,CRBN,,SD-91,NC(=O)CC[C@H](NC(=O)[C@@H]1CC[C@@H]2CCN(C(=O)CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C[C@H](NC(=O)C3=CC4=CC(C(=O)P(=O)(O)O)=CC=C4[NH]3)C(=O)N12)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,Degradation of STAT3 in MOLM-16/SU-DHL-1/SUP-M2 cells after 4/14/14 h treatment,,,,,,,28,BLI,5.5,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,170/2600/460,Inhibit growth of MOLM-16/SU-DHL-1/SUP-M2 cells,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00155,1136.169,1135.42047,2.46,82,9,11,8,19,327.88,C59H62N9O13P,"InChI=1S/C59H62N9O13P/c60-49(69)27-24-44(53(72)65-52(36-14-7-4-8-15-36)37-16-9-5-10-17-37)62-56(75)48-25-22-40-29-30-66(34-46(58(77)68(40)48)63-54(73)45-32-39-31-38(21-23-43(39)61-45)59(78)82(79,80)81)51(71)20-11-3-1-2-6-13-35-18-12-19-41-42(35)33-67(57(41)76)47-26-28-50(70)64-55(47)74/h4-5,7-10,12,14-19,21,23,31-32,40,44,46-48,52,61H,1-3,11,20,22,24-30,33-34H2,(H2,60,69)(H,62,75)(H,63,73)(H,65,72)(H,64,70,74)(H2,79,80,81)/t40-,44+,46+,47?,48+/m1/s1",OHDMEJTVYXXZNQ-OPKPGBGESA-N
2878,4.35,85,4.35,85,P11362,FGFR1,VHL,,DGY-09-192,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(CC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)=NC=N2)=C1Cl,Degradation of FGFR1 in CCLP1 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,Inhibit proliferation of CCLP1 cells,,,,,,,,,,,,,,,10.1002/anie.202101328,1017.054,1015.36967,6.81,70,7,14,5,15,206.72,C49H59Cl2N11O7S,"InChI=1S/C49H59Cl2N11O7S/c1-28(30-9-11-31(12-10-30)44-29(2)54-27-70-44)55-46(65)35-21-34(63)24-62(35)47(66)45(49(3,4)5)57-40(64)25-60-17-19-61(20-18-60)33-15-13-32(14-16-33)56-38-23-39(53-26-52-38)59(6)48(67)58-43-41(50)36(68-7)22-37(69-8)42(43)51/h9-16,22-23,26-28,34-35,45,63H,17-21,24-25H2,1-8H3,(H,55,65)(H,57,64)(H,58,67)(H,52,53,56)/t28-,34+,35-,45+/m0/s1",WDBUEMWHXKHQNB-AURZXHAXSA-N
2878,70,74,70,74,P21802,FGFR2,VHL,,DGY-09-192,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(CC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)=NC=N2)=C1Cl,Degradation of FGFR2 in KATO III cells after 6 h treatment,,,34,IC50 was assessed by Z'-LYTE kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Inhibit proliferation of KATO III cells,,,,,,,,,,,,,,,10.1002/anie.202101328,1017.054,1015.36967,6.81,70,7,14,5,15,206.72,C49H59Cl2N11O7S,"InChI=1S/C49H59Cl2N11O7S/c1-28(30-9-11-31(12-10-30)44-29(2)54-27-70-44)55-46(65)35-21-34(63)24-62(35)47(66)45(49(3,4)5)57-40(64)25-60-17-19-61(20-18-60)33-15-13-32(14-16-33)56-38-23-39(53-26-52-38)59(6)48(67)58-43-41(50)36(68-7)22-37(69-8)42(43)51/h9-16,22-23,26-28,34-35,45,63H,17-21,24-25H2,1-8H3,(H,55,65)(H,57,64)(H,58,67)(H,52,53,56)/t28-,34+,35-,45+/m0/s1",WDBUEMWHXKHQNB-AURZXHAXSA-N
2887,125.9,95,125.9,,Q05397,FAK,VHL,,,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=CC=C(N3CCN(CCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2OC)=NC=C1C(F)(F)F,Degradation of FAK in A549 cells after 24 h treatment,,,0.63,IC50 was assessed by FRET,,,,,,,,,,,,,,,316.2,FP,,,,,,,,,,,,,,,5.01,IC50 between VHL and the complex of protac and FAK was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202109237,1161.359,1160.534044,6.81,82,7,17,6,27,230.31,C58H75F3N10O10S,"InChI=1S/C58H75F3N10O10S/c1-37(39-12-14-40(15-13-39)52-38(2)64-36-82-52)65-55(75)48-31-42(72)34-71(48)56(76)53(57(3,4)5)68-51(73)35-81-29-28-80-27-26-79-25-24-78-23-22-69-18-20-70(21-19-69)41-16-17-46(49(30-41)77-7)67-50-32-47(44(33-63-50)58(59,60)61)66-45-11-9-8-10-43(45)54(74)62-6/h8-17,30,32-33,36-37,42,48,53,72H,18-29,31,34-35H2,1-7H3,(H,62,74)(H,65,75)(H,68,73)(H2,63,66,67)/t37-,42+,48-,53+/m0/s1",FOOHAGZPIHCYKX-ZSFXBAAMSA-N
2888,20,99,20,,Q05397,FAK,VHL,,,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=CC=C(N3CCN(CCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2OC)=NC=C1C(F)(F)F,Degradation of FAK in A549 cells after 24 h treatment,,,7.94,IC50 was assessed by FRET,,,,,,,,,,,,,,,1995.3,FP,,,,,,,,,,,,,,,2,IC50 between VHL and the complex of protac and FAK was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202109237,1111.39,1110.570036,11.09,79,7,13,6,24,193.39,C59H77F3N10O6S,"InChI=1S/C59H77F3N10O6S/c1-38(40-21-23-41(24-22-40)53-39(2)65-37-79-53)66-56(76)49-33-43(73)36-72(49)57(77)54(58(3,4)5)69-52(74)20-14-12-10-8-9-11-13-17-27-70-28-30-71(31-29-70)42-25-26-47(50(32-42)78-7)68-51-34-48(45(35-64-51)59(60,61)62)67-46-19-16-15-18-44(46)55(75)63-6/h15-16,18-19,21-26,32,34-35,37-38,43,49,54,73H,8-14,17,20,27-31,33,36H2,1-7H3,(H,63,75)(H,66,76)(H,69,74)(H2,64,67,68)/t38-,43+,49-,54+/m0/s1",LCSUSCWWBGDOAP-JJVMVOSYSA-N
2889,158.5,95,158.5,,Q05397,FAK,VHL,,,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=CC=C(N3CCN(CCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2OC)=NC=C1C(F)(F)F,Degradation of FAK in A549 cells after 24 h treatment,,,1,IC50 was assessed by FRET,,,,,,,,,,,,,,,501.2,FP,,,,,,,,,,,,,,,7.94,IC50 between VHL and the complex of protac and FAK was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202109237,1073.253,1072.481615,7.11,76,7,15,6,21,211.85,C54H67F3N10O8S,"InChI=1S/C54H67F3N10O8S/c1-33(35-12-14-36(15-13-35)48-34(2)60-32-76-48)61-51(71)44-27-38(68)30-67(44)52(72)49(53(3,4)5)64-47(69)31-75-25-24-74-23-22-65-18-20-66(21-19-65)37-16-17-42(45(26-37)73-7)63-46-28-43(40(29-59-46)54(55,56)57)62-41-11-9-8-10-39(41)50(70)58-6/h8-17,26,28-29,32-33,38,44,49,68H,18-25,27,30-31H2,1-7H3,(H,58,70)(H,61,71)(H,64,69)(H2,59,62,63)/t33-,38+,44-,49+/m0/s1",RDCVMTUYWQXPEC-FSHOLZCKSA-N
2890,31.6,99,31.6,,Q05397,FAK,VHL,,,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=CC=C(N3CCN(CCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2OC)=NC=C1C(F)(F)F,Degradation of FAK in A549 cells after 24 h treatment,,,1,IC50 was assessed by FRET,,,,,,,,,,,,,,,794.3,FP,,,,,,,,,,,,,,,6.31,IC50 between VHL and the complex of protac and FAK was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202109237,1029.2,1028.4554,7.26,73,7,14,6,18,202.62,C52H63F3N10O7S,"InChI=1S/C52H63F3N10O7S/c1-31(33-12-14-34(15-13-33)46-32(2)58-30-73-46)59-49(69)42-25-36(66)28-65(42)50(70)47(51(3,4)5)62-45(67)29-72-23-22-63-18-20-64(21-19-63)35-16-17-40(43(24-35)71-7)61-44-26-41(38(27-57-44)52(53,54)55)60-39-11-9-8-10-37(39)48(68)56-6/h8-17,24,26-27,30-31,36,42,47,66H,18-23,25,28-29H2,1-7H3,(H,56,68)(H,59,69)(H,62,67)(H2,57,60,61)/t31-,36+,42-,47+/m0/s1",SLSLLSIRBMAERC-MGVZSLQJSA-N
2891,39.8,99,39.8,,Q05397,FAK,VHL,,,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=CC=C(N3CCN(CCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2OC)=NC=C1C(F)(F)F,Degradation of FAK in A549 cells after 24 h treatment,,,1.26,IC50 was assessed by FRET,,,,,,,,,,,,,,,1258.9,FP,,,,,,,,,,,,,,,10,IC50 between VHL and the complex of protac and FAK was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202109237,999.174,998.4448353,7.31,71,7,13,6,16,193.39,C51H61F3N10O6S,"InChI=1S/C51H61F3N10O6S/c1-30(32-12-14-33(15-13-32)45-31(2)57-29-71-45)58-48(68)41-25-35(65)28-64(41)49(69)46(50(3,4)5)61-44(66)18-19-62-20-22-63(23-21-62)34-16-17-39(42(24-34)70-7)60-43-26-40(37(27-56-43)51(52,53)54)59-38-11-9-8-10-36(38)47(67)55-6/h8-17,24,26-27,29-30,35,41,46,65H,18-23,25,28H2,1-7H3,(H,55,67)(H,58,68)(H,61,66)(H2,56,59,60)/t30-,35+,41-,46+/m0/s1",ASRIXACKPXMNKY-FCFVTTBASA-N
2892,4,99,4,,Q05397,FAK,VHL,7PI4,GSK215,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=CC=C(N3CCN(CC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2OC)=NC=C1C(F)(F)F,Degradation of FAK in A549 cells after 24 h treatment,,,1.58,IC50 was assessed by FRET,,,,,,,,,,,,,,,1000,FP,,,,,,,,,,,,,,,1.26,IC50 between VHL and the complex of protac and FAK was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202109237,985.147,984.4291853,7.4,70,7,13,6,15,193.39,C50H59F3N10O6S,"InChI=1S/C50H59F3N10O6S/c1-29(31-12-14-32(15-13-31)44-30(2)56-28-70-44)57-47(67)40-23-34(64)26-63(40)48(68)45(49(3,4)5)60-43(65)27-61-18-20-62(21-19-61)33-16-17-38(41(22-33)69-7)59-42-24-39(36(25-55-42)50(51,52)53)58-37-11-9-8-10-35(37)46(66)54-6/h8-17,22,24-25,28-29,34,40,45,64H,18-21,23,26-27H2,1-7H3,(H,54,66)(H,57,67)(H,60,65)(H2,55,58,59)/t29-,34+,40-,45+/m0/s1",ZGSWGXNEXAXEGV-XFCHVEHOSA-N
2898,0.16,99,0.87/0.16,,O60885,BRD4,CRBN,,SJ995973,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC(=O)COC1=CC=C(C3CCC(=O)NC3=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MV4-11 cells after 12/24 h treatment,,,3531,IC50 of BRD4 BD2 was assessed by TR-FRET,,,,,,,,,,,,,,,17,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.003,Inhibit proliferation of MV4-11 cells,,,,,,,,,,,14.3,Compounds were administered at 10000 nM and incubated for 2 h,,,10.1002/anie.202108848,730.291,729.2500161,4.47,51,6,10,3,13,156.67,C37H40ClN7O5S,"InChI=1S/C37H40ClN7O5S/c1-21-22(2)51-37-33(21)34(25-7-11-26(38)12-8-25)41-29(35-44-43-23(3)45(35)37)19-31(47)39-17-5-4-6-18-40-32(48)20-50-27-13-9-24(10-14-27)28-15-16-30(46)42-36(28)49/h7-14,28-29H,4-6,15-20H2,1-3H3,(H,39,47)(H,40,48)(H,42,46,49)/t28?,29-/m0/s1",VVRONDSUSMJAEI-XIJSCUBXSA-N
2898,24,99,24,,O60885,BRD4,CRBN,,SJ995973,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC(=O)COC1=CC=C(C3CCC(=O)NC3=O)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HD-MB03 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.83,Inhibit proliferation of HD-MB03 cells,,,,,,,,,,,,,,,10.1002/anie.202108848,730.291,729.2500161,4.47,51,6,10,3,13,156.67,C37H40ClN7O5S,"InChI=1S/C37H40ClN7O5S/c1-21-22(2)51-37-33(21)34(25-7-11-26(38)12-8-25)41-29(35-44-43-23(3)45(35)37)19-31(47)39-17-5-4-6-18-40-32(48)20-50-27-13-9-24(10-14-27)28-15-16-30(46)42-36(28)49/h7-14,28-29H,4-6,15-20H2,1-3H3,(H,39,47)(H,40,48)(H,42,46,49)/t28?,29-/m0/s1",VVRONDSUSMJAEI-XIJSCUBXSA-N
2909,1500,99,1500,,P14174,MIF,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCC(=O)NC4=CC=C(N5CC6=CC=C(O)C=C6OC5=O)C=C4)=C3C2=O)C(=O)N1,Degradation of MIF in A549 cells after 12 h treatment,,,,,,,,,51,Ki was assessed by MIF catalyzed 4-HPP tautomerization assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202101864,639.665,639.232913,3.62,47,6,9,4,11,174.45,C34H33N5O8,"InChI=1S/C34H33N5O8/c40-23-14-9-20-19-38(34(46)47-27(20)18-23)22-12-10-21(11-13-22)36-28(41)8-3-1-2-4-17-35-25-7-5-6-24-30(25)33(45)39(32(24)44)26-15-16-29(42)37-31(26)43/h5-7,9-14,18,26,35,40H,1-4,8,15-17,19H2,(H,36,41)(H,37,42,43)",NQPSGZCAWSOJJH-UHFFFAOYSA-N
2913,100,90,100,90-95,P14174,MIF,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCCC(=O)NC4=CC=C(N5CC6=CC=C(O)C=C6OC5=O)C=C4)=C3C2=O)C(=O)N1,Degradation of MIF in A549 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202101864,653.692,653.2485631,4.16,48,6,9,4,12,174.45,C35H35N5O8,"InChI=1S/C35H35N5O8/c41-24-15-10-21-20-39(35(47)48-28(21)19-24)23-13-11-22(12-14-23)37-29(42)9-4-2-1-3-5-18-36-26-8-6-7-25-31(26)34(46)40(33(25)45)27-16-17-30(43)38-32(27)44/h6-8,10-15,19,27,36,41H,1-5,9,16-18,20H2,(H,37,42)(H,38,43,44)",HAHDZDUOFHMMEA-UHFFFAOYSA-N
2942,76.7,99,76.7,,P36888,FLT3-ITD,CRBN,,,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C3=CN(CCCCC4=CN(CCCCC(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=N4)C4=NC=NC(N)=C34)C=C2)=NO1,Degradation of FLT3-ITD in BaF3 FLT3-ITD cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.85,Inhibit proliferation of BaF3 FLT3-ITD cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2021.105508,855.961,855.3928763,3.06,63,8,14,5,15,250.18,C44H49N13O6,"InChI=1S/C44H49N13O6/c1-44(2,3)34-21-35(53-63-34)50-43(62)48-27-15-13-26(14-16-27)30-23-55(40-38(30)39(45)46-25-47-40)19-6-4-9-28-22-56(54-52-28)20-7-5-12-36(58)49-32-11-8-10-29-31(32)24-57(42(29)61)33-17-18-37(59)51-41(33)60/h8,10-11,13-16,21-23,25,33H,4-7,9,12,17-20,24H2,1-3H3,(H,49,58)(H2,45,46,47)(H,51,59,60)(H2,48,50,53,62)",BQDQZCCNJKVYDD-UHFFFAOYSA-N
2985,1250,99,1250/2500,,P01116,KRAS G12C,CRBN,,,COC1=CC(Cl)=C(C2=CC(Cl)=CC=C2Cl)C=C1C(=O)N1CCN(C(=O)/C=C/C(=O)NCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of KRAS G12C in NCI-H358/NCI-H23 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17410,Inhibit proliferation of NCI-H358 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2021.105447,852.172,850.2051453,5.51,58,6,9,3,14,174.53,C41H41Cl3N6O8,"InChI=1S/C41H41Cl3N6O8/c1-58-33-23-30(44)27(26-21-24(42)9-10-29(26)43)22-28(33)39(55)49-19-17-48(18-20-49)36(53)14-13-34(51)46-16-5-3-2-4-15-45-31-8-6-7-25-37(31)41(57)50(40(25)56)32-11-12-35(52)47-38(32)54/h6-10,13-14,21-23,32,45H,2-5,11-12,15-20H2,1H3,(H,46,51)(H,47,52,54)/b14-13+",LPVAFJZSEOPFFT-BUHFOSPRSA-N
3018,350,53,350,53,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCOC3=CC=C(C4=CSC(N5CCOCC5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1360,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,775.01,774.3233253,5.44,54,6,11,3,13,146.22,C40H50N6O6S2,"InChI=1S/C40H50N6O6S2/c1-25(27-8-10-29(11-9-27)35-26(2)41-24-54-35)42-37(49)33-21-30(47)22-46(33)38(50)36(40(3,4)5)44-34(48)7-6-18-52-31-14-12-28(13-15-31)32-23-53-39(43-32)45-16-19-51-20-17-45/h8-15,23-25,30,33,36,47H,6-7,16-22H2,1-5H3,(H,42,49)(H,44,48)/t25-,30+,33-,36+/m0/s1",DNHMBIDODIOPOD-JJOXSQEKSA-N
3021,320,67,320,67,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(C4=CSC(N5CCOCC5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,880,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,789.037,788.3389754,5.8,55,6,11,3,14,146.22,C41H52N6O6S2,"InChI=1S/C41H52N6O6S2/c1-26(28-9-11-30(12-10-28)36-27(2)42-25-55-36)43-38(50)34-22-31(48)23-47(34)39(51)37(41(3,4)5)45-35(49)8-6-7-19-53-32-15-13-29(14-16-32)33-24-54-40(44-33)46-17-20-52-21-18-46/h9-16,24-26,31,34,37,48H,6-8,17-23H2,1-5H3,(H,43,50)(H,45,49)/t26-,31+,34-,37+/m0/s1",GGBZAQUSRYNTSQ-ASCDMGAVSA-N
3024,,,>10000,,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(C4=CSC(N5CCOCC5C)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,803.064,802.3546254,6.23,56,6,11,3,14,146.22,C42H54N6O6S2,"InChI=1S/C42H54N6O6S2/c1-26-23-53-20-18-47(26)41-45-34(24-55-41)30-14-16-33(17-15-30)54-19-8-7-9-36(50)46-38(42(4,5)6)40(52)48-22-32(49)21-35(48)39(51)44-27(2)29-10-12-31(13-11-29)37-28(3)43-25-56-37/h10-17,24-27,32,35,38,49H,7-9,18-23H2,1-6H3,(H,44,51)(H,46,50)/t26?,27-,32+,35-,38+/m0/s1",UNSGLSMVFYYYDD-PCKHRFHFSA-N
3027,,,>10000,,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(C4=CSC(N5CCOC(C)(C)C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,817.091,816.3702755,6.42,57,6,11,3,14,146.22,C43H56N6O6S2,"InChI=1S/C43H56N6O6S2/c1-27(29-11-13-31(14-12-29)37-28(2)44-26-57-37)45-39(52)35-22-32(50)23-49(35)40(53)38(42(3,4)5)47-36(51)10-8-9-20-54-33-17-15-30(16-18-33)34-24-56-41(46-34)48-19-21-55-43(6,7)25-48/h11-18,24,26-27,32,35,38,50H,8-10,19-23,25H2,1-7H3,(H,45,52)(H,47,51)/t27-,32+,35-,38+/m0/s1",YIACDKDYDLPVNM-UTMFLMNVSA-N
3029,,,>10000,,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(C4=CSC(N5CC6CCC(C5)O6)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,815.075,814.3546254,6.42,57,7,11,3,14,146.22,C43H54N6O6S2,"InChI=1S/C43H54N6O6S2/c1-26(28-9-11-30(12-10-28)38-27(2)44-25-57-38)45-40(52)36-20-31(50)21-49(36)41(53)39(43(3,4)5)47-37(51)8-6-7-19-54-32-15-13-29(14-16-32)35-24-56-42(46-35)48-22-33-17-18-34(23-48)55-33/h9-16,24-26,31,33-34,36,39,50H,6-8,17-23H2,1-5H3,(H,45,52)(H,47,51)/t26-,31+,33?,34?,36-,39+/m0/s1",VQDMQIVWDWRGNL-AEGWPRKASA-N
3035,,,>10000,,P10275,AR-V7,VHL,,,COC1=C(C2=CSC(N3CCOCC3)=N2)C=CC(OCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=C1F,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,837.053,836.3401183,5.87,58,6,12,3,15,155.45,C42H53FN6O7S2,"InChI=1S/C42H53FN6O7S2/c1-25(27-10-12-28(13-11-27)37-26(2)44-24-58-37)45-39(52)32-21-29(50)22-49(32)40(53)38(42(3,4)5)47-34(51)9-7-8-18-56-33-15-14-30(36(54-6)35(33)43)31-23-57-41(46-31)48-16-19-55-20-17-48/h10-15,23-25,29,32,38,50H,7-9,16-22H2,1-6H3,(H,45,52)(H,47,51)/t25-,29+,32-,38+/m0/s1",QDRLQXPFNAHLMJ-KBBXSPJUSA-N
3053,0.1,99,0.1/1.1,99/98,P10275,AR,CRBN,,ARD-1676,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.5,Inhibit cell growth in the VCaP cells,,,,,,,,,,,0.07,permeability data in Caco-2 cells,0.13,permeability data in Caco-2 cells,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m0/s1",GAXWAKXJBZHVQF-ZVENJKCTSA-N
3053,1.1,98,1.1,98,P10275,AR T878A,CRBN,,ARD-1676,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8,Inhibit cell growth in the VCaP cells,,,,,,,,,,,0.07,permeability data in Caco-2 cells,0.13,permeability data in Caco-2 cells,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m0/s1",GAXWAKXJBZHVQF-ZVENJKCTSA-N
3053,8,95,8,>95,P10275,AR L702H and T878A,CRBN,,ARD-1676,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in MDA-Pca-2b cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.07,permeability data in Caco-2 cells,0.13,permeability data in Caco-2 cells,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m0/s1",GAXWAKXJBZHVQF-ZVENJKCTSA-N
3056,0.3,99,0.3/1.0,99/97,P10275,AR,CRBN,,ARD-1684,COC1(CN2CC3=CC4=C(C=C3C2)C(=O)N(C2CCC(=O)NC2=O)C4=O)CCN(C(=O)C2=CC=C(N3CCC4(CC3)C[C@H](C)N(C3=CC=C(C#N)C(Cl)=C3)C4)C=C2)CC1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.9,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,818.375,817.3354599,4.37,59,9,10,1,7,146.6,C45H48ClN7O6,"InChI=1S/C45H48ClN7O6/c1-28-22-44(26-52(28)34-8-5-30(23-47)37(46)21-34)11-15-50(16-12-44)33-6-3-29(4-7-33)41(56)51-17-13-45(59-2,14-18-51)27-49-24-31-19-35-36(20-32(31)25-49)43(58)53(42(35)57)38-9-10-39(54)48-40(38)55/h3-8,19-21,28,38H,9-18,22,24-27H2,1-2H3,(H,48,54,55)/t28-,38?/m0/s1",MYAUGYDOTJZSSR-XRTOLJPQSA-N
3059,0.5,99,0.5/2.9,99/99,P10275,AR,CRBN,,ARD-1690,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)C4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25.7,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,760.295,759.2935951,4.18,55,9,9,1,6,137.37,C42H42ClN7O5,"InChI=1S/C42H42ClN7O5/c1-25-17-42(24-49(25)32-7-4-28(18-44)35(43)16-32)10-12-47(13-11-42)31-5-2-27(3-6-31)39(53)48-20-26(21-48)19-46-22-29-14-33-34(15-30(29)23-46)41(55)50(40(33)54)36-8-9-37(51)45-38(36)52/h2-7,14-16,25-26,36H,8-13,17,19-24H2,1H3,(H,45,51,52)/t25-,36?/m0/s1",SIFVRCPVOMAZLY-XFCCSEHESA-N
3065,16,95,16,95,P51617,IRAK1,VHL,,,COC1=CC(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,864.042,863.378866,4.63,62,7,12,5,14,204,C45H53N9O7S,"InChI=1S/C45H53N9O7S/c1-27-40(62-26-47-27)29-11-9-28(10-12-29)23-46-43(58)37-22-31(55)24-54(37)44(59)41(45(2,3)4)51-39(56)25-61-32-16-19-53(20-17-32)30-13-14-35(38(21-30)60-5)50-42(57)36-8-6-7-33(49-36)34-15-18-48-52-34/h6-15,18,21,26,31-32,37,41,55H,16-17,19-20,22-25H2,1-5H3,(H,46,58)(H,48,52)(H,50,57)(H,51,56)/t31-,37+,41-/m1/s1",PWCLOPMRUGHLET-SPVIJIGUSA-N
3066,3,96,3,96,P51617,IRAK1,VHL,,,COC1=CC(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,878.069,877.3945161,5.03,63,7,12,5,14,204,C46H55N9O7S,"InChI=1S/C46H55N9O7S/c1-27(29-10-12-30(13-11-29)41-28(2)47-26-63-41)49-44(59)38-23-32(56)24-55(38)45(60)42(46(3,4)5)52-40(57)25-62-33-17-20-54(21-18-33)31-14-15-36(39(22-31)61-6)51-43(58)37-9-7-8-34(50-37)35-16-19-48-53-35/h7-16,19,22,26-27,32-33,38,42,56H,17-18,20-21,23-25H2,1-6H3,(H,48,53)(H,49,59)(H,51,58)(H,52,57)/t27-,32+,38-,42+/m0/s1",MHRNVFQJUUXQIG-VIFUUBRESA-N
3067,16,97,16,97,P51617,IRAK1,VHL,,,COC1=CC(N2CCN(C(=O)OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,893.04,892.3690296,3.9,64,7,13,5,13,224.31,C45H52N10O8S,"InChI=1S/C45H52N10O8S/c1-27-39(64-26-47-27)29-11-9-28(10-12-29)23-46-42(59)36-22-31(56)24-55(36)43(60)40(45(2,3)4)51-38(57)25-63-44(61)54-19-17-53(18-20-54)30-13-14-34(37(21-30)62-5)50-41(58)35-8-6-7-32(49-35)33-15-16-48-52-33/h6-16,21,26,31,36,40,56H,17-20,22-25H2,1-5H3,(H,46,59)(H,48,52)(H,50,58)(H,51,57)/t31-,36+,40-/m1/s1",GGEHXEZNDKXJIX-OXGRJUKFSA-N
3068,9,90,9,90,P51617,IRAK1,VHL,,,COC1=CC(N2CCN(C(=O)OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,907.067,906.3846797,4.3,65,7,13,5,13,224.31,C46H54N10O8S,"InChI=1S/C46H54N10O8S/c1-27(29-10-12-30(13-11-29)40-28(2)47-26-65-40)49-43(60)37-23-32(57)24-56(37)44(61)41(46(3,4)5)52-39(58)25-64-45(62)55-20-18-54(19-21-55)31-14-15-35(38(22-31)63-6)51-42(59)36-9-7-8-33(50-36)34-16-17-48-53-34/h7-17,22,26-27,32,37,41,57H,18-21,23-25H2,1-6H3,(H,48,53)(H,49,60)(H,51,59)(H,52,58)/t27-,32+,37-,41+/m0/s1",MWQAAQOVPMFJQP-KTOUKBDOSA-N
3069,13,96,13,96,P51617,IRAK1,VHL,,,COC1=CC(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3F)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,882.032,881.3694442,4.73,63,7,12,5,14,204,C45H52FN9O7S,"InChI=1S/C45H52FN9O7S/c1-26-40(63-25-48-26)27-9-10-28(32(46)19-27)22-47-43(59)37-21-30(56)23-55(37)44(60)41(45(2,3)4)52-39(57)24-62-31-14-17-54(18-15-31)29-11-12-35(38(20-29)61-5)51-42(58)36-8-6-7-33(50-36)34-13-16-49-53-34/h6-13,16,19-20,25,30-31,37,41,56H,14-15,17-18,21-24H2,1-5H3,(H,47,59)(H,49,53)(H,51,58)(H,52,57)/t30-,37+,41-/m1/s1",NEMQBDGIUBMFBU-UAFBGOENSA-N
3070,13,94,13,94,P51617,IRAK1,VHL,,,COC1=CC(N2CC[C@@H](OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C[C@@H]2C)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,892.096,891.4101662,5.46,64,7,12,5,14,204,C47H57N9O7S,"InChI=1S/C47H57N9O7S/c1-27-21-34(18-20-55(27)32-15-16-37(40(22-32)62-7)52-44(59)38-10-8-9-35(51-38)36-17-19-49-54-36)63-25-41(58)53-43(47(4,5)6)46(61)56-24-33(57)23-39(56)45(60)50-28(2)30-11-13-31(14-12-30)42-29(3)48-26-64-42/h8-17,19,22,26-28,33-34,39,43,57H,18,20-21,23-25H2,1-7H3,(H,49,54)(H,50,60)(H,52,59)(H,53,58)/t27-,28-,33+,34+,39-,43+/m0/s1",ITIRIVDRAPMHII-LHJQLXEHSA-N
3071,21,96,21,96,P51617,IRAK1,VHL,,,COC1=CC(N2CC[C@@H](OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)[C@H](C)C2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,892.096,891.4101662,5.46,64,7,12,5,14,204,C47H57N9O7S,"InChI=1S/C47H57N9O7S/c1-27-23-55(32-15-16-36(40(21-32)62-7)52-44(59)37-10-8-9-34(51-37)35-17-19-49-54-35)20-18-39(27)63-25-41(58)53-43(47(4,5)6)46(61)56-24-33(57)22-38(56)45(60)50-28(2)30-11-13-31(14-12-30)42-29(3)48-26-64-42/h8-17,19,21,26-28,33,38-39,43,57H,18,20,22-25H2,1-7H3,(H,49,54)(H,50,60)(H,52,59)(H,53,58)/t27-,28+,33-,38+,39-,43-/m1/s1",GHFASOYKYKNVGE-YLSOEQEJSA-N
3083,68,99,68,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)C4=CN(CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,988.072,987.4239016,2.5,72,9,18,4,23,265.69,C50H57N11O11,"InChI=1S/C50H57N11O11/c51-45(63)43-44(33-9-11-35(12-10-33)72-34-5-2-1-3-6-34)56-61-39(15-18-53-46(43)61)32-16-20-58(21-17-32)49(66)38-31-59(57-55-38)22-24-69-26-28-71-30-29-70-27-25-68-23-19-52-37-8-4-7-36-42(37)50(67)60(48(36)65)40-13-14-41(62)54-47(40)64/h1-12,31-32,39-40,52-53H,13-30H2,(H2,51,63)(H,54,62,64)/t39-,40?/m0/s1",OTABWVDGVKWCAE-KLBOFATRSA-N
3084,78,99,78,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)C4=CN(CCOCCOCCOCCOCCOCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)N=N4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,1032.125,1031.450116,1.8,75,9,19,4,26,274.92,C52H61N11O12,"InChI=1S/C52H61N11O12/c53-47(65)45-46(35-6-9-38(10-7-35)75-37-4-2-1-3-5-37)58-63-42(14-17-55-48(45)63)34-15-19-60(20-16-34)52(69)41-33-61(59-57-41)21-23-71-25-27-73-29-31-74-30-28-72-26-24-70-22-18-54-36-8-11-39-40(32-36)51(68)62(50(39)67)43-12-13-44(64)56-49(43)66/h1-11,32-34,42-43,54-55H,12-31H2,(H2,53,65)(H,56,64,66)/t42-,43?/m0/s1",CQNKHUHLWCRJEJ-ZAGGQVEOSA-N
3085,78,99,78,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)C4=CN(CCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,1032.125,1031.450116,2.35,75,9,19,4,26,274.92,C52H61N11O12,"InChI=1S/C52H61N11O12/c53-47(65)45-46(35-9-11-37(12-10-35)75-36-5-2-1-3-6-36)58-63-41(15-18-55-48(45)63)34-16-20-60(21-17-34)51(68)40-33-61(59-57-40)22-24-71-26-28-73-30-32-74-31-29-72-27-25-70-23-19-54-39-8-4-7-38-44(39)52(69)62(50(38)67)42-13-14-43(64)56-49(42)66/h1-12,33-34,41-42,54-55H,13-32H2,(H2,53,65)(H,56,64,66)/t41-,42?/m0/s1",AGXYYQWHBFFAPC-DYJLHVNUSA-N
3086,107,99,107,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)C4=CN(CCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,1076.178,1075.476331,2.2,78,9,20,4,29,284.15,C54H65N11O13,"InChI=1S/C54H65N11O13/c55-49(67)47-48(37-9-11-39(12-10-37)78-38-5-2-1-3-6-38)60-65-43(15-18-57-50(47)65)36-16-20-62(21-17-36)53(70)42-35-63(61-59-42)22-24-73-26-28-75-30-32-77-34-33-76-31-29-74-27-25-72-23-19-56-41-8-4-7-40-46(41)54(71)64(52(40)69)44-13-14-45(66)58-51(44)68/h1-12,35-36,43-44,56-57H,13-34H2,(H2,55,67)(H,58,66,68)/t43-,44?/m0/s1",QIZHAOLULZRBCK-XASUVLGYSA-N
3087,34,99,34,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)C4=CN(CCOCCOCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)N=N4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,913.949,913.3507367,1.46,67,9,16,4,16,264.3,C46H47N11O10,"InChI=1S/C46H47N11O10/c47-41(60)39-40(28-6-9-31(10-7-28)67-30-4-2-1-3-5-30)52-57-35(14-17-48-42(39)57)27-15-18-54(19-16-27)46(64)34-25-55(53-51-34)20-21-65-22-23-66-26-38(59)49-29-8-11-32-33(24-29)45(63)56(44(32)62)36-12-13-37(58)50-43(36)61/h1-11,24-25,27,35-36,48H,12-23,26H2,(H2,47,60)(H,49,59)(H,50,58,61)/t35-,36?/m0/s1",FDGLVGNHOUVJEC-TYIYNAFKSA-N
3088,74,99,74,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)CCC4=CC=C(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,890.014,889.391145,4.77,66,10,12,3,11,192.51,C50H51N9O7,"InChI=1S/C50H51N9O7/c51-46(62)44-45(33-9-14-37(15-10-33)66-36-4-2-1-3-5-36)54-59-40(20-23-52-47(44)59)32-21-24-57(25-22-32)43(61)19-8-31-6-11-34(12-7-31)55-26-28-56(29-27-55)35-13-16-38-39(30-35)50(65)58(49(38)64)41-17-18-42(60)53-48(41)63/h1-7,9-16,30,32,40-41,52H,8,17-29H2,(H2,51,62)(H,53,60,63)/t40-,41?/m0/s1",TUMQILUEGUUTTR-KCXVWBLISA-N
3089,28,99,28,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)CCCC4=CC=C(NC(=O)CNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C=C4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,891.986,891.3704095,4.3,66,9,12,5,14,227.16,C49H49N9O8,"InChI=1S/C49H49N9O8/c50-45(62)43-44(31-11-16-35(17-12-31)66-34-6-2-1-3-7-34)55-58-38(21-24-51-46(43)58)30-22-25-56(26-23-30)42(61)8-4-5-29-9-13-32(14-10-29)53-41(60)28-52-33-15-18-36-37(27-33)49(65)57(48(36)64)39-19-20-40(59)54-47(39)63/h1-3,6-7,9-18,27,30,38-39,51-52H,4-5,8,19-26,28H2,(H2,50,62)(H,53,60)(H,54,59,63)/t38-,39?/m0/s1",BCFBPSTVQNVIPE-SQTCDLSVSA-N
3090,2.9,99,2.9,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)CCN4CCN(C(=O)CNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,870.968,870.3813086,2.12,64,9,13,4,12,221.61,C46H50N10O8,"InChI=1S/C46H50N10O8/c47-42(60)40-41(29-6-9-32(10-7-29)64-31-4-2-1-3-5-31)51-56-35(14-18-48-43(40)56)28-15-20-53(21-16-28)38(58)17-19-52-22-24-54(25-23-52)39(59)27-49-30-8-11-33-34(26-30)46(63)55(45(33)62)36-12-13-37(57)50-44(36)61/h1-11,26,28,35-36,48-49H,12-25,27H2,(H2,47,60)(H,50,57,61)/t35-,36?/m0/s1",JPJRLFDIZBTSTD-TYIYNAFKSA-N
3091,35,99,35,,Q06187,BTK,CRBN,,,CN(CCC(=O)N1CCC([C@@H]2CCNC3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1)CC1CCN(C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,855.997,855.406795,3.7,63,9,12,3,12,192.51,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-52(28-29-16-23-53(24-17-29)32-9-12-35-36(27-32)47(62)55(46(35)61)38-13-14-39(57)50-45(38)60)22-20-40(58)54-25-18-30(19-26-54)37-15-21-49-44-41(43(48)59)42(51-56(37)44)31-7-10-34(11-8-31)63-33-5-3-2-4-6-33/h2-12,27,29-30,37-38,49H,13-26,28H2,1H3,(H2,48,59)(H,50,57,60)/t37-,38?/m0/s1",VYKLDHRNKFTKOT-AIQPRDSRSA-N
3092,17,99,17,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)CCC4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,896.062,895.4380952,4.61,66,10,12,3,11,192.51,C50H57N9O7,"InChI=1S/C50H57N9O7/c51-46(62)44-45(33-9-14-37(15-10-33)66-36-4-2-1-3-5-36)54-59-40(20-23-52-47(44)59)32-21-24-57(25-22-32)43(61)19-8-31-6-11-34(12-7-31)55-26-28-56(29-27-55)35-13-16-38-39(30-35)50(65)58(49(38)64)41-17-18-42(60)53-48(41)63/h1-5,9-10,13-16,30-32,34,40-41,52H,6-8,11-12,17-29H2,(H2,51,62)(H,53,60,63)/t31?,34?,40-,41?/m0/s1",GIDSHQNPQLLDGD-VHPJZFMFSA-N
3093,35,99,35,,Q06187,BTK,CRBN,,,NC(=O)C1=C2NCC[C@@H](C3CCN(C(=O)CCCN4CCN(C(=O)CNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,884.995,884.3969586,2.47,65,9,13,4,13,221.61,C47H52N10O8,"InChI=1S/C47H52N10O8/c48-43(61)41-42(30-8-11-33(12-9-30)65-32-5-2-1-3-6-32)52-57-36(16-19-49-44(41)57)29-17-21-54(22-18-29)39(59)7-4-20-53-23-25-55(26-24-53)40(60)28-50-31-10-13-34-35(27-31)47(64)56(46(34)63)37-14-15-38(58)51-45(37)62/h1-3,5-6,8-13,27,29,36-37,49-50H,4,7,14-26,28H2,(H2,48,61)(H,51,58,62)/t36-,37?/m0/s1",ZRHRJLMEFZTXRX-NWDJCJOJSA-N
3094,7.2,99,7.2,,Q06187,BTK,CRBN,,,CN(CC1CCN(C(=O)C2=CC=C(N3CCC(=O)NC3=O)C=C2)CC1)C1CC(C(=O)N2CCC([C@@H]3CCNC4=C(C(N)=O)C(C5=CC=C(OC6=CC=CC=C6)C=C5)=NN43)CC2)C1,Degradation of BTK in Ramos cells after 16 h treatment by ELISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00178,842.014,841.4275305,4.1,62,9,10,3,11,175.44,C47H55N9O6,"InChI=1S/C47H55N9O6/c1-52(29-30-16-22-53(23-17-30)45(59)33-7-11-35(12-8-33)55-26-20-40(57)50-47(55)61)36-27-34(28-36)46(60)54-24-18-31(19-25-54)39-15-21-49-44-41(43(48)58)42(51-56(39)44)32-9-13-38(14-10-32)62-37-5-3-2-4-6-37/h2-14,30-31,34,36,39,49H,15-29H2,1H3,(H2,48,58)(H,50,57,61)/t34?,36?,39-/m0/s1",JCHKKGUWOQWSRJ-MOGPQGRSSA-N
3095,1,99,1,,Q9H8M2,BRD9,CRBN,,,COC1=CC(C2=CN(C)C(=O)C(C)=C2C)=CC(OC)=C1CCN1CCC(OC2CCN(C(=O)C3=CC=C(Cl)C(N4CCC(=O)NC4=O)=C3)CC2)CC1,Degradation of BRD9 in HEK293A cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00580,734.294,733.3242266,3.52,52,6,9,1,10,122.65,C39H48ClN5O7,"InChI=1S/C39H48ClN5O7/c1-24-25(2)37(47)42(3)23-31(24)27-21-34(50-4)30(35(22-27)51-5)12-16-43-14-8-28(9-15-43)52-29-10-17-44(18-11-29)38(48)26-6-7-32(40)33(20-26)45-19-13-36(46)41-39(45)49/h6-7,20-23,28-29H,8-19H2,1-5H3,(H,41,46,49)",DBQTXWRLCKDYPJ-UHFFFAOYSA-N
3096,1,99,1,,Q9H8M2,BRD9,CRBN,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CCN1CCC(OC2CCN(C(=O)C3=CC=C(Cl)C(N4CCC(=O)NC4=O)=C3)CC2)CC1,Degradation of BRD9 in HEK293A cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00580,757.288,756.3038255,3.29,54,7,10,1,10,135.54,C40H45ClN6O7,"InChI=1S/C40H45ClN6O7/c1-44-24-32(29-6-13-42-23-31(29)39(44)50)26-21-35(52-2)30(36(22-26)53-3)11-16-45-14-7-27(8-15-45)54-28-9-17-46(18-10-28)38(49)25-4-5-33(41)34(20-25)47-19-12-37(48)43-40(47)51/h4-6,13,20-24,27-28H,7-12,14-19H2,1-3H3,(H,43,48,51)",QCZROHALGMEVOV-UHFFFAOYSA-N
3097,1,99,1,,Q9H8M2,BRD9,CRBN,,,CCCCN1C=C(C2=CC=C(OC3CCN(CC4CCN(C(=O)C5=CC=C(Cl)C(N6CCC(=O)NC6=O)=C5)CC4)CC3)C(OC)=C2)C2=CC=NC=C2C1=O,Degradation of BRD9 in HEK293A cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00580,755.316,754.3245609,4.61,54,7,9,1,11,126.31,C41H47ClN6O6,"InChI=1S/C41H47ClN6O6/c1-3-4-16-47-26-33(31-9-15-43-24-32(31)40(47)51)28-6-8-36(37(23-28)53-2)54-30-12-17-45(18-13-30)25-27-10-19-46(20-11-27)39(50)29-5-7-34(42)35(22-29)48-21-14-38(49)44-41(48)52/h5-9,15,22-24,26-27,30H,3-4,10-14,16-21,25H2,1-2H3,(H,44,49,52)",MQXFOTNUITWXQX-UHFFFAOYSA-N
3098,1,99,1,,Q9H8M2,BRD9,CRBN,,,CCCCN1C=C(C2=CC(OC)=C(OC3CCN(CC4CCN(C(=O)C5=CC=C(Cl)C(N6CCC(=O)NC6=O)=C5)CC4)CC3)C(OC)=C2)C2=CC=NC=C2C1=O,Degradation of BRD9 in HEK293A cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00580,785.342,784.3351256,4.59,56,7,10,1,12,135.54,C42H49ClN6O7,"InChI=1S/C42H49ClN6O7/c1-4-5-15-48-26-33(31-8-14-44-24-32(31)41(48)52)29-22-36(54-2)39(37(23-29)55-3)56-30-11-16-46(17-12-30)25-27-9-18-47(19-10-27)40(51)28-6-7-34(43)35(21-28)49-20-13-38(50)45-42(49)53/h6-8,14,21-24,26-27,30H,4-5,9-13,15-20,25H2,1-3H3,(H,45,50,53)",XGYWVYJNKZAZLG-UHFFFAOYSA-N
3099,1,99,1,,Q9H8M2,BRD9,CRBN,,,CCCCN1C=C(C2=CC=C(O[C@H]3CCN(CC4CCN(C(=O)C5=CC=C(OC)C(N6CCC(=O)NC6=O)=C5)CC4)C[C@@H]3F)C(OC)=C2)C2=CC=NC=C2C1=O,Degradation of BRD9 in HEK293A cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00580,768.887,768.3646761,4.01,56,7,10,1,12,135.54,C42H49FN6O7,"InChI=1S/C42H49FN6O7/c1-4-5-16-48-25-32(30-10-15-44-23-31(30)41(48)52)28-6-9-37(38(22-28)55-3)56-35-13-17-46(26-33(35)43)24-27-11-18-47(19-12-27)40(51)29-7-8-36(54-2)34(21-29)49-20-14-39(50)45-42(49)53/h6-10,15,21-23,25,27,33,35H,4-5,11-14,16-20,24,26H2,1-3H3,(H,45,50,53)/t33-,35-/m0/s1",RHYLAIPZKCALML-LRHLLKFHSA-N
3100,1,99,1,,Q9H8M2,BRD9,CRBN,,,CCCCN1C=C(C2=CC(F)=C(O[C@H]3CCN(CC4CCN(C(=O)C5=CC=C(OC)C(N6CCC(=O)NC6=O)=C5)CC4)C[C@@H]3F)C(F)=C2)C2=CC=NC=C2C1=O,Degradation of BRD9 in HEK293A cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00580,774.841,774.3352678,4.24,56,7,9,1,11,126.31,C41H45F3N6O6,"InChI=1S/C41H45F3N6O6/c1-3-4-13-49-23-30(28-7-12-45-21-29(28)40(49)53)27-18-31(42)38(32(43)19-27)56-35-10-14-47(24-33(35)44)22-25-8-15-48(16-9-25)39(52)26-5-6-36(55-2)34(20-26)50-17-11-37(51)46-41(50)54/h5-7,12,18-21,23,25,33,35H,3-4,8-11,13-17,22,24H2,1-2H3,(H,46,51,54)/t33-,35-/m0/s1",WJKOYUQUWSPEDI-LRHLLKFHSA-N
3101,4,99,4,,P51531,SMARCA2,CRBN,,,NC1=NN=C(C2=CC=CC=C2O)C=C1N1CCN(C2=CC=CC(CN3CCN(C(=O)C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)=C2)C2(CC2)C1,Degradation of SMARCA2 HiBiT in HT1080 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00657,838.97,838.3914793,2.48,62,10,13,3,8,188.85,C46H50N10O6,"InChI=1S/C46H50N10O6/c47-41-38(26-36(49-50-41)34-6-1-2-7-39(34)57)54-22-23-55(46(28-54)14-15-46)32-5-3-4-29(24-32)27-51-18-20-53(21-19-51)43(60)30-12-16-52(17-13-30)31-8-9-33-35(25-31)45(62)56(44(33)61)37-10-11-40(58)48-42(37)59/h1-9,24-26,30,37,57H,10-23,27-28H2,(H2,47,50)(H,48,58,59)",QCCHVYRUHHHVFL-UHFFFAOYSA-N
3102,2,99,2,,P51531,SMARCA2,CRBN,,,NC1=NN=C(C2=CC=CC=C2O)C=C1N1CC2CCC(C1)N2C1=CC=CC(OCCN2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)=C1,Degradation of SMARCA2 HiBiT in HT1080 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00657,855.013,854.4227794,3.73,63,10,14,3,11,181.01,C47H54N10O6,"InChI=1S/C47H54N10O6/c48-44-41(26-39(50-51-44)37-6-1-2-7-42(37)58)55-28-33-8-9-34(29-55)56(33)32-4-3-5-35(24-32)63-23-22-52-18-20-53(21-19-52)27-30-14-16-54(17-15-30)31-10-11-36-38(25-31)47(62)57(46(36)61)40-12-13-43(59)49-45(40)60/h1-7,10-11,24-26,30,33-34,40,58H,8-9,12-23,27-29H2,(H2,48,51)(H,49,59,60)",NZXFUHUZHUMMLU-UHFFFAOYSA-N
3103,2,99,2,,P51531,SMARCA2,CRBN,,,NC1=NN=C(C2=CC=CC=C2O)C=C1N1CC2CCC(C1)N2C1=CC=CC(OCCN2CCN(CCCC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)=C1,Degradation of SMARCA2 HiBiT in HT1080 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00657,883.067,882.4540796,4.44,65,10,14,3,13,181.01,C49H58N10O6,"InChI=1S/C49H58N10O6/c50-46-43(29-41(52-53-46)39-8-1-2-9-44(39)60)57-30-35-10-11-36(31-57)58(35)34-6-3-7-37(27-34)65-26-25-55-23-21-54(22-24-55)18-4-5-32-16-19-56(20-17-32)33-12-13-38-40(28-33)49(64)59(48(38)63)42-14-15-45(61)51-47(42)62/h1-3,6-9,12-13,27-29,32,35-36,42,60H,4-5,10-11,14-26,30-31H2,(H2,50,53)(H,51,61,62)",UTLOUOROEIRWIF-UHFFFAOYSA-N
3104,3,99,3,,P51531,SMARCA2,CRBN,,,NC1=NN=C(C2=CC=CC=C2O)C=C1N1CC(OC2=CC=CC(CN3CCN(C(=O)CN4CCC(C5=CC=C(NC6CCC(=O)NC6=O)C=C5)CC4)CC3)=C2)C1,Degradation of SMARCA2 HiBiT in HT1080 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00657,759.912,759.3856657,3.06,56,8,12,4,11,169.49,C42H49N9O5,"InChI=1S/C42H49N9O5/c43-41-37(23-36(46-47-41)34-6-1-2-7-38(34)52)51-25-33(26-51)56-32-5-3-4-28(22-32)24-49-18-20-50(21-19-49)40(54)27-48-16-14-30(15-17-48)29-8-10-31(11-9-29)44-35-12-13-39(53)45-42(35)55/h1-11,22-23,30,33,35,44,52H,12-21,24-27H2,(H2,43,47)(H,45,53,55)",VVNYHGLUTRJGFK-UHFFFAOYSA-N
3105,3,99,3,,P51531,SMARCA2,CRBN,,,NC1=NN=C(C2=CC(F)=CC=C2O)C=C1N1CC2CCC(C1)N2C1=CC=CC(CN2CCN(C(=O)C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)=C1,Degradation of SMARCA2 HiBiT in HT1080 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00657,856.96,856.3820575,2.83,63,10,13,3,8,188.85,C46H49FN10O6,"InChI=1S/C46H49FN10O6/c47-29-4-10-40(58)36(21-29)37-23-39(42(48)51-50-37)55-25-32-5-6-33(26-55)56(32)31-3-1-2-27(20-31)24-52-16-18-54(19-17-52)44(61)28-12-14-53(15-13-28)30-7-8-34-35(22-30)46(63)57(45(34)62)38-9-11-41(59)49-43(38)60/h1-4,7-8,10,20-23,28,32-33,38,58H,5-6,9,11-19,24-26H2,(H2,48,51)(H,49,59,60)",JDTSERWCVQGCFT-UHFFFAOYSA-N
3106,3,99,3,,P51531,SMARCA2,CRBN,,,NC1=NN=C(C2=CC=CC=C2O)C=C1N1CCC(C(=O)N2CCC(C(=O)N3CCN(C4=CC=C(C5CCC(=O)NC5=O)C=C4)CC3)CC2)(C2=CC=CC=C2)CC1,Degradation of SMARCA2 HiBiT in HT1080 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00657,756.908,756.3747666,3,56,8,10,3,7,165.3,C43H48N8O5,"InChI=1S/C43H48N8O5/c44-39-36(28-35(46-47-39)34-8-4-5-9-37(34)52)49-22-18-43(19-23-49,31-6-2-1-3-7-31)42(56)51-20-16-30(17-21-51)41(55)50-26-24-48(25-27-50)32-12-10-29(11-13-32)33-14-15-38(53)45-40(33)54/h1-13,28,30,33,52H,14-27H2,(H2,44,47)(H,45,53,54)",GPZCDIKIONXKJM-UHFFFAOYSA-N
3107,26,99,26,,P15056,BRAF V600E,CRBN,,,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)C=C23)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00039,896.934,896.2875857,3.11,64,8,12,4,14,227.18,C43H42F2N10O8S,"InChI=1S/C43H42F2N10O8S/c1-3-52(2)64(62,63)51-31-11-10-29(44)37(38(31)45)39(58)28-23-49-40-27(28)20-25(22-48-40)24-9-13-33(47-21-24)53-16-18-54(19-17-53)35(57)8-5-15-46-30-7-4-6-26-36(30)43(61)55(42(26)60)32-12-14-34(56)50-41(32)59/h4,6-7,9-11,13,20-23,32,46,51H,3,5,8,12,14-19H2,1-2H3,(H,48,49)(H,50,56,59)",IDIDGUPJKXQFDW-UHFFFAOYSA-N
3108,10,99,10,,P15056,BRAF V600E,CRBN,,,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)[C@H]6C[C@H](NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)CC5)N=C4)C=C23)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00039,908.945,908.2875857,2.79,65,9,12,4,12,227.18,C44H42F2N10O8S,"InChI=1S/C44H42F2N10O8S/c1-3-53(2)65(63,64)52-32-9-8-30(45)37(38(32)46)39(58)29-22-49-40-28(29)19-25(21-48-40)23-7-11-34(47-20-23)54-13-15-55(16-14-54)42(60)24-17-26(18-24)50-31-6-4-5-27-36(31)44(62)56(43(27)61)33-10-12-35(57)51-41(33)59/h4-9,11,19-22,24,26,33,50,52H,3,10,12-18H2,1-2H3,(H,48,49)(H,51,57,59)/t24-,26-,33?",ODASMJWPZUAEOH-KBOGUJPVSA-N
3109,10,99,10,,P15056,BRAF V600E,CRBN,,,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCCOC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)C=C23)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00039,883.935,883.2923368,2.6,63,8,11,3,14,207.31,C43H43F2N9O8S,"InChI=1S/C43H43F2N9O8S/c1-3-51(2)63(60,61)50-32-11-10-31(44)38(39(32)45)40(57)29-23-48-41-28(29)20-26(22-47-41)25-9-13-35(46-21-25)52-15-17-53(18-16-52)37(56)8-5-19-62-34-7-4-6-27-30(34)24-54(43(27)59)33-12-14-36(55)49-42(33)58/h4,6-7,9-11,13,20-23,33,50H,3,5,8,12,14-19,24H2,1-2H3,(H,47,48)(H,49,55,58)",XDLVFGNNSKLZTE-UHFFFAOYSA-N
3110,20,99,20,,P15056,BRAF V600E,CRBN,,,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CN=C(N5CCN(C(=O)CCCOC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)C=C23)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00039,884.923,884.2875857,1.95,63,8,12,3,14,220.2,C42H42F2N10O8S,"InChI=1S/C42H42F2N10O8S/c1-3-51(2)63(60,61)50-31-10-9-30(43)36(37(31)44)38(57)28-22-46-39-27(28)18-24(19-45-39)25-20-47-42(48-21-25)53-15-13-52(14-16-53)35(56)8-5-17-62-33-7-4-6-26-29(33)23-54(41(26)59)32-11-12-34(55)49-40(32)58/h4,6-7,9-10,18-22,32,50H,3,5,8,11-17,23H2,1-2H3,(H,45,46)(H,49,55,58)",FOPROWALTSOUAU-UHFFFAOYSA-N
3111,23,99,23,,P15056,BRAF V600E,CRBN,,,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)[C@H]6C[C@H](NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)CC5)C=C4)C=C23)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00039,907.957,907.2923368,3.52,65,9,11,4,12,214.29,C45H43F2N9O8S,"InChI=1S/C45H43F2N9O8S/c1-3-53(2)65(63,64)52-34-12-11-32(46)38(39(34)47)40(58)31-23-49-41-30(31)21-26(22-48-41)24-7-9-28(10-8-24)54-15-17-55(18-16-54)43(60)25-19-27(20-25)50-33-6-4-5-29-37(33)45(62)56(44(29)61)35-13-14-36(57)51-42(35)59/h4-12,21-23,25,27,35,50,52H,3,13-20H2,1-2H3,(H,48,49)(H,51,57,59)/t25-,27-,35?",DFAPPDJMTAQYIX-KDDZAWODSA-N
3112,16,99,16,,P15056,BRAF V600E,CRBN,,,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCCOC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4)C=C23)=C1F,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00039,882.947,882.2970878,3.33,63,8,10,3,14,194.42,C44H44F2N8O8S,"InChI=1S/C44H44F2N8O8S/c1-3-51(2)63(60,61)50-34-14-13-33(45)39(40(34)46)41(57)31-24-48-42-30(31)22-27(23-47-42)26-9-11-28(12-10-26)52-17-19-53(20-18-52)38(56)8-5-21-62-36-7-4-6-29-32(36)25-54(44(29)59)35-15-16-37(55)49-43(35)58/h4,6-7,9-14,22-24,35,50H,3,5,8,15-21,25H2,1-2H3,(H,47,48)(H,49,55,58)",LSJXTQQYRIMOFI-UHFFFAOYSA-N
3120,1010,95,1010,>95,Q00987,MDM2,MDM2,,,CCOC1=CC(C(C)(C)C)=CC=C1C1=NC(C2=CC=C(Cl)C=C2)C(C2=CC=C(Cl)C=C2)N1C(=O)N1CCN(CC(=O)NCCOCCOCCOCCNC(=O)CN2CCN(C(=O)N3C(C4=CC=C(C(C)(C)C)C=C4OCC)=NC(C4=CC=C(Cl)C=C4)C3C3=CC=C(Cl)C=C3)CC2=O)C(=O)C1,Degradation of MDM2 in A549 cells after 24 h treatment,,,,,,,,,100,MDM2-P53 competitive binding activities were tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1000/3300/1900,Inhibit proliferation of A549/HepG2/HCT116 cells,,,,,,,,,,,0.06,Compounds were administered at 10000 nM and incubated for 2 h,0.02,Compounds were administered at 10000 nM and incubated for 2 h,10.1016/j.apsb.2020.11.022,1459.411,1456.538814,11.32,101,10,13,2,26,216.79,C76H88Cl4N10O11,"InChI=1S/C76H88Cl4N10O11/c1-9-100-61-43-53(75(3,4)5)19-29-59(61)71-83-67(49-11-21-55(77)22-12-49)69(51-15-25-57(79)26-16-51)89(71)73(95)87-35-33-85(65(93)47-87)45-63(91)81-31-37-97-39-41-99-42-40-98-38-32-82-64(92)46-86-34-36-88(48-66(86)94)74(96)90-70(52-17-27-58(80)28-18-52)68(50-13-23-56(78)24-14-50)84-72(90)60-30-20-54(76(6,7)8)44-62(60)101-10-2/h11-30,43-44,67-70H,9-10,31-42,45-48H2,1-8H3,(H,81,91)(H,82,92)",BYXQFJDQDXLTHH-UHFFFAOYSA-N
3139,108.7,99,108.7,,,BCR-ABL T315I,CRBN,,,CC1=CC=C(C(=O)NC2=CC=C(CN3CCN(CCCCCCC(=O)NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C(C(F)(F)F)=C2)C=C1C#CC1=CN=C2[NH]N=CC2=C1,Degradation of BCR-ABL T315I in Ba/F3 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.7/4.2/26.8,Inhibit proliferation of K562/(Ba/F3 WT)/(Ba/F3 BCR-ABL T315I) cells,,,,,,,,,,,,,,,10.1016/j.apsb.2020.11.009,901.947,901.3523149,5.74,66,8,10,4,13,189.8,C48H46F3N9O6,"InChI=1S/C48H46F3N9O6/c1-29-10-12-32(24-31(29)13-11-30-23-34-27-53-57-43(34)52-26-30)44(63)54-35-15-14-33(37(25-35)48(49,50)51)28-59-21-19-58(20-22-59)18-5-3-2-4-9-40(61)55-38-8-6-7-36-42(38)47(66)60(46(36)65)39-16-17-41(62)56-45(39)64/h6-8,10,12,14-15,23-27,39H,2-5,9,16-22,28H2,1H3,(H,54,63)(H,55,61)(H,52,53,57)(H,56,62,64)",HNQVKMYCDZGKOD-UHFFFAOYSA-N
3149,120,76,120,76,P04035,HMGCR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)O[C@H]3C[C@@H](C)C=C4C=C[C@H](C)[C@H](CCC(O)C[C@@H](O)CC(=O)O)[C@H]43)C(C)(C)C)C=C2)SC=N1,Degradation of HMGCR in HepG2 cells after 16 h treatment,,,250,Inhibition of HMGCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18.22,Caco-2 A2B assay,,,10.1016/j.apsb.2020.11.001,978.307,977.5547647,7.73,69,5,11,7,25,227.72,C53H79N5O10S,"InChI=1S/C53H79N5O10S/c1-33-25-38-19-16-34(2)42(23-22-39(59)27-40(60)29-46(63)64)47(38)44(26-33)68-52(67)54-24-14-12-10-8-7-9-11-13-15-45(62)57-49(53(4,5)6)51(66)58-31-41(61)28-43(58)50(65)55-30-36-17-20-37(21-18-36)48-35(3)56-32-69-48/h16-21,25,32-34,39-44,47,49,59-61H,7-15,22-24,26-31H2,1-6H3,(H,54,67)(H,55,65)(H,57,62)(H,63,64)/t33-,34-,39?,40+,41+,42-,43-,44-,47-,49+/m0/s1",YASBQIQZXTUKLR-SHAIEYSUSA-N
3150,5,97,5,97,O60885,BRD4,CRBN,,CFT-1297,CC1=NN=C2N1C1=CC=C(C3=CN(CCCCCCCN4CCC(C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)N=C3)C=C1C(C1=CC=C(Cl)C=C1)=NC21CC1,Degradation of BRD4 in HEK293T cells after 3 h treatment,,,,,,,58,Kd of BRD4 BD1 was assessed by FP,,,,,,,,,,,,,,,2100,FP,,,,,,,,,,,,,,,4,Kd was tested by AlphaLISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.1c00376,824.43,823.3725141,5.95,60,10,10,1,12,130.61,C47H50ClN9O3,"InChI=1S/C47H50ClN9O3/c1-30-52-53-46-47(20-21-47)51-43(32-10-13-35(48)14-11-32)38-26-33(12-15-40(38)57(30)46)34-27-49-55(28-34)23-6-4-2-3-5-22-54-24-18-31(19-25-54)36-8-7-9-37-39(36)29-56(45(37)60)41-16-17-42(58)50-44(41)59/h7-15,26-28,31,41H,2-6,16-25,29H2,1H3,(H,50,58,59)",SDKKICDYRHTFNX-UHFFFAOYSA-N
3171,75,75,75/77,>75/>85,P10275,AR,CRBN,,,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(C2=CC=C(O[C@@H]3CCN(C(=O)C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)C=C1,Degradation of AR in A549/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/ardp.202100467,917.967,917.2818523,6,66,9,10,1,8,163.67,C48H42F3N7O7S,"InChI=1S/C48H42F3N7O7S/c1-47(2)45(64)56(33-10-5-30(25-52)38(24-33)48(49,50)51)46(66)58(47)31-8-3-27(4-9-31)28-6-12-34(13-7-28)65-35-19-22-55(26-35)42(61)29-17-20-54(21-18-29)32-11-14-36-37(23-32)44(63)57(43(36)62)39-15-16-40(59)53-41(39)60/h3-14,23-24,29,35,39H,15-22,26H2,1-2H3,(H,53,59,60)/t35-,39?/m1/s1",PMTYRQFZOZEPEI-QQKHLPPFSA-N
3173,244,99,244,,O75533,SF3B1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCNC(=O)C4=CSC(NC5=CC=C(Cl)C=C5)=N4)=C3C2=O)C(=O)N1,Degradation of SF3B1 in K562 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,227.9,Inhibit growth of K562 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2021.04.018,609.108,608.1608667,4.93,42,5,9,4,12,149.6,C29H29ClN6O5S,"InChI=1S/C29H29ClN6O5S/c30-17-8-10-18(11-9-17)33-29-34-21(16-42-29)25(38)32-15-4-2-1-3-14-31-20-7-5-6-19-24(20)28(41)36(27(19)40)22-12-13-23(37)35-26(22)39/h5-11,16,22,31H,1-4,12-15H2,(H,32,38)(H,33,34)(H,35,37,39)",UWYLVQJEOCYCEW-UHFFFAOYSA-N
3174,15,99,15,,Q06187,BTK C481A,CRBN,,L18I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK C481A in HeLa cells after 96 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41375-019-0440-x,897.994,897.3922076,2.8,66,9,16,2,19,224.04,C47H51N11O8,"InChI=1S/C47H51N11O8/c48-43-41-42(32-13-15-35(16-14-32)66-34-10-2-1-3-11-34)53-58(44(41)50-30-49-43)33-9-5-19-55(27-33)47(62)38-29-56(54-52-38)20-22-64-24-26-65-25-23-63-21-6-8-31-7-4-12-36-37(31)28-57(46(36)61)39-17-18-40(59)51-45(39)60/h1-4,7,10-16,29-30,33,39H,5-6,8-9,17-28H2,(H2,48,49,50)(H,51,59,60)/t33-,39?/m1/s1",PQIHIELQKZACPK-LXJLEQQOSA-N
3174,18,99,18,,Q06187,BTK,CRBN,,L18I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK in HeLa cells after 96 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12,Inhibit growth of HBL-1 cells,,,,,,,,,,,10.1038/s41375-019-0440-x,897.994,897.3922076,2.8,66,9,16,2,19,224.04,C47H51N11O8,"InChI=1S/C47H51N11O8/c48-43-41-42(32-13-15-35(16-14-32)66-34-10-2-1-3-11-34)53-58(44(41)50-30-49-43)33-9-5-19-55(27-33)47(62)38-29-56(54-52-38)20-22-64-24-26-65-25-23-63-21-6-8-31-7-4-12-36-37(31)28-57(46(36)61)39-17-18-40(59)51-45(39)60/h1-4,7,10-16,29-30,33,39H,5-6,8-9,17-28H2,(H2,48,49,50)(H,51,59,60)/t33-,39?/m1/s1",PQIHIELQKZACPK-LXJLEQQOSA-N
3174,26,99,26,,Q06187,BTK C481G,CRBN,,L18I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK C481G in HeLa cells after 96 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41375-019-0440-x,897.994,897.3922076,2.8,66,9,16,2,19,224.04,C47H51N11O8,"InChI=1S/C47H51N11O8/c48-43-41-42(32-13-15-35(16-14-32)66-34-10-2-1-3-11-34)53-58(44(41)50-30-49-43)33-9-5-19-55(27-33)47(62)38-29-56(54-52-38)20-22-64-24-26-65-25-23-63-21-6-8-31-7-4-12-36-37(31)28-57(46(36)61)39-17-18-40(59)51-45(39)60/h1-4,7,10-16,29-30,33,39H,5-6,8-9,17-28H2,(H2,48,49,50)(H,51,59,60)/t33-,39?/m1/s1",PQIHIELQKZACPK-LXJLEQQOSA-N
3174,29,99,29,,Q06187,BTK C481S,CRBN,,L18I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK C481S in HBL-1 cells after 36 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64/<10,Inhibit growth of HBL-1 (BTK C481S)/Mino (BTK C481S) cells,,,,,,,,,,,10.1038/s41375-019-0440-x,897.994,897.3922076,2.8,66,9,16,2,19,224.04,C47H51N11O8,"InChI=1S/C47H51N11O8/c48-43-41-42(32-13-15-35(16-14-32)66-34-10-2-1-3-11-34)53-58(44(41)50-30-49-43)33-9-5-19-55(27-33)47(62)38-29-56(54-52-38)20-22-64-24-26-65-25-23-63-21-6-8-31-7-4-12-36-37(31)28-57(46(36)61)39-17-18-40(59)51-45(39)60/h1-4,7,10-16,29-30,33,39H,5-6,8-9,17-28H2,(H2,48,49,50)(H,51,59,60)/t33-,39?/m1/s1",PQIHIELQKZACPK-LXJLEQQOSA-N
3174,38,99,38,,Q06187,BTK C481T,CRBN,,L18I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK C481T in HeLa cells after 96 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41375-019-0440-x,897.994,897.3922076,2.8,66,9,16,2,19,224.04,C47H51N11O8,"InChI=1S/C47H51N11O8/c48-43-41-42(32-13-15-35(16-14-32)66-34-10-2-1-3-11-34)53-58(44(41)50-30-49-43)33-9-5-19-55(27-33)47(62)38-29-56(54-52-38)20-22-64-24-26-65-25-23-63-21-6-8-31-7-4-12-36-37(31)28-57(46(36)61)39-17-18-40(59)51-45(39)60/h1-4,7,10-16,29-30,33,39H,5-6,8-9,17-28H2,(H2,48,49,50)(H,51,59,60)/t33-,39?/m1/s1",PQIHIELQKZACPK-LXJLEQQOSA-N
3174,41,99,41,,Q06187,BTK C481W,CRBN,,L18I,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)C2=CN(CCOCCOCCOCCCC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)N=N2)C1,Degradation of BTK C481W in HeLa cells after 96 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41375-019-0440-x,897.994,897.3922076,2.8,66,9,16,2,19,224.04,C47H51N11O8,"InChI=1S/C47H51N11O8/c48-43-41-42(32-13-15-35(16-14-32)66-34-10-2-1-3-11-34)53-58(44(41)50-30-49-43)33-9-5-19-55(27-33)47(62)38-29-56(54-52-38)20-22-64-24-26-65-25-23-63-21-6-8-31-7-4-12-36-37(31)28-57(46(36)61)39-17-18-40(59)51-45(39)60/h1-4,7,10-16,29-30,33,39H,5-6,8-9,17-28H2,(H2,48,49,50)(H,51,59,60)/t33-,39?/m1/s1",PQIHIELQKZACPK-LXJLEQQOSA-N
3181,37,99,37,,Q06187,BTK,CRBN,,GBD-9,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)CCCCCCCCNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)C1,Degradation of BTK in DOHH2 cells after 24 h treatment,,,,,,,990/44,Kd was tested by ITC/KINOMEscan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,133,Inhibit proliferation of DOHH2 cells,,,,,,,,,,,,,,,10.1038/s41422-021-00533-6,797.917,797.3649302,5.5,59,8,12,3,15,194.74,C44H47N9O6,"InChI=1S/C44H47N9O6/c45-40-38-39(28-15-18-32(19-16-28)59-31-12-6-5-7-13-31)50-53(41(38)48-27-47-40)30-11-10-24-51(26-30)37(55)14-8-3-1-2-4-9-23-46-29-17-20-33-34(25-29)44(58)52(43(33)57)35-21-22-36(54)49-42(35)56/h5-7,12-13,15-20,25,27,30,35,46H,1-4,8-11,14,21-24,26H2,(H2,45,47,48)(H,49,54,56)/t30-,35?/m1/s1",DCJYQURCBHSFEP-OSRRZMJMSA-N
3192,702,99,702,,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCCCCCCNC(=O)C4=CC=CC(SCC5=CN(C6=CC=CC(C(=O)NO)=C6)N=N5)=C4)=C3C2=O)C(=O)N1,Degradation of HDAC8 in Jurkat cells after 24 h treatment,,,372,IC50 was tested by an HDAC8 deacetylase fluorometric assay kit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,780,Inhibit growth of Jurkat cells,,,,,,,,,,,10.1039/d2cc00272h,794.935,794.3210168,6.02,57,6,12,5,20,204.72,C41H46N8O7S,"InChI=1S/C41H46N8O7S/c50-35-20-19-34(39(53)44-35)49-40(54)32-17-12-18-33(36(32)41(49)55)42-21-8-6-4-2-1-3-5-7-9-22-43-37(51)28-14-11-16-31(24-28)57-26-29-25-48(47-45-29)30-15-10-13-27(23-30)38(52)46-56/h10-18,23-25,34,42,56H,1-9,19-22,26H2,(H,43,51)(H,46,52)(H,44,50,53)",CRZGRNBMUQNJFY-UHFFFAOYSA-N
3193,702,99,702,,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCCCCCCNC(=O)C4=CC=C(SCC5=CN(C6=CC=CC(C(=O)NO)=C6)N=N5)C=C4)=C3C2=O)C(=O)N1,Degradation of HDAC8 in T-cell leukemia Jurkat cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,794.935,794.3210168,6.02,57,6,12,5,20,204.72,C41H46N8O7S,"InChI=1S/C41H46N8O7S/c50-35-21-20-34(39(53)44-35)49-40(54)32-14-11-15-33(36(32)41(49)55)42-22-8-6-4-2-1-3-5-7-9-23-43-37(51)27-16-18-31(19-17-27)57-26-29-25-48(47-45-29)30-13-10-12-28(24-30)38(52)46-56/h10-19,24-25,34,42,56H,1-9,20-23,26H2,(H,43,51)(H,46,52)(H,44,50,53)",ZLYIZXIABSQPCB-UHFFFAOYSA-N
3213,316.2,56,316.2,56,Q07817,BCL-xL,VHL,,PPC5,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1599.442,1597.604899,10.87,109,11,19,5,28,263.54,C79H99ClF3N11O11S4,"InChI=1S/C79H99ClF3N11O11S4/c1-53(55-15-17-57(18-16-55)72-54(2)84-52-107-72)85-75(99)68-45-63(95)49-94(68)76(100)73(77(3,4)5)87-70(96)13-10-14-71(97)93-39-35-91(36-40-93)51-78(6)31-29-66(56-19-23-60(80)24-20-56)59(47-78)48-90-33-37-92(38-34-90)62-25-21-58(22-26-62)74(98)88-109(103,104)65-27-28-67(69(46-65)108(101,102)79(81,82)83)86-61(30-32-89-41-43-105-44-42-89)50-106-64-11-8-7-9-12-64/h7-9,11-12,15-28,46,52-53,61,63,68,73,86,95H,10,13-14,29-45,47-51H2,1-6H3,(H,85,99)(H,87,96)(H,88,98)/t53-,61+,63+,68-,73+,78?/m0/s1",BRIZMACXBJUXJT-UWPVXNPMSA-N
3214,39.9,91,39.9,91,Q07817,BCL-xL,VHL,,PPC6,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1613.469,1611.620549,11.23,110,11,19,5,29,263.54,C80H101ClF3N11O11S4,"InChI=1S/C80H101ClF3N11O11S4/c1-54(56-16-18-58(19-17-56)73-55(2)85-53-108-73)86-76(100)69-46-64(96)50-95(69)77(101)74(78(3,4)5)88-71(97)14-10-11-15-72(98)94-40-36-92(37-41-94)52-79(6)32-30-67(57-20-24-61(81)25-21-57)60(48-79)49-91-34-38-93(39-35-91)63-26-22-59(23-27-63)75(99)89-110(104,105)66-28-29-68(70(47-66)109(102,103)80(82,83)84)87-62(31-33-90-42-44-106-45-43-90)51-107-65-12-8-7-9-13-65/h7-9,12-13,16-29,47,53-54,62,64,69,74,87,96H,10-11,14-15,30-46,48-52H2,1-6H3,(H,86,100)(H,88,97)(H,89,99)/t54-,62+,64+,69-,74+,79?/m0/s1",KVQKGBLSBLWZKE-AAWIYDMSSA-N
3215,12.8,85,12.8,85,Q07817,BCL-xL,VHL,,PPC7,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1627.496,1625.636199,11.77,111,11,19,5,30,263.54,C81H103ClF3N11O11S4,"InChI=1S/C81H103ClF3N11O11S4/c1-55(57-17-19-59(20-18-57)74-56(2)86-54-109-74)87-77(101)70-47-65(97)51-96(70)78(102)75(79(3,4)5)89-72(98)15-11-8-12-16-73(99)95-41-37-93(38-42-95)53-80(6)33-31-68(58-21-25-62(82)26-22-58)61(49-80)50-92-35-39-94(40-36-92)64-27-23-60(24-28-64)76(100)90-111(105,106)67-29-30-69(71(48-67)110(103,104)81(83,84)85)88-63(32-34-91-43-45-107-46-44-91)52-108-66-13-9-7-10-14-66/h7,9-10,13-14,17-30,48,54-55,63,65,70,75,88,97H,8,11-12,15-16,31-47,49-53H2,1-6H3,(H,87,101)(H,89,98)(H,90,100)/t55-,63+,65+,70-,75+,80?/m0/s1",XXWWYTHQXVIKLW-WGWDJEQESA-N
3215,179.9,79,179.9,79,P10415,BCL2,VHL,,PPC7,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1627.496,1625.636199,11.77,111,11,19,5,30,263.54,C81H103ClF3N11O11S4,"InChI=1S/C81H103ClF3N11O11S4/c1-55(57-17-19-59(20-18-57)74-56(2)86-54-109-74)87-77(101)70-47-65(97)51-96(70)78(102)75(79(3,4)5)89-72(98)15-11-8-12-16-73(99)95-41-37-93(38-42-95)53-80(6)33-31-68(58-21-25-62(82)26-22-58)61(49-80)50-92-35-39-94(40-36-92)64-27-23-60(24-28-64)76(100)90-111(105,106)67-29-30-69(71(48-67)110(103,104)81(83,84)85)88-63(32-34-91-43-45-107-46-44-91)52-108-66-13-9-7-10-14-66/h7,9-10,13-14,17-30,48,54-55,63,65,70,75,88,97H,8,11-12,15-16,31-47,49-53H2,1-6H3,(H,87,101)(H,89,98)(H,90,100)/t55-,63+,65+,70-,75+,80?/m0/s1",XXWWYTHQXVIKLW-WGWDJEQESA-N
3216,12.9,94,12.9,94,Q07817,BCL-xL,VHL,,PPC8,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1641.523,1639.65185,12.31,112,11,19,5,31,263.54,C82H105ClF3N11O11S4,"InChI=1S/C82H105ClF3N11O11S4/c1-56(58-18-20-60(21-19-58)75-57(2)87-55-110-75)88-78(102)71-48-66(98)52-97(71)79(103)76(80(3,4)5)90-73(99)16-12-7-8-13-17-74(100)96-42-38-94(39-43-96)54-81(6)34-32-69(59-22-26-63(83)27-23-59)62(50-81)51-93-36-40-95(41-37-93)65-28-24-61(25-29-65)77(101)91-112(106,107)68-30-31-70(72(49-68)111(104,105)82(84,85)86)89-64(33-35-92-44-46-108-47-45-92)53-109-67-14-10-9-11-15-67/h9-11,14-15,18-31,49,55-56,64,66,71,76,89,98H,7-8,12-13,16-17,32-48,50-54H2,1-6H3,(H,88,102)(H,90,99)(H,91,101)/t56-,64+,66+,71-,76+,81?/m0/s1",KQEMZZJSHJCPSI-KGENNJKMSA-N
3216,54,94,54,94,P10415,BCL2,VHL,,PPC8,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1641.523,1639.65185,12.31,112,11,19,5,31,263.54,C82H105ClF3N11O11S4,"InChI=1S/C82H105ClF3N11O11S4/c1-56(58-18-20-60(21-19-58)75-57(2)87-55-110-75)88-78(102)71-48-66(98)52-97(71)79(103)76(80(3,4)5)90-73(99)16-12-7-8-13-17-74(100)96-42-38-94(39-43-96)54-81(6)34-32-69(59-22-26-63(83)27-23-59)62(50-81)51-93-36-40-95(41-37-93)65-28-24-61(25-29-65)77(101)91-112(106,107)68-30-31-70(72(49-68)111(104,105)82(84,85)86)89-64(33-35-92-44-46-108-47-45-92)53-109-67-14-10-9-11-15-67/h9-11,14-15,18-31,49,55-56,64,66,71,76,89,98H,7-8,12-13,16-17,32-48,50-54H2,1-6H3,(H,88,102)(H,90,99)(H,91,101)/t56-,64+,66+,71-,76+,81?/m0/s1",KQEMZZJSHJCPSI-KGENNJKMSA-N
3217,12.8,96,12.8,96,Q07817,BCL-xL,VHL,,PPC9,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1655.55,1653.6675,12.86,113,11,19,5,32,263.54,C83H107ClF3N11O11S4,"InChI=1S/C83H107ClF3N11O11S4/c1-57(59-19-21-61(22-20-59)76-58(2)88-56-111-76)89-79(103)72-49-67(99)53-98(72)80(104)77(81(3,4)5)91-74(100)17-13-8-7-9-14-18-75(101)97-43-39-95(40-44-97)55-82(6)35-33-70(60-23-27-64(84)28-24-60)63(51-82)52-94-37-41-96(42-38-94)66-29-25-62(26-30-66)78(102)92-113(107,108)69-31-32-71(73(50-69)112(105,106)83(85,86)87)90-65(34-36-93-45-47-109-48-46-93)54-110-68-15-11-10-12-16-68/h10-12,15-16,19-32,50,56-57,65,67,72,77,90,99H,7-9,13-14,17-18,33-49,51-55H2,1-6H3,(H,89,103)(H,91,100)(H,92,102)/t57-,65+,67+,72-,77+,82?/m0/s1",YCSHJMBQFQHZEP-BMNBLYSOSA-N
3217,316.2,79,316.2,79,P10415,BCL2,VHL,,PPC9,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1655.55,1653.6675,12.86,113,11,19,5,32,263.54,C83H107ClF3N11O11S4,"InChI=1S/C83H107ClF3N11O11S4/c1-57(59-19-21-61(22-20-59)76-58(2)88-56-111-76)89-79(103)72-49-67(99)53-98(72)80(104)77(81(3,4)5)91-74(100)17-13-8-7-9-14-18-75(101)97-43-39-95(40-44-97)55-82(6)35-33-70(60-23-27-64(84)28-24-60)63(51-82)52-94-37-41-96(42-38-94)66-29-25-62(26-30-66)78(102)92-113(107,108)69-31-32-71(73(50-69)112(105,106)83(85,86)87)90-65(34-36-93-45-47-109-48-46-93)54-110-68-15-11-10-12-16-68/h10-12,15-16,19-32,50,56-57,65,67,72,77,90,99H,7-9,13-14,17-18,33-49,51-55H2,1-6H3,(H,89,103)(H,91,100)(H,92,102)/t57-,65+,67+,72-,77+,82?/m0/s1",YCSHJMBQFQHZEP-BMNBLYSOSA-N
3218,12.1,81,12.1,81,Q07817,BCL-xL,VHL,,PPC10,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1669.577,1667.68315,13.4,114,11,19,5,33,263.54,C84H109ClF3N11O11S4,"InChI=1S/C84H109ClF3N11O11S4/c1-58(60-20-22-62(23-21-60)77-59(2)89-57-112-77)90-80(104)73-50-68(100)54-99(73)81(105)78(82(3,4)5)92-75(101)18-14-9-7-8-10-15-19-76(102)98-44-40-96(41-45-98)56-83(6)36-34-71(61-24-28-65(85)29-25-61)64(52-83)53-95-38-42-97(43-39-95)67-30-26-63(27-31-67)79(103)93-114(108,109)70-32-33-72(74(51-70)113(106,107)84(86,87)88)91-66(35-37-94-46-48-110-49-47-94)55-111-69-16-12-11-13-17-69/h11-13,16-17,20-33,51,57-58,66,68,73,78,91,100H,7-10,14-15,18-19,34-50,52-56H2,1-6H3,(H,90,104)(H,92,101)(H,93,103)/t58-,66+,68+,73-,78+,83?/m0/s1",CGIQKSDNJNCLMP-PVVVILJQSA-N
3218,354.8,69,354.8,69,P10415,BCL2,VHL,,PPC10,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1669.577,1667.68315,13.4,114,11,19,5,33,263.54,C84H109ClF3N11O11S4,"InChI=1S/C84H109ClF3N11O11S4/c1-58(60-20-22-62(23-21-60)77-59(2)89-57-112-77)90-80(104)73-50-68(100)54-99(73)81(105)78(82(3,4)5)92-75(101)18-14-9-7-8-10-15-19-76(102)98-44-40-96(41-45-98)56-83(6)36-34-71(61-24-28-65(85)29-25-61)64(52-83)53-95-38-42-97(43-39-95)67-30-26-63(27-31-67)79(103)93-114(108,109)70-32-33-72(74(51-70)113(106,107)84(86,87)88)91-66(35-37-94-46-48-110-49-47-94)55-111-69-16-12-11-13-17-69/h11-13,16-17,20-33,51,57-58,66,68,73,78,91,100H,7-10,14-15,18-19,34-50,52-56H2,1-6H3,(H,90,104)(H,92,101)(H,93,103)/t58-,66+,68+,73-,78+,83?/m0/s1",CGIQKSDNJNCLMP-PVVVILJQSA-N
3221,6,99,6,,Q07817,BCL-xL,VHL,,753b,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCC(=O)N3CCN(C[C@]4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,1.313,Ki was tested by AlphaScreen assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1641.523,1639.65185,12.31,112,11,19,5,31,263.54,C82H105ClF3N11O11S4,"InChI=1S/C82H105ClF3N11O11S4/c1-56(58-18-20-60(21-19-58)75-57(2)87-55-110-75)88-78(102)71-48-66(98)52-97(71)79(103)76(80(3,4)5)90-73(99)16-12-7-8-13-17-74(100)96-42-38-94(39-43-96)54-81(6)34-32-69(59-22-26-63(83)27-23-59)62(50-81)51-93-36-40-95(41-37-93)65-28-24-61(25-29-65)77(101)91-112(106,107)68-30-31-70(72(49-68)111(104,105)82(84,85)86)89-64(33-35-92-44-46-108-47-45-92)53-109-67-14-10-9-11-15-67/h9-11,14-15,18-31,49,55-56,64,66,71,76,89,98H,7-8,12-13,16-17,32-48,50-54H2,1-6H3,(H,88,102)(H,90,99)(H,91,101)/t56-,64+,66+,71-,76+,81+/m0/s1",KQEMZZJSHJCPSI-RYFXIQSLSA-N
3221,48,99,48,,P10415,BCL2,VHL,,753b,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCC(=O)N3CCN(C[C@]4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,1.054,Ki was tested by AlphaScreen assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1641.523,1639.65185,12.31,112,11,19,5,31,263.54,C82H105ClF3N11O11S4,"InChI=1S/C82H105ClF3N11O11S4/c1-56(58-18-20-60(21-19-58)75-57(2)87-55-110-75)88-78(102)71-48-66(98)52-97(71)79(103)76(80(3,4)5)90-73(99)16-12-7-8-13-17-74(100)96-42-38-94(39-43-96)54-81(6)34-32-69(59-22-26-63(83)27-23-59)62(50-81)51-93-36-40-95(41-37-93)65-28-24-61(25-29-65)77(101)91-112(106,107)68-30-31-70(72(49-68)111(104,105)82(84,85)86)89-64(33-35-92-44-46-108-47-45-92)53-109-67-14-10-9-11-15-67/h9-11,14-15,18-31,49,55-56,64,66,71,76,89,98H,7-8,12-13,16-17,32-48,50-54H2,1-6H3,(H,88,102)(H,90,99)(H,91,101)/t56-,64+,66+,71-,76+,81+/m0/s1",KQEMZZJSHJCPSI-RYFXIQSLSA-N
3245,260,71,260,71,P61964,WDR5,VHL,7JTO,MS33,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCC(=O)NCCN3CCN(CC4=CC=CC(C5=CC=C(N6CCN(C)CC6)C(NC(=O)C6=C[NH]C(=O)C=C6C(F)(F)F)=C5)=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5 in MV4;11 cells after 18 h treatment,,,,,,,120,ITC,,,,,,,,,,,,,,,870,ITC,,,,,,,,,,,,,,,520,Kd between VHL and the complex of protac and WDR5 was tested by ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1126/scitranslmed.abj1578,1208.507,1207.6228,7.09,86,8,13,6,25,215.65,C64H84F3N11O7S,"InChI=1S/C64H84F3N11O7S/c1-43-58(86-42-71-43)46-20-18-44(19-21-46)38-70-61(84)54-36-49(79)41-78(54)62(85)59(63(2,3)4)73-56(81)17-12-10-8-6-7-9-11-16-55(80)68-24-25-75-28-30-76(31-29-75)40-45-14-13-15-47(34-45)48-22-23-53(77-32-26-74(5)27-33-77)52(35-48)72-60(83)50-39-69-57(82)37-51(50)64(65,66)67/h13-15,18-23,34-35,37,39,42,49,54,59,79H,6-12,16-17,24-33,36,38,40-41H2,1-5H3,(H,68,80)(H,69,82)(H,70,84)(H,72,83)(H,73,81)/t49-,54+,59-/m1/s1",GLYGYEQLMMPSAW-QWQPEEPRSA-N
3254,92,73,92,73,P61964,WDR5,VHL,,MS132,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CNC(=O)C3=CC=C(F)C(C4=CC=C(N5C[C@H](C)N(C)[C@H](C)C5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5 in MIA PaCa-2 cells after 18 h treatment,,,,,,,122,ITC,,,,,,,,,,,,,,,534,ITC,,,,,,,,,,,,,,,232,ITC,,,,,,,,,,,,,,,5700/4000/9200,Inhibit proliferation of MIA PaCa-2/BxPC-3/HPAF-II cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01521,1016.132,1015.403779,5.11,72,7,11,6,13,209.17,C51H57F4N9O7S,"InChI=1S/C51H57F4N9O7S/c1-27-23-63(24-28(2)62(27)7)40-15-13-32(17-39(40)60-47(69)36-21-56-42(66)19-37(36)51(53,54)55)35-16-33(12-14-38(35)52)46(68)58-22-43(67)61-45(50(4,5)6)49(71)64-25-34(65)18-41(64)48(70)57-20-30-8-10-31(11-9-30)44-29(3)59-26-72-44/h8-17,19,21,26-28,34,41,45,65H,18,20,22-25H2,1-7H3,(H,56,66)(H,57,70)(H,58,68)(H,60,69)(H,61,67)/t27-,28+,34-,41+,45-/m1/s1",OJCYPKZNPSJLGY-KQNJQULYSA-N
3255,3.7,94,3.7/45,94/85,P61964,WDR5,VHL,7JTP,MS67,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CNC(=O)C3=CC=C(F)C(C4=CC=C(N5C[C@H](C)N(C)[C@H](C)C5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of WDR5 in MV4;11/MIA PaCa-2 cells after 18 h treatment,,,,,,,63,ITC,,,,,,,,,,,,,,,140,ITC,,,,,,,,,,,,,,,52,Kd between VHL and the complex of protac and WDR5 was tested by ITC,,,,,,,,,,,,,,,15/38/110,Inhibit growth of MV4;11/EOL-1/MOLM13 cells,,,,,,,,,,,10.1126/scitranslmed.abj1578,1030.159,1029.419429,5.52,73,7,11,6,13,209.17,C52H59F4N9O7S,"InChI=1S/C52H59F4N9O7S/c1-27-23-64(24-28(2)63(27)8)41-16-14-33(18-40(41)61-48(70)37-21-57-43(67)20-38(37)52(54,55)56)36-17-34(13-15-39(36)53)47(69)58-22-44(68)62-46(51(5,6)7)50(72)65-25-35(66)19-42(65)49(71)60-29(3)31-9-11-32(12-10-31)45-30(4)59-26-73-45/h9-18,20-21,26-29,35,42,46,66H,19,22-25H2,1-8H3,(H,57,67)(H,58,69)(H,60,71)(H,61,70)(H,62,68)/t27-,28+,29-,35+,42-,46+/m0/s1",HBHSDSLZXDASLT-FLKKWHKHSA-N
3256,7.85,99,7.85,,P10636,Tau,VHL,,C004019,CC(=O)N1CCCN(C2=NC(NCCC3=CC=CS3)=NC(N(C)CC(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N3C[C@@H](O)C[C@@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=N2)CC1,Degradation of Tau5 in HEK293-hTau cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.7150/thno.55680,1035.308,1034.483014,3.52,72,6,18,5,25,245.91,C49H70N12O9S2,"InChI=1S/C49H70N12O9S2/c1-33-42(72-32-53-33)36-12-10-35(11-13-36)28-52-44(66)39-27-37(63)29-61(39)45(67)43(49(3,4)5)54-41(65)31-70-25-24-69-23-22-68-21-16-50-40(64)30-58(6)47-55-46(51-15-14-38-9-7-26-71-38)56-48(57-47)60-18-8-17-59(19-20-60)34(2)62/h7,9-13,26,32,37,39,43,63H,8,14-25,27-31H2,1-6H3,(H,50,64)(H,52,66)(H,54,65)(H,51,55,56,57)/t37-,39+,43+/m0/s1",IXTMPMLKABNFTQ-LLIFGLRNSA-N
3258,85,96,85,96,P51531,SMARCA2,VHL,,AU-15330,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CN3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5740000,0.034,20.2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,755.946,755.3577367,3.25,54,6,12,5,10,190.14,C39H49N9O5S,"InChI=1S/C39H49N9O5S/c1-23(25-10-12-26(13-11-25)34-24(2)41-22-54-34)42-37(52)31-18-27(49)20-48(31)38(53)35(39(3,4)5)43-33(51)21-46-14-16-47(17-15-46)30-19-29(44-45-36(30)40)28-8-6-7-9-32(28)50/h6-13,19,22-23,27,31,35,49-50H,14-18,20-21H2,1-5H3,(H2,40,45)(H,42,52)(H,43,51)/t23-,27+,31-,35+/m0/s1",HDCCMCFIGHIDJR-TUDDPRDOSA-N
3259,37,95,37,95,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,Degradation of ENL in MV4;11 cells after 24 h treatment,,,170,Inhibition of ENL YEATS-H3K27ac interaction was tested by an Alpha assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,320/570/1100,Inhibit proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,757.896,757.3700156,5.64,56,8,10,4,15,174.42,C42H47N9O5,"InChI=1S/C42H47N9O5/c1-26-10-9-20-49(26)25-36-46-31-15-14-29(23-33(31)47-36)45-39(53)27-13-16-34-28(22-27)24-44-50(34)21-7-5-3-2-4-6-19-43-32-12-8-11-30-38(32)42(56)51(41(30)55)35-17-18-37(52)48-40(35)54/h8,11-16,22-24,26,35,43H,2-7,9-10,17-21,25H2,1H3,(H,45,53)(H,46,47)(H,48,52,54)/t26-,35?/m0/s1",SCZWWJDUQGVEMY-HJYWNDIWSA-N
3259,37,95,37,95,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,Degradation of ENL in MV4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,320/570/1100,Inhibit cell proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,757.896,757.3700156,5.64,56,8,10,4,15,174.42,C42H47N9O5,"InChI=1S/C42H47N9O5/c1-26-10-9-20-49(26)25-36-46-31-15-14-29(23-33(31)47-36)45-39(53)27-13-16-34-28(22-27)24-44-50(34)21-7-5-3-2-4-6-19-43-32-12-8-11-30-38(32)42(56)51(41(30)55)35-17-18-37(52)48-40(35)54/h8,11-16,22-24,26,35,43H,2-7,9-10,17-21,25H2,1H3,(H,45,53)(H,46,47)(H,48,52,54)/t26-,35?/m0/s1",SCZWWJDUQGVEMY-HJYWNDIWSA-N
3260,50,68,50,68,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,Degradation of ENL in MV4;11 cells after 24 h treatment,,,100,Inhibition of ENL YEATS-H3K27ac interaction was tested by an Alpha assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,490/1600/19000,Inhibit proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,729.842,729.3387155,4.56,54,8,10,4,13,174.42,C40H43N9O5,"InChI=1S/C40H43N9O5/c1-24-8-7-18-47(24)23-34-44-29-13-12-27(21-31(29)45-34)43-37(51)25-11-14-32-26(20-25)22-42-48(32)19-5-3-2-4-17-41-30-10-6-9-28-36(30)40(54)49(39(28)53)33-15-16-35(50)46-38(33)52/h6,9-14,20-22,24,33,41H,2-5,7-8,15-19,23H2,1H3,(H,43,51)(H,44,45)(H,46,50,52)/t24-,33?/m0/s1",PCQKARKEVDFIEV-PPVAYSNCSA-N
3260,50,68,50,68,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,Degradation of ENL in MV4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,490/1600/19000,Inhibit cell proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,729.842,729.3387155,4.56,54,8,10,4,13,174.42,C40H43N9O5,"InChI=1S/C40H43N9O5/c1-24-8-7-18-47(24)23-34-44-29-13-12-27(21-31(29)45-34)43-37(51)25-11-14-32-26(20-25)22-42-48(32)19-5-3-2-4-17-41-30-10-6-9-28-36(30)40(54)49(39(28)53)33-15-16-35(50)46-38(33)52/h6,9-14,20-22,24,33,41H,2-5,7-8,15-19,23H2,1H3,(H,43,51)(H,44,45)(H,46,50,52)/t24-,33?/m0/s1",PCQKARKEVDFIEV-PPVAYSNCSA-N
3261,72,89,72,89,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,Degradation of ENL in MV4;11 cells after 24 h treatment,,,610,Inhibition of ENL YEATS-H3K27ac interaction was tested by an Alpha assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2100/1200/50000,Inhibit proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,701.788,701.3074153,3.85,52,8,10,4,11,174.42,C38H39N9O5,"InChI=1S/C38H39N9O5/c1-22-6-5-16-45(22)21-32-42-27-11-10-25(19-29(27)43-32)41-35(49)23-9-12-30-24(18-23)20-40-46(30)17-3-2-15-39-28-8-4-7-26-34(28)38(52)47(37(26)51)31-13-14-33(48)44-36(31)50/h4,7-12,18-20,22,31,39H,2-3,5-6,13-17,21H2,1H3,(H,41,49)(H,42,43)(H,44,48,50)/t22-,31?/m0/s1",BQKBBOYUPLMTRW-DEUJGTPJSA-N
3261,72,89,72,89,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,Degradation of ENL in MV4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2100/1200/50000,Inhibit cell proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,701.788,701.3074153,3.85,52,8,10,4,11,174.42,C38H39N9O5,"InChI=1S/C38H39N9O5/c1-22-6-5-16-45(22)21-32-42-27-11-10-25(19-29(27)43-32)41-35(49)23-9-12-30-24(18-23)20-40-46(30)17-3-2-15-39-28-8-4-7-26-34(28)38(52)47(37(26)51)31-13-14-33(48)44-36(31)50/h4,7-12,18-20,22,31,39H,2-3,5-6,13-17,21H2,1H3,(H,41,49)(H,42,43)(H,44,48,50)/t22-,31?/m0/s1",BQKBBOYUPLMTRW-DEUJGTPJSA-N
3262,810,71,810,71,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,806.777,805.2328418,3.73,55,6,12,2,15,167.07,C38H41Cl2N9O5S,"InChI=1S/C38H41Cl2N9O5S/c1-23-24(2)55-38-35(23)36(26-5-7-27(40)8-6-26)44-29(37-46-45-25(3)49(37)38)20-32(50)42-12-16-53-17-13-43-33(51)22-47-15-18-54-31-19-28(9-10-30(31)47)48(14-4-11-41)34(52)21-39/h5-10,19,29H,4,12-18,20-22H2,1-3H3,(H,42,50)(H,43,51)/t29-/m0/s1",QVNLOGQWJMAEJT-LJAQVGFWSA-N
3262,820,81,820,81,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,806.777,805.2328418,3.73,55,6,12,2,15,167.07,C38H41Cl2N9O5S,"InChI=1S/C38H41Cl2N9O5S/c1-23-24(2)55-38-35(23)36(26-5-7-27(40)8-6-26)44-29(37-46-45-25(3)49(37)38)20-32(50)42-12-16-53-17-13-43-33(51)22-47-15-18-54-31-19-28(9-10-30(31)47)48(14-4-11-41)34(52)21-39/h5-10,19,29H,4,12-18,20-22H2,1-3H3,(H,42,50)(H,43,51)/t29-/m0/s1",QVNLOGQWJMAEJT-LJAQVGFWSA-N
3263,198,99,198/313,,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in 231MFP/HAP1 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,804.805,803.2535772,4.94,55,6,11,2,15,157.84,C39H43Cl2N9O4S,"InChI=1S/C39H43Cl2N9O4S/c1-24-25(2)55-39-36(24)37(27-8-10-28(41)11-9-27)45-30(38-47-46-26(3)50(38)39)21-33(51)43-15-5-4-6-16-44-34(52)23-48-18-19-54-32-20-29(12-13-31(32)48)49(17-7-14-42)35(53)22-40/h8-13,20,30H,4-7,15-19,21-23H2,1-3H3,(H,43,51)(H,44,52)/t30-/m0/s1",IEXUFNUFUSSKQI-PMERELPUSA-N
3263,250,94,250,94,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,1500,Inhibit FEM1B-FNIP1 degron fluorescence polarization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,804.805,803.2535772,4.94,55,6,11,2,15,157.84,C39H43Cl2N9O4S,"InChI=1S/C39H43Cl2N9O4S/c1-24-25(2)55-39-36(24)37(27-8-10-28(41)11-9-27)45-30(38-47-46-26(3)50(38)39)21-33(51)43-15-5-4-6-16-44-34(52)23-48-18-19-54-32-20-29(12-13-31(32)48)49(17-7-14-42)35(53)22-40/h8-13,20,30H,4-7,15-19,21-23H2,1-3H3,(H,43,51)(H,44,52)/t30-/m0/s1",IEXUFNUFUSSKQI-PMERELPUSA-N
3264,1100,85,1100,85,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,850.83,849.2590565,3.58,58,6,13,2,18,176.3,C40H45Cl2N9O6S,"InChI=1S/C40H45Cl2N9O6S/c1-25-26(2)58-40-37(25)38(28-5-7-29(42)8-6-28)46-31(39-48-47-27(3)51(39)40)22-34(52)44-12-16-55-19-20-56-17-13-45-35(53)24-49-15-18-57-33-21-30(9-10-32(33)49)50(14-4-11-43)36(54)23-41/h5-10,21,31H,4,12-20,22-24H2,1-3H3,(H,44,52)(H,45,53)/t31-/m0/s1",CPDVGNBJFIONLX-HKBQPEDESA-N
3265,3600,60,3600,60,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,894.883,893.2852713,3.43,61,6,14,2,21,185.53,C42H49Cl2N9O7S,"InChI=1S/C42H49Cl2N9O7S/c1-27-28(2)61-42-39(27)40(30-5-7-31(44)8-6-30)48-33(41-50-49-29(3)53(41)42)24-36(54)46-12-16-57-19-21-59-22-20-58-17-13-47-37(55)26-51-15-18-60-35-23-32(9-10-34(35)51)52(14-4-11-45)38(56)25-43/h5-10,23,33H,4,12-22,24-26H2,1-3H3,(H,46,54)(H,47,55)/t33-/m0/s1",QMBOIOPJFSHXPV-XIFFEERXSA-N
3266,1600,80,1600,80,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCOCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,938.936,937.311486,3.28,64,6,15,2,24,194.76,C44H53Cl2N9O8S,"InChI=1S/C44H53Cl2N9O8S/c1-29-30(2)64-44-41(29)42(32-5-7-33(46)8-6-32)50-35(43-52-51-31(3)55(43)44)26-38(56)48-12-16-59-19-21-61-23-24-62-22-20-60-17-13-49-39(57)28-53-15-18-63-37-25-34(9-10-36(37)53)54(14-4-11-47)40(58)27-45/h5-10,25,35H,4,12-24,26-28H2,1-3H3,(H,48,56)(H,49,57)/t35-/m0/s1",UUCUKSPUFPMKNK-DHUJRADRSA-N
3269,2,99,2,,P03372,ER,CRBN,,ARV-471,O=C1CC[C@H](N2CC3=CC(N4CCN(CC5CCN(C6=CC=C([C@@H]7C8=CC=C(O)C=C8CC[C@@H]7C7=CC=CC=C7)C=C6)CC5)CC4)=CC=C3C2=O)C(=O)N1,Degradation of ER in ER-positive breast cancer cell lines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1158/1538-7445.SABCS18-P5-04-18,723.918,723.378455,6.36,54,9,7,2,7,96.43,C45H49N5O4,"InChI=1S/C45H49N5O4/c51-37-12-15-39-33(27-37)8-13-38(31-4-2-1-3-5-31)43(39)32-6-9-35(10-7-32)48-20-18-30(19-21-48)28-47-22-24-49(25-23-47)36-11-14-40-34(26-36)29-50(45(40)54)41-16-17-42(52)46-44(41)53/h1-7,9-12,14-15,26-27,30,38,41,43,51H,8,13,16-25,28-29H2,(H,46,52,53)/t38-,41+,43+/m1/s1",TZZDVPMABRWKIZ-XMOGEVODSA-N
3270,1,99,1,,P10275,AR,CRBN,,ARV-110,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(CN5CCN(C6=CC7=C(C=C6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)N=N3)CC2)C=C1Cl,Degradation of AR in LNCaP cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1200/JCO.2019.37.7_suppl.259,812.303,811.300886,3.94,58,8,12,2,9,181.17,C41H43ClFN9O6,"InChI=1S/C41H43ClFN9O6/c42-31-19-28(4-1-25(31)22-44)58-27-5-2-26(3-6-27)45-38(54)33-7-9-36(48-47-33)51-13-11-24(12-14-51)23-49-15-17-50(18-16-49)35-21-30-29(20-32(35)43)40(56)52(41(30)57)34-8-10-37(53)46-39(34)55/h1,4,7,9,19-21,24,26-27,34H,2-3,5-6,8,10-18,23H2,(H,45,54)(H,46,53,55)/t26-,27-,34?",CLCTZVRHDOAUGJ-SYVGMNBRSA-N
3270,3.6,92,3.6/5.5,92/81,P10275,AR,CRBN,,ARV-110,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(CN5CCN(C6=CC7=C(C=C6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)N=N3)CC2)C=C1Cl,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41/32,Inhibit of cell growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00118,812.303,811.300886,3.94,58,8,12,2,9,181.17,C41H43ClFN9O6,"InChI=1S/C41H43ClFN9O6/c42-31-19-28(4-1-25(31)22-44)58-27-5-2-26(3-6-27)45-38(54)33-7-9-36(48-47-33)51-13-11-24(12-14-51)23-49-15-17-50(18-16-49)35-21-30-29(20-32(35)43)40(56)52(41(30)57)34-8-10-37(53)46-39(34)55/h1,4,7,9,19-21,24,26-27,34H,2-3,5-6,8,10-18,23H2,(H,45,54)(H,46,53,55)/t26-,27-,34?",CLCTZVRHDOAUGJ-SYVGMNBRSA-N
3281,35.2,99,35.2,,Q06124,SHP2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3CCN(C(=O)CCCCCC4(CN)CCN(C5=CN=C(SC6=CC=CC(Cl)=C6Cl)C(N)=N5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SHP2 in HEK293 cells after 16 h treatment,>95,% SHP2 degradation at 1 μM for 16 hours in HEK293 cells,95,The biochemical enzymatic assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3390/molecules28196947,1163.441,1161.555362,9.91,79,7,14,5,26,216.24,C59H85Cl2N11O5S2,"InChI=1S/C59H85Cl2N11O5S2/c1-40(42-21-23-43(24-22-42)52-41(2)65-39-78-52)66-55(76)46-35-44(73)37-72(46)57(77)53(58(3,4)5)68-49(74)19-12-9-7-6-8-10-15-28-69-31-33-71(34-32-69)50(75)20-13-11-14-25-59(38-62)26-29-70(30-27-59)48-36-64-56(54(63)67-48)79-47-18-16-17-45(60)51(47)61/h16-18,21-24,36,39-40,44,46,53,73H,6-15,19-20,25-35,37-38,62H2,1-5H3,(H2,63,67)(H,66,76)(H,68,74)/t40-,44+,46-,53+/m0/s1",WRCQLCHATMHMMV-HRHAQSRWSA-N
3285,419,99,419,,P0DTD1,Mpro,CRBN,,MPD1,C[C@@H](OC(C)(C)C)[C@H](NC(=O)OCC1=CC=CC(OCCCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=C1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H](C=O)C[C@@H]1CCNC1=O,Degradation of MPro in MPro-eGFP stable cell lines,,,39,Inhibition of Mpro,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1780,Antiviral efficacy against SARS-CoV-2 in ACE2+ A549 cells infected with hCoV-19/USA/HP05647/2021,,,,,,,,,,,,,10.1101/2023.09.29.560163,945.08,944.4531361,4.46,68,6,13,5,22,253.94,C49H64N6O13,"InChI=1S/C49H64N6O13/c1-29(68-49(2,3)4)41(45(61)52-36(25-30-12-6-5-7-13-30)43(59)51-33(27-56)26-32-20-21-50-42(32)58)54-48(64)67-28-31-14-10-15-34(24-31)65-22-8-9-23-66-38-17-11-16-35-40(38)47(63)55(46(35)62)37-18-19-39(57)53-44(37)60/h10-11,14-17,24,27,29-30,32-33,36-37,41H,5-9,12-13,18-23,25-26,28H2,1-4H3,(H,50,58)(H,51,59)(H,52,61)(H,54,64)(H,53,57,60)/t29-,32+,33+,36+,37?,41+/m1/s1",XXLUFJJNMDGULO-CUFXFIHSSA-N
3286,296,99,296,,P0DTD1,Mpro,CRBN,,MPD2,C[C@@H](OC(C)(C)C)[C@H](NC(=O)OCC1=CC=CC(OCCCCCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=C1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H](C=O)C[C@@H]1CCNC1=O,Degradation of MPro in MPro-eGFP stable cell lines,,,41,Inhibition of Mpro,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,492,Antiviral efficacy against SARS-CoV-2 in ACE2+ A549 cells infected with hCoV-19/USA/HP05647/2021,,,,,,,,,,,,,10.1101/2023.09.29.560163,973.134,972.4844362,5.17,70,6,13,5,24,253.94,C51H68N6O13,"InChI=1S/C51H68N6O13/c1-31(70-51(2,3)4)43(47(63)54-38(27-32-14-8-7-9-15-32)45(61)53-35(29-58)28-34-22-23-52-44(34)60)56-50(66)69-30-33-16-12-17-36(26-33)67-24-10-5-6-11-25-68-40-19-13-18-37-42(40)49(65)57(48(37)64)39-20-21-41(59)55-46(39)62/h12-13,16-19,26,29,31-32,34-35,38-39,43H,5-11,14-15,20-25,27-28,30H2,1-4H3,(H,52,60)(H,53,61)(H,54,63)(H,56,66)(H,55,59,62)/t31-,34+,35+,38+,39?,43+/m1/s1",ZKSDAFLRLHGTNH-DTKLLKMQSA-N
3287,431,99,431,,P0DTD1,Mpro,CRBN,,MPD3,C[C@@H](OC(C)(C)C)[C@H](NC(=O)OCC1=CC=CC(OCCCCCCCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=C1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H](C=O)C[C@@H]1CCNC1=O,Degradation of MPro in MPro-eGFP stable cell lines,,,51,Inhibition of Mpro,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1160,Antiviral efficacy against SARS-CoV-2 in ACE2+ A549 cells infected with hCoV-19/USA/HP05647/2021,,,,,,,,,,,,,10.1101/2023.09.29.560163,1001.188,1000.515736,6.25,72,6,13,5,26,253.94,C53H72N6O13,"InChI=1S/C53H72N6O13/c1-33(72-53(2,3)4)45(49(65)56-40(29-34-16-10-9-11-17-34)47(63)55-37(31-60)30-36-24-25-54-46(36)62)58-52(68)71-32-35-18-14-19-38(28-35)69-26-12-7-5-6-8-13-27-70-42-21-15-20-39-44(42)51(67)59(50(39)66)41-22-23-43(61)57-48(41)64/h14-15,18-21,28,31,33-34,36-37,40-41,45H,5-13,16-17,22-27,29-30,32H2,1-4H3,(H,54,62)(H,55,63)(H,56,65)(H,58,68)(H,57,61,64)/t33-,36+,37+,40+,41?,45+/m1/s1",YVDFYSZDTDNVGI-IULYUVDUSA-N
3300,5.6,88.9,22.7/23.5/5.6,86.7/89.4/88.9,Q13164,ERK5,VHL,,PPM-3,COC1=CC(N2CCN(CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,Degradation of ERK5 in MDA-MB-231/PC-3/HCT116 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00864,1000.284,999.5152999,7.13,72,8,14,4,17,188.7,C54H69N11O6S,"InChI=1S/C54H69N11O6S/c1-34(36-18-20-37(21-19-36)47-35(2)56-33-72-47)57-50(68)43-30-39(66)32-65(43)52(70)48(54(3,4)5)59-46(67)17-11-9-10-14-24-63-25-27-64(28-26-63)38-22-23-41(45(29-38)71-8)58-53-55-31-44-49(60-53)61(6)42-16-13-12-15-40(42)51(69)62(44)7/h12-13,15-16,18-23,29,31,33-34,39,43,48,66H,9-11,14,17,24-28,30,32H2,1-8H3,(H,57,68)(H,59,67)(H,55,58,60)/t34-,39+,43-,48+/m0/s1",QGJQNPNZAYRDMS-OESUUHGFSA-N
3300,11.5,94.7,41.4/11.5/13.7,91.4/94.7/92.7,Q13164,ERK5,VHL,,PPM-3,COC1=CC(N2CCN(CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,Degradation of ERK5 in A375/H1975/HepG2 cells after 12h treatment,,,62.4,IC50 of ERK5 (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00864,1000.284,999.5152999,7.13,72,8,14,4,17,188.7,C54H69N11O6S,"InChI=1S/C54H69N11O6S/c1-34(36-18-20-37(21-19-36)47-35(2)56-33-72-47)57-50(68)43-30-39(66)32-65(43)52(70)48(54(3,4)5)59-46(67)17-11-9-10-14-24-63-25-27-64(28-26-63)38-22-23-41(45(29-38)71-8)58-53-55-31-44-49(60-53)61(6)42-16-13-12-15-40(42)51(69)62(44)7/h12-13,15-16,18-23,29,31,33-34,39,43,48,66H,9-11,14,17,24-28,30,32H2,1-8H3,(H,57,68)(H,59,67)(H,55,58,60)/t34-,39+,43-,48+/m0/s1",QGJQNPNZAYRDMS-OESUUHGFSA-N
3301,36.4,99,36.4,,Q13164,ERK5,VHL,,PPM-4,COC1=CC(N2CCN(CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,Degradation of ERK5 in A375 Cells,,,67.1,IC50 of ERK5 (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00864,1014.311,1013.53095,7.67,73,8,14,4,18,188.7,C55H71N11O6S,"InChI=1S/C55H71N11O6S/c1-35(37-19-21-38(22-20-37)48-36(2)57-34-73-48)58-51(69)44-31-40(67)33-66(44)53(71)49(55(3,4)5)60-47(68)18-12-10-9-11-15-25-64-26-28-65(29-27-64)39-23-24-42(46(30-39)72-8)59-54-56-32-45-50(61-54)62(6)43-17-14-13-16-41(43)52(70)63(45)7/h13-14,16-17,19-24,30,32,34-35,40,44,49,67H,9-12,15,18,25-29,31,33H2,1-8H3,(H,58,69)(H,60,68)(H,56,59,61)/t35-,40+,44-,49+/m0/s1",WSXJWLLKHKRHRS-XJLLBULKSA-N
3302,54.5,99,54.5,,Q13164,ERK5,VHL,,PPM-5,COC1=CC(N2CCN(CCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,Degradation of ERK5 in A375 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00864,1028.338,1027.5466,8.21,74,8,14,4,19,188.7,C56H73N11O6S,"InChI=1S/C56H73N11O6S/c1-36(38-20-22-39(23-21-38)49-37(2)58-35-74-49)59-52(70)45-32-41(68)34-67(45)54(72)50(56(3,4)5)61-48(69)19-13-11-9-10-12-16-26-65-27-29-66(30-28-65)40-24-25-43(47(31-40)73-8)60-55-57-33-46-51(62-55)63(6)44-18-15-14-17-42(44)53(71)64(46)7/h14-15,17-18,20-25,31,33,35-36,41,45,50,68H,9-13,16,19,26-30,32,34H2,1-8H3,(H,59,70)(H,61,69)(H,57,60,62)/t36-,41+,45-,50+/m0/s1",KVPRLDYCHCLUHV-NYJWCRJYSA-N
3319,8.1,97,8.1,97,Q86X55,CARM1,VHL,,,CNCCN1CCC(C2=CC(CN(C)C(=O)C3=CC=CC(OC4=CC=C(OCC(=O)N5CCC(CN6CCC(CN7CCN(CC(=O)N[C@H](C(=O)N8C[C@H](O)C[C@H]8C(=O)N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)C(C)(C)C)CC7)CC6)CC5)C=C4)=C3)=CC=N2)CC1,Degradation of CARM1 in MCF7 Cells (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00982,1279.708,1278.735129,6.91,92,10,16,4,24,208.59,C71H98N12O8S,"InChI=1S/C71H98N12O8S/c1-49(54-11-13-56(14-12-54)66-50(2)74-48-92-66)75-68(87)63-41-58(84)45-83(63)70(89)67(71(3,4)5)76-64(85)46-81-37-35-80(36-38-81)44-51-20-28-79(29-21-51)43-52-22-32-82(33-23-52)65(86)47-90-59-15-17-60(18-16-59)91-61-10-8-9-57(40-61)69(88)77(7)42-53-19-26-73-62(39-53)55-24-30-78(31-25-55)34-27-72-6/h8-19,26,39-40,48-49,51-52,55,58,63,67,72,84H,20-25,27-38,41-47H2,1-7H3,(H,75,87)(H,76,85)/t49-,58+,63-,67+/m0/s1",UVTQPVBDGGQLTA-YSPOSDDXSA-N
3322,8.8,98,8.8,98,Q86X55,CARM1,VHL,,,CNCCN1CCC(C2=CC(CN(C)C(=O)C3=CC=CC(OC4=CC=C(CCC(=O)N5CCC(CN6CCC(CN7CCN(CC(=O)N[C@H](C(=O)N8C[C@H](O)C[C@H]8C(=O)N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)C(C)(C)C)CC7)CC6)CC5)C=C4)=C3)=CC=N2)CC1,Degradation of CARM1 in MCF7 Cells (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00982,1277.736,1276.755865,7.1,92,10,15,4,24,199.36,C72H100N12O7S,"InChI=1S/C72H100N12O7S/c1-50(56-14-16-58(17-15-56)67-51(2)75-49-92-67)76-69(88)64-43-60(85)47-84(64)71(90)68(72(3,4)5)77-65(86)48-82-39-37-81(38-40-82)46-53-22-30-80(31-23-53)45-54-24-34-83(35-25-54)66(87)20-13-52-11-18-61(19-12-52)91-62-10-8-9-59(42-62)70(89)78(7)44-55-21-28-74-63(41-55)57-26-32-79(33-27-57)36-29-73-6/h8-12,14-19,21,28,41-42,49-50,53-54,57,60,64,68,73,85H,13,20,22-27,29-40,43-48H2,1-7H3,(H,76,88)(H,77,86)/t50-,60+,64-,68+/m0/s1",WRQKOZXHYYEKER-KLLGSTGQSA-N
3327,9.7,89,9.7,89,P10275,AR,CRBN,,ARD-1631,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(N6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,760.295,759.2935951,4.27,55,9,9,1,5,137.37,C42H42ClN7O5,"InChI=1S/C42H42ClN7O5/c43-35-21-32(6-3-27(35)22-44)48-18-13-42(25-48)11-16-46(17-12-42)30-4-1-26(2-5-30)39(53)47-14-9-31(10-15-47)49-23-28-19-33-34(20-29(28)24-49)41(55)50(40(33)54)36-7-8-37(51)45-38(36)52/h1-6,19-21,31,36H,7-18,23-25H2,(H,45,51,52)",NCYQVXBQCGPHHH-UHFFFAOYSA-N
3328,5.7,88,5.7,88,P10275,AR,CRBN,,ARD-1632,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CN6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,774.322,773.3092452,4.46,56,9,9,1,6,137.37,C43H44ClN7O5,"InChI=1S/C43H44ClN7O5/c44-36-21-33(6-3-29(36)22-45)50-18-13-43(26-50)11-16-48(17-12-43)32-4-1-28(2-5-32)40(54)49-14-9-27(10-15-49)23-47-24-30-19-34-35(20-31(30)25-47)42(56)51(41(34)55)37-7-8-38(52)46-39(37)53/h1-6,19-21,27,37H,7-18,23-26H2,(H,46,52,53)",DNYOJYXHYCVJKW-UHFFFAOYSA-N
3329,92,78,92,78,P10275,AR,CRBN,,ARD-1633,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CCN6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.81,57,9,9,1,7,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c45-37-23-34(6-3-30(37)24-46)51-20-14-44(27-51)12-18-49(19-13-44)33-4-1-29(2-5-33)41(55)50-16-10-28(11-17-50)9-15-48-25-31-21-35-36(22-32(31)26-48)43(57)52(42(35)56)38-7-8-39(53)47-40(38)54/h1-6,21-23,28,38H,7-20,25-27H2,(H,47,53,54)",QWGRMVRMZJRYBH-UHFFFAOYSA-N
3330,73,63,73,63,P10275,AR,CRBN,,ARD-1628,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(N6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,774.322,773.3092452,4.73,56,9,9,1,5,137.37,C43H44ClN7O5,"InChI=1S/C43H44ClN7O5/c44-36-23-33(6-3-29(36)24-45)50-20-14-43(26-50)12-18-47(19-13-43)31-4-1-27(2-5-31)40(54)48-16-10-32(11-17-48)49-15-9-28-21-34-35(22-30(28)25-49)42(56)51(41(34)55)37-7-8-38(52)46-39(37)53/h1-6,21-23,32,37H,7-20,25-26H2,(H,46,52,53)",WISQYAWVRSJAJK-UHFFFAOYSA-N
3331,25,53,25,53,P10275,AR,CRBN,,ARD-1629,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CN6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.92,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c45-37-23-34(6-3-31(37)24-46)51-20-14-44(27-51)12-18-49(19-13-44)33-4-1-29(2-5-33)41(55)50-16-9-28(10-17-50)25-48-15-11-30-21-35-36(22-32(30)26-48)43(57)52(42(35)56)38-7-8-39(53)47-40(38)54/h1-6,21-23,28,38H,7-20,25-27H2,(H,47,53,54)",SXZKGSBCJAOABL-UHFFFAOYSA-N
3332,125,79,125,79,P10275,AR,CRBN,,ARD-1630,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CCN6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.28,58,9,9,1,7,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c46-38-25-35(6-3-32(38)26-47)52-22-15-45(28-52)13-20-50(21-14-45)34-4-1-30(2-5-34)42(56)51-18-10-29(11-19-51)9-16-49-17-12-31-23-36-37(24-33(31)27-49)44(58)53(43(36)57)39-7-8-40(54)48-41(39)55/h1-6,23-25,29,39H,7-22,27-28H2,(H,48,54,55)",AJLHRCDOQDFNEX-UHFFFAOYSA-N
3333,18,81,18,81,P10275,AR,CRBN,,ARD-4050,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(N6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,5.19,57,9,9,1,5,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c45-37-25-34(6-3-31(37)26-46)51-22-15-44(27-51)13-20-49(21-14-44)32-4-1-28(2-5-32)41(55)50-18-11-33(12-19-50)48-16-9-29-23-35-36(24-30(29)10-17-48)43(57)52(42(35)56)38-7-8-39(53)47-40(38)54/h1-6,23-25,33,38H,7-22,27H2,(H,47,53,54)",DVJGBZOCDDYJLY-UHFFFAOYSA-N
3334,51,51,51,51,P10275,AR,CRBN,,ARD-4051,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CN6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.38,58,9,9,1,6,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c46-38-25-35(6-3-33(38)26-47)52-22-15-45(28-52)13-20-50(21-14-45)34-4-1-30(2-5-34)42(56)51-18-9-29(10-19-51)27-49-16-11-31-23-36-37(24-32(31)12-17-49)44(58)53(43(36)57)39-7-8-40(54)48-41(39)55/h1-6,23-25,29,39H,7-22,27-28H2,(H,48,54,55)",VOHRGIXPJZQORO-UHFFFAOYSA-N
3335,3000,76,3000,76,P10275,AR,CRBN,,ARD-4052,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CCN6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,816.403,815.3561954,5.74,59,9,9,1,7,137.37,C46H50ClN7O5,"InChI=1S/C46H50ClN7O5/c47-39-27-36(6-3-34(39)28-48)53-24-16-46(29-53)14-22-51(23-15-46)35-4-1-31(2-5-35)43(57)52-20-10-30(11-21-52)9-17-50-18-12-32-25-37-38(26-33(32)13-19-50)45(59)54(44(37)58)40-7-8-41(55)49-42(40)56/h1-6,25-27,30,40H,7-24,29H2,(H,49,55,56)",PUTPSSPEPURXTK-UHFFFAOYSA-N
3336,385,81,385,81,P10275,AR,CRBN,,ARD-1719,C[C@@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m1/s1",GAXWAKXJBZHVQF-FFTVHEIDSA-N
3337,0.2,99,0.2/3.5,99/99,P10275,AR,CRBN,,ARD-1693,CC[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.42,58,9,9,1,7,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c1-2-33-22-45(27-52(33)35-8-5-30(23-47)38(46)21-35)13-17-50(18-14-45)34-6-3-29(4-7-34)42(56)51-15-11-28(12-16-51)24-49-25-31-19-36-37(20-32(31)26-49)44(58)53(43(36)57)39-9-10-40(54)48-41(39)55/h3-8,19-21,28,33,39H,2,9-18,22,24-27H2,1H3,(H,48,54,55)/t33-,39?/m0/s1",AWHKRHYGENDDAD-YNWFVEANSA-N
3338,0.4,91,0.4/0.8,91/97,P10275,AR,CRBN,,ARD-1671,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(N5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.5,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,774.322,773.3092452,4.7,56,9,9,1,5,137.37,C43H44ClN7O5,"InChI=1S/C43H44ClN7O5/c1-26-21-43(25-50(26)33-7-4-28(22-45)36(44)20-33)12-16-47(17-13-43)31-5-2-27(3-6-31)40(54)48-14-10-32(11-15-48)49-23-29-18-34-35(19-30(29)24-49)42(56)51(41(34)55)37-8-9-38(52)46-39(37)53/h2-7,18-20,26,32,37H,8-17,21,23-25H2,1H3,(H,46,52,53)/t26-,37?/m0/s1",RMWRKGGZMDZIQO-XVNGORCSSA-N
3339,0.7,89,0.7/5.0,89/93,P10275,AR,CRBN,,ARD-1689,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CC(N5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)C4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,746.268,745.2779451,3.98,54,9,9,1,5,137.37,C41H40ClN7O5,"InChI=1S/C41H40ClN7O5/c1-24-17-41(23-48(24)30-7-4-26(18-43)34(42)16-30)10-12-45(13-11-41)29-5-2-25(3-6-29)38(52)47-21-31(22-47)46-19-27-14-32-33(15-28(27)20-46)40(54)49(39(32)53)35-8-9-36(50)44-37(35)51/h2-7,14-16,24,31,35H,8-13,17,19-23H2,1H3,(H,44,50,51)/t24-,35?/m0/s1",PGGVAVRBFXQAOY-FRIBFZOTSA-N
3340,0.9,99,0.9/3.7,99/96,P10275,AR,CRBN,,ARD-1683,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(F)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,806.339,805.3154734,4.86,58,9,9,1,6,137.37,C44H45ClFN7O5,"InChI=1S/C44H45ClFN7O5/c1-27-21-43(25-52(27)33-7-4-29(22-47)36(45)20-33)10-14-50(15-11-43)32-5-2-28(3-6-32)40(56)51-16-12-44(46,13-17-51)26-49-23-30-18-34-35(19-31(30)24-49)42(58)53(41(34)57)37-8-9-38(54)48-39(37)55/h2-7,18-20,27,37H,8-17,21,23-26H2,1H3,(H,48,54,55)/t27-,37?/m0/s1",IJKCXDOACVWFTB-YTCZSSRZSA-N
3341,3.8,97,3.8/8.9,97/94,P10275,AR,CRBN,,ARD-1694,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(C)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.28,58,9,9,1,6,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c1-28-22-45(27-52(28)34-8-5-30(23-47)37(46)21-34)13-17-50(18-14-45)33-6-3-29(4-7-33)41(56)51-15-11-44(2,12-16-51)26-49-24-31-19-35-36(20-32(31)25-49)43(58)53(42(35)57)38-9-10-39(54)48-40(38)55/h3-8,19-21,28,38H,9-18,22,24-27H2,1-2H3,(H,48,54,55)/t28-,38?/m0/s1",YECMHOCJNONAQJ-XRTOLJPQSA-N
3342,290,71,290,71,P10275,AR,CRBN,,ARD-1705,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(O)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,804.348,803.3198099,3.83,58,9,10,2,6,157.6,C44H46ClN7O6,"InChI=1S/C44H46ClN7O6/c1-27-21-43(25-51(27)33-7-4-29(22-46)36(45)20-33)10-14-49(15-11-43)32-5-2-28(3-6-32)40(55)50-16-12-44(58,13-17-50)26-48-23-30-18-34-35(19-31(30)24-48)42(57)52(41(34)56)37-8-9-38(53)47-39(37)54/h2-7,18-20,27,37,58H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,37?/m0/s1",FTLFVUZDLOWJLU-YTCZSSRZSA-N
3343,0.5,99,2.7/0.5,99/99,P10275,AR,CRBN,,ARD-7063,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)N=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,790.325,789.3153932,3.48,57,9,11,1,6,163.15,C42H44ClN9O5,"InChI=1S/C42H44ClN9O5/c1-25-19-42(24-51(25)30-3-2-27(20-44)33(43)18-30)10-14-49(15-11-42)36-6-4-34(46-47-36)41(57)50-12-8-26(9-13-50)21-48-22-28-16-31-32(17-29(28)23-48)40(56)52(39(31)55)35-5-7-37(53)45-38(35)54/h2-4,6,16-18,25-26,35H,5,7-15,19,21-24H2,1H3,(H,45,53,54)/t25-,35?/m0/s1",YXANKPHSGKSVAX-LLIHCOLESA-N
3344,1.2,99,4.6/1.2,99/99,P10275,AR,CRBN,,ARD-7064,C[C@H]1CC2(CCN(C3=CN=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,790.325,789.3153932,3.42,57,9,11,1,6,163.15,C42H44ClN9O5,"InChI=1S/C42H44ClN9O5/c1-25-17-42(24-51(25)30-3-2-27(18-44)33(43)16-30)8-12-49(13-9-42)36-20-45-34(19-46-36)41(57)50-10-6-26(7-11-50)21-48-22-28-14-31-32(15-29(28)23-48)40(56)52(39(31)55)35-4-5-37(53)47-38(35)54/h2-3,14-16,19-20,25-26,35H,4-13,17,21-24H2,1H3,(H,47,53,54)/t25-,35?/m0/s1",KBVMPLTYXHSHLH-LLIHCOLESA-N
3345,4.6,99,15.6/4.6,99/99,P10275,AR,CRBN,,ARD-4055,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)N=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,789.337,788.3201442,4.15,57,9,10,1,6,150.26,C43H45ClN8O5,"InChI=1S/C43H45ClN8O5/c1-26-19-43(25-51(26)31-3-2-28(20-45)35(44)18-31)10-14-49(15-11-43)32-4-5-36(46-21-32)42(57)50-12-8-27(9-13-50)22-48-23-29-16-33-34(17-30(29)24-48)41(56)52(40(33)55)37-6-7-38(53)47-39(37)54/h2-5,16-18,21,26-27,37H,6-15,19,22-25H2,1H3,(H,47,53,54)/t26-,37?/m0/s1",IBCRRCGKMSVYRY-XVNGORCSSA-N
3346,2.2,99,2.3/2.2,99/99,P10275,AR,CRBN,,ARD-4056,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,789.337,788.3201442,4.15,57,9,10,1,6,150.26,C43H45ClN8O5,"InChI=1S/C43H45ClN8O5/c1-26-19-43(25-51(26)32-4-2-28(20-45)35(44)18-32)10-14-49(15-11-43)37-6-3-29(21-46-37)40(55)50-12-8-27(9-13-50)22-48-23-30-16-33-34(17-31(30)24-48)42(57)52(41(33)56)36-5-7-38(53)47-39(36)54/h2-4,6,16-18,21,26-27,36H,5,7-15,19,22-25H2,1H3,(H,47,53,54)/t26-,36?/m0/s1",KYXYESGJSUXASK-FDLYHPRCSA-N
3353,43,99,43,,P50750,CDK9,CRBN,,CP-07,COC1=CC(O)=C2C(=O)C=C(C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)OC2=C1C1=CCN(C)CC1,Degradation of CDK9 in 22RV1 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60,Inhibit cell proliferation of 22RV1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115774,800.913,800.3533625,4.26,59,9,12,2,8,156.18,C45H48N6O8,"InChI=1S/C45H48N6O8/c1-47-15-13-29(14-16-47)40-38(58-2)25-36(53)41-35(52)24-37(59-42(40)41)28-3-5-30(6-4-28)50-21-19-48(20-22-50)26-27-11-17-49(18-12-27)31-7-8-32-33(23-31)45(57)51(44(32)56)34-9-10-39(54)46-43(34)55/h3-8,13,23-25,27,34,53H,9-12,14-22,26H2,1-2H3,(H,46,54,55)",XYXVVDGNOBODDO-UHFFFAOYSA-N
3362,2,96.7,2,96.7,Q16342,PDCD2,CRBN,,,C[C@H](NC(=O)C1=CC=C2C(C3=CC=C(C(F)(F)F)C=C3)=CC=CC2=C1)C1=CC=CC(NC2CCN(C(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of PDCD2 in MOLT-4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202308292,832.836,832.2832322,6.09,61,8,9,3,10,167.11,C45H39F3N6O7,"InChI=1S/C45H39F3N6O7/c1-25(49-41(57)28-13-16-32-27(23-28)5-2-6-31(32)26-11-14-29(15-12-26)45(46,47)48)34-8-4-10-37(51-34)50-30-19-21-53(22-20-30)39(56)24-61-36-9-3-7-33-40(36)44(60)54(43(33)59)35-17-18-38(55)52-42(35)58/h2-16,23,25,30,35H,17-22,24H2,1H3,(H,49,57)(H,50,51)(H,52,55,58)/t25-,35?/m0/s1",FHYJXONYZYZLTJ-LLIHCOLESA-N
3366,,,>1000,32,P03372,ERalpha,CRBN,,ERD-838,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,680.805,680.2998704,5.59,51,9,7,2,5,110.26,C42H40N4O5,"InChI=1S/C42H40N4O5/c47-32-11-13-34-27(20-32)8-12-33(25-4-2-1-3-5-25)39(34)26-6-9-30(10-7-26)44-18-16-31(17-19-44)45-23-28-21-35-36(22-29(28)24-45)42(51)46(41(35)50)37-14-15-38(48)43-40(37)49/h1-7,9-11,13,20-22,31,33,37,39,47H,8,12,14-19,23-24H2,(H,43,48,49)/t33-,37?,39+/m1/s1",STHPOQGBRMGDBA-XANLJJFCSA-N
3367,415,65,415,65,P03372,ERalpha,CRBN,,ERD-821,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,694.832,694.3155204,5.78,52,9,7,2,6,110.26,C43H42N4O5,"InChI=1S/C43H42N4O5/c48-33-11-13-35-29(20-33)8-12-34(27-4-2-1-3-5-27)40(35)28-6-9-32(10-7-28)46-18-16-26(17-19-46)23-45-24-30-21-36-37(22-31(30)25-45)43(52)47(42(36)51)38-14-15-39(49)44-41(38)50/h1-7,9-11,13,20-22,26,34,38,40,48H,8,12,14-19,23-25H2,(H,44,49,50)/t34-,38?,40+/m1/s1",IOOQRZXUJWIKSK-AZISWICNSA-N
3368,,,>1000,50,P03372,ERalpha,CRBN,,ERD-839,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,708.859,708.3311705,6.14,53,9,7,2,7,110.26,C44H44N4O5,"InChI=1S/C44H44N4O5/c49-34-11-13-36-30(22-34)8-12-35(28-4-2-1-3-5-28)41(36)29-6-9-33(10-7-29)47-20-17-27(18-21-47)16-19-46-25-31-23-37-38(24-32(31)26-46)44(53)48(43(37)52)39-14-15-40(50)45-42(39)51/h1-7,9-11,13,22-24,27,35,39,41,49H,8,12,14-21,25-26H2,(H,45,50,51)/t35-,39?,41+/m1/s1",YWCHTWJTAVEIKG-OCRFBPLNSA-N
3369,171,79,171,79,P03372,ERalpha,CRBN,,ERD-840,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,722.886,722.3468206,6.49,54,9,7,2,8,110.26,C45H46N4O5,"InChI=1S/C45H46N4O5/c50-35-13-15-37-31(23-35)10-14-36(29-6-2-1-3-7-29)42(37)30-8-11-34(12-9-30)48-21-18-28(19-22-48)5-4-20-47-26-32-24-38-39(25-33(32)27-47)45(54)49(44(38)53)40-16-17-41(51)46-43(40)52/h1-3,6-9,11-13,15,23-25,28,36,40,42,50H,4-5,10,14,16-22,26-27H2,(H,46,51,52)/t36-,40?,42+/m1/s1",VSVKGKAVEFCRLD-FFWRRKSCSA-N
3370,236,67,236,67,P03372,ERalpha,CRBN,,ERD-841,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,736.913,736.3624706,7.04,55,9,7,2,9,110.26,C46H48N4O5,"InChI=1S/C46H48N4O5/c51-36-14-16-38-32(24-36)11-15-37(30-7-2-1-3-8-30)43(38)31-9-12-35(13-10-31)49-22-19-29(20-23-49)6-4-5-21-48-27-33-25-39-40(26-34(33)28-48)46(55)50(45(39)54)41-17-18-42(52)47-44(41)53/h1-3,7-10,12-14,16,24-26,29,37,41,43,51H,4-6,11,15,17-23,27-28H2,(H,47,52,53)/t37-,41?,43+/m1/s1",SQPYBBMCORULCB-OUFUGTNJSA-N
3371,31,99.9,31,106,P03372,ERalpha,CRBN,,ERD-842,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,750.94,750.3781207,7.58,56,9,7,2,10,110.26,C47H50N4O5,"InChI=1S/C47H50N4O5/c52-37-15-17-39-33(25-37)12-16-38(31-8-4-1-5-9-31)44(39)32-10-13-36(14-11-32)50-23-20-30(21-24-50)7-3-2-6-22-49-28-34-26-40-41(27-35(34)29-49)47(56)51(46(40)55)42-18-19-43(53)48-45(42)54/h1,4-5,8-11,13-15,17,25-27,30,38,42,44,52H,2-3,6-7,12,16,18-24,28-29H2,(H,48,53,54)/t38-,42?,44+/m1/s1",IVGNPUWRFBJCCN-WWEQOKPKSA-N
3372,129,99.9,129,101,P03372,ERalpha,CRBN,,ERD-843,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCCCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,764.967,764.3937708,8.12,57,9,7,2,11,110.26,C48H52N4O5,"InChI=1S/C48H52N4O5/c53-38-16-18-40-34(26-38)13-17-39(32-9-5-3-6-10-32)45(40)33-11-14-37(15-12-33)51-24-21-31(22-25-51)8-4-1-2-7-23-50-29-35-27-41-42(28-36(35)30-50)48(57)52(47(41)56)43-19-20-44(54)49-46(43)55/h3,5-6,9-12,14-16,18,26-28,31,39,43,45,53H,1-2,4,7-8,13,17,19-25,29-30H2,(H,49,54,55)/t39-,43?,45+/m1/s1",PQNOZPBSZAWSGX-GDIQCRDJSA-N
3373,989,50,989,50,P03372,ERalpha,CRBN,,ERD-2218,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.912,749.3577196,5.66,56,10,8,2,7,113.5,C46H47N5O5,"InChI=1S/C46H47N5O5/c52-36-11-13-38-31(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-34(10-7-30)49-18-16-28(17-19-49)23-48-26-35(27-48)50-24-32-21-39-40(22-33(32)25-50)46(56)51(45(39)55)41-14-15-42(53)47-44(41)54/h1-7,9-11,13,20-22,28,35,37,41,43,52H,8,12,14-19,23-27H2,(H,47,53,54)/t37-,41?,43+/m1/s1",XMQFHNQKUCBVPQ-OUFUGTNJSA-N
3374,21,59,21,59,P03372,ERalpha,CRBN,,ERD-9038,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.939,763.3733697,5.85,57,10,8,2,8,113.5,C47H49N5O5,"InChI=1S/C47H49N5O5/c53-37-11-13-39-33(20-37)8-12-38(31-4-2-1-3-5-31)44(39)32-6-9-36(10-7-32)51-18-16-29(17-19-51)23-49-24-30(25-49)26-50-27-34-21-40-41(22-35(34)28-50)47(57)52(46(40)56)42-14-15-43(54)48-45(42)55/h1-7,9-11,13,20-22,29-30,38,42,44,53H,8,12,14-19,23-28H2,(H,48,54,55)/t38-,42?,44+/m1/s1",JOPGQIZLLSYHFY-WWEQOKPKSA-N
3375,2.3,84,2.3,84,P03372,ERalpha,CRBN,,ERD-2217,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.966,777.3890197,6.37,58,10,8,2,7,113.5,C48H51N5O5,"InChI=1S/C48H51N5O5/c54-38-11-13-40-33(24-38)8-12-39(31-4-2-1-3-5-31)45(40)32-6-9-36(10-7-32)51-22-16-30(17-23-51)27-50-20-18-37(19-21-50)52-28-34-25-41-42(26-35(34)29-52)48(58)53(47(41)57)43-14-15-44(55)49-46(43)56/h1-7,9-11,13,24-26,30,37,39,43,45,54H,8,12,14-23,27-29H2,(H,49,55,56)/t39-,43?,45+/m1/s1",LJVKRQPLCQUUFT-GDIQCRDJSA-N
3376,4.3,79,4.3,79,P03372,ERalpha,CRBN,,ERD-9033,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.993,791.4046698,6.56,59,10,8,2,8,113.5,C49H53N5O5,"InChI=1S/C49H53N5O5/c55-39-11-13-41-35(24-39)8-12-40(33-4-2-1-3-5-33)46(41)34-6-9-38(10-7-34)53-22-18-32(19-23-53)27-51-20-16-31(17-21-51)28-52-29-36-25-42-43(26-37(36)30-52)49(59)54(48(42)58)44-14-15-45(56)50-47(44)57/h1-7,9-11,13,24-26,31-32,40,44,46,55H,8,12,14-23,27-30H2,(H,50,56,57)/t40-,44?,46+/m1/s1",GLIOFKBFGNGYKR-GVRKZEHUSA-N
3377,295,57,295,57,P03372,ERalpha,CRBN,,ERD-2141,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.912,749.3577196,5.66,56,10,8,2,7,113.5,C46H47N5O5,"InChI=1S/C46H47N5O5/c52-36-11-13-38-31(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-34(10-7-30)49-24-28(25-49)23-48-18-16-35(17-19-48)50-26-32-21-39-40(22-33(32)27-50)46(56)51(45(39)55)41-14-15-42(53)47-44(41)54/h1-7,9-11,13,20-22,28,35,37,41,43,52H,8,12,14-19,23-27H2,(H,47,53,54)/t37-,41?,43+/m1/s1",GDRMTFAUTGSZHO-OUFUGTNJSA-N
3378,19,64,19,64,P03372,ERalpha,CRBN,,ERD-2142,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.939,763.3733697,5.85,57,10,8,2,8,113.5,C47H49N5O5,"InChI=1S/C47H49N5O5/c53-37-11-13-39-33(20-37)8-12-38(31-4-2-1-3-5-31)44(39)32-6-9-36(10-7-32)51-25-30(26-51)24-49-18-16-29(17-19-49)23-50-27-34-21-40-41(22-35(34)28-50)47(57)52(46(40)56)42-14-15-43(54)48-45(42)55/h1-7,9-11,13,20-22,29-30,38,42,44,53H,8,12,14-19,23-28H2,(H,48,54,55)/t38-,42?,44+/m1/s1",HVMKSQIOKMVOOE-WWEQOKPKSA-N
3379,6,84,6,84,P03372,ERalpha,CRBN,,ERD-849,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.02,58,10,8,2,7,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-36-11-13-38-32(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-35(10-7-30)50-18-16-31(17-19-50)45(56)51-24-28(25-51)23-49-26-33-21-39-40(22-34(33)27-49)47(58)52(46(39)57)41-14-15-42(54)48-44(41)55/h1-7,9-11,13,20-22,28,31,37,41,43,53H,8,12,14-19,23-27H2,(H,48,54,55)/t37-,41?,43+/m1/s1",KWHREFRVFQGWOC-OUFUGTNJSA-N
3380,1.6,95,1.6,95,P03372,ERalpha,CRBN,,ERD-9115,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.54,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-37-11-13-39-32(24-37)8-12-38(29-4-2-1-3-5-29)44(39)30-6-9-35(10-7-30)50-20-16-31(17-21-50)46(57)51-22-18-36(19-23-51)52-27-33-25-40-41(26-34(33)28-52)48(59)53(47(40)58)42-14-15-43(55)49-45(42)56/h1-7,9-11,13,24-26,31,36,38,42,44,54H,8,12,14-23,27-28H2,(H,49,55,56)/t38-,42?,44+/m1/s1",BAWWFFPYQBHNQE-WWEQOKPKSA-N
3381,13,76,13,76,P03372,ERalpha,CRBN,,ERD-10108,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,805.976,805.3839344,5.73,60,10,8,2,7,130.57,C49H51N5O6,"InChI=1S/C49H51N5O6/c55-38-11-13-40-34(24-38)8-12-39(31-4-2-1-3-5-31)45(40)32-6-9-37(10-7-32)52-22-18-33(19-23-52)47(58)53-20-16-30(17-21-53)27-51-28-35-25-41-42(26-36(35)29-51)49(60)54(48(41)59)43-14-15-44(56)50-46(43)57/h1-7,9-11,13,24-26,30,33,39,43,45,55H,8,12,14-23,27-29H2,(H,50,56,57)/t39-,43?,45+/m1/s1",YHTOZJXOOFKGHU-GDIQCRDJSA-N
3382,9.7,63,9.7,63,P03372,ERalpha,CRBN,,ERD-846,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C(=O)C2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,805.976,805.3839344,5.73,60,10,8,2,7,130.57,C49H51N5O6,"InChI=1S/C49H51N5O6/c55-38-11-13-40-34(24-38)8-12-39(31-4-2-1-3-5-31)45(40)32-6-9-37(10-7-32)52-22-16-30(17-23-52)27-51-20-18-33(19-21-51)47(58)53-28-35-25-41-42(26-36(35)29-53)49(60)54(48(41)59)43-14-15-44(56)50-46(43)57/h1-7,9-11,13,24-26,30,33,39,43,45,55H,8,12,14-23,27-29H2,(H,50,56,57)/t39-,43?,45+/m1/s1",NJBVKJIGWSMPIW-GDIQCRDJSA-N
3383,32,87,32,87,P03372,ERalpha,CRBN,,ERD-9096,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(C(=O)C3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.02,58,10,8,2,7,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-36-11-13-38-31(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-35(10-7-30)51-26-34(27-51)45(56)50-18-16-28(17-19-50)23-49-24-32-21-39-40(22-33(32)25-49)47(58)52(46(39)57)41-14-15-42(54)48-44(41)55/h1-7,9-11,13,20-22,28,34,37,41,43,53H,8,12,14-19,23-27H2,(H,48,54,55)/t37-,41?,43+/m1/s1",YCBIOWPIZXJGRB-OUFUGTNJSA-N
3384,,,>1000,40,P03372,ERalpha,CRBN,,ERD-2270,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C(=O)C2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.02,58,10,8,2,7,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-36-11-13-38-32(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-35(10-7-30)50-24-28(25-50)23-49-18-16-31(17-19-49)45(56)51-26-33-21-39-40(22-34(33)27-51)47(58)52(46(39)57)41-14-15-42(54)48-44(41)55/h1-7,9-11,13,20-22,28,31,37,41,43,53H,8,12,14-19,23-27H2,(H,48,54,55)/t37-,41?,43+/m1/s1",JSOJSELRECLYBC-OUFUGTNJSA-N
3385,11,65,11,65,P03372,ERalpha,CRBN,,ERD-853,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CC3(C2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,735.841,735.305684,4.23,55,10,8,2,6,130.57,C44H41N5O6,"InChI=1S/C44H41N5O6/c50-32-11-13-34-28(16-32)8-12-33(26-4-2-1-3-5-26)40(34)27-6-9-31(10-7-27)47-22-44(23-47)24-48(25-44)39(52)21-46-19-29-17-35-36(18-30(29)20-46)43(55)49(42(35)54)37-14-15-38(51)45-41(37)53/h1-7,9-11,13,16-18,33,37,40,50H,8,12,14-15,19-25H2,(H,45,51,53)/t33-,37?,40+/m1/s1",DYJMBAGARLOCGL-OYKJAVFLSA-N
3386,,,>1000,23,P03372,ERalpha,CRBN,,ERD-854,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(C2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.868,749.3213341,4.58,56,10,8,2,6,130.57,C45H43N5O6,"InChI=1S/C45H43N5O6/c51-33-11-13-35-29(18-33)8-12-34(27-4-2-1-3-5-27)41(35)28-6-9-32(10-7-28)49-25-45(26-49)16-17-48(24-45)40(53)23-47-21-30-19-36-37(20-31(30)22-47)44(56)50(43(36)55)38-14-15-39(52)46-42(38)54/h1-7,9-11,13,18-20,34,38,41,51H,8,12,14-17,21-26H2,(H,46,52,54)/t34-,38?,41+/m1/s1",WBCDANJGKYYWKX-OFEAQGJVSA-N
3387,4,63,4,63,P03372,ERalpha,CRBN,,ERD-855,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.868,749.3213341,4.58,56,10,8,2,6,130.57,C45H43N5O6,"InChI=1S/C45H43N5O6/c51-33-11-13-35-29(18-33)8-12-34(27-4-2-1-3-5-27)41(35)28-6-9-32(10-7-28)48-17-16-45(24-48)25-49(26-45)40(53)23-47-21-30-19-36-37(20-31(30)22-47)44(56)50(43(36)55)38-14-15-39(52)46-42(38)54/h1-7,9-11,13,18-20,34,38,41,51H,8,12,14-17,21-26H2,(H,46,52,54)/t34-,38?,41+/m1/s1",JLTNQZFNQLUGOC-OFEAQGJVSA-N
3388,1.8,68,1.8,68,P03372,ERalpha,CRBN,,ERD-856,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CC2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.895,763.3369842,4.94,57,10,8,2,6,130.57,C46H45N5O6,"InChI=1S/C46H45N5O6/c52-34-11-13-36-30(20-34)8-12-35(28-4-2-1-3-5-28)42(36)29-6-9-33(10-7-29)50-26-46(27-50)16-18-49(19-17-46)41(54)25-48-23-31-21-37-38(22-32(31)24-48)45(57)51(44(37)56)39-14-15-40(53)47-43(39)55/h1-7,9-11,13,20-22,35,39,42,52H,8,12,14-19,23-27H2,(H,47,53,55)/t35-,39?,42+/m1/s1",JSLJXCMFGCYXEV-HJNPNHQXSA-N
3389,2.8,71,2.8,71,P03372,ERalpha,CRBN,,ERD-1152,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.895,763.3369842,4.94,57,10,8,2,6,130.57,C46H45N5O6,"InChI=1S/C46H45N5O6/c52-34-11-13-36-30(20-34)8-12-35(28-4-2-1-3-5-28)42(36)29-6-9-33(10-7-29)49-18-16-46(17-19-49)26-50(27-46)41(54)25-48-23-31-21-37-38(22-32(31)24-48)45(57)51(44(37)56)39-14-15-40(53)47-43(39)55/h1-7,9-11,13,20-22,35,39,42,52H,8,12,14-19,23-27H2,(H,47,53,55)/t35-,39?,42+/m1/s1",VTOSAOJQRFRJRP-HJNPNHQXSA-N
3390,18,58,18,58,P03372,ERalpha,CRBN,,ERD-857,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.3,58,10,8,2,6,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-35-11-13-37-31(22-35)8-12-36(29-4-2-1-3-5-29)43(37)30-6-9-34(10-7-30)51-21-18-47(28-51)16-19-50(20-17-47)42(55)27-49-25-32-23-38-39(24-33(32)26-49)46(58)52(45(38)57)40-14-15-41(54)48-44(40)56/h1-7,9-11,13,22-24,36,40,43,53H,8,12,14-21,25-28H2,(H,48,54,56)/t36-,40?,43+/m1/s1",IICKZTABJMLFAS-YNXYBLEHSA-N
3391,4.6,75,4.6,75,P03372,ERalpha,CRBN,,ERD-851,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.3,58,10,8,2,6,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-35-11-13-37-31(22-35)8-12-36(29-4-2-1-3-5-29)43(37)30-6-9-34(10-7-30)50-19-16-47(17-20-50)18-21-51(28-47)42(55)27-49-25-32-23-38-39(24-33(32)26-49)46(58)52(45(38)57)40-14-15-41(54)48-44(40)56/h1-7,9-11,13,22-24,36,40,43,53H,8,12,14-21,25-28H2,(H,48,54,56)/t36-,40?,43+/m1/s1",CMXBIGSUZMPPRI-YNXYBLEHSA-N
3392,5.5,90,5.5,90,P03372,ERalpha,CRBN,,ERD-1173,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)CC3)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.65,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-36-11-13-38-32(24-36)8-12-37(30-4-2-1-3-5-30)44(38)31-6-9-35(10-7-31)51-20-16-48(17-21-51)18-22-52(23-19-48)43(56)29-50-27-33-25-39-40(26-34(33)28-50)47(59)53(46(39)58)41-14-15-42(55)49-45(41)57/h1-7,9-11,13,24-26,37,41,44,54H,8,12,14-23,27-29H2,(H,49,55,57)/t37-,41?,44+/m1/s1",QSLOGDDNCAUEOM-ALPHEJHSSA-N
3393,393,58,393,58,P03372,ERalpha,CRBN,,ERD-852,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCCC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.65,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-36-12-14-38-32(23-36)9-13-37(30-5-2-1-3-6-30)44(38)31-7-10-35(11-8-31)51-21-18-48(19-22-51)17-4-20-52(29-48)43(56)28-50-26-33-24-39-40(25-34(33)27-50)47(59)53(46(39)58)41-15-16-42(55)49-45(41)57/h1-3,5-8,10-12,14,23-25,37,41,44,54H,4,9,13,15-22,26-29H2,(H,49,55,57)/t37-,41?,44+/m1/s1",CXVXDOPSPYRBNI-ALPHEJHSSA-N
3394,,,>1000,16,P03372,ERalpha,CRBN,,ERD-858,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C(=O)CN2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)CC3)C4)C(=O)N1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.65,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-36-11-13-38-32(24-36)8-12-37(30-4-2-1-3-5-30)44(38)31-6-9-35(10-7-31)51-22-18-48(19-23-51)16-20-50(21-17-48)29-43(56)52-27-33-25-39-40(26-34(33)28-52)47(59)53(46(39)58)41-14-15-42(55)49-45(41)57/h1-7,9-11,13,24-26,37,41,44,54H,8,12,14-23,27-29H2,(H,49,55,57)/t37-,41?,44+/m1/s1",UPQRJEMPJLRIMJ-ALPHEJHSSA-N
3395,0.1,97,0.1,97,P03372,ERalpha,CRBN,,ERD-876,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)(F)CO,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,883.944,883.3680452,4.32,64,10,9,3,8,149.6,C47H49F4N7O6,"InChI=1S/C47H49F4N7O6/c1-26-16-31-30-4-2-3-5-36(30)52-41(31)42(57(26)24-47(50,51)25-59)40-34(48)19-29(20-35(40)49)55-12-8-46(9-13-55)10-14-56(15-11-46)39(61)23-54-21-27-17-32-33(18-28(27)22-54)45(64)58(44(32)63)37-6-7-38(60)53-43(37)62/h2-5,17-20,26,37,42,52,59H,6-16,21-25H2,1H3,(H,53,60,62)/t26-,37?,42-/m1/s1",SEHKDMKQRSFFAP-NIFBIGKZSA-N
3396,0.8,83,0.8,83,P03372,ERalpha,CRBN,,ERD-2279,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(C)(C)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,863.982,863.3982024,5.3,63,10,8,2,7,129.37,C48H52F3N7O5,"InChI=1S/C48H52F3N7O5/c1-27-18-32-31-6-4-5-7-37(31)52-42(32)43(57(27)26-47(2,3)51)41-35(49)21-30(22-36(41)50)55-14-10-48(11-15-55)12-16-56(17-13-48)40(60)25-54-23-28-19-33-34(20-29(28)24-54)46(63)58(45(33)62)38-8-9-39(59)53-44(38)61/h4-7,19-22,27,38,43,52H,8-18,23-26H2,1-3H3,(H,53,59,61)/t27-,38?,43-/m1/s1",VLJYPDPFDHUAPD-UKIYHOJXSA-N
3397,0.8,99.9,0.8,106,P03372,ERalpha,CRBN,,ERD-1099,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,853.918,853.3574805,5.19,62,10,8,2,7,129.37,C46H47F4N7O5,"InChI=1S/C46H47F4N7O5/c1-25-16-30-29-4-2-3-5-35(29)51-41(30)42(56(25)23-37(49)50)40-33(47)19-28(20-34(40)48)54-12-8-46(9-13-54)10-14-55(15-11-46)39(59)24-53-21-26-17-31-32(18-27(26)22-53)45(62)57(44(31)61)36-6-7-38(58)52-43(36)60/h2-5,17-20,25,36-37,42,51H,6-16,21-24H2,1H3,(H,52,58,60)/t25-,36?,42-/m1/s1",BQMMQVMQKXUBSK-GVFWYEFESA-N
3398,3.8,99.9,3.8,107,P03372,ERalpha,CRBN,,ERD-3327,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=CC=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=N2)N1CC(F)(F)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,837.904,837.3574002,3.68,61,10,10,2,6,155.15,C44H46F3N9O5,"InChI=1S/C44H46F3N9O5/c1-25-16-30-29(3-5-34-33(30)20-49-51-34)39(55(25)24-44(45,46)47)35-4-2-28(19-48-35)53-12-8-43(9-13-53)10-14-54(15-11-43)38(58)23-52-21-26-17-31-32(18-27(26)22-52)42(61)56(41(31)60)36-6-7-37(57)50-40(36)59/h2-5,17-20,25,36,39H,6-16,21-24H2,1H3,(H,49,51)(H,50,57,59)/t25-,36?,39+/m1/s1",WAIHYAJCHLPMKK-BABVPROQSA-N
3399,2,88,2,88,P03372,ERalpha,CRBN,,ERD-809,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)(F)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,872.896,872.3433076,4.92,63,10,9,2,6,142.26,C45H45F5N8O5,"InChI=1S/C45H45F5N8O5/c1-24-14-29-28(2-3-35-32(29)19-51-53-35)40(57(24)23-45(48,49)50)39-33(46)17-27(18-34(39)47)55-10-6-44(7-11-55)8-12-56(13-9-44)38(60)22-54-20-25-15-30-31(16-26(25)21-54)43(63)58(42(30)62)36-4-5-37(59)52-41(36)61/h2-3,15-19,24,36,40H,4-14,20-23H2,1H3,(H,51,53)(H,52,59,61)/t24-,36?,40+/m1/s1",LXFAGTBVIUWBOR-MJRZQNSGSA-N
3400,0.5,91,0.5,91,P03372,ERalpha,CRBN,,ERD-3111,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,854.906,854.3527295,4.66,62,10,9,2,7,142.26,C45H46F4N8O5,"InChI=1S/C45H46F4N8O5/c1-24-14-29-28(2-3-35-32(29)19-50-52-35)41(56(24)22-37(48)49)40-33(46)17-27(18-34(40)47)54-10-6-45(7-11-54)8-12-55(13-9-45)39(59)23-53-20-25-15-30-31(16-26(25)21-53)44(62)57(43(30)61)36-4-5-38(58)51-42(36)60/h2-3,15-19,24,36-37,41H,4-14,20-23H2,1H3,(H,50,52)(H,51,58,60)/t24-,36?,41+/m1/s1",RASJDLFEGKXLIV-LQFKIQTBSA-N
3401,14,99.9,14,112,P03372,ERalpha,CRBN,,ERD-576,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=CC=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=N2)N1CC(F)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,819.914,819.366822,3.42,60,10,10,2,7,155.15,C44H47F2N9O5,"InChI=1S/C44H47F2N9O5/c1-25-16-30-29(3-5-34-33(30)20-48-50-34)40(54(25)23-37(45)46)35-4-2-28(19-47-35)52-12-8-44(9-13-52)10-14-53(15-11-44)39(57)24-51-21-26-17-31-32(18-27(26)22-51)43(60)55(42(31)59)36-6-7-38(56)49-41(36)58/h2-5,17-20,25,36-37,40H,6-16,21-24H2,1H3,(H,48,50)(H,49,56,58)/t25-,36?,40+/m1/s1",IJLLDTDBKVJVRA-DPUXDYCHSA-N
3402,1.4,82,1.4,82,P03372,ERalpha,CRBN,,ERD-570,COC1=CC(N2CCC3(CCN(C(=O)CN4CC5=CC6=C(C=C5C4)C(=O)N(C4CCC(=O)NC4=O)C6=O)CC3)CC2)=CC=C1[C@@H]1C2=CC=C3[NH]N=CC3=C2C[C@@H](C)N1CC(F)F,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,848.952,848.3821378,4.43,62,10,10,2,8,151.49,C46H50F2N8O6,"InChI=1S/C46H50F2N8O6/c1-26-17-32-30(5-6-36-35(32)21-49-51-36)42(55(26)24-39(47)48)31-4-3-29(20-38(31)62-2)53-13-9-46(10-14-53)11-15-54(16-12-46)41(58)25-52-22-27-18-33-34(19-28(27)23-52)45(61)56(44(33)60)37-7-8-40(57)50-43(37)59/h3-6,18-21,26,37,39,42H,7-17,22-25H2,1-2H3,(H,49,51)(H,50,57,59)/t26-,37?,42+/m1/s1",ZHYXPILHQRRHFF-UYFBRPAHSA-N
3417,0.6,90,0.6,90,O15379,HDAC3,VHL,,,CCCNNC(=O)C1=CC=C(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)C=C1,Degradation of HDAC3 in THP-1 cells after 24 h treatment,86/17,% HDAC3 degradation at 500/5000 nM in THP-1 cells,40,Inhibitory of HDAC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202310059,804.071,803.4404037,6.27,57,4,9,6,20,181.86,C43H61N7O6S,"InChI=1S/C43H61N7O6S/c1-7-24-45-49-40(54)32-20-22-33(23-21-32)47-36(52)14-12-10-8-9-11-13-15-37(53)48-39(43(4,5)6)42(56)50-26-34(51)25-35(50)41(55)46-28(2)30-16-18-31(19-17-30)38-29(3)44-27-57-38/h16-23,27-28,34-35,39,45,51H,7-15,24-26H2,1-6H3,(H,46,55)(H,47,52)(H,48,53)(H,49,54)/t28-,34+,35-,39+/m0/s1",QVKJJUGUFZBXRO-UNVCQTPUSA-N
3417,75,94,75,94,Q9BY41,HDAC8,VHL,,,CCCNNC(=O)C1=CC=C(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)C=C1,Degradation of HDAC8 in THP-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202310059,804.071,803.4404037,6.27,57,4,9,6,20,181.86,C43H61N7O6S,"InChI=1S/C43H61N7O6S/c1-7-24-45-49-40(54)32-20-22-33(23-21-32)47-36(52)14-12-10-8-9-11-13-15-37(53)48-39(43(4,5)6)42(56)50-26-34(51)25-35(50)41(55)46-28(2)30-16-18-31(19-17-30)38-29(3)44-27-57-38/h16-23,27-28,34-35,39,45,51H,7-15,24-26H2,1-6H3,(H,46,55)(H,47,52)(H,48,53)(H,49,54)/t28-,34+,35-,39+/m0/s1",QVKJJUGUFZBXRO-UNVCQTPUSA-N
3419,44.66,99,44.66,,P62937,CypA,VHL,,,CC1=C(C2=CC=C(C(C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOC3=CC=CC(O)=C3C(=O)NC(=O)NC3CCCCC3)C(C)(C)C)C=C2)SC=N1,Degradation of CypA in A549 cells after 12 h treatment,,,,,,,11740,The affinity and binding kinetics of PROTACs for CypA measured by SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.isci.2023.107535,849.064,848.4142485,6.23,60,5,11,6,17,208.52,C44H60N6O9S,"InChI=1S/C44H60N6O9S/c1-27(29-17-19-30(20-18-29)38-28(2)45-26-60-38)46-40(54)33-23-32(51)24-50(33)42(56)39(44(3,4)5)48-36(53)25-58-21-10-7-11-22-59-35-16-12-15-34(52)37(35)41(55)49-43(57)47-31-13-8-6-9-14-31/h12,15-20,26-27,31-33,39,51-52H,6-11,13-14,21-25H2,1-5H3,(H,46,54)(H,48,53)(H2,47,49,55,57)/t27?,32-,33+,39-/m1/s1",TZTTULKUKMSPSD-BAMNMADASA-N
3420,57.86,99,57.86,,P62937,CypA,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOCCCCCC3=CC=CC(O)=C3C(=O)NC(=O)NC3CCCCC3)C(C)(C)C)C=C2)SC=N1,Degradation of CypA in A549 cells after 12 h treatment,,,,,,,84600,The affinity and binding kinetics of PROTACs for CypA measured by SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.isci.2023.107535,891.145,890.4611987,6.86,63,5,11,6,21,208.52,C47H66N6O9S,"InChI=1S/C47H66N6O9S/c1-31-41(63-30-49-31)34-21-19-32(20-22-34)27-48-43(57)37-26-36(54)28-53(37)45(59)42(47(2,3)4)51-39(56)29-62-25-12-11-24-61-23-10-6-7-14-33-15-13-18-38(55)40(33)44(58)52-46(60)50-35-16-8-5-9-17-35/h13,15,18-22,30,35-37,42,54-55H,5-12,14,16-17,23-29H2,1-4H3,(H,48,57)(H,51,56)(H2,50,52,58,60)/t36-,37+,42-/m1/s1",NPIKETIZSKSAOC-OHXZDEFFSA-N
3421,32.49,99,32.49,,P62937,CypA,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOC3=CC=CC(F)=C3C(=O)NC(=O)NC3C4=CC=CC=C4C4=CC=CC=C43)C(C)(C)C)C=C2)SC=N1,Degradation of CypA in A549 cells after 12 h treatment,,,,,,,47670,The affinity and binding kinetics of PROTACs for CypA measured by SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.isci.2023.107535,933.116,932.394262,7.77,67,7,10,5,17,188.29,C51H57FN6O8S,"InChI=1S/C51H57FN6O8S/c1-30(32-20-22-33(23-21-32)45-31(2)53-29-67-45)54-47(61)40-26-34(59)27-58(40)49(63)46(51(3,4)5)55-42(60)28-65-24-11-6-12-25-66-41-19-13-18-39(52)43(41)48(62)57-50(64)56-44-37-16-9-7-14-35(37)36-15-8-10-17-38(36)44/h7-10,13-23,29-30,34,40,44,46,59H,6,11-12,24-28H2,1-5H3,(H,54,61)(H,55,60)(H2,56,57,62,64)/t30-,34+,40-,46+/m0/s1",MDDYIBPBJZSMON-GFQRTZTCSA-N
3423,295,66.4,295,66.4,P07900,HSP90alpha,CRBN,,,CC(C)C1=CC(C(=O)N2CC3=CC=C(CN4CCN(CCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3C2)=CC=C1O,Degradation of HSP90alpha in MCF-7 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51480/16460/8930,Inhibit cell growth in MDA-MB-231/MDA-MB-468/MCF-7 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115690,762.908,762.3740979,4.04,56,7,9,3,13,159.67,C43H50N6O7,"InChI=1S/C43H50N6O7/c1-27(2)33-23-29(13-15-36(33)50)41(54)48-25-30-12-11-28(22-31(30)26-48)24-47-20-18-46(19-21-47)17-6-4-3-5-10-37(51)44-34-9-7-8-32-39(34)43(56)49(42(32)55)35-14-16-38(52)45-40(35)53/h7-9,11-13,15,22-23,27,35,50H,3-6,10,14,16-21,24-26H2,1-2H3,(H,44,51)(H,45,52,53)",LHEOCGZFVGFDNZ-UHFFFAOYSA-N
3426,228.5,99,228.5/518.8,,P22736,NR4A1,VHL,,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]3(C)CC[C@@]4(C)CC[C@@](C)(C(=O)NCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C[C@H]4[C@]3(C)CC[C@@]21C,Degradation of NR4A1 in CHL-1/A375 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1101/2023.08.09.552650,1110.469,1109.61228,7.62,79,8,13,5,21,214.95,C62H87N5O11S,"InChI=1S/C62H87N5O11S/c1-38-44-16-17-48-60(9,45(44)33-47(69)51(38)71)21-23-62(11)49-34-59(8,19-18-58(49,7)20-22-61(48,62)10)56(74)63-24-25-75-26-27-76-28-29-77-30-31-78-36-50(70)66-53(57(4,5)6)55(73)67-35-43(68)32-46(67)54(72)65-39(2)41-12-14-42(15-13-41)52-40(3)64-37-79-52/h12-17,33,37,39,43,46,49,53,68,71H,18-32,34-36H2,1-11H3,(H,63,74)(H,65,72)(H,66,70)/t39-,43+,46-,49+,53+,58+,59+,60-,61+,62-/m0/s1",GAZVCLAVEAXIQM-ZVXNWPGJSA-N
3435,1.48,97.9,1.48,97.9,Q9Y2I7,PIKfyve,VHL,,PIK5-12d,CC1=CC=CC(/C=N/NC2=CC(N3CCOCC3)=NC(OCCC3=CC=C(NC(=O)CCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)=N2)=C1,Degradation of PIKfyve in VCaP cells after 24h treatment,97/91,% PIKfyve degradation of  in VCaP cells after 24h treatment with 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,522.3,Inhibit cell proliferation in VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00912,973.214,972.4680154,6.7,70,7,14,5,20,212.6,C52H64N10O7S,"InChI=1S/C52H64N10O7S/c1-34-9-8-10-38(27-34)31-55-60-43-29-44(61-22-25-68-26-23-61)58-51(57-43)69-24-21-36-15-19-40(20-16-36)56-45(64)11-6-7-12-46(65)59-48(52(3,4)5)50(67)62-32-41(63)28-42(62)49(66)53-30-37-13-17-39(18-14-37)47-35(2)54-33-70-47/h8-10,13-20,27,29,31,33,41-42,48,63H,6-7,11-12,21-26,28,30,32H2,1-5H3,(H,53,66)(H,56,64)(H,59,65)(H,57,58,60)/b55-31+/t41-,42+,48-/m1/s1",BQGREFVYIDLIFJ-CATAWDBESA-N
3457,1.7,99,1.7,,O15379,HDAC3,VHL,,YX968,CCCNNC(=O)C1=CC=C(N2CCN(CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)C=C1,Degradation of HDAC3 in MDA-MB-231 cells after 8 h treatment,,,591/283/740,Inhibit of HDAC1/HDAC3/HDAC8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2023.07.010,831.141,830.4876882,6.37,59,5,10,5,19,159.24,C45H66N8O5S,"InChI=1S/C45H66N8O5S/c1-7-22-47-50-42(56)35-18-20-36(21-19-35)52-26-24-51(25-27-52)23-12-10-8-9-11-13-39(55)49-41(45(4,5)6)44(58)53-29-37(54)28-38(53)43(57)48-31(2)33-14-16-34(17-15-33)40-32(3)46-30-59-40/h14-21,30-31,37-38,41,47,54H,7-13,22-29H2,1-6H3,(H,48,57)(H,49,55)(H,50,56)/t31-,37+,38-,41+/m0/s1",KBTKRNXLECYGBY-NERSTHRASA-N
3457,6.1,99,6.1,,Q9BY41,HDAC8,VHL,,YX968,CCCNNC(=O)C1=CC=C(N2CCN(CCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)C=C1,Degradation of HDAC8 in MDA-MB-231 cells after 8 h treatment,,,591/283/740,Inhibit of HDAC1/HDAC3/HDAC8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2023.07.010,831.141,830.4876882,6.37,59,5,10,5,19,159.24,C45H66N8O5S,"InChI=1S/C45H66N8O5S/c1-7-22-47-50-42(56)35-18-20-36(21-19-35)52-26-24-51(25-27-52)23-12-10-8-9-11-13-39(55)49-41(45(4,5)6)44(58)53-29-37(54)28-38(53)43(57)48-31(2)33-14-16-34(17-15-33)40-32(3)46-30-59-40/h14-21,30-31,37-38,41,47,54H,7-13,22-29H2,1-6H3,(H,48,57)(H,49,55)(H,50,56)/t31-,37+,38-,41+/m0/s1",KBTKRNXLECYGBY-NERSTHRASA-N
3482,670,99,670/760,,P10275,AR-V7,CRBN,,BWA-522,CC(C)(C1=CC=C(OCC2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C=C1)C1=CC=C(OC[C@H](O)CCl)C=C1,Degradation of AR-V7 in VCaP/22Rv1 cells,77.3/84.6,% AR-V7 degradation in VCaP cells after treatment at 1000/5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00585,771.355,770.3446277,6.18,55,7,9,2,13,128.72,C43H51ClN4O7,"InChI=1S/C43H51ClN4O7/c1-43(2,31-5-10-35(11-6-31)55-27-33(49)24-44)30-3-8-34(9-4-30)54-26-29-15-19-46(20-16-29)25-28-17-21-47(22-18-28)32-7-12-36-37(23-32)42(53)48(41(36)52)38-13-14-39(50)45-40(38)51/h3-12,23,28-29,33,38,49H,13-22,24-27H2,1-2H3,(H,45,50,51)/t33-,38?/m1/s1",MYCPBYLZNZTLBC-OVFDOZPJSA-N
3482,730,99,3450/730/2410,,P10275,AR,CRBN,,BWA-522,CC(C)(C1=CC=C(OCC2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C=C1)C1=CC=C(OC[C@H](O)CCl)C=C1,Degradation of AR-FL in LNCaP/VCaP/22Rv1 cells,48.7/72/52.4/73.1,% AR-FL degradation in LNCaP cells after treatment at 1000/5000 nM and in VCaP cells after treatment at 1000/5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1070/5590/4080,Inhibit AR-independent PC-3 cell growth in LNCaP/VCaP/22Rv1 cell,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00585,771.355,770.3446277,6.18,55,7,9,2,13,128.72,C43H51ClN4O7,"InChI=1S/C43H51ClN4O7/c1-43(2,31-5-10-35(11-6-31)55-27-33(49)24-44)30-3-8-34(9-4-30)54-26-29-15-19-46(20-16-29)25-28-17-21-47(22-18-28)32-7-12-36-37(23-32)42(53)48(41(36)52)38-13-14-39(50)45-40(38)51/h3-12,23,28-29,33,38,49H,13-22,24-27H2,1-2H3,(H,45,50,51)/t33-,38?/m1/s1",MYCPBYLZNZTLBC-OVFDOZPJSA-N
3499,54.92,95,54.92,95,Q15004,PCLAF,CRBN,,,C[C@@H]1CCC2[C@@H](C)[C@@H](OCCN(CCO[C@H]3O[C@@H]4O[C@@]5(C)CCC6[C@H](C)CCC([C@H]3C)[C@]64OO5)C(=O)CCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)O[C@@H]3O[C@@]4(C)CCC1[C@@]23OO4,Degradation of PCLAF in RS4;11 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50.6/235.3/342.8,Inhibit cell proliferation in RS4;11/RPMI8226/U266 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00824,1035.242,1034.546368,7.9,74,13,16,2,18,208.19,C55H78N4O15,"InChI=1S/C55H78N4O15/c1-31-16-18-38-33(3)48(67-50-54(38)36(31)22-24-52(5,69-50)71-73-54)65-29-27-58(28-30-66-49-34(4)39-19-17-32(2)37-23-25-53(6)70-51(68-49)55(37,39)74-72-53)43(61)15-10-8-7-9-11-26-56-40-14-12-13-35-44(40)47(64)59(46(35)63)41-20-21-42(60)57-45(41)62/h12-14,31-34,36-39,41,48-51,56H,7-11,15-30H2,1-6H3,(H,57,60,62)/t31-,32-,33-,34-,36?,37?,38?,39?,41?,48+,49+,50-,51-,52-,53-,54-,55-/m1/s1",ZLJLKXURBBWTFW-RJHWUJBZSA-N
3513,2400,99,2400,,Q8NB16,MLKL,CRBN,,,COC1=CC=C(C(=O)N2CCC3(CCN(C(=O)CCCCCCCOC4=CC=CC(NC5=C(C(N)=O)C(C6=CC=C(NS(=O)(=O)C(F)F)C=C6)=N[NH]5)=C4)CC3)CC2)C=C1N1CCC(=O)NC1=O,Degradation of MLKL in HT29 cells for 24h,26/93,% MLKL degradation in HT29 cells after 24h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1200,Protecting cells against TSZ-induced necroptosis,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00665,948.063,947.3811518,5.55,67,7,11,5,19,238.46,C46H55F2N9O9S,"InChI=1S/C46H55F2N9O9S/c1-65-36-16-13-31(28-35(36)57-22-17-37(58)51-45(57)62)43(61)56-25-20-46(21-26-56)18-23-55(24-19-46)38(59)10-5-3-2-4-6-27-66-34-9-7-8-33(29-34)50-42-39(41(49)60)40(52-53-42)30-11-14-32(15-12-30)54-67(63,64)44(47)48/h7-9,11-16,28-29,44,54H,2-6,10,17-27H2,1H3,(H2,49,60)(H2,50,52,53)(H,51,58,62)",XDPRKJSOJYMCMZ-UHFFFAOYSA-N
3516,,,>1000,19,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,751.914,751.3264365,3.09,54,6,12,5,11,201.48,C39H45N9O5S,"InChI=1S/C39H45N9O5S/c1-22(24-10-12-25(13-11-24)34-23(2)41-21-54-34)43-37(52)31-16-27(49)20-48(31)38(53)35(39(3,4)5)44-33(51)14-15-47-19-26(18-42-47)29-17-30(45-46-36(29)40)28-8-6-7-9-32(28)50/h6-13,17-19,21-22,27,31,35,49-50H,14-16,20H2,1-5H3,(H2,40,46)(H,43,52)(H,44,51)/t22-,27+,31-,35+/m0/s1",WMEBCPXSPHQTBP-CRWYZYDWSA-N
3516,,,>1000,0,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,751.914,751.3264365,3.09,54,6,12,5,11,201.48,C39H45N9O5S,"InChI=1S/C39H45N9O5S/c1-22(24-10-12-25(13-11-24)34-23(2)41-21-54-34)43-37(52)31-16-27(49)20-48(31)38(53)35(39(3,4)5)44-33(51)14-15-47-19-26(18-42-47)29-17-30(45-46-36(29)40)28-8-6-7-9-32(28)50/h6-13,17-19,21-22,27,31,35,49-50H,14-16,20H2,1-5H3,(H2,40,46)(H,43,52)(H,44,51)/t22-,27+,31-,35+/m0/s1",WMEBCPXSPHQTBP-CRWYZYDWSA-N
3517,132,88,132,88,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,765.941,765.3420866,3.45,55,6,12,5,12,201.48,C40H47N9O5S,"InChI=1S/C40H47N9O5S/c1-23(25-12-14-26(15-13-25)35-24(2)42-22-55-35)44-38(53)32-17-28(50)21-49(32)39(54)36(40(3,4)5)45-34(52)11-8-16-48-20-27(19-43-48)30-18-31(46-47-37(30)41)29-9-6-7-10-33(29)51/h6-7,9-10,12-15,18-20,22-23,28,32,36,50-51H,8,11,16-17,21H2,1-5H3,(H2,41,47)(H,44,53)(H,45,52)/t23-,28+,32-,36+/m0/s1",QNAUPOPGMKWGCH-AQTHQPNVSA-N
3517,463,84,463,84,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,765.941,765.3420866,3.45,55,6,12,5,12,201.48,C40H47N9O5S,"InChI=1S/C40H47N9O5S/c1-23(25-12-14-26(15-13-25)35-24(2)42-22-55-35)44-38(53)32-17-28(50)21-49(32)39(54)36(40(3,4)5)45-34(52)11-8-16-48-20-27(19-43-48)30-18-31(46-47-37(30)41)29-9-6-7-10-33(29)51/h6-7,9-10,12-15,18-20,22-23,28,32,36,50-51H,8,11,16-17,21H2,1-5H3,(H2,41,47)(H,44,53)(H,45,52)/t23-,28+,32-,36+/m0/s1",QNAUPOPGMKWGCH-AQTHQPNVSA-N
3518,134,85,134,85,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,779.968,779.3577367,3.81,56,6,12,5,13,201.48,C41H49N9O5S,"InChI=1S/C41H49N9O5S/c1-24(26-13-15-27(16-14-26)36-25(2)43-23-56-36)45-39(54)33-18-29(51)22-50(33)40(55)37(41(3,4)5)46-35(53)12-8-9-17-49-21-28(20-44-49)31-19-32(47-48-38(31)42)30-10-6-7-11-34(30)52/h6-7,10-11,13-16,19-21,23-24,29,33,37,51-52H,8-9,12,17-18,22H2,1-5H3,(H2,42,48)(H,45,54)(H,46,53)/t24-,29+,33-,37+/m0/s1",ZRDNEVGTKURPRA-QSRUXFIBSA-N
3518,,,>1000,57,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,779.968,779.3577367,3.81,56,6,12,5,13,201.48,C41H49N9O5S,"InChI=1S/C41H49N9O5S/c1-24(26-13-15-27(16-14-26)36-25(2)43-23-56-36)45-39(54)33-18-29(51)22-50(33)40(55)37(41(3,4)5)46-35(53)12-8-9-17-49-21-28(20-44-49)31-19-32(47-48-38(31)42)30-10-6-7-11-34(30)52/h6-7,10-11,13-16,19-21,23-24,29,33,37,51-52H,8-9,12,17-18,22H2,1-5H3,(H2,42,48)(H,45,54)(H,46,53)/t24-,29+,33-,37+/m0/s1",ZRDNEVGTKURPRA-QSRUXFIBSA-N
3519,12,93,12,93,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,793.995,793.3733867,4.16,57,6,12,5,14,201.48,C42H51N9O5S,"InChI=1S/C42H51N9O5S/c1-25(27-14-16-28(17-15-27)37-26(2)44-24-57-37)46-40(55)34-19-30(52)23-51(34)41(56)38(42(3,4)5)47-36(54)13-7-6-10-18-50-22-29(21-45-50)32-20-33(48-49-39(32)43)31-11-8-9-12-35(31)53/h8-9,11-12,14-17,20-22,24-25,30,34,38,52-53H,6-7,10,13,18-19,23H2,1-5H3,(H2,43,49)(H,46,55)(H,47,54)/t25-,30+,34-,38+/m0/s1",NVZBZJSNIZDMHZ-IKYVMSNGSA-N
3519,,,>1000,73,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,793.995,793.3733867,4.16,57,6,12,5,14,201.48,C42H51N9O5S,"InChI=1S/C42H51N9O5S/c1-25(27-14-16-28(17-15-27)37-26(2)44-24-57-37)46-40(55)34-19-30(52)23-51(34)41(56)38(42(3,4)5)47-36(54)13-7-6-10-18-50-22-29(21-45-50)32-20-33(48-49-39(32)43)31-11-8-9-12-35(31)53/h8-9,11-12,14-17,20-22,24-25,30,34,38,52-53H,6-7,10,13,18-19,23H2,1-5H3,(H2,43,49)(H,46,55)(H,47,54)/t25-,30+,34-,38+/m0/s1",NVZBZJSNIZDMHZ-IKYVMSNGSA-N
3520,16,89,16,89,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,808.022,807.3890368,4.71,58,6,12,5,15,201.48,C43H53N9O5S,"InChI=1S/C43H53N9O5S/c1-26(28-15-17-29(18-16-28)38-27(2)45-25-58-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-8-6-7-11-19-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-12-9-10-13-36(32)54/h9-10,12-13,15-18,21-23,25-26,31,35,39,53-54H,6-8,11,14,19-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",RVGZNDYILKOBGV-SZKWLDFMSA-N
3520,212,81,212,81,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,808.022,807.3890368,4.71,58,6,12,5,15,201.48,C43H53N9O5S,"InChI=1S/C43H53N9O5S/c1-26(28-15-17-29(18-16-28)38-27(2)45-25-58-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-8-6-7-11-19-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-12-9-10-13-36(32)54/h9-10,12-13,15-18,21-23,25-26,31,35,39,53-54H,6-8,11,14,19-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",RVGZNDYILKOBGV-SZKWLDFMSA-N
3521,3,95,3,95,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,822.049,821.4046869,5.25,59,6,12,5,16,201.48,C44H55N9O5S,"InChI=1S/C44H55N9O5S/c1-27(29-16-18-30(19-17-29)39-28(2)46-26-59-39)48-42(57)36-21-32(54)25-53(36)43(58)40(44(3,4)5)49-38(56)15-9-7-6-8-12-20-52-24-31(23-47-52)34-22-35(50-51-41(34)45)33-13-10-11-14-37(33)55/h10-11,13-14,16-19,22-24,26-27,32,36,40,54-55H,6-9,12,15,20-21,25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",UAHMFJLWVDFQBK-STCARXAESA-N
3521,23,90,23,90,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,822.049,821.4046869,5.25,59,6,12,5,16,201.48,C44H55N9O5S,"InChI=1S/C44H55N9O5S/c1-27(29-16-18-30(19-17-29)39-28(2)46-26-59-39)48-42(57)36-21-32(54)25-53(36)43(58)40(44(3,4)5)49-38(56)15-9-7-6-8-12-20-52-24-31(23-47-52)34-22-35(50-51-41(34)45)33-13-10-11-14-37(33)55/h10-11,13-14,16-19,22-24,26-27,32,36,40,54-55H,6-9,12,15,20-21,25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",UAHMFJLWVDFQBK-STCARXAESA-N
3522,3,95,3,95,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,836.076,835.4203369,5.79,60,6,12,5,17,201.48,C45H57N9O5S,"InChI=1S/C45H57N9O5S/c1-28(30-17-19-31(20-18-30)40-29(2)47-27-60-40)49-43(58)37-22-33(55)26-54(37)44(59)41(45(3,4)5)50-39(57)16-10-8-6-7-9-13-21-53-25-32(24-48-53)35-23-36(51-52-42(35)46)34-14-11-12-15-38(34)56/h11-12,14-15,17-20,23-25,27-28,33,37,41,55-56H,6-10,13,16,21-22,26H2,1-5H3,(H2,46,52)(H,49,58)(H,50,57)/t28-,33+,37-,41+/m0/s1",NAAJTPJKFIVOCL-LVMPZMPGSA-N
3522,31,93,31,93,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,836.076,835.4203369,5.79,60,6,12,5,17,201.48,C45H57N9O5S,"InChI=1S/C45H57N9O5S/c1-28(30-17-19-31(20-18-30)40-29(2)47-27-60-40)49-43(58)37-22-33(55)26-54(37)44(59)41(45(3,4)5)50-39(57)16-10-8-6-7-9-13-21-53-25-32(24-48-53)35-23-36(51-52-42(35)46)34-14-11-12-15-38(34)56/h11-12,14-15,17-20,23-25,27-28,33,37,41,55-56H,6-10,13,16,21-22,26H2,1-5H3,(H2,46,52)(H,49,58)(H,50,57)/t28-,33+,37-,41+/m0/s1",NAAJTPJKFIVOCL-LVMPZMPGSA-N
3523,2,93,2,93,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,850.103,849.435987,6.33,61,6,12,5,18,201.48,C46H59N9O5S,"InChI=1S/C46H59N9O5S/c1-29(31-18-20-32(21-19-31)41-30(2)48-28-61-41)50-44(59)38-23-34(56)27-55(38)45(60)42(46(3,4)5)51-40(58)17-11-9-7-6-8-10-14-22-54-26-33(25-49-54)36-24-37(52-53-43(36)47)35-15-12-13-16-39(35)57/h12-13,15-16,18-21,24-26,28-29,34,38,42,56-57H,6-11,14,17,22-23,27H2,1-5H3,(H2,47,53)(H,50,59)(H,51,58)/t29-,34+,38-,42+/m0/s1",DOMKEVZKZDAYBX-NXUMEATPSA-N
3523,8,94,8,94,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,850.103,849.435987,6.33,61,6,12,5,18,201.48,C46H59N9O5S,"InChI=1S/C46H59N9O5S/c1-29(31-18-20-32(21-19-31)41-30(2)48-28-61-41)50-44(59)38-23-34(56)27-55(38)45(60)42(46(3,4)5)51-40(58)17-11-9-7-6-8-10-14-22-54-26-33(25-49-54)36-24-37(52-53-43(36)47)35-15-12-13-16-39(35)57/h12-13,15-16,18-21,24-26,28-29,34,38,42,56-57H,6-11,14,17,22-23,27H2,1-5H3,(H2,47,53)(H,50,59)(H,51,58)/t29-,34+,38-,42+/m0/s1",DOMKEVZKZDAYBX-NXUMEATPSA-N
3524,6,93,6,93,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,864.13,863.4516371,6.87,62,6,12,5,19,201.48,C47H61N9O5S,"InChI=1S/C47H61N9O5S/c1-30(32-19-21-33(22-20-32)42-31(2)49-29-62-42)51-45(60)39-24-35(57)28-56(39)46(61)43(47(3,4)5)52-41(59)18-12-10-8-6-7-9-11-15-23-55-27-34(26-50-55)37-25-38(53-54-44(37)48)36-16-13-14-17-40(36)58/h13-14,16-17,19-22,25-27,29-30,35,39,43,57-58H,6-12,15,18,23-24,28H2,1-5H3,(H2,48,54)(H,51,60)(H,52,59)/t30-,35+,39-,43+/m0/s1",NKSDXVLDAPUIEJ-LHSLIBFUSA-N
3524,47,87,47,87,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,864.13,863.4516371,6.87,62,6,12,5,19,201.48,C47H61N9O5S,"InChI=1S/C47H61N9O5S/c1-30(32-19-21-33(22-20-32)42-31(2)49-29-62-42)51-45(60)39-24-35(57)28-56(39)46(61)43(47(3,4)5)52-41(59)18-12-10-8-6-7-9-11-15-23-55-27-34(26-50-55)37-25-38(53-54-44(37)48)36-16-13-14-17-40(36)58/h13-14,16-17,19-22,25-27,29-30,35,39,43,57-58H,6-12,15,18,23-24,28H2,1-5H3,(H2,48,54)(H,51,60)(H,52,59)/t30-,35+,39-,43+/m0/s1",NKSDXVLDAPUIEJ-LHSLIBFUSA-N
3525,3,95,3,95,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.157,877.4672871,7.41,63,6,12,5,20,201.48,C48H63N9O5S,"InChI=1S/C48H63N9O5S/c1-31(33-20-22-34(23-21-33)43-32(2)50-30-63-43)52-46(61)40-25-36(58)29-57(40)47(62)44(48(3,4)5)53-42(60)19-13-11-9-7-6-8-10-12-16-24-56-28-35(27-51-56)38-26-39(54-55-45(38)49)37-17-14-15-18-41(37)59/h14-15,17-18,20-23,26-28,30-31,36,40,44,58-59H,6-13,16,19,24-25,29H2,1-5H3,(H2,49,55)(H,52,61)(H,53,60)/t31-,36+,40-,44+/m0/s1",VFCKFYFVFDCREF-UOKCIILFSA-N
3525,13,96,13,96,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.157,877.4672871,7.41,63,6,12,5,20,201.48,C48H63N9O5S,"InChI=1S/C48H63N9O5S/c1-31(33-20-22-34(23-21-33)43-32(2)50-30-63-43)52-46(61)40-25-36(58)29-57(40)47(62)44(48(3,4)5)53-42(60)19-13-11-9-7-6-8-10-12-16-24-56-28-35(27-51-56)38-26-39(54-55-45(38)49)37-17-14-15-18-41(37)59/h14-15,17-18,20-23,26-28,30-31,36,40,44,58-59H,6-13,16,19,24-25,29H2,1-5H3,(H2,49,55)(H,52,61)(H,53,60)/t31-,36+,40-,44+/m0/s1",VFCKFYFVFDCREF-UOKCIILFSA-N
3526,18,86,18,86,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,875.069,874.3948504,4.21,63,7,14,5,18,227.51,C46H54N10O6S,"InChI=1S/C46H54N10O6S/c1-27(2)42(40-19-28(3)54-62-40)46(61)56-25-33(57)20-38(56)45(60)51-36(30-13-15-31(16-14-30)43-29(4)49-26-63-43)22-41(59)48-17-9-5-6-10-18-55-24-32(23-50-55)35-21-37(52-53-44(35)47)34-11-7-8-12-39(34)58/h7-8,11-16,19,21,23-24,26-27,33,36,38,42,57-58H,5-6,9-10,17-18,20,22,25H2,1-4H3,(H2,47,53)(H,48,59)(H,51,60)/t33-,36+,38+,42+/m1/s1",AJYXITCISXKKRG-NRMCDFMFSA-N
3526,213,84,213,84,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,875.069,874.3948504,4.21,63,7,14,5,18,227.51,C46H54N10O6S,"InChI=1S/C46H54N10O6S/c1-27(2)42(40-19-28(3)54-62-40)46(61)56-25-33(57)20-38(56)45(60)51-36(30-13-15-31(16-14-30)43-29(4)49-26-63-43)22-41(59)48-17-9-5-6-10-18-55-24-32(23-50-55)35-21-37(52-53-44(35)47)34-11-7-8-12-39(34)58/h7-8,11-16,19,21,23-24,26-27,33,36,38,42,57-58H,5-6,9-10,17-18,20,22,25H2,1-4H3,(H2,47,53)(H,48,59)(H,51,60)/t33-,36+,38+,42+/m1/s1",AJYXITCISXKKRG-NRMCDFMFSA-N
3527,91,92,91,92,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,889.096,888.4105005,4.75,64,7,14,5,19,227.51,C47H56N10O6S,"InChI=1S/C47H56N10O6S/c1-28(2)43(41-20-29(3)55-63-41)47(62)57-26-34(58)21-39(57)46(61)52-37(31-14-16-32(17-15-31)44-30(4)50-27-64-44)23-42(60)49-18-10-6-5-7-11-19-56-25-33(24-51-56)36-22-38(53-54-45(36)48)35-12-8-9-13-40(35)59/h8-9,12-17,20,22,24-25,27-28,34,37,39,43,58-59H,5-7,10-11,18-19,21,23,26H2,1-4H3,(H2,48,54)(H,49,60)(H,52,61)/t34-,37+,39+,43+/m1/s1",DUKQQJLHIWJHMV-JTPFYNRPSA-N
3527,96,91,96,91,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,889.096,888.4105005,4.75,64,7,14,5,19,227.51,C47H56N10O6S,"InChI=1S/C47H56N10O6S/c1-28(2)43(41-20-29(3)55-63-41)47(62)57-26-34(58)21-39(57)46(61)52-37(31-14-16-32(17-15-31)44-30(4)50-27-64-44)23-42(60)49-18-10-6-5-7-11-19-56-25-33(24-51-56)36-22-38(53-54-45(36)48)35-12-8-9-13-40(35)59/h8-9,12-17,20,22,24-25,27-28,34,37,39,43,58-59H,5-7,10-11,18-19,21,23,26H2,1-4H3,(H2,48,54)(H,49,60)(H,52,61)/t34-,37+,39+,43+/m1/s1",DUKQQJLHIWJHMV-JTPFYNRPSA-N
3528,66,93,66,93,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,903.123,902.4261506,5.29,65,7,14,5,20,227.51,C48H58N10O6S,"InChI=1S/C48H58N10O6S/c1-29(2)44(42-21-30(3)56-64-42)48(63)58-27-35(59)22-40(58)47(62)53-38(32-15-17-33(18-16-32)45-31(4)51-28-65-45)24-43(61)50-19-11-7-5-6-8-12-20-57-26-34(25-52-57)37-23-39(54-55-46(37)49)36-13-9-10-14-41(36)60/h9-10,13-18,21,23,25-26,28-29,35,38,40,44,59-60H,5-8,11-12,19-20,22,24,27H2,1-4H3,(H2,49,55)(H,50,61)(H,53,62)/t35-,38+,40+,44+/m1/s1",WZAJDWUHOWVKTB-SZNIMANLSA-N
3528,67,91,67,91,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,903.123,902.4261506,5.29,65,7,14,5,20,227.51,C48H58N10O6S,"InChI=1S/C48H58N10O6S/c1-29(2)44(42-21-30(3)56-64-42)48(63)58-27-35(59)22-40(58)47(62)53-38(32-15-17-33(18-16-32)45-31(4)51-28-65-45)24-43(61)50-19-11-7-5-6-8-12-20-57-26-34(25-52-57)37-23-39(54-55-46(37)49)36-13-9-10-14-41(36)60/h9-10,13-18,21,23,25-26,28-29,35,38,40,44,59-60H,5-8,11-12,19-20,22,24,27H2,1-4H3,(H2,49,55)(H,50,61)(H,53,62)/t35-,38+,40+,44+/m1/s1",WZAJDWUHOWVKTB-SZNIMANLSA-N
3529,71,94,71,94,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,917.15,916.4418006,5.83,66,7,14,5,21,227.51,C49H60N10O6S,"InChI=1S/C49H60N10O6S/c1-30(2)45(43-22-31(3)57-65-43)49(64)59-28-36(60)23-41(59)48(63)54-39(33-16-18-34(19-17-33)46-32(4)52-29-66-46)25-44(62)51-20-12-8-6-5-7-9-13-21-58-27-35(26-53-58)38-24-40(55-56-47(38)50)37-14-10-11-15-42(37)61/h10-11,14-19,22,24,26-27,29-30,36,39,41,45,60-61H,5-9,12-13,20-21,23,25,28H2,1-4H3,(H2,50,56)(H,51,62)(H,54,63)/t36-,39+,41+,45+/m1/s1",OLNHVDRHEGVZMV-YOKDRVLNSA-N
3529,75,94,75,94,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,917.15,916.4418006,5.83,66,7,14,5,21,227.51,C49H60N10O6S,"InChI=1S/C49H60N10O6S/c1-30(2)45(43-22-31(3)57-65-43)49(64)59-28-36(60)23-41(59)48(63)54-39(33-16-18-34(19-17-33)46-32(4)52-29-66-46)25-44(62)51-20-12-8-6-5-7-9-13-21-58-27-35(26-53-58)38-24-40(55-56-47(38)50)37-14-10-11-15-42(37)61/h10-11,14-19,22,24,26-27,29-30,36,39,41,45,60-61H,5-9,12-13,20-21,23,25,28H2,1-4H3,(H2,50,56)(H,51,62)(H,54,63)/t36-,39+,41+,45+/m1/s1",OLNHVDRHEGVZMV-YOKDRVLNSA-N
3530,37,95,37,95,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,931.177,930.4574507,6.37,67,7,14,5,22,227.51,C50H62N10O6S,"InChI=1S/C50H62N10O6S/c1-31(2)46(44-23-32(3)58-66-44)50(65)60-29-37(61)24-42(60)49(64)55-40(34-17-19-35(20-18-34)47-33(4)53-30-67-47)26-45(63)52-21-13-9-7-5-6-8-10-14-22-59-28-36(27-54-59)39-25-41(56-57-48(39)51)38-15-11-12-16-43(38)62/h11-12,15-20,23,25,27-28,30-31,37,40,42,46,61-62H,5-10,13-14,21-22,24,26,29H2,1-4H3,(H2,51,57)(H,52,63)(H,55,64)/t37-,40+,42+,46+/m1/s1",MZJPOLYUIZRRPP-REZXPVIVSA-N
3530,53,93,53,93,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,931.177,930.4574507,6.37,67,7,14,5,22,227.51,C50H62N10O6S,"InChI=1S/C50H62N10O6S/c1-31(2)46(44-23-32(3)58-66-44)50(65)60-29-37(61)24-42(60)49(64)55-40(34-17-19-35(20-18-34)47-33(4)53-30-67-47)26-45(63)52-21-13-9-7-5-6-8-10-14-22-59-28-36(27-54-59)39-25-41(56-57-48(39)51)38-15-11-12-16-43(38)62/h11-12,15-20,23,25,27-28,30-31,37,40,42,46,61-62H,5-10,13-14,21-22,24,26,29H2,1-4H3,(H2,51,57)(H,52,63)(H,55,64)/t37-,40+,42+,46+/m1/s1",MZJPOLYUIZRRPP-REZXPVIVSA-N
3531,46,93,46,93,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,959.231,958.4887508,7.46,69,7,14,5,24,227.51,C52H66N10O6S,"InChI=1S/C52H66N10O6S/c1-33(2)48(46-25-34(3)60-68-46)52(67)62-31-39(63)26-44(62)51(66)57-42(36-19-21-37(22-20-36)49-35(4)55-32-69-49)28-47(65)54-23-15-11-9-7-5-6-8-10-12-16-24-61-30-38(29-56-61)41-27-43(58-59-50(41)53)40-17-13-14-18-45(40)64/h13-14,17-22,25,27,29-30,32-33,39,42,44,48,63-64H,5-12,15-16,23-24,26,28,31H2,1-4H3,(H2,53,59)(H,54,65)(H,57,66)/t39-,42+,44+,48+/m1/s1",MLZVIASYUVCSEA-XOZNCJPQSA-N
3531,90,89,90,89,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,959.231,958.4887508,7.46,69,7,14,5,24,227.51,C52H66N10O6S,"InChI=1S/C52H66N10O6S/c1-33(2)48(46-25-34(3)60-68-46)52(67)62-31-39(63)26-44(62)51(66)57-42(36-19-21-37(22-20-36)49-35(4)55-32-69-49)28-47(65)54-23-15-11-9-7-5-6-8-10-12-16-24-61-30-38(29-56-61)41-27-43(58-59-50(41)53)40-17-13-14-18-45(40)64/h13-14,17-22,25,27,29-30,32-33,39,42,44,48,63-64H,5-12,15-16,23-24,26,28,31H2,1-4H3,(H2,53,59)(H,54,65)(H,57,66)/t39-,42+,44+,48+/m1/s1",MLZVIASYUVCSEA-XOZNCJPQSA-N
3532,455,70.5,455,70.5,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,870.046,869.3894307,2.75,62,6,15,5,19,229.17,C44H55N9O8S,"InChI=1S/C44H55N9O8S/c1-27(29-10-12-30(13-11-29)39-28(2)46-26-62-39)48-42(57)36-20-32(54)24-53(36)43(58)40(44(3,4)5)49-38(56)25-61-19-18-60-17-16-59-15-14-52-23-31(22-47-52)34-21-35(50-51-41(34)45)33-8-6-7-9-37(33)55/h6-13,21-23,26-27,32,36,40,54-55H,14-20,24-25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",AKBJWICECZPIMD-STCARXAESA-N
3532,,,>1000,46.5,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,870.046,869.3894307,2.75,62,6,15,5,19,229.17,C44H55N9O8S,"InChI=1S/C44H55N9O8S/c1-27(29-10-12-30(13-11-29)39-28(2)46-26-62-39)48-42(57)36-20-32(54)24-53(36)43(58)40(44(3,4)5)49-38(56)25-61-19-18-60-17-16-59-15-14-52-23-31(22-47-52)34-21-35(50-51-41(34)45)33-8-6-7-9-37(33)55/h6-13,21-23,26-27,32,36,40,54-55H,14-20,24-25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",AKBJWICECZPIMD-STCARXAESA-N
3533,313,76.5,313,76.5,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,840.02,839.378866,2.8,60,6,14,5,17,219.94,C43H53N9O7S,"InChI=1S/C43H53N9O7S/c1-26(28-10-12-29(13-11-28)38-27(2)45-25-60-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-16-58-18-19-59-17-15-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-8-6-7-9-36(32)54/h6-13,21-23,25-26,31,35,39,53-54H,14-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",HSTRRNDJSXXGTP-SZKWLDFMSA-N
3533,,,>1000,58.5,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,840.02,839.378866,2.8,60,6,14,5,17,219.94,C43H53N9O7S,"InChI=1S/C43H53N9O7S/c1-26(28-10-12-29(13-11-28)38-27(2)45-25-60-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-16-58-18-19-59-17-15-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-8-6-7-9-36(32)54/h6-13,21-23,25-26,31,35,39,53-54H,14-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",HSTRRNDJSXXGTP-SZKWLDFMSA-N
3534,585,76,585,76,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCN(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.117,877.442135,3.3,63,7,14,5,15,207.96,C46H59N11O5S,"InChI=1S/C46H59N11O5S/c1-29(31-11-13-32(14-12-31)41-30(2)48-28-63-41)50-44(61)38-23-34(58)27-57(38)45(62)42(46(3,4)5)51-40(60)15-18-55-21-19-54(20-22-55)16-8-17-56-26-33(25-49-56)36-24-37(52-53-43(36)47)35-9-6-7-10-39(35)59/h6-7,9-14,24-26,28-29,34,38,42,58-59H,8,15-23,27H2,1-5H3,(H2,47,53)(H,50,61)(H,51,60)/t29-,34+,38-,42+/m0/s1",PTCYFAOYSKJZCC-NXUMEATPSA-N
3534,682,62,682,62,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCN(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.117,877.442135,3.3,63,7,14,5,15,207.96,C46H59N11O5S,"InChI=1S/C46H59N11O5S/c1-29(31-11-13-32(14-12-31)41-30(2)48-28-63-41)50-44(61)38-23-34(58)27-57(38)45(62)42(46(3,4)5)51-40(60)15-18-55-21-19-54(20-22-55)16-8-17-56-26-33(25-49-56)36-24-37(52-53-43(36)47)35-9-6-7-10-39(35)59/h6-7,9-14,24-26,28-29,34,38,42,58-59H,8,15-23,27H2,1-5H3,(H2,47,53)(H,50,61)(H,51,60)/t29-,34+,38-,42+/m0/s1",PTCYFAOYSKJZCC-NXUMEATPSA-N
3535,,,>1000,12,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCC(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.59,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(32-12-14-33(15-13-32)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-57(39)46(62)43(47(3,4)5)52-41(60)18-22-55-20-16-31(17-21-55)9-8-19-56-26-34(25-50-56)37-24-38(53-54-44(37)48)36-10-6-7-11-40(36)59/h6-7,10-15,24-26,28-29,31,35,39,43,58-59H,8-9,16-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",UUUQRHRNYAGRFZ-UWCRVIMOSA-N
3535,,,>1000,0,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCC(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.59,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(32-12-14-33(15-13-32)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-57(39)46(62)43(47(3,4)5)52-41(60)18-22-55-20-16-31(17-21-55)9-8-19-56-26-34(25-50-56)37-24-38(53-54-44(37)48)36-10-6-7-11-40(36)59/h6-7,10-15,24-26,28-29,31,35,39,43,58-59H,8-9,16-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",UUUQRHRNYAGRFZ-UWCRVIMOSA-N
3536,6,94,6,94,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCC(N4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.73,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(31-14-16-32(17-15-31)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-56(39)46(62)43(47(3,4)5)52-41(60)13-7-6-10-20-55-21-18-34(19-22-55)57-26-33(25-50-57)37-24-38(53-54-44(37)48)36-11-8-9-12-40(36)59/h8-9,11-12,14-17,24-26,28-29,34-35,39,43,58-59H,6-7,10,13,18-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",ONPKOOOYNSWZGQ-UWCRVIMOSA-N
3536,248,77,248,77,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCC(N4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.73,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(31-14-16-32(17-15-31)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-56(39)46(62)43(47(3,4)5)52-41(60)13-7-6-10-20-55-21-18-34(19-22-55)57-26-33(25-50-57)37-24-38(53-54-44(37)48)36-11-8-9-12-40(36)59/h8-9,11-12,14-17,24-26,28-29,34-35,39,43,58-59H,6-7,10,13,18-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",ONPKOOOYNSWZGQ-UWCRVIMOSA-N
3537,12,91,12/35/20/63,91/98/94/90,P51531,SMARCA2,VHL,,SMD-3040,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay/in SK-Mel-28 cells for 24h/in SK-Mel-5 cells for 24h/in H838 cells for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,943.232,942.4938362,5.75,68,9,13,5,12,204.72,C52H66N10O5S,"InChI=1S/C52H66N10O5S/c1-31(34-14-16-35(17-15-34)45-32(2)54-30-68-45)56-49(66)43-22-39(63)27-61(43)50(67)46(51(3,4)5)57-48(65)36-12-10-33(11-13-36)25-60-28-52(29-60)20-18-38(19-21-52)62-26-37(24-55-62)41-23-42(58-59-47(41)53)40-8-6-7-9-44(40)64/h6-9,14-17,23-24,26,30-31,33,36,38-39,43,46,63-64H,10-13,18-22,25,27-29H2,1-5H3,(H2,53,59)(H,56,66)(H,57,65)/t31-,33-,36-,39+,43-,46+/m0/s1",GMCWCUOAGNWNLO-YTZIVEPUSA-N
3537,,,>1000/>1000,44/24,P51532,SMARCA4,VHL,,SMD-3040,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay/in SK-Mel-28 cells for 24h ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,943.232,942.4938362,5.75,68,9,13,5,12,204.72,C52H66N10O5S,"InChI=1S/C52H66N10O5S/c1-31(34-14-16-35(17-15-34)45-32(2)54-30-68-45)56-49(66)43-22-39(63)27-61(43)50(67)46(51(3,4)5)57-48(65)36-12-10-33(11-13-36)25-60-28-52(29-60)20-18-38(19-21-52)62-26-37(24-55-62)41-23-42(58-59-47(41)53)40-8-6-7-9-44(40)64/h6-9,14-17,23-24,26,30-31,33,36,38-39,43,46,63-64H,10-13,18-22,25,27-29H2,1-5H3,(H2,53,59)(H,56,66)(H,57,65)/t31-,33-,36-,39+,43-,46+/m0/s1",GMCWCUOAGNWNLO-YTZIVEPUSA-N
3538,5,90,5,90,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,971.286,970.5251363,6.47,70,9,13,5,12,204.72,C54H70N10O5S,"InChI=1S/C54H70N10O5S/c1-33(36-14-16-37(17-15-36)47-34(2)56-32-70-47)58-51(68)45-26-41(65)31-63(45)52(69)48(53(3,4)5)59-50(67)38-12-10-35(11-13-38)29-62-24-22-54(23-25-62)20-18-40(19-21-54)64-30-39(28-57-64)43-27-44(60-61-49(43)55)42-8-6-7-9-46(42)66/h6-9,14-17,27-28,30,32-33,35,38,40-41,45,48,65-66H,10-13,18-26,29,31H2,1-5H3,(H2,55,61)(H,58,68)(H,59,67)/t33-,35-,38-,41+,45-,48+/m0/s1",UVAFNIDORKJQQG-VZZHBTBASA-N
3538,219,66,219,66,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,971.286,970.5251363,6.47,70,9,13,5,12,204.72,C54H70N10O5S,"InChI=1S/C54H70N10O5S/c1-33(36-14-16-37(17-15-36)47-34(2)56-32-70-47)58-51(68)45-26-41(65)31-63(45)52(69)48(53(3,4)5)59-50(67)38-12-10-35(11-13-38)29-62-24-22-54(23-25-62)20-18-40(19-21-54)64-30-39(28-57-64)43-27-44(60-61-49(43)55)42-8-6-7-9-46(42)66/h6-9,14-17,27-28,30,32-33,35,38,40-41,45,48,65-66H,10-13,18-26,29,31H2,1-5H3,(H2,55,61)(H,58,68)(H,59,67)/t33-,35-,38-,41+,45-,48+/m0/s1",UVAFNIDORKJQQG-VZZHBTBASA-N
3539,25,85,25,85,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,929.205,928.4781861,5.56,67,9,13,5,11,204.72,C51H64N10O5S,"InChI=1S/C51H64N10O5S/c1-30(32-10-12-33(13-11-32)44-31(2)53-29-67-44)55-48(65)42-22-38(62)26-60(42)49(66)45(50(3,4)5)56-47(64)34-14-16-36(17-15-34)59-27-51(28-59)20-18-37(19-21-51)61-25-35(24-54-61)40-23-41(57-58-46(40)52)39-8-6-7-9-43(39)63/h6-13,23-25,29-30,34,36-38,42,45,62-63H,14-22,26-28H2,1-5H3,(H2,52,58)(H,55,65)(H,56,64)/t30-,34?,36?,38+,42-,45+/m0/s1",MXFZXZUWICUBOI-VVBCONDBSA-N
3539,,,>1000,55,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,929.205,928.4781861,5.56,67,9,13,5,11,204.72,C51H64N10O5S,"InChI=1S/C51H64N10O5S/c1-30(32-10-12-33(13-11-32)44-31(2)53-29-67-44)55-48(65)42-22-38(62)26-60(42)49(66)45(50(3,4)5)56-47(64)34-14-16-36(17-15-34)59-27-51(28-59)20-18-37(19-21-51)61-25-35(24-54-61)40-23-41(57-58-46(40)52)39-8-6-7-9-43(39)63/h6-13,23-25,29-30,34,36-38,42,45,62-63H,14-22,26-28H2,1-5H3,(H2,52,58)(H,55,65)(H,56,64)/t30-,34?,36?,38+,42-,45+/m0/s1",MXFZXZUWICUBOI-VVBCONDBSA-N
3540,34,90,34,90,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,957.259,956.5094863,6.27,69,9,13,5,11,204.72,C53H68N10O5S,"InChI=1S/C53H68N10O5S/c1-32(34-10-12-35(13-11-34)46-33(2)55-31-69-46)57-50(67)44-26-40(64)30-62(44)51(68)47(52(3,4)5)58-49(66)36-14-16-38(17-15-36)61-24-22-53(23-25-61)20-18-39(19-21-53)63-29-37(28-56-63)42-27-43(59-60-48(42)54)41-8-6-7-9-45(41)65/h6-13,27-29,31-32,36,38-40,44,47,64-65H,14-26,30H2,1-5H3,(H2,54,60)(H,57,67)(H,58,66)/t32-,36?,38?,40+,44-,47+/m0/s1",GEFVFURTMGEFHQ-FIHKADGOSA-N
3540,315,72,315,72,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,957.259,956.5094863,6.27,69,9,13,5,11,204.72,C53H68N10O5S,"InChI=1S/C53H68N10O5S/c1-32(34-10-12-35(13-11-34)46-33(2)55-31-69-46)57-50(67)44-26-40(64)30-62(44)51(68)47(52(3,4)5)58-49(66)36-14-16-38(17-15-36)61-24-22-53(23-25-61)20-18-39(19-21-53)63-29-37(28-56-63)42-27-43(59-60-48(42)54)41-8-6-7-9-45(41)65/h6-13,27-29,31-32,36,38-40,44,47,64-65H,14-26,30H2,1-5H3,(H2,54,60)(H,57,67)(H,58,66)/t32-,36?,38?,40+,44-,47+/m0/s1",GEFVFURTMGEFHQ-FIHKADGOSA-N
3553,51.1,97.75,51.1,97.75,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CC2=CC=C(C#CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)N=C2)CC1,Degradation of BTK in Ramos cells after 24 h treatment,62.68,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,840.945,840.3496145,4.94,63,10,13,2,8,181.77,C48H44N10O5,"InChI=1S/C48H44N10O5/c49-44-42-43(32-8-13-37(14-9-32)63-36-4-2-1-3-5-36)54-58(45(42)52-29-51-44)34-20-22-55(23-21-34)28-31-7-11-33(50-27-31)10-6-30-18-24-56(25-19-30)35-12-15-38-39(26-35)48(62)57(47(38)61)40-16-17-41(59)53-46(40)60/h1-5,7-9,11-15,26-27,29-30,34,40H,16-25,28H2,(H2,49,51,52)(H,53,59,60)",XMWSKICAFPPYSY-UHFFFAOYSA-N
3554,26.87,97.78,26.87,97.78,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)C2=CC=C(N3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)N=C2)CC1,Degradation of BTK in Ramos cells after 24 h treatment,71.7,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,831.894,831.324128,3.82,62,10,14,2,8,202.08,C45H41N11O6,"InChI=1S/C45H41N11O6/c46-40-38-39(27-6-10-32(11-7-27)62-31-4-2-1-3-5-31)51-56(41(38)49-26-48-40)29-16-18-54(19-17-29)43(59)28-8-14-36(47-25-28)53-22-20-52(21-23-53)30-9-12-33-34(24-30)45(61)55(44(33)60)35-13-15-37(57)50-42(35)58/h1-12,14,24-26,29,35H,13,15-23H2,(H2,46,48,49)(H,50,57,58)",JNESGEBHIQTVTD-UHFFFAOYSA-N
3555,2.93,99.73,6.11/2.93,99.73/99.73,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)CC1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,99.68,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,865.996,865.4023784,3.63,64,10,14,2,10,192.43,C47H51N11O6,"InChI=1S/C47H51N11O6/c48-43-41-42(31-6-9-35(10-7-31)64-34-4-2-1-3-5-34)52-58(44(41)50-29-49-43)32-16-20-56(21-17-32)40(60)28-54-24-22-53(23-25-54)27-30-14-18-55(19-15-30)33-8-11-36-37(26-33)47(63)57(46(36)62)38-12-13-39(59)51-45(38)61/h1-11,26,29-30,32,38H,12-25,27-28H2,(H2,48,49,50)(H,51,59,61)",LFNMIAGMJGUCIW-UHFFFAOYSA-N
3556,3.18,99.9,3.18/7.07,99.9/99.99,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)CC1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,99.42,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,837.942,837.3710782,2.91,62,10,14,2,10,192.43,C45H47N11O6,"InChI=1S/C45H47N11O6/c46-41-39-40(29-6-9-33(10-7-29)62-32-4-2-1-3-5-32)50-56(42(39)48-27-47-41)30-14-16-53(17-15-30)38(58)26-52-20-18-51(19-21-52)23-28-24-54(25-28)31-8-11-34-35(22-31)45(61)55(44(34)60)36-12-13-37(57)49-43(36)59/h1-11,22,27-28,30,36H,12-21,23-26H2,(H2,46,47,48)(H,49,57,59)",SPGWKNITNYHIGX-UHFFFAOYSA-N
3558,9.37,99.36,9.37/10.34 ,99.36/99.51,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)CC1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,90.96,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,865.996,865.4023784,3.63,64,10,14,2,10,192.43,C47H51N11O6,"InChI=1S/C47H51N11O6/c48-43-41-42(31-9-11-34(12-10-31)64-33-5-2-1-3-6-33)52-58(44(41)50-29-49-43)32-17-21-56(22-18-32)39(60)28-54-25-23-53(24-26-54)27-30-15-19-55(20-16-30)36-8-4-7-35-40(36)47(63)57(46(35)62)37-13-14-38(59)51-45(37)61/h1-12,29-30,32,37H,13-28H2,(H2,48,49,50)(H,51,59,61)",FCQYWOVXHUEFAG-UHFFFAOYSA-N
3559,7.27,97.56,7.27/9.06,97.56/99.70,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)CC1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,67.51,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,837.942,837.3710782,2.91,62,10,14,2,10,192.43,C45H47N11O6,"InChI=1S/C45H47N11O6/c46-41-39-40(29-9-11-32(12-10-29)62-31-5-2-1-3-6-31)50-56(42(39)48-27-47-41)30-15-17-53(18-16-30)37(58)26-52-21-19-51(20-22-52)23-28-24-54(25-28)34-8-4-7-33-38(34)45(61)55(44(33)60)35-13-14-36(57)49-43(35)59/h1-12,27-28,30,35H,13-26H2,(H2,46,47,48)(H,49,57,59)",BZECJEIHNUUQGB-UHFFFAOYSA-N
3562,46.1,95.01,46.1,95.01,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CC2=CC=C(C#CC3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)N=C2)CC1,Degradation of BTK in Ramos cells after 24 h treatment,58.57,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,840.945,840.3496145,4.94,63,10,13,2,8,181.77,C48H44N10O5,"InChI=1S/C48H44N10O5/c49-44-42-43(32-11-15-36(16-12-32)63-35-5-2-1-3-6-35)54-58(45(42)52-29-51-44)34-21-23-55(24-22-34)28-31-10-14-33(50-27-31)13-9-30-19-25-56(26-20-30)38-8-4-7-37-41(38)48(62)57(47(37)61)39-17-18-40(59)53-46(39)60/h1-8,10-12,14-16,27,29-30,34,39H,17-26,28H2,(H2,49,51,52)(H,53,59,60)",QSCOJWKWSHBBPQ-UHFFFAOYSA-N
3565,3.46,84.47,3.46,84.47,Q9UBN7,HDAC6,CRBN,,,O=C(CCCCCCNC(=O)C1=CC=C(NC(=O)CCCCCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1)NO,Degradation of HDAC6 in HL-60 cells after 6h treatment,,,4.86,Inhibit of HDAC6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31170/17550/24460,Inhibition of cell proliferation of MV4-11/Molm-13/SKNO-1 cells,400,dose-dependent alpha-tubulin hyperacetylation,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01659,734.807,734.3275417,2.05,53,4,10,6,21,229.41,C37H46N6O10,"InChI=1S/C37H46N6O10/c44-29(40-25-17-15-24(16-18-25)34(48)39-22-9-5-3-7-14-31(46)42-52)13-6-2-1-4-8-21-38-32(47)23-53-28-12-10-11-26-33(28)37(51)43(36(26)50)27-19-20-30(45)41-35(27)49/h10-12,15-18,27,52H,1-9,13-14,19-23H2,(H,38,47)(H,39,48)(H,40,44)(H,42,46)(H,41,45,49)",FQLCLMHMOFLVSV-UHFFFAOYSA-N
3566,130,67.5,130,67.5,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCN4C=C(CCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,240/1290/500,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,847.761,846.2771491,4.41,59,7,12,4,17,213.61,C40H44Cl2N10O7,"InChI=1S/C40H44Cl2N10O7/c41-27-10-7-11-28(42)34(27)37(55)45-29-22-43-48-35(29)38(56)44-24-15-19-50(20-16-24)17-4-2-8-25-23-51(49-47-25)18-3-1-5-21-59-31-12-6-9-26-33(31)40(58)52(39(26)57)30-13-14-32(53)46-36(30)54/h6-7,9-12,22-24,30H,1-5,8,13-21H2,(H,43,48)(H,44,56)(H,45,55)(H,46,53,54)",WQYDJYODLBQPRD-UHFFFAOYSA-N
3567,70,79.1,70,79.1,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,190/720/500,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,833.734,832.261499,4.05,58,7,12,4,16,213.61,C39H42Cl2N10O7,"InChI=1S/C39H42Cl2N10O7/c40-26-9-6-10-27(41)33(26)36(54)44-28-21-42-47-34(28)37(55)43-23-14-18-49(19-15-23)16-2-1-7-24-22-50(48-46-24)17-3-4-20-58-30-11-5-8-25-32(30)39(57)51(38(25)56)29-12-13-31(52)45-35(29)53/h5-6,8-11,21-23,29H,1-4,7,12-20H2,(H,42,47)(H,43,55)(H,44,54)(H,45,52,53)",RWZUENRHOXLKRD-UHFFFAOYSA-N
3568,400,58.6,400,58.6,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,190/690/400,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,847.761,846.2771491,4.41,59,7,12,4,17,213.61,C40H44Cl2N10O7,"InChI=1S/C40H44Cl2N10O7/c41-27-10-7-11-28(42)34(27)37(55)45-29-22-43-48-35(29)38(56)44-24-15-19-50(20-16-24)17-3-1-2-8-25-23-51(49-47-25)18-4-5-21-59-31-12-6-9-26-33(31)40(58)52(39(26)57)30-13-14-32(53)46-36(30)54/h6-7,9-12,22-24,30H,1-5,8,13-21H2,(H,43,48)(H,44,56)(H,45,55)(H,46,53,54)",IFGRJEDDLDJVFO-UHFFFAOYSA-N
3569,60,88.3,60,88.3,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCCN4C=C(CCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50/250/100,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,861.788,860.2927992,5.13,60,7,12,4,18,213.61,C41H46Cl2N10O7,"InChI=1S/C41H46Cl2N10O7/c42-28-10-8-11-29(43)35(28)38(56)46-30-23-44-49-36(30)39(57)45-25-15-19-51(20-16-25)21-17-26-24-52(50-48-26)18-5-3-1-2-4-6-22-60-32-12-7-9-27-34(32)41(59)53(40(27)58)31-13-14-33(54)47-37(31)55/h7-12,23-25,31H,1-6,13-22H2,(H,44,49)(H,45,57)(H,46,56)(H,47,54,55)",KQYIIOGMBKKCCZ-UHFFFAOYSA-N
3570,950,68.5,950,68.5,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCN4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,130/450/260,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,861.788,860.2927992,4.77,60,7,12,4,18,213.61,C41H46Cl2N10O7,"InChI=1S/C41H46Cl2N10O7/c42-28-11-8-12-29(43)35(28)38(56)46-30-23-44-49-36(30)39(57)45-25-16-20-51(21-17-25)18-4-1-3-9-26-24-52(50-48-26)19-5-2-6-22-60-32-13-7-10-27-34(32)41(59)53(40(27)58)31-14-15-33(54)47-37(31)55/h7-8,10-13,23-25,31H,1-6,9,14-22H2,(H,44,49)(H,45,57)(H,46,56)(H,47,54,55)",RVWBTXSGZFJYEH-UHFFFAOYSA-N
3571,100,75.3,100,75.3,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70/260/120,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,861.788,860.2927992,4.95,60,7,12,4,18,213.61,C41H46Cl2N10O7,"InChI=1S/C41H46Cl2N10O7/c42-28-11-8-12-29(43)35(28)38(56)46-30-23-44-49-36(30)39(57)45-25-16-20-51(21-17-25)18-4-2-1-3-9-26-24-52(50-48-26)19-5-6-22-60-32-13-7-10-27-34(32)41(59)53(40(27)58)31-14-15-33(54)47-37(31)55/h7-8,10-13,23-25,31H,1-6,9,14-22H2,(H,44,49)(H,45,57)(H,46,56)(H,47,54,55)",ZIUVTWBLWUJBEY-UHFFFAOYSA-N
3572,70,86.2,70,86.2,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCCN4C=C(CCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70/340/230,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,917.896,916.3553994,6.75,64,7,12,4,22,213.61,C45H54Cl2N10O7,"InChI=1S/C45H54Cl2N10O7/c46-32-15-12-16-33(47)39(32)42(60)50-34-27-48-53-40(34)43(61)49-29-20-24-55(25-21-29)22-8-5-3-7-13-30-28-56(54-52-30)23-9-4-1-2-6-10-26-64-36-17-11-14-31-38(36)45(63)57(44(31)62)35-18-19-37(58)51-41(35)59/h11-12,14-17,27-29,35H,1-10,13,18-26H2,(H,48,53)(H,49,61)(H,50,60)(H,51,58,59)",RFWQGGOBVSJKDT-UHFFFAOYSA-N
3573,60,78,60,78,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCN4C=C(CCCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60/110/90,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,917.896,916.3553994,6.75,64,7,12,4,22,213.61,C45H54Cl2N10O7,"InChI=1S/C45H54Cl2N10O7/c46-32-15-12-16-33(47)39(32)42(60)50-34-27-48-53-40(34)43(61)49-29-20-24-55(25-21-29)22-8-4-1-3-7-13-30-28-56(54-52-30)23-9-5-2-6-10-26-64-36-17-11-14-31-38(36)45(63)57(44(31)62)35-18-19-37(58)51-41(35)59/h11-12,14-17,27-29,35H,1-10,13,18-26H2,(H,48,53)(H,49,61)(H,50,60)(H,51,58,59)",UJUPYASGRVZCKP-UHFFFAOYSA-N
3574,40,88.6,40,88.6,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCCCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/20/20,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,917.896,916.3553994,7.12,64,7,12,4,22,213.61,C45H54Cl2N10O7,"InChI=1S/C45H54Cl2N10O7/c46-32-15-12-16-33(47)39(32)42(60)50-34-27-48-53-40(34)43(61)49-29-20-24-55(25-21-29)22-8-6-4-2-1-3-5-7-13-30-28-56(54-52-30)23-9-10-26-64-36-17-11-14-31-38(36)45(63)57(44(31)62)35-18-19-37(58)51-41(35)59/h11-12,14-17,27-29,35H,1-10,13,18-26H2,(H,48,53)(H,49,61)(H,50,60)(H,51,58,59)",CSNPVEIUSQQSBW-UHFFFAOYSA-N
3575,100,70.1,100,70.1,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCN4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50/80/80,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,889.842,888.3240993,5.66,62,7,12,4,20,213.61,C43H50Cl2N10O7,"InChI=1S/C43H50Cl2N10O7/c44-30-13-10-14-31(45)37(30)40(58)48-32-25-46-51-38(32)41(59)47-27-18-22-53(23-19-27)20-6-4-5-11-28-26-54(52-50-28)21-7-2-1-3-8-24-62-34-15-9-12-29-36(34)43(61)55(42(29)60)33-16-17-35(56)49-39(33)57/h9-10,12-15,25-27,33H,1-8,11,16-24H2,(H,46,51)(H,47,59)(H,48,58)(H,49,56,57)",VUUHHNWFNGGVNN-UHFFFAOYSA-N
3578,220,99,220,,P40337,VHL,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C3=CN(CCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C(=O)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of pVHL30 in HeLa cells after 12 h treatment,94/78,% pVHL30 degradation in HeLa cells after 12 h treatment at 10000 nM/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300392,1343.634,1342.597769,2.73,94,7,21,7,35,329.74,C66H90N10O16S2,"InChI=1S/C66H90N10O16S2/c1-42-56(93-40-70-42)46-13-9-44(10-14-46)33-68-61(83)51-31-49(77)36-75(51)63(85)58(65(3,4)5)72-53(79)38-91-29-27-89-25-23-87-21-19-67-60(82)48-17-18-55(81)74(35-48)20-22-88-24-26-90-28-30-92-39-54(80)73-59(66(6,7)8)64(86)76-37-50(78)32-52(76)62(84)69-34-45-11-15-47(16-12-45)57-43(2)71-41-94-57/h9-18,35,40-41,49-52,58-59,77-78H,19-34,36-39H2,1-8H3,(H,67,82)(H,68,83)(H,69,84)(H,72,79)(H,73,80)/t49-,50-,51+,52+,58-,59-/m1/s1",XBNTYTKCXWVQLE-LYKLQHLJSA-N
3603,28,98,28,98,P51531,SMARCA2,VHL,8G1Q,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3520000,0.017,41.5,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.005,818.3686357,4.23,59,7,13,5,10,203.03,C43H50N10O5S,"InChI=1S/C43H50N10O5S/c1-25(27-10-12-28(13-11-27)37-26(2)46-24-59-37)47-41(57)34-21-30(54)23-53(34)42(58)38(43(3,4)5)48-40(56)29-14-15-45-36(20-29)52-18-16-51(17-19-52)33-22-32(49-50-39(33)44)31-8-6-7-9-35(31)55/h6-15,20,22,24-25,30,34,38,54-55H,16-19,21,23H2,1-5H3,(H2,44,50)(H,47,57)(H,48,56)/t25-,30+,34-,38+/m0/s1",UTVJRQFHWBOCCR-IKYVMSNGSA-N
3604,95,95,95,95,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,870000,0.031,24.3,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.005,818.3686357,4.56,59,7,13,5,10,203.03,C43H50N10O5S,"InChI=1S/C43H50N10O5S/c1-25(27-13-15-28(16-14-27)37-26(2)45-24-59-37)46-41(57)34-21-29(54)23-53(34)42(58)38(43(3,4)5)48-40(56)31-10-8-12-36(47-31)52-19-17-51(18-20-52)33-22-32(49-50-39(33)44)30-9-6-7-11-35(30)55/h6-16,22,24-25,29,34,38,54-55H,17-21,23H2,1-5H3,(H2,44,50)(H,46,57)(H,48,56)/t25-,29+,34-,38+/m0/s1",CPUGPFMQNPPUFH-XYOATWAASA-N
3605,,,>10000,N.D.,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=C(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)N=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N.D.,N.D.,2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.005,818.3686357,4.23,59,7,13,5,10,203.03,C43H50N10O5S,"InChI=1S/C43H50N10O5S/c1-25(27-10-12-28(13-11-27)37-26(2)46-24-59-37)47-41(57)34-20-30(54)23-53(34)42(58)38(43(3,4)5)48-40(56)29-14-15-36(45-22-29)52-18-16-51(17-19-52)33-21-32(49-50-39(33)44)31-8-6-7-9-35(31)55/h6-15,21-22,24-25,30,34,38,54-55H,16-20,23H2,1-5H3,(H2,44,50)(H,47,57)(H,48,56)/t25-,30+,34-,38+/m0/s1",LYDAUMKICSLYRP-IKYVMSNGSA-N
3606,99,96,99,96,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,590000,0.039,18.1,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,818.017,817.3733867,4.97,59,7,12,5,10,190.14,C44H51N9O5S,"InChI=1S/C44H51N9O5S/c1-26(28-13-15-29(16-14-28)38-27(2)46-25-59-38)47-42(57)36-22-32(54)24-53(36)43(58)39(44(3,4)5)48-41(56)30-9-8-10-31(21-30)51-17-19-52(20-18-51)35-23-34(49-50-40(35)45)33-11-6-7-12-37(33)55/h6-16,21,23,25-26,32,36,39,54-55H,17-20,22,24H2,1-5H3,(H2,45,50)(H,47,57)(H,48,56)/t26-,32+,36-,39+/m0/s1",VJSRTKOZKJSNOV-ZNWVETRHSA-N
3607,112,96,112,96,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CSC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2070000,0.09,7.4,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,825.034,824.3250566,4.66,58,7,14,5,10,203.03,C41H48N10O5S2,"InChI=1S/C41H48N10O5S2/c1-23(25-10-12-26(13-11-25)34-24(2)43-22-58-34)44-38(55)32-18-27(52)20-51(32)39(56)35(41(3,4)5)46-37(54)30-21-57-40(45-30)50-16-14-49(15-17-50)31-19-29(47-48-36(31)42)28-8-6-7-9-33(28)53/h6-13,19,21-23,27,32,35,52-53H,14-18,20H2,1-5H3,(H2,42,48)(H,44,55)(H,46,54)/t23-,27+,32-,35+/m0/s1",QSIFVPKHIDVWQB-OFGFXWDRSA-N
3608,850,55,850,55,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CC3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2170000,0.19,3.6,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,833.032,832.3842858,4.17,60,7,13,5,11,203.03,C44H52N10O5S,"InChI=1S/C44H52N10O5S/c1-26(29-10-12-30(13-11-29)39-27(2)47-25-60-39)48-42(58)35-22-31(55)24-54(35)43(59)40(44(3,4)5)49-38(57)21-28-14-15-46-37(20-28)53-18-16-52(17-19-53)34-23-33(50-51-41(34)45)32-8-6-7-9-36(32)56/h6-15,20,23,25-26,31,35,40,55-56H,16-19,21-22,24H2,1-5H3,(H2,45,51)(H,48,58)(H,49,57)/t26-,31+,35-,40+/m0/s1",JSJNRSSILOESKP-JQJHNVGOSA-N
3609,379,80,379,80,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3700000,0.11,6.3,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,847.059,846.3999358,4.46,61,7,13,5,12,203.03,C45H54N10O5S,"InChI=1S/C45H54N10O5S/c1-27(30-11-13-31(14-12-30)40-28(2)48-26-61-40)49-43(59)36-23-32(56)25-55(36)44(60)41(45(3,4)5)50-39(58)15-10-29-16-17-47-38(22-29)54-20-18-53(19-21-54)35-24-34(51-52-42(35)46)33-8-6-7-9-37(33)57/h6-9,11-14,16-17,22,24,26-27,32,36,41,56-57H,10,15,18-21,23,25H2,1-5H3,(H2,46,52)(H,49,59)(H,50,58)/t27-,32+,36-,41+/m0/s1",XMIOCXZSPKUWLC-SFQXCRKHSA-N
3610,372,74,372,74,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=NC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N.D.,N.D.,2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.993,819.3638847,4.25,59,7,14,5,10,215.92,C42H49N11O5S,"InChI=1S/C42H49N11O5S/c1-24(26-13-15-27(16-14-26)34-25(2)44-23-59-34)45-40(57)31-21-28(54)22-53(31)41(58)35(42(3,4)5)47-39(56)30-10-8-12-33(46-30)51-17-19-52(20-18-51)38-36(43)49-50-37(48-38)29-9-6-7-11-32(29)55/h6-16,23-24,28,31,35,54-55H,17-22H2,1-5H3,(H2,43,49)(H,45,57)(H,47,56)/t24-,28+,31-,35+/m0/s1",YFJUNDZEBBSSOT-JMUDFPMGSA-N
3611,469,65,469,65,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=NC(N4CCN(C5=CN=NC(C6=CC=CC=C6O)=C5)CC4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,350000,0.08,8.4,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,803.99,803.3577367,4.58,58,7,12,4,10,177.01,C43H49N9O5S,"InChI=1S/C43H49N9O5S/c1-26(28-10-12-29(13-11-28)38-27(2)45-25-58-38)47-41(56)35-22-32(53)24-52(35)42(57)39(43(3,4)5)48-40(55)30-14-15-44-37(20-30)51-18-16-50(17-19-51)31-21-34(49-46-23-31)33-8-6-7-9-36(33)54/h6-15,20-21,23,25-26,32,35,39,53-54H,16-19,22,24H2,1-5H3,(H,47,56)(H,48,55)/t26-,32+,35-,39+/m0/s1",CZPJJHAGQOTYEJ-GNAZCYGUSA-N
3614,3.1,95,3.1/8.3,>95/>99,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=N4)=C3)C(=O)C=C2)=C1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.45/76.3/413,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,833.906,833.3285447,3.63,62,8,13,2,14,209.58,C46H43N9O7,"InChI=1S/C46H43N9O7/c47-24-30-6-3-8-32(22-30)36-13-16-41(58)54(52-36)27-31-7-4-9-33(23-31)43-48-25-34(26-49-43)62-28-29-17-20-53(21-18-29)19-2-1-12-39(56)50-37-11-5-10-35-42(37)46(61)55(45(35)60)38-14-15-40(57)51-44(38)59/h3-11,13,16,22-23,25-26,29,38H,1-2,12,14-15,17-21,27-28H2,(H,50,56)(H,51,57,59)",UGRBBCCLXHIOQB-UHFFFAOYSA-N
3621,0.69,99,0.69/0.77,>99/>99,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)NCCOCCNC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=N4)=C3)C(=O)C=C2)=C1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.34/5.89/511,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,878.947,878.3500084,2.43,65,8,15,3,17,230.84,C47H46N10O8,"InChI=1S/C47H46N10O8/c48-24-31-3-1-5-33(21-31)39-9-12-43(60)56(54-39)27-32-4-2-6-34(22-32)44-51-25-36(26-52-44)65-29-30-13-17-55(18-14-30)28-42(59)50-16-20-64-19-15-49-35-7-8-37-38(23-35)47(63)57(46(37)62)40-10-11-41(58)53-45(40)61/h1-9,12,21-23,25-26,30,40,49H,10-11,13-20,27-29H2,(H,50,59)(H,53,58,61)",BKRHXSCTDWOIHA-UHFFFAOYSA-N
3623,1.7,95,1.7/2.7,>95/>99,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)NCCOCCOCCOCCNC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=N4)=C3)C(=O)C=C2)=C1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.61/7.72/433,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,967.053,966.4024379,2.14,71,8,17,3,23,249.3,C51H54N10O10,"InChI=1S/C51H54N10O10/c52-28-35-3-1-5-37(25-35)43-9-12-47(64)60(58-43)31-36-4-2-6-38(26-36)48-55-29-40(30-56-48)71-33-34-13-17-59(18-14-34)32-46(63)54-16-20-69-22-24-70-23-21-68-19-15-53-39-7-8-41-42(27-39)51(67)61(50(41)66)44-10-11-45(62)57-49(44)65/h1-9,12,25-27,29-30,34,44,53H,10-11,13-24,31-33H2,(H,54,63)(H,57,62,65)",LJVOTWPXASNBJI-UHFFFAOYSA-N
3625,0.6,99,0.83/0.60,>99/>99,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)N6CCN(CCNC7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C=N4)=C3)C(=O)C=C2)=C1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.44/3.88/665,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,904.001,903.3816429,2.57,67,9,15,2,14,216.06,C49H49N11O7,"InChI=1S/C49H49N11O7/c50-26-33-3-1-5-35(23-33)41-9-12-44(62)59(55-41)29-34-4-2-6-36(24-34)46-52-27-38(28-53-46)67-31-32-13-16-57(17-14-32)30-45(63)58-21-19-56(20-22-58)18-15-51-37-7-8-39-40(25-37)49(66)60(48(39)65)42-10-11-43(61)54-47(42)64/h1-9,12,23-25,27-28,32,42,51H,10-11,13-22,29-31H2,(H,54,61,64)",USNPVGJUXHCJDF-UHFFFAOYSA-N
3626,0.35,99,0.44/0.35,>99/>99,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)N6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C=N4)=C3)C(=O)C=C2)=C1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.11/3.50/377,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,860.932,860.3394437,2.68,64,9,14,1,11,204.03,C47H44N10O7,"InChI=1S/C47H44N10O7/c48-24-31-3-1-5-33(21-31)39-9-12-42(59)56(52-39)27-32-4-2-6-34(22-32)44-49-25-36(26-50-44)64-29-30-13-15-53(16-14-30)28-43(60)55-19-17-54(18-20-55)35-7-8-37-38(23-35)47(63)57(46(37)62)40-10-11-41(58)51-45(40)61/h1-9,12,21-23,25-26,30,40H,10-11,13-20,27-29H2,(H,51,58,61)",ONBFXZQYDXKUOB-UHFFFAOYSA-N
3627,143,99,143,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)CCC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)CC3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,439.899,439.1298839,2.24,31,4,4,2,5,95.58,C23H22ClN3O4,"InChI=1S/C23H22ClN3O4/c1-13-2-5-16(11-18(13)24)25-20(28)8-4-14-3-6-17-15(10-14)12-27(23(17)31)19-7-9-21(29)26-22(19)30/h2-3,5-6,10-11,19H,4,7-9,12H2,1H3,(H,25,28)(H,26,29,30)",HVGVXTMIJBEFSO-UHFFFAOYSA-N
3628,447,99,447,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)CCC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,453.882,453.1091484,2.18,32,4,5,2,5,112.65,C23H20ClN3O5,"InChI=1S/C23H20ClN3O5/c1-12-2-5-14(11-17(12)24)25-19(28)8-4-13-3-6-15-16(10-13)23(32)27(22(15)31)18-7-9-20(29)26-21(18)30/h2-3,5-6,10-11,18H,4,7-9H2,1H3,(H,25,28)(H,26,29,30)",IRDBZSYSXQQJQO-UHFFFAOYSA-N
3629,3063,99,3063,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)CCC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,439.899,439.1298839,2.24,31,4,4,2,5,95.58,C23H22ClN3O4,"InChI=1S/C23H22ClN3O4/c1-13-5-7-15(11-18(13)24)25-20(28)9-6-14-3-2-4-16-17(14)12-27(23(16)31)19-8-10-21(29)26-22(19)30/h2-5,7,11,19H,6,8-10,12H2,1H3,(H,25,28)(H,26,29,30)",ZHSKDNZFKUGRBS-UHFFFAOYSA-N
3630,18,99,18,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,439.899,439.1298839,2.24,31,4,4,2,5,95.58,C23H22ClN3O4,"InChI=1S/C23H22ClN3O4/c1-13-2-6-16(11-18(13)24)25-20(28)8-4-14-3-5-15-12-27(23(31)17(15)10-14)19-7-9-21(29)26-22(19)30/h2-3,5-6,10-11,19H,4,7-9,12H2,1H3,(H,25,28)(H,26,29,30)",VTNTURHOFZDIDN-UHFFFAOYSA-N
3631,,,>10000,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)CNC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,440.887,440.1251328,2.06,31,4,5,3,5,107.61,C22H21ClN4O4,"InChI=1S/C22H21ClN4O4/c1-12-2-4-15(9-17(12)23)25-20(29)10-24-14-5-3-13-11-27(22(31)16(13)8-14)18-6-7-19(28)26-21(18)30/h2-5,8-9,18,24H,6-7,10-11H2,1H3,(H,25,29)(H,26,28,30)",WQTRIUDZDKAKTG-UHFFFAOYSA-N
3632,,,>10000,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)COC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,441.871,441.1091484,2.05,31,4,5,2,5,104.81,C22H20ClN3O5,"InChI=1S/C22H20ClN3O5/c1-12-2-4-14(8-17(12)23)24-20(28)11-31-15-5-3-13-10-26(22(30)16(13)9-15)18-6-7-19(27)25-21(18)29/h2-5,8-9,18H,6-7,10-11H2,1H3,(H,24,28)(H,25,27,29)",BXMFMNBYVCNHCH-UHFFFAOYSA-N
3633,,,>10000,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)/C=C/C2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,437.883,437.1142338,2.43,31,4,4,2,4,95.58,C23H20ClN3O4,"InChI=1S/C23H20ClN3O4/c1-13-2-6-16(11-18(13)24)25-20(28)8-4-14-3-5-15-12-27(23(31)17(15)10-14)19-7-9-21(29)26-22(19)30/h2-6,8,10-11,19H,7,9,12H2,1H3,(H,25,28)(H,26,29,30)/b8-4+",YWVOORFJARFYGT-XBXARRHUSA-N
3634,,,>10000,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)CC(C)C2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,453.926,453.1455339,2.57,32,4,4,2,5,95.58,C24H24ClN3O4,"InChI=1S/C24H24ClN3O4/c1-13-3-6-17(11-19(13)25)26-22(30)9-14(2)15-4-5-16-12-28(24(32)18(16)10-15)20-7-8-21(29)27-23(20)31/h3-6,10-11,14,20H,7-9,12H2,1-2H3,(H,26,30)(H,27,29,31)",YUVUDFGVAMCSLE-UHFFFAOYSA-N
3635,,,>10000,,P15170,GSPT1,CRBN,,,CC1=CC=C(NC(=O)C(C)CC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)CC3=C2)C=C1Cl,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,453.926,453.1455339,2.81,32,4,4,2,5,95.58,C24H24ClN3O4,"InChI=1S/C24H24ClN3O4/c1-13-3-5-17(11-19(13)25)26-22(30)14(2)9-15-4-6-18-16(10-15)12-28(24(18)32)20-7-8-21(29)27-23(20)31/h3-6,10-11,14,20H,7-9,12H2,1-2H3,(H,26,30)(H,27,29,31)",QJVQYFQJBAZBOL-UHFFFAOYSA-N
3636,2204,99,2204,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CCN(C)CC1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,552.075,551.2299322,1.89,39,5,6,2,7,102.06,C29H34ClN5O4,"InChI=1S/C29H34ClN5O4/c1-18-21(16-34-11-9-33(2)10-12-34)14-22(15-24(18)30)31-26(36)7-4-19-3-5-20-17-35(29(39)23(20)13-19)25-6-8-27(37)32-28(25)38/h3,5,13-15,25H,4,6-12,16-17H2,1-2H3,(H,31,36)(H,32,37,38)",VNPAEWZAZAPDIJ-UHFFFAOYSA-N
3637,48,99,48,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CCOCC1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,539.032,538.1982978,1.7,38,5,6,2,7,108.05,C28H31ClN4O5,"InChI=1S/C28H31ClN4O5/c1-17-20(15-32-8-10-38-11-9-32)13-21(14-23(17)29)30-25(34)6-3-18-2-4-19-16-33(28(37)22(19)12-18)24-5-7-26(35)31-27(24)36/h2,4,12-14,24H,3,5-11,15-16H2,1H3,(H,30,34)(H,31,35,36)",YNSXEKYFUGVPFM-UHFFFAOYSA-N
3638,251,99,251,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CCN(C2CCOCC2)CC1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,622.166,621.2717971,2.29,44,6,7,2,8,111.29,C33H40ClN5O5,"InChI=1S/C33H40ClN5O5/c1-21-24(19-37-10-12-38(13-11-37)26-8-14-44-15-9-26)17-25(18-28(21)34)35-30(40)6-3-22-2-4-23-20-39(33(43)27(23)16-22)29-5-7-31(41)36-32(29)42/h2,4,16-18,26,29H,3,5-15,19-20H2,1H3,(H,35,40)(H,36,41,42)",SRPYVYWQLCJJBP-UHFFFAOYSA-N
3639,176,99,176,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CCC(N2CCOCC2)CC1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,622.166,621.2717971,2.29,44,6,7,2,8,111.29,C33H40ClN5O5,"InChI=1S/C33H40ClN5O5/c1-21-24(19-37-10-8-26(9-11-37)38-12-14-44-15-13-38)17-25(18-28(21)34)35-30(40)6-3-22-2-4-23-20-39(33(43)27(23)16-22)29-5-7-31(41)36-32(29)42/h2,4,16-18,26,29H,3,5-15,19-20H2,1H3,(H,35,40)(H,36,41,42)",LUZPLOCJLQXLQA-UHFFFAOYSA-N
3640,220,99,220,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CCN(C2COC2)CC1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,594.112,593.2404969,1.58,42,6,7,2,8,111.29,C31H36ClN5O5,"InChI=1S/C31H36ClN5O5/c1-19-22(15-35-8-10-36(11-9-35)24-17-42-18-24)13-23(14-26(19)32)33-28(38)6-3-20-2-4-21-16-37(31(41)25(21)12-20)27-5-7-29(39)34-30(27)40/h2,4,12-14,24,27H,3,5-11,15-18H2,1H3,(H,33,38)(H,34,39,40)",SBGJSWPUBBJYLC-UHFFFAOYSA-N
3641,208,99,208,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CC(N2CCOCC2)C1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,594.112,593.2404969,1.58,42,6,7,2,8,111.29,C31H36ClN5O5,"InChI=1S/C31H36ClN5O5/c1-19-22(15-35-17-24(18-35)36-8-10-42-11-9-36)13-23(14-26(19)32)33-28(38)6-3-20-2-4-21-16-37(31(41)25(21)12-20)27-5-7-29(39)34-30(27)40/h2,4,12-14,24,27H,3,5-11,15-18H2,1H3,(H,33,38)(H,34,39,40)",UBDPXGXKOOHSIE-UHFFFAOYSA-N
3642,86,99,86,,P15170,GSPT1,CRBN,,,CC1=C(Cl)C=C(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C=C1CN1CC2(COC2)C1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,551.043,550.1982978,1.59,39,6,6,2,7,108.05,C29H31ClN4O5,"InChI=1S/C29H31ClN4O5/c1-17-20(11-33-13-29(14-33)15-39-16-29)9-21(10-23(17)30)31-25(35)6-3-18-2-4-19-12-34(28(38)22(19)8-18)24-5-7-26(36)32-27(24)37/h2,4,8-10,24H,3,5-7,11-16H2,1H3,(H,31,35)(H,32,36,37)",BWOFQPMIDXIVLV-UHFFFAOYSA-N
3643,35,81.65,35,81.65,P15170,GSPT1,CRBN,,,COCCN(C)CC1=CC(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)=CC(Cl)=C1C,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,190/6/27,Inhibit the growth of U937/MOLT-4/MV4-11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,541.048,540.2139478,1.93,38,4,6,2,10,108.05,C28H33ClN4O5,"InChI=1S/C28H33ClN4O5/c1-17-20(15-32(2)10-11-38-3)13-21(14-23(17)29)30-25(34)8-5-18-4-6-19-16-33(28(37)22(19)12-18)24-7-9-26(35)31-27(24)36/h4,6,12-14,24H,5,7-11,15-16H2,1-3H3,(H,30,34)(H,31,35,36)",BSFAJHWUNIDRJW-UHFFFAOYSA-N
3659,210,99,210,,Q14145,KEAP1,CRBN,,,CC1(C)CC[C@]2(C(=O)NCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC[C@]3(C)C(C(=O)C=C4[C@@]3(C)CCC3C(C)(C)C(=O)C(C#N)=C[C@]43C)C2C1,Degradation of Keap1 in AML12 cells after 24h treatment,,,,,,,11870,SPR,,,,,,,,,,,,,,,2420,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,18210,IC50 in AML12 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00822,832.055,831.4570993,7.65,61,8,9,3,9,182.61,C49H61N5O7,"InChI=1S/C49H61N5O7/c1-44(2)18-20-49(43(61)52-23-10-8-9-22-51-31-13-11-12-29-37(31)42(60)54(41(29)59)32-14-15-36(56)53-40(32)58)21-19-48(7)38(30(49)26-44)33(55)24-35-46(5)25-28(27-50)39(57)45(3,4)34(46)16-17-47(35,48)6/h11-13,24-25,30,32,34,38,51H,8-10,14-23,26H2,1-7H3,(H,52,61)(H,53,56,58)/t30?,32?,34?,38?,46-,47+,48+,49-/m0/s1",NOJJELRNFCQZQC-AOAVJBMASA-N
3680,0.6,97,0.6/0.6,97/92,P10275,AR,CRBN,,ARD-2051,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,>95/>95/>95,% AR degradation in VCaP cells at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10�� 13��,Inhibit of cell growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00405,789.337,788.3201442,4.51,57,9,10,1,6,140.61,C43H45ClN8O5,"InChI=1S/C43H45ClN8O5/c1-27-22-43(26-51(27)32-7-4-29(23-45)36(44)21-32)12-14-47(15-13-43)30-5-2-28(3-6-30)40(55)49-18-16-48(17-19-49)33-24-50(25-33)31-8-9-34-35(20-31)42(57)52(41(34)56)37-10-11-38(53)46-39(37)54/h2-9,20-21,27,33,37H,10-19,22,24-26H2,1H3,(H,46,53,54)/t27-,37?/m0/s1",WBMJNGGUHCHFHY-YTCZSSRZSA-N
3709,790,99,2560/790,,P52789,HK2,CRBN,,C-02,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCNC(=O)C4=NN(CC5=CC=C(Cl)C=C5Cl)C5=CC=CC=C45)=C3C2=O)C(=O)N1,Degradation of HK2 in 4T1/MDA-MB-231 cells after 36 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5080/34070/31530,IC50 was determined by the MTT assay in 4T1/786-O/PANC-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00118,647.519,646.1498234,5.18,45,6,8,3,10,142.5,C32H28Cl2N6O5,"InChI=1S/C32H28Cl2N6O5/c33-19-11-10-18(22(34)16-19)17-39-24-9-2-1-6-20(24)28(38-39)30(43)36-15-4-3-14-35-23-8-5-7-21-27(23)32(45)40(31(21)44)25-12-13-26(41)37-29(25)42/h1-2,5-11,16,25,35H,3-4,12-15,17H2,(H,36,43)(H,37,41,42)",OFEUWOIETWIJID-UHFFFAOYSA-N
3723,189.5,99,189.5,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,2.67,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.0/210,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,961.243,960.4931675,6.12,69,6,10,5,20,203.03,C53H68N8O7S,"InChI=1S/C53H68N8O7S/c1-35(39-15-17-40(18-16-39)47-36(2)57-34-69-47)58-50(66)44-31-43(62)33-61(44)52(68)48(53(3,4)5)59-46(64)13-7-9-28-56-49(65)41-19-21-42(22-20-41)51(67)60-29-24-37(25-30-60)11-6-8-27-55-45(63)23-14-38-12-10-26-54-32-38/h10,12,14-23,26,32,34-35,37,43-44,48,62H,6-9,11,13,24-25,27-31,33H2,1-5H3,(H,55,63)(H,56,65)(H,58,66)(H,59,64)/b23-14+/t35-,43+,44-,48+/m0/s1",UYNXDFCNCZJSMH-ARKLOZAXSA-N
3724,293.5,99,293.5,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,5.59,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4/450,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,975.27,974.5088176,6.48,70,6,10,5,21,203.03,C54H70N8O7S,"InChI=1S/C54H70N8O7S/c1-36(40-16-18-41(19-17-40)48-37(2)58-35-70-48)59-51(67)45-32-44(63)34-62(45)53(69)49(54(3,4)5)60-47(65)14-7-6-9-29-57-50(66)42-20-22-43(23-21-42)52(68)61-30-25-38(26-31-61)12-8-10-28-56-46(64)24-15-39-13-11-27-55-33-39/h11,13,15-24,27,33,35-36,38,44-45,49,63H,6-10,12,14,25-26,28-32,34H2,1-5H3,(H,56,64)(H,57,66)(H,59,67)(H,60,65)/b24-15+/t36-,44+,45-,49+/m0/s1",WHNLXQIXFMEJMK-FXNAQQOJSA-N
3725,56,99,56,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,1.59,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.9/70,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,989.297,988.5244676,7.02,71,6,10,5,22,203.03,C55H72N8O7S,"InChI=1S/C55H72N8O7S/c1-37(41-17-19-42(20-18-41)49-38(2)59-36-71-49)60-52(68)46-33-45(64)35-63(46)54(70)50(55(3,4)5)61-48(66)15-8-6-7-10-30-58-51(67)43-21-23-44(24-22-43)53(69)62-31-26-39(27-32-62)13-9-11-29-57-47(65)25-16-40-14-12-28-56-34-40/h12,14,16-25,28,34,36-37,39,45-46,50,64H,6-11,13,15,26-27,29-33,35H2,1-5H3,(H,57,65)(H,58,67)(H,60,68)(H,61,66)/b25-16+/t37-,45+,46-,50+/m0/s1",OGFPEFARZYBOEV-ZRADWQCJSA-N
3726,31.7,99,31.7,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,2.14,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30.6/300,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,1003.324,1002.540118,7.56,72,6,10,5,23,203.03,C56H74N8O7S,"InChI=1S/C56H74N8O7S/c1-38(42-18-20-43(21-19-42)50-39(2)60-37-72-50)61-53(69)47-34-46(65)36-64(47)55(71)51(56(3,4)5)62-49(67)16-9-7-6-8-11-31-59-52(68)44-22-24-45(25-23-44)54(70)63-32-27-40(28-33-63)14-10-12-30-58-48(66)26-17-41-15-13-29-57-35-41/h13,15,17-26,29,35,37-38,40,46-47,51,65H,6-12,14,16,27-28,30-34,36H2,1-5H3,(H,58,66)(H,59,68)(H,61,69)(H,62,67)/b26-17+/t38-,46+,47-,51+/m0/s1",WVDMNRIXHVDNLQ-GXSYQCEUSA-N
3727,54.4,99,54.4,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,3.12,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37.9/900,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,1017.351,1016.555768,8.1,73,6,10,5,24,203.03,C57H76N8O7S,"InChI=1S/C57H76N8O7S/c1-39(43-19-21-44(22-20-43)51-40(2)61-38-73-51)62-54(70)48-35-47(66)37-65(48)56(72)52(57(3,4)5)63-50(68)17-10-8-6-7-9-12-32-60-53(69)45-23-25-46(26-24-45)55(71)64-33-28-41(29-34-64)15-11-13-31-59-49(67)27-18-42-16-14-30-58-36-42/h14,16,18-27,30,36,38-39,41,47-48,52,66H,6-13,15,17,28-29,31-35,37H2,1-5H3,(H,59,67)(H,60,69)(H,62,70)(H,63,68)/b27-18+/t39-,47+,48-,52+/m0/s1",GKTBNRIAPSRNLT-INIVRFOBSA-N
3728,,,>500,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,7.3,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,69.2/1510,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,1031.378,1030.571418,8.65,74,6,10,5,25,203.03,C58H78N8O7S,"InChI=1S/C58H78N8O7S/c1-40(44-20-22-45(23-21-44)52-41(2)62-39-74-52)63-55(71)49-36-48(67)38-66(49)57(73)53(58(3,4)5)64-51(69)18-11-9-7-6-8-10-13-33-61-54(70)46-24-26-47(27-25-46)56(72)65-34-29-42(30-35-65)16-12-14-32-60-50(68)28-19-43-17-15-31-59-37-43/h15,17,19-28,31,37,39-40,42,48-49,53,67H,6-14,16,18,29-30,32-36,38H2,1-5H3,(H,60,68)(H,61,70)(H,63,71)(H,64,69)/b28-19+/t40-,48+,49-,53+/m0/s1",KWJABVUBCJFJCX-SMICPIEHSA-N
3729,111.2,99,111.2,,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)C3=CC=C(C(=O)N4CCC(CCCCNC(=O)/C=C/C5=CC=CN=C5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24 h treatment,,,1.47,Inhibit of enzymatic NAMPT activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41.1/2230,Inhibit proliferation of A2780/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2023.129393,1045.405,1044.587068,9.19,75,6,10,5,26,203.03,C59H80N8O7S,"InChI=1S/C59H80N8O7S/c1-41(45-21-23-46(24-22-45)53-42(2)63-40-75-53)64-56(72)50-37-49(68)39-67(50)58(74)54(59(3,4)5)65-52(70)19-12-10-8-6-7-9-11-14-34-62-55(71)47-25-27-48(28-26-47)57(73)66-35-30-43(31-36-66)17-13-15-33-61-51(69)29-20-44-18-16-32-60-38-44/h16,18,20-29,32,38,40-41,43,49-50,54,68H,6-15,17,19,30-31,33-37,39H2,1-5H3,(H,61,69)(H,62,71)(H,64,72)(H,65,70)/b29-20+/t41-,49+,50-,54+/m0/s1",XKZPOOWZQHZRSR-GZLRDZNMSA-N
3730,8.1,82.3,8.1/16.8,82.3/76.5,Q14145,KEAP1,CRBN,,SD2267,CC1=CC=C(C(CC(=O)O)C2=CC(OCCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C3C(=C2)N=NN3C)C=C1CN1C[C@@H](C)OC2=CC=CC=C2S1(=O)=O,Degradation of KEAP1 in HepG2/AML12 cells after 24 h treatment,64,% KEAP1 degradation in HepG2 cells after 6 h treatment at 1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57.7,FRET-based competition assay,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.redox.2023.102783,920.058,919.3574619,6.43,66,8,13,3,18,219.43,C48H53N7O10S,"InChI=1S/C48H53N7O10S/c1-29-17-18-31(23-33(29)28-54-27-30(2)65-39-15-8-9-16-41(39)66(54,62)63)35(26-43(57)58)32-24-37-45(53(3)52-51-37)40(25-32)64-22-11-7-5-4-6-10-21-49-36-14-12-13-34-44(36)48(61)55(47(34)60)38-19-20-42(56)50-46(38)59/h8-9,12-18,23-25,30,35,38,49H,4-7,10-11,19-22,26-28H2,1-3H3,(H,57,58)(H,50,56,59)/t30-,35?,38?/m1/s1",VXOYJRRGTMUDKQ-AXOGOZOFSA-N
3737,5049,99,5049,,P37840,Alpha-syn,cIAP1,,,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(=O)NCCOCCOCCOCCNC1=CC=C(C2=CC(C3=CC=CC(Br)=C3)=N[NH]2)C=C1,Degradation of alpha-synuclein in H293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3390/molecules28114458,779.777,778.3053455,4.62,52,4,9,6,23,172.85,C39H51BrN6O6,"InChI=1S/C39H51BrN6O6/c1-27(2)23-36(44-39(49)37(47)33(41)24-28-7-4-3-5-8-28)38(48)43-16-18-51-20-22-52-21-19-50-17-15-42-32-13-11-29(12-14-32)34-26-35(46-45-34)30-9-6-10-31(40)25-30/h3-14,25-27,33,36-37,42,47H,15-24,41H2,1-2H3,(H,43,48)(H,44,49)(H,45,46)/t33-,36+,37+/m1/s1",OEZPBOJCRQAJJZ-HTVAGRJCSA-N
3742,4.3,99,4.3,,Q93009,USP7,CRBN,,PU7-1,O=C1CCC(N2CC3=C(CCCCCN4CCN(CCC(=O)NC5=CC=C6C(=O)N(CC7(O)CCN(C(=O)C(CCCNC(=O)C8=CC=C9C(Cl)=C%10CCCCC%10=NC9=C8)CC8=CC=CC=C8)CC7)C=NC6=C5)CC4)C=CC=C3C2=O)C(=O)N1,Degradation of USP7 in CAL33 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41418-023-01180-7,1159.83,1158.545787,6.24,84,11,13,4,21,219.48,C65H75ClN10O8,"InChI=1S/C65H75ClN10O8/c66-59-49-16-6-7-18-53(49)70-55-38-45(19-21-50(55)59)60(79)67-28-10-15-46(37-43-11-3-1-4-12-43)62(81)74-31-26-65(84,27-32-74)41-75-42-68-54-39-47(20-22-51(54)63(75)82)69-58(78)25-30-73-35-33-72(34-36-73)29-8-2-5-13-44-14-9-17-48-52(44)40-76(64(48)83)56-23-24-57(77)71-61(56)80/h1,3-4,9,11-12,14,17,19-22,38-39,42,46,56,84H,2,5-8,10,13,15-16,18,23-37,40-41H2,(H,67,79)(H,69,78)(H,71,77,80)",JHAKKJWGNYLIKC-UHFFFAOYSA-N
3743,0.1,98,0.1,98,O60885,BRD4,CRBN,,BD-7102,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,712.792,712.2216371,3.03,52,9,12,1,6,144.55,C38H32N8O5S,"InChI=1S/C38H32N8O5S/c1-22-41-42-32-21-51-20-28-27(14-23-6-3-2-4-7-23)31(52-38(28)45(22)32)12-10-24-15-39-44(18-24)19-25-16-43(17-25)29-9-5-8-26-34(29)37(50)46(36(26)49)30-11-13-33(47)40-35(30)48/h2-9,15,18,25,30H,11,13-14,16-17,19-21H2,1H3,(H,40,47,48)",YINXRHBANVHQMY-UHFFFAOYSA-N
3743,0.3,97,0.3,97,P25440,BRD2,CRBN,,BD-7102,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,712.792,712.2216371,3.03,52,9,12,1,6,144.55,C38H32N8O5S,"InChI=1S/C38H32N8O5S/c1-22-41-42-32-21-51-20-28-27(14-23-6-3-2-4-7-23)31(52-38(28)45(22)32)12-10-24-15-39-44(18-24)19-25-16-43(17-25)29-9-5-8-26-34(29)37(50)46(36(26)49)30-11-13-33(47)40-35(30)48/h2-9,15,18,25,30H,11,13-14,16-17,19-21H2,1H3,(H,40,47,48)",YINXRHBANVHQMY-UHFFFAOYSA-N
3743,0.4,98,0.4,98,Q15059,BRD3,CRBN,,BD-7102,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,712.792,712.2216371,3.03,52,9,12,1,6,144.55,C38H32N8O5S,"InChI=1S/C38H32N8O5S/c1-22-41-42-32-21-51-20-28-27(14-23-6-3-2-4-7-23)31(52-38(28)45(22)32)12-10-24-15-39-44(18-24)19-25-16-43(17-25)29-9-5-8-26-34(29)37(50)46(36(26)49)30-11-13-33(47)40-35(30)48/h2-9,15,18,25,30H,11,13-14,16-17,19-21H2,1H3,(H,40,47,48)",YINXRHBANVHQMY-UHFFFAOYSA-N
3744,0.4,98,0.4,98,O60885,BRD4,CRBN,,BD-7163,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,726.819,726.2372872,3.52,53,9,12,1,5,144.55,C39H34N8O5S,"InChI=1S/C39H34N8O5S/c1-23-42-43-33-22-52-21-29-28(18-24-6-3-2-4-7-24)32(53-39(29)46(23)33)12-10-25-19-40-45(20-25)26-14-16-44(17-15-26)30-9-5-8-27-35(30)38(51)47(37(27)50)31-11-13-34(48)41-36(31)49/h2-9,19-20,26,31H,11,13-18,21-22H2,1H3,(H,41,48,49)",LBOQQOZSFDCXGL-UHFFFAOYSA-N
3744,50,68,50,68,P25440,BRD2,CRBN,,BD-7163,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,726.819,726.2372872,3.52,53,9,12,1,5,144.55,C39H34N8O5S,"InChI=1S/C39H34N8O5S/c1-23-42-43-33-22-52-21-29-28(18-24-6-3-2-4-7-24)32(53-39(29)46(23)33)12-10-25-19-40-45(20-25)26-14-16-44(17-15-26)30-9-5-8-27-35(30)38(51)47(37(27)50)31-11-13-34(48)41-36(31)49/h2-9,19-20,26,31H,11,13-18,21-22H2,1H3,(H,41,48,49)",LBOQQOZSFDCXGL-UHFFFAOYSA-N
3744,,,>100,56,Q15059,BRD3,CRBN,,BD-7163,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,726.819,726.2372872,3.52,53,9,12,1,5,144.55,C39H34N8O5S,"InChI=1S/C39H34N8O5S/c1-23-42-43-33-22-52-21-29-28(18-24-6-3-2-4-7-24)32(53-39(29)46(23)33)12-10-25-19-40-45(20-25)26-14-16-44(17-15-26)30-9-5-8-27-35(30)38(51)47(37(27)50)31-11-13-34(48)41-36(31)49/h2-9,19-20,26,31H,11,13-18,21-22H2,1H3,(H,41,48,49)",LBOQQOZSFDCXGL-UHFFFAOYSA-N
3745,0.2,95,3.5/0.2,90/95,O60885,BRD4,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,0.2,93,0.9/0.2/3.6,99/93/93,O60885,BRD4,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MV4;11/RS4;11/HL60 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,1,93,13/1.0/5.6,92/93/95,O60885,BRD4,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MOLM13/MDA-MB-231/MDA-MB-453 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,,,>1000/>1000,0/0,P25440,BRD2,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37.8/3.3,Inhibit of cell growth in MCF-7/T47D cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,,,>1000/>1000,34/22,Q15059,BRD3,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,,,>1000/>1000/>1000,0/<10/10,P25440,BRD2,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MV4;11/RS4;11/HL60 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/25/4.9,Inhibit of cell growth in MV4;11/MOLM13/HL60 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,,,>1000/>1000/>1000,27/0/18,P25440,BRD2,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MOLM13/MDA-MB-231/MDA-MB-453 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4/15.9/59.9,Inhibit of cell growth in RS4;11/MDA-MB-231/MDA-MB-453 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,,,>1000/>1000/>1000,36695,Q15059,BRD3,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MV4;11/RS4;11/HL60 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,,,>1000/>1000/>1000,13/19/5,Q15059,BRD3,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MOLM13/MDA-MB-231/MDA-MB-453 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3746,0.2,99,0.2,99,P25440,BRD2,CRBN,,BD-7162,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-32-20-50-19-29-27(13-22-5-3-2-4-6-22)31(51-37(29)44(21)32)11-7-23-15-38-43(16-23)25-17-42(18-25)24-8-9-26-28(14-24)36(49)45(35(26)48)30-10-12-33(46)39-34(30)47/h2-6,8-9,14-16,25,30H,10,12-13,17-20H2,1H3,(H,39,46,47)",OJCRNHCUTYXXFI-UHFFFAOYSA-N
3746,0.3,98,0.3,98,O60885,BRD4,CRBN,,BD-7162,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-32-20-50-19-29-27(13-22-5-3-2-4-6-22)31(51-37(29)44(21)32)11-7-23-15-38-43(16-23)25-17-42(18-25)24-8-9-26-28(14-24)36(49)45(35(26)48)30-10-12-33(46)39-34(30)47/h2-6,8-9,14-16,25,30H,10,12-13,17-20H2,1H3,(H,39,46,47)",OJCRNHCUTYXXFI-UHFFFAOYSA-N
3746,0.7,99,0.7,99,Q15059,BRD3,CRBN,,BD-7162,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-32-20-50-19-29-27(13-22-5-3-2-4-6-22)31(51-37(29)44(21)32)11-7-23-15-38-43(16-23)25-17-42(18-25)24-8-9-26-28(14-24)36(49)45(35(26)48)30-10-12-33(46)39-34(30)47/h2-6,8-9,14-16,25,30H,10,12-13,17-20H2,1H3,(H,39,46,47)",OJCRNHCUTYXXFI-UHFFFAOYSA-N
3747,0.1,99,0.6/<0.1/0.2,99/99/99,O60885,BRD4,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MDA-MB-453/MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,0.5,99,0.5/0.7/0.5,99/99/95,O60885,BRD4,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in HL60/RS4;11/MDA-MB-231 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,1.2,99,1.2/4.7/1.5,99/96/90,O60885,BRD4,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD4 in MV4;11/MV-4-11/MOLM13 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,,,>1000/>1000/>1000,0/0/0,P25440,BRD2,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MV4;11/MV-4-11/MOLM13 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/69/5.1,Inhibit of cell growth in MV4;11/MOLM13/HL60 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,,,>1000/>1000/>1000,18/15/0,P25440,BRD2,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in HL60/RS4;11/MDA-MB-231 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6/17.6/80.9,Inhibit of cell growth in RS4;11/MDA-MB-231/MDA-MB-453 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,,,>1000/>1000/>1000,36836,P25440,BRD2,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD2 in MDA-MB-453/MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38.4/3.8,Inhibit of cell growth in MCF-7/T47D cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,,,>1000/>1000/>1000,0/0/9,Q15059,BRD3,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MV4;11/MV-4-11/MOLM13 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,,,>1000/>1000/>1000,10/15/0,Q15059,BRD3,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in HL60/RS4;11/MDA-MB-231 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3747,,,>1000/>1000/>1000,14/0/25,Q15059,BRD3,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,Degradation of BRD3 in MDA-MB-453/MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3781,6500,89,6500,>89,P11802,CDK4,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCCCCCNC(=O)COC5=CC=C6C(=C5)CCCN6C(=O)CCl)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in MDA-MB-231 cells after 12 h treatment,,,6.14,Inhibition activity of PARP1 assay was carried out by Bioduro-Sundia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1540/850/830,Inhibit proliferation of MDA-MB-231/MV4-11/H1299 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106637,869.468,868.4151072,4.44,62,7,13,3,18,183.99,C45H57ClN10O6,"InChI=1S/C45H57ClN10O6/c1-30-36-27-50-45(52-43(36)56(33-11-5-6-12-33)44(61)42(30)31(2)57)51-38-16-13-34(26-49-38)54-22-20-53(21-23-54)28-39(58)47-17-7-3-4-8-18-48-40(59)29-62-35-14-15-37-32(24-35)10-9-19-55(37)41(60)25-46/h13-16,24,26-27,33H,3-12,17-23,25,28-29H2,1-2H3,(H,47,58)(H,48,59)(H,49,50,51,52)",ODACRUNFSNEWFN-UHFFFAOYSA-N
3781,8000,83,8000,>83,Q00534,CDK6,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCCCCCNC(=O)COC5=CC=C6C(=C5)CCCN6C(=O)CCl)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in MDA-MB-231 cells after 12 h treatment,,,13.97,Inhibition activity of PARP1 assay was carried out by Bioduro-Sundia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106637,869.468,868.4151072,4.44,62,7,13,3,18,183.99,C45H57ClN10O6,"InChI=1S/C45H57ClN10O6/c1-30-36-27-50-45(52-43(36)56(33-11-5-6-12-33)44(61)42(30)31(2)57)51-38-16-13-34(26-49-38)54-22-20-53(21-23-54)28-39(58)47-17-7-3-4-8-18-48-40(59)29-62-35-14-15-37-32(24-35)10-9-19-55(37)41(60)25-46/h13-16,24,26-27,33H,3-12,17-23,25,28-29H2,1-2H3,(H,47,58)(H,48,59)(H,49,50,51,52)",ODACRUNFSNEWFN-UHFFFAOYSA-N
3804,1.7,66,1.7,66,Q92793,CBP,CRBN,,JET-129,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,196,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.857,795.3128947,2.39,59,9,12,3,9,197.82,C43H41N9O7,"InChI=1S/C43H41N9O7/c1-24(53)50-17-12-35-31(23-50)39(49-52(35)27-13-18-59-19-14-27)28-5-2-4-25-20-34(47-22-30(25)28)26-8-9-33(46-21-26)40(55)45-16-15-44-32-7-3-6-29-38(32)43(58)51(42(29)57)36-10-11-37(54)48-41(36)56/h2-9,20-22,27,36,44H,10-19,23H2,1H3,(H,45,55)(H,48,54,56)",HKMUULSLHVOHMZ-UHFFFAOYSA-N
3805,0.7,90,0.7,90,Q09472,EP300,CRBN,,JET-142,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,809.884,809.3285447,2.74,60,9,12,3,10,197.82,C44H43N9O7,"InChI=1S/C44H43N9O7/c1-25(54)51-18-13-36-32(24-51)40(50-53(36)28-14-19-60-20-15-28)29-6-2-5-26-21-35(48-23-31(26)29)27-9-10-34(47-22-27)41(56)46-17-4-16-45-33-8-3-7-30-39(33)44(59)52(43(30)58)37-11-12-38(55)49-42(37)57/h2-3,5-10,21-23,28,37,45H,4,11-20,24H2,1H3,(H,46,56)(H,49,55,57)",GRTUCEOYBLSCJP-UHFFFAOYSA-N
3805,1.2,71,1.2,71,Q92793,CBP,CRBN,,JET-142,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,809.884,809.3285447,2.74,60,9,12,3,10,197.82,C44H43N9O7,"InChI=1S/C44H43N9O7/c1-25(54)51-18-13-36-32(24-51)40(50-53(36)28-14-19-60-20-15-28)29-6-2-5-26-21-35(48-23-31(26)29)27-9-10-34(47-22-27)41(56)46-17-4-16-45-33-8-3-7-30-39(33)44(59)52(43(30)58)37-11-12-38(55)49-42(37)57/h2-3,5-10,21-23,28,37,45H,4,11-20,24H2,1H3,(H,46,56)(H,49,55,57)",GRTUCEOYBLSCJP-UHFFFAOYSA-N
3806,0.8,77,0.8,77,Q09472,EP300,CRBN,,JET-130,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,823.911,823.3441948,3.1,61,9,12,3,11,197.82,C45H45N9O7,"InChI=1S/C45H45N9O7/c1-26(55)52-19-14-37-33(25-52)41(51-54(37)29-15-20-61-21-16-29)30-7-4-6-27-22-36(49-24-32(27)30)28-10-11-35(48-23-28)42(57)47-18-3-2-17-46-34-9-5-8-31-40(34)45(60)53(44(31)59)38-12-13-39(56)50-43(38)58/h4-11,22-24,29,38,46H,2-3,12-21,25H2,1H3,(H,47,57)(H,50,56,58)",VQVZAQCNYUSBIJ-UHFFFAOYSA-N
3806,1.3,70,1.3,70,Q92793,CBP,CRBN,,JET-130,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.4,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,823.911,823.3441948,3.1,61,9,12,3,11,197.82,C45H45N9O7,"InChI=1S/C45H45N9O7/c1-26(55)52-19-14-37-33(25-52)41(51-54(37)29-15-20-61-21-16-29)30-7-4-6-27-22-36(49-24-32(27)30)28-10-11-35(48-23-28)42(57)47-18-3-2-17-46-34-9-5-8-31-40(34)45(60)53(44(31)59)38-12-13-39(56)50-43(38)58/h4-11,22-24,29,38,46H,2-3,12-21,25H2,1H3,(H,47,57)(H,50,56,58)",VQVZAQCNYUSBIJ-UHFFFAOYSA-N
3807,0.3,95,0.3,95,Q09472,EP300,CRBN,,JET-135,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,837.938,837.3598448,3.46,62,9,12,3,12,197.82,C46H47N9O7,"InChI=1S/C46H47N9O7/c1-27(56)53-20-15-38-34(26-53)42(52-55(38)30-16-21-62-22-17-30)31-8-5-7-28-23-37(50-25-33(28)31)29-11-12-36(49-24-29)43(58)48-19-4-2-3-18-47-35-10-6-9-32-41(35)46(61)54(45(32)60)39-13-14-40(57)51-44(39)59/h5-12,23-25,30,39,47H,2-4,13-22,26H2,1H3,(H,48,58)(H,51,57,59)",HYHSJYMZWGTVLB-UHFFFAOYSA-N
3807,1,92,1,92,Q92793,CBP,CRBN,,JET-135,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,837.938,837.3598448,3.46,62,9,12,3,12,197.82,C46H47N9O7,"InChI=1S/C46H47N9O7/c1-27(56)53-20-15-38-34(26-53)42(52-55(38)30-16-21-62-22-17-30)31-8-5-7-28-23-37(50-25-33(28)31)29-11-12-36(49-24-29)43(58)48-19-4-2-3-18-47-35-10-6-9-32-41(35)46(61)54(45(32)60)39-13-14-40(57)51-44(39)59/h5-12,23-25,30,39,47H,2-4,13-22,26H2,1H3,(H,48,58)(H,51,57,59)",HYHSJYMZWGTVLB-UHFFFAOYSA-N
3808,0.6,99,0.6,99,Q92793,CBP,CRBN,,JET-131,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.3,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,851.965,851.3754949,3.82,63,9,12,3,13,197.82,C47H49N9O7,"InChI=1S/C47H49N9O7/c1-28(57)54-21-16-39-35(27-54)43(53-56(39)31-17-22-63-23-18-31)32-9-6-8-29-24-38(51-26-34(29)32)30-12-13-37(50-25-30)44(59)49-20-5-3-2-4-19-48-36-11-7-10-33-42(36)47(62)55(46(33)61)40-14-15-41(58)52-45(40)60/h6-13,24-26,31,40,48H,2-5,14-23,27H2,1H3,(H,49,59)(H,52,58,60)",AXPGRWCCCLWKQJ-UHFFFAOYSA-N
3808,0.6,87,0.6,87,Q09472,EP300,CRBN,,JET-131,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,851.965,851.3754949,3.82,63,9,12,3,13,197.82,C47H49N9O7,"InChI=1S/C47H49N9O7/c1-28(57)54-21-16-39-35(27-54)43(53-56(39)31-17-22-63-23-18-31)32-9-6-8-29-24-38(51-26-34(29)32)30-12-13-37(50-25-30)44(59)49-20-5-3-2-4-19-48-36-11-7-10-33-42(36)47(62)55(46(33)61)40-14-15-41(58)52-45(40)60/h6-13,24-26,31,40,48H,2-5,14-23,27H2,1H3,(H,49,59)(H,52,58,60)",AXPGRWCCCLWKQJ-UHFFFAOYSA-N
3809,1.2,99,1.2,99,Q92793,CBP,CRBN,,JET-136,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,865.992,865.391145,4.36,64,9,12,3,14,197.82,C48H51N9O7,"InChI=1S/C48H51N9O7/c1-29(58)55-22-17-40-36(28-55)44(54-57(40)32-18-23-64-24-19-32)33-10-7-9-30-25-39(52-27-35(30)33)31-13-14-38(51-26-31)45(60)50-21-6-4-2-3-5-20-49-37-12-8-11-34-43(37)48(63)56(47(34)62)41-15-16-42(59)53-46(41)61/h7-14,25-27,32,41,49H,2-6,15-24,28H2,1H3,(H,50,60)(H,53,59,61)",IDFDLTKSQGRMMG-UHFFFAOYSA-N
3809,2.3,87,2.3,87,Q09472,EP300,CRBN,,JET-136,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,865.992,865.391145,4.36,64,9,12,3,14,197.82,C48H51N9O7,"InChI=1S/C48H51N9O7/c1-29(58)55-22-17-40-36(28-55)44(54-57(40)32-18-23-64-24-19-32)33-10-7-9-30-25-39(52-27-35(30)33)31-13-14-38(51-26-31)45(60)50-21-6-4-2-3-5-20-49-37-12-8-11-34-43(37)48(63)56(47(34)62)41-15-16-42(59)53-46(41)61/h7-14,25-27,32,41,49H,2-6,15-24,28H2,1H3,(H,50,60)(H,53,59,61)",IDFDLTKSQGRMMG-UHFFFAOYSA-N
3810,0.2,99,0.2,99,Q92793,CBP,CRBN,,JET-132,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,880.019,879.406795,4.9,65,9,12,3,15,197.82,C49H53N9O7,"InChI=1S/C49H53N9O7/c1-30(59)56-23-18-41-37(29-56)45(55-58(41)33-19-24-65-25-20-33)34-11-8-10-31-26-40(53-28-36(31)34)32-14-15-39(52-27-32)46(61)51-22-7-5-3-2-4-6-21-50-38-13-9-12-35-44(38)49(64)57(48(35)63)42-16-17-43(60)54-47(42)62/h8-15,26-28,33,42,50H,2-7,16-25,29H2,1H3,(H,51,61)(H,54,60,62)",GRCWKRCQBMPDDA-UHFFFAOYSA-N
3810,1.6,97,1.6,97,Q09472,EP300,CRBN,,JET-132,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,880.019,879.406795,4.9,65,9,12,3,15,197.82,C49H53N9O7,"InChI=1S/C49H53N9O7/c1-30(59)56-23-18-41-37(29-56)45(55-58(41)33-19-24-65-25-20-33)34-11-8-10-31-26-40(53-28-36(31)34)32-14-15-39(52-27-32)46(61)51-22-7-5-3-2-4-6-21-50-38-13-9-12-35-44(38)49(64)57(48(35)63)42-16-17-43(60)54-47(42)62/h8-15,26-28,33,42,50H,2-7,16-25,29H2,1H3,(H,51,61)(H,54,60,62)",GRCWKRCQBMPDDA-UHFFFAOYSA-N
3811,0.3,99,0.3,99,Q09472,EP300,CRBN,,JET-145,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,780.886,780.3383811,2.52,58,9,10,2,9,168.72,C44H44N8O6,"InChI=1S/C44H44N8O6/c1-26(53)50-18-14-38-35(24-50)41(49-52(38)30-15-19-58-20-16-30)31-8-3-6-28-21-37(47-23-33(28)31)29-10-11-36(46-22-29)42(55)45-17-4-7-27-5-2-9-32-34(27)25-51(44(32)57)39-12-13-40(54)48-43(39)56/h2-3,5-6,8-11,21-23,30,39H,4,7,12-20,24-25H2,1H3,(H,45,55)(H,48,54,56)",IIMIYRHGPQNUTI-UHFFFAOYSA-N
3811,3.3,95,3.3,95,Q92793,CBP,CRBN,,JET-145,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.5,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,780.886,780.3383811,2.52,58,9,10,2,9,168.72,C44H44N8O6,"InChI=1S/C44H44N8O6/c1-26(53)50-18-14-38-35(24-50)41(49-52(38)30-15-19-58-20-16-30)31-8-3-6-28-21-37(47-23-33(28)31)29-10-11-36(46-22-29)42(55)45-17-4-7-27-5-2-9-32-34(27)25-51(44(32)57)39-12-13-40(54)48-43(39)56/h2-3,5-6,8-11,21-23,30,39H,4,7,12-20,24-25H2,1H3,(H,45,55)(H,48,54,56)",IIMIYRHGPQNUTI-UHFFFAOYSA-N
3812,0.1,99,<0.1,99,Q09472,EP300,CRBN,,JET-146,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,794.913,794.3540312,2.88,59,9,10,2,10,168.72,C45H46N8O6,"InChI=1S/C45H46N8O6/c1-27(54)51-19-15-39-36(25-51)42(50-53(39)31-16-20-59-21-17-31)32-9-5-8-29-22-38(48-24-34(29)32)30-11-12-37(47-23-30)43(56)46-18-3-2-6-28-7-4-10-33-35(28)26-52(45(33)58)40-13-14-41(55)49-44(40)57/h4-5,7-12,22-24,31,40H,2-3,6,13-21,25-26H2,1H3,(H,46,56)(H,49,55,57)",HLFIMIUCZKHKSI-UHFFFAOYSA-N
3812,0.2,80,0.2,80,Q92793,CBP,CRBN,,JET-146,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,794.913,794.3540312,2.88,59,9,10,2,10,168.72,C45H46N8O6,"InChI=1S/C45H46N8O6/c1-27(54)51-19-15-39-36(25-51)42(50-53(39)31-16-20-59-21-17-31)32-9-5-8-29-22-38(48-24-34(29)32)30-11-12-37(47-23-30)43(56)46-18-3-2-6-28-7-4-10-33-35(28)26-52(45(33)58)40-13-14-41(55)49-44(40)57/h4-5,7-12,22-24,31,40H,2-3,6,13-21,25-26H2,1H3,(H,46,56)(H,49,55,57)",HLFIMIUCZKHKSI-UHFFFAOYSA-N
3813,0.1,99,0.1,99,Q09472,EP300,CRBN,,JET-147,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,808.94,808.3696813,3.42,60,9,10,2,11,168.72,C46H48N8O6,"InChI=1S/C46H48N8O6/c1-28(55)52-20-16-40-37(26-52)43(51-54(40)32-17-21-60-22-18-32)33-10-6-9-30-23-39(49-25-35(30)33)31-12-13-38(48-24-31)44(57)47-19-4-2-3-7-29-8-5-11-34-36(29)27-53(46(34)59)41-14-15-42(56)50-45(41)58/h5-6,8-13,23-25,32,41H,2-4,7,14-22,26-27H2,1H3,(H,47,57)(H,50,56,58)",WBYWTMBEFZPCDI-UHFFFAOYSA-N
3813,0.2,99,0.2,99,Q92793,CBP,CRBN,,JET-147,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,808.94,808.3696813,3.42,60,9,10,2,11,168.72,C46H48N8O6,"InChI=1S/C46H48N8O6/c1-28(55)52-20-16-40-37(26-52)43(51-54(40)32-17-21-60-22-18-32)33-10-6-9-30-23-39(49-25-35(30)33)31-12-13-38(48-24-31)44(57)47-19-4-2-3-7-29-8-5-11-34-36(29)27-53(46(34)59)41-14-15-42(56)50-45(41)58/h5-6,8-13,23-25,32,41H,2-4,7,14-22,26-27H2,1H3,(H,47,57)(H,50,56,58)",WBYWTMBEFZPCDI-UHFFFAOYSA-N
3814,0.6,99,0.6,99,Q92793,CBP,CRBN,,JET-156,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-17-12-37-33(23-50)40(49-52(37)28-13-18-58-19-14-28)29-5-2-4-26-20-36(47-22-31(26)29)27-8-9-35(46-21-27)41(55)45-16-15-44-34-7-3-6-30-32(34)24-51(43(30)57)38-10-11-39(54)48-42(38)56/h2-9,20-22,28,38,44H,10-19,23-24H2,1H3,(H,45,55)(H,48,54,56)",MYMXYDSTYJHREL-UHFFFAOYSA-N
3814,1.8,97,1.8,97,Q09472,EP300,CRBN,,JET-156,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-17-12-37-33(23-50)40(49-52(37)28-13-18-58-19-14-28)29-5-2-4-26-20-36(47-22-31(26)29)27-8-9-35(46-21-27)41(55)45-16-15-44-34-7-3-6-30-32(34)24-51(43(30)57)38-10-11-39(54)48-42(38)56/h2-9,20-22,28,38,44H,10-19,23-24H2,1H3,(H,45,55)(H,48,54,56)",MYMXYDSTYJHREL-UHFFFAOYSA-N
3815,0.2,98,0.2,98,Q92793,CBP,CRBN,,JET-153,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-18-13-38-34(24-51)41(50-53(38)29-14-19-59-20-15-29)30-6-2-5-27-21-37(48-23-32(27)30)28-9-10-36(47-22-28)42(56)46-17-4-16-45-35-8-3-7-31-33(35)25-52(44(31)58)39-11-12-40(55)49-43(39)57/h2-3,5-10,21-23,29,39,45H,4,11-20,24-25H2,1H3,(H,46,56)(H,49,55,57)",XETBTLFBEYTSGJ-UHFFFAOYSA-N
3815,1.8,95,1.8,95,Q09472,EP300,CRBN,,JET-153,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-18-13-38-34(24-51)41(50-53(38)29-14-19-59-20-15-29)30-6-2-5-27-21-37(48-23-32(27)30)28-9-10-36(47-22-28)42(56)46-17-4-16-45-35-8-3-7-31-33(35)25-52(44(31)58)39-11-12-40(55)49-43(39)57/h2-3,5-10,21-23,29,39,45H,4,11-20,24-25H2,1H3,(H,46,56)(H,49,55,57)",XETBTLFBEYTSGJ-UHFFFAOYSA-N
3816,1.1,80,1.1,80,Q92793,CBP,CRBN,,JET-157,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-16-11-37-34(24-50)40(49-52(37)30-12-17-58-18-13-30)32-4-2-3-26-20-36(47-22-33(26)32)27-5-8-35(46-21-27)41(55)45-15-14-44-29-6-7-31-28(19-29)23-51(43(31)57)38-9-10-39(54)48-42(38)56/h2-8,19-22,30,38,44H,9-18,23-24H2,1H3,(H,45,55)(H,48,54,56)",XHEUEZODLRVMMV-UHFFFAOYSA-N
3816,5.1,73,5.1,73,Q09472,EP300,CRBN,,JET-157,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-16-11-37-34(24-50)40(49-52(37)30-12-17-58-18-13-30)32-4-2-3-26-20-36(47-22-33(26)32)27-5-8-35(46-21-27)41(55)45-15-14-44-29-6-7-31-28(19-29)23-51(43(31)57)38-9-10-39(54)48-42(38)56/h2-8,19-22,30,38,44H,9-18,23-24H2,1H3,(H,45,55)(H,48,54,56)",XHEUEZODLRVMMV-UHFFFAOYSA-N
3817,0.1,99,<0.1,99,Q92793,CBP,CRBN,,JET-158,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-17-12-38-35(25-51)41(50-53(38)31-13-18-59-19-14-31)33-5-2-4-27-21-37(48-23-34(27)33)28-6-9-36(47-22-28)42(56)46-16-3-15-45-30-7-8-32-29(20-30)24-52(44(32)58)39-10-11-40(55)49-43(39)57/h2,4-9,20-23,31,39,45H,3,10-19,24-25H2,1H3,(H,46,56)(H,49,55,57)",JJWLIXJPPKOFQJ-UHFFFAOYSA-N
3817,0.3,99,0.3,99,Q09472,EP300,CRBN,,JET-158,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-17-12-38-35(25-51)41(50-53(38)31-13-18-59-19-14-31)33-5-2-4-27-21-37(48-23-34(27)33)28-6-9-36(47-22-28)42(56)46-16-3-15-45-30-7-8-32-29(20-30)24-52(44(32)58)39-10-11-40(55)49-43(39)57/h2,4-9,20-23,31,39,45H,3,10-19,24-25H2,1H3,(H,46,56)(H,49,55,57)",JJWLIXJPPKOFQJ-UHFFFAOYSA-N
3818,1.8,86,1.8,86,Q92793,CBP,CRBN,,JET-179,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.57,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-19-14-38-34(25-53)42(51-55(38)30-15-20-62-21-16-30)31-5-2-4-27-22-37(48-24-33(27)31)28-8-9-36(47-23-28)45(60)52-17-12-29(13-18-52)49-35-7-3-6-32-41(35)46(61)54(44(32)59)39-10-11-40(57)50-43(39)58/h2-9,22-24,29-30,39,49H,10-21,25H2,1H3,(H,50,57,58)",GQZPPJBTNANHER-UHFFFAOYSA-N
3819,0.2,99,0.2,99,Q92793,CBP,CRBN,,JET-181,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-19-14-37-34(25-53)42(51-55(37)30-15-20-62-21-16-30)31-5-2-4-27-22-36(48-24-33(27)31)28-8-9-35(47-23-28)43(58)49-29-12-17-52(18-13-29)38-7-3-6-32-41(38)46(61)54(45(32)60)39-10-11-40(57)50-44(39)59/h2-9,22-24,29-30,39H,10-21,25H2,1H3,(H,49,58)(H,50,57,59)",XPOGTFDQDPCEDH-UHFFFAOYSA-N
3819,1.6,99,1.6,99,Q09472,EP300,CRBN,,JET-181,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-19-14-37-34(25-53)42(51-55(37)30-15-20-62-21-16-30)31-5-2-4-27-22-36(48-24-33(27)31)28-8-9-35(47-23-28)43(58)49-29-12-17-52(18-13-29)38-7-3-6-32-41(38)46(61)54(45(32)60)39-10-11-40(57)50-44(39)59/h2-9,22-24,29-30,39H,10-21,25H2,1H3,(H,49,58)(H,50,57,59)",XPOGTFDQDPCEDH-UHFFFAOYSA-N
3820,3.7,85,3.7,85,Q92793,CBP,CRBN,,JET-184,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(C6CN(C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,2.93,65,11,12,1,7,180.24,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)55-19-14-40-37(27-55)45(53-58(40)33-15-20-65-21-16-33)34-5-2-4-30-22-39(51-24-36(30)34)31-8-9-38(50-23-31)48(63)54-17-12-29(13-18-54)32-25-56(26-32)41-7-3-6-35-44(41)49(64)57(47(35)62)42-10-11-43(60)52-46(42)61/h2-9,22-24,29,32-33,42H,10-21,25-27H2,1H3,(H,52,60,61)",ZXEZOPTWSHMEHU-UHFFFAOYSA-N
3821,40,58,40,58,Q92793,CBP,CRBN,,JET-185,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(C6CCN(C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,904.041,903.406795,3.65,67,11,12,1,7,180.24,C51H53N9O7,"InChI=1S/C51H53N9O7/c1-30(61)58-23-16-42-39(29-58)47(55-60(42)35-17-24-67-25-18-35)36-5-2-4-33-26-41(53-28-38(33)36)34-8-9-40(52-27-34)50(65)57-21-14-32(15-22-57)31-12-19-56(20-13-31)43-7-3-6-37-46(43)51(66)59(49(37)64)44-10-11-45(62)54-48(44)63/h2-9,26-28,31-32,35,44H,10-25,29H2,1H3,(H,54,62,63)",ITSNPCRTAAEVPC-UHFFFAOYSA-N
3822,1.7,96,1.7,96,Q92793,CBP,CRBN,,JET-188,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC6(CC5)CC(NC5=CC=CC7=C5C(=O)N(C5CCC(=O)NC5=O)C7=O)C6)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)56-17-12-40-36(27-56)44(54-58(40)32-13-20-65-21-14-32)33-5-2-4-29-22-39(51-26-35(29)33)30-8-9-38(50-25-30)47(63)55-18-15-49(16-19-55)23-31(24-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22,25-26,31-32,41,52H,10-21,23-24,27H2,1H3,(H,53,60,61)",CLMAGEKQBJFDQU-UHFFFAOYSA-N
3822,9.3,51,9.3,51,Q09472,EP300,CRBN,,JET-188,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC6(CC5)CC(NC5=CC=CC7=C5C(=O)N(C5CCC(=O)NC5=O)C7=O)C6)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)56-17-12-40-36(27-56)44(54-58(40)32-13-20-65-21-14-32)33-5-2-4-29-22-39(51-26-35(29)33)30-8-9-38(50-25-30)47(63)55-18-15-49(16-19-55)23-31(24-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22,25-26,31-32,41,52H,10-21,23-24,27H2,1H3,(H,53,60,61)",CLMAGEKQBJFDQU-UHFFFAOYSA-N
3824,4.8,81,4.8,81,Q92793,CBP,CRBN,,JET-192,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CCC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,44,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)55-19-14-40-36(25-55)44(54-58(40)32-15-20-65-21-16-32)33-5-2-4-29-22-39(51-24-35(29)33)30-8-9-38(50-23-30)47(63)56-26-49(27-56)17-12-31(13-18-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22-24,31-32,41,52H,10-21,25-27H2,1H3,(H,53,60,61)",HMLXCHFBGHUPHQ-UHFFFAOYSA-N
3824,25,62,25,62,Q09472,EP300,CRBN,,JET-192,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CCC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)55-19-14-40-36(25-55)44(54-58(40)32-15-20-65-21-16-32)33-5-2-4-29-22-39(51-24-35(29)33)30-8-9-38(50-23-30)47(63)56-26-49(27-56)17-12-31(13-18-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22-24,31-32,41,52H,10-21,25-27H2,1H3,(H,53,60,61)",HMLXCHFBGHUPHQ-UHFFFAOYSA-N
3825,0.3,99,0.3,99,Q92793,CBP,CRBN,,JET-193,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.3,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,847.933,847.3441948,2.46,63,11,12,2,7,189.03,C47H45N9O7,"InChI=1S/C47H45N9O7/c1-26(57)53-15-12-38-34(23-53)42(52-56(38)30-13-16-63-17-14-30)31-5-2-4-27-18-37(49-22-33(27)31)28-8-9-36(48-21-28)45(61)54-24-47(25-54)19-29(20-47)50-35-7-3-6-32-41(35)46(62)55(44(32)60)39-10-11-40(58)51-43(39)59/h2-9,18,21-22,29-30,39,50H,10-17,19-20,23-25H2,1H3,(H,51,58,59)",ANFFPFFAJDSUIN-UHFFFAOYSA-N
3825,1.1,95,1.1,95,Q09472,EP300,CRBN,,JET-193,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,847.933,847.3441948,2.46,63,11,12,2,7,189.03,C47H45N9O7,"InChI=1S/C47H45N9O7/c1-26(57)53-15-12-38-34(23-53)42(52-56(38)30-13-16-63-17-14-30)31-5-2-4-27-18-37(49-22-33(27)31)28-8-9-36(48-21-28)45(61)54-24-47(25-54)19-29(20-47)50-35-7-3-6-32-41(35)46(62)55(44(32)60)39-10-11-40(58)51-43(39)59/h2-9,18,21-22,29-30,39,50H,10-17,19-20,23-25H2,1H3,(H,51,58,59)",ANFFPFFAJDSUIN-UHFFFAOYSA-N
3826,1,99,1,99,Q92793,CBP,CRBN,,JET-200,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-18-13-39-36(25-53)42(51-55(39)30-14-19-62-20-15-30)32-4-2-3-27-21-38(48-24-35(27)32)28-5-8-37(47-23-28)43(58)49-29-11-16-52(17-12-29)31-6-7-33-34(22-31)46(61)54(45(33)60)40-9-10-41(57)50-44(40)59/h2-8,21-24,29-30,40H,9-20,25H2,1H3,(H,49,58)(H,50,57,59)",YDXGLXSGGLHGPG-UHFFFAOYSA-N
3826,1.9,99,1.9,99,Q09472,EP300,CRBN,,JET-200,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-18-13-39-36(25-53)42(51-55(39)30-14-19-62-20-15-30)32-4-2-3-27-21-38(48-24-35(27)32)28-5-8-37(47-23-28)43(58)49-29-11-16-52(17-12-29)31-6-7-33-34(22-31)46(61)54(45(33)60)40-9-10-41(57)50-44(40)59/h2-8,21-24,29-30,40H,9-20,25H2,1H3,(H,49,58)(H,50,57,59)",YDXGLXSGGLHGPG-UHFFFAOYSA-N
3827,0.1,99,0.1,99,Q92793,CBP,CRBN,,JET-209,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19.7/0.04/0.54,Inhibit of cell growth of RS4;11/MV4;11/HL-60 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,821.939,821.3649302,2.58,61,10,11,2,7,171.96,C46H47N9O6,"InChI=1S/C46H47N9O6/c1-27(56)53-18-13-40-37(26-53)43(51-55(40)32-14-19-61-20-15-32)35-4-2-3-28-22-39(48-24-36(28)35)29-5-8-38(47-23-29)44(58)49-31-11-16-52(17-12-31)33-6-7-34-30(21-33)25-54(46(34)60)41-9-10-42(57)50-45(41)59/h2-8,21-24,31-32,41H,9-20,25-26H2,1H3,(H,49,58)(H,50,57,59)",OGNHAQXAAGMVOV-UHFFFAOYSA-N
3827,0.2,99,0.2,99,Q09472,EP300,CRBN,,JET-209,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3,Inhibit of cell growth of MOLM-13 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,821.939,821.3649302,2.58,61,10,11,2,7,171.96,C46H47N9O6,"InChI=1S/C46H47N9O6/c1-27(56)53-18-13-40-37(26-53)43(51-55(40)32-14-19-61-20-15-32)35-4-2-3-28-22-39(48-24-36(28)35)29-5-8-38(47-23-29)44(58)49-31-11-16-52(17-12-31)33-6-7-34-30(21-33)25-54(46(34)60)41-9-10-42(57)50-45(41)59/h2-8,21-24,31-32,41H,9-20,25-26H2,1H3,(H,49,58)(H,50,57,59)",OGNHAQXAAGMVOV-UHFFFAOYSA-N
3832,3320,89,7510/3320,89,P37840,Alpha-syn,CRBN,,,O=C(CNC1=CC=CC(C2=CC(C3=CC=C4OCOC4=C3)=N[NH]2)=C1)NCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,"Degradation of alphaSyn in Snca OE-PFF seeding HEK293T cells after 48 h treatment/Immunoblot and dot blot (native, conformation-specific) analysis ofHEK293T cells",,,,,,,1161,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00274,767.796,767.2914905,2.67,56,7,13,5,19,211.54,C39H41N7O10,"InChI=1S/C39H41N7O10/c47-34-10-8-31(37(49)43-34)46-38(50)27-5-2-6-28(36(27)39(46)51)40-11-13-52-15-17-54-18-16-53-14-12-41-35(48)22-42-26-4-1-3-24(19-26)29-21-30(45-44-29)25-7-9-32-33(20-25)56-23-55-32/h1-7,9,19-21,31,40,42H,8,10-18,22-23H2,(H,41,48)(H,44,45)(H,43,47,49)",IYFKRANQUJUTKF-UHFFFAOYSA-N
3881,41.5,99,41.5,,P21802,FGFR2,CRBN,,LC-MB3,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(CC(=O)NCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3)=NC=N2)=C1Cl,Degradation of FGFR2 in KATO III cells after 6 h treatment,66,% FGFR2 degradation in KATO III cells after 6 h treatment at 500 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00150,930.851,929.3142629,5.14,65,7,14,5,17,219.77,C44H49Cl2N11O8,"InChI=1S/C44H49Cl2N11O8/c1-54(44(63)53-40-38(45)31(64-2)22-32(65-3)39(40)46)34-23-33(49-25-50-34)51-26-10-12-27(13-11-26)56-20-18-55(19-21-56)24-36(59)48-17-6-4-5-16-47-29-9-7-8-28-37(29)43(62)57(42(28)61)30-14-15-35(58)52-41(30)60/h7-13,22-23,25,30,47H,4-6,14-21,24H2,1-3H3,(H,48,59)(H,53,63)(H,49,50,51)(H,52,58,60)",LDDCFXPRZCUBQQ-UHFFFAOYSA-N
3889,11.8,80,11.8,80,P21802,FGFR2,CRBN,,LC-MB12,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)=NC=N2)=C1Cl,Degradation of FGFR2 in KATO III cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3/29.1/3.7,Inhibit the proliferation of Ba/F3-TEL-FGFR2/KATO III/SNU16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00150,899.793,898.2720637,4.23,63,8,13,3,10,198.95,C43H44Cl2N10O8,"InChI=1S/C43H44Cl2N10O8/c1-51(43(61)50-38-36(44)31(62-2)21-32(63-3)37(38)45)34-22-33(46-23-47-34)48-25-4-6-26(7-5-25)53-16-18-54(19-17-53)40(58)24-12-14-52(15-13-24)27-8-9-28-29(20-27)42(60)55(41(28)59)30-10-11-35(56)49-39(30)57/h4-9,20-24,30H,10-19H2,1-3H3,(H,50,61)(H,46,47,48)(H,49,56,57)",BUEXWHUMUYQITQ-UHFFFAOYSA-N
3893,6220,99,6220,,P49841,GSK-3beta,CRBN,,,O=C(CN1C=C(C2=C(C3=CC=C(Cl)C=C3Cl)C(=O)NC2=O)C2=CC=CC=C21)NCCCOCCCCOCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of GSK-3bata in SH-SY5Y cells after 48 h treatment,,,833,Inhibit of GSK-3beta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.33,PAMPA-BBB assay,,,,,10.1021/acschemneuro.3c00096,857.748,856.2390323,4.92,60,7,11,4,19,194.24,C43H42Cl2N6O9,"InChI=1S/C43H42Cl2N6O9/c44-25-12-13-27(30(45)22-25)37-38(41(56)49-40(37)55)29-23-50(32-11-2-1-8-26(29)32)24-35(53)47-17-7-21-60-19-4-3-18-59-20-6-16-46-31-10-5-9-28-36(31)43(58)51(42(28)57)33-14-15-34(52)48-39(33)54/h1-2,5,8-13,22-23,33,46H,3-4,6-7,14-21,24H2,(H,47,53)(H,48,52,54)(H,49,55,56)",QGECSMFGVLFLIS-UHFFFAOYSA-N
3899,0.2883,99,0.2883/0.7839,,P16591,FER,CRBN,,SIAIS352008,COC1=CC(N2CCC(N3CCN(CCCCCC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of FER in OVCAR-5/CAOV4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.jbc.2023.104825,882.447,881.3908802,6.12,62,8,12,3,15,152.34,C46H57ClN9O5P,"InChI=1S/C46H57ClN9O5P/c1-61-40-28-33(15-16-37(40)50-46-48-29-36(47)43(52-46)49-38-13-6-7-14-41(38)62(2,3)60)54-22-19-32(20-23-54)55-26-24-53(25-27-55)21-8-4-5-10-31-11-9-12-34-35(31)30-56(45(34)59)39-17-18-42(57)51-44(39)58/h6-7,9,11-16,28-29,32,39H,4-5,8,10,17-27,30H2,1-3H3,(H,51,57,58)(H2,48,49,50,52)",RMADJZZMVLKVKG-UHFFFAOYSA-N
3900,0.4113,99,0.4113/0.4356,,P16591,FER,CRBN,,SIAIS262039,COC1=CC(N2CCC(N3CCN(CCCC#CC4=CC=CC5=C4CC(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1,Degradation of FER in OVCAR-5/CAOV4 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.jbc.2023.104825,877.427,876.3643311,6.26,62,8,12,3,12,149.1,C47H54ClN8O5P,"InChI=1S/C47H54ClN8O5P/c1-61-41-28-33(15-17-39(41)51-47-49-30-38(48)45(53-47)50-40-13-6-7-14-42(40)62(2,3)60)55-22-19-32(20-23-55)56-26-24-54(25-27-56)21-8-4-5-10-31-11-9-12-34-36(31)29-37(44(34)58)35-16-18-43(57)52-46(35)59/h6-7,9,11-15,17,28,30,32,35,37H,4,8,16,18-27,29H2,1-3H3,(H,52,57,59)(H2,49,50,51,53)",GJAQYPRTMBNTHS-UHFFFAOYSA-N
3901,31.2,94,31.2/32.1,94/97.1,Q06187,BTK,CRBN,,PTD1,C[C@H]1CN(C(=O)CCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1034.232,1033.517408,5.71,76,10,15,4,18,224.41,C57H67N11O8,"InChI=1S/C57H67N11O8/c1-35-32-64(49(71)15-10-8-6-5-7-9-11-21-58-42-14-12-13-40-50(42)56(76)68(53(40)73)44-17-19-48(70)62-52(44)72)23-24-65(35)38-16-18-47(60-31-38)61-43-27-37(33-63(4)54(43)74)39-20-22-59-51(41(39)34-69)67-26-25-66-45(55(67)75)28-36-29-57(2,3)30-46(36)66/h12-14,16,18,20,22,27-28,31,33,35,44,58,69H,5-11,15,17,19,21,23-26,29-30,32,34H2,1-4H3,(H,60,61)(H,62,70,72)/t35-,44?/m0/s1",NOYFZERQOYOFSG-FZXGYKHYSA-N
3902,4.1,97.7,6.6/4.1,97.1/97.7,Q06187,BTK,CRBN,,PTD2,C[C@H]1CN(C(=O)CCCCCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1094.24,1093.502152,3.01,80,10,17,4,20,259.94,C58H67N11O11,"InChI=1S/C58H67N11O11/c1-35-31-65(50(73)12-7-5-6-8-23-79-24-25-80-34-49(72)62-42-11-9-10-40-51(42)57(78)69(54(40)75)44-14-16-48(71)63-53(44)74)19-20-66(35)38-13-15-47(60-30-38)61-43-26-37(32-64(4)55(43)76)39-17-18-59-52(41(39)33-70)68-22-21-67-45(56(68)77)27-36-28-58(2,3)29-46(36)67/h9-11,13,15,17-18,26-27,30,32,35,44,70H,5-8,12,14,16,19-25,28-29,31,33-34H2,1-4H3,(H,60,61)(H,62,72)(H,63,71,74)/t35-,44?/m0/s1",YEEWMSGCZCRCGP-FZXGYKHYSA-N
3903,,,>3000/>3000,25720,Q06187,BTK,VHL,,PTD3,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCCCCCC(=O)N3CCN(C4=CC=C(NC5=CC(C6=CC=NC(N7CCN8C(=CC9=C8CC(C)(C)C9)C7=O)=C6CO)=CN(C)C5=O)N=C4)[C@@H](C)C3)C(C)(C)C)C=C2)SC=N1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1251.566,1250.631058,5.47,90,10,18,5,24,258.92,C67H86N12O10S,"InChI=1S/C67H86N12O10S/c1-42-36-75(22-23-76(42)48-18-19-56(69-35-48)72-52-29-47(37-74(8)63(52)85)50-20-21-68-61(51(50)39-80)78-25-24-77-54(64(78)86)30-46-32-67(6,7)33-55(46)77)58(83)13-11-9-10-12-26-88-27-28-89-40-57(82)73-60(66(3,4)5)65(87)79-38-49(81)31-53(79)62(84)70-34-44-14-16-45(17-15-44)59-43(2)71-41-90-59/h14-21,29-30,35,37,41-42,49,53,60,80-81H,9-13,22-28,31-34,36,38-40H2,1-8H3,(H,69,72)(H,70,84)(H,73,82)/t42-,49+,53-,60+/m0/s1",AVBGZOOQMRTGSE-FTRQEPDZSA-N
3904,7,95.6,7/9.7,95.6/96.9,Q06187,BTK,CRBN,,PTD4,C[C@H]1CN(CCCCCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1066.23,1065.507237,3.44,78,10,17,4,20,242.87,C57H67N11O10,"InChI=1S/C57H67N11O10/c1-35-31-64(18-7-5-6-8-23-77-24-25-78-34-49(71)61-42-11-9-10-40-50(42)56(76)68(53(40)73)44-13-15-48(70)62-52(44)72)19-20-65(35)38-12-14-47(59-30-38)60-43-26-37(32-63(4)54(43)74)39-16-17-58-51(41(39)33-69)67-22-21-66-45(55(67)75)27-36-28-57(2,3)29-46(36)66/h9-12,14,16-17,26-27,30,32,35,44,69H,5-8,13,15,18-25,28-29,31,33-34H2,1-4H3,(H,59,60)(H,61,71)(H,62,70,72)/t35-,44?/m0/s1",RMZBDXZBUMCJJL-FZXGYKHYSA-N
3905,4,98.3,4/7.2,98.3/98.8,Q06187,BTK,CRBN,,PTD5,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(C(=O)CCCCCCOCCOCC(=O)NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1080.213,1079.486502,2.58,79,10,17,4,20,259.94,C57H65N11O11,"InChI=1S/C57H65N11O11/c1-57(2)29-35-28-44-55(76)67(23-22-66(44)45(35)30-57)51-40(33-69)38(16-17-58-51)36-27-42(54(75)63(3)32-36)60-46-14-12-37(31-59-46)64-18-20-65(21-19-64)49(72)11-6-4-5-7-24-78-25-26-79-34-48(71)61-41-10-8-9-39-50(41)56(77)68(53(39)74)43-13-15-47(70)62-52(43)73/h8-10,12,14,16-17,27-28,31-32,43,69H,4-7,11,13,15,18-26,29-30,33-34H2,1-3H3,(H,59,60)(H,61,71)(H,62,70,73)",XLGXYNSRFYOHBS-UHFFFAOYSA-N
3906,5.3,97.2,5.3/6.8,97.2/97.7,Q06187,BTK,CRBN,,PTD6,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(CCCCCCOCCOCC(=O)NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1052.203,1051.491587,3,77,10,17,4,20,242.87,C56H65N11O10,"InChI=1S/C56H65N11O10/c1-56(2)29-35-28-44-54(74)66(23-22-65(44)45(35)30-56)50-40(33-68)38(15-16-57-50)36-27-42(53(73)62(3)32-36)59-46-13-11-37(31-58-46)64-20-18-63(19-21-64)17-6-4-5-7-24-76-25-26-77-34-48(70)60-41-10-8-9-39-49(41)55(75)67(52(39)72)43-12-14-47(69)61-51(43)71/h8-11,13,15-16,27-28,31-32,43,68H,4-7,12,14,17-26,29-30,33-34H2,1-3H3,(H,58,59)(H,60,70)(H,61,69,71)",ZWXDWXHNSALXLR-UHFFFAOYSA-N
3907,2,96.9,2/3.5,96.9/98,Q06187,BTK,CRBN,,PTD7,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(C(=O)CCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,978.124,977.4548078,3.65,72,10,15,4,15,224.41,C53H59N11O8,"InChI=1S/C53H59N11O8/c1-53(2)27-32-26-41-51(71)63(24-23-62(41)42(32)28-53)47-37(31-65)35(16-18-55-47)33-25-39(50(70)59(3)30-33)57-43-14-12-34(29-56-43)60-19-21-61(22-20-60)45(67)11-6-4-5-7-17-54-38-10-8-9-36-46(38)52(72)64(49(36)69)40-13-15-44(66)58-48(40)68/h8-10,12,14,16,18,25-26,29-30,40,54,65H,4-7,11,13,15,17,19-24,27-28,31H2,1-3H3,(H,56,57)(H,58,66,68)",WQCUYCXVAFPYDC-UHFFFAOYSA-N
3908,3.2,95,3.2/3.3,95/97,Q06187,BTK,CRBN,,PTD8,C[C@H]1CN(C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,992.151,991.4704579,4.09,73,10,15,4,15,224.41,C54H61N11O8,"InChI=1S/C54H61N11O8/c1-32-29-61(46(68)12-7-5-6-8-18-55-39-11-9-10-37-47(39)53(73)65(50(37)70)41-14-16-45(67)59-49(41)69)20-21-62(32)35-13-15-44(57-28-35)58-40-24-34(30-60(4)51(40)71)36-17-19-56-48(38(36)31-66)64-23-22-63-42(52(64)72)25-33-26-54(2,3)27-43(33)63/h9-11,13,15,17,19,24-25,28,30,32,41,55,66H,5-8,12,14,16,18,20-23,26-27,29,31H2,1-4H3,(H,57,58)(H,59,67,69)/t32-,41?/m0/s1",NCZRXARMAOKBHX-IROIYFLTSA-N
3909,0.9,95.7,0.9/1.0,95.7/97.4,Q06187,BTK,CRBN,,PTD9,C[C@H]1CN(C(=O)CCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,950.07,949.4235077,2.83,70,10,15,4,12,224.41,C51H55N11O8,"InChI=1S/C51H55N11O8/c1-29-26-58(43(65)9-6-15-52-36-8-5-7-34-44(36)50(70)62(47(34)67)38-11-13-42(64)56-46(38)66)17-18-59(29)32-10-12-41(54-25-32)55-37-21-31(27-57(4)48(37)68)33-14-16-53-45(35(33)28-63)61-20-19-60-39(49(61)69)22-30-23-51(2,3)24-40(30)60/h5,7-8,10,12,14,16,21-22,25,27,29,38,52,63H,6,9,11,13,15,17-20,23-24,26,28H2,1-4H3,(H,54,55)(H,56,64,66)/t29-,38?/m0/s1",HSWPRTMIJULITP-SYOBGBQASA-N
3910,0.5,97.1,0.5/0.6,97.1/95.7,Q06187,BTK,CRBN,,PTD10,C[C@H]1CN(C(=O)CNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,97,Inhibit of BTK of HEK293 cells,,,2.28,TR-FRET,,,,,,,,,,,107,Inhibit of CRBN of HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4/2.2,Inhibition of TMD8/Mino cells growth after 48h treatment,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,922.016,921.3922076,2.57,68,10,15,4,10,224.41,C49H51N11O8,"InChI=1S/C49H51N11O8/c1-27-24-56(41(63)23-51-34-7-5-6-32-42(34)48(68)60(45(32)65)36-9-11-40(62)54-44(36)64)14-15-57(27)30-8-10-39(52-22-30)53-35-18-29(25-55(4)46(35)66)31-12-13-50-43(33(31)26-61)59-17-16-58-37(47(59)67)19-28-20-49(2,3)21-38(28)58/h5-8,10,12-13,18-19,22,25,27,36,51,61H,9,11,14-17,20-21,23-24,26H2,1-4H3,(H,52,53)(H,54,62,64)/t27-,36?/m0/s1",DGDYTCIJBXSVPQ-XLYAUNJQSA-N
3911,1.3,96.1,1.3/4.1,96.1/95.1,Q06187,BTK,CRBN,,PTD11,C[C@H]1CN(C(=O)CCOCCOCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1024.149,1023.460287,2.18,75,10,17,4,17,242.87,C54H61N11O10,"InChI=1S/C54H61N11O10/c1-32-29-61(46(68)13-20-74-22-23-75-21-15-55-39-7-5-6-37-47(39)53(73)65(50(37)70)41-9-11-45(67)59-49(41)69)16-17-62(32)35-8-10-44(57-28-35)58-40-24-34(30-60(4)51(40)71)36-12-14-56-48(38(36)31-66)64-19-18-63-42(52(64)72)25-33-26-54(2,3)27-43(33)63/h5-8,10,12,14,24-25,28,30,32,41,55,66H,9,11,13,15-23,26-27,29,31H2,1-4H3,(H,57,58)(H,59,67,69)/t32-,41?/m0/s1",FVLYVMPYPNMLBF-IROIYFLTSA-N
3912,3.6,89.8,3.6/4.6,89.8/89.2,Q06187,BTK,CRBN,,PTD12,C[C@H]1CN(C(=O)CNC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,908.033,907.412943,2.07,67,10,14,4,10,207.34,C49H53N11O7,"InChI=1S/C49H53N11O7/c1-28-24-56(43(63)23-51-36-7-5-6-33-34(36)26-60(46(33)65)38-9-11-42(62)54-45(38)64)14-15-57(28)31-8-10-41(52-22-31)53-37-18-30(25-55(4)47(37)66)32-12-13-50-44(35(32)27-61)59-17-16-58-39(48(59)67)19-29-20-49(2,3)21-40(29)58/h5-8,10,12-13,18-19,22,25,28,38,51,61H,9,11,14-17,20-21,23-24,26-27H2,1-4H3,(H,52,53)(H,54,62,64)/t28-,38?/m0/s1",KFODTDSGVNLISY-XRTOLJPQSA-N
3913,,,>3000/>3000,30.1/30,Q06187,BTK,CRBN,,PTD13,C[C@H]1CN(C(=O)C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,320,Inhibit of BTK of HEK293 cells,,,0.86,TR-FRET,,,,,,,,,,,7000,Inhibit of CRBN of HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,892.974,892.3656585,1.97,66,10,14,3,8,212.38,C48H48N10O8,"InChI=1S/C48H48N10O8/c1-26-23-54(43(62)31-6-5-7-32-40(31)47(66)58(44(32)63)35-9-11-39(60)52-42(35)61)14-15-55(26)29-8-10-38(50-22-29)51-34-18-28(24-53(4)45(34)64)30-12-13-49-41(33(30)25-59)57-17-16-56-36(46(57)65)19-27-20-48(2,3)21-37(27)56/h5-8,10,12-13,18-19,22,24,26,35,59H,9,11,14-17,20-21,23,25H2,1-4H3,(H,50,51)(H,52,60,61)/t26-,35?/m0/s1",TZJCAGSJIMIXFS-HJYWNDIWSA-N
3914,1.7,96.2,1.7/3.1,96.2/97,Q06187,BTK,CRBN,,PTD14,C[C@H]1CN(C(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,923,922.3762232,2.01,68,10,15,3,10,221.61,C49H50N10O9,"InChI=1S/C49H50N10O9/c1-27-23-55(41(62)26-68-38-7-5-6-32-42(38)48(67)59(45(32)64)35-9-11-40(61)53-44(35)63)14-15-56(27)30-8-10-39(51-22-30)52-34-18-29(24-54(4)46(34)65)31-12-13-50-43(33(31)25-60)58-17-16-57-36(47(58)66)19-28-20-49(2,3)21-37(28)57/h5-8,10,12-13,18-19,22,24,27,35,60H,9,11,14-17,20-21,23,25-26H2,1-4H3,(H,51,52)(H,53,61,63)/t27-,35?/m0/s1",ACFXVKUYZHYIDS-UAJNXHJVSA-N
3915,113,89,113/348,89/89.8,Q06187,BTK,CRBN,,PTD15,C[C@H]1CN(C(=O)CCCCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,3200,Inhibit of BTK of HEK293 cells,,,107,TR-FRET,,,,,,,,,,,5000,Inhibit of CRBN of HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1062.286,1061.548708,6.79,78,10,15,4,20,224.41,C59H71N11O8,"InChI=1S/C59H71N11O8/c1-37-34-66(51(73)17-12-10-8-6-5-7-9-11-13-23-60-44-16-14-15-42-52(44)58(78)70(55(42)75)46-19-21-50(72)64-54(46)74)25-26-67(37)40-18-20-49(62-33-40)63-45-29-39(35-65(4)56(45)76)41-22-24-61-53(43(41)36-71)69-28-27-68-47(57(69)77)30-38-31-59(2,3)32-48(38)68/h14-16,18,20,22,24,29-30,33,35,37,46,60,71H,5-13,17,19,21,23,25-28,31-32,34,36H2,1-4H3,(H,62,63)(H,64,72,74)/t37-,46?/m0/s1",HYZMVIWTOQSXRR-YLKGYVPLSA-N
3916,0.8,97.6,0.9/0.8,97.3/97.6,Q06187,BTK,CRBN,,PTD16,C[C@H]1CN(C(=O)CNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,922.016,921.3922076,2.02,68,10,15,4,10,224.41,C49H51N11O8,"InChI=1S/C49H51N11O8/c1-27-24-56(42(63)23-51-30-5-7-33-34(19-30)46(66)60(45(33)65)37-8-10-41(62)54-44(37)64)13-14-57(27)31-6-9-40(52-22-31)53-36-17-29(25-55(4)47(36)67)32-11-12-50-43(35(32)26-61)59-16-15-58-38(48(59)68)18-28-20-49(2,3)21-39(28)58/h5-7,9,11-12,17-19,22,25,27,37,51,61H,8,10,13-16,20-21,23-24,26H2,1-4H3,(H,52,53)(H,54,62,64)/t27-,37?/m0/s1",QOXMMJLQRKLFLI-YTCZSSRZSA-N
3940,3017,91.78,3017,91.78,Q86WV6,STING,VHL,,UNC8885,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1362.63,1361.649168,5.04,98,10,22,7,29,344.23,C69H87N17O11S,"InChI=1S/C69H87N17O11S/c1-10-85-52(31-41(3)79-85)64(92)77-67-75-50-34-47(62(90)71-22-13-12-17-56(88)76-60(69(6,7)8)66(94)84-39-48(87)37-51(84)63(91)72-38-44-18-20-45(21-19-44)59-43(5)73-40-98-59)36-54(95-9)57(50)82(67)24-14-15-25-83-58-49(74-68(83)78-65(93)53-32-42(4)80-86(53)11-2)33-46(61(70)89)35-55(58)97-28-16-23-81-26-29-96-30-27-81/h14-15,18-21,31-36,40,48,51,60,87H,10-13,16-17,22-30,37-39H2,1-9H3,(H2,70,89)(H,71,90)(H,72,91)(H,76,88)(H,74,78,93)(H,75,77,92)/b15-14+/t48-,51+,60-/m1/s1",AMAUGUBSDJILRS-FBHKZBIFSA-N
3941,3340,88.84,3340,88.84,Q86WV6,STING,VHL,,UNC8957,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1378.629,1377.644082,4.18,99,10,23,7,30,353.46,C69H87N17O12S,"InChI=1S/C69H87N17O12S/c1-10-85-52(31-41(3)79-85)64(92)77-67-75-50-34-47(62(90)71-20-28-96-27-19-56(88)76-60(69(6,7)8)66(94)84-39-48(87)37-51(84)63(91)72-38-44-15-17-45(18-16-44)59-43(5)73-40-99-59)36-54(95-9)57(50)82(67)22-12-13-23-83-58-49(74-68(83)78-65(93)53-32-42(4)80-86(53)11-2)33-46(61(70)89)35-55(58)98-26-14-21-81-24-29-97-30-25-81/h12-13,15-18,31-36,40,48,51,60,87H,10-11,14,19-30,37-39H2,1-9H3,(H2,70,89)(H,71,90)(H,72,91)(H,76,88)(H,74,78,93)(H,75,77,92)/b13-12+/t48-,51+,60-/m1/s1",ZLDHPMABKBJAKO-KPSRRQFOSA-N
3942,2568,84.21,2568,84.21,Q86WV6,STING,VHL,,UNC8958,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1392.656,1391.659732,4.53,100,10,23,7,31,353.46,C70H89N17O12S,"InChI=1S/C70H89N17O12S/c1-10-86-53(32-42(3)80-86)65(93)78-68-76-51-35-48(63(91)72-21-14-27-97-29-20-57(89)77-61(70(6,7)8)67(95)85-40-49(88)38-52(85)64(92)73-39-45-16-18-46(19-17-45)60-44(5)74-41-100-60)37-55(96-9)58(51)83(68)23-12-13-24-84-59-50(75-69(84)79-66(94)54-33-43(4)81-87(54)11-2)34-47(62(71)90)36-56(59)99-28-15-22-82-25-30-98-31-26-82/h12-13,16-19,32-37,41,49,52,61,88H,10-11,14-15,20-31,38-40H2,1-9H3,(H2,71,90)(H,72,91)(H,73,92)(H,77,89)(H,75,79,94)(H,76,78,93)/b13-12+/t49-,52+,61-/m1/s1",SKGNNCJNUBGYLI-UZHNTXPQSA-N
3943,1097,99.94,1097,99.94,Q86WV6,STING,VHL,,UNC8899,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1422.682,1421.670297,4.03,102,10,24,7,33,362.69,C71H91N17O13S,"InChI=1S/C71H91N17O13S/c1-10-87-54(33-43(3)81-87)66(94)79-69-77-52-36-49(64(92)73-20-28-99-32-31-98-27-19-58(90)78-62(71(6,7)8)68(96)86-41-50(89)39-53(86)65(93)74-40-46-15-17-47(18-16-46)61-45(5)75-42-102-61)38-56(97-9)59(52)84(69)22-12-13-23-85-60-51(76-70(85)80-67(95)55-34-44(4)82-88(55)11-2)35-48(63(72)91)37-57(60)101-26-14-21-83-24-29-100-30-25-83/h12-13,15-18,33-38,42,50,53,62,89H,10-11,14,19-32,39-41H2,1-9H3,(H2,72,91)(H,73,92)(H,74,93)(H,78,90)(H,76,80,95)(H,77,79,94)/b13-12+/t50-,53+,62-/m1/s1",YHNIOHUOOHUSHO-RSGOQLSOSA-N
3944,2470,89.41,2470,89.41,Q86WV6,STING,VHL,,UNC8972,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1452.708,1451.680862,3.98,104,10,25,7,35,371.92,C72H93N17O14S,"InChI=1S/C72H93N17O14S/c1-10-88-55(33-44(3)82-88)67(95)80-70-78-53-36-50(65(93)74-19-26-99-29-30-101-31-32-102-42-59(91)79-63(72(6,7)8)69(97)87-41-51(90)39-54(87)66(94)75-40-47-15-17-48(18-16-47)62-46(5)76-43-104-62)38-57(98-9)60(53)85(70)21-12-13-22-86-61-52(77-71(86)81-68(96)56-34-45(4)83-89(56)11-2)35-49(64(73)92)37-58(61)103-25-14-20-84-23-27-100-28-24-84/h12-13,15-18,33-38,43,51,54,63,90H,10-11,14,19-32,39-42H2,1-9H3,(H2,73,92)(H,74,93)(H,75,94)(H,79,91)(H,77,81,96)(H,78,80,95)/b13-12+/t51-,54+,63-/m1/s1",IOBMLPNSOHTLEO-USWBJAFXSA-N
3945,924,97.65,924,97.65,Q86WV6,STING,VHL,,UNC8900,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1510.788,1509.722726,3.73,108,10,26,7,39,381.15,C75H99N17O15S,"InChI=1S/C75H99N17O15S/c1-10-91-58(37-47(3)85-91)70(98)83-73-81-56-40-53(42-60(101-9)63(56)88(73)22-12-13-23-89-64-55(80-74(89)84-71(99)59-38-48(4)86-92(59)11-2)39-52(67(76)95)41-61(64)107-26-14-21-87-24-29-104-30-25-87)68(96)77-20-28-103-32-34-106-36-35-105-33-31-102-27-19-62(94)82-66(75(6,7)8)72(100)90-45-54(93)43-57(90)69(97)78-44-50-15-17-51(18-16-50)65-49(5)79-46-108-65/h12-13,15-18,37-42,46,54,57,66,93H,10-11,14,19-36,43-45H2,1-9H3,(H2,76,95)(H,77,96)(H,78,97)(H,82,94)(H,80,84,99)(H,81,83,98)/b13-12+/t54-,57+,66-/m1/s1",IADMWNJOSJGQFE-TUMCZPSUSA-N
3946,4610,80.87,4610,80.87,Q86WV6,STING,VHL,,UNC8910,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1598.894,1597.775156,3.44,114,10,28,7,45,399.61,C79H107N17O17S,"InChI=1S/C79H107N17O17S/c1-10-95-62(41-51(3)89-95)74(102)87-77-85-60-44-57(46-64(105-9)67(60)92(77)22-12-13-23-93-68-59(84-78(93)88-75(103)63-42-52(4)90-96(63)11-2)43-56(71(80)99)45-65(68)113-26-14-21-91-24-29-108-30-25-91)72(100)81-20-28-107-32-34-110-36-38-112-40-39-111-37-35-109-33-31-106-27-19-66(98)86-70(79(6,7)8)76(104)94-49-58(97)47-61(94)73(101)82-48-54-15-17-55(18-16-54)69-53(5)83-50-114-69/h12-13,15-18,41-46,50,58,61,70,97H,10-11,14,19-40,47-49H2,1-9H3,(H2,80,99)(H,81,100)(H,82,101)(H,86,98)(H,84,88,103)(H,85,87,102)/b13-12+/t58-,61+,70-/m1/s1",JNALTWZFLHQBFT-XQTFLGHQSA-N
3947,227,91.68,227,91.68,Q86WV6,STING,VHL,,UNC9036,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1418.738,1417.711768,7.02,102,10,22,7,33,344.23,C73H95N17O11S,"InChI=1S/C73H95N17O11S/c1-10-89-56(35-45(3)83-89)68(96)81-71-79-54-38-51(66(94)75-26-17-15-13-12-14-16-21-60(92)80-64(73(6,7)8)70(98)88-43-52(91)41-55(88)67(95)76-42-48-22-24-49(25-23-48)63-47(5)77-44-102-63)40-58(99-9)61(54)86(71)28-18-19-29-87-62-53(78-72(87)82-69(97)57-36-46(4)84-90(57)11-2)37-50(65(74)93)39-59(62)101-32-20-27-85-30-33-100-34-31-85/h18-19,22-25,35-40,44,52,55,64,91H,10-17,20-21,26-34,41-43H2,1-9H3,(H2,74,93)(H,75,94)(H,76,95)(H,80,92)(H,78,82,97)(H,79,81,96)/b19-18+/t52-,55+,64-/m1/s1",BDSHEGJPPSYXPH-BHPKDWFESA-N
3949,5000,99,5000,,Q00987,MDM2,MDM2,,XR4,COC1=CC(C(N)=O)=CC=C1NC(=O)[C@H]1[C@H](C2=CC=CC(Cl)=C2F)[C@]2(C(=O)NC3=CC(Cl)=CC=C32)[C@H](CC(C)(C)C)N1C(=O)OCCOCCOCCOCCOC(=O)N1[C@@H](CC(C)(C)C)[C@@]2(C(=O)NC3=CC(Cl)=CC=C32)[C@@H](C2=CC=CC(Cl)=C2F)[C@@H]1C(=O)NC1=CC=C(C(N)=O)C=C1OC,Degradation of MDM2 in 22Rv1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3390/molecules28093912,1473.249,1470.415231,10.02,101,10,15,6,24,307.81,C72H76Cl4F2N8O15,"InChI=1S/C72H76Cl4F2N8O15/c1-69(2,3)35-53-71(43-19-17-39(73)33-49(43)83-65(71)91)55(41-11-9-13-45(75)57(41)77)59(63(89)81-47-21-15-37(61(79)87)31-51(47)95-7)85(53)67(93)100-29-27-98-25-23-97-24-26-99-28-30-101-68(94)86-54(36-70(4,5)6)72(44-20-18-40(74)34-50(44)84-66(72)92)56(42-12-10-14-46(76)58(42)78)60(86)64(90)82-48-22-16-38(62(80)88)32-52(48)96-8/h9-22,31-34,53-56,59-60H,23-30,35-36H2,1-8H3,(H2,79,87)(H2,80,88)(H,81,89)(H,82,90)(H,83,91)(H,84,92)/t53-,54-,55-,56-,59+,60+,71+,72+/m0/s1",MWXCGYNSNMJAPZ-GNVMZRKFSA-N
3951,330,99,330/570,,P03372,ERalpha,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCOC3=CC=C(N(CC(F)(F)F)S(=O)(=O)C4C[C@@H]5O[C@H]4C(C4=CC=C(OCC6=CC=C([N+](=O)[O-])C=C6)C=C4)=C5C4=CC=C(O)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of ERalpha in MCF-7/LCC2 cells after 24 h treatment,,,,,,,,,2030,Binding affinity of ERalpha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70930/15230/1560,Inhibition of cell proliferation in MCF-10A (N)/MCF-7 (N)/MCF-7 (H),,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106590,1209.376,1208.421048,9.29,85,9,14,4,23,240.07,C62H67F3N6O12S2,"InChI=1S/C62H67F3N6O12S2/c1-37(40-12-14-43(15-13-40)57-38(2)66-36-84-57)67-59(75)50-31-47(73)33-69(50)60(76)58(61(3,4)5)68-53(74)9-7-6-8-30-81-48-28-22-44(23-29-48)70(35-62(63,64)65)85(79,80)52-32-51-54(41-16-24-46(72)25-17-41)55(56(52)83-51)42-18-26-49(27-19-42)82-34-39-10-20-45(21-11-39)71(77)78/h10-29,36-37,47,50-52,56,58,72-73H,6-9,30-35H2,1-5H3,(H,67,75)(H,68,74)/t37-,47+,50-,51-,52?,56+,58+/m0/s1",PNZJQDPPJCEDMR-ZKDDQZBNSA-N
3987,100.4,99,100.4,,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CCN5CCC(CN[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,76.0/69.5,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,926.519,925.4042082,7.29,67,10,12,4,14,181.96,C51H56ClN9O6,"InChI=1S/C51H56ClN9O6/c52-42-27-37(67-36-4-2-1-3-5-36)11-13-39(42)46(63)41-29-54-47-45(41)48(56-30-55-47)57-34-8-6-33(7-9-34)53-28-32-17-22-59(23-18-32)21-16-31-19-24-60(25-20-31)35-10-12-38-40(26-35)51(66)61(50(38)65)43-14-15-44(62)58-49(43)64/h1-5,10-13,26-27,29-34,43,53H,6-9,14-25,28H2,(H,58,62,64)(H2,54,55,56,57)/t33-,34+,43?",DUUXNDSFGCSPHG-TWZCHNMGSA-N
3995,24,99,24,,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,79.5/73.5,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,940.502,939.3834727,6.61,68,10,12,4,13,199.03,C51H54ClN9O7,"InChI=1S/C51H54ClN9O7/c52-41-26-36(68-35-4-2-1-3-5-35)11-13-38(41)46(64)40-27-53-47-45(40)48(55-29-54-47)57-33-8-6-32(7-9-33)56-44(63)24-30-16-20-59(21-17-30)28-31-18-22-60(23-19-31)34-10-12-37-39(25-34)51(67)61(50(37)66)42-14-15-43(62)58-49(42)65/h1-5,10-13,25-27,29-33,42H,6-9,14-24,28H2,(H,56,63)(H,58,62,65)(H2,53,54,55,57)/t32-,33+,42?",CSQPDRJYNLSGQW-GJYNQWBJSA-N
3997,8.8,94.1,8.8,94.1,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,85.0/82.5,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.4/82.1/59.5,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,954.529,953.3991228,6.97,69,10,12,4,14,199.03,C52H56ClN9O7,"InChI=1S/C52H56ClN9O7/c53-42-28-37(69-36-4-2-1-3-5-36)11-13-39(42)47(65)41-29-54-48-46(41)49(56-30-55-48)58-34-8-6-33(7-9-34)57-45(64)26-32-17-22-60(23-18-32)21-16-31-19-24-61(25-20-31)35-10-12-38-40(27-35)52(68)62(51(38)67)43-14-15-44(63)59-50(43)66/h1-5,10-13,27-34,43H,6-9,14-26H2,(H,57,64)(H,59,63,66)(H2,54,55,56,58)/t33-,34+,43?",VWELFQOMWDAJDG-TWZCHNMGSA-N
3998,9.3,93.6,9.3,93.6,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC(F)=C(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,87.0/88.5,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.2/47.0/116.5,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,972.519,971.389701,7.07,70,10,12,4,14,199.03,C52H55ClFN9O7,"InChI=1S/C52H55ClFN9O7/c53-40-25-35(70-34-4-2-1-3-5-34)10-11-36(40)47(66)39-28-55-48-46(39)49(57-29-56-48)59-33-8-6-32(7-9-33)58-45(65)24-31-15-20-61(21-16-31)19-14-30-17-22-62(23-18-30)43-27-38-37(26-41(43)54)51(68)63(52(38)69)42-12-13-44(64)60-50(42)67/h1-5,10-11,25-33,42H,6-9,12-24H2,(H,58,65)(H,60,64,67)(H2,55,56,57,59)/t32-,33+,42?",DXWNLVKIDXFRLV-GJYNQWBJSA-N
3999,7.4,90.6,7.4,90.6,Q06187,BTK,CRBN,,,O=C1CCC(N2CC3=CC=C(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,83.0/87.0,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.9/9.3/34.4,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,940.546,939.4198583,7.02,68,10,11,4,14,181.96,C52H58ClN9O6,"InChI=1S/C52H58ClN9O6/c53-43-28-39(68-38-4-2-1-3-5-38)12-13-40(43)48(65)42-29-54-49-47(42)50(56-31-55-49)58-36-9-7-35(8-10-36)57-46(64)26-33-17-22-60(23-18-33)21-16-32-19-24-61(25-20-32)37-11-6-34-30-62(52(67)41(34)27-37)44-14-15-45(63)59-51(44)66/h1-6,11-13,27-29,31-33,35-36,44H,7-10,14-26,30H2,(H,57,64)(H,59,63,66)(H2,54,55,56,58)/t35-,36+,44?",JHVZXEQESAUISG-GAOBAYOOSA-N
4000,10.1,90.1,10.1,90.1,Q06187,BTK,CRBN,,,O=C1CCC(N2CC3=CC(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)=CC=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,80.4/86.0,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.7/15.5,Inhibition of cell proliferation in OCI-ly10/TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,940.546,939.4198583,7.02,68,10,11,4,14,181.96,C52H58ClN9O6,"InChI=1S/C52H58ClN9O6/c53-43-28-39(68-38-4-2-1-3-5-38)11-13-41(43)48(65)42-29-54-49-47(42)50(56-31-55-49)58-36-8-6-35(7-9-36)57-46(64)26-33-17-22-60(23-18-33)21-16-32-19-24-61(25-20-32)37-10-12-40-34(27-37)30-62(52(40)67)44-14-15-45(63)59-51(44)66/h1-5,10-13,27-29,31-33,35-36,44H,6-9,14-26,30H2,(H,57,64)(H,59,63,66)(H2,54,55,56,58)/t35-,36+,44?",MZOWIXBWDNSXQH-GAOBAYOOSA-N
4001,7,96.5,7,96.5,Q06187,BTK,CRBN,,,O=C1CCC(N2CC3=CC(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)=C(F)C=C3C2=O)C(=O)N1,Degradation of BTK in JeKo-1 cells after 24 h treatment,91.0/89.0,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3/4.5/38.1,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,958.536,957.4104364,7.13,69,10,11,4,14,181.96,C52H57ClFN9O6,"InChI=1S/C52H57ClFN9O6/c53-41-26-37(69-36-4-2-1-3-5-36)10-11-38(41)48(66)40-28-55-49-47(40)50(57-30-56-49)59-35-8-6-34(7-9-35)58-46(65)24-32-15-20-61(21-16-32)19-14-31-17-22-62(23-18-31)44-25-33-29-63(52(68)39(33)27-42(44)54)43-12-13-45(64)60-51(43)67/h1-5,10-11,25-28,30-32,34-35,43H,6-9,12-24,29H2,(H,58,65)(H,60,64,67)(H2,55,56,57,59)/t34-,35+,43?",YWMGYZOTBRTAPC-IMTSFBIHSA-N
4002,4.6,92.28,4.6/357.6,92.28/81.34,Q9UM73,ALK,CRBN,,AP-1,COC1=CC(N2CCN(C(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of ALK in Karpas299/H3122 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1469/2704/>200000,Inhibition of cell viability in Karpas299/THP-1/HeLa cells after 60/60/48 h treatment,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106556,830.324,829.2409079,5,58,7,14,4,12,212.34,C39H40ClN9O8S,"InChI=1S/C39H40ClN9O8S/c1-22(2)58(55,56)31-10-5-4-8-27(31)43-35-25(40)20-42-39(46-35)44-26-12-11-23(19-30(26)57-3)47-15-17-48(18-16-47)33(51)21-41-28-9-6-7-24-34(28)38(54)49(37(24)53)29-13-14-32(50)45-36(29)52/h4-12,19-20,22,29,41H,13-18,21H2,1-3H3,(H,45,50,52)(H2,42,43,44,46)",MCCIEZLYIAJGSE-UHFFFAOYSA-N
4023,17.9,99,37.4/17.9/22.9,,P36969,GPX4,CRBN,,,COC(=O)[C@H]1CC2=C([NH]C3=CC=CC=C23)[C@H](C2=CC=C(C(=O)N3CCN(CCCCCCCCCCCCCNC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)N1C(=O)CCl,Degradation of GPX4 in HT1080 cells after 6 h treatment/H1650 cells after 24 h treatment/H1650R cells after 24 h treatment,69,% GPX4 degradation in HT 1080 cells after 6 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68/205,Inhibition of cell proliferation in HT1080/HEK293T cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115393,934.579,933.4555751,8.12,67,8,9,3,20,164.46,C52H64ClN7O7,"InChI=1S/C52H64ClN7O7/c1-67-52(66)44-32-39-37-16-11-12-18-42(37)55-47(39)48(60(44)46(62)33-53)35-20-22-36(23-21-35)50(64)58-30-28-57(29-31-58)27-14-10-8-6-4-2-3-5-7-9-13-26-54-41-19-15-17-38-40(41)34-59(51(38)65)43-24-25-45(61)56-49(43)63/h11-12,15-23,43-44,48,54-55H,2-10,13-14,24-34H2,1H3,(H,56,61,63)/t43?,44-,48+/m1/s1",WTMGBRQUTXPEQV-PEEVFNJXSA-N
4033,53,95,53,95,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC8 in MDA-MB-231 cells after 24 h treatment,90/93,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,600.584,600.1856285,2.6,44,5,9,4,11,180.44,C31H28N4O9,"InChI=1S/C31H28N4O9/c1-43-23-11-9-19(31(41)42)15-24(23)44-16-17-5-7-18(8-6-17)27(37)33-14-13-32-21-4-2-3-20-26(21)30(40)35(29(20)39)22-10-12-25(36)34-28(22)38/h2-9,11,15,22,32H,10,12-14,16H2,1H3,(H,33,37)(H,41,42)(H,34,36,38)",OVGJMQWPRUXZPK-UHFFFAOYSA-N
4033,1812,59,1812,59,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC6 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,600.584,600.1856285,2.6,44,5,9,4,11,180.44,C31H28N4O9,"InChI=1S/C31H28N4O9/c1-43-23-11-9-19(31(41)42)15-24(23)44-16-17-5-7-18(8-6-17)27(37)33-14-13-32-21-4-2-3-20-26(21)30(40)35(29(20)39)22-10-12-25(36)34-28(22)38/h2-9,11,15,22,32H,10,12-14,16H2,1H3,(H,33,37)(H,41,42)(H,34,36,38)",OVGJMQWPRUXZPK-UHFFFAOYSA-N
4034,119,96,119,96,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC8 in MDA-MB-231 cells after 24 h treatment,83/75,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,628.638,628.2169286,3.31,46,5,9,4,13,180.44,C33H32N4O9,"InChI=1S/C33H32N4O9/c1-45-25-13-11-21(33(43)44)17-26(25)46-18-19-7-9-20(10-8-19)29(39)35-16-3-2-15-34-23-6-4-5-22-28(23)32(42)37(31(22)41)24-12-14-27(38)36-30(24)40/h4-11,13,17,24,34H,2-3,12,14-16,18H2,1H3,(H,35,39)(H,43,44)(H,36,38,40)",SFAZMJOUZPQYHW-UHFFFAOYSA-N
4034,1114,55,1114,55,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC6 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,628.638,628.2169286,3.31,46,5,9,4,13,180.44,C33H32N4O9,"InChI=1S/C33H32N4O9/c1-45-25-13-11-21(33(43)44)17-26(25)46-18-19-7-9-20(10-8-19)29(39)35-16-3-2-15-34-23-6-4-5-22-28(23)32(42)37(31(22)41)24-12-14-27(38)36-30(24)40/h4-11,13,17,24,34H,2-3,12,14-16,18H2,1H3,(H,35,39)(H,43,44)(H,36,38,40)",SFAZMJOUZPQYHW-UHFFFAOYSA-N
4035,14,91,14,91,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC8 in MDA-MB-231 cells after 24 h treatment,94/44,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,656.692,656.2482287,4.03,48,5,9,4,15,180.44,C35H36N4O9,"InChI=1S/C35H36N4O9/c1-47-27-15-13-23(35(45)46)19-28(27)48-20-21-9-11-22(12-10-21)31(41)37-18-5-3-2-4-17-36-25-8-6-7-24-30(25)34(44)39(33(24)43)26-14-16-29(40)38-32(26)42/h6-13,15,19,26,36H,2-5,14,16-18,20H2,1H3,(H,37,41)(H,45,46)(H,38,40,42)",OHGZHFFSUIAVDY-UHFFFAOYSA-N
4035,129,71,129,71,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC6 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,656.692,656.2482287,4.03,48,5,9,4,15,180.44,C35H36N4O9,"InChI=1S/C35H36N4O9/c1-47-27-15-13-23(35(45)46)19-28(27)48-20-21-9-11-22(12-10-21)31(41)37-18-5-3-2-4-17-36-25-8-6-7-24-30(25)34(44)39(33(24)43)26-14-16-29(40)38-32(26)42/h6-13,15,19,26,36H,2-5,14,16-18,20H2,1H3,(H,37,41)(H,45,46)(H,38,40,42)",OHGZHFFSUIAVDY-UHFFFAOYSA-N
4036,1.8,97,1.8/4.7,97/95,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC8 in MDA-MB-231/T-cell leukemia Jurkat cells after 24 h treatment,94/62,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,1600,Inhibition of HDAC8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2400,Inhibition of cell proliferation in Jurkat cells,,,,,,,,,,,10.1016/j.bioorg.2023.106546,684.746,684.2795289,5.11,50,5,9,4,17,180.44,C37H40N4O9,"InChI=1S/C37H40N4O9/c1-49-29-17-15-25(37(47)48)21-30(29)50-22-23-11-13-24(14-12-23)33(43)39-20-7-5-3-2-4-6-19-38-27-10-8-9-26-32(27)36(46)41(35(26)45)28-16-18-31(42)40-34(28)44/h8-15,17,21,28,38H,2-7,16,18-20,22H2,1H3,(H,39,43)(H,47,48)(H,40,42,44)",NIPLZZSOGWKOEY-UHFFFAOYSA-N
4036,38,69,38/78.5,69/76,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of HDAC6 in MDA-MB-231/T-cell leukemia Jurkat cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,684.746,684.2795289,5.11,50,5,9,4,17,180.44,C37H40N4O9,"InChI=1S/C37H40N4O9/c1-49-29-17-15-25(37(47)48)21-30(29)50-22-23-11-13-24(14-12-23)33(43)39-20-7-5-3-2-4-6-19-38-27-10-8-9-26-32(27)36(46)41(35(26)45)28-16-18-31(42)40-34(28)44/h8-15,17,21,28,38H,2-7,16,18-20,22H2,1H3,(H,39,43)(H,47,48)(H,40,42,44)",NIPLZZSOGWKOEY-UHFFFAOYSA-N
4042,400,99,400,,P36969,GPX4,CRBN,,,CC1=C([N+](=O)[O-])C(C(=O)N2CCN(C(C3=CC=C(Cl)C=C3)C3=CC=C(OCC(=O)N4CCN(CCCCCCCCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)C=C3)CC2)=NO1,Degradation of GPX4 in HT1080 cells after 24 h treatment,82,% GPX4 degradation in HT1080 cells after 24 h treatment at 1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,300,Inhibition of cell proliferation in HT1080 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115343,966.537,965.4202522,6.32,69,8,13,2,20,204.01,C50H60ClN9O9,"InChI=1S/C50H60ClN9O9/c1-34-46(60(66)67)45(54-69-34)50(65)58-30-28-57(29-31-58)47(35-12-16-37(51)17-13-35)36-14-18-38(19-15-36)68-33-44(62)56-26-24-55(25-27-56)23-8-6-4-2-3-5-7-22-52-41-11-9-10-39-40(41)32-59(49(39)64)42-20-21-43(61)53-48(42)63/h9-19,42,47,52H,2-8,20-33H2,1H3,(H,53,61,63)",WQIDTGMFXQVWKB-UHFFFAOYSA-N
4050,30,99,30,,P36969,GPX4,CRBN,,,CC1=C([N+](=O)[O-])C(C(=O)N2CCN(C(C3=CC=C(Cl)C=C3)C3=CC=C(OCC(=O)N4CCC(CN5CCN(CCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)C=C3)CC2)=NO1,Degradation of GPX4 in HT1080 cells after 24 h treatment,>80/82,% GPX4 degradation in HT1080 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100/300/200,Inhibition of cell proliferation in HT1080/Calu-1/A375 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115343,993.519,992.3947657,4.91,71,9,15,2,16,224.32,C50H57ClN10O10,"InChI=1S/C50H57ClN10O10/c1-32-45(61(68)69)44(54-71-32)50(67)59-28-26-58(27-29-59)46(34-6-10-36(51)11-7-34)35-8-12-37(13-9-35)70-31-42(63)57-20-16-33(17-21-57)30-56-24-22-55(23-25-56)19-3-18-52-39-5-2-4-38-43(39)49(66)60(48(38)65)40-14-15-41(62)53-47(40)64/h2,4-13,33,40,46,52H,3,14-31H2,1H3,(H,53,62,64)",HMSNFNLFZRKDIO-UHFFFAOYSA-N
4075,100,93.1,100/140,93.1,P50750,CDK9,CRBN,,,O=C(COC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCCCCCCCCC(=O)N1CCC(NC(=O)C2=N[NH]C=C2NC(=O)C2=C(Cl)C=CC=C2Cl)CC1,Degradation of CDK942/CDK955 in MOLM13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.21,Inhibition of cell proliferation of Molm13 cells,400,Inhibition of cell viability of MV-411 cells after treatment for 6h,,,,,,,,,,,,,10.1016/j.ejmech.2023.115342,879.799,878.2921305,5.45,61,6,10,5,19,229.07,C42H48Cl2N8O9,"InChI=1S/C42H48Cl2N8O9/c43-27-12-10-13-28(44)36(27)39(57)48-29-23-46-50-37(29)40(58)47-25-18-21-51(22-19-25)34(55)15-7-5-3-1-2-4-6-8-20-45-33(54)24-61-31-14-9-11-26-35(31)42(60)52(41(26)59)30-16-17-32(53)49-38(30)56/h9-14,23,25,30H,1-8,15-22,24H2,(H,45,54)(H,46,50)(H,47,58)(H,48,57)(H,49,53,56)",DZJCTNGKFRUZQI-UHFFFAOYSA-N
4077,30,91.6,30/50,91.6,P50750,CDK9,CRBN,,,O=C(CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCCCCCCCCC(=O)N1CCC(NC(=O)C2=N[NH]C=C2NC(=O)C2=C(Cl)C=CC=C2Cl)CC1,Degradation of CDK942/CDK955 in MOLM13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.12,Inhibition of cell proliferation of Molm13 cells,200,Inhibition of cell viability of MV-411 cells after treatment for 6h,,,,,,,,,,,,,10.1016/j.ejmech.2023.115342,878.815,877.3081149,6.01,61,6,10,6,19,231.87,C42H49Cl2N9O8,"InChI=1S/C42H49Cl2N9O8/c43-27-12-10-13-28(44)36(27)39(58)49-30-23-47-51-37(30)40(59)48-25-18-21-52(22-19-25)34(56)15-7-5-3-1-2-4-6-8-20-45-33(55)24-46-29-14-9-11-26-35(29)42(61)53(41(26)60)31-16-17-32(54)50-38(31)57/h9-14,23,25,31,46H,1-8,15-22,24H2,(H,45,55)(H,47,51)(H,48,59)(H,49,58)(H,50,54,57)",SRUVBNFPTDBESG-UHFFFAOYSA-N
4096,116,90,116,90,,EML4-ALK,CRBN,,CPD-198,COC1=CC(CCNCCCCCC#CC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,869,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,840.403,839.2867955,7.15,59,6,12,4,16,188.79,C43H46ClN7O7S,"InChI=1S/C43H46ClN7O7S/c1-26(2)59(56,57)36-17-10-9-16-32(36)47-39-31(44)25-46-43(50-39)48-33-23-27(3)29(24-35(33)58-4)20-22-45-21-11-7-5-6-8-13-28-14-12-15-30-38(28)42(55)51(41(30)54)34-18-19-37(52)49-40(34)53/h9-10,12,14-17,23-26,34,45H,5-7,11,18-22H2,1-4H3,(H,49,52,53)(H2,46,47,48,50)",FSVOHZYFFZAREF-UHFFFAOYSA-N
4096,304,87,304,87,,EML4-ALK G1202R,CRBN,,CPD-198,COC1=CC(CCNCCCCCC#CC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,840.403,839.2867955,7.15,59,6,12,4,16,188.79,C43H46ClN7O7S,"InChI=1S/C43H46ClN7O7S/c1-26(2)59(56,57)36-17-10-9-16-32(36)47-39-31(44)25-46-43(50-39)48-33-23-27(3)29(24-35(33)58-4)20-22-45-21-11-7-5-6-8-13-28-14-12-15-30-38(28)42(55)51(41(30)54)34-18-19-37(52)49-40(34)53/h9-10,12,14-17,23-26,34,45H,5-7,11,18-22H2,1-4H3,(H,49,52,53)(H2,46,47,48,50)",FSVOHZYFFZAREF-UHFFFAOYSA-N
4097,124,88,124,88,,EML4-ALK,CRBN,,CPD-985,COC1=CC(CCNCCCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,546,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,826.42,825.3075309,7.2,58,6,11,4,16,171.72,C43H48ClN7O6S,"InChI=1S/C43H48ClN7O6S/c1-27(2)58(55,56)38-17-10-9-16-34(38)47-40-33(44)25-46-43(50-40)48-35-23-28(3)30(24-37(35)57-4)20-22-45-21-11-7-5-6-8-13-29-14-12-15-31-32(29)26-51(42(31)54)36-18-19-39(52)49-41(36)53/h9-10,12,14-17,23-25,27,36,45H,5-7,11,18-22,26H2,1-4H3,(H,49,52,53)(H2,46,47,48,50)",BCWBZOKDNSLMRD-UHFFFAOYSA-N
4097,223,68,223,68,,EML4-ALK G1202R,CRBN,,CPD-985,COC1=CC(CCNCCCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,826.42,825.3075309,7.2,58,6,11,4,16,171.72,C43H48ClN7O6S,"InChI=1S/C43H48ClN7O6S/c1-27(2)58(55,56)38-17-10-9-16-34(38)47-40-33(44)25-46-43(50-40)48-35-23-28(3)30(24-37(35)57-4)20-22-45-21-11-7-5-6-8-13-29-14-12-15-31-32(29)26-51(42(31)54)36-18-19-39(52)49-41(36)53/h9-10,12,14-17,23-25,27,36,45H,5-7,11,18-22,26H2,1-4H3,(H,49,52,53)(H2,46,47,48,50)",BCWBZOKDNSLMRD-UHFFFAOYSA-N
4098,7.2,90,7.2,90,,EML4-ALK,CRBN,,CPD-1108,COC1=CC(C2CCN(CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,286,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,866.485,865.3388311,7.95,61,7,11,3,14,162.93,C46H52ClN7O6S,"InChI=1S/C46H52ClN7O6S/c1-29(2)61(58,59)41-17-10-9-16-37(41)49-43-36(47)27-48-46(52-43)50-38-25-30(3)34(26-40(38)60-4)32-20-23-53(24-21-32)22-11-7-5-6-8-13-31-14-12-15-33-35(31)28-54(45(33)57)39-18-19-42(55)51-44(39)56/h9-10,12,14-17,25-27,29,32,39H,5-7,11,18-24,28H2,1-4H3,(H,51,55,56)(H2,48,49,50,52)",GSPZSESBLZAXJD-UHFFFAOYSA-N
4098,21,75,21,75,,EML4-ALK G1202R,CRBN,,CPD-1108,COC1=CC(C2CCN(CCCCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,866.485,865.3388311,7.95,61,7,11,3,14,162.93,C46H52ClN7O6S,"InChI=1S/C46H52ClN7O6S/c1-29(2)61(58,59)41-17-10-9-16-37(41)49-43-36(47)27-48-46(52-43)50-38-25-30(3)34(26-40(38)60-4)32-20-23-53(24-21-32)22-11-7-5-6-8-13-31-14-12-15-33-35(31)28-54(45(33)57)39-18-19-42(55)51-44(39)56/h9-10,12,14-17,25-27,29,32,39H,5-7,11,18-24,28H2,1-4H3,(H,51,55,56)(H2,48,49,50,52)",GSPZSESBLZAXJD-UHFFFAOYSA-N
4099,6.6,88,6.6,88,,EML4-ALK,CRBN,,CPD-1131,COC1=CC(C2CCN(CCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,542,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,838.431,837.3075309,7.05,59,7,11,3,12,162.93,C44H48ClN7O6S,"InChI=1S/C44H48ClN7O6S/c1-27(2)59(56,57)39-15-8-7-14-35(39)47-41-34(45)25-46-44(50-41)48-36-23-28(3)32(24-38(36)58-4)30-18-21-51(22-19-30)20-9-5-6-11-29-12-10-13-31-33(29)26-52(43(31)55)37-16-17-40(53)49-42(37)54/h7-8,10,12-15,23-25,27,30,37H,5,9,16-22,26H2,1-4H3,(H,49,53,54)(H2,46,47,48,50)",QJMDACHGDOVSAD-UHFFFAOYSA-N
4099,43,65,43,65,,EML4-ALK G1202R,CRBN,,CPD-1131,COC1=CC(C2CCN(CCCC#CC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,838.431,837.3075309,7.05,59,7,11,3,12,162.93,C44H48ClN7O6S,"InChI=1S/C44H48ClN7O6S/c1-27(2)59(56,57)39-15-8-7-14-35(39)47-41-34(45)25-46-44(50-41)48-36-23-28(3)32(24-38(36)58-4)30-18-21-51(22-19-30)20-9-5-6-11-29-12-10-13-31-33(29)26-52(43(31)55)37-16-17-40(53)49-42(37)54/h7-8,10,12-15,23-25,27,30,37H,5,9,16-22,26H2,1-4H3,(H,49,53,54)(H2,46,47,48,50)",QJMDACHGDOVSAD-UHFFFAOYSA-N
4100,3.9,75,3.9,75,,EML4-ALK,CRBN,,CPD-1193,COC1=CC(C2CCN(CC#CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,769,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,810.377,809.2762308,6.23,57,7,11,3,10,162.93,C42H44ClN7O6S,"InChI=1S/C42H44ClN7O6S/c1-25(2)57(54,55)37-10-6-5-9-33(37)45-39-32(43)23-44-42(48-39)46-34-20-26(3)31(22-36(34)56-4)28-15-18-49(19-16-28)17-7-8-27-11-12-30-29(21-27)24-50(41(30)53)35-13-14-38(51)47-40(35)52/h5-6,9-12,20-23,25,28,35H,13-19,24H2,1-4H3,(H,47,51,52)(H2,44,45,46,48)",AXFPGFHGJZYNJW-UHFFFAOYSA-N
4100,14,85,14,85,,EML4-ALK G1202R,CRBN,,CPD-1193,COC1=CC(C2CCN(CC#CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,810.377,809.2762308,6.23,57,7,11,3,10,162.93,C42H44ClN7O6S,"InChI=1S/C42H44ClN7O6S/c1-25(2)57(54,55)37-10-6-5-9-33(37)45-39-32(43)23-44-42(48-39)46-34-20-26(3)31(22-36(34)56-4)28-15-18-49(19-16-28)17-7-8-27-11-12-30-29(21-27)24-50(41(30)53)35-13-14-38(51)47-40(35)52/h5-6,9-12,20-23,25,28,35H,13-19,24H2,1-4H3,(H,47,51,52)(H2,44,45,46,48)",AXFPGFHGJZYNJW-UHFFFAOYSA-N
4101,2.7,83,2.7,83,,EML4-ALK,CRBN,,CPD-1402,C[C@@H](OC1=CC(C2=CN(C3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,Degradation of EML4-ALK in Ba/F3 cells,,,5400,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,775.669,774.2247999,4.21,54,8,11,2,9,155.99,C38H37Cl2FN8O5,"InChI=1S/C38H37Cl2FN8O5/c1-20(33-28(39)4-5-29(41)34(33)40)54-31-12-22(14-43-35(31)42)23-15-44-48(19-23)24-8-10-46(11-9-24)16-21-17-47(18-21)25-2-3-26-27(13-25)38(53)49(37(26)52)30-6-7-32(50)45-36(30)51/h2-5,12-15,19-21,24,30H,6-11,16-18H2,1H3,(H2,42,43)(H,45,50,51)/t20-,30?/m1/s1",GHKRWEYGVPYTAH-UEWHNOOISA-N
4101,7.6,61,7.6,61,,EML4-ALK L1196M,CRBN,,CPD-1402,C[C@@H](OC1=CC(C2=CN(C3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,Degradation of EML4-ALK L1196M in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,775.669,774.2247999,4.21,54,8,11,2,9,155.99,C38H37Cl2FN8O5,"InChI=1S/C38H37Cl2FN8O5/c1-20(33-28(39)4-5-29(41)34(33)40)54-31-12-22(14-43-35(31)42)23-15-44-48(19-23)24-8-10-46(11-9-24)16-21-17-47(18-21)25-2-3-26-27(13-25)38(53)49(37(26)52)30-6-7-32(50)45-36(30)51/h2-5,12-15,19-21,24,30H,6-11,16-18H2,1H3,(H2,42,43)(H,45,50,51)/t20-,30?/m1/s1",GHKRWEYGVPYTAH-UEWHNOOISA-N
4101,8.8,73,8.8,73,,EML4-ALK C1156Y,CRBN,,CPD-1402,C[C@@H](OC1=CC(C2=CN(C3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,Degradation of EML4-ALK C1156Y in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,775.669,774.2247999,4.21,54,8,11,2,9,155.99,C38H37Cl2FN8O5,"InChI=1S/C38H37Cl2FN8O5/c1-20(33-28(39)4-5-29(41)34(33)40)54-31-12-22(14-43-35(31)42)23-15-44-48(19-23)24-8-10-46(11-9-24)16-21-17-47(18-21)25-2-3-26-27(13-25)38(53)49(37(26)52)30-6-7-32(50)45-36(30)51/h2-5,12-15,19-21,24,30H,6-11,16-18H2,1H3,(H2,42,43)(H,45,50,51)/t20-,30?/m1/s1",GHKRWEYGVPYTAH-UEWHNOOISA-N
4101,103,13,103,13,,EML4-ALK G1202R,CRBN,,CPD-1402,C[C@@H](OC1=CC(C2=CN(C3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,775.669,774.2247999,4.21,54,8,11,2,9,155.99,C38H37Cl2FN8O5,"InChI=1S/C38H37Cl2FN8O5/c1-20(33-28(39)4-5-29(41)34(33)40)54-31-12-22(14-43-35(31)42)23-15-44-48(19-23)24-8-10-46(11-9-24)16-21-17-47(18-21)25-2-3-26-27(13-25)38(53)49(37(26)52)30-6-7-32(50)45-36(30)51/h2-5,12-15,19-21,24,30H,6-11,16-18H2,1H3,(H2,42,43)(H,45,50,51)/t20-,30?/m1/s1",GHKRWEYGVPYTAH-UEWHNOOISA-N
4102,12,94,12,94,,EML4-ALK,CRBN,,CPD-1403,CCC1=CC2=C(C=C1N1CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of EML4-ALK in Ba/F3 cells,,,2810,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,723.834,723.3169174,4.9,54,9,9,2,6,149.92,C42H41N7O5,"InChI=1S/C42H41N7O5/c1-4-25-16-30-31(42(2,3)38-36(37(30)51)28-7-5-23(19-43)15-32(28)44-38)18-34(25)47-13-11-46(12-14-47)20-24-21-48(22-24)26-6-8-27-29(17-26)41(54)49(40(27)53)33-9-10-35(50)45-39(33)52/h5-8,15-18,24,33,44H,4,9-14,20-22H2,1-3H3,(H,45,50,52)",CUVMOMGLJOQXCM-UHFFFAOYSA-N
4102,18,79,18,79,,EML4-ALK L1196M,CRBN,,CPD-1403,CCC1=CC2=C(C=C1N1CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of EML4-ALK L1196M in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,723.834,723.3169174,4.9,54,9,9,2,6,149.92,C42H41N7O5,"InChI=1S/C42H41N7O5/c1-4-25-16-30-31(42(2,3)38-36(37(30)51)28-7-5-23(19-43)15-32(28)44-38)18-34(25)47-13-11-46(12-14-47)20-24-21-48(22-24)26-6-8-27-29(17-26)41(54)49(40(27)53)33-9-10-35(50)45-39(33)52/h5-8,15-18,24,33,44H,4,9-14,20-22H2,1-3H3,(H,45,50,52)",CUVMOMGLJOQXCM-UHFFFAOYSA-N
4102,21,66,21,66,,EML4-ALK C1156Y,CRBN,,CPD-1403,CCC1=CC2=C(C=C1N1CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of EML4-ALK C1156Y in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,723.834,723.3169174,4.9,54,9,9,2,6,149.92,C42H41N7O5,"InChI=1S/C42H41N7O5/c1-4-25-16-30-31(42(2,3)38-36(37(30)51)28-7-5-23(19-43)15-32(28)44-38)18-34(25)47-13-11-46(12-14-47)20-24-21-48(22-24)26-6-8-27-29(17-26)41(54)49(40(27)53)33-9-10-35(50)45-39(33)52/h5-8,15-18,24,33,44H,4,9-14,20-22H2,1-3H3,(H,45,50,52)",CUVMOMGLJOQXCM-UHFFFAOYSA-N
4102,63,70,63,70,,EML4-ALK G1202R,CRBN,,CPD-1403,CCC1=CC2=C(C=C1N1CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,723.834,723.3169174,4.9,54,9,9,2,6,149.92,C42H41N7O5,"InChI=1S/C42H41N7O5/c1-4-25-16-30-31(42(2,3)38-36(37(30)51)28-7-5-23(19-43)15-32(28)44-38)18-34(25)47-13-11-46(12-14-47)20-24-21-48(22-24)26-6-8-27-29(17-26)41(54)49(40(27)53)33-9-10-35(50)45-39(33)52/h5-8,15-18,24,33,44H,4,9-14,20-22H2,1-3H3,(H,45,50,52)",CUVMOMGLJOQXCM-UHFFFAOYSA-N
4102,92,23,92,23,,EML4-ALK L1196M/G1202R,CRBN,,CPD-1403,CCC1=CC2=C(C=C1N1CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,Degradation of EML4-ALK L1196M/G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,723.834,723.3169174,4.9,54,9,9,2,6,149.92,C42H41N7O5,"InChI=1S/C42H41N7O5/c1-4-25-16-30-31(42(2,3)38-36(37(30)51)28-7-5-23(19-43)15-32(28)44-38)18-34(25)47-13-11-46(12-14-47)20-24-21-48(22-24)26-6-8-27-29(17-26)41(54)49(40(27)53)33-9-10-35(50)45-39(33)52/h5-8,15-18,24,33,44H,4,9-14,20-22H2,1-3H3,(H,45,50,52)",CUVMOMGLJOQXCM-UHFFFAOYSA-N
4103,8.8,73,8.8,73,,EML4-ALK L1196M,CRBN,,CPD-1451,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CC2CN(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)C(=O)C4=C3)C2)CC1,Degradation of EML4-ALK L1196M in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,883.472,882.3289947,6.94,62,8,13,3,13,183.24,C45H51ClN8O7S,"InChI=1S/C45H51ClN8O7S/c1-25(2)61-38-20-32(27(5)18-36(38)49-45-47-21-34(46)41(51-45)48-35-8-6-7-9-39(35)62(59,60)26(3)4)29-14-16-52(17-15-29)22-28-23-53(24-28)30-10-11-31-33(19-30)44(58)54(43(31)57)37-12-13-40(55)50-42(37)56/h6-11,18-21,25-26,28-29,37H,12-17,22-24H2,1-5H3,(H,50,55,56)(H2,47,48,49,51)",VHCXOQQJJHOBPD-UHFFFAOYSA-N
4103,26,90,26,90,,EML4-ALK,CRBN,,CPD-1451,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CC2CN(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)C(=O)C4=C3)C2)CC1,Degradation of EML4-ALK in Ba/F3 cells,,,1630,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,883.472,882.3289947,6.94,62,8,13,3,13,183.24,C45H51ClN8O7S,"InChI=1S/C45H51ClN8O7S/c1-25(2)61-38-20-32(27(5)18-36(38)49-45-47-21-34(46)41(51-45)48-35-8-6-7-9-39(35)62(59,60)26(3)4)29-14-16-52(17-15-29)22-28-23-53(24-28)30-10-11-31-33(19-30)44(58)54(43(31)57)37-12-13-40(55)50-42(37)56/h6-11,18-21,25-26,28-29,37H,12-17,22-24H2,1-5H3,(H,50,55,56)(H2,47,48,49,51)",VHCXOQQJJHOBPD-UHFFFAOYSA-N
4103,43,71,43,71,,EML4-ALK C1156Y,CRBN,,CPD-1451,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CC2CN(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)C(=O)C4=C3)C2)CC1,Degradation of EML4-ALK C1156Y in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,883.472,882.3289947,6.94,62,8,13,3,13,183.24,C45H51ClN8O7S,"InChI=1S/C45H51ClN8O7S/c1-25(2)61-38-20-32(27(5)18-36(38)49-45-47-21-34(46)41(51-45)48-35-8-6-7-9-39(35)62(59,60)26(3)4)29-14-16-52(17-15-29)22-28-23-53(24-28)30-10-11-31-33(19-30)44(58)54(43(31)57)37-12-13-40(55)50-42(37)56/h6-11,18-21,25-26,28-29,37H,12-17,22-24H2,1-5H3,(H,50,55,56)(H2,47,48,49,51)",VHCXOQQJJHOBPD-UHFFFAOYSA-N
4103,73,90,73,90,,EML4-ALK G1202R,CRBN,,CPD-1451,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(CC2CN(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)C(=O)C4=C3)C2)CC1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,883.472,882.3289947,6.94,62,8,13,3,13,183.24,C45H51ClN8O7S,"InChI=1S/C45H51ClN8O7S/c1-25(2)61-38-20-32(27(5)18-36(38)49-45-47-21-34(46)41(51-45)48-35-8-6-7-9-39(35)62(59,60)26(3)4)29-14-16-52(17-15-29)22-28-23-53(24-28)30-10-11-31-33(19-30)44(58)54(43(31)57)37-12-13-40(55)50-42(37)56/h6-11,18-21,25-26,28-29,37H,12-17,22-24H2,1-5H3,(H,50,55,56)(H2,47,48,49,51)",VHCXOQQJJHOBPD-UHFFFAOYSA-N
4104,1.3,74,1.3,74,,EML4-ALK L1196M,CRBN,,CPD-1793,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK L1196M in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,841.435,840.31843,6.19,59,8,12,3,12,166.17,C43H49ClN8O6S,"InChI=1S/C43H49ClN8O6S/c1-25(2)59(56,57)38-8-6-5-7-34(38)46-40-33(44)20-45-43(49-40)47-35-17-26(3)32(19-37(35)58-4)28-13-15-50(16-14-28)21-27-22-51(23-27)30-9-10-31-29(18-30)24-52(42(31)55)36-11-12-39(53)48-41(36)54/h5-10,17-20,25,27-28,36H,11-16,21-24H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",UFFRQTDXIZTPDM-UHFFFAOYSA-N
4104,2.9,92,2.9,92,,EML4-ALK,CRBN,,CPD-1793,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,589,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,841.435,840.31843,6.19,59,8,12,3,12,166.17,C43H49ClN8O6S,"InChI=1S/C43H49ClN8O6S/c1-25(2)59(56,57)38-8-6-5-7-34(38)46-40-33(44)20-45-43(49-40)47-35-17-26(3)32(19-37(35)58-4)28-13-15-50(16-14-28)21-27-22-51(23-27)30-9-10-31-29(18-30)24-52(42(31)55)36-11-12-39(53)48-41(36)54/h5-10,17-20,25,27-28,36H,11-16,21-24H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",UFFRQTDXIZTPDM-UHFFFAOYSA-N
4104,5.7,94,5.7,94,,EML4-ALK G1202R,CRBN,,CPD-1793,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,841.435,840.31843,6.19,59,8,12,3,12,166.17,C43H49ClN8O6S,"InChI=1S/C43H49ClN8O6S/c1-25(2)59(56,57)38-8-6-5-7-34(38)46-40-33(44)20-45-43(49-40)47-35-17-26(3)32(19-37(35)58-4)28-13-15-50(16-14-28)21-27-22-51(23-27)30-9-10-31-29(18-30)24-52(42(31)55)36-11-12-39(53)48-41(36)54/h5-10,17-20,25,27-28,36H,11-16,21-24H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",UFFRQTDXIZTPDM-UHFFFAOYSA-N
4104,5.9,69,5.9,69,,EML4-ALK C1156Y,CRBN,,CPD-1793,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK C1156Y in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,841.435,840.31843,6.19,59,8,12,3,12,166.17,C43H49ClN8O6S,"InChI=1S/C43H49ClN8O6S/c1-25(2)59(56,57)38-8-6-5-7-34(38)46-40-33(44)20-45-43(49-40)47-35-17-26(3)32(19-37(35)58-4)28-13-15-50(16-14-28)21-27-22-51(23-27)30-9-10-31-29(18-30)24-52(42(31)55)36-11-12-39(53)48-41(36)54/h5-10,17-20,25,27-28,36H,11-16,21-24H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",UFFRQTDXIZTPDM-UHFFFAOYSA-N
4105,5.4,93,5.4,93,,EML4-ALK,CRBN,,CPD-1224,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK in Ba/F3 cells,,,399,NanoBRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,855.418,854.2976945,6.14,60,8,13,3,12,183.24,C43H47ClN8O7S,"InChI=1S/C43H47ClN8O7S/c1-24(2)60(57,58)37-8-6-5-7-33(37)46-39-32(44)20-45-43(49-39)47-34-17-25(3)30(19-36(34)59-4)27-13-15-50(16-14-27)21-26-22-51(23-26)28-9-10-29-31(18-28)42(56)52(41(29)55)35-11-12-38(53)48-40(35)54/h5-10,17-20,24,26-27,35H,11-16,21-23H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",YROLXKJYDUJWRK-UHFFFAOYSA-N
4105,8.4,88,8.4,88,,EML4-ALK L1196M,CRBN,,CPD-1224,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK L1196M in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,855.418,854.2976945,6.14,60,8,13,3,12,183.24,C43H47ClN8O7S,"InChI=1S/C43H47ClN8O7S/c1-24(2)60(57,58)37-8-6-5-7-33(37)46-39-32(44)20-45-43(49-39)47-34-17-25(3)30(19-36(34)59-4)27-13-15-50(16-14-27)21-26-22-51(23-26)28-9-10-29-31(18-28)42(56)52(41(29)55)35-11-12-38(53)48-40(35)54/h5-10,17-20,24,26-27,35H,11-16,21-23H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",YROLXKJYDUJWRK-UHFFFAOYSA-N
4105,15,86,15,86,,EML4-ALK C1156Y,CRBN,,CPD-1224,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK C1156Y in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,855.418,854.2976945,6.14,60,8,13,3,12,183.24,C43H47ClN8O7S,"InChI=1S/C43H47ClN8O7S/c1-24(2)60(57,58)37-8-6-5-7-33(37)46-39-32(44)20-45-43(49-39)47-34-17-25(3)30(19-36(34)59-4)27-13-15-50(16-14-27)21-26-22-51(23-26)28-9-10-29-31(18-28)42(56)52(41(29)55)35-11-12-38(53)48-40(35)54/h5-10,17-20,24,26-27,35H,11-16,21-23H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",YROLXKJYDUJWRK-UHFFFAOYSA-N
4105,21,95,21,95,,EML4-ALK G1202R,CRBN,,CPD-1224,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,855.418,854.2976945,6.14,60,8,13,3,12,183.24,C43H47ClN8O7S,"InChI=1S/C43H47ClN8O7S/c1-24(2)60(57,58)37-8-6-5-7-33(37)46-39-32(44)20-45-43(49-39)47-34-17-25(3)30(19-36(34)59-4)27-13-15-50(16-14-27)21-26-22-51(23-26)28-9-10-29-31(18-28)42(56)52(41(29)55)35-11-12-38(53)48-40(35)54/h5-10,17-20,24,26-27,35H,11-16,21-23H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",YROLXKJYDUJWRK-UHFFFAOYSA-N
4105,64,81,64,81,,EML4-ALK L1196M/G1202R,CRBN,,CPD-1224,COC1=CC(C2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)=C(C)C=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,Degradation of EML4-ALK L1196M/G1202R in Ba/F3 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01864,855.418,854.2976945,6.14,60,8,13,3,12,183.24,C43H47ClN8O7S,"InChI=1S/C43H47ClN8O7S/c1-24(2)60(57,58)37-8-6-5-7-33(37)46-39-32(44)20-45-43(49-39)47-34-17-25(3)30(19-36(34)59-4)27-13-15-50(16-14-27)21-26-22-51(23-26)28-9-10-29-31(18-28)42(56)52(41(29)55)35-11-12-38(53)48-40(35)54/h5-10,17-20,24,26-27,35H,11-16,21-23H2,1-4H3,(H,48,53,54)(H2,45,46,47,49)",YROLXKJYDUJWRK-UHFFFAOYSA-N
4109,0.0276,99,0.0276,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-5-TFC-007,O=C1CCC(N2C(=O)C3=CC=C(N4CCN(C(=O)C5CCN(C6=CC=C(NC(=O)C7=CN=C(OC8=CC=CC=C8)N=C7)C=C6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of H-PGDS in KU182 cells after 24h treatment,,,196.3,Inhibit of H-PGDS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2md00284a,742.793,742.2863456,2.77,55,8,11,2,8,174.45,C40H38N8O7,"InChI=1S/C40H38N8O7/c49-34-13-12-33(36(51)44-34)48-38(53)31-11-10-29(22-32(31)39(48)54)46-18-20-47(21-19-46)37(52)25-14-16-45(17-15-25)28-8-6-27(7-9-28)43-35(50)26-23-41-40(42-24-26)55-30-4-2-1-3-5-30/h1-11,22-25,33H,12-21H2,(H,43,50)(H,44,49,51)",HBZXIWJRQLOWPC-UHFFFAOYSA-N
4109,0.175,99,0.175,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-5-TFC,O=C1CCC(N2C(=O)C3=CC=C(N4CCN(C(=O)C5CCN(C6=CC=C(NC(=O)C7=CN=C(OC8=CC=CC=C8)N=C7)C=C6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of H-PGDS in KU812 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.049,PAMPA assay,,,,,10.1016/j.bmc.2023.117259,742.793,742.2863456,2.77,55,8,11,2,8,174.45,C40H38N8O7,"InChI=1S/C40H38N8O7/c49-34-13-12-33(36(51)44-34)48-38(53)31-11-10-29(22-32(31)39(48)54)46-18-20-47(21-19-46)37(52)25-14-16-45(17-15-25)28-8-6-27(7-9-28)43-35(50)26-23-41-40(42-24-26)55-30-4-2-1-3-5-30/h1-11,22-25,33H,12-21H2,(H,43,50)(H,44,49,51)",HBZXIWJRQLOWPC-UHFFFAOYSA-N
4110,0.0714,99,0.0714,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-4-TAS-205,CN1C=CC=C1C(=O)N1CCN(C(=O)NC2=CC=C(N3CCC(C(=O)N4CCN(C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C=C2)CC1,Degradation of H-PGDS in KU182 cells after 24h treatment,,,78.1,Inhibit of H-PGDS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2md00284a,763.856,763.3441948,0.99,56,8,10,2,6,167.92,C40H45N9O7,"InChI=1S/C40H45N9O7/c1-43-15-3-6-32(43)38(54)47-22-24-48(25-23-47)40(56)41-27-7-9-28(10-8-27)44-16-13-26(14-17-44)36(52)46-20-18-45(19-21-46)30-5-2-4-29-34(30)39(55)49(37(29)53)31-11-12-33(50)42-35(31)51/h2-10,15,26,31H,11-14,16-25H2,1H3,(H,41,56)(H,42,50,51)",BNWOEWUWHFLSPN-UHFFFAOYSA-N
4111,0.0238,99,0.0238,,O60760,HPGDS,CRBN,,PROTAC(H-PGDS)-5-TAS-205,CN1C=CC=C1C(=O)N1CCN(C(=O)NC2=CC=C(N3CCC(C(=O)N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,Degradation of H-PGDS in KU182 cells after 24h treatment,,,123.9,Inhibit of H-PGDS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2md00284a,763.856,763.3441948,0.99,56,8,10,2,6,167.92,C40H45N9O7,"InChI=1S/C40H45N9O7/c1-43-14-2-3-33(43)39(55)47-21-23-48(24-22-47)40(56)41-27-4-6-28(7-5-27)44-15-12-26(13-16-44)36(52)46-19-17-45(18-20-46)29-8-9-30-31(25-29)38(54)49(37(30)53)32-10-11-34(50)42-35(32)51/h2-9,14,25-26,32H,10-13,15-24H2,1H3,(H,41,56)(H,42,50,51)",VRNMALHFNHEWOB-UHFFFAOYSA-N
4112,0.104,99,0.104,,O60760,HPGDS,CRBN,,,O=C1CCC(C2=CC=C(NCC(=O)N3CCN(C(=O)C4CCN(C5=CC=C(NC(=O)C6=CN=C(OC7=CC=CC=C7)N=C6)C=C5)CC4)CC3)C=C2)C(=O)N1,Degradation of H-PGDS in KU812 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2,PAMPA assay,,,,,10.1016/j.bmc.2023.117259,730.826,730.3227311,3.05,54,7,10,3,10,166.17,C40H42N8O6,"InChI=1S/C40H42N8O6/c49-35-15-14-34(38(52)45-35)27-6-8-30(9-7-27)41-26-36(50)47-20-22-48(23-21-47)39(53)28-16-18-46(19-17-28)32-12-10-31(11-13-32)44-37(51)29-24-42-40(43-25-29)54-33-4-2-1-3-5-33/h1-13,24-25,28,34,41H,14-23,26H2,(H,44,51)(H,45,49,52)",VQEULCHZDWVFOR-UHFFFAOYSA-N
4113,0.147,99,0.147,,O60760,HPGDS,CRBN,,,O=C1CCC(N2C(=O)C3=CC(F)=C(N4CCN(C(=O)C5CCN(C6=CC=C(NC(=O)C7=CN=C(OC8=CC=CC=C8)N=C7)C=C6)CC5)CC4)C=C3C2=O)C(=O)N1,Degradation of H-PGDS in KU812 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.007,PAMPA assay,,,,,10.1016/j.bmc.2023.117259,760.783,760.2769237,2.87,56,8,11,2,8,174.45,C40H37FN8O7,"InChI=1S/C40H37FN8O7/c41-31-20-29-30(39(55)49(38(29)54)32-10-11-34(50)45-36(32)52)21-33(31)47-16-18-48(19-17-47)37(53)24-12-14-46(15-13-24)27-8-6-26(7-9-27)44-35(51)25-22-42-40(43-23-25)56-28-4-2-1-3-5-28/h1-9,20-24,32H,10-19H2,(H,44,51)(H,45,50,52)",WUKCZLQLSCQODB-UHFFFAOYSA-N
4114,1300,65,1300,65,Q9C5S2,IRE1alpha,CRBN,,CPD-2828,CC1=C(CC(=O)N2CCC(C3=CC=C(NC4CCC(=O)NC4=O)C=C3)CC2)C(=O)OC2=C(C=O)C(O)=CC=C12,Degradation of IRE1alpha in HEK293T cells after 24h treatment,,,800,Inhibition of IRE1alpha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.3c00084,531.565,531.2005503,2.34,39,5,8,3,6,146.02,C29H29N3O7,"InChI=1S/C29H29N3O7/c1-16-20-6-8-24(34)22(15-33)27(20)39-29(38)21(16)14-26(36)32-12-10-18(11-13-32)17-2-4-19(5-3-17)30-23-7-9-25(35)31-28(23)37/h2-6,8,15,18,23,30,34H,7,9-14H2,1H3,(H,31,35,37)",JUIHFQABBIMEAQ-UHFFFAOYSA-N
4138,0.7,99,0.7,>99,P98170,XIAP,VHL,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,Degradation of XIAP in MM.1S cells after 16h treatment,93,% XIAP degradation in MM.1S cells after 100 nM treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1690/1.6/510,Inhibition of cell growth in SUDHL4/SUDHL6/DB cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01817,1103.441,1102.592547,8.1,79,8,12,6,21,220.63,C61H82N8O9S,"InChI=1S/C61H82N8O9S/c1-37(40-26-28-43(29-27-40)54-38(2)63-36-79-54)64-57(73)50-31-44(70)34-68(50)60(76)55(61(4,5)6)66-52(71)25-13-14-30-77-45-21-16-22-46(32-45)78-47-33-51(58(74)65-49-24-15-20-41-17-11-12-23-48(41)49)69(35-47)59(75)53(42-18-9-8-10-19-42)67-56(72)39(3)62-7/h11-12,16-17,21-23,26-29,32,36-37,39,42,44,47,49-51,53,55,62,70H,8-10,13-15,18-20,24-25,30-31,33-35H2,1-7H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t37-,39-,44+,47-,49+,50-,51-,53-,55+/m0/s1",SMENADKMMXTZAZ-FMVATYOPSA-N
4138,2.4,99,2.4,>99,Q13490,cIAP1,VHL,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,Degradation of cIAP1 in MM.1S cells after 16h treatment,95,% cIAP1 degradation in MM.1S cells after 100 nM treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2540/1140/8.5,Inhibition of cell growth in RPMI-8826/JJN3/NCI-H929 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01817,1103.441,1102.592547,8.1,79,8,12,6,21,220.63,C61H82N8O9S,"InChI=1S/C61H82N8O9S/c1-37(40-26-28-43(29-27-40)54-38(2)63-36-79-54)64-57(73)50-31-44(70)34-68(50)60(76)55(61(4,5)6)66-52(71)25-13-14-30-77-45-21-16-22-46(32-45)78-47-33-51(58(74)65-49-24-15-20-41-17-11-12-23-48(41)49)69(35-47)59(75)53(42-18-9-8-10-19-42)67-56(72)39(3)62-7/h11-12,16-17,21-23,26-29,32,36-37,39,42,44,47,49-51,53,55,62,70H,8-10,13-15,18-20,24-25,30-31,33-35H2,1-7H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t37-,39-,44+,47-,49+,50-,51-,53-,55+/m0/s1",SMENADKMMXTZAZ-FMVATYOPSA-N
4138,6.2,90,6.2,>90,Q13489,cIAP2,VHL,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,Degradation of cIAP2 in MM.1S cells after 16h treatment,79,% cIAP2 degradation in MM.1S cells after 100 nM treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1170/2.1/420,Inhibition of cell growth in HEL/MOLM13/K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01817,1103.441,1102.592547,8.1,79,8,12,6,21,220.63,C61H82N8O9S,"InChI=1S/C61H82N8O9S/c1-37(40-26-28-43(29-27-40)54-38(2)63-36-79-54)64-57(73)50-31-44(70)34-68(50)60(76)55(61(4,5)6)66-52(71)25-13-14-30-77-45-21-16-22-46(32-45)78-47-33-51(58(74)65-49-24-15-20-41-17-11-12-23-48(41)49)69(35-47)59(75)53(42-18-9-8-10-19-42)67-56(72)39(3)62-7/h11-12,16-17,21-23,26-29,32,36-37,39,42,44,47,49-51,53,55,62,70H,8-10,13-15,18-20,24-25,30-31,33-35H2,1-7H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t37-,39-,44+,47-,49+,50-,51-,53-,55+/m0/s1",SMENADKMMXTZAZ-FMVATYOPSA-N
4171,4.3,99,4.3,,P18031,PTP1B,VHL,,,COC1=CC(CC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(C(F)(F)P(=O)(O)O)C=C2)C(=O)N[C@@H](CCCCNC(=O)C2=CC=C(C)C(Br)=C2)C(=O)NCC2=CC=CC(CC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)=CC=C1O,Degradation of PTP1B in HEK293 cells after 16h treatment,73/95,% PTP1B degradation in HEK293 cells after 16h treatment at 50/200 nM,30.1,Inhibition of PTP1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202303818,1505.484,1503.482575,8.5,102,8,14,11,31,344.12,C74H85BrF2N9O14PS,"InChI=1S/C74H85BrF2N9O14PS/c1-43-19-23-53(38-56(43)75)67(91)78-31-12-11-18-57(83-70(94)59(34-47-20-28-54(29-21-47)74(76,77)101(97,98)99)84-69(93)58(33-46-14-9-8-10-15-46)82-63(89)37-49-22-30-61(88)62(35-49)100-7)68(92)79-40-50-17-13-16-48(32-50)36-64(90)85-66(73(4,5)6)72(96)86-41-55(87)39-60(86)71(95)81-44(2)51-24-26-52(27-25-51)65-45(3)80-42-102-65/h8-10,13-17,19-30,32,35,38,42,44,55,57-60,66,87-88H,11-12,18,31,33-34,36-37,39-41H2,1-7H3,(H,78,91)(H,79,92)(H,81,95)(H,82,89)(H,83,94)(H,84,93)(H,85,90)(H2,97,98,99)/t44-,55+,57-,58-,59-,60-,66+/m0/s1",QZUOSZAORFBNEN-XMZKEKGRSA-N
4171,4.8,99,4.8,,P17706,PTPN2,VHL,,,COC1=CC(CC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(C(F)(F)P(=O)(O)O)C=C2)C(=O)N[C@@H](CCCCNC(=O)C2=CC=C(C)C(Br)=C2)C(=O)NCC2=CC=CC(CC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)=CC=C1O,Degradation of TC-PTP in HEK293 cells after 16h treatment,75/92,% TCPTP degradation in HEK293 cells after 16h treatment at 50/200 nM ,24.2,Inhibition of TC-PTP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202303818,1505.484,1503.482575,8.5,102,8,14,11,31,344.12,C74H85BrF2N9O14PS,"InChI=1S/C74H85BrF2N9O14PS/c1-43-19-23-53(38-56(43)75)67(91)78-31-12-11-18-57(83-70(94)59(34-47-20-28-54(29-21-47)74(76,77)101(97,98)99)84-69(93)58(33-46-14-9-8-10-15-46)82-63(89)37-49-22-30-61(88)62(35-49)100-7)68(92)79-40-50-17-13-16-48(32-50)36-64(90)85-66(73(4,5)6)72(96)86-41-55(87)39-60(86)71(95)81-44(2)51-24-26-52(27-25-51)65-45(3)80-42-102-65/h8-10,13-17,19-30,32,35,38,42,44,55,57-60,66,87-88H,11-12,18,31,33-34,36-37,39-41H2,1-7H3,(H,78,91)(H,79,92)(H,81,95)(H,82,89)(H,83,94)(H,84,93)(H,85,90)(H2,97,98,99)/t44-,55+,57-,58-,59-,60-,66+/m0/s1",QZUOSZAORFBNEN-XMZKEKGRSA-N
4173,93,99,93,,,p-p38,CRBN,,PRZ-18002,CC1=CC=C(C(=O)NC2CC2)C=C1C1=CC=C(C(=O)C2=CC=C(OCCOCCOC(=O)NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2)C=C1,Degradation of p-p38 in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.2c01369,758.784,758.2587934,4.94,56,7,10,3,14,186.51,C42H38N4O10,"InChI=1S/C42H38N4O10/c1-24-5-6-28(38(49)43-29-13-14-29)23-32(24)25-7-9-26(10-8-25)37(48)27-11-15-30(16-12-27)55-21-19-54-20-22-56-42(53)44-33-4-2-3-31-36(33)41(52)46(40(31)51)34-17-18-35(47)45-39(34)50/h2-12,15-16,23,29,34H,13-14,17-22H2,1H3,(H,43,49)(H,44,53)(H,45,47,50)",FSJAJERSBHEGMN-UHFFFAOYSA-N
4179,220.5,75,220.5,75,Q08881,ITK,CRBN,,,CN(CCOCCOCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,46.4,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,807.909,807.3704095,3.14,59,7,12,4,17,209.95,C42H49N9O8,"InChI=1S/C42H49N9O8/c1-42(2)16-14-28-31(22-42)47-48-37(28)39(55)44-27-23-43-50(24-27)32(26-8-5-4-6-9-26)15-17-49(3)18-19-58-20-21-59-25-35(53)45-30-11-7-10-29-36(30)41(57)51(40(29)56)33-12-13-34(52)46-38(33)54/h4-11,23-24,32-33H,12-22,25H2,1-3H3,(H,44,55)(H,45,53)(H,47,48)(H,46,52,54)/t32-,33?/m0/s1",ZWQJQEMPNYBFQE-JEFWXSHNSA-N
4180,352.6,75,352.6,75,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,44.5,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,851.962,851.3966243,3,62,7,13,4,20,219.18,C44H53N9O9,"InChI=1S/C44H53N9O9/c1-44(2)16-14-30-33(24-44)49-50-39(30)41(57)46-29-25-45-52(26-29)34(28-8-5-4-6-9-28)15-17-51(3)18-19-60-20-21-61-22-23-62-27-37(55)47-32-11-7-10-31-38(32)43(59)53(42(31)58)35-12-13-36(54)48-40(35)56/h4-11,25-26,34-35H,12-24,27H2,1-3H3,(H,46,57)(H,47,55)(H,49,50)(H,48,54,56)/t34-,35?/m0/s1",SEPZFBBSIBKESI-SFCXHYMASA-N
4181,286.2,75,286.2,75,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCCOCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,896.015,895.422839,2.85,65,7,14,4,23,228.41,C46H57N9O10,"InChI=1S/C46H57N9O10/c1-46(2)16-14-32-35(26-46)51-52-41(32)43(59)48-31-27-47-54(28-31)36(30-8-5-4-6-9-30)15-17-53(3)18-19-62-20-21-63-22-23-64-24-25-65-29-39(57)49-34-11-7-10-33-40(34)45(61)55(44(33)60)37-12-13-38(56)50-42(37)58/h4-11,27-28,36-37H,12-26,29H2,1-3H3,(H,48,59)(H,49,57)(H,51,52)(H,50,56,58)/t36-,37?/m0/s1",ADRHCEUDBUBWKX-NWDJCJOJSA-N
4182,32.7,99,32.7,99,Q08881,ITK,CRBN,,,CN(CCOCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,20,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,806.925,806.3863939,3.41,59,7,12,5,17,212.75,C42H50N10O7,"InChI=1S/C42H50N10O7/c1-42(2)16-14-28-31(22-42)48-49-37(28)39(56)46-27-23-45-51(25-27)32(26-8-5-4-6-9-26)15-18-50(3)19-21-59-20-17-43-35(54)24-44-30-11-7-10-29-36(30)41(58)52(40(29)57)33-12-13-34(53)47-38(33)55/h4-11,23,25,32-33,44H,12-22,24H2,1-3H3,(H,43,54)(H,46,56)(H,48,49)(H,47,53,55)/t32-,33?/m0/s1",LOJMZDCMSCZZAJ-JEFWXSHNSA-N
4183,32.7,95,32.7,95,Q08881,ITK,CRBN,,,CN(CCOCCOCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,850.978,850.4126087,3.26,62,7,13,5,20,221.98,C44H54N10O8,"InChI=1S/C44H54N10O8/c1-44(2)16-14-30-33(24-44)50-51-39(30)41(58)48-29-25-47-53(27-29)34(28-8-5-4-6-9-28)15-18-52(3)19-21-62-23-22-61-20-17-45-37(56)26-46-32-11-7-10-31-38(32)43(60)54(42(31)59)35-12-13-36(55)49-40(35)57/h4-11,25,27,34-35,46H,12-24,26H2,1-3H3,(H,45,56)(H,48,58)(H,50,51)(H,49,55,57)/t34-,35?/m0/s1",SGUKLZBZSKIVPN-SFCXHYMASA-N
4184,62.2,93,62.2,93,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,895.031,894.4388234,3.12,65,7,14,5,23,231.21,C46H58N10O9,"InChI=1S/C46H58N10O9/c1-46(2)16-14-32-35(26-46)52-53-41(32)43(60)50-31-27-49-55(29-31)36(30-8-5-4-6-9-30)15-18-54(3)19-21-64-23-25-65-24-22-63-20-17-47-39(58)28-48-34-11-7-10-33-40(34)45(62)56(44(33)61)37-12-13-38(57)51-42(37)59/h4-11,27,29,36-37,48H,12-26,28H2,1-3H3,(H,47,58)(H,50,60)(H,52,53)(H,51,57,59)/t36-,37?/m0/s1",KDCYYVAKGGBCRY-NWDJCJOJSA-N
4185,15.6,97,15.6,97,Q08881,ITK,CRBN,,,CN(CCOCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,777.883,777.3598448,2.64,57,7,11,4,15,200.72,C41H47N9O7,"InChI=1S/C41H47N9O7/c1-41(2)16-13-29-31(22-41)46-47-36(29)38(54)44-27-23-42-49(24-27)32(25-7-5-4-6-8-25)14-17-48(3)18-20-57-19-15-35(52)43-26-9-10-28-30(21-26)40(56)50(39(28)55)33-11-12-34(51)45-37(33)53/h4-10,21,23-24,32-33H,11-20,22H2,1-3H3,(H,43,52)(H,44,54)(H,46,47)(H,45,51,53)/t32-,33?/m0/s1",POZBIGMNEGXRFC-JEFWXSHNSA-N
4186,26.7,95,26.7,95,Q08881,ITK,CRBN,,,CN(CCOCCOCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,24.1,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,807.909,807.3704095,2.59,59,7,12,4,17,209.95,C42H49N9O8,"InChI=1S/C42H49N9O8/c1-42(2)15-13-30-32(22-42)47-48-37(30)39(55)45-28-23-43-50(24-28)33(26-7-5-4-6-8-26)14-16-49(3)17-18-58-19-20-59-25-36(53)44-27-9-10-29-31(21-27)41(57)51(40(29)56)34-11-12-35(52)46-38(34)54/h4-10,21,23-24,33-34H,11-20,22,25H2,1-3H3,(H,44,53)(H,45,55)(H,47,48)(H,46,52,54)/t33-,34?/m0/s1",YRMYHBHIFJXIGI-CDRRMRQFSA-N
4187,94.1,93,94.1,93,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,23.4,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,851.962,851.3966243,2.44,62,7,13,4,20,219.18,C44H53N9O9,"InChI=1S/C44H53N9O9/c1-44(2)15-13-32-34(24-44)49-50-39(32)41(57)47-30-25-45-52(26-30)35(28-7-5-4-6-8-28)14-16-51(3)17-18-60-19-20-61-21-22-62-27-38(55)46-29-9-10-31-33(23-29)43(59)53(42(31)58)36-11-12-37(54)48-40(36)56/h4-10,23,25-26,35-36H,11-22,24,27H2,1-3H3,(H,46,55)(H,47,57)(H,49,50)(H,48,54,56)/t35-,36?/m0/s1",RSIUYCUBMQDZLI-TYIYNAFKSA-N
4188,105.9,92,105.9,92,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCCOCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,896.015,895.422839,2.3,65,7,14,4,23,228.41,C46H57N9O10,"InChI=1S/C46H57N9O10/c1-46(2)15-13-34-36(26-46)51-52-41(34)43(59)49-32-27-47-54(28-32)37(30-7-5-4-6-8-30)14-16-53(3)17-18-62-19-20-63-21-22-64-23-24-65-29-40(57)48-31-9-10-33-35(25-31)45(61)55(44(33)60)38-11-12-39(56)50-42(38)58/h4-10,25,27-28,37-38H,11-24,26,29H2,1-3H3,(H,48,57)(H,49,59)(H,51,52)(H,50,56,58)/t37-,38?/m0/s1",DKWMHDBRVHNYTN-AIQPRDSRSA-N
4189,5.3,90,5.3,90,Q08881,ITK,CRBN,,,CN(CCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,761.884,761.3649302,3.5,56,7,10,4,14,191.49,C41H47N9O6,"InChI=1S/C41H47N9O6/c1-41(2)18-16-29-31(22-41)46-47-36(29)38(54)44-27-23-42-49(24-27)32(25-9-5-4-6-10-25)17-20-48(3)19-8-7-11-34(51)43-26-12-13-28-30(21-26)40(56)50(39(28)55)33-14-15-35(52)45-37(33)53/h4-6,9-10,12-13,21,23-24,32-33H,7-8,11,14-20,22H2,1-3H3,(H,43,51)(H,44,54)(H,46,47)(H,45,52,53)/t32-,33?/m0/s1",LEUWQTQWZRMFBC-JEFWXSHNSA-N
4190,6,99,07 06,99/>99,Q08881,ITK,CRBN,,,CN(CCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat/Molt-4 cells after 16h treatment,,,29.4,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25.3,Inhibition activity of IL2 secretion in Jurkat cells,>10000/>10000/>10000,Inhibition of cell proliferation of Jurkat/Molt-4/A3 cells,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,775.911,775.3805803,3.86,57,7,10,4,15,191.49,C42H49N9O6,"InChI=1S/C42H49N9O6/c1-42(2)19-17-30-32(23-42)47-48-37(30)39(55)45-28-24-43-50(25-28)33(26-10-6-4-7-11-26)18-21-49(3)20-9-5-8-12-35(52)44-27-13-14-29-31(22-27)41(57)51(40(29)56)34-15-16-36(53)46-38(34)54/h4,6-7,10-11,13-14,22,24-25,33-34H,5,8-9,12,15-21,23H2,1-3H3,(H,44,52)(H,45,55)(H,47,48)(H,46,53,54)/t33-,34?/m0/s1",HGFFZPKBYNCGJP-CDRRMRQFSA-N
4191,9,90,9,90,Q08881,ITK,CRBN,,,CN(CCCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,789.938,789.3962304,4.4,58,7,10,4,16,191.49,C43H51N9O6,"InChI=1S/C43H51N9O6/c1-43(2)20-18-31-33(24-43)48-49-38(31)40(56)46-29-25-44-51(26-29)34(27-11-7-6-8-12-27)19-22-50(3)21-10-5-4-9-13-36(53)45-28-14-15-30-32(23-28)42(58)52(41(30)57)35-16-17-37(54)47-39(35)55/h6-8,11-12,14-15,23,25-26,34-35H,4-5,9-10,13,16-22,24H2,1-3H3,(H,45,53)(H,46,56)(H,48,49)(H,47,54,55)/t34-,35?/m0/s1",ZLOIRWPQMNYBGL-SFCXHYMASA-N
4192,5.5,93,5.5,93,Q08881,ITK,CRBN,,,CN(CCCCCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,817.992,817.4275305,5.49,60,7,10,4,18,191.49,C45H55N9O6,"InChI=1S/C45H55N9O6/c1-45(2)22-20-33-35(26-45)50-51-40(33)42(58)48-31-27-46-53(28-31)36(29-13-9-8-10-14-29)21-24-52(3)23-12-7-5-4-6-11-15-38(55)47-30-16-17-32-34(25-30)44(60)54(43(32)59)37-18-19-39(56)49-41(37)57/h8-10,13-14,16-17,25,27-28,36-37H,4-7,11-12,15,18-24,26H2,1-3H3,(H,47,55)(H,48,58)(H,50,51)(H,49,56,57)/t36-,37?/m0/s1",VBMKCGVNGRQNJV-NWDJCJOJSA-N
4193,75.4,82,75.4,82,Q08881,ITK,CRBN,,,CN(CCCCCCCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,846.046,845.4588306,6.57,62,7,10,4,20,191.49,C47H59N9O6,"InChI=1S/C47H59N9O6/c1-47(2)24-22-35-37(28-47)52-53-42(35)44(60)50-33-29-48-55(30-33)38(31-15-11-10-12-16-31)23-26-54(3)25-14-9-7-5-4-6-8-13-17-40(57)49-32-18-19-34-36(27-32)46(62)56(45(34)61)39-20-21-41(58)51-43(39)59/h10-12,15-16,18-19,27,29-30,38-39H,4-9,13-14,17,20-26,28H2,1-3H3,(H,49,57)(H,50,60)(H,52,53)(H,51,58,59)/t38-,39?/m0/s1",FXHSLFPHSQGRHN-SQTCDLSVSA-N
4194,3.6,95,3.6,95,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CCC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C2=CC=CC=C2)N=C1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35.2,Inhibition activity of IL2 secretion in Jurkat cells,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,829.019,828.4435149,4.72,61,9,11,3,12,168.87,C46H56N10O5,"InChI=1S/C46H56N10O5/c1-46(2)17-12-35-37(27-46)50-51-41(35)43(59)48-32-28-47-55(29-32)38(31-6-4-3-5-7-31)16-19-53-24-22-52(23-25-53)18-13-30-14-20-54(21-15-30)33-8-9-34-36(26-33)45(61)56(44(34)60)39-10-11-40(57)49-42(39)58/h3-9,26,28-30,38-39H,10-25,27H2,1-2H3,(H,48,59)(H,50,51)(H,49,57,58)/t38-,39?/m0/s1",QEXIHSMROQCLDO-SQTCDLSVSA-N
4195,29.3,90,29.3,90,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C2=CC=CC=C2)N=C1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,814.992,814.4278648,4.36,60,9,11,3,11,168.87,C45H54N10O5,"InChI=1S/C45H54N10O5/c1-45(2)16-12-34-36(25-45)49-50-40(34)42(58)47-31-26-46-54(28-31)37(30-6-4-3-5-7-30)15-17-51-20-22-52(23-21-51)27-29-13-18-53(19-14-29)32-8-9-33-35(24-32)44(60)55(43(33)59)38-10-11-39(56)48-41(38)57/h3-9,24,26,28-29,37-38H,10-23,25,27H2,1-2H3,(H,47,58)(H,49,50)(H,48,56,57)/t37-,38?/m0/s1",MANMYZQCTDYCCS-AIQPRDSRSA-N
4196,142,90,142,90,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CCC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)C2=CC=CC=C2)N=C1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,800.965,800.4122148,4,59,9,11,3,12,168.87,C44H52N10O5,"InChI=1S/C44H52N10O5/c1-44(2)15-12-33-35(23-44)48-49-39(33)41(57)46-30-24-45-53(27-30)36(29-6-4-3-5-7-29)14-17-51-20-18-50(19-21-51)16-13-28-25-52(26-28)31-8-9-32-34(22-31)43(59)54(42(32)58)37-10-11-38(55)47-40(37)56/h3-9,22,24,27-28,36-37H,10-21,23,25-26H2,1-2H3,(H,46,57)(H,48,49)(H,47,55,56)/t36-,37?/m0/s1",TXNMTSWVZKOGFM-NWDJCJOJSA-N
4197,10,85,10,85,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)C2=CC=CC=C2)N=C1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,786.938,786.3965647,3.64,58,9,11,3,11,168.87,C43H50N10O5,"InChI=1S/C43H50N10O5/c1-43(2)14-12-32-34(21-43)47-48-38(32)40(56)45-29-22-44-52(26-29)35(28-6-4-3-5-7-28)13-15-49-16-18-50(19-17-49)23-27-24-51(25-27)30-8-9-31-33(20-30)42(58)53(41(31)57)36-10-11-37(54)46-39(36)55/h3-9,20,22,26-27,35-36H,10-19,21,23-25H2,1-2H3,(H,45,56)(H,47,48)(H,46,54,55)/t35-,36?/m0/s1",JGLKHXACODUKAA-TYIYNAFKSA-N
4215,,,>5000,,P36969,GPX4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCN(C(=O)CCl)C(C(=O)NCC4=CC=CC=C4)C4=CC=CS4)=C3C2=O)C(=O)N1,Degradation of GPX4 in HT1080 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000,Inhibition of cell proliferation of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106461,622.103,621.1448823,3.03,43,5,8,3,11,144.99,C30H28ClN5O6S,"InChI=1S/C30H28ClN5O6S/c31-16-24(38)35(26(22-10-5-15-43-22)28(40)33-17-18-6-2-1-3-7-18)14-13-32-20-9-4-8-19-25(20)30(42)36(29(19)41)21-11-12-23(37)34-27(21)39/h1-10,15,21,26,32H,11-14,16-17H2,(H,33,40)(H,34,37,39)",VLGGOBPNNXSLBK-UHFFFAOYSA-N
4216,130,99,130,,P36969,GPX4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCN(C(=O)CCl)C(C(=O)NCC4=CC=CC=C4)C4=CC=CS4)=C3C2=O)C(=O)N1,Degradation of GPX4 in HT1080 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,860,Inhibition of cell proliferation of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106461,650.157,649.1761824,3.75,45,5,8,3,13,144.99,C32H32ClN5O6S,"InChI=1S/C32H32ClN5O6S/c33-18-26(40)37(28(24-12-7-17-45-24)30(42)35-19-20-8-2-1-3-9-20)16-5-4-15-34-22-11-6-10-21-27(22)32(44)38(31(21)43)23-13-14-25(39)36-29(23)41/h1-3,6-12,17,23,28,34H,4-5,13-16,18-19H2,(H,35,42)(H,36,39,41)",MUZYGUIZQYPRMS-UHFFFAOYSA-N
4217,,,>1000,,P36969,GPX4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCN(C(=O)CCl)C(C(=O)NCC4=CC=CC=C4)C4=CC=CS4)=C3C2=O)C(=O)N1,Degradation of GPX4 in HT1080 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000,Inhibition of cell proliferation of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106461,678.211,677.2074826,4.46,47,5,8,3,15,144.99,C34H36ClN5O6S,"InChI=1S/C34H36ClN5O6S/c35-20-28(42)39(30(26-14-9-19-47-26)32(44)37-21-22-10-4-3-5-11-22)18-7-2-1-6-17-36-24-13-8-12-23-29(24)34(46)40(33(23)45)25-15-16-27(41)38-31(25)43/h3-5,8-14,19,25,30,36H,1-2,6-7,15-18,20-21H2,(H,37,44)(H,38,41,43)",QADDWJPRFFRLAD-UHFFFAOYSA-N
4218,,,>5000,,P36969,GPX4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCN(C(=O)CCl)C(C(=O)NCC4=CC=CC=C4)C4=CC=CS4)=C3C2=O)C(=O)N1,Degradation of GPX4 in HT1080 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3000,Inhibition of cell proliferation of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106461,710.209,709.1973118,2.74,49,5,10,3,17,163.45,C34H36ClN5O8S,"InChI=1S/C34H36ClN5O8S/c35-20-28(42)39(30(26-10-5-19-49-26)32(44)37-21-22-6-2-1-3-7-22)14-16-48-18-17-47-15-13-36-24-9-4-8-23-29(24)34(46)40(33(23)45)25-11-12-27(41)38-31(25)43/h1-10,19,25,30,36H,11-18,20-21H2,(H,37,44)(H,38,41,43)",YFVYIFQMWXMLOO-UHFFFAOYSA-N
4219,210,99,210,,P36969,GPX4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCN(C(=O)CCl)C(C(=O)NCC4=CC=CC=C4)C4=CC=CS4)=C3C2=O)C(=O)N1,Degradation of GPX4 in HT1080 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2930,Inhibition of cell proliferation of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106461,754.262,753.2235265,2.59,52,5,11,3,20,172.68,C36H40ClN5O9S,"InChI=1S/C36H40ClN5O9S/c37-22-30(44)41(32(28-10-5-21-52-28)34(46)39-23-24-6-2-1-3-7-24)14-16-50-18-20-51-19-17-49-15-13-38-26-9-4-8-25-31(26)36(48)42(35(25)47)27-11-12-29(43)40-33(27)45/h1-10,21,27,32,38H,11-20,22-23H2,(H,39,46)(H,40,43,45)",AHCLVUFTWMWRSE-UHFFFAOYSA-N
4224,6.1,99,6.1,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCCCNC(=O)C(C1=CC=C(CNC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C=C1)N1CCOCC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in Namalwa cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cb00223j,1001.655,1000.418478,6.25,71,9,13,4,19,192.25,C53H61ClN10O6S,"InChI=1S/C53H61ClN10O6S/c1-32-33(2)71-53-46(32)47(36-17-19-38(54)20-18-36)58-42(49-61-60-34(3)64(49)53)29-45(66)55-23-8-6-4-5-7-9-24-56-51(68)48(62-25-27-70-28-26-62)37-15-13-35(14-16-37)30-57-41-12-10-11-39-40(41)31-63(52(39)69)43-21-22-44(65)59-50(43)67/h10-20,42-43,48,57H,4-9,21-31H2,1-3H3,(H,55,66)(H,56,68)(H,59,65,67)/t42-,43?,48?/m0/s1",DXPKCAIYQZNSOS-HPDKPOLASA-N
4225,88,99,88,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCNC(=O)C(C1=CC=C(CNC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C=C1)N1CCOCC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in Namalwa cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cb00223j,961.546,960.3507927,3.59,68,9,14,4,16,201.48,C49H53ClN10O7S,"InChI=1S/C49H53ClN10O7S/c1-28-29(2)68-49-42(28)43(32-11-13-34(50)14-12-32)54-38(45-57-56-30(3)60(45)49)25-41(62)51-17-21-66-22-18-52-47(64)44(58-19-23-67-24-20-58)33-9-7-31(8-10-33)26-53-37-6-4-5-35-36(37)27-59(48(35)65)39-15-16-40(61)55-46(39)63/h4-14,38-39,44,53H,15-27H2,1-3H3,(H,51,62)(H,52,64)(H,55,61,63)/t38-,39?,44?/m0/s1",RVHWMQLDSWBYQW-LUOMUOLQSA-N
4226,162,99,162,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCNC(=O)C(C1=CC=C(CNC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C=C1)N1CCOCC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in Namalwa cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cb00223j,1005.599,1004.377007,3.44,71,9,15,4,19,210.71,C51H57ClN10O8S,"InChI=1S/C51H57ClN10O8S/c1-30-31(2)71-51-44(30)45(34-11-13-36(52)14-12-34)56-40(47-59-58-32(3)62(47)51)27-43(64)53-17-21-68-25-26-69-22-18-54-49(66)46(60-19-23-70-24-20-60)35-9-7-33(8-10-35)28-55-39-6-4-5-37-38(39)29-61(50(37)67)41-15-16-42(63)57-48(41)65/h4-14,40-41,46,55H,15-29H2,1-3H3,(H,53,64)(H,54,66)(H,57,63,65)/t40-,41?,46?/m0/s1",UVUYDKGYRDXYLP-IHHBLWBZSA-N
4227,83,99,83,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCOCCNC(=O)C(C1=CC=C(CNC3=CC=CC4=C3CN(C3CCC(=O)NC3=O)C4=O)C=C1)N1CCOCC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in Namalwa cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cb00223j,1049.652,1048.403222,3.29,74,9,16,4,22,219.94,C53H61ClN10O9S,"InChI=1S/C53H61ClN10O9S/c1-32-33(2)74-53-46(32)47(36-11-13-38(54)14-12-36)58-42(49-61-60-34(3)64(49)53)29-45(66)55-17-21-70-25-27-73-28-26-71-22-18-56-51(68)48(62-19-23-72-24-20-62)37-9-7-35(8-10-37)30-57-41-6-4-5-39-40(41)31-63(52(39)69)43-15-16-44(65)59-50(43)67/h4-14,42-43,48,57H,15-31H2,1-3H3,(H,55,66)(H,56,68)(H,59,65,67)/t42-,43?,48?/m0/s1",LSNYTUPUZALNJO-HPDKPOLASA-N
4232,74,99,74/85,,Q9NYV4,CDK12,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC(=O)CN3CCC[C@@H](NC4=NC=C(Cl)C(NC5=CC=CC=C5S(=O)(=O)C(C)C)=N4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of CDK12 in HeLa cells after 24h treatment (cytoblot/westernblot),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,316/468/491,Inhibition of cell proliferation of Hela/MDA-MB-231/Bel-7402 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115248,1021.752,1020.448064,7.58,70,6,14,6,21,227.95,C50H69ClN10O7S2,"InChI=1S/C50H69ClN10O7S2/c1-31(2)70(67,68)41-17-12-11-16-39(41)57-46-38(51)26-53-49(59-46)56-36-15-14-24-60(27-36)29-43(64)52-23-13-9-8-10-18-42(63)58-45(50(5,6)7)48(66)61-28-37(62)25-40(61)47(65)55-32(3)34-19-21-35(22-20-34)44-33(4)54-30-69-44/h11-12,16-17,19-22,26,30-32,36-37,40,45,62H,8-10,13-15,18,23-25,27-29H2,1-7H3,(H,52,64)(H,55,65)(H,58,63)(H2,53,56,57,59)/t32-,36+,37+,40-,45+/m0/s1",IVLKCZISACPHCE-VMKWIGLFSA-N
4237,107,70,107,70,Q8TBX8,PIP4K2C,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCCCCC(=O)N3CCC4(CC3)CCN(C3=CN=CC(NC5=NC=C(Cl)C(C6=CC=CC(C7=CC=CC=C7)=C6)=N5)=C3)C4=O)=C2)SC=N1,Degradation of PIP4K2C in MOLT4 cells after 6h treatment,,,,,,,625,KD ELECT assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202302364,1153.823,1152.482221,8.51,82,10,13,4,20,212.18,C62H70ClFN10O7S,"InChI=1S/C62H70ClFN10O7S/c1-39-53(82-38-68-39)43-18-19-44(33-66-55(77)49-32-47(75)37-74(49)56(78)54(60(2,3)4)71-57(79)62(64)20-21-62)50(30-43)81-28-11-6-5-10-17-51(76)72-25-22-61(23-26-72)24-27-73(58(61)80)46-31-45(34-65-35-46)69-59-67-36-48(63)52(70-59)42-16-12-15-41(29-42)40-13-8-7-9-14-40/h7-9,12-16,18-19,29-31,34-36,38,47,49,54,75H,5-6,10-11,17,20-28,32-33,37H2,1-4H3,(H,66,77)(H,71,79)(H,67,69,70)/t47-,49+,54-/m1/s1",VCOSWEBKUXOFPA-PHCPANOJSA-N
4238,24,91,24/361,91/59,Q8TBX8,PIP4K2C,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCC4(CC3)CCN(C3=CN=CC(NC5=NC=C(Cl)C(C6=CC=CC(C7=CC=CC=C7)=C6)=N5)=C3)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of PIP4K2C in MOLT4/HAP 1 cells after 6h treatment,,,,,,,42,KD ELECT assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202302364,1079.769,1078.465429,7.8,77,9,12,4,17,202.95,C59H67ClN10O6S,"InChI=1S/C59H67ClN10O6S/c1-37(39-19-21-41(22-20-39)52-38(2)63-36-77-52)64-54(74)48-31-46(71)35-70(48)55(75)53(58(3,4)5)66-49(72)17-10-7-11-18-50(73)68-26-23-59(24-27-68)25-28-69(56(59)76)45-30-44(32-61-33-45)65-57-62-34-47(60)51(67-57)43-16-12-15-42(29-43)40-13-8-6-9-14-40/h6,8-9,12-16,19-22,29-30,32-34,36-37,46,48,53,71H,7,10-11,17-18,23-28,31,35H2,1-5H3,(H,64,74)(H,66,72)(H,62,65,67)/t37-,46+,48-,53+/m0/s1",NIQFZCJNEODJTE-CSIWTOAPSA-N
4239,105,99,105,,Q8TBX8,PIP4K2C,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCC(=O)N3CCC4(CC3)CCN(C3=CN=CC(NC5=NC=C(Cl)C(C6=CC=CC(C7=CC=CC=C7)=C6)=N5)=C3)C4=O)C(C)(C)C)C=C2)SC=N1,Degradation of PIP4K2C in MOLT4 cells after 6h treatment,,,,,,,61,KD ELECT assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202302364,1081.741,1080.444693,6.4,77,9,13,4,17,212.18,C58H65ClN10O7S,"InChI=1S/C58H65ClN10O7S/c1-36(38-14-16-40(17-15-38)51-37(2)62-35-77-51)63-53(73)47-30-45(70)34-69(47)54(74)52(57(3,4)5)65-48(71)18-26-76-27-19-49(72)67-23-20-58(21-24-67)22-25-68(55(58)75)44-29-43(31-60-32-44)64-56-61-33-46(59)50(66-56)42-13-9-12-41(28-42)39-10-7-6-8-11-39/h6-17,28-29,31-33,35-36,45,47,52,70H,18-27,30,34H2,1-5H3,(H,63,73)(H,65,71)(H,61,64,66)/t36-,45+,47-,52+/m0/s1",GDRGAEVFBXZLQO-LIXFOKFJSA-N
4242,15.7,99.9,15.7,100,Q07889,SOS1,VHL,,ZZ151,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1C1CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,Degradation of SOS1 in NCI-H358 cells after 24h treatment,83.9/98.2,% SOS1 protein degradation in NCI-H358 cells at 100/1000 nM,,,,,93,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8.13,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00075,1028.256,1027.496537,7.97,73,7,12,5,17,205,C54H68F3N9O6S,"InChI=1S/C54H68F3N9O6S/c1-30(34-14-16-36(17-15-34)48-32(3)59-29-73-48)61-51(70)44-25-40(67)28-66(44)52(71)49(53(5,6)7)64-46(68)12-10-9-11-13-47(69)65-20-18-35(19-21-65)41-26-42-43(27-45(41)72-8)62-33(4)63-50(42)60-31(2)37-22-38(54(55,56)57)24-39(58)23-37/h14-17,22-24,26-27,29-31,35,40,44,49,67H,9-13,18-21,25,28,58H2,1-8H3,(H,61,70)(H,64,68)(H,60,62,63)/t30-,31+,40+,44-,49+/m0/s1",IIUMLDLNPGCAPX-GGCSJQPYSA-N
4247,49.3,97.9,49.3,97.9,Q07889,SOS1,VHL,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1C1CCN(C(=O)COCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,Degradation of SOS1 in NCI-H358 cells after 24h treatment,54.6/90.2,% SOS1 protein degradation in NCI-H358 cells at 100/1000 nM,,,,,155,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17.4,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00075,1030.228,1029.475801,7.03,73,7,13,5,17,214.23,C53H66F3N9O7S,"InChI=1S/C53H66F3N9O7S/c1-29(33-11-13-35(14-12-33)47-31(3)58-28-73-47)60-50(69)43-23-39(66)26-65(43)51(70)48(52(5,6)7)63-45(67)10-9-19-72-27-46(68)64-17-15-34(16-18-64)40-24-41-42(25-44(40)71-8)61-32(4)62-49(41)59-30(2)36-20-37(53(54,55)56)22-38(57)21-36/h11-14,20-22,24-25,28-30,34,39,43,48,66H,9-10,15-19,23,26-27,57H2,1-8H3,(H,60,69)(H,63,67)(H,59,61,62)/t29-,30+,39+,43-,48+/m0/s1",AIHGVELLLJOFHL-AHHHCUNGSA-N
4266,111,84,111,84,O75530,EED,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of EED in DB cells after 24h treatment,,,47,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31+,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-AOBTXCIISA-N
4266,275,86,275,86,Q15910,EZH2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of EZH2 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31+,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-AOBTXCIISA-N
4266,,,0,44,Q15022,SUZ12,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of SUZ12 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31+,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-AOBTXCIISA-N
4267,67,64,67,64,O75530,EED,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of EED in DB cells after 24h treatment,,,33,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31-,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-RQQRUTLXSA-N
4267,,,0,15,Q15910,EZH2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of EZH2 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31-,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-RQQRUTLXSA-N
4267,,,0,29,Q15022,SUZ12,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,Degradation of SUZ12 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31-,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-RQQRUTLXSA-N
4268,290,63,4720/290,100/63,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR V7 in CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,908.061,907.4026362,5.11,64,7,13,3,15,176.4,C45H56F3N9O6S,"InChI=1S/C45H56F3N9O6S/c1-28-39(64-27-50-28)32-9-7-29(8-10-32)24-49-41(60)35-23-33(58)25-56(35)42(61)40(44(2,3)4)51-38(59)26-62-21-5-6-22-63-34-13-11-30(12-14-34)31-17-19-55(20-18-31)37-16-15-36-52-53-43(45(46,47)48)57(36)54-37/h7-14,27,31,33,35,40,58H,5-6,15-26H2,1-4H3,(H,49,60)(H,51,59)/t33-,35+,40-/m1/s1",BLWSMGOTKQNWIF-LJWMJXRYSA-N
4268,2120,88,2120/5730/8670,88/98/90,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP/CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6587/4134/5454,Inhibit cell growth in LNCaP/CWR22Rv1/VCaP cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,908.061,907.4026362,5.11,64,7,13,3,15,176.4,C45H56F3N9O6S,"InChI=1S/C45H56F3N9O6S/c1-28-39(64-27-50-28)32-9-7-29(8-10-32)24-49-41(60)35-23-33(58)25-56(35)42(61)40(44(2,3)4)51-38(59)26-62-21-5-6-22-63-34-13-11-30(12-14-34)31-17-19-55(20-18-31)37-16-15-36-52-53-43(45(46,47)48)57(36)54-37/h7-14,27,31,33,35,40,58H,5-6,15-26H2,1-4H3,(H,49,60)(H,51,59)/t33-,35+,40-/m1/s1",BLWSMGOTKQNWIF-LJWMJXRYSA-N
4269,1890,99,1890/520,99/67,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR V7 in CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,936.115,935.4339363,5.82,66,7,13,3,17,176.4,C47H60F3N9O6S,"InChI=1S/C47H60F3N9O6S/c1-30-41(66-29-52-30)34-11-9-31(10-12-34)26-51-43(62)37-25-35(60)27-58(37)44(63)42(46(2,3)4)53-40(61)28-64-23-7-5-6-8-24-65-36-15-13-32(14-16-36)33-19-21-57(22-20-33)39-18-17-38-54-55-45(47(48,49)50)59(38)56-39/h9-16,29,33,35,37,42,60H,5-8,17-28H2,1-4H3,(H,51,62)(H,53,61)/t35-,37-,42+/m0/s1",XXORMIPKQOJWQL-FFHGCIBJSA-N
4269,6100,71,6100/6640/9050,71/96/85,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,Degradation of AR in LNCaP/CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6360/6921/3057,Inhibit cell growth in LNCaP/CWR22Rv1/VCaP cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,936.115,935.4339363,5.82,66,7,13,3,17,176.4,C47H60F3N9O6S,"InChI=1S/C47H60F3N9O6S/c1-30-41(66-29-52-30)34-11-9-31(10-12-34)26-51-43(62)37-25-35(60)27-58(37)44(63)42(46(2,3)4)53-40(61)28-64-23-7-5-6-8-24-65-36-15-13-32(14-16-36)33-19-21-57(22-20-33)39-18-17-38-54-55-45(47(48,49)50)59(38)56-39/h9-16,29,33,35,37,42,60H,5-8,17-28H2,1-4H3,(H,51,62)(H,53,61)/t35-,37-,42+/m0/s1",XXORMIPKQOJWQL-FFHGCIBJSA-N
4270,11,91,11/430,91/82,P10275,AR-V7,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)COCCCCOC4=CC=C(C5CCN(C6=NN7C(=NN=C7C(F)(F)F)CC6)CC5)C=C4)C=CC=C3C2=O)C(=O)N1,Degradation of AR V7 in CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,736.752,736.2944656,2.15,53,7,11,2,11,160.35,C36H39F3N8O6,"InChI=1S/C36H39F3N8O6/c37-36(38,39)35-43-42-29-11-12-30(44-47(29)35)45-16-14-23(15-17-45)22-6-8-24(9-7-22)53-19-2-1-18-52-21-32(49)40-27-5-3-4-25-26(27)20-46(34(25)51)28-10-13-31(48)41-33(28)50/h3-9,23,28H,1-2,10-21H2,(H,40,49)(H,41,48,50)",LCTDAEHHXXZLPR-UHFFFAOYSA-N
4270,110,74,3410/110/851,99/74/94,P10275,AR,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)COCCCCOC4=CC=C(C5CCN(C6=NN7C(=NN=C7C(F)(F)F)CC6)CC5)C=C4)C=CC=C3C2=O)C(=O)N1,Degradation of AR in LNCaP/CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,464/71/448,Inhibit cell growth in LNCaP/CWR22Rv1/VCaP cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,736.752,736.2944656,2.15,53,7,11,2,11,160.35,C36H39F3N8O6,"InChI=1S/C36H39F3N8O6/c37-36(38,39)35-43-42-29-11-12-30(44-47(29)35)45-16-14-23(15-17-45)22-6-8-24(9-7-22)53-19-2-1-18-52-21-32(49)40-27-5-3-4-25-26(27)20-46(34(25)51)28-10-13-31(48)41-33(28)50/h3-9,23,28H,1-2,10-21H2,(H,40,49)(H,41,48,50)",LCTDAEHHXXZLPR-UHFFFAOYSA-N
4273,6,99,6,,O15379,HDAC3,CRBN,,SJ11646,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCNC(=O)COC3=CC=C(C4CCC(=O)NC4=O)C=C3)CC2)=N1,Degradation of LCK in KOPT-K1 cells after 4h treatment,,,,,,,,,,,,,,,,,,,1.4,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00436,746.294,745.2561641,4.73,52,6,12,4,13,170.78,C36H40ClN9O5S,"InChI=1S/C36H40ClN9O5S/c1-22-5-3-6-27(37)33(22)44-35(50)28-20-39-36(52-28)42-29-19-30(41-23(2)40-29)46-17-15-45(16-18-46)14-4-13-38-32(48)21-51-25-9-7-24(8-10-25)26-11-12-31(47)43-34(26)49/h3,5-10,19-20,26H,4,11-18,21H2,1-2H3,(H,38,48)(H,44,50)(H,43,47,49)(H,39,40,41,42)",AJNQGWOQPRWRML-UHFFFAOYSA-N
4274,15,99,15,,O15379,HDAC3,CRBN,,SJ34739,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCNC(=O)COC3=CC=C(N4CCC(=O)NC4=O)C=C3)CC2)=N1,Degradation of LCK in KOPT-K1 cells after 4h treatment,,,,,,,,,,,,,,,,,,,52,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00436,747.282,746.251413,4.32,52,6,12,4,13,174.02,C35H39ClN10O5S,"InChI=1S/C35H39ClN10O5S/c1-22-5-3-6-26(36)32(22)43-33(49)27-20-38-34(52-27)41-28-19-29(40-23(2)39-28)45-17-15-44(16-18-45)13-4-12-37-31(48)21-51-25-9-7-24(8-10-25)46-14-11-30(47)42-35(46)50/h3,5-10,19-20H,4,11-18,21H2,1-2H3,(H,37,48)(H,43,49)(H,42,47,50)(H,38,39,40,41)",NFCLUGCJOGGYFA-UHFFFAOYSA-N
4275,13,99,13,,O15379,HDAC3,CRBN,,SJ42176,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of LCK in KOPT-K1 cells after 4h treatment,,,,,,,,,,,,,,,,,,,1028.7,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00436,815.313,814.2412423,3.84,57,7,14,4,13,208.16,C38H39ClN10O7S,"InChI=1S/C38H39ClN10O7S/c1-21-6-3-8-24(39)33(21)46-35(53)27-19-41-38(57-27)44-28-18-29(43-22(2)42-28)48-16-14-47(15-17-48)13-5-12-40-31(51)20-56-26-9-4-7-23-32(26)37(55)49(36(23)54)25-10-11-30(50)45-34(25)52/h3-4,6-9,18-19,25H,5,10-17,20H2,1-2H3,(H,40,51)(H,46,53)(H,45,50,52)(H,41,42,43,44)",UTSJZOKCLVAKMH-UHFFFAOYSA-N
4276,8,99,8,,O15379,HDAC3,CRBN,,SJ34769,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCC(=O)N3CCN(C4=CC=C(C5CCC(=O)NC5=O)C=C4)CC3)CC2)=N1,Degradation of LCK in KOPT-K1 cells after 4h treatment,,,,,,,,,,,,,,,,,,,7.1,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00436,785.375,784.3034486,4.75,55,7,12,3,11,156,C39H45ClN10O4S,"InChI=1S/C39H45ClN10O4S/c1-25-5-3-6-30(40)36(25)46-38(54)31-24-41-39(55-31)44-32-23-33(43-26(2)42-32)49-17-15-47(16-18-49)14-4-7-35(52)50-21-19-48(20-22-50)28-10-8-27(9-11-28)29-12-13-34(51)45-37(29)53/h3,5-6,8-11,23-24,29H,4,7,12-22H2,1-2H3,(H,46,54)(H,45,51,53)(H,41,42,43,44)",UVLQOVGDDSJYRQ-UHFFFAOYSA-N
4277,0.8,99,0.8,,O15379,HDAC3,CRBN,,SJ43489,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCC(=O)N3CCN(C4=CC=C(N5CCC(=O)NC5=O)C=C4)CC3)CC2)=N1,Degradation of LCK in KOPT-K1 cells after 4h treatment,,,,,,,,,,,,,,,,,,,217.3,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00436,786.363,785.2986976,4.33,55,7,12,3,11,159.24,C38H44ClN11O4S,"InChI=1S/C38H44ClN11O4S/c1-25-5-3-6-29(39)35(25)45-36(53)30-24-40-37(55-30)43-31-23-32(42-26(2)41-31)48-17-15-46(16-18-48)13-4-7-34(52)49-21-19-47(20-22-49)27-8-10-28(11-9-27)50-14-12-33(51)44-38(50)54/h3,5-6,8-11,23-24H,4,7,12-22H2,1-2H3,(H,45,53)(H,44,51,54)(H,40,41,42,43)",UBWYPSMSVKLWNN-UHFFFAOYSA-N
4284,11.55,99,11.55,,Q16539,p38alpha,VHL,,,CC1=CC=C(C(=O)NCCC2=CN(CCCC(=O)NCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1N1C(C)=CC(OCC2=CC=C(F)C=C2F)=C(Br)C1=O,Degradation of p38alpha in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3390/cancers15030611,1184.219,1182.417199,7.04,80,7,14,5,24,231.77,C58H69BrF2N10O8S,"InChI=1S/C58H69BrF2N10O8S/c1-34-14-15-40(27-46(34)71-35(2)26-48(51(59)56(71)77)79-32-41-20-21-42(60)28-45(41)61)54(75)63-24-22-43-30-69(68-67-43)25-11-13-49(73)62-23-10-8-9-12-50(74)66-53(58(5,6)7)57(78)70-31-44(72)29-47(70)55(76)65-36(3)38-16-18-39(19-17-38)52-37(4)64-33-80-52/h14-21,26-28,30,33,36,44,47,53,72H,8-13,22-25,29,31-32H2,1-7H3,(H,62,73)(H,63,75)(H,65,76)(H,66,74)/t36-,44+,47-,53+/m0/s1",ZOBYVOUQIXMJIP-XLVHCTKXSA-N
4285,15,87,15,87,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,810.996,810.3080692,4.49,56,5,14,2,18,174.66,C39H50N6O9S2,"InChI=1S/C39H50N6O9S2/c1-39(2,3)30-22-41-32(54-30)25-55-35-23-42-38(56-35)43-37(49)27-11-15-44(16-12-27)24-31(46)40-13-17-52-18-19-53-36-28(50-4)20-26(21-29(36)51-5)9-10-34(48)45-14-7-6-8-33(45)47/h6,8-10,20-23,27H,7,11-19,24-25H2,1-5H3,(H,40,46)(H,42,43,49)/b10-9+",VJANLMROQUGZQD-MDZDMXLPSA-N
4286,12,93,12,93,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,138,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,855.049,854.3342839,4.35,59,5,15,2,21,183.89,C41H54N6O10S2,"InChI=1S/C41H54N6O10S2/c1-41(2,3)32-24-43-34(57-32)27-58-37-25-44-40(59-37)45-39(51)29-11-15-46(16-12-29)26-33(48)42-13-17-54-18-19-55-20-21-56-38-30(52-4)22-28(23-31(38)53-5)9-10-36(50)47-14-7-6-8-35(47)49/h6,8-10,22-25,29H,7,11-21,26-27H2,1-5H3,(H,42,48)(H,44,45,51)/b10-9+",TXKCUGSZTOPCDO-MDZDMXLPSA-N
4287,10,96,10,96,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCCOCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,132,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,899.102,898.3604987,4.2,62,5,16,2,24,193.12,C43H58N6O11S2,"InChI=1S/C43H58N6O11S2/c1-43(2,3)34-26-45-36(60-34)29-61-39-27-46-42(62-39)47-41(53)31-11-15-48(16-12-31)28-35(50)44-13-17-56-18-19-57-20-21-58-22-23-59-40-32(54-4)24-30(25-33(40)55-5)9-10-38(52)49-14-7-6-8-37(49)51/h6,8-10,24-27,31H,7,11-23,28-29H2,1-5H3,(H,44,50)(H,46,47,53)/b10-9+",RZZUETFFPWLZJB-MDZDMXLPSA-N
4288,102,74,102,74,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCCCCCCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,318,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,851.105,850.3757548,7.15,59,5,13,2,21,165.43,C43H58N6O8S2,"InChI=1S/C43H58N6O8S2/c1-43(2,3)34-26-45-36(57-34)29-58-39-27-46-42(59-39)47-41(53)31-17-21-48(22-18-31)28-35(50)44-19-11-8-6-7-9-13-23-56-40-32(54-4)24-30(25-33(40)55-5)15-16-38(52)49-20-12-10-14-37(49)51/h10,14-16,24-27,31H,6-9,11-13,17-23,28-29H2,1-5H3,(H,44,50)(H,46,47,53)/b16-15+",RATDLIDZDBRMJD-FOCLMDBBSA-N
4289,28,87,28,87,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCC(=O)N1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,119,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,811.98,811.2920848,4.49,56,5,14,1,18,171.86,C39H49N5O10S2,"InChI=1S/C39H49N5O10S2/c1-39(2,3)30-22-40-31(54-30)25-55-35-23-41-38(56-35)42-37(48)27-11-14-43(15-12-27)34(47)24-52-17-16-51-18-19-53-36-28(49-4)20-26(21-29(36)50-5)9-10-33(46)44-13-7-6-8-32(44)45/h6,8-10,20-23,27H,7,11-19,24-25H2,1-5H3,(H,41,42,48)/b10-9+",ZBRDTLMHOHYRGL-MDZDMXLPSA-N
4290,15,92,15,92,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCCOCC(=O)N1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,107,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,856.033,855.3182995,4.34,59,5,15,1,21,181.09,C41H53N5O11S2,"InChI=1S/C41H53N5O11S2/c1-41(2,3)32-24-42-33(57-32)27-58-37-25-43-40(59-37)44-39(50)29-11-14-45(15-12-29)36(49)26-55-19-18-53-16-17-54-20-21-56-38-30(51-4)22-28(23-31(38)52-5)9-10-35(48)46-13-7-6-8-34(46)47/h6,8-10,22-25,29H,7,11-21,26-27H2,1-5H3,(H,43,44,50)/b10-9+",LWSHARCZUPCYNR-MDZDMXLPSA-N
4291,9,96,9,96,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCN1CCN(C(=O)CN2CCC(C(=O)NC3=NC=C(SCC4=NC=C(C(C)(C)C)O4)S3)CC2)CC1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,836.05,835.3397037,4.64,58,6,14,1,15,159.88,C41H53N7O8S2,"InChI=1S/C41H53N7O8S2/c1-41(2,3)32-24-42-33(56-32)27-57-37-25-43-40(58-37)44-39(52)29-11-14-46(15-12-29)26-36(51)47-18-16-45(17-19-47)20-21-55-38-30(53-4)22-28(23-31(38)54-5)9-10-35(50)48-13-7-6-8-34(48)49/h6,8-10,22-25,29H,7,11-21,26-27H2,1-5H3,(H,43,44,52)/b10-9+",FNMOBNDTZONNKY-MDZDMXLPSA-N
4293,190,80,190,80,O60885,BRD4,VHL,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCOC1=NOC([C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(Cl)C=C3)C(C)C)=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,187,ITC,,,,,,,,,,,,,,,,,,,,,,,0.05,Caco-2 A2B assay,16,Caco-2 B2A assay,10.1002/cmdc.202200615,903.934,902.3107577,7.03,62,7,12,3,16,177.07,C45H52Cl2N8O6S,"InChI=1S/C45H52Cl2N8O6S/c1-24(2)39(44(59)54-23-33(56)20-35(54)43(58)49-26(4)29-10-14-31(46)15-11-29)36-22-38(53-61-36)60-19-9-7-8-18-48-37(57)21-34-42-52-51-28(6)55(42)45-40(25(3)27(5)62-45)41(50-34)30-12-16-32(47)17-13-30/h10-17,22,24,26,33-35,39,56H,7-9,18-21,23H2,1-6H3,(H,48,57)(H,49,58)/t26-,33+,34-,35-,39-/m0/s1",MEHBZJQWERYZKL-VBKHBCKHSA-N
4294,4,99,4,99,O60885,BRD4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCCCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)=NO3)C(C)C)C=C2)SC=N1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,ITC,,,,,,,,,,,,,,,,,,,,,,,N.D.,Caco-2 A2B assay,N.D.,Caco-2 B2A assay,10.1002/cmdc.202200615,966.631,965.3483502,7.49,67,8,14,3,17,189.96,C49H56ClN9O6S2,"InChI=1S/C49H56ClN9O6S2/c1-26(2)42(48(63)58-24-36(60)21-38(58)47(62)53-28(4)32-11-13-34(14-12-32)45-29(5)52-25-66-45)39-23-41(57-65-39)64-20-10-8-9-19-51-40(61)22-37-46-56-55-31(7)59(46)49-43(27(3)30(6)67-49)44(54-37)33-15-17-35(50)18-16-33/h11-18,23,25-26,28,36-38,42,60H,8-10,19-22,24H2,1-7H3,(H,51,61)(H,53,62)/t28-,36+,37-,38-,42+/m0/s1",KXHYUMQIBXKYPG-KOMHUTCNSA-N
4295,210,89,210,89,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(Cl)C=C2OCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33,ITC,,,,,,,,,,,,,,,,,,,,,,,0.07,Caco-2 A2B assay,20,Caco-2 B2A assay,10.1002/cmdc.202200615,1008.039,1006.358102,5.58,69,7,15,3,22,204.76,C49H60Cl2N8O9S,"InChI=1S/C49H60Cl2N8O9S/c1-27(2)43(41-22-28(3)57-68-41)48(63)58-26-36(60)24-39(58)47(62)53-30(5)37-13-12-35(51)23-40(37)67-21-20-66-19-18-65-17-16-64-15-14-52-42(61)25-38-46-56-55-32(7)59(46)49-44(29(4)31(6)69-49)45(54-38)33-8-10-34(50)11-9-33/h8-13,22-23,27,30,36,38-39,43,60H,14-21,24-26H2,1-7H3,(H,52,61)(H,53,62)/t30-,36+,38-,39-,43+/m0/s1",QMDXZTNQRYGNEC-SKEOZXKHSA-N
4296,16,82,16,82,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2OCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4,ITC,,,,,,,,,,,,,,,,,,,,,,,0.07,Caco-2 A2B assay,11,Caco-2 B2A assay,10.1002/cmdc.202200615,1070.736,1069.395694,6.04,74,8,17,3,23,217.65,C53H64ClN9O9S2,"InChI=1S/C53H64ClN9O9S2/c1-29(2)46(44-23-30(3)61-72-44)52(67)62-27-39(64)25-42(62)51(66)57-32(5)40-14-11-37(49-33(6)56-28-73-49)24-43(40)71-22-21-70-20-19-69-18-17-68-16-15-55-45(65)26-41-50-60-59-35(8)63(50)53-47(31(4)34(7)74-53)48(58-41)36-9-12-38(54)13-10-36/h9-14,23-24,28-29,32,39,41-42,46,64H,15-22,25-27H2,1-8H3,(H,55,65)(H,57,66)/t32-,39+,41-,42-,46+/m0/s1",UIERTIMQQRRSTO-BEDMWFMASA-N
4297,190,80,190,80,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63,ITC,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,7.5,Caco-2 B2A assay,10.1002/cmdc.202200615,930.96,929.3216568,5.65,64,7,12,4,16,196.94,C46H53Cl2N9O6S,"InChI=1S/C46H53Cl2N9O6S/c1-24(2)40(37-19-25(3)55-63-37)45(62)56-23-33(58)20-36(56)44(61)52-34(29-9-13-31(47)14-10-29)21-38(59)49-17-7-8-18-50-39(60)22-35-43-54-53-28(6)57(43)46-41(26(4)27(5)64-46)42(51-35)30-11-15-32(48)16-12-30/h9-16,19,24,33-36,40,58H,7-8,17-18,20-23H2,1-6H3,(H,49,59)(H,50,60)(H,52,61)/t33-,34+,35+,36+,40-/m1/s1",STGFOSWNXWQTTP-LADHRSEISA-N
4298,1500,99.9,1500,100,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64,ITC,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,6,Caco-2 B2A assay,10.1002/cmdc.202200615,991.012,989.3427861,4.64,68,7,14,4,20,215.4,C48H57Cl2N9O8S,"InChI=1S/C48H57Cl2N9O8S/c1-26(2)42(39-21-27(3)57-67-39)47(64)58-25-35(60)22-38(58)46(63)54-36(31-7-11-33(49)12-8-31)23-40(61)51-15-17-65-19-20-66-18-16-52-41(62)24-37-45-56-55-30(6)59(45)48-43(28(4)29(5)68-48)44(53-37)32-9-13-34(50)14-10-32/h7-14,21,26,35-38,42,60H,15-20,22-25H2,1-6H3,(H,51,61)(H,52,62)(H,54,63)/t35-,36+,37+,38+,42-/m1/s1",MIHQDVSIMCDUSP-PXYAPSQZSA-N
4299,1100,99.9,1100,100,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,43,ITC,,,,,,,,,,,,,,,,,,,,,,,0.04,Caco-2 A2B assay,5.5,Caco-2 B2A assay,10.1002/cmdc.202200615,1035.065,1033.369001,4.49,71,7,15,4,23,224.63,C50H61Cl2N9O9S,"InChI=1S/C50H61Cl2N9O9S/c1-28(2)44(41-23-29(3)59-70-41)49(66)60-27-37(62)24-40(60)48(65)56-38(33-7-11-35(51)12-8-33)25-42(63)53-15-17-67-19-21-69-22-20-68-18-16-54-43(64)26-39-47-58-57-32(6)61(47)50-45(30(4)31(5)71-50)46(55-39)34-9-13-36(52)14-10-34/h7-14,23,28,37-40,44,62H,15-22,24-27H2,1-6H3,(H,53,63)(H,54,64)(H,56,65)/t37-,38+,39+,40+,44-/m1/s1",VPCHZAQARNLMRU-YLIPSVQPSA-N
4300,320,94,320,94,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,ITC,,,,,,,,,,,,,,,,,,,,,,,0.08,Caco-2 A2B assay,2,Caco-2 B2A assay,10.1002/cmdc.202200615,993.657,992.3592492,6.11,69,8,14,4,17,209.83,C50H57ClN10O6S2,"InChI=1S/C50H57ClN10O6S2/c1-26(2)43(40-20-27(3)59-67-40)49(66)60-24-36(62)21-39(60)48(65)56-37(32-10-12-34(13-11-32)46-29(5)54-25-68-46)22-41(63)52-18-8-9-19-53-42(64)23-38-47-58-57-31(7)61(47)50-44(28(4)30(6)69-50)45(55-38)33-14-16-35(51)17-15-33/h10-17,20,25-26,36-39,43,62H,8-9,18-19,21-24H2,1-7H3,(H,52,63)(H,53,64)(H,56,65)/t36-,37+,38+,39+,43-/m1/s1",KRPIEYYWXMOWMP-CFAWEHKJSA-N
4301,570,79,570,79,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14,ITC,,,,,,,,,,,,,,,,,,,,,,,0.07,Caco-2 A2B assay,2.2,Caco-2 B2A assay,10.1002/cmdc.202200615,1053.709,1052.380379,5.1,73,8,16,4,21,228.29,C52H61ClN10O8S2,"InChI=1S/C52H61ClN10O8S2/c1-28(2)45(42-22-29(3)61-71-42)51(68)62-26-38(64)23-41(62)50(67)58-39(34-8-10-36(11-9-34)48-31(5)56-27-72-48)24-43(65)54-16-18-69-20-21-70-19-17-55-44(66)25-40-49-60-59-33(7)63(49)52-46(30(4)32(6)73-52)47(57-40)35-12-14-37(53)15-13-35/h8-15,22,27-28,38-41,45,64H,16-21,23-26H2,1-7H3,(H,54,65)(H,55,66)(H,58,67)/t38-,39+,40+,41+,45-/m1/s1",PMMBPUFPJGYZDS-NNYWTZBRSA-N
4302,560,93,560,93,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,ITC,,,,,,,,,,,,,,,,,,,,,,,0.08,Caco-2 A2B assay,1.8,Caco-2 B2A assay,10.1002/cmdc.202200615,1097.762,1096.406593,4.95,76,8,17,4,24,237.52,C54H65ClN10O9S2,"InChI=1S/C54H65ClN10O9S2/c1-30(2)47(44-24-31(3)63-74-44)53(70)64-28-40(66)25-43(64)52(69)60-41(36-8-10-38(11-9-36)50-33(5)58-29-75-50)26-45(67)56-16-18-71-20-22-73-23-21-72-19-17-57-46(68)27-42-51-62-61-35(7)65(51)54-48(32(4)34(6)76-54)49(59-42)37-12-14-39(55)15-13-37/h8-15,24,29-30,40-43,47,66H,16-23,25-28H2,1-7H3,(H,56,67)(H,57,68)(H,60,69)/t40-,41+,42+,43+,47-/m1/s1",COKARWVIPXUBBF-RBFTVJCPSA-N
4303,16,98,16,98,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C#CCOCCOCCOCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=CS3)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8,ITC,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,8.9,Caco-2 B2A assay,10.1002/cmdc.202200615,1050.705,1049.36948,5.9,73,8,16,3,20,208.42,C53H60ClN9O8S2,"InChI=1S/C53H60ClN9O8S2/c1-30(2)46(44-25-31(3)61-71-44)52(67)62-28-40(64)26-43(62)51(66)57-33(5)36-10-12-38(13-11-36)49-41(56-29-72-49)9-8-19-68-21-23-70-24-22-69-20-18-55-45(65)27-42-50-60-59-35(7)63(50)53-47(32(4)34(6)73-53)48(58-42)37-14-16-39(54)17-15-37/h10-17,25,29-30,33,40,42-43,46,64H,18-24,26-28H2,1-7H3,(H,55,65)(H,57,66)/t33-,40+,42-,43-,46+/m0/s1",WUYXNOSTUQQLBT-RXJHFLANSA-N
4304,40,99.9,40,100,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C#CCOCCOCCOCCOCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=CS3)C=C2)C(C)C)=C1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cmdc.202200615,1094.758,1093.395694,5.75,76,8,17,3,23,217.65,C55H64ClN9O9S2,"InChI=1S/C55H64ClN9O9S2/c1-32(2)48(46-27-33(3)63-74-46)54(69)64-30-42(66)28-45(64)53(68)59-35(5)38-10-12-40(13-11-38)51-43(58-31-75-51)9-8-19-70-21-23-72-25-26-73-24-22-71-20-18-57-47(67)29-44-52-62-61-37(7)65(52)55-49(34(4)36(6)76-55)50(60-44)39-14-16-41(56)17-15-39/h10-17,27,31-32,35,42,44-45,48,66H,18-26,28-30H2,1-7H3,(H,57,67)(H,59,68)/t35-,42+,44-,45-,48+/m0/s1",YLFPZGFBGPLUOM-YIFYIKBSSA-N
4308,0.022,97,0.022,97,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1CCN(C(=O)COC3=CC=CC(N4CCC(=O)NC4=O)=C3C)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MV4; 11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01941,743.29,742.245265,4.08,52,7,10,2,8,151.12,C37H39ClN8O5S,"InChI=1S/C37H39ClN8O5S/c1-20-22(3)52-36-33(20)34(24-8-10-25(38)11-9-24)40-27(35-43-42-23(4)46(35)36)18-31(48)39-26-12-15-44(16-13-26)32(49)19-51-29-7-5-6-28(21(29)2)45-17-14-30(47)41-37(45)50/h5-11,26-27H,12-19H2,1-4H3,(H,39,48)(H,41,47,50)/t27-/m0/s1",RGTZCSFQBVIJHW-MHZLTWQESA-N
4320,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1037.874,1036.204168,4.71,68,7,9,5,13,222.83,C47H48BrF2N6O10PS,"InChI=1S/C47H48BrF2N6O10PS/c1-46(2,3)40(53-42(60)37-25-28-24-29(12-18-36(28)68-37)47(49,50)67(64,65)66)45(63)55-22-7-11-35(55)44(62)54(31-15-13-30(48)14-16-31)23-20-38(57)51-21-5-4-8-27-9-6-10-32-33(27)26-56(43(32)61)34-17-19-39(58)52-41(34)59/h6,9-10,12-16,18,24-25,34-35,40H,5,7,11,17,19-23,26H2,1-3H3,(H,51,57)(H,53,60)(H,52,58,59)(H2,64,65,66)/t34?,35-,40+/m0/s1",WHXKEQBPZHOVPT-TUCHNYEJSA-N
4320,,,>5000,,P42226,STAT6,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1037.874,1036.204168,4.71,68,7,9,5,13,222.83,C47H48BrF2N6O10PS,"InChI=1S/C47H48BrF2N6O10PS/c1-46(2,3)40(53-42(60)37-25-28-24-29(12-18-36(28)68-37)47(49,50)67(64,65)66)45(63)55-22-7-11-35(55)44(62)54(31-15-13-30(48)14-16-31)23-20-38(57)51-21-5-4-8-27-9-6-10-32-33(27)26-56(43(32)61)34-17-19-39(58)52-41(34)59/h6,9-10,12-16,18,24-25,34-35,40H,5,7,11,17,19-23,26H2,1-3H3,(H,51,57)(H,53,60)(H,52,58,59)(H2,64,65,66)/t34?,35-,40+/m0/s1",WHXKEQBPZHOVPT-TUCHNYEJSA-N
4320,,,>5000,,P42229,STAT5,CRBN,,AK-020,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1037.874,1036.204168,4.71,68,7,9,5,13,222.83,C47H48BrF2N6O10PS,"InChI=1S/C47H48BrF2N6O10PS/c1-46(2,3)40(53-42(60)37-25-28-24-29(12-18-36(28)68-37)47(49,50)67(64,65)66)45(63)55-22-7-11-35(55)44(62)54(31-15-13-30(48)14-16-31)23-20-38(57)51-21-5-4-8-27-9-6-10-32-33(27)26-56(43(32)61)34-17-19-39(58)52-41(34)59/h6,9-10,12-16,18,24-25,34-35,40H,5,7,11,17,19-23,26H2,1-3H3,(H,51,57)(H,53,60)(H,52,58,59)(H2,64,65,66)/t34?,35-,40+/m0/s1",WHXKEQBPZHOVPT-TUCHNYEJSA-N
4321,230,95,230,>95,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1051.901,1050.219818,5.07,69,7,9,5,14,222.83,C48H50BrF2N6O10PS,"InChI=1S/C48H50BrF2N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",LKAGUNLLLAEGQP-DCCNWUIXSA-N
4321,500,95,500,95,P42229,STAT5,CRBN,,AK-021,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1051.901,1050.219818,5.07,69,7,9,5,14,222.83,C48H50BrF2N6O10PS,"InChI=1S/C48H50BrF2N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",LKAGUNLLLAEGQP-DCCNWUIXSA-N
4321,,,>5000,,P42226,STAT6,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1051.901,1050.219818,5.07,69,7,9,5,14,222.83,C48H50BrF2N6O10PS,"InChI=1S/C48H50BrF2N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",LKAGUNLLLAEGQP-DCCNWUIXSA-N
4322,500,99,500,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1065.928,1064.235468,5.42,70,7,9,5,15,222.83,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(55-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-40(59)53-23-7-5-4-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-41(60)54-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,4-5,7,9,13,19,21-25,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",YSAZNOUHNXURMZ-KUYIJJHHSA-N
4322,800,99,800,,P42229,STAT5,CRBN,,AK-022,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1065.928,1064.235468,5.42,70,7,9,5,15,222.83,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(55-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-40(59)53-23-7-5-4-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-41(60)54-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,4-5,7,9,13,19,21-25,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",YSAZNOUHNXURMZ-KUYIJJHHSA-N
4322,,,>5000,,P42226,STAT6,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1065.928,1064.235468,5.42,70,7,9,5,15,222.83,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(55-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-40(59)53-23-7-5-4-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-41(60)54-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,4-5,7,9,13,19,21-25,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",YSAZNOUHNXURMZ-KUYIJJHHSA-N
4323,1100,99,1100,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1079.955,1078.251118,5.97,71,7,9,5,16,222.83,C50H54BrF2N6O10PS,"InChI=1S/C50H54BrF2N6O10PS/c1-49(2,3)43(56-45(63)40-28-31-27-32(15-21-39(31)71-40)50(52,53)70(67,68)69)48(66)58-25-10-14-38(58)47(65)57(34-18-16-33(51)17-19-34)26-23-41(60)54-24-8-6-4-5-7-11-30-12-9-13-35-36(30)29-59(46(35)64)37-20-22-42(61)55-44(37)62/h9,12-13,15-19,21,27-28,37-38,43H,4-6,8,10,14,20,22-26,29H2,1-3H3,(H,54,60)(H,56,63)(H,55,61,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",BZJBBMNCQVZIPD-WZPNQEGDSA-N
4323,1200,99,1200,,P42229,STAT5,CRBN,,AK-023,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1079.955,1078.251118,5.97,71,7,9,5,16,222.83,C50H54BrF2N6O10PS,"InChI=1S/C50H54BrF2N6O10PS/c1-49(2,3)43(56-45(63)40-28-31-27-32(15-21-39(31)71-40)50(52,53)70(67,68)69)48(66)58-25-10-14-38(58)47(65)57(34-18-16-33(51)17-19-34)26-23-41(60)54-24-8-6-4-5-7-11-30-12-9-13-35-36(30)29-59(46(35)64)37-20-22-42(61)55-44(37)62/h9,12-13,15-19,21,27-28,37-38,43H,4-6,8,10,14,20,22-26,29H2,1-3H3,(H,54,60)(H,56,63)(H,55,61,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",BZJBBMNCQVZIPD-WZPNQEGDSA-N
4323,,,>5000,,P42226,STAT6,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1079.955,1078.251118,5.97,71,7,9,5,16,222.83,C50H54BrF2N6O10PS,"InChI=1S/C50H54BrF2N6O10PS/c1-49(2,3)43(56-45(63)40-28-31-27-32(15-21-39(31)71-40)50(52,53)70(67,68)69)48(66)58-25-10-14-38(58)47(65)57(34-18-16-33(51)17-19-34)26-23-41(60)54-24-8-6-4-5-7-11-30-12-9-13-35-36(30)29-59(46(35)64)37-20-22-42(61)55-44(37)62/h9,12-13,15-19,21,27-28,37-38,43H,4-6,8,10,14,20,22-26,29H2,1-3H3,(H,54,60)(H,56,63)(H,55,61,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",BZJBBMNCQVZIPD-WZPNQEGDSA-N
4324,1400,99,1400,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1093.982,1092.266768,6.51,72,7,9,5,17,222.83,C51H56BrF2N6O10PS,"InChI=1S/C51H56BrF2N6O10PS/c1-50(2,3)44(57-46(64)41-29-32-28-33(16-22-40(32)72-41)51(53,54)71(68,69)70)49(67)59-26-11-15-39(59)48(66)58(35-19-17-34(52)18-20-35)27-24-42(61)55-25-9-7-5-4-6-8-12-31-13-10-14-36-37(31)30-60(47(36)65)38-21-23-43(62)56-45(38)63/h10,13-14,16-20,22,28-29,38-39,44H,4-7,9,11,15,21,23-27,30H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t38?,39-,44+/m0/s1",UJXGQTZMSUQPQW-QOIUHGAOSA-N
4324,,,>5000,,P42226,STAT6,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1093.982,1092.266768,6.51,72,7,9,5,17,222.83,C51H56BrF2N6O10PS,"InChI=1S/C51H56BrF2N6O10PS/c1-50(2,3)44(57-46(64)41-29-32-28-33(16-22-40(32)72-41)51(53,54)71(68,69)70)49(67)59-26-11-15-39(59)48(66)58(35-19-17-34(52)18-20-35)27-24-42(61)55-25-9-7-5-4-6-8-12-31-13-10-14-36-37(31)30-60(47(36)65)38-21-23-43(62)56-45(38)63/h10,13-14,16-20,22,28-29,38-39,44H,4-7,9,11,15,21,23-27,30H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t38?,39-,44+/m0/s1",UJXGQTZMSUQPQW-QOIUHGAOSA-N
4325,190,95,190,>95,P42229,STAT5,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1065.928,1064.235468,5.25,70,7,9,4,14,214.04,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-41(60)55(4)23-7-5-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-40(59)53-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",LMDQPXIZTVECEI-KUYIJJHHSA-N
4325,380,95,380,>95,P42229,STAT5,CRBN,,AK-027,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1065.928,1064.235468,5.25,70,7,9,4,14,214.04,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-41(60)55(4)23-7-5-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-40(59)53-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",LMDQPXIZTVECEI-KUYIJJHHSA-N
4325,,,>5000,,P42226,STAT6,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1065.928,1064.235468,5.25,70,7,9,4,14,214.04,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-41(60)55(4)23-7-5-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-40(59)53-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",LMDQPXIZTVECEI-KUYIJJHHSA-N
4326,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CCC(NC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1068.932,1067.246367,4.78,70,8,10,5,13,226.07,C48H53BrF2N7O10PS,"InChI=1S/C48H53BrF2N7O10PS/c1-47(2,3)41(54-43(62)38-25-27-24-28(9-15-37(27)70-38)48(50,51)69(66,67)68)46(65)57-20-5-8-36(57)45(64)56(31-12-10-29(49)11-13-31)23-19-40(60)55-21-17-30(18-22-55)52-34-7-4-6-32-33(34)26-58(44(32)63)35-14-16-39(59)53-42(35)61/h4,6-7,9-13,15,24-25,30,35-36,41,52H,5,8,14,16-23,26H2,1-3H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t35?,36-,41+/m0/s1",DTCKJAWZEBXRQM-DCCNWUIXSA-N
4327,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CCC(C#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1077.939,1076.235468,5.17,71,8,9,4,11,214.04,C50H52BrF2N6O10PS,"InChI=1S/C50H52BrF2N6O10PS/c1-49(2,3)43(55-45(63)40-27-31-26-32(11-17-39(31)71-40)50(52,53)70(67,68)69)48(66)58-22-5-8-38(58)47(65)57(34-14-12-33(51)13-15-34)25-21-42(61)56-23-19-29(20-24-56)9-10-30-6-4-7-35-36(30)28-59(46(35)64)37-16-18-41(60)54-44(37)62/h4,6-7,11-15,17,26-27,29,37-38,43H,5,8,16,18-25,28H2,1-3H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",AXZHSASBFBRJTN-WZPNQEGDSA-N
4327,,,>5000,,P42229,STAT5,CRBN,,AK-024,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CCC(C#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1077.939,1076.235468,5.17,71,8,9,4,11,214.04,C50H52BrF2N6O10PS,"InChI=1S/C50H52BrF2N6O10PS/c1-49(2,3)43(55-45(63)40-27-31-26-32(11-17-39(31)71-40)50(52,53)70(67,68)69)48(66)58-22-5-8-38(58)47(65)57(34-14-12-33(51)13-15-34)25-21-42(61)56-23-19-29(20-24-56)9-10-30-6-4-7-35-36(30)28-59(46(35)64)37-16-18-41(60)54-44(37)62/h4,6-7,11-15,17,26-27,29,37-38,43H,5,8,16,18-25,28H2,1-3H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",AXZHSASBFBRJTN-WZPNQEGDSA-N
4328,4200,99,4200,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CC(CCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C1)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1077.939,1076.235468,5.28,71,8,9,4,13,214.04,C50H52BrF2N6O10PS,"InChI=1S/C50H52BrF2N6O10PS/c1-49(2,3)43(55-45(63)40-25-31-24-32(13-19-39(31)71-40)50(52,53)70(67,68)69)48(66)58-22-7-12-38(58)47(65)57(34-16-14-33(51)15-17-34)23-21-42(61)56-26-29(27-56)8-4-5-9-30-10-6-11-35-36(30)28-59(46(35)64)37-18-20-41(60)54-44(37)62/h6,10-11,13-17,19,24-25,29,37-38,43H,4,7-8,12,18,20-23,26-28H2,1-3H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",DQVHCKGBHCAIAV-WZPNQEGDSA-N
4328,,,>5000,,P42229,STAT5,CRBN,,AK-026,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CC(CCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C1)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1077.939,1076.235468,5.28,71,8,9,4,13,214.04,C50H52BrF2N6O10PS,"InChI=1S/C50H52BrF2N6O10PS/c1-49(2,3)43(55-45(63)40-25-31-24-32(13-19-39(31)71-40)50(52,53)70(67,68)69)48(66)58-22-7-12-38(58)47(65)57(34-16-14-33(51)15-17-34)23-21-42(61)56-26-29(27-56)8-4-5-9-30-10-6-11-35-36(30)28-59(46(35)64)37-18-20-41(60)54-44(37)62/h6,10-11,13-17,19,24-25,29,37-38,43H,4,7-8,12,18,20-23,26-28H2,1-3H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t37?,38-,43+/m0/s1",DQVHCKGBHCAIAV-WZPNQEGDSA-N
4329,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CC(CC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C1)C1=CC=C(Br)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1063.912,1062.219818,4.92,70,8,9,4,12,214.04,C49H50BrF2N6O10PS,"InChI=1S/C49H50BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-24-30-23-31(12-18-38(30)70-39)49(51,52)69(66,67)68)47(65)57-21-6-11-37(57)46(64)56(33-15-13-32(50)14-16-33)22-20-41(60)55-25-28(26-55)7-4-8-29-9-5-10-34-35(29)27-58(45(34)63)36-17-19-40(59)53-43(36)61/h5,9-10,12-16,18,23-24,28,36-37,42H,6-7,11,17,19-22,25-27H2,1-3H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",USPYKBNVXPWCQY-KUYIJJHHSA-N
4329,,,>5000,,P42229,STAT5,CRBN,,AK-025,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)N1CC(CC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C1)C1=CC=C(Br)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1063.912,1062.219818,4.92,70,8,9,4,12,214.04,C49H50BrF2N6O10PS,"InChI=1S/C49H50BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-24-30-23-31(12-18-38(30)70-39)49(51,52)69(66,67)68)47(65)57-21-6-11-37(57)46(64)56(33-15-13-32(50)14-16-33)22-20-41(60)55-25-28(26-55)7-4-8-29-9-5-10-34-35(29)27-58(45(34)63)36-17-19-40(59)53-43(36)61/h5,9-10,12-16,18,23-24,28,36-37,42H,6-7,11,17,19-22,25-27H2,1-3H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",USPYKBNVXPWCQY-KUYIJJHHSA-N
4330,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=CC=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,973.005,972.3093059,4.38,68,7,9,5,14,222.83,C48H51F2N6O10PS,"InChI=1S/C48H51F2N6O10PS/c1-47(2,3)41(53-43(60)38-27-30-26-31(18-20-37(30)68-38)48(49,50)67(64,65)66)46(63)55-24-11-17-36(55)45(62)54(32-14-7-4-8-15-32)25-22-39(57)51-23-9-5-6-12-29-13-10-16-33-34(29)28-56(44(33)61)35-19-21-40(58)52-42(35)59/h4,7-8,10,13-16,18,20,26-27,35-36,41H,5,9,11,17,19,21-25,28H2,1-3H3,(H,51,57)(H,53,60)(H,52,58,59)(H2,64,65,66)/t35?,36-,41+/m0/s1",NCCUGRFEFYKPGD-DCCNWUIXSA-N
4331,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(F)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,990.995,990.2998841,4.48,69,7,9,5,14,222.83,C48H50F3N6O10PS,"InChI=1S/C48H50F3N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",HAPQXCZVCPYDQI-DCCNWUIXSA-N
4332,2100,99,2100,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Cl)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1007.45,1006.270334,5,69,7,9,5,14,222.83,C48H50ClF2N6O10PS,"InChI=1S/C48H50ClF2N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",QIMQSVKKEJLRHW-DCCNWUIXSA-N
4333,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Cl)C(F)=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1025.44,1024.260912,5.1,70,7,9,5,14,222.83,C48H49ClF3N6O10PS,"InChI=1S/C48H49ClF3N6O10PS/c1-47(2,3)41(55-43(62)38-24-28-23-29(13-17-37(28)70-38)48(51,52)69(66,67)68)46(65)57-21-8-12-36(57)45(64)56(30-14-15-33(49)34(50)25-30)22-19-39(59)53-20-6-4-5-9-27-10-7-11-31-32(27)26-58(44(31)63)35-16-18-40(60)54-42(35)61/h7,10-11,13-15,17,23-25,35-36,41H,4,6,8,12,16,18-22,26H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t35?,36-,41+/m0/s1",NMRMTPYNXUAWQX-DCCNWUIXSA-N
4334,530,99,530,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(I)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1098.901,1098.205954,5.03,69,7,9,5,14,222.83,C48H50F2IN6O10PS,"InChI=1S/C48H50F2IN6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(49,50)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(51)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",DIADDVZPHMPQSI-DCCNWUIXSA-N
4335,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C#N)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,998.015,997.3045549,4.09,70,7,10,5,14,246.62,C49H50F2N7O10PS,"InChI=1S/C49H50F2N7O10PS/c1-48(2,3)42(55-44(62)39-26-31-25-32(15-19-38(31)70-39)49(50,51)69(66,67)68)47(65)57-23-8-12-37(57)46(64)56(33-16-13-29(27-52)14-17-33)24-21-40(59)53-22-6-4-5-9-30-10-7-11-34-35(30)28-58(45(34)63)36-18-20-41(60)54-43(36)61/h7,10-11,13-17,19,25-26,36-37,42H,4,6,8,12,18,20-24,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",RHOIOVJTUARMAK-KUYIJJHHSA-N
4336,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=CC(C#N)=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,998.015,997.3045549,4.09,70,7,10,5,14,246.62,C49H50F2N7O10PS,"InChI=1S/C49H50F2N7O10PS/c1-48(2,3)42(55-44(62)39-26-31-25-32(16-18-38(31)70-39)49(50,51)69(66,67)68)47(65)57-22-9-15-37(57)46(64)56(33-13-7-10-29(24-33)27-52)23-20-40(59)53-21-6-4-5-11-30-12-8-14-34-35(30)28-58(45(34)63)36-17-19-41(60)54-43(36)61/h7-8,10,12-14,16,18,24-26,36-37,42H,4,6,9,15,17,19-23,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",LPULSJIJHCQFCV-KUYIJJHHSA-N
4337,2000,99,2000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C(F)(F)F)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1041.002,1040.296691,5.26,72,7,9,5,14,222.83,C49H50F5N6O10PS,"InChI=1S/C49H50F5N6O10PS/c1-47(2,3)41(57-43(64)38-26-29-25-31(15-19-37(29)72-38)49(53,54)71(68,69)70)46(67)59-23-8-12-36(59)45(66)58(32-16-13-30(14-17-32)48(50,51)52)24-21-39(61)55-22-6-4-5-9-28-10-7-11-33-34(28)27-60(44(33)65)35-18-20-40(62)56-42(35)63/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t35?,36-,41+/m0/s1",CSDHHWOBZJKFQL-DCCNWUIXSA-N
4338,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=CC(C(F)(F)F)=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1041.002,1040.296691,5.26,72,7,9,5,14,222.83,C49H50F5N6O10PS,"InChI=1S/C49H50F5N6O10PS/c1-47(2,3)41(57-43(64)38-25-29-24-31(16-18-37(29)72-38)49(53,54)71(68,69)70)46(67)59-22-9-15-36(59)45(66)58(32-13-8-12-30(26-32)48(50,51)52)23-20-39(61)55-21-6-4-5-10-28-11-7-14-33-34(28)27-60(44(33)65)35-17-19-40(62)56-42(35)63/h7-8,11-14,16,18,24-26,35-36,41H,4,6,9,15,17,19-23,27H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t35?,36-,41+/m0/s1",NIURKDNOKWSXGM-DCCNWUIXSA-N
4339,310,99,310,,P42229,STAT5,CRBN,,,CC1=CC=C(N(CCC(=O)NCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C2=CC3=CC(C(F)(F)P(=O)(O)O)=CC=C3S2)C(C)(C)C)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,987.032,986.324956,4.74,69,7,9,5,14,222.83,C49H53F2N6O10PS,"InChI=1S/C49H53F2N6O10PS/c1-29-14-17-33(18-15-29)55(25-22-40(58)52-23-7-5-6-10-30-11-8-12-34-35(30)28-57(45(34)62)36-19-21-41(59)53-43(36)60)46(63)37-13-9-24-56(37)47(64)42(48(2,3)4)54-44(61)39-27-31-26-32(16-20-38(31)69-39)49(50,51)68(65,66)67/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t36?,37-,42+/m0/s1",GWHQSJPXKDWGPX-KUYIJJHHSA-N
4340,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)C1=CC=C(N(CCC(=O)NCCCC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C2=CC3=CC(C(F)(F)P(=O)(O)O)=CC=C3S2)C(C)(C)C)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1029.113,1028.371906,6.05,72,7,9,5,14,222.83,C52H59F2N6O10PS,"InChI=1S/C52H59F2N6O10PS/c1-50(2,3)33-16-19-35(20-17-33)58(27-24-42(61)55-25-9-7-8-12-31-13-10-14-36-37(31)30-60(47(36)65)38-21-23-43(62)56-45(38)63)48(66)39-15-11-26-59(39)49(67)44(51(4,5)6)57-46(64)41-29-32-28-34(18-22-40(32)72-41)52(53,54)71(68,69)70/h10,13-14,16-20,22,28-29,38-39,44H,7,9,11,15,21,23-27,30H2,1-6H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t38?,39-,44+/m0/s1",NKAUFZCRCNJSIM-QOIUHGAOSA-N
4341,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(S(C)(=O)=O)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1051.097,1050.286856,3.61,72,7,11,5,15,256.97,C49H53F2N6O12PS2,"InChI=1S/C49H53F2N6O12PS2/c1-48(2,3)42(54-44(61)39-27-30-26-31(14-20-38(30)71-39)49(50,51)70(65,66)67)47(64)56-24-9-13-37(56)46(63)55(32-15-17-33(18-16-32)72(4,68)69)25-22-40(58)52-23-7-5-6-10-29-11-8-12-34-35(29)28-57(45(34)62)36-19-21-41(59)53-43(36)60/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t36?,37-,42+/m0/s1",WZRGQYOIUTYCKK-KUYIJJHHSA-N
4342,210,99,210,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C2=CC=CS2)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1055.132,1054.297027,5.72,73,8,10,5,15,222.83,C52H53F2N6O10PS2,"InChI=1S/C52H53F2N6O10PS2/c1-51(2,3)45(57-47(64)42-29-33-28-34(17-21-41(33)73-42)52(53,54)71(68,69)70)50(67)59-25-8-13-39(59)49(66)58(35-18-15-32(16-19-35)40-14-9-27-72-40)26-23-43(61)55-24-6-4-5-10-31-11-7-12-36-37(31)30-60(48(36)65)38-20-22-44(62)56-46(38)63/h7,9,11-12,14-19,21,27-29,38-39,45H,4,6,8,13,20,22-26,30H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t38?,39-,45+/m0/s1",WESLVONUUUMSOZ-AWRRGKHMSA-N
4343,130,99,130,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,1008/579,Binding affinity of STAT5A/STAT5B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1056.12,1055.292276,5.07,73,8,11,5,15,235.72,C51H52F2N7O10PS2,"InChI=1S/C51H52F2N7O10PS2/c1-50(2,3)43(57-45(64)40-28-32-27-33(15-19-39(32)73-40)51(52,53)71(68,69)70)49(67)59-24-8-12-38(59)48(66)58(34-16-13-31(14-17-34)46-55-23-26-72-46)25-21-41(61)54-22-6-4-5-9-30-10-7-11-35-36(30)29-60(47(35)65)37-18-20-42(62)56-44(37)63/h7,10-11,13-17,19,23,26-28,37-38,43H,4,6,8,12,18,20-22,24-25,29H2,1-3H3,(H,54,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t37?,38-,43+/m0/s1",WUADASPIHZQGRY-WZPNQEGDSA-N
4343,400,95,400,>95,P42229,STAT5,CRBN,,AK-028,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1056.12,1055.292276,5.07,73,8,11,5,15,235.72,C51H52F2N7O10PS2,"InChI=1S/C51H52F2N7O10PS2/c1-50(2,3)43(57-45(64)40-28-32-27-33(15-19-39(32)73-40)51(52,53)71(68,69)70)49(67)59-24-8-12-38(59)48(66)58(34-16-13-31(14-17-34)46-55-23-26-72-46)25-21-41(61)54-22-6-4-5-9-30-10-7-11-35-36(30)29-60(47(35)65)37-18-20-42(62)56-44(37)63/h7,10-11,13-17,19,23,26-28,37-38,43H,4,6,8,12,18,20-22,24-25,29H2,1-3H3,(H,54,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t37?,38-,43+/m0/s1",WUADASPIHZQGRY-WZPNQEGDSA-N
4344,180,99,180,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2SC=CC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,1249/815,Binding affinity of STAT5A/STAT5B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1029.094,1028.281377,5.39,71,8,10,5,14,222.83,C50H51F2N6O10PS2,"InChI=1S/C50H51F2N6O10PS2/c1-49(2,3)43(55-45(62)40-27-31-25-32(13-16-39(31)71-40)50(51,52)69(66,67)68)48(65)57-22-8-12-37(57)47(64)56(33-14-17-38-30(26-33)20-24-70-38)23-19-41(59)53-21-6-4-5-9-29-10-7-11-34-35(29)28-58(46(34)63)36-15-18-42(60)54-44(36)61/h7,10-11,13-14,16-17,20,24-27,36-37,43H,4,6,8,12,15,18-19,21-23,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,43+/m0/s1",FNYXNNYHKHWJAE-VKFQMAHUSA-N
4345,450,99,450,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2SC=NC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,981/406,Binding affinity of STAT5A/STAT5B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1030.082,1029.276626,4.83,71,8,11,5,14,235.72,C49H50F2N7O10PS2,"InChI=1S/C49H50F2N7O10PS2/c1-48(2,3)42(55-44(62)39-24-29-23-30(13-16-37(29)71-39)49(50,51)69(66,67)68)47(65)57-21-8-12-36(57)46(64)56(31-14-17-38-34(25-31)53-27-70-38)22-19-40(59)52-20-6-4-5-9-28-10-7-11-32-33(28)26-58(45(32)63)35-15-18-41(60)54-43(35)61/h7,10-11,13-14,16-17,23-25,27,35-36,42H,4,6,8,12,15,18-22,26H2,1-3H3,(H,52,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t35?,36-,42+/m0/s1",QOYWPVULYMHMHY-MTPLVRQTSA-N
4345,1400,99,1400,,P42229,STAT5,CRBN,,AK-030,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2SC=NC2=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1030.082,1029.276626,4.83,71,8,11,5,14,235.72,C49H50F2N7O10PS2,"InChI=1S/C49H50F2N7O10PS2/c1-48(2,3)42(55-44(62)39-24-29-23-30(13-16-37(29)71-39)49(50,51)69(66,67)68)47(65)57-21-8-12-36(57)46(64)56(31-14-17-38-34(25-31)53-27-70-38)22-19-40(59)52-20-6-4-5-9-28-10-7-11-32-33(28)26-58(45(32)63)35-15-18-41(60)54-43(35)61/h7,10-11,13-14,16-17,23-25,27,35-36,42H,4,6,8,12,15,18-22,26H2,1-3H3,(H,52,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t35?,36-,42+/m0/s1",QOYWPVULYMHMHY-MTPLVRQTSA-N
4346,330,99,330,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2OC=CC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1013.026,1012.304221,4.78,71,8,10,5,14,235.97,C50H51F2N6O11PS,"InChI=1S/C50H51F2N6O11PS/c1-49(2,3)43(55-45(62)40-27-31-25-32(13-17-39(31)71-40)50(51,52)70(66,67)68)48(65)57-22-8-12-37(57)47(64)56(33-14-16-38-30(26-33)20-24-69-38)23-19-41(59)53-21-6-4-5-9-29-10-7-11-34-35(29)28-58(46(34)63)36-15-18-42(60)54-44(36)61/h7,10-11,13-14,16-17,20,24-27,36-37,43H,4,6,8,12,15,18-19,21-23,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,43+/m0/s1",ASEXSDYUJXKPNE-VKFQMAHUSA-N
4347,210,99,210,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2C=CC=CC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1023.065,1022.324956,5.63,72,8,9,5,14,222.83,C52H53F2N6O10PS,"InChI=1S/C52H53F2N6O10PS/c1-51(2,3)45(57-47(64)42-29-34-27-35(18-21-41(34)72-42)52(53,54)71(68,69)70)50(67)59-25-10-16-40(59)49(66)58(36-19-17-31-11-6-7-13-33(31)28-36)26-23-43(61)55-24-8-4-5-12-32-14-9-15-37-38(32)30-60(48(37)65)39-20-22-44(62)56-46(39)63/h6-7,9,11,13-15,17-19,21,27-29,39-40,45H,4,8,10,16,20,22-26,30H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t39?,40-,45+/m0/s1",ZLJPBECRSGHFSQ-NZPNZZNKSA-N
4347,800,99,800,,P42229,STAT5,CRBN,,AK-032,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2C=CC=CC2=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1023.065,1022.324956,5.63,72,8,9,5,14,222.83,C52H53F2N6O10PS,"InChI=1S/C52H53F2N6O10PS/c1-51(2,3)45(57-47(64)42-29-34-27-35(18-21-41(34)72-42)52(53,54)71(68,69)70)50(67)59-25-10-16-40(59)49(66)58(36-19-17-31-11-6-7-13-33(31)28-36)26-23-43(61)55-24-8-4-5-12-32-14-9-15-37-38(32)30-60(48(37)65)39-20-22-44(62)56-46(39)63/h6-7,9,11,13-15,17-19,21,27-29,39-40,45H,4,8,10,16,20,22-26,30H2,1-3H3,(H,55,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t39?,40-,45+/m0/s1",ZLJPBECRSGHFSQ-NZPNZZNKSA-N
4348,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C2N=CSC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,6140/5943,Binding affinity of STAT5A/STAT5B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1030.082,1029.276626,4.83,71,8,11,5,14,235.72,C49H50F2N7O10PS2,"InChI=1S/C49H50F2N7O10PS2/c1-48(2,3)42(55-44(62)39-24-29-23-30(13-17-37(29)71-39)49(50,51)69(66,67)68)47(65)57-21-8-12-36(57)46(64)56(31-14-15-34-38(25-31)70-27-53-34)22-19-40(59)52-20-6-4-5-9-28-10-7-11-32-33(28)26-58(45(32)63)35-16-18-41(60)54-43(35)61/h7,10-11,13-15,17,23-25,27,35-36,42H,4,6,8,12,16,18-22,26H2,1-3H3,(H,52,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t35?,36-,42+/m0/s1",WQPCNJIYXPYSRL-MTPLVRQTSA-N
4349,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=CC2=C1C=CS2,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,6596/5581,Binding affinity of STAT5A/STAT5B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1029.094,1028.281377,5.39,71,8,10,5,14,222.83,C50H51F2N6O10PS2,"InChI=1S/C50H51F2N6O10PS2/c1-49(2,3)43(55-45(62)40-27-30-26-31(16-18-38(30)71-40)50(51,52)69(66,67)68)48(65)56-23-9-14-37(56)47(64)57(35-13-8-15-39-33(35)21-25-70-39)24-20-41(59)53-22-6-4-5-10-29-11-7-12-32-34(29)28-58(46(32)63)36-17-19-42(60)54-44(36)61/h7-8,11-13,15-16,18,21,25-27,36-37,43H,4,6,9,14,17,19-20,22-24,28H2,1-3H3,(H,53,59)(H,55,62)(H,54,60,61)(H2,66,67,68)/t36?,37-,43+/m0/s1",QTXJOVYTQFQZJH-VKFQMAHUSA-N
4350,130,99,130,,P42229,STAT5,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C2SC=CC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1043.121,1042.297027,5.58,72,8,10,4,14,214.04,C51H53F2N6O10PS2,"InChI=1S/C51H53F2N6O10PS2/c1-50(2,3)44(55-46(63)41-28-32-26-33(14-17-40(32)72-41)51(52,53)70(67,68)69)49(66)58-23-9-13-38(58)48(65)57(34-15-18-39-31(27-34)21-25-71-39)24-20-43(61)56(4)22-7-5-6-10-30-11-8-12-35-36(30)29-59(47(35)64)37-16-19-42(60)54-45(37)62/h8,11-12,14-15,17-18,21,25-28,37-38,44H,5,7,9,13,16,19-20,22-24,29H2,1-4H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t37?,38-,44+/m0/s1",MRAQSVPXZQPCOY-PXFDYUPCSA-N
4351,330,99,330,,P42229,STAT5,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C2SC=NC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1044.109,1043.292276,5.01,72,8,11,4,14,226.93,C50H52F2N7O10PS2,"InChI=1S/C50H52F2N7O10PS2/c1-49(2,3)43(55-45(63)40-25-30-24-31(14-17-38(30)72-40)50(51,52)70(67,68)69)48(66)58-22-9-13-37(58)47(65)57(32-15-18-39-35(26-32)53-28-71-39)23-20-42(61)56(4)21-7-5-6-10-29-11-8-12-33-34(29)27-59(46(33)64)36-16-19-41(60)54-44(36)62/h8,11-12,14-15,17-18,24-26,28,36-37,43H,5,7,9,13,16,19-23,27H2,1-4H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t36?,37-,43+/m0/s1",MMBCMAARLUUVMK-VKFQMAHUSA-N
4351,500,99,500,,P42229,STAT5,CRBN,,AK-031,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C2SC=NC2=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1044.109,1043.292276,5.01,72,8,11,4,14,226.93,C50H52F2N7O10PS2,"InChI=1S/C50H52F2N7O10PS2/c1-49(2,3)43(55-45(63)40-25-30-24-31(14-17-38(30)72-40)50(51,52)70(67,68)69)48(66)58-22-9-13-37(58)47(65)57(32-15-18-39-35(26-32)53-28-71-39)23-20-42(61)56(4)21-7-5-6-10-29-11-8-12-33-34(29)27-59(46(33)64)36-16-19-41(60)54-44(36)62/h8,11-12,14-15,17-18,24-26,28,36-37,43H,5,7,9,13,16,19-23,27H2,1-4H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t36?,37-,43+/m0/s1",MMBCMAARLUUVMK-VKFQMAHUSA-N
4352,200,99,200,,P42229,STAT5,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C2OC=CC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1027.053,1026.319871,4.96,72,8,10,4,14,227.18,C51H53F2N6O11PS,"InChI=1S/C51H53F2N6O11PS/c1-50(2,3)44(55-46(63)41-28-32-26-33(14-18-40(32)72-41)51(52,53)71(67,68)69)49(66)58-23-9-13-38(58)48(65)57(34-15-17-39-31(27-34)21-25-70-39)24-20-43(61)56(4)22-7-5-6-10-30-11-8-12-35-36(30)29-59(47(35)64)37-16-19-42(60)54-45(37)62/h8,11-12,14-15,17-18,21,25-28,37-38,44H,5,7,9,13,16,19-20,22-24,29H2,1-4H3,(H,55,63)(H,54,60,62)(H2,67,68,69)/t37?,38-,44+/m0/s1",VLOSCIBDYPNFET-PXFDYUPCSA-N
4353,130,99,130,,P42229,STAT5,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C2C=CC=CC2=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1037.092,1036.340606,5.81,73,8,9,4,14,214.04,C53H55F2N6O10PS,"InChI=1S/C53H55F2N6O10PS/c1-52(2,3)46(57-48(65)43-30-35-28-36(19-22-42(35)73-43)53(54,55)72(69,70)71)51(68)60-26-11-17-41(60)50(67)59(37-20-18-32-12-7-8-14-34(32)29-37)27-24-45(63)58(4)25-9-5-6-13-33-15-10-16-38-39(33)31-61(49(38)66)40-21-23-44(62)56-47(40)64/h7-8,10,12,14-16,18-20,22,28-30,40-41,46H,5,9,11,17,21,23-27,31H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t40?,41-,46+/m0/s1",ROBOYFVTYHGWDS-AOEMPMSCSA-N
4353,200,99,200,,P42229,STAT5,CRBN,,AK-033,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C2C=CC=CC2=C1,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1037.092,1036.340606,5.81,73,8,9,4,14,214.04,C53H55F2N6O10PS,"InChI=1S/C53H55F2N6O10PS/c1-52(2,3)46(57-48(65)43-30-35-28-36(19-22-42(35)73-43)53(54,55)72(69,70)71)51(68)60-26-11-17-41(60)50(67)59(37-20-18-32-12-7-8-14-34(32)29-37)27-24-45(63)58(4)25-9-5-6-13-33-15-10-16-38-39(33)31-61(49(38)66)40-21-23-44(62)56-47(40)64/h7-8,10,12,14-16,18-20,22,28-30,40-41,46H,5,9,11,17,21,23-27,31H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t40?,41-,46+/m0/s1",ROBOYFVTYHGWDS-AOEMPMSCSA-N
4354,,,>5000,,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCCCCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1041.149,1040.317762,7.8,72,8,10,4,16,206.62,C52H55F2N6O9PS2,"InChI=1S/C52H55F2N6O9PS2/c1-51(2,3)44(57-46(63)42-30-34-29-35(19-23-41(34)72-42)52(53,54)70(67,68)69)50(66)59-27-12-16-40(59)49(65)58(36-20-17-33(18-21-36)47-55-25-28-71-47)26-10-8-6-4-5-7-9-13-32-14-11-15-37-38(32)31-60(48(37)64)39-22-24-43(61)56-45(39)62/h11,14-15,17-21,23,25,28-30,39-40,44H,4-8,10,12,16,22,24,26-27,31H2,1-3H3,(H,57,63)(H,56,61,62)(H2,67,68,69)/t39?,40-,44+/m0/s1",ZJHQCOSKSARZNZ-FURWAYEFSA-N
4355,80,99,80,,P42229,STAT5,CRBN,,AK-2292,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,210/308,Binding affinity of STAT5A/STAT5B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,170,Binding affinity of CRBN,,,,,,,,,360/180/350,Inhibit cell growth in SKNO1/MV4;11/KASUMI-3 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1070.147,1069.307926,5.25,74,8,11,4,15,226.93,C52H54F2N7O10PS2,"InChI=1S/C52H54F2N7O10PS2/c1-51(2,3)44(57-46(65)41-29-33-28-34(16-20-40(33)74-41)52(53,54)72(69,70)71)50(68)60-25-9-13-39(60)49(67)59(35-17-14-32(15-18-35)47-55-23-27-73-47)26-22-43(63)58(4)24-7-5-6-10-31-11-8-12-36-37(31)30-61(48(36)66)38-19-21-42(62)56-45(38)64/h8,11-12,14-18,20,23,27-29,38-39,44H,5,7,9,13,19,21-22,24-26,30H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t38?,39-,44+/m0/s1",LOPYPDQOHNOVBM-QOIUHGAOSA-N
4355,110,95,110/200,95/95,P51692,STAT5B,CRBN,,AK-2292,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT5 in KU812/PBMC cells after 18h treatment,,,,,,,,,200,Binding affinity of STAT5B,,,,,,,,,,,,,,,170,Binding affinity of CRBN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1070.147,1069.307926,5.25,74,8,11,4,15,226.93,C52H54F2N7O10PS2,"InChI=1S/C52H54F2N7O10PS2/c1-51(2,3)44(57-46(65)41-29-33-28-34(16-20-40(33)74-41)52(53,54)72(69,70)71)50(68)60-25-9-13-39(60)49(67)59(35-17-14-32(15-18-35)47-55-23-27-73-47)26-22-43(63)58(4)24-7-5-6-10-31-11-8-12-36-37(31)30-61(48(36)66)38-19-21-42(62)56-45(38)64/h8,11-12,14-18,20,23,27-29,38-39,44H,5,7,9,13,19,21-22,24-26,30H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t38?,39-,44+/m0/s1",LOPYPDQOHNOVBM-QOIUHGAOSA-N
4355,160,95,160/200,95/95,P42229,STAT5,CRBN,,AK-2292,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT5 in KU812/PBMC cells after 18h treatment,,,,,,,,,500,Binding affinity of STAT5A,,,,,,,,,,,,,,,170,Binding affinity of CRBN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,0.09,Caco-2 B2A assay,10.1038/s41589-022-01248-4,1070.147,1069.307926,5.25,74,8,11,4,15,226.93,C52H54F2N7O10PS2,"InChI=1S/C52H54F2N7O10PS2/c1-51(2,3)44(57-46(65)41-29-33-28-34(16-20-40(33)74-41)52(53,54)72(69,70)71)50(68)60-25-9-13-39(60)49(67)59(35-17-14-32(15-18-35)47-55-23-27-73-47)26-22-43(63)58(4)24-7-5-6-10-31-11-8-12-36-37(31)30-61(48(36)66)38-19-21-42(62)56-45(38)64/h8,11-12,14-18,20,23,27-29,38-39,44H,5,7,9,13,19,21-22,24-26,30H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t38?,39-,44+/m0/s1",LOPYPDQOHNOVBM-QOIUHGAOSA-N
4355,,,>5000,,P42226,STAT6,CRBN,,AK-2292,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,Degradation of STAT6 in SKNO1 cells after 18h treatment,,,,,,,,,768000,Binding affinity of STAT6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>15000/>15000/>15000,Inhibit cell growth in RS4;11/OCI-AML-2/OCI-M2 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1070.147,1069.307926,5.25,74,8,11,4,15,226.93,C52H54F2N7O10PS2,"InChI=1S/C52H54F2N7O10PS2/c1-51(2,3)44(57-46(65)41-29-33-28-34(16-20-40(33)74-41)52(53,54)72(69,70)71)50(68)60-25-9-13-39(60)49(67)59(35-17-14-32(15-18-35)47-55-23-27-73-47)26-22-43(63)58(4)24-7-5-6-10-31-11-8-12-36-37(31)30-61(48(36)66)38-19-21-42(62)56-45(38)64/h8,11-12,14-18,20,23,27-29,38-39,44H,5,7,9,13,19,21-22,24-26,30H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t38?,39-,44+/m0/s1",LOPYPDQOHNOVBM-QOIUHGAOSA-N
4359,5,96,5,96,P00918,CA2,CRBN,,,NS(=O)(=O)C1=CC=C(C(=O)NCCCOCCCCOCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of hCAII in HEK293 cells after 24h treatment,,,<20,Inhibit of hCA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01843,643.719,643.2311988,1.33,45,4,10,4,17,203.3,C30H37N5O9S,"InChI=1S/C30H37N5O9S/c31-45(41,42)21-10-8-20(9-11-21)27(37)33-15-5-19-44-17-2-1-16-43-18-4-14-32-23-7-3-6-22-26(23)30(40)35(29(22)39)24-12-13-25(36)34-28(24)38/h3,6-11,24,32H,1-2,4-5,12-19H2,(H,33,37)(H2,31,41,42)(H,34,36,38)",RBECNOZCCFLMDH-UHFFFAOYSA-N
4360,245,86,245,86,P00918,CA2,CRBN,,,NS(=O)(=O)C1=CC=C(C(=O)NCCCOCCOCCOCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of hCAII in HEK293 cells after 24h treatment,,,<20,Inhibit of hCA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01843,659.718,659.2261134,0.47,46,4,11,4,18,212.53,C30H37N5O10S,"InChI=1S/C30H37N5O10S/c31-46(41,42)21-8-6-20(7-9-21)27(37)33-13-3-15-44-17-19-45-18-16-43-14-2-12-32-23-5-1-4-22-26(23)30(40)35(29(22)39)24-10-11-25(36)34-28(24)38/h1,4-9,24,32H,2-3,10-19H2,(H,33,37)(H2,31,41,42)(H,34,36,38)",QQTRJZGGTODEON-UHFFFAOYSA-N
4361,0.5,99.9,0.5,100,P00918,CA2,CRBN,,,NS(=O)(=O)C1=CC=C(C(=O)NCCCCCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of hCAII in HEK293 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01843,639.775,639.2726697,4.88,45,4,8,4,17,184.84,C32H41N5O7S,"InChI=1S/C32H41N5O7S/c33-45(43,44)23-16-14-22(15-17-23)29(39)35-21-10-8-6-4-2-1-3-5-7-9-20-34-25-13-11-12-24-28(25)32(42)37(31(24)41)26-18-19-27(38)36-30(26)40/h11-17,26,34H,1-10,18-21H2,(H,35,39)(H2,33,43,44)(H,36,38,40)",AZBRPAQQOMDJLZ-UHFFFAOYSA-N
4364,,,>1000,,Q06187,BTK,CRBN,,PS-RC-1,CC(C)(C)/C=C(\C#N)C(=O)NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3)=NC3=C2OC=C3)=C1,Degradation of BTK in Mino cells after 24h treatment,,,>10000,Binding to BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000/12,Inhibit cell growth in MOLM-14/Mino cells,,,,,,,,,,,,,,,10.1016/j.crchbi.2022.100029,850.893,850.3187083,6.08,63,8,14,4,11,232.2,C45H42N10O8,"InChI=1S/C45H42N10O8/c1-45(2,3)23-26(24-46)39(58)48-28-6-4-7-30(22-28)63-41-38-33(16-21-62-38)50-44(52-41)49-27-10-12-29(13-11-27)53-17-19-54(20-18-53)36(57)25-47-32-9-5-8-31-37(32)43(61)55(42(31)60)34-14-15-35(56)51-40(34)59/h4-13,16,21-23,34,47H,14-15,17-20,25H2,1-3H3,(H,48,58)(H,49,50,52)(H,51,56,59)/b26-23+",JCCULZKLJDDLMJ-WNAAXNPUSA-N
4365,,,>1000,,Q06187,BTK,CRBN,,PS-RC-2,CC(C)(C)/C=C(\C#N)C(=O)NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C(=O)CCOCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3)=NC3=C2OC=C3)=C1,Degradation of BTK in Mino cells after 24h treatment,,,>10000,Binding to BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000/584,Inhibit cell growth in MOLM-14/Mino cells,,,,,,,,,,,,,,,10.1016/j.crchbi.2022.100029,966.025,965.3820368,5.18,71,8,16,5,17,270.53,C50H51N11O10,"InChI=1S/C50H51N11O10/c1-50(2,3)27-30(28-51)44(65)54-32-6-4-7-34(26-32)71-46-43-37(16-24-70-43)56-49(58-46)55-31-10-12-33(13-11-31)59-19-21-60(22-20-59)41(64)17-23-69-25-18-52-40(63)29-53-36-9-5-8-35-42(36)48(68)61(47(35)67)38-14-15-39(62)57-45(38)66/h4-13,16,24,26-27,38,53H,14-15,17-23,25,29H2,1-3H3,(H,52,63)(H,54,65)(H,55,56,58)(H,57,62,66)/b30-27+",LBKKWHUKGHYCTR-KDJFERLWSA-N
4366,,,>1000,,Q06187,BTK,CRBN,,PS-RC-3,CC(C)(C)/C=C(\C#N)C(=O)NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C(=O)CCOCCOCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3)=NC3=C2OC=C3)=C1,Degradation of BTK in Mino cells after 24h treatment,,,4367,Binding to BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000/>10000,Inhibit cell growth in MOLM-14/Mino cells,,,,,,,,,,,,,,,10.1016/j.crchbi.2022.100029,1010.078,1009.408252,5.03,74,8,17,5,20,279.76,C52H55N11O11,"InChI=1S/C52H55N11O11/c1-52(2,3)29-32(30-53)46(67)56-34-6-4-7-36(28-34)74-48-45-39(16-24-73-45)58-51(60-48)57-33-10-12-35(13-11-33)61-19-21-62(22-20-61)43(66)17-23-71-26-27-72-25-18-54-42(65)31-55-38-9-5-8-37-44(38)50(70)63(49(37)69)40-14-15-41(64)59-47(40)68/h4-13,16,24,28-29,40,55H,14-15,17-23,25-27,31H2,1-3H3,(H,54,65)(H,56,67)(H,57,58,60)(H,59,64,68)/b32-29+",IWWPVUDUOWUIHZ-UUDCSCGESA-N
4367,,,>1000,,Q06187,BTK,CRBN,,PS-RC-4,CC(C)(C)/C=C(\C#N)C(=O)NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C(=O)CCOCCOCCOCCNC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3)=NC3=C2OC=C3)=C1,Degradation of BTK in Mino cells after 24h treatment,,,6614,Binding to BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>10000/7800,Inhibit cell growth in MOLM-14/Mino cells,,,,,,,,,,,,,,,10.1016/j.crchbi.2022.100029,1054.131,1053.434466,4.88,77,8,18,5,23,288.99,C54H59N11O12,"InChI=1S/C54H59N11O12/c1-54(2,3)31-34(32-55)48(69)58-36-6-4-7-38(30-36)77-50-47-41(16-24-76-47)60-53(62-50)59-35-10-12-37(13-11-35)63-19-21-64(22-20-63)45(68)17-23-73-26-28-75-29-27-74-25-18-56-44(67)33-57-40-9-5-8-39-46(40)52(72)65(51(39)71)42-14-15-43(66)61-49(42)70/h4-13,16,24,30-31,42,57H,14-15,17-23,25-29,33H2,1-3H3,(H,56,67)(H,58,69)(H,59,60,62)(H,61,66,70)/b34-31+",XHEIZWODNAIXEX-WUVHBKSUSA-N
4368,,,>10000,,P30530,AXL,VHL,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,999.135,998.3796746,7.55,72,8,14,4,15,216.2,C53H55FN8O9S,"InChI=1S/C53H55FN8O9S/c1-9-30-12-16-39-36(18-30)46(65)45(29(3)61(39)7)50(67)59-33-15-17-41(37(54)19-33)71-51-35-21-42(69-8)43(22-38(35)56-26-57-51)70-25-44(64)60-48(53(4,5)6)52(68)62-24-34(63)20-40(62)49(66)55-23-31-10-13-32(14-11-31)47-28(2)58-27-72-47/h10-19,21-22,26-27,34,40,48,63H,9,20,23-25H2,1-8H3,(H,55,66)(H,59,67)(H,60,64)/t34-,40+,48-/m1/s1",DASXGGUUVOHJDL-HQHCFIODSA-N
4369,,,>10000,,P30530,AXL,VHL,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,1027.189,1026.410975,7.81,74,8,14,4,17,216.2,C55H59FN8O9S,"InChI=1S/C55H59FN8O9S/c1-9-32-14-18-41-38(21-32)48(67)47(31(3)63(41)7)52(69)61-35-17-19-43(39(56)22-35)73-53-37-24-44(71-8)45(25-40(37)58-28-59-53)72-20-10-11-46(66)62-50(55(4,5)6)54(70)64-27-36(65)23-42(64)51(68)57-26-33-12-15-34(16-13-33)49-30(2)60-29-74-49/h12-19,21-22,24-25,28-29,36,42,50,65H,9-11,20,23,26-27H2,1-8H3,(H,57,68)(H,61,69)(H,62,66)/t36-,42+,50-/m1/s1",UYRLWZPDZVOGED-KXSCYLGLSA-N
4370,,,>10000,,P30530,AXL,VHL,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,1055.243,1054.442275,8.52,76,8,14,4,19,216.2,C57H63FN8O9S,"InChI=1S/C57H63FN8O9S/c1-9-34-16-20-43-40(23-34)50(69)49(33(3)65(43)7)54(71)63-37-19-21-45(41(58)24-37)75-55-39-26-46(73-8)47(27-42(39)60-30-61-55)74-22-12-10-11-13-48(68)64-52(57(4,5)6)56(72)66-29-38(67)25-44(66)53(70)59-28-35-14-17-36(18-15-35)51-32(2)62-31-76-51/h14-21,23-24,26-27,30-31,38,44,52,67H,9-13,22,25,28-29H2,1-8H3,(H,59,70)(H,63,71)(H,64,68)/t38-,44+,52-/m1/s1",GXNLSEDEVCKGNK-GZTYHUJVSA-N
4371,,,>10000,,P30530,AXL,VHL,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,1083.297,1082.473575,9.61,78,8,14,4,21,216.2,C59H67FN8O9S,"InChI=1S/C59H67FN8O9S/c1-9-36-18-22-45-42(25-36)52(71)51(35(3)67(45)7)56(73)65-39-21-23-47(43(60)26-39)77-57-41-28-48(75-8)49(29-44(41)62-32-63-57)76-24-14-12-10-11-13-15-50(70)66-54(59(4,5)6)58(74)68-31-40(69)27-46(68)55(72)61-30-37-16-19-38(20-17-37)53-34(2)64-33-78-53/h16-23,25-26,28-29,32-33,40,46,54,69H,9-15,24,27,30-31H2,1-8H3,(H,61,72)(H,65,73)(H,66,70)/t40-,46+,54-/m1/s1",HDDGHOSSMUMYHY-WPHXOLCSSA-N
4372,,,>10000,,P30530,AXL,VHL,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,1111.351,1110.504875,10.69,80,8,14,4,23,216.2,C61H71FN8O9S,"InChI=1S/C61H71FN8O9S/c1-9-38-20-24-47-44(27-38)54(73)53(37(3)69(47)7)58(75)67-41-23-25-49(45(62)28-41)79-59-43-30-50(77-8)51(31-46(43)64-34-65-59)78-26-16-14-12-10-11-13-15-17-52(72)68-56(61(4,5)6)60(76)70-33-42(71)29-48(70)57(74)63-32-39-18-21-40(22-19-39)55-36(2)66-35-80-55/h18-25,27-28,30-31,34-35,42,48,56,71H,9-17,26,29,32-33H2,1-8H3,(H,63,74)(H,67,75)(H,68,72)/t42-,48+,56-/m1/s1",RBFFASXRLMCBJB-HEYFEAJISA-N
4373,,,>10000,,P30530,AXL,VHL,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,1139.405,1138.536175,11.77,82,8,14,4,25,216.2,C63H75FN8O9S,"InChI=1S/C63H75FN8O9S/c1-9-40-22-26-49-46(29-40)56(75)55(39(3)71(49)7)60(77)69-43-25-27-51(47(64)30-43)81-61-45-32-52(79-8)53(33-48(45)66-36-67-61)80-28-18-16-14-12-10-11-13-15-17-19-54(74)70-58(63(4,5)6)62(78)72-35-44(73)31-50(72)59(76)65-34-41-20-23-42(24-21-41)57-38(2)68-37-82-57/h20-27,29-30,32-33,36-37,44,50,58,73H,9-19,28,31,34-35H2,1-8H3,(H,65,76)(H,69,77)(H,70,74)/t44-,50+,58-/m1/s1",GYXTYNABCSTYBP-XNVOUWPASA-N
4374,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,841.809,841.2507686,5.09,62,8,13,3,11,217.22,C44H36FN7O10,"InChI=1S/C44H36FN7O10/c1-5-22-9-11-30-26(15-22)39(55)37(21(2)51(30)3)41(57)48-23-10-13-32(27(45)16-23)62-42-25-17-33(60-4)34(18-29(25)46-20-47-42)61-19-36(54)49-28-8-6-7-24-38(28)44(59)52(43(24)58)31-12-14-35(53)50-40(31)56/h6-11,13,15-18,20,31H,5,12,14,19H2,1-4H3,(H,48,57)(H,49,54)(H,50,53,56)",ZAYMYLLHNOWQSE-UHFFFAOYSA-N
4375,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,883.89,883.2977188,5.71,65,8,13,3,14,217.22,C47H42FN7O10,"InChI=1S/C47H42FN7O10/c1-5-25-12-14-33-29(19-25)42(58)40(24(2)54(33)3)44(60)51-26-13-16-35(30(48)20-26)65-45-28-21-36(63-4)37(22-32(28)49-23-50-45)64-18-7-6-11-38(56)52-31-10-8-9-27-41(31)47(62)55(46(27)61)34-15-17-39(57)53-43(34)59/h8-10,12-14,16,19-23,34H,5-7,11,15,17-18H2,1-4H3,(H,51,60)(H,52,56)(H,53,57,59)",FTMYTRVNJJCTFM-UHFFFAOYSA-N
4376,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,897.917,897.3133688,6.07,66,8,13,3,15,217.22,C48H44FN7O10,"InChI=1S/C48H44FN7O10/c1-5-26-13-15-34-30(20-26)43(59)41(25(2)55(34)3)45(61)52-27-14-17-36(31(49)21-27)66-46-29-22-37(64-4)38(23-33(29)50-24-51-46)65-19-8-6-7-12-39(57)53-32-11-9-10-28-42(32)48(63)56(47(28)62)35-16-18-40(58)54-44(35)60/h9-11,13-15,17,20-24,35H,5-8,12,16,18-19H2,1-4H3,(H,52,61)(H,53,57)(H,54,58,60)",PBGCCABQTGLITJ-UHFFFAOYSA-N
4377,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,925.971,925.344669,7.15,68,8,13,3,17,217.22,C50H48FN7O10,"InChI=1S/C50H48FN7O10/c1-5-28-15-17-36-32(22-28)45(61)43(27(2)57(36)3)47(63)54-29-16-19-38(33(51)23-29)68-48-31-24-39(66-4)40(25-35(31)52-26-53-48)67-21-10-8-6-7-9-14-41(59)55-34-13-11-12-30-44(34)50(65)58(49(30)64)37-18-20-42(60)56-46(37)62/h11-13,15-17,19,22-26,37H,5-10,14,18,20-21H2,1-4H3,(H,54,63)(H,55,59)(H,56,60,62)",ZTDBMDXPKXOPQN-UHFFFAOYSA-N
4378,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,954.025,953.3759691,8.23,70,8,13,3,19,217.22,C52H52FN7O10,"InChI=1S/C52H52FN7O10/c1-5-30-17-19-38-34(24-30)47(63)45(29(2)59(38)3)49(65)56-31-18-21-40(35(53)25-31)70-50-33-26-41(68-4)42(27-37(33)54-28-55-50)69-23-12-10-8-6-7-9-11-16-43(61)57-36-15-13-14-32-46(36)52(67)60(51(32)66)39-20-22-44(62)58-48(39)64/h13-15,17-19,21,24-28,39H,5-12,16,20,22-23H2,1-4H3,(H,56,65)(H,57,61)(H,58,62,64)",KUTLZFZYONUXQG-UHFFFAOYSA-N
4379,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,982.079,981.4072692,9.32,72,8,13,3,21,217.22,C54H56FN7O10,"InChI=1S/C54H56FN7O10/c1-5-32-19-21-40-36(26-32)49(65)47(31(2)61(40)3)51(67)58-33-20-23-42(37(55)27-33)72-52-35-28-43(70-4)44(29-39(35)56-30-57-52)71-25-14-12-10-8-6-7-9-11-13-18-45(63)59-38-17-15-16-34-48(38)54(69)62(53(34)68)41-22-24-46(64)60-50(41)66/h15-17,19-21,23,26-30,41H,5-14,18,22,24-25H2,1-4H3,(H,58,67)(H,59,63)(H,60,64,66)",MIFIXPRETWGQRU-UHFFFAOYSA-N
4380,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,841.809,841.2507686,4.54,62,8,13,3,11,217.22,C44H36FN7O10,"InChI=1S/C44H36FN7O10/c1-5-22-6-10-31-28(14-22)39(55)38(21(2)51(31)3)41(57)49-24-8-12-33(29(45)16-24)62-42-27-17-34(60-4)35(18-30(27)46-20-47-42)61-19-37(54)48-23-7-9-25-26(15-23)44(59)52(43(25)58)32-11-13-36(53)50-40(32)56/h6-10,12,14-18,20,32H,5,11,13,19H2,1-4H3,(H,48,54)(H,49,57)(H,50,53,56)",HVUNBLFRLGGQAI-UHFFFAOYSA-N
4381,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,883.89,883.2977188,5.16,65,8,13,3,14,217.22,C47H42FN7O10,"InChI=1S/C47H42FN7O10/c1-5-25-9-13-34-31(18-25)42(58)41(24(2)54(34)3)44(60)52-27-11-15-36(32(48)20-27)65-45-30-21-37(63-4)38(22-33(30)49-23-50-45)64-17-7-6-8-39(56)51-26-10-12-28-29(19-26)47(62)55(46(28)61)35-14-16-40(57)53-43(35)59/h9-13,15,18-23,35H,5-8,14,16-17H2,1-4H3,(H,51,56)(H,52,60)(H,53,57,59)",MMGRSIPIHULKFQ-UHFFFAOYSA-N
4382,40,99,40,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,897.917,897.3133688,5.52,66,8,13,3,15,217.22,C48H44FN7O10,"InChI=1S/C48H44FN7O10/c1-5-26-10-14-35-32(19-26)43(59)42(25(2)55(35)3)45(61)53-28-12-16-37(33(49)21-28)66-46-31-22-38(64-4)39(23-34(31)50-24-51-46)65-18-8-6-7-9-40(57)52-27-11-13-29-30(20-27)48(63)56(47(29)62)36-15-17-41(58)54-44(36)60/h10-14,16,19-24,36H,5-9,15,17-18H2,1-4H3,(H,52,57)(H,53,61)(H,54,58,60)",WZTXRLVYEOBKNE-UHFFFAOYSA-N
4383,108,99,108,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,925.971,925.344669,6.6,68,8,13,3,17,217.22,C50H48FN7O10,"InChI=1S/C50H48FN7O10/c1-5-28-12-16-37-34(21-28)45(61)44(27(2)57(37)3)47(63)55-30-14-18-39(35(51)23-30)68-48-33-24-40(66-4)41(25-36(33)52-26-53-48)67-20-10-8-6-7-9-11-42(59)54-29-13-15-31-32(22-29)50(65)58(49(31)64)38-17-19-43(60)56-46(38)62/h12-16,18,21-26,38H,5-11,17,19-20H2,1-4H3,(H,54,59)(H,55,63)(H,56,60,62)",HJUNPXSWJAHNJA-UHFFFAOYSA-N
4384,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCCCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,954.025,953.3759691,7.68,70,8,13,3,19,217.22,C52H52FN7O10,"InChI=1S/C52H52FN7O10/c1-5-30-14-18-39-36(23-30)47(63)46(29(2)59(39)3)49(65)57-32-16-20-41(37(53)25-32)70-50-35-26-42(68-4)43(27-38(35)54-28-55-50)69-22-12-10-8-6-7-9-11-13-44(61)56-31-15-17-33-34(24-31)52(67)60(51(33)66)40-19-21-45(62)58-48(40)64/h14-18,20,23-28,40H,5-13,19,21-22H2,1-4H3,(H,56,61)(H,57,65)(H,58,62,64)",SRRGPYQBGKWAMS-UHFFFAOYSA-N
4385,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCCCCCCCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,982.079,981.4072692,8.77,72,8,13,3,21,217.22,C54H56FN7O10,"InChI=1S/C54H56FN7O10/c1-5-32-16-20-41-38(25-32)49(65)48(31(2)61(41)3)51(67)59-34-18-22-43(39(55)27-34)72-52-37-28-44(70-4)45(29-40(37)56-30-57-52)71-24-14-12-10-8-6-7-9-11-13-15-46(63)58-33-17-19-35-36(26-33)54(69)62(53(35)68)42-21-23-47(64)60-50(42)66/h16-20,22,25-30,42H,5-15,21,23-24H2,1-4H3,(H,58,63)(H,59,67)(H,60,64,66)",QWVFURVIKGDASU-UHFFFAOYSA-N
4386,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)NC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,883.934,883.3341043,5.57,65,8,12,3,15,200.15,C48H46FN7O9,"InChI=1S/C48H46FN7O9/c1-5-27-13-15-36-31(20-27)44(59)43(26(2)55(36)3)46(61)52-28-14-17-38(33(49)21-28)65-47-30-22-39(63-4)40(23-35(30)50-25-51-47)64-19-8-6-7-12-41(57)53-34-11-9-10-29-32(34)24-56(48(29)62)37-16-18-42(58)54-45(37)60/h9-11,13-15,17,20-23,25,37H,5-8,12,16,18-19,24H2,1-4H3,(H,52,61)(H,53,57)(H,54,58,60)",CBSWMHARCHKLAI-UHFFFAOYSA-N
4387,5,99,5,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)NC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/5/>5000,Inhibition of cell proliferation of MDA-MB-231/MDA-MB-436/MDA-MB-453 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,883.934,883.3341043,5.57,65,8,12,3,15,200.15,C48H46FN7O9,"InChI=1S/C48H46FN7O9/c1-5-27-10-14-36-33(19-27)44(59)43(26(2)55(36)3)46(61)53-30-12-16-38(34(49)21-30)65-47-32-22-39(63-4)40(23-35(32)50-25-51-47)64-18-8-6-7-9-41(57)52-29-11-13-31-28(20-29)24-56(48(31)62)37-15-17-42(58)54-45(37)60/h10-14,16,19-23,25,37H,5-9,15,17-18,24H2,1-4H3,(H,52,57)(H,53,61)(H,54,58,60)",JYSRAVKFFOQFCG-UHFFFAOYSA-N
4388,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)NC5=CC=C6CN(C7CCC(=O)NC7=O)C(=O)C6=C5)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,883.934,883.3341043,5.57,65,8,12,3,15,200.15,C48H46FN7O9,"InChI=1S/C48H46FN7O9/c1-5-27-10-14-36-33(19-27)44(59)43(26(2)55(36)3)46(61)53-30-13-16-38(34(49)21-30)65-47-32-22-39(63-4)40(23-35(32)50-25-51-47)64-18-8-6-7-9-41(57)52-29-12-11-28-24-56(48(62)31(28)20-29)37-15-17-42(58)54-45(37)60/h10-14,16,19-23,25,37H,5-9,15,17-18,24H2,1-4H3,(H,52,57)(H,53,61)(H,54,58,60)",JKTGDSPJOJPMET-UHFFFAOYSA-N
4389,,,>10000,,P30530,AXL,CRBN,,,CCC1=CC=C2C(=C1)C(=O)C(C(=O)NC1=CC=C(OC3=NC=NC4=CC(OCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6)=C(OC)C=C34)C(F)=C1)=C(C)N2C,Degradation of AXL in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01682,883.934,883.3341043,6.12,65,8,12,3,15,200.15,C48H46FN7O9,"InChI=1S/C48H46FN7O9/c1-5-27-13-15-35-31(20-27)44(59)42(26(2)55(35)3)46(61)52-29-14-17-37(32(49)21-29)65-47-30-22-38(63-4)39(23-34(30)50-25-51-47)64-19-8-6-7-12-40(57)53-33-11-9-10-28-24-56(48(62)43(28)33)36-16-18-41(58)54-45(36)60/h9-11,13-15,17,20-23,25,36H,5-8,12,16,18-19,24H2,1-4H3,(H,52,61)(H,53,57)(H,54,58,60)",KSLXSFPUBSGCSP-UHFFFAOYSA-N
4401,203,82.8,203,82.8,P08581,c-Met,CRBN,,PRO-6E,C[C@@H](OC1=CC(C2=CN(C3CCN(C(=O)CCCCCCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,Degradation of MET in MKN-45 cells after 48h treatment,,,,,,,5380,Binding affinity of MET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,347,Inhibition of cell proliferation of MKN-45 cells for 72h,,,,,,,,,,,,,,,10.1111/cas.15733,848.76,847.2663303,5.58,59,7,11,2,15,179.05,C42H44Cl2FN7O7,"InChI=1S/C42H44Cl2FN7O7/c1-24(36-29(43)11-12-30(45)38(36)44)59-33-20-25(21-47-39(33)46)26-22-48-51(23-26)27-15-17-50(18-16-27)35(54)10-5-3-2-4-6-19-58-32-9-7-8-28-37(32)42(57)52(41(28)56)31-13-14-34(53)49-40(31)55/h7-9,11-12,20-24,27,31H,2-6,10,13-19H2,1H3,(H2,46,47)(H,49,53,55)/t24-,31?/m1/s1",JSQFSAUVTNADLF-LZDHLTRGSA-N
4434,200,99,200,,P36507,MEK2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC(=O)NCCCCC(=O)NC3=CC=CC(CC4=C(C)C5=CC=C(OC6=NC=CC=N6)C=C5OC4=O)=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK2 in A549 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00446,1003.167,1002.410975,5.49,72,7,13,5,19,235.05,C53H59FN8O9S,"InChI=1S/C53H59FN8O9S/c1-30-38-19-18-37(70-52-56-23-10-24-57-52)27-42(38)71-51(69)39(30)25-35-11-9-12-40(46(35)54)60-44(65)13-7-8-22-55-43(64)20-21-45(66)61-48(53(4,5)6)50(68)62-28-36(63)26-41(62)49(67)59-31(2)33-14-16-34(17-15-33)47-32(3)58-29-72-47/h9-12,14-19,23-24,27,29,31,36,41,48,63H,7-8,13,20-22,25-26,28H2,1-6H3,(H,55,64)(H,59,67)(H,60,65)(H,61,66)/t31-,36+,41-,48+/m0/s1",LMAPKIKMRRTUGC-QXXUAEQASA-N
4434,300,99,300/2800,,Q02750,MEK1,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC(=O)NCCCCC(=O)NC3=CC=CC(CC4=C(C)C5=CC=C(OC6=NC=CC=N6)C=C5OC4=O)=C3F)C(C)(C)C)C=C2)SC=N1,Degradation of MEK1 in A549/ MEK1/2 in A375 cells after 24h treatment,85,% MEK1/2 protein degradation in A549 cells at 1000 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,27300/2800,Inhibition of cell proliferation of A549/A375 cells,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00446,1003.167,1002.410975,5.49,72,7,13,5,19,235.05,C53H59FN8O9S,"InChI=1S/C53H59FN8O9S/c1-30-38-19-18-37(70-52-56-23-10-24-57-52)27-42(38)71-51(69)39(30)25-35-11-9-12-40(46(35)54)60-44(65)13-7-8-22-55-43(64)20-21-45(66)61-48(53(4,5)6)50(68)62-28-36(63)26-41(62)49(67)59-31(2)33-14-16-34(17-15-33)47-32(3)58-29-72-47/h9-12,14-19,23-24,27,29,31,36,41,48,63H,7-8,13,20-22,25-26,28H2,1-6H3,(H,55,64)(H,59,67)(H,60,65)(H,61,66)/t31-,36+,41-,48+/m0/s1",LMAPKIKMRRTUGC-QXXUAEQASA-N
4448,2830,99,2830,,Q9UM73,ALK,CRBN,,,CC1=CC(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)=C(OC(C)C)C=C1C1CCN(C(=O)CCCCCCC(=O)N(CCS)CC(=O)NCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of EML4-ALK in H3122 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4730/1760/90,Inhibition of cell proliferation of H1299/H2228/H3122 cells under GSH,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.115082,1129.804,1128.432808,7.57,78,7,16,6,25,258.51,C55H69ClN10O10S2,"InChI=1S/C55H69ClN10O10S2/c1-33(2)76-44-30-38(35(5)29-42(44)61-55-59-31-39(56)51(63-55)60-40-14-10-11-16-45(40)78(74,75)34(3)4)36-21-25-64(26-22-36)48(69)17-8-6-7-9-18-49(70)65(27-28-77)32-47(68)58-24-23-57-41-15-12-13-37-50(41)54(73)66(53(37)72)43-19-20-46(67)62-52(43)71/h10-16,29-31,33-34,36,43,57,77H,6-9,17-28,32H2,1-5H3,(H,58,68)(H,62,67,71)(H2,59,60,61,63)",KSOJCEHKQVDULQ-UHFFFAOYSA-N
4475,23.26,99,23.26/136/42.69,,P36969,GPX4,VHL,,,COC(=O)[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=CC=C(C(=O)N3CCN(CCCCCCCCCCCCCN[C@@H](C(=O)N4C[C@@H](O)C[C@@H]4C(=O)N[C@H](C)C4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2)N1C(=O)CCl,Degradation of GPX4 in HT1080 cells after 6h treatment/in Calu-1 cells after 24h treatment/in H1650 cells after 24h treatment,63,% GPX4 protein degradation in HT1080 cells at 100 nM for 6 h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58/25/130,Inhibition of cell proliferation of HT1080/Calu-1/HEK293T cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.115072,1119.915,1118.579396,10.92,79,8,11,4,24,180.51,C62H83ClN8O7S,"InChI=1S/C62H83ClN8O7S/c1-41(43-22-26-45(27-23-43)56-42(2)65-40-79-56)66-58(74)51-36-47(72)39-70(51)60(76)57(62(3,4)5)64-30-18-14-12-10-8-7-9-11-13-15-19-31-68-32-34-69(35-33-68)59(75)46-28-24-44(25-29-46)55-54-49(48-20-16-17-21-50(48)67-54)37-52(61(77)78-6)71(55)53(73)38-63/h16-17,20-29,40-41,47,51-52,55,57,64,67,72H,7-15,18-19,30-39H2,1-6H3,(H,66,74)/t41-,47+,51-,52+,55-,57+/m1/s1",XQGWKMPLXWKSTO-VVLPFZEESA-N
4507,,,>10000,N.D.,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,120,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,930.211,929.4291874,4.34,65,6,11,5,18,206.27,C47H63N9O7S2,"InChI=1S/C47H63N9O7S2/c1-32(35-13-15-36(16-14-35)42-33(2)50-31-64-42)51-44(59)40-27-38(57)30-56(40)45(60)43(47(3,4)5)53-41(58)12-8-6-7-9-22-54-23-25-55(26-24-54)65(62,63)39-19-17-37(18-20-39)52-46(61)49-29-34-11-10-21-48-28-34/h10-11,13-21,28,31-32,38,40,43,57H,6-9,12,22-27,29-30H2,1-5H3,(H,51,59)(H,53,58)(H2,49,52,61)/t32-,38+,40-,43+/m0/s1",XWTKYEZDEXRCBK-RVCBHFSWSA-N
4508,,,>100,N.D.,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,100,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.9,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,944.238,943.4448374,4.88,66,6,11,5,19,206.27,C48H65N9O7S2,"InChI=1S/C48H65N9O7S2/c1-33(36-14-16-37(17-15-36)43-34(2)51-32-65-43)52-45(60)41-28-39(58)31-57(41)46(61)44(48(3,4)5)54-42(59)13-9-7-6-8-10-23-55-24-26-56(27-25-55)66(63,64)40-20-18-38(19-21-40)53-47(62)50-30-35-12-11-22-49-29-35/h11-12,14-22,29,32-33,39,41,44,58H,6-10,13,23-28,30-31H2,1-5H3,(H,52,60)(H,54,59)(H2,50,53,62)/t33-,39+,41-,44+/m0/s1",QUQLWEYDHCPEGN-QYMKNGPYSA-N
4509,0.17,93,<0.17,93,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,150,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,958.265,957.4604875,5.43,67,6,11,5,20,206.27,C49H67N9O7S2,"InChI=1S/C49H67N9O7S2/c1-34(37-15-17-38(18-16-37)44-35(2)52-33-66-44)53-46(61)42-29-40(59)32-58(42)47(62)45(49(3,4)5)55-43(60)14-10-8-6-7-9-11-24-56-25-27-57(28-26-56)67(64,65)41-21-19-39(20-22-41)54-48(63)51-31-36-13-12-23-50-30-36/h12-13,15-23,30,33-34,40,42,45,59H,6-11,14,24-29,31-32H2,1-5H3,(H,53,61)(H,55,60)(H2,51,54,63)/t34-,40+,42-,45+/m0/s1",OFDVMTIVOGMTRU-CZSAYBOZSA-N
4510,1.5,92,1.5,92,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,190,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,972.292,971.4761375,5.97,68,6,11,5,21,206.27,C50H69N9O7S2,"InChI=1S/C50H69N9O7S2/c1-35(38-16-18-39(19-17-38)45-36(2)53-34-67-45)54-47(62)43-30-41(60)33-59(43)48(63)46(50(3,4)5)56-44(61)15-11-9-7-6-8-10-12-25-57-26-28-58(29-27-57)68(65,66)42-22-20-40(21-23-42)55-49(64)52-32-37-14-13-24-51-31-37/h13-14,16-24,31,34-35,41,43,46,60H,6-12,15,25-30,32-33H2,1-5H3,(H,54,62)(H,56,61)(H2,52,55,64)/t35-,41+,43-,46+/m0/s1",FWVYIAMLXGSLBA-ACVSEINWSA-N
4511,4.6,70,<4.6,70,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,230,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,986.319,985.4917876,6.51,69,6,11,5,22,206.27,C51H71N9O7S2,"InChI=1S/C51H71N9O7S2/c1-36(39-17-19-40(20-18-39)46-37(2)54-35-68-46)55-48(63)44-31-42(61)34-60(44)49(64)47(51(3,4)5)57-45(62)16-12-10-8-6-7-9-11-13-26-58-27-29-59(30-28-58)69(66,67)43-23-21-41(22-24-43)56-50(65)53-33-38-15-14-25-52-32-38/h14-15,17-25,32,35-36,42,44,47,61H,6-13,16,26-31,33-34H2,1-5H3,(H,55,63)(H,57,62)(H2,53,56,65)/t36-,42+,44-,47+/m0/s1",UVIVLGHOUAQSRA-MFUWQLKVSA-N
4512,2.4,98,2.4,98,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,310,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1000.346,999.5074377,7.05,70,6,11,5,23,206.27,C52H73N9O7S2,"InChI=1S/C52H73N9O7S2/c1-37(40-18-20-41(21-19-40)47-38(2)55-36-69-47)56-49(64)45-32-43(62)35-61(45)50(65)48(52(3,4)5)58-46(63)17-13-11-9-7-6-8-10-12-14-27-59-28-30-60(31-29-59)70(67,68)44-24-22-42(23-25-44)57-51(66)54-34-39-16-15-26-53-33-39/h15-16,18-26,33,36-37,43,45,48,62H,6-14,17,27-32,34-35H2,1-5H3,(H,56,64)(H,58,63)(H2,54,57,66)/t37-,43+,45-,48+/m0/s1",ULJQYAQDSOFCIJ-OFXOIJPASA-N
4513,,,>100,N.D.,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,160,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5512,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,904.129,903.3771518,2.68,63,6,12,5,16,215.5,C44H57N9O8S2,"InChI=1S/C44H57N9O8S2/c1-29(32-8-10-33(11-9-32)39-30(2)47-28-62-39)48-41(56)37-23-35(54)26-53(37)42(57)40(44(3,4)5)50-38(55)27-61-22-21-51-17-19-52(20-18-51)63(59,60)36-14-12-34(13-15-36)49-43(58)46-25-31-7-6-16-45-24-31/h6-16,24,28-29,35,37,40,54H,17-23,25-27H2,1-5H3,(H,48,56)(H,50,55)(H2,46,49,58)/t29-,35+,37-,40+/m0/s1",FZHPTHJRGGLHBL-QUOGVQPDSA-N
4514,,,>100,N.D.,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,150,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1227,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,948.182,947.4033665,2.53,66,6,13,5,19,224.73,C46H61N9O9S2,"InChI=1S/C46H61N9O9S2/c1-31(34-8-10-35(11-9-34)41-32(2)49-30-65-41)50-43(58)39-25-37(56)28-55(39)44(59)42(46(3,4)5)52-40(57)29-64-24-23-63-22-21-53-17-19-54(20-18-53)66(61,62)38-14-12-36(13-15-38)51-45(60)48-27-33-7-6-16-47-26-33/h6-16,26,30-31,37,39,42,56H,17-25,27-29H2,1-5H3,(H,50,58)(H,52,57)(H2,48,51,60)/t31-,37+,39-,42+/m0/s1",HKOMBGDHYJAELG-XMJUXVDFSA-N
4515,93,83,93,83,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,130,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,992.235,991.4295813,2.38,69,6,14,5,22,233.96,C48H65N9O10S2,"InChI=1S/C48H65N9O10S2/c1-33(36-8-10-37(11-9-36)43-34(2)51-32-68-43)52-45(60)41-27-39(58)30-57(41)46(61)44(48(3,4)5)54-42(59)31-67-26-25-66-24-23-65-22-21-55-17-19-56(20-18-55)69(63,64)40-14-12-38(13-15-40)53-47(62)50-29-35-7-6-16-49-28-35/h6-16,28,32-33,39,41,44,58H,17-27,29-31H2,1-5H3,(H,52,60)(H,54,59)(H2,50,53,62)/t33-,39+,41-,44+/m0/s1",MDJQPVDBUJDBNX-QYMKNGPYSA-N
4516,19,92,19,92,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,130,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,173,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1036.288,1035.455796,2.24,72,6,15,5,25,243.19,C50H69N9O11S2,"InChI=1S/C50H69N9O11S2/c1-35(38-8-10-39(11-9-38)45-36(2)53-34-71-45)54-47(62)43-29-41(60)32-59(43)48(63)46(50(3,4)5)56-44(61)33-70-28-27-69-26-25-68-24-23-67-22-21-57-17-19-58(20-18-57)72(65,66)42-14-12-40(13-15-42)55-49(64)52-31-37-7-6-16-51-30-37/h6-16,30,34-35,41,43,46,60H,17-29,31-33H2,1-5H3,(H,54,62)(H,56,61)(H2,52,55,64)/t35-,41+,43-,46+/m0/s1",NVLIYOBRPUSFFX-ACVSEINWSA-N
4517,22,90,22,90,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,190,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,133,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1080.341,1079.482011,2.09,75,6,16,5,28,252.42,C52H73N9O12S2,"InChI=1S/C52H73N9O12S2/c1-37(40-8-10-41(11-9-40)47-38(2)55-36-74-47)56-49(64)45-31-43(62)34-61(45)50(65)48(52(3,4)5)58-46(63)35-73-30-29-72-28-27-71-26-25-70-24-23-69-22-21-59-17-19-60(20-18-59)75(67,68)44-14-12-42(13-15-44)57-51(66)54-33-39-7-6-16-53-32-39/h6-16,32,36-37,43,45,48,62H,17-31,33-35H2,1-5H3,(H,56,64)(H,58,63)(H2,54,57,66)/t37-,43+,45-,48+/m0/s1",XRLBKHJZDZFNAM-OFXOIJPASA-N
4518,50,91,50-500,91,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,120,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,433,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,999.234,998.4254989,2.37,70,7,15,5,19,246.21,C48H62N12O8S2,"InChI=1S/C48H62N12O8S2/c1-32(35-8-10-36(11-9-35)43-33(2)51-31-69-43)52-45(63)41-25-39(61)29-60(41)46(64)44(48(3,4)5)54-42(62)30-68-24-23-58-28-38(55-56-58)16-18-57-19-21-59(22-20-57)70(66,67)40-14-12-37(13-15-40)53-47(65)50-27-34-7-6-17-49-26-34/h6-15,17,26,28,31-32,39,41,44,61H,16,18-25,27,29-30H2,1-5H3,(H,52,63)(H,54,62)(H2,50,53,65)/t32-,39+,41-,44+/m0/s1",IOAUOUBJRZKDGR-YBQSWKSMSA-N
4519,50,87,50-500,87,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,190,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,737,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1043.287,1042.451714,2.22,73,7,16,5,22,255.44,C50H66N12O9S2,"InChI=1S/C50H66N12O9S2/c1-34(37-8-10-38(11-9-37)45-35(2)53-33-72-45)54-47(65)43-27-41(63)31-62(43)48(66)46(50(3,4)5)56-44(64)32-71-26-25-70-24-23-60-30-40(57-58-60)16-18-59-19-21-61(22-20-59)73(68,69)42-14-12-39(13-15-42)55-49(67)52-29-36-7-6-17-51-28-36/h6-15,17,28,30,33-34,41,43,46,63H,16,18-27,29,31-32H2,1-5H3,(H,54,65)(H,56,64)(H2,52,55,67)/t34-,41+,43-,46+/m0/s1",ZOJKJHCLSCQUOK-TZYAYNJLSA-N
4520,50,97,50-500,97,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,94,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,487,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1087.34,1086.477928,2.08,76,7,17,5,25,264.67,C52H70N12O10S2,"InChI=1S/C52H70N12O10S2/c1-36(39-8-10-40(11-9-39)47-37(2)55-35-75-47)56-49(67)45-29-43(65)33-64(45)50(68)48(52(3,4)5)58-46(66)34-74-28-27-73-26-25-72-24-23-62-32-42(59-60-62)16-18-61-19-21-63(22-20-61)76(70,71)44-14-12-41(13-15-44)57-51(69)54-31-38-7-6-17-53-30-38/h6-15,17,30,32,35-36,43,45,48,65H,16,18-29,31,33-34H2,1-5H3,(H,56,67)(H,58,66)(H2,54,57,69)/t36-,43+,45-,48+/m0/s1",HHLYGKNZIUCQMF-YPVOJFEDSA-N
4521,50,84,50-500,84,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,83,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,401,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1131.393,1130.504143,1.93,79,7,18,5,28,273.9,C54H74N12O11S2,"InChI=1S/C54H74N12O11S2/c1-38(41-8-10-42(11-9-41)49-39(2)57-37-78-49)58-51(69)47-31-45(67)35-66(47)52(70)50(54(3,4)5)60-48(68)36-77-30-29-76-28-27-75-26-25-74-24-23-64-34-44(61-62-64)16-18-63-19-21-65(22-20-63)79(72,73)46-14-12-43(13-15-46)59-53(71)56-33-40-7-6-17-55-32-40/h6-15,17,32,34,37-38,45,47,50,67H,16,18-31,33,35-36H2,1-5H3,(H,58,69)(H,60,68)(H2,56,59,71)/t38-,45+,47-,50+/m0/s1",PPXNGQMBEYFGAO-ZLVPICEKSA-N
4522,50,80,50-500,80,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of NAMPT in A2780 cells after 24h treatment,,,970,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,477,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1175.446,1174.530358,1.78,82,7,19,5,31,283.13,C56H78N12O12S2,"InChI=1S/C56H78N12O12S2/c1-40(43-8-10-44(11-9-43)51-41(2)59-39-81-51)60-53(71)49-33-47(69)37-68(49)54(72)52(56(3,4)5)62-50(70)38-80-32-31-79-30-29-78-28-27-77-26-25-76-24-23-66-36-46(63-64-66)16-18-65-19-21-67(22-20-65)82(74,75)48-14-12-45(13-15-48)61-55(73)58-35-42-7-6-17-57-34-42/h6-15,17,34,36,39-40,47,49,52,69H,16,18-33,35,37-38H2,1-5H3,(H,60,71)(H,62,70)(H2,58,61,73)/t40-,47+,49-,52+/m0/s1",WGKKCFYLKUUWSZ-YUNFSWSQSA-N
4550,3.9,89,3.9,89,O14965,AURKA,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCOCCOCCOCCNC(=O)[C@]4(CC5=CC=CC(NC6=NC=CS6)=N5)CC[C@@H](OC5=CC=CC(Cl)=C5F)CC4)=C3C2=O)C(=O)N1,Degradation of AURKA in NGP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.115033,893.391,892.2668686,4.58,62,7,14,3,21,196.61,C43H46ClFN6O10S,"InChI=1S/C43H46ClFN6O10S/c44-30-6-3-8-33(37(30)45)61-28-12-14-43(15-13-28,26-27-4-1-9-34(48-27)49-42-47-17-25-62-42)41(56)46-16-18-57-19-20-58-21-22-59-23-24-60-32-7-2-5-29-36(32)40(55)51(39(29)54)31-10-11-35(52)50-38(31)53/h1-9,17,25,28,31H,10-16,18-24,26H2,(H,46,56)(H,47,48,49)(H,50,52,53)/t28-,31?,43-",YDRHAKKUUAJFHB-YCDNTZAYSA-N
4564,2840,62,2840,62,Q13547,HDAC1,VHL,,JMC-137,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3C=C(CCCOC(=O)NCC4=CC=C(C(=O)NC5=CC=CC=C5N)C=C4)N=N3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC 1 in HCT116 cells after 24h treatment,,,1040,Inhibit of HDAC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2md00199c,977.246,976.4993155,6.9,70,6,13,6,24,235.79,C52H68N10O7S,"InChI=1S/C52H68N10O7S/c1-35-46(70-34-56-35)38-23-19-36(20-24-38)30-54-49(66)44-29-41(63)33-62(44)50(67)47(52(2,3)4)58-45(64)18-10-8-6-5-7-9-13-27-61-32-40(59-60-61)15-14-28-69-51(68)55-31-37-21-25-39(26-22-37)48(65)57-43-17-12-11-16-42(43)53/h11-12,16-17,19-26,32,34,41,44,47,63H,5-10,13-15,18,27-31,33,53H2,1-4H3,(H,54,66)(H,55,68)(H,57,65)(H,58,64)/t41-,44+,47-/m1/s1",HWEFEZUTECUWNS-IIWOMYBWSA-N
4567,31.23,77.47,31.23,77.47,O60885,BRD4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)C3C[C@@H](O)CN3C(=O)[C@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,Degradation of BRD4 in MCF-7 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.2c10177,1016.688,1015.38513,5.37,70,7,15,4,20,211.49,C50H62ClN9O8S2,"InChI=1S/C50H62ClN9O8S2/c1-28-31(4)70-49-42(28)43(34-13-15-36(51)16-14-34)55-38(46-58-57-32(5)60(46)49)24-40(62)52-17-18-66-19-20-67-21-22-68-26-41(63)56-45(50(6,7)8)48(65)59-25-37(61)23-39(59)47(64)54-29(2)33-9-11-35(12-10-33)44-30(3)53-27-69-44/h9-16,27,29,37-39,45,61H,17-26H2,1-8H3,(H,52,62)(H,54,64)(H,56,63)/t29-,37+,38-,39?,45-/m0/s1",SLPWRCRRHVRNRM-ANFJVDRGSA-N
4577,38,93,38,93,P00338,LDHA,VHL,,MS6105,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCC(=O)NCCCCC#CC3=CC=CC(C4=NN(C5=NC(C(=O)O)=CS5)C(CC5CC5)=C4CC4=CC=C(S(N)(=O)=O)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of LDHA in PANC1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16100/12200/>13000,Inhibition of cell proliferation of PANC1/MiaPaca2/BxPC3 cells,,,,,,,,,,,10.1021/acs.jmedchem.2c01505,1228.618,1227.531938,11.81,86,8,14,6,30,268.9,C65H81N9O9S3,"InChI=1S/C65H81N9O9S3/c1-43-59(85-42-69-43)48-30-26-47(27-31-48)39-68-61(78)55-38-50(75)40-73(55)62(79)60(65(2,3)4)71-57(77)23-16-11-9-7-5-6-8-10-15-22-56(76)67-34-17-13-12-14-19-44-20-18-21-49(35-44)58-52(36-45-28-32-51(33-29-45)86(66,82)83)54(37-46-24-25-46)74(72-58)64-70-53(41-84-64)63(80)81/h18,20-21,26-33,35,41-42,46,50,55,60,75H,5-13,15-17,22-25,34,36-40H2,1-4H3,(H,67,76)(H,68,78)(H,71,77)(H,80,81)(H2,66,82,83)/t50-,55+,60-/m1/s1",APEYSKGQWJKJAZ-LCLGPXMOSA-N
4577,74,86,74,86,P07195,LDHB,VHL,,MS6105,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCC(=O)NCCCCC#CC3=CC=CC(C4=NN(C5=NC(C(=O)O)=CS5)C(CC5CC5)=C4CC4=CC=C(S(N)(=O)=O)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of LDHB in PANC1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01505,1228.618,1227.531938,11.81,86,8,14,6,30,268.9,C65H81N9O9S3,"InChI=1S/C65H81N9O9S3/c1-43-59(85-42-69-43)48-30-26-47(27-31-48)39-68-61(78)55-38-50(75)40-73(55)62(79)60(65(2,3)4)71-57(77)23-16-11-9-7-5-6-8-10-15-22-56(76)67-34-17-13-12-14-19-44-20-18-21-49(35-44)58-52(36-45-28-32-51(33-29-45)86(66,82)83)54(37-46-24-25-46)74(72-58)64-70-53(41-84-64)63(80)81/h18,20-21,26-33,35,41-42,46,50,55,60,75H,5-13,15-17,22-25,34,36-40H2,1-4H3,(H,67,76)(H,68,78)(H,71,77)(H,80,81)(H2,66,82,83)/t50-,55+,60-/m1/s1",APEYSKGQWJKJAZ-LCLGPXMOSA-N
4601,470,90.21,470,90.21,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(CCCCOC5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,Degradation of HDAC8 in A549 cells,30.6/83.6,% HDAC8 protein degradation in A549 cells at 200/2000 nM for 20 h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7110,Inhibition of cell proliferation of CCK-8 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00739,690.717,690.2550454,2.73,51,7,12,4,13,189.78,C36H34N8O7,"InChI=1S/C36H34N8O7/c45-31-13-12-29(34(47)38-31)44-35(48)27-4-3-5-28(32(27)36(44)49)37-19-25-21-43(41-39-25)15-1-2-17-51-26-10-6-22(7-11-26)20-42-16-14-23-8-9-24(18-30(23)42)33(46)40-50/h3-11,14,16,18,21,29,37,50H,1-2,12-13,15,17,19-20H2,(H,40,46)(H,38,45,47)",SUEXREHSPDZBHX-UHFFFAOYSA-N
4602,620,90.16,620,90.16,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(CCCCCOC5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,Degradation of HDAC8 in A549 cells,39.5/85.9,% HDAC8 protein degradation in A549 cells at 200/2000 nM for 20 h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12520,Inhibition of cell proliferation of CCK-8 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00739,704.744,704.2706955,3.09,52,7,12,4,14,189.78,C37H36N8O7,"InChI=1S/C37H36N8O7/c46-32-14-13-30(35(48)39-32)45-36(49)28-5-4-6-29(33(28)37(45)50)38-20-26-22-44(42-40-26)16-2-1-3-18-52-27-11-7-23(8-12-27)21-43-17-15-24-9-10-25(19-31(24)43)34(47)41-51/h4-12,15,17,19,22,30,38,51H,1-3,13-14,16,18,20-21H2,(H,41,47)(H,39,46,48)",VXKRNJLOBYGLJC-UHFFFAOYSA-N
4604,580,95,580,>95,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(CCOCCOC5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,Degradation of HDAC8 in A549 cells,39.7/85.4,% HDAC8 protein degradation in A549 cells at 200/2000 nM for 20 h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9550,Inhibition of cell proliferation of CCK-8 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00739,706.716,706.24996,1.87,52,7,13,4,14,199.01,C36H34N8O8,"InChI=1S/C36H34N8O8/c45-31-11-10-29(34(47)38-31)44-35(48)27-2-1-3-28(32(27)36(44)49)37-19-25-21-43(41-39-25)14-15-51-16-17-52-26-8-4-22(5-9-26)20-42-13-12-23-6-7-24(18-30(23)42)33(46)40-50/h1-9,12-13,18,21,29,37,50H,10-11,14-17,19-20H2,(H,40,46)(H,38,45,47)",OCXICBCMNKOWFI-UHFFFAOYSA-N
4649,11,94,11,94,Q14145,KEAP1,CRBN,,,CC1=CC=C(C(CC(=O)O)C2=CC(OCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C3C(=C2)N=NN3C)C=C1CN1C[C@@H](C)OC2=CC=CC=C2S1(=O)=O,Degradation of KEAP1 in HEK293T cells after 24h treatment,,,46,Binding affinity of KEAP1-Kelch domain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<0.005,parallel artificial membrane permeability assay,,,,,10.1016/j.redox.2022.102552,906.031,905.3418118,5.89,65,8,13,3,17,219.43,C47H51N7O10S,"InChI=1S/C47H51N7O10S/c1-28-16-17-30(22-32(28)27-53-26-29(2)64-38-14-7-8-15-40(38)65(53,61)62)34(25-42(56)57)31-23-36-44(52(3)51-50-36)39(24-31)63-21-10-6-4-5-9-20-48-35-13-11-12-33-43(35)47(60)54(46(33)59)37-18-19-41(55)49-45(37)58/h7-8,11-17,22-24,29,34,37,48H,4-6,9-10,18-21,25-27H2,1-3H3,(H,56,57)(H,49,55,58)/t29-,34?,37?/m1/s1",WZSDKFOIVKEWJJ-URGMBGNWSA-N
4659,19.39,92.77,19.39,92.77,Q9UBN7,HDAC6,CRBN,,,CC1=NC2=CC(NC(=O)CCCCCCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2N1CC1=CC=C(C(=O)NO)C=C1F,Degradation of HDAC6 in HL-60 cells after 6h treatment,,,4.54,Inhibit of HDAC6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50000/>50000/>50000,Inhibition of cell proliferation of MV4-11/Molm-13/SKNO-1 cells,5500,dose-dependent alpha-tubulin hyperacetylation,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01659,769.787,769.2871541,2.8,56,6,11,5,16,218.13,C39H40FN7O9,"InChI=1S/C39H40FN7O9/c1-22-42-28-19-25(13-14-29(28)46(22)20-24-12-11-23(18-27(24)40)36(51)45-55)43-32(48)10-5-3-2-4-6-17-41-34(50)21-56-31-9-7-8-26-35(31)39(54)47(38(26)53)30-15-16-33(49)44-37(30)52/h7-9,11-14,18-19,30,55H,2-6,10,15-17,20-21H2,1H3,(H,41,50)(H,43,48)(H,45,51)(H,44,49,52)",HFDHVDIXYSXIRN-UHFFFAOYSA-N
4679,,,>10000,<50,P11802,CDK4,VHL,,MS28,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Calu-1 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1000/750,Inhibition of cell proliferation of Calu-1/NCI-H2110 cells,,,,,,,,,,,10.1021/jacs.2c09255,1002.256,1001.494564,4.95,72,8,15,4,17,224.95,C53H67N11O7S,"InChI=1S/C53H67N11O7S/c1-32-40-29-56-52(60-48(40)64(37-12-10-11-13-37)50(70)45(32)34(3)65)58-42-21-20-38(28-54-42)61-22-24-62(25-23-61)44(68)15-9-7-8-14-43(67)59-47(53(4,5)6)51(71)63-30-39(66)26-41(63)49(69)55-27-35-16-18-36(19-17-35)46-33(2)57-31-72-46/h16-21,28-29,31,37,39,41,47,66H,7-15,22-27,30H2,1-6H3,(H,55,69)(H,59,67)(H,54,56,58,60)/t39-,41+,47-/m1/s1",MWVNDEBEHBRZEC-WWTLGBROSA-N
4679,,,>10000,<50,Q00534,CDK6,VHL,,MS28,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Calu-1 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.2c09255,1002.256,1001.494564,4.95,72,8,15,4,17,224.95,C53H67N11O7S,"InChI=1S/C53H67N11O7S/c1-32-40-29-56-52(60-48(40)64(37-12-10-11-13-37)50(70)45(32)34(3)65)58-42-21-20-38(28-54-42)61-22-24-62(25-23-61)44(68)15-9-7-8-14-43(67)59-47(53(4,5)6)51(71)63-30-39(66)26-41(63)49(69)55-27-35-16-18-36(19-17-35)46-33(2)57-31-72-46/h16-21,28-29,31,37,39,41,47,66H,7-15,22-27,30H2,1-6H3,(H,55,69)(H,59,67)(H,54,56,58,60)/t39-,41+,47-/m1/s1",MWVNDEBEHBRZEC-WWTLGBROSA-N
4687,8.4,99,8.4,,P43490,NAMPT,VHL,,,CCCN1C(=O)C(C2=CC=C(C(=O)NCC3=CC=CN=C3)C=C2)=NC2=CC=C(NC(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=C21,Degradation of NAMPT in A2780 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12.1,Inhibition of cell growth of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01243,1052.356,1051.535367,8.62,76,7,12,5,24,217.61,C59H73N9O7S,"InChI=1S/C59H73N9O7S/c1-7-31-67-48-32-45(28-29-47(48)65-52(57(67)74)42-22-26-44(27-23-42)55(72)61-35-40-17-16-30-60-34-40)64-50(70)18-14-12-10-8-9-11-13-15-19-51(71)66-54(59(4,5)6)58(75)68-36-46(69)33-49(68)56(73)63-38(2)41-20-24-43(25-21-41)53-39(3)62-37-76-53/h16-17,20-30,32,34,37-38,46,49,54,69H,7-15,18-19,31,33,35-36H2,1-6H3,(H,61,72)(H,63,73)(H,64,70)(H,66,71)/t38-,46+,49-,54+/m0/s1",MLJZDBCOWWJHEE-LPLKMGJNSA-N
4715,230,77,230,77,P29597,TYK2,VHL,,,CNC(=O)C1=CN=C(NC2=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C(=O)NC)=C1OC,Degradation of TYK2 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1032.282,1031.505129,7.14,74,6,14,8,24,258,C54H69N11O8S,"InChI=1S/C54H69N11O8S/c1-33-47(74-32-61-33)35-21-19-34(20-22-35)28-60-52(71)42-26-37(66)31-65(42)53(72)48(54(2,3)4)64-45(67)18-13-11-9-8-10-12-14-25-57-49(68)36-23-24-43(58-29-36)63-44-27-41(39(30-59-44)51(70)56-6)62-40-17-15-16-38(46(40)73-7)50(69)55-5/h15-17,19-24,27,29-30,32,37,42,48,66H,8-14,18,25-26,28,31H2,1-7H3,(H,55,69)(H,56,70)(H,57,68)(H,60,71)(H,64,67)(H2,58,59,62,63)/t37-,42+,48-/m1/s1",GGLGXBGGASXSIW-GPPJZCFZSA-N
4718,23,85,23,85,P29597,TYK2,VHL,,,CNC(=O)C1=CC=CC(NC2=CC(NC3=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=N3)=NC=C2C(N)=O)=C1OC,Degradation of TYK2 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1018.255,1017.489479,6.74,73,6,14,8,24,271.99,C53H67N11O8S,"InChI=1S/C53H67N11O8S/c1-32-46(73-31-60-32)34-20-18-33(19-21-34)27-59-51(70)41-25-36(65)30-64(41)52(71)47(53(2,3)4)63-44(66)17-12-10-8-7-9-11-13-24-56-49(68)35-22-23-42(57-28-35)62-43-26-40(38(29-58-43)48(54)67)61-39-16-14-15-37(45(39)72-6)50(69)55-5/h14-16,18-23,26,28-29,31,36,41,47,65H,7-13,17,24-25,27,30H2,1-6H3,(H2,54,67)(H,55,69)(H,56,68)(H,59,70)(H,63,66)(H2,57,58,61,62)/t36-,41+,47-/m1/s1",QYKZIZGHSUMTGL-FGUOTCRGSA-N
4718,1095,49,1095,49,P23458,JAK1,VHL,,,CNC(=O)C1=CC=CC(NC2=CC(NC3=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=N3)=NC=C2C(N)=O)=C1OC,Degradation of JAK1 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1018.255,1017.489479,6.74,73,6,14,8,24,271.99,C53H67N11O8S,"InChI=1S/C53H67N11O8S/c1-32-46(73-31-60-32)34-20-18-33(19-21-34)27-59-51(70)41-25-36(65)30-64(41)52(71)47(53(2,3)4)63-44(66)17-12-10-8-7-9-11-13-24-56-49(68)35-22-23-42(57-28-35)62-43-26-40(38(29-58-43)48(54)67)61-39-16-14-15-37(45(39)72-6)50(69)55-5/h14-16,18-23,26,28-29,31,36,41,47,65H,7-13,17,24-25,27,30H2,1-6H3,(H2,54,67)(H,55,69)(H,56,68)(H,59,70)(H,63,66)(H2,57,58,61,62)/t36-,41+,47-/m1/s1",QYKZIZGHSUMTGL-FGUOTCRGSA-N
4719,14,78,14,78,P29597,TYK2,VHL,,,CNC(=O)C1=CN=C(NC2=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,Degradation of TYK2 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1056.308,1055.516363,7.61,76,7,16,7,24,259.61,C55H69N13O7S,"InChI=1S/C55H69N13O7S/c1-34-48(76-33-62-34)36-21-19-35(20-22-36)28-60-53(73)43-26-38(69)31-68(43)54(74)49(55(2,3)4)65-46(70)18-13-11-9-8-10-12-14-25-57-51(71)37-23-24-44(58-29-37)64-45-27-42(40(30-59-45)52(72)56-5)63-41-17-15-16-39(47(41)75-7)50-61-32-67(6)66-50/h15-17,19-24,27,29-30,32-33,38,43,49,69H,8-14,18,25-26,28,31H2,1-7H3,(H,56,72)(H,57,71)(H,60,73)(H,65,70)(H2,58,59,63,64)/t38-,43+,49-/m1/s1",ZQBPERKIXUCCNQ-DXGZDBETSA-N
4719,,,>10000,25,P23458,JAK1,VHL,,,CNC(=O)C1=CN=C(NC2=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,Degradation of JAK1 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1056.308,1055.516363,7.61,76,7,16,7,24,259.61,C55H69N13O7S,"InChI=1S/C55H69N13O7S/c1-34-48(76-33-62-34)36-21-19-35(20-22-36)28-60-53(73)43-26-38(69)31-68(43)54(74)49(55(2,3)4)65-46(70)18-13-11-9-8-10-12-14-25-57-51(71)37-23-24-44(58-29-37)64-45-27-42(40(30-59-45)52(72)56-5)63-41-17-15-16-39(47(41)75-7)50-61-32-67(6)66-50/h15-17,19-24,27,29-30,32-33,38,43,49,69H,8-14,18,25-26,28,31H2,1-7H3,(H,56,72)(H,57,71)(H,60,73)(H,65,70)(H2,58,59,63,64)/t38-,43+,49-/m1/s1",ZQBPERKIXUCCNQ-DXGZDBETSA-N
4733,329,99,329/543.8,,P14902,IDO1,CRBN,,,C[C@@H](C(=O)NC1=CC=C(OC2CCN(C(=O)CCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)C=C1)[C@H]1CC[C@@H](C2=CC=NC3=CC=C(F)C=C32)CC1,Degradation of IDO1 in U87/GBM43 cells after 24h treatment,94,% IDO1 protein degradation in U87 cells at 10000 nM for 24 h,,,,,640,Binding affinity of IDO1,,,,,,,68900,0.042,16,BLI,,,,,290,Binding affinity of CRBN,,,,,,,,,,,,,,,,,,,,,,,12800,0.0015,462,BLI,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00771,891.01,890.4014556,6.01,65,8,11,3,17,185.57,C49H55FN6O9,"InChI=1S/C49H55FN6O9/c1-30(31-5-7-32(8-6-31)37-17-21-51-40-14-9-33(50)29-39(37)40)46(59)53-34-10-12-35(13-11-34)65-36-18-23-55(24-19-36)44(58)20-25-63-27-28-64-26-22-52-41-4-2-3-38-45(41)49(62)56(48(38)61)42-15-16-43(57)54-47(42)60/h2-4,9-14,17,21,29-32,36,42,52H,5-8,15-16,18-20,22-28H2,1H3,(H,53,59)(H,54,57,60)/t30-,31-,32+,42?/m1/s1",PLYOHMQINGIYDN-MXPGEODHSA-N
4836,0.1,99,0.1,,Q06187,BTK,CRBN,,,CN1CCN([C@@H]2CCCN(C3=CN=C(C(N)=O)C(NC4=CC=C(C5CCN(C[C@H]6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)C6)CC5)C=C4)=N3)C2)C1=O,Degradation of BTK in TMD8 cells after 4h treatment,,,1.2,FRET,,,,,,,,,,,,,,,9,FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1182/blood.2022016934,817.952,817.4023784,2.7,60,9,12,3,10,197.72,C43H51N11O6,"InChI=1S/C43H51N11O6/c1-49-19-20-53(43(49)60)31-3-2-15-52(25-31)35-22-45-37(38(44)56)39(47-35)46-29-6-4-27(5-7-29)28-13-16-50(17-14-28)23-26-12-18-51(24-26)30-8-9-32-33(21-30)42(59)54(41(32)58)34-10-11-36(55)48-40(34)57/h4-9,21-22,26,28,31,34H,2-3,10-20,23-25H2,1H3,(H2,44,56)(H,46,47)(H,48,55,57)/t26-,31-,34?/m1/s1",WFDYOAWNEOGIPM-WYRFSKNSSA-N
4836,0.2,99,0.2,,Q06187,BTK C481S,CRBN,,,CN1CCN([C@@H]2CCCN(C3=CN=C(C(N)=O)C(NC4=CC=C(C5CCN(C[C@H]6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)C6)CC5)C=C4)=N3)C2)C1=O,Degradation of BTK C481S in TMD8 cells after 4h treatment,,,2.7,FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1182/blood.2022016934,817.952,817.4023784,2.7,60,9,12,3,10,197.72,C43H51N11O6,"InChI=1S/C43H51N11O6/c1-49-19-20-53(43(49)60)31-3-2-15-52(25-31)35-22-45-37(38(44)56)39(47-35)46-29-6-4-27(5-7-29)28-13-16-50(17-14-28)23-26-12-18-51(24-26)30-8-9-32-33(21-30)42(59)54(41(32)58)34-10-11-36(55)48-40(34)57/h4-9,21-22,26,28,31,34H,2-3,10-20,23-25H2,1H3,(H2,44,56)(H,46,47)(H,48,55,57)/t26-,31-,34?/m1/s1",WFDYOAWNEOGIPM-WYRFSKNSSA-N
4837,0.039,99,0.039,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.58/6.5 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1121.423,1120.568064,7.46,81,12,18,4,17,224.9,C61H76N12O7S,"InChI=1S/C61H76N12O7S/c1-36(2)57(61(77)72-34-45(74)26-52(72)60(76)65-37(3)40-9-11-41(12-10-40)58-38(4)64-35-81-58)54-30-55(68-80-54)70-23-16-39(17-24-70)31-69-21-18-46(19-22-69)78-47-27-48(28-47)79-56-25-42(15-20-63-56)73-43-13-14-44(73)33-71(32-43)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)75/h5-12,15,20,25,29-30,35-37,39,43-48,52,57,74-75H,13-14,16-19,21-24,26-28,31-34H2,1-4H3,(H2,62,67)(H,65,76)/t37-,43?,44?,45+,47-,48-,52-,57+/m0/s1",QQVCUSPUMMUFTD-JBVRKRIASA-N
4837,0.039,96,0.039,96,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 20h treatment,,,,,,,93,Binding affinity of SMARCA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-34562-5,1121.423,1120.568064,7.46,81,12,18,4,17,224.9,C61H76N12O7S,"InChI=1S/C61H76N12O7S/c1-36(2)57(61(77)72-34-45(74)26-52(72)60(76)65-37(3)40-9-11-41(12-10-40)58-38(4)64-35-81-58)54-30-55(68-80-54)70-23-16-39(17-24-70)31-69-21-18-46(19-22-69)78-47-27-48(28-47)79-56-25-42(15-20-63-56)73-43-13-14-44(73)33-71(32-43)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)75/h5-12,15,20,25,29-30,35-37,39,43-48,52,57,74-75H,13-14,16-19,21-24,26-28,31-34H2,1-4H3,(H2,62,67)(H,65,76)/t37-,43?,44?,45+,47-,48-,52-,57+/m0/s1",QQVCUSPUMMUFTD-JBVRKRIASA-N
4837,1.1,99,1.1,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1121.423,1120.568064,7.46,81,12,18,4,17,224.9,C61H76N12O7S,"InChI=1S/C61H76N12O7S/c1-36(2)57(61(77)72-34-45(74)26-52(72)60(76)65-37(3)40-9-11-41(12-10-40)58-38(4)64-35-81-58)54-30-55(68-80-54)70-23-16-39(17-24-70)31-69-21-18-46(19-22-69)78-47-27-48(28-47)79-56-25-42(15-20-63-56)73-43-13-14-44(73)33-71(32-43)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)75/h5-12,15,20,25,29-30,35-37,39,43-48,52,57,74-75H,13-14,16-19,21-24,26-28,31-34H2,1-4H3,(H2,62,67)(H,65,76)/t37-,43?,44?,45+,47-,48-,52-,57+/m0/s1",QQVCUSPUMMUFTD-JBVRKRIASA-N
4837,1.1,92,1.1,92,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 20h treatment,,,,,,,65,Binding affinity of SMARCA4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-34562-5,1121.423,1120.568064,7.46,81,12,18,4,17,224.9,C61H76N12O7S,"InChI=1S/C61H76N12O7S/c1-36(2)57(61(77)72-34-45(74)26-52(72)60(76)65-37(3)40-9-11-41(12-10-40)58-38(4)64-35-81-58)54-30-55(68-80-54)70-23-16-39(17-24-70)31-69-21-18-46(19-22-69)78-47-27-48(28-47)79-56-25-42(15-20-63-56)73-43-13-14-44(73)33-71(32-43)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)75/h5-12,15,20,25,29-30,35-37,39,43-48,52,57,74-75H,13-14,16-19,21-24,26-28,31-34H2,1-4H3,(H2,62,67)(H,65,76)/t37-,43?,44?,45+,47-,48-,52-,57+/m0/s1",QQVCUSPUMMUFTD-JBVRKRIASA-N
4868,97.1,88,97.1,88,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC(=O)NCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,771.256,770.2037941,2.87,54,7,12,3,11,194.05,C37H35ClN8O7S,"InChI=1S/C37H35ClN8O7S/c1-18-19(2)54-37-30(18)32(21-8-10-22(38)11-9-21)41-24(33-44-43-20(3)45(33)37)16-28(48)40-17-29(49)39-14-5-15-53-26-7-4-6-23-31(26)36(52)46(35(23)51)25-12-13-27(47)42-34(25)50/h4,6-11,24-25H,5,12-17H2,1-3H3,(H,39,49)(H,40,48)(H,42,47,50)/t24-,25?/m0/s1",FZPFOKCSBXRUCY-SKCDSABHSA-N
4869,134,79,134,79,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC(=O)NCCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,785.283,784.2194442,3.22,55,7,12,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)41-18-30(50)40-15-4-5-16-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,50)(H,41,49)(H,43,48,51)/t25-,26?/m0/s1",DZBLWYQPZXUQGG-PMCHYTPCSA-N
4870,184,86,184,86,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC(=O)NCCCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,799.31,798.2350943,3.58,56,7,12,3,13,194.05,C39H39ClN8O7S,"InChI=1S/C39H39ClN8O7S/c1-20-21(2)56-39-32(20)34(23-10-12-24(40)13-11-23)43-26(35-46-45-22(3)47(35)39)18-30(50)42-19-31(51)41-16-5-4-6-17-55-28-9-7-8-25-33(28)38(54)48(37(25)53)27-14-15-29(49)44-36(27)52/h7-13,26-27H,4-6,14-19H2,1-3H3,(H,41,51)(H,42,50)(H,44,49,52)/t26-,27?/m0/s1",ILDJWQYNDNRRFS-QBHOUYDASA-N
4873,239,81,239,81,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(CC(=O)NCCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,840.363,839.2616434,2.86,59,8,13,2,11,188.5,C41H42ClN9O7S,"InChI=1S/C41H42ClN9O7S/c1-22-23(2)59-41-34(22)36(25-8-10-26(42)11-9-25)44-28(37-47-46-24(3)50(37)41)20-33(54)49-17-15-48(16-18-49)21-32(53)43-14-5-19-58-30-7-4-6-27-35(30)40(57)51(39(27)56)29-12-13-31(52)45-38(29)55/h4,6-11,28-29H,5,12-21H2,1-3H3,(H,43,53)(H,45,52,55)/t28-,29?/m0/s1",ITDXUECDKFMKGU-XLTVJXRZSA-N
4874,89.9,78,89.9,78,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(CC(=O)NCCCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,854.39,853.2772934,3.22,60,8,13,2,12,188.5,C42H44ClN9O7S,"InChI=1S/C42H44ClN9O7S/c1-23-24(2)60-42-35(23)37(26-9-11-27(43)12-10-26)45-29(38-48-47-25(3)51(38)42)21-34(55)50-18-16-49(17-19-50)22-33(54)44-15-4-5-20-59-31-8-6-7-28-36(31)41(58)52(40(28)57)30-13-14-32(53)46-39(30)56/h6-12,29-30H,4-5,13-22H2,1-3H3,(H,44,54)(H,46,53,56)/t29-,30?/m0/s1",LAECKGLWOSIZEO-UFXYQILXSA-N
4875,60,94,60,94,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(CC(=O)NCCCCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,868.417,867.2929435,3.57,61,8,13,2,13,188.5,C43H46ClN9O7S,"InChI=1S/C43H46ClN9O7S/c1-24-25(2)61-43-36(24)38(27-10-12-28(44)13-11-27)46-30(39-49-48-26(3)52(39)43)22-35(56)51-19-17-50(18-20-51)23-34(55)45-16-5-4-6-21-60-32-9-7-8-29-37(32)42(59)53(41(29)58)31-14-15-33(54)47-40(31)57/h7-13,30-31H,4-6,14-23H2,1-3H3,(H,45,55)(H,47,54,57)/t30-,31?/m0/s1",SDWUURRMSCHVOR-FSRLHOSWSA-N
4878,62,86,62,86,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OCC(=O)NCCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,786.267,785.2034598,3.8,55,7,13,2,12,191.25,C38H36ClN7O8S,"InChI=1S/C38H36ClN7O8S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)41-25(34-44-43-21(3)45(34)38)17-30(49)54-18-29(48)40-15-4-5-16-53-27-8-6-7-24-32(27)37(52)46(36(24)51)26-13-14-28(47)42-35(26)50/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,48)(H,42,47,50)/t25-,26?/m0/s1",PLVCAPPHMNXCHP-PMCHYTPCSA-N
4884,1.443,57.4,1.443,57.4,P43490,NAMPT,CRBN,,,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(C(=O)CCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,830.987,830.4115461,4.19,61,7,10,3,16,181.43,C46H54N8O7,"InChI=1S/C46H54N8O7/c55-39(18-12-33-8-6-22-47-31-33)49-24-3-1-7-32-20-25-53(26-21-32)44(59)34-13-15-35(16-14-34)51-27-29-52(30-28-51)41(57)11-2-4-23-48-37-10-5-9-36-42(37)46(61)54(45(36)60)38-17-19-40(56)50-43(38)58/h5-6,8-10,12-16,18,22,31-32,38,48H,1-4,7,11,17,19-21,23-30H2,(H,49,55)(H,50,56,58)/b18-12+",ZCFIVZIHMGWOER-LDADJPATSA-N
4885,1,74.9,<1,74.9,P43490,NAMPT,CRBN,,,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(C(=O)CCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,859.041,858.4428462,5.09,63,7,10,3,18,181.43,C48H58N8O7,"InChI=1S/C48H58N8O7/c57-41(20-14-35-10-8-24-49-33-35)51-26-6-4-9-34-22-27-55(28-23-34)46(61)36-15-17-37(18-16-36)53-29-31-54(32-30-53)43(59)13-3-1-2-5-25-50-39-12-7-11-38-44(39)48(63)56(47(38)62)40-19-21-42(58)52-45(40)60/h7-8,10-12,14-18,20,24,33-34,40,50H,1-6,9,13,19,21-23,25-32H2,(H,51,57)(H,52,58,60)/b20-14+",GFYHVYLOXRVHDM-XSFVSMFZSA-N
4891,5.85,73.4,5.85,73.4,P43490,NAMPT,CRBN,,,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(C(=O)CCCCCCNC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,845.058,844.4635816,4.59,62,7,9,3,18,164.36,C48H60N8O6,"InChI=1S/C48H60N8O6/c57-43(20-14-36-10-8-24-49-33-36)51-26-6-4-9-35-22-27-55(28-23-35)47(61)37-15-17-38(18-16-37)53-29-31-54(32-30-53)45(59)13-3-1-2-5-25-50-41-12-7-11-39-40(41)34-56(48(39)62)42-19-21-44(58)52-46(42)60/h7-8,10-12,14-18,20,24,33,35,42,50H,1-6,9,13,19,21-23,25-32,34H2,(H,51,57)(H,52,58,60)/b20-14+",KBASXKZKMMUHSI-XSFVSMFZSA-N
4892,1,93.3,<1,93.3,P43490,NAMPT,CRBN,,SIAIS630120,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(CCCCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.456/8.565/2.964,Degradation potency of endogenous NAMPT protein in Jurkat cells/ CTG luminescent cell viability assay in  HL60 and MOLT4 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,812.028,811.4421179,5.51,60,7,8,2,15,135.26,C48H57N7O5,"InChI=1S/C48H57N7O5/c56-44(21-15-37-11-9-25-49-34-37)50-26-6-5-10-36-23-28-54(29-24-36)47(59)39-16-18-40(19-17-39)53-32-30-52(31-33-53)27-7-3-1-2-4-12-38-13-8-14-41-42(38)35-55(48(41)60)43-20-22-45(57)51-46(43)58/h8-9,11,13-19,21,25,34,36,43H,1-3,5-7,10,20,22-24,26-33,35H2,(H,50,56)(H,51,57,58)/b21-15+",MQVBARDYXLTACJ-RCCKNPSSSA-N
4893,1,92.5,<1,92.5,P43490,NAMPT,CRBN,,SIAIS630121,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(CCCCCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.968/8.497/4.681,Degradation potency of endogenous NAMPT protein in Jurkat cells/ CTG luminescent cell viability assay in  HL60 and MOLT4 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,826.055,825.457768,6.05,61,7,8,2,16,135.26,C49H59N7O5,"InChI=1S/C49H59N7O5/c57-45(22-16-38-12-10-26-50-35-38)51-27-7-6-11-37-24-29-55(30-25-37)48(60)40-17-19-41(20-18-40)54-33-31-53(32-34-54)28-8-4-2-1-3-5-13-39-14-9-15-42-43(39)36-56(49(42)61)44-21-23-46(58)52-47(44)59/h9-10,12,14-20,22,26,35,37,44H,1-4,6-8,11,21,23-25,27-34,36H2,(H,51,57)(H,52,58,59)/b22-16+",JTTGVFCANBFLCE-CJLVFECKSA-N
4934,2.7,91.2,2.7,91.2,,BCR-ABL,CRBN,,SIAIS100,O=C1CCC(N2CC3=C(SCCCCCCN4CCN(C5CCN(C6=NC=C(C(=O)NC7=CC=C(OC(F)(F)Cl)C=C7)C=C6C6=CC=N[NH]6)CC5)CC4)C=CC=C3C2=O)C(=O)N1,Degradation of BCR-ABL in K562 cells after 16h treatment,81.78/91.20,% BCR-ABL protein degradation in K562 cells at 5/100 nM,,,,,4740,Binding affinity with ABL recombinant protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12,Inhibition of cell proliferation of K562 cells,,,,,,,,,,,0.11,Permeation of the test compounds from A to B direction in Coca-2 was determined,1.03,Permeation of the test compounds from B to A direction in Coca-2 was determined,10.1016/j.ejmech.2022.114810,890.458,889.3312208,5.82,62,8,11,3,16,156.1,C44H50ClF2N9O5S,"InChI=1S/C44H50ClF2N9O5S/c45-44(46,47)61-32-10-8-30(9-11-32)50-41(58)29-26-34(36-14-17-49-52-36)40(48-27-29)55-19-15-31(16-20-55)54-23-21-53(22-24-54)18-3-1-2-4-25-62-38-7-5-6-33-35(38)28-56(43(33)60)37-12-13-39(57)51-42(37)59/h5-11,14,17,26-27,31,37H,1-4,12-13,15-16,18-25,28H2,(H,49,52)(H,50,58)(H,51,57,59)",QRGISIMVAZWDHL-UHFFFAOYSA-N
4970,4.56,99,4.56,,Q06187,BTK,CRBN,,UBX-382,CC1=CC=CC(C)=C1NC1=NN(C)C2=NC(NC3=CC=C4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4=C3)=NC=C12,Degradation of BTK in TMD-8 cells after 24h treatment,,,6.312,FRET,,,,,,,,,,,,,,,5.511,FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14/18/199,Inhibition of cell proliferation of TMD-8/WSU-DLCL2/OCI-Ly3 cells,,,,,,,,,,,,,,,10.1182/bloodadvances.2022008121,752.88,752.3546999,5.3,56,9,12,3,8,157.69,C42H44N10O4,"InChI=1S/C42H44N10O4/c1-24-5-4-6-25(2)36(24)46-37-33-21-43-42(47-38(33)49(3)48-37)44-29-8-7-27-15-16-50(23-28(27)19-29)22-26-13-17-51(18-14-26)30-9-10-31-32(20-30)41(56)52(40(31)55)34-11-12-35(53)45-39(34)54/h4-10,19-21,26,34H,11-18,22-23H2,1-3H3,(H,46,48)(H,43,44,47)(H,45,53,54)",WIAKHDZSMZDZQL-UHFFFAOYSA-N
4971,280,77,280,77,O60885,BRD4,CRBN,,dBRD4-BD1,CC1=CC=C(C(C)C)C=C1OC1=NC=CC(C2=C(C3=CC=C(C(F)(F)F)C=C3)N=CN2C2CCN(CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,Degradation of BRD4 in MM.1S cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00300,967.015,966.3887599,5.31,70,8,14,2,19,196.41,C50H53F3N8O9,"InChI=1S/C50H53F3N8O9/c1-30(2)33-8-7-31(3)40(27-33)70-49-55-18-15-37(57-49)45-44(32-9-11-34(12-10-32)50(51,52)53)56-29-60(45)35-16-20-59(21-17-35)22-24-68-26-25-67-23-19-54-42(63)28-69-39-6-4-5-36-43(39)48(66)61(47(36)65)38-13-14-41(62)58-46(38)64/h4-12,15,18,27,29-30,35,38H,13-14,16-17,19-26,28H2,1-3H3,(H,54,63)(H,58,62,64)",JNAQDGFRVGMPDL-UHFFFAOYSA-N
4995,330,62.6,330,62.6,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10090/46830/13040,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1074.2,1073.419349,6.75,77,8,12,7,18,245.43,C55H58F3N11O7S,"InChI=1S/C55H58F3N11O7S/c1-31-10-18-39(23-42(31)55(56,57)58)63-47(73)29-68-27-37(26-61-68)36-17-21-41-43(22-36)66-67-50(41)65-51(74)35-15-19-38(20-16-35)62-45(71)8-6-7-9-46(72)64-49(54(3,4)5)53(76)69-28-40(70)24-44(69)52(75)59-25-33-11-13-34(14-12-33)48-32(2)60-30-77-48/h10-23,26-27,30,40,44,49,70H,6-9,24-25,28-29H2,1-5H3,(H,59,75)(H,62,71)(H,63,73)(H,64,72)(H2,65,66,67,74)/t40-,44+,49-/m1/s1",XYPXCLNICDKSPC-VINRIKPSSA-N
4996,,,3330,N.D.,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7260/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1088.227,1087.434999,7.3,78,8,12,7,19,245.43,C56H60F3N11O7S,"InChI=1S/C56H60F3N11O7S/c1-32-11-19-40(24-43(32)56(57,58)59)64-48(74)30-69-28-38(27-62-69)37-18-22-42-44(23-37)67-68-51(42)66-52(75)36-16-20-39(21-17-36)63-46(72)9-7-6-8-10-47(73)65-50(55(3,4)5)54(77)70-29-41(71)25-45(70)53(76)60-26-34-12-14-35(15-13-34)49-33(2)61-31-78-49/h11-24,27-28,31,41,45,50,71H,6-10,25-26,29-30H2,1-5H3,(H,60,76)(H,63,72)(H,64,74)(H,65,73)(H2,66,67,68,75)/t41-,45+,50-/m1/s1",POPKVZNHGKPLMU-VTRKIVCCSA-N
4997,280,48,280,48,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4360/17870/4130,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1102.254,1101.450649,7.84,79,8,12,7,20,245.43,C57H62F3N11O7S,"InChI=1S/C57H62F3N11O7S/c1-33-12-20-41(25-44(33)57(58,59)60)65-49(75)31-70-29-39(28-63-70)38-19-23-43-45(24-38)68-69-52(43)67-53(76)37-17-21-40(22-18-37)64-47(73)10-8-6-7-9-11-48(74)66-51(56(3,4)5)55(78)71-30-42(72)26-46(71)54(77)61-27-35-13-15-36(16-14-35)50-34(2)62-32-79-50/h12-25,28-29,32,42,46,51,72H,6-11,26-27,30-31H2,1-5H3,(H,61,77)(H,64,73)(H,65,75)(H,66,74)(H2,67,68,69,76)/t42-,46+,51-/m1/s1",WLTPLZGGRXBLKV-DRHKINIBSA-N
4998,,,>3330,13.5,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10720/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1116.281,1115.466299,8.38,80,8,12,7,21,245.43,C58H64F3N11O7S,"InChI=1S/C58H64F3N11O7S/c1-34-13-21-42(26-45(34)58(59,60)61)66-50(76)32-71-30-40(29-64-71)39-20-24-44-46(25-39)69-70-53(44)68-54(77)38-18-22-41(23-19-38)65-48(74)11-9-7-6-8-10-12-49(75)67-52(57(3,4)5)56(79)72-31-43(73)27-47(72)55(78)62-28-36-14-16-37(17-15-36)51-35(2)63-33-80-51/h13-26,29-30,33,43,47,52,73H,6-12,27-28,31-32H2,1-5H3,(H,62,78)(H,65,74)(H,66,76)(H,67,75)(H2,68,69,70,77)/t43-,47+,52-/m1/s1",NFWQAJIASJIBNX-ORZXESOZSA-N
4999,84,73.7,84/510,73.7/76.6,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2030/14470/7070,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1130.308,1129.481949,8.92,81,8,12,7,22,245.43,C59H66F3N11O7S,"InChI=1S/C59H66F3N11O7S/c1-35-14-22-43(27-46(35)59(60,61)62)67-51(77)33-72-31-41(30-65-72)40-21-25-45-47(26-40)70-71-54(45)69-55(78)39-19-23-42(24-20-39)66-49(75)12-10-8-6-7-9-11-13-50(76)68-53(58(3,4)5)57(80)73-32-44(74)28-48(73)56(79)63-29-37-15-17-38(18-16-37)52-36(2)64-34-81-52/h14-27,30-31,34,44,48,53,74H,6-13,28-29,32-33H2,1-5H3,(H,63,79)(H,66,75)(H,67,77)(H,68,76)(H2,69,70,71,78)/t44-,48+,53-/m1/s1",OMBFZCSGOOTQOG-WDXSTBBASA-N
5001,890,42.9,890,42.9,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5130/9450/17630,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1158.362,1157.513249,10,83,8,12,7,24,245.43,C61H70F3N11O7S,"InChI=1S/C61H70F3N11O7S/c1-37-16-24-45(29-48(37)61(62,63)64)69-53(79)35-74-33-43(32-67-74)42-23-27-47-49(28-42)72-73-56(47)71-57(80)41-21-25-44(26-22-41)68-51(77)14-12-10-8-6-7-9-11-13-15-52(78)70-55(60(3,4)5)59(82)75-34-46(76)30-50(75)58(81)65-31-39-17-19-40(20-18-39)54-38(2)66-36-83-54/h16-29,32-33,36,46,50,55,76H,6-15,30-31,34-35H2,1-5H3,(H,65,81)(H,68,77)(H,69,79)(H,70,78)(H2,71,72,73,80)/t46-,50+,55-/m1/s1",VRDKRKMMGPZFND-KVDJATBYSA-N
5003,640,38.5,640,38.5,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCC(=O)N6CCN(CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27/HUVEC cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23860/38680/9360,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1242.44,1241.545612,6.71,89,9,14,7,23,268.98,C64H74F3N13O8S,"InChI=1S/C64H74F3N13O8S/c1-39-13-21-47(31-50(39)64(65,66)67)72-55(84)37-79-35-45(34-70-79)44-20-24-49-51(30-44)75-76-59(49)74-60(86)43-18-22-46(23-19-43)71-53(82)10-6-7-12-56(85)78-28-26-77(27-29-78)25-9-8-11-54(83)73-58(63(3,4)5)62(88)80-36-48(81)32-52(80)61(87)68-33-41-14-16-42(17-15-41)57-40(2)69-38-89-57/h13-24,30-31,34-35,38,48,52,58,81H,6-12,25-29,32-33,36-37H2,1-5H3,(H,68,87)(H,71,82)(H,72,84)(H,73,83)(H2,74,75,76,86)/t48-,52+,58-/m1/s1",CYKIHYPQZUDKDD-PZCJAATJSA-N
5005,,,>3330,31,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCC(=O)N6CCN(CCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20390/24140/29620,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1270.494,1269.576912,7.61,91,9,14,7,25,268.98,C66H78F3N13O8S,"InChI=1S/C66H78F3N13O8S/c1-41-15-23-49(33-52(41)66(67,68)69)74-57(86)39-81-37-47(36-72-81)46-22-26-51-53(32-46)77-78-61(51)76-62(88)45-20-24-48(25-21-45)73-55(84)13-9-10-14-58(87)80-30-28-79(29-31-80)27-11-7-6-8-12-56(85)75-60(65(3,4)5)64(90)82-38-50(83)34-54(82)63(89)70-35-43-16-18-44(19-17-43)59-42(2)71-40-91-59/h15-26,32-33,36-37,40,50,54,60,83H,6-14,27-31,34-35,38-39H2,1-5H3,(H,70,89)(H,73,84)(H,74,86)(H,75,85)(H2,76,77,78,88)/t50-,54+,60-/m1/s1",SVVPYQZZEPKRFE-DWIBGWASSA-N
5007,,,>3330,8.7,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50000/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1115.297,1114.482283,7.58,80,9,13,6,18,222.81,C58H65F3N12O6S,"InChI=1S/C58H65F3N12O6S/c1-35-9-17-42(27-46(35)58(59,60)61)65-50(76)33-72-31-41(30-64-72)40-16-20-45-47(26-40)68-69-53(45)67-54(77)39-14-18-43(19-15-39)71-24-22-70(23-25-71)21-7-6-8-49(75)66-52(57(3,4)5)56(79)73-32-44(74)28-48(73)55(78)62-29-37-10-12-38(13-11-37)51-36(2)63-34-80-51/h9-20,26-27,30-31,34,44,48,52,74H,6-8,21-25,28-29,32-33H2,1-5H3,(H,62,78)(H,65,76)(H,66,75)(H2,67,68,69,77)/t44-,48+,52-/m1/s1",AMUZAYCPNSMZKI-CPKYMOPRSA-N
5009,,,>3330,38.2,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(CCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5500/38610/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1143.351,1142.513584,8.48,82,9,13,6,20,222.81,C60H69F3N12O6S,"InChI=1S/C60H69F3N12O6S/c1-37-11-19-44(29-48(37)60(61,62)63)67-52(78)35-74-33-43(32-66-74)42-18-22-47-49(28-42)70-71-55(47)69-56(79)41-16-20-45(21-17-41)73-26-24-72(25-27-73)23-9-7-6-8-10-51(77)68-54(59(3,4)5)58(81)75-34-46(76)30-50(75)57(80)64-31-39-12-14-40(15-13-39)53-38(2)65-36-82-53/h11-22,28-29,32-33,36,46,50,54,76H,6-10,23-27,30-31,34-35H2,1-5H3,(H,64,80)(H,67,78)(H,68,77)(H2,69,70,71,79)/t46-,50+,54-/m1/s1",IJVINXKSZVCULY-XAJGXQBMSA-N
5010,,,>3330,N.D.,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(CCCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22570/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1157.378,1156.529234,9.02,83,9,13,6,21,222.81,C61H71F3N12O6S,"InChI=1S/C61H71F3N12O6S/c1-38-12-20-45(30-49(38)61(62,63)64)68-53(79)36-75-34-44(33-67-75)43-19-23-48-50(29-43)71-72-56(48)70-57(80)42-17-21-46(22-18-42)74-27-25-73(26-28-74)24-10-8-6-7-9-11-52(78)69-55(60(3,4)5)59(82)76-35-47(77)31-51(76)58(81)65-32-40-13-15-41(16-14-40)54-39(2)66-37-83-54/h12-23,29-30,33-34,37,47,51,55,77H,6-11,24-28,31-32,35-36H2,1-5H3,(H,65,81)(H,68,79)(H,69,78)(H2,70,71,72,80)/t47-,51+,55-/m1/s1",QPBZMFJPACIGBT-IGYHCSNNSA-N
5011,,,>3330,17.3,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(C(=O)CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50000/>100000/>100000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1143.307,1142.477198,6.97,82,9,13,6,18,239.88,C59H65F3N12O7S,"InChI=1S/C59H65F3N12O7S/c1-35-10-18-42(27-46(35)59(60,61)62)66-50(77)33-73-31-41(30-65-73)40-17-21-45-47(26-40)69-70-54(45)68-55(79)39-15-19-43(20-16-39)71-22-24-72(25-23-71)51(78)9-7-6-8-49(76)67-53(58(3,4)5)57(81)74-32-44(75)28-48(74)56(80)63-29-37-11-13-38(14-12-37)52-36(2)64-34-82-52/h10-21,26-27,30-31,34,44,48,53,75H,6-9,22-25,28-29,32-33H2,1-5H3,(H,63,80)(H,66,77)(H,67,76)(H2,68,69,70,79)/t44-,48+,53-/m1/s1",CYJKOWYZBRAJJB-WDXSTBBASA-N
5015,,,>3330,N.D.,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N)C=C5)=NN(C(=O)CCCCCCCCC(=O)N[C@@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12120/44890/5500,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1130.308,1129.481949,8.96,81,8,14,6,21,248.56,C59H66F3N11O7S,"InChI=1S/C59H66F3N11O7S/c1-35-14-24-43(27-46(35)59(60,61)62)67-50(76)33-71-31-41(30-66-71)40-21-25-45-47(26-40)73(70-54(45)69-55(78)39-19-22-42(63)23-20-39)51(77)13-11-9-7-6-8-10-12-49(75)68-53(58(3,4)5)57(80)72-32-44(74)28-48(72)56(79)64-29-37-15-17-38(18-16-37)52-36(2)65-34-81-52/h14-27,30-31,34,44,48,53,74H,6-13,28-29,32-33,63H2,1-5H3,(H,64,79)(H,67,76)(H,68,75)(H,69,70,78)/t44-,48+,53+/m1/s1",BPHRXUICXLKBKI-UASWIANHSA-N
5016,320,81.7,320,81.7,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N)C=C5)=NN(C(=O)CCCCCCCCCCC(=O)N[C@@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C4=C3)C=N2)C=C1C(F)(F)F,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1440/25860/34610,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1158.362,1157.513249,10.04,83,8,14,6,23,248.56,C61H70F3N11O7S,"InChI=1S/C61H70F3N11O7S/c1-37-16-26-45(29-48(37)61(62,63)64)69-52(78)35-73-33-43(32-68-73)42-23-27-47-49(28-42)75(72-56(47)71-57(80)41-21-24-44(65)25-22-41)53(79)15-13-11-9-7-6-8-10-12-14-51(77)70-55(60(3,4)5)59(82)74-34-46(76)30-50(74)58(81)66-31-39-17-19-40(20-18-39)54-38(2)67-36-83-54/h16-29,32-33,36,46,50,55,76H,6-15,30-31,34-35,65H2,1-5H3,(H,66,81)(H,69,78)(H,70,77)(H,71,72,80)/t46-,50+,55+/m1/s1",PLBNAPRUSKNYKK-RFZMQRKDSA-N
5017,7530,99,7530/18100,,Q9BV86,NTMT1,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCNC(=O)C3=CC=CC=C3NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)CC3=CC=CC4=CC=CC=C34)=C2)SC=N1,Degradation of NTMT1 in HCT116/HT29 cells after 24h treatment,,,1770,Inhibit of NTMT1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114830,1104.344,1103.493896,6.41,80,9,12,6,22,245.7,C61H69N9O9S,"InChI=1S/C61H69N9O9S/c1-37(2)54(70-34-43-15-5-7-19-46(43)60(70)77)61(78)69-35-44(71)32-51(69)58(75)64-33-42-25-24-41(55-38(3)65-36-80-55)30-52(42)79-29-27-63-56(73)47-20-8-9-21-48(47)66-57(74)49(22-10-11-26-62)67-59(76)50-23-13-28-68(50)53(72)31-40-17-12-16-39-14-4-6-18-45(39)40/h4-9,12,14-21,24-25,30,36-37,44,49-51,54,71H,10-11,13,22-23,26-29,31-35,62H2,1-3H3,(H,63,73)(H,64,75)(H,66,74)(H,67,76)/t44-,49+,50+,51+,54+/m1/s1",CHPPXVHKCHZTIK-ZDSJKMSPSA-N
5018,,,79700/53700,,Q9BV86,NTMT1,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCOCCNC(=O)C3=CC=CC=C3NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)CC3=CC=CC4=CC=CC=C34)=C2)SC=N1,Degradation of NTMT1 in HCT116/HT29 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114830,1148.397,1147.520111,6.26,83,9,13,6,25,254.93,C63H73N9O10S,"InChI=1S/C63H73N9O10S/c1-39(2)56(72-36-45-15-5-7-19-48(45)62(72)79)63(80)71-37-46(73)34-53(71)60(77)66-35-44-25-24-43(57-40(3)67-38-83-57)32-54(44)82-31-30-81-29-27-65-58(75)49-20-8-9-21-50(49)68-59(76)51(22-10-11-26-64)69-61(78)52-23-13-28-70(52)55(74)33-42-17-12-16-41-14-4-6-18-47(41)42/h4-9,12,14-21,24-25,32,38-39,46,51-53,56,73H,10-11,13,22-23,26-31,33-37,64H2,1-3H3,(H,65,75)(H,66,77)(H,68,76)(H,69,78)/t46-,51+,52+,53+,56+/m1/s1",TZUOEZBQUKEEEL-LLRYOLIBSA-N
5019,,,66400/53700,,Q9BV86,NTMT1,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCOCCOCCOCCNC(=O)C3=CC=CC=C3NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)CC3=CC=CC4=CC=CC=C34)=C2)SC=N1,Degradation of NTMT1 in HCT116/HT29 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114830,1236.503,1235.57254,5.96,89,9,15,6,31,273.39,C67H81N9O12S,"InChI=1S/C67H81N9O12S/c1-43(2)60(76-40-49-15-5-7-19-52(49)66(76)83)67(84)75-41-50(77)38-57(75)64(81)70-39-48-25-24-47(61-44(3)71-42-89-61)36-58(48)88-35-34-87-33-32-86-31-30-85-29-27-69-62(79)53-20-8-9-21-54(53)72-63(80)55(22-10-11-26-68)73-65(82)56-23-13-28-74(56)59(78)37-46-17-12-16-45-14-4-6-18-51(45)46/h4-9,12,14-21,24-25,36,42-43,50,55-57,60,77H,10-11,13,22-23,26-35,37-41,68H2,1-3H3,(H,69,79)(H,70,81)(H,72,80)(H,73,82)/t50-,55+,56+,57+,60+/m1/s1",JNCJGHAWKIMBIN-VVDNDRTASA-N
5020,167,99,167,,Q13164,MAPK7,VHL,,INY-05-091,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCN(C(=O)C4=CC=C(NC5=NC=C6C(=N5)N(C5CCCC5)C5=CC=CC=C5C(=O)N6C)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of ERK5 in MOLT4 cells after 5h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,392,Inhibition of cell proliferation of MOLT4 cells,,,,,,,,,,,,,10.1016/j.chembiol.2022.09.004,1038.333,1037.53095,7.22,75,9,13,4,16,196.54,C57H71N11O6S,"InChI=1S/C57H71N11O6S/c1-36(38-19-21-39(22-20-38)49-37(2)59-35-75-49)60-52(71)46-32-43(69)34-67(46)55(74)50(57(3,4)5)62-48(70)18-8-7-13-27-65-28-30-66(31-29-65)53(72)40-23-25-41(26-24-40)61-56-58-33-47-51(63-56)68(42-14-9-10-15-42)45-17-12-11-16-44(45)54(73)64(47)6/h11-12,16-17,19-26,33,35-36,42-43,46,50,69H,7-10,13-15,18,27-32,34H2,1-6H3,(H,60,71)(H,62,70)(H,58,61,63)/t36-,43+,46-,50+/m0/s1",JZBIISQSJMQJMG-HWSZRRIVSA-N
5021,281,99,281,,Q13164,MAPK7,VHL,,INY-05-128,CCC(C)N1C2=CC=CC=C2C(=O)N(C)C2=CN=C(NC3=CC=C(C(=O)N4CCN(CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)N=C21,Degradation of ERK5 in MOLT4 cells after 5h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1100,Inhibition of cell proliferation of MOLT4 cells,,,,,,,,,,,,,10.1016/j.chembiol.2022.09.004,1026.322,1025.53095,7.28,74,8,13,4,17,196.54,C56H71N11O6S,"InChI=1S/C56H71N11O6S/c1-9-35(2)67-44-16-13-12-15-43(44)53(72)63(8)46-32-57-55(62-50(46)67)60-41-24-22-40(23-25-41)52(71)65-29-27-64(28-30-65)26-14-10-11-17-47(69)61-49(56(5,6)7)54(73)66-33-42(68)31-45(66)51(70)59-36(3)38-18-20-39(21-19-38)48-37(4)58-34-74-48/h12-13,15-16,18-25,32,34-36,42,45,49,68H,9-11,14,17,26-31,33H2,1-8H3,(H,59,70)(H,61,69)(H,57,60,62)/t35?,36-,42+,45-,49+/m0/s1",XKPRPHCYTPANCP-JIHPVYIJSA-N
5022,21,99,21,,Q13164,MAPK7,VHL,,INY-06-061,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCN(C4=CC=C5C(C6CCN(C(=O)C7=CC=C(OC(F)(F)F)C=C7N)CC6)=NC=NC5=C4)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of ERK5 in MOLT4 cells after 5h treatment,,,,,,,12,Binding affinity of ERK5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6000,Inhibition of cell proliferation of MM. 1S cells,,,,,,,,,,,,,10.1016/j.chembiol.2022.09.004,1041.255,1040.491786,7.75,74,8,13,4,16,199.45,C54H67F3N10O6S,"InChI=1S/C54H67F3N10O6S/c1-33(35-10-12-37(13-11-35)48-34(2)61-32-74-48)62-50(70)45-28-39(68)30-67(45)52(72)49(53(3,4)5)63-46(69)9-7-6-8-20-64-23-25-65(26-24-64)38-14-16-42-44(27-38)59-31-60-47(42)36-18-21-66(22-19-36)51(71)41-17-15-40(29-43(41)58)73-54(55,56)57/h10-17,27,29,31-33,36,39,45,49,68H,6-9,18-26,28,30,58H2,1-5H3,(H,62,70)(H,63,69)/t33-,39+,45-,49+/m0/s1",BOXPLNRWIHHHBO-CHCOZFFLSA-N
5023,78,46,78/25000,46/N.D.,P51531,SMARCA2,VHL,7Z6L,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,175,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.75,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-57-31)34-13-14-35(28-56-47(65)42-27-37(64)29-61(42)49(67)46(52(2,3)4)58-50(68)53(55)19-20-53)43(26-34)69-24-8-21-60-22-17-32(18-23-60)33-15-16-39-41(25-33)62(36-9-5-6-10-36)51-59-48(66)44-38(54)11-7-12-40(44)63(39)51/h7,11-16,25-26,30,32,36-37,42,46,64H,5-6,8-10,17-24,27-29H2,1-4H3,(H,56,65)(H,58,68)/t37-,42+,46-/m1/s1",YUFHVVATBPCYPQ-BQGOKDIQSA-N
5023,,,>25000/>25000,N.D./N.D.,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.75,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-57-31)34-13-14-35(28-56-47(65)42-27-37(64)29-61(42)49(67)46(52(2,3)4)58-50(68)53(55)19-20-53)43(26-34)69-24-8-21-60-22-17-32(18-23-60)33-15-16-39-41(25-33)62(36-9-5-6-10-36)51-59-48(66)44-38(54)11-7-12-40(44)63(39)51/h7,11-16,25-26,30,32,36-37,42,46,64H,5-6,8-10,17-24,27-29H2,1-4H3,(H,56,65)(H,58,68)/t37-,42+,46-/m1/s1",YUFHVVATBPCYPQ-BQGOKDIQSA-N
5024,1,84,01 02,84/77,P51531,SMARCA2,VHL,7Z77,,CC1=C(C2=CC=C([C@H](CCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1022.099,1020.373128,8.17,69,10,11,3,13,154.17,C53H62BrFN8O5S,"InChI=1S/C53H62BrFN8O5S/c1-31-45(69-30-56-31)34-16-14-33(15-17-34)39(57-47(65)43-28-37(64)29-61(43)49(67)46(52(2,3)4)58-50(68)53(55)22-23-53)12-8-24-60-25-20-32(21-26-60)35-18-19-40-42(27-35)62(36-9-5-6-10-36)51-59-48(66)44-38(54)11-7-13-41(44)63(40)51/h7,11,13-19,27,30,32,36-37,39,43,46,64H,5-6,8-10,12,20-26,28-29H2,1-4H3,(H,57,65)(H,58,68)/t37-,39+,43+,46-/m1/s1",DUPGTSRNDUFWBT-BYIGUQMMSA-N
5024,5,84,06 05,89/84,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1022.099,1020.373128,8.17,69,10,11,3,13,154.17,C53H62BrFN8O5S,"InChI=1S/C53H62BrFN8O5S/c1-31-45(69-30-56-31)34-16-14-33(15-17-34)39(57-47(65)43-28-37(64)29-61(43)49(67)46(52(2,3)4)58-50(68)53(55)22-23-53)12-8-24-60-25-20-32(21-26-60)35-18-19-40-42(27-35)62(36-9-5-6-10-36)51-59-48(66)44-38(54)11-7-13-41(44)63(40)51/h7,11,13-19,27,30,32,36-37,39,43,46,64H,5-6,8-10,12,20-26,28-29H2,1-4H3,(H,57,65)(H,58,68)/t37-,39+,43+,46-/m1/s1",DUPGTSRNDUFWBT-BYIGUQMMSA-N
5025,10,80,10 23,80/75,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](COCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.31,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-56-31)34-14-12-33(13-15-34)39(57-47(65)43-27-37(64)28-61(43)49(67)46(52(2,3)4)58-50(68)53(55)20-21-53)29-69-25-24-60-22-18-32(19-23-60)35-16-17-40-42(26-35)62(36-8-5-6-9-36)51-59-48(66)44-38(54)10-7-11-41(44)63(40)51/h7,10-17,26,30,32,36-37,39,43,46,64H,5-6,8-9,18-25,27-29H2,1-4H3,(H,57,65)(H,58,68)/t37-,39+,43+,46-/m1/s1",HOBINWBQKZMFPS-BYIGUQMMSA-N
5025,,,>25000/>25000,N.D./N.D.,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](COCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.31,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-56-31)34-14-12-33(13-15-34)39(57-47(65)43-27-37(64)28-61(43)49(67)46(52(2,3)4)58-50(68)53(55)20-21-53)29-69-25-24-60-22-18-32(19-23-60)35-16-17-40-42(26-35)62(36-8-5-6-9-36)51-59-48(66)44-38(54)10-7-11-41(44)63(40)51/h7,10-17,26,30,32,36-37,39,43,46,64H,5-6,8-9,18-25,27-29H2,1-4H3,(H,57,65)(H,58,68)/t37-,39+,43+,46-/m1/s1",HOBINWBQKZMFPS-BYIGUQMMSA-N
5026,5,76,05 12,76/72,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](CO[C@H](C)CN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1052.125,1050.383693,7.74,71,10,12,3,14,163.4,C54H64BrFN8O6S,"InChI=1S/C54H64BrFN8O6S/c1-31(27-61-23-19-33(20-24-61)36-17-18-41-43(25-36)63(37-9-6-7-10-37)52-60-49(67)45-39(55)11-8-12-42(45)64(41)52)70-29-40(34-13-15-35(16-14-34)46-32(2)57-30-71-46)58-48(66)44-26-38(65)28-62(44)50(68)47(53(3,4)5)59-51(69)54(56)21-22-54/h8,11-18,25,30-31,33,37-38,40,44,47,65H,6-7,9-10,19-24,26-29H2,1-5H3,(H,58,66)(H,59,69)/t31-,38-,40+,44+,47-/m1/s1",BWFPCIGALPXWPF-BLVIHPBHSA-N
5026,1779,88,1779/>25000,88/N.D.,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CO[C@H](C)CN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1052.125,1050.383693,7.74,71,10,12,3,14,163.4,C54H64BrFN8O6S,"InChI=1S/C54H64BrFN8O6S/c1-31(27-61-23-19-33(20-24-61)36-17-18-41-43(25-36)63(37-9-6-7-10-37)52-60-49(67)45-39(55)11-8-12-42(45)64(41)52)70-29-40(34-13-15-35(16-14-34)46-32(2)57-30-71-46)58-48(66)44-26-38(65)28-62(44)50(68)47(53(3,4)5)59-51(69)54(56)21-22-54/h8,11-18,25,30-31,33,37-38,40,44,47,65H,6-7,9-10,19-24,26-29H2,1-5H3,(H,58,66)(H,59,69)/t31-,38-,40+,44+,47-/m1/s1",BWFPCIGALPXWPF-BLVIHPBHSA-N
5027,3,82,03 06,82/70,P51531,SMARCA2,VHL,7Z76,,CC1=C(C2=CC=C([C@H](CO[C@H](C)CN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(N(C)C)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1077.204,1075.435314,7.44,73,10,13,3,15,166.64,C56H70BrN9O6S,"InChI=1S/C56H70BrN9O6S/c1-33(29-63-25-21-35(22-26-63)38-19-20-43-45(27-38)65(39-11-8-9-12-39)54-61-51(69)47-41(57)13-10-14-44(47)66(43)54)72-31-42(36-15-17-37(18-16-36)48-34(2)58-32-73-48)59-50(68)46-28-40(67)30-64(46)52(70)49(55(3,4)5)60-53(71)56(23-24-56)62(6)7/h10,13-20,27,32-33,35,39-40,42,46,49,67H,8-9,11-12,21-26,28-31H2,1-7H3,(H,59,68)(H,60,71)/t33-,40-,42+,46+,49-/m1/s1",AYSNCSVZNJFPCS-JAHFJGENSA-N
5027,174,68,174/83,68/34,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CO[C@H](C)CN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(N(C)C)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1077.204,1075.435314,7.44,73,10,13,3,15,166.64,C56H70BrN9O6S,"InChI=1S/C56H70BrN9O6S/c1-33(29-63-25-21-35(22-26-63)38-19-20-43-45(27-38)65(39-11-8-9-12-39)54-61-51(69)47-41(57)13-10-14-44(47)66(43)54)72-31-42(36-15-17-37(18-16-36)48-34(2)58-32-73-48)59-50(68)46-28-40(67)30-64(46)52(70)49(55(3,4)5)60-53(71)56(23-24-56)62(6)7/h10,13-20,27,32-33,35,39-40,42,46,49,67H,8-9,11-12,21-26,28-31H2,1-7H3,(H,59,68)(H,60,71)/t33-,40-,42+,46+,49-/m1/s1",AYSNCSVZNJFPCS-JAHFJGENSA-N
5028,1,87,01 02,87/73,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](CCCCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1050.153,1048.404429,8.89,71,10,11,3,15,154.17,C55H66BrFN8O5S,"InChI=1S/C55H66BrFN8O5S/c1-33-47(71-32-58-33)36-18-16-35(17-19-36)41(59-49(67)45-30-39(66)31-63(45)51(69)48(54(2,3)4)60-52(70)55(57)24-25-55)14-6-5-9-26-62-27-22-34(23-28-62)37-20-21-42-44(29-37)64(38-11-7-8-12-38)53-61-50(68)46-40(56)13-10-15-43(46)65(42)53/h10,13,15-21,29,32,34,38-39,41,45,48,66H,5-9,11-12,14,22-28,30-31H2,1-4H3,(H,59,67)(H,60,70)/t39-,41+,45+,48-/m1/s1",NWAHMEWTPAKOEQ-UQZDYNHJSA-N
5028,12,78,12 15,78/53,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CCCCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1050.153,1048.404429,8.89,71,10,11,3,15,154.17,C55H66BrFN8O5S,"InChI=1S/C55H66BrFN8O5S/c1-33-47(71-32-58-33)36-18-16-35(17-19-36)41(59-49(67)45-30-39(66)31-63(45)51(69)48(54(2,3)4)60-52(70)55(57)24-25-55)14-6-5-9-26-62-27-22-34(23-28-62)37-20-21-42-44(29-37)64(38-11-7-8-12-38)53-61-50(68)46-40(56)13-10-15-43(46)65(42)53/h10,13,15-21,29,32,34,38-39,41,45,48,66H,5-9,11-12,14,22-28,30-31H2,1-4H3,(H,59,67)(H,60,70)/t39-,41+,45+,48-/m1/s1",NWAHMEWTPAKOEQ-UQZDYNHJSA-N
5029,1,81,01 04,81/71,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](CC[C@H](C)CCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1064.18,1062.420079,9.32,72,10,11,3,15,154.17,C56H68BrFN8O5S,"InChI=1S/C56H68BrFN8O5S/c1-33(21-26-63-27-22-35(23-28-63)38-18-20-43-45(29-38)65(39-9-6-7-10-39)54-62-51(69)47-41(57)11-8-12-44(47)66(43)54)13-19-42(36-14-16-37(17-15-36)48-34(2)59-32-72-48)60-50(68)46-30-40(67)31-64(46)52(70)49(55(3,4)5)61-53(71)56(58)24-25-56/h8,11-12,14-18,20,29,32-33,35,39-40,42,46,49,67H,6-7,9-10,13,19,21-28,30-31H2,1-5H3,(H,60,68)(H,61,71)/t33-,40+,42-,46-,49+/m0/s1",JBTHUOYYUUPUOZ-LIHPQFRDSA-N
5029,32,67,32/>25000,67/N.D.,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CC[C@H](C)CCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1064.18,1062.420079,9.32,72,10,11,3,15,154.17,C56H68BrFN8O5S,"InChI=1S/C56H68BrFN8O5S/c1-33(21-26-63-27-22-35(23-28-63)38-18-20-43-45(29-38)65(39-9-6-7-10-39)54-62-51(69)47-41(57)11-8-12-44(47)66(43)54)13-19-42(36-14-16-37(17-15-36)48-34(2)59-32-72-48)60-50(68)46-30-40(67)31-64(46)52(70)49(55(3,4)5)61-53(71)56(58)24-25-56/h8,11-12,14-18,20,29,32-33,35,39-40,42,46,49,67H,6-7,9-10,13,19,21-28,30-31H2,1-5H3,(H,60,68)(H,61,71)/t33-,40+,42-,46-,49+/m0/s1",JBTHUOYYUUPUOZ-LIHPQFRDSA-N
5089,23,99,23,,P31749,AKT1,VHL,,MS15,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)CCC3=CC=CC(C4=CC=C5N=C(C6=CC=CN=C6N)N(C6=CC=C(C7(N)CCC7)C=C6)C5=N4)=C3)C(C)(C)C)C=C2)SC=N1,Degradation of T-AKT in SW620 cells after 24h treatment,,,798,Inhibit of AKT1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3100,Inhibition of cell proliferation of KRAS mutant SW620 cells,,,,,,,,,,,10.1021/acs.jmedchem.2c01454,1114.475,1113.598636,9.53,81,9,13,6,24,236.37,C64H79N11O5S,"InChI=1S/C64H79N11O5S/c1-41(44-22-24-45(25-23-44)56-42(2)69-40-81-56)70-61(79)53-38-49(76)39-74(53)62(80)57(63(3,4)5)73-55(78)20-12-10-8-6-7-9-11-13-35-67-54(77)32-21-43-17-14-18-46(37-43)51-30-31-52-60(71-51)75(59(72-52)50-19-15-36-68-58(50)65)48-28-26-47(27-29-48)64(66)33-16-34-64/h14-15,17-19,22-31,36-37,40-41,49,53,57,76H,6-13,16,20-21,32-35,38-39,66H2,1-5H3,(H2,65,68)(H,67,77)(H,70,79)(H,73,78)/t41-,49+,53-,57+/m0/s1",XYGBNRINQSQNJG-IQDHSYJRSA-N
5114,11.94,99,11.94,,P03372,ERalpha,CRBN,,,CC/C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)CCC2=CN(CCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114770,928.056,927.416691,5.86,68,7,14,3,25,203.75,C51H57N7O10,"InChI=1S/C51H57N7O10/c1-3-41(35-8-5-4-6-9-35)47(36-12-17-39(59)18-13-36)37-14-19-40(20-15-37)68-29-25-56(2)46(61)23-16-38-34-57(55-54-38)26-28-66-31-33-67-32-30-65-27-24-52-43-11-7-10-42-48(43)51(64)58(50(42)63)44-21-22-45(60)53-49(44)62/h4-15,17-20,34,44,52,59H,3,16,21-33H2,1-2H3,(H,53,60,62)/b47-41+",QWDUSDZQXZGBDE-YXNXHRDCSA-N
5116,4.5,99,4.5,,P03372,ERalpha,VHL,,,CC/C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)CCC2=CN(CCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114770,1009.287,1008.493168,8.65,73,7,12,4,21,192.11,C57H68N8O7S,"InChI=1S/C57H68N8O7S/c1-8-48(40-13-10-9-11-14-40)52(41-20-25-45(66)26-21-41)42-22-27-47(28-23-42)72-32-31-63(7)51(69)29-24-44-34-64(62-61-44)30-12-15-50(68)60-54(57(4,5)6)56(71)65-35-46(67)33-49(65)55(70)59-37(2)39-16-18-43(19-17-39)53-38(3)58-36-73-53/h9-11,13-14,16-23,25-28,34,36-37,46,49,54,66-67H,8,12,15,24,29-33,35H2,1-7H3,(H,59,70)(H,60,68)/b52-48+/t37-,46+,49-,54+/m0/s1",XHGJXRVENIZOAC-SVKNGWHQSA-N
5117,5.29,99,5.29,,P03372,ERalpha,VHL,,,CC/C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C(=O)CCC2=CN(CCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1)C1=CC=CC=C1,Degradation of ERalpha in MCF-7 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114770,1037.341,1036.524468,9.36,75,7,12,4,23,192.11,C59H72N8O7S,"InChI=1S/C59H72N8O7S/c1-8-50(42-15-11-9-12-16-42)54(43-22-27-47(68)28-23-43)44-24-29-49(30-25-44)74-34-33-65(7)53(71)31-26-46-36-66(64-63-46)32-14-10-13-17-52(70)62-56(59(4,5)6)58(73)67-37-48(69)35-51(67)57(72)61-39(2)41-18-20-45(21-19-41)55-40(3)60-38-75-55/h9,11-12,15-16,18-25,27-30,36,38-39,48,51,56,68-69H,8,10,13-14,17,26,31-35,37H2,1-7H3,(H,61,72)(H,62,70)/b54-50+/t39-,48+,51-,56+/m0/s1",UQXZGZNVBMPYIX-KLNOOTFSSA-N
5121,28,77,28,77,P56524,HDAC4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCC(F)(F)C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,410,"Inhibit of HDAC4	",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,150,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,962.061,961.365582,4.5,68,6,13,5,21,214.43,C48H54F3N7O9S,"InChI=1S/C48H54F3N7O9S/c1-29-41(68-28-55-29)32-11-9-30(10-12-32)22-54-44(61)38-21-35(59)25-58(38)46(63)42(47(2,3)4)56-39(60)26-66-19-17-65-18-20-67-27-48(50,51)34-23-52-43(53-24-34)33-15-13-31(14-16-33)40(45(62)57-64)36-7-5-6-8-37(36)49/h5-16,23-24,28,35,38,40,42,59,64H,17-22,25-27H2,1-4H3,(H,54,61)(H,56,60)(H,57,62)/t35-,38+,40?,42-/m1/s1",CUCLIKLMKDOFAE-PELIQRIMSA-N
5122,48,82,48,82,P56524,HDAC4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCC(F)(F)C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,560,"Inhibit of HDAC4	",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,160,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1006.114,1005.391797,4.35,71,6,14,5,24,223.66,C50H58F3N7O10S,"InChI=1S/C50H58F3N7O10S/c1-31-43(71-30-57-31)34-11-9-32(10-12-34)24-56-46(63)40-23-37(61)27-60(40)48(65)44(49(2,3)4)58-41(62)28-69-21-19-67-17-18-68-20-22-70-29-50(52,53)36-25-54-45(55-26-36)35-15-13-33(14-16-35)42(47(64)59-66)38-7-5-6-8-39(38)51/h5-16,25-26,30,37,40,42,44,61,66H,17-24,27-29H2,1-4H3,(H,56,63)(H,58,62)(H,59,64)/t37-,40+,42?,44-/m1/s1",JCIGJBGCHCAMMB-DGTRGAFGSA-N
5123,37,83,37,83,P56524,HDAC4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC(F)(F)C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,1100,"Inhibit of HDAC4	",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1050.167,1049.418011,4.2,74,6,15,5,27,232.89,C52H62F3N7O11S,"InChI=1S/C52H62F3N7O11S/c1-33-45(74-32-59-33)36-11-9-34(10-12-36)26-58-48(65)42-25-39(63)29-62(42)50(67)46(51(2,3)4)60-43(64)30-72-23-21-70-19-17-69-18-20-71-22-24-73-31-52(54,55)38-27-56-47(57-28-38)37-15-13-35(14-16-37)44(49(66)61-68)40-7-5-6-8-41(40)53/h5-16,27-28,32,39,42,44,46,63,68H,17-26,29-31H2,1-4H3,(H,58,65)(H,60,64)(H,61,66)/t39-,42+,44?,46-/m1/s1",HCYVFIZSHJPMGM-BZWIJWRHSA-N
5124,3,72,3,72,P56524,HDAC4,VHL,,,CCCN(CCCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,90,"Inhibit of HDAC4	",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,987.156,986.4547313,5.75,69,5,14,4,26,210.58,C48H65F3N8O9S,"InChI=1S/C48H65F3N8O9S/c1-7-18-58(27-31(2)54-43(62)36-16-14-35(15-17-36)42-56-46(68-57-42)48(49,50)51)19-8-9-20-65-21-22-66-23-24-67-29-39(61)55-41(47(4,5)6)45(64)59-28-37(60)25-38(59)44(63)52-26-33-10-12-34(13-11-33)40-32(3)53-30-69-40/h10-17,30-31,37-38,41,60H,7-9,18-29H2,1-6H3,(H,52,63)(H,54,62)(H,55,61)/t31-,37-,38+,41-/m1/s1",LNVXIMZTYRLPDR-UYNIEJFQSA-N
5125,4,85,4,85,P56524,HDAC4,VHL,,,CCCN(CCCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,100,"Inhibit of HDAC4	",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1031.209,1030.480946,5.6,72,5,15,4,29,219.81,C50H69F3N8O10S,"InChI=1S/C50H69F3N8O10S/c1-7-18-60(29-33(2)56-45(64)38-16-14-37(15-17-38)44-58-48(71-59-44)50(51,52)53)19-8-9-20-67-21-22-68-23-24-69-25-26-70-31-41(63)57-43(49(4,5)6)47(66)61-30-39(62)27-40(61)46(65)54-28-35-10-12-36(13-11-35)42-34(3)55-32-72-42/h10-17,32-33,39-40,43,62H,7-9,18-31H2,1-6H3,(H,54,65)(H,56,64)(H,57,63)/t33-,39-,40+,43-/m1/s1",QONCFSQPRCINOK-WIIHZIRBSA-N
5126,4,78,4,78,P56524,HDAC4,VHL,,,CCCN(CCCCOCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,92,"Inhibit of HDAC4	",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1075.262,1074.507161,5.45,75,5,16,4,32,229.04,C52H73F3N8O11S,"InChI=1S/C52H73F3N8O11S/c1-7-18-62(31-35(2)58-47(66)40-16-14-39(15-17-40)46-60-50(74-61-46)52(53,54)55)19-8-9-20-69-21-22-70-23-24-71-25-26-72-27-28-73-33-43(65)59-45(51(4,5)6)49(68)63-32-41(64)29-42(63)48(67)56-30-37-10-12-38(13-11-37)44-36(3)57-34-75-44/h10-17,34-35,41-42,45,64H,7-9,18-33H2,1-6H3,(H,56,67)(H,58,66)(H,59,65)/t35-,41-,42+,45-/m1/s1",KBDZFZJFGKYVBZ-KLSSUPLUSA-N
5190,2,78,2,78,Q00534,CDK6,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOC5=CC=C(CN6CCC(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)CC8=C7)CC6)C=C5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK6 in Jurkat cells after 4 h treatment,,,33,Inhibit of CDK6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00439,907.089,906.4540796,4.28,67,10,14,2,13,175.2,C51H58N10O6,"InChI=1S/C51H58N10O6/c1-32-42-29-53-51(56-47(42)61(38-5-3-4-6-38)50(66)46(32)33(2)62)54-44-15-10-39(28-52-44)59-23-21-57(22-24-59)25-26-67-40-11-7-34(8-12-40)30-58-19-17-35(18-20-58)36-9-13-41-37(27-36)31-60(49(41)65)43-14-16-45(63)55-48(43)64/h7-13,15,27-29,35,38,43H,3-6,14,16-26,30-31H2,1-2H3,(H,55,63,64)(H,52,53,54,56)",PJLUKTVSGYDGFZ-UHFFFAOYSA-N
5190,10,45,10,45,P11802,CDK4,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOC5=CC=C(CN6CCC(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)CC8=C7)CC6)C=C5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,Degradation of CDK4 in Jurkat cells after 4 h treatment,,,70,Inhibit of CDK4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00439,907.089,906.4540796,4.28,67,10,14,2,13,175.2,C51H58N10O6,"InChI=1S/C51H58N10O6/c1-32-42-29-53-51(56-47(42)61(38-5-3-4-6-38)50(66)46(32)33(2)62)54-44-15-10-39(28-52-44)59-23-21-57(22-24-59)25-26-67-40-11-7-34(8-12-40)30-58-19-17-35(18-20-58)36-9-13-41-37(27-36)31-60(49(41)65)43-14-16-45(63)55-48(43)64/h7-13,15,27-29,35,38,43H,3-6,14,16-26,30-31H2,1-2H3,(H,55,63,64)(H,52,53,54,56)",PJLUKTVSGYDGFZ-UHFFFAOYSA-N
5215,14,90,14,90,Q5S007,LRRK2 G2019S,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,Degradation of G2019S LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15,Dephosphorylation of Rab10 in G2019S LRRK2 MEFs,,,,,,,,,,,,,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33-,36-,39+,42-/m1/s1",HKSBXNVKPFTBIG-SHFRUIRLSA-N
5215,32,82,32,82,Q5S007,LRRK2,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,Degradation of LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,54,Dephosphorylation of Rab10 in WT LRRK2 MEFs,,,,,,,,,0.74,Caco-2 permeability,1.43,Caco-2 permeability,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33-,36-,39+,42-/m1/s1",HKSBXNVKPFTBIG-SHFRUIRLSA-N
5216,7,81,7,81,Q5S007,LRRK2 G2019S,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,Degradation of G2019S LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12,Dephosphorylation of Rab10 in G2019S LRRK2 MEFs,,,,,,,,,,,,,,,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33+,36-,39-,42-/m1/s1",HKSBXNVKPFTBIG-SCXIOOGQSA-N
5216,32,59,32,59,Q5S007,LRRK2,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,Degradation of LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74,Dephosphorylation of Rab10 in WT LRRK2 MEFs,,,,,,,,,,,,,,,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33+,36-,39-,42-/m1/s1",HKSBXNVKPFTBIG-SCXIOOGQSA-N
5264,200,99,200,,P36969,GPX4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCN4C=C(COC5=CC=C(N(C(=O)CCl)C(C(=O)NCCC6=CC=CC=C6)C6=CC=CS6)C=C5Cl)N=N4)=C3C2=O)C(=O)N1,Degradation of GPX4 in HT-1080 fibrosarcoma cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202206277,975.909,974.2591161,4.44,67,7,15,3,25,212.62,C46H48Cl2N8O10S,"InChI=1S/C46H48Cl2N8O10S/c47-27-40(58)55(42(38-10-5-25-67-38)44(60)50-16-15-30-6-2-1-3-7-30)32-11-13-37(34(48)26-32)66-29-31-28-54(53-52-31)18-20-64-22-24-65-23-21-63-19-17-49-35-9-4-8-33-41(35)46(62)56(45(33)61)36-12-14-39(57)51-43(36)59/h1-11,13,25-26,28,36,42,49H,12,14-24,27,29H2,(H,50,60)(H,51,57,59)",XKGCAEZHAOGHFF-UHFFFAOYSA-N
5274,5200,82,5200,>82,O96028,NSD2,CRBN,,MS159,O=C(CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCOC1=CC=C(NC(=O)C2=CC=C(CN(C(=O)C3=CC=C4NC(=O)COC4=C3)C3CC3)C=C2)N=C1,Degradation of NSD2 in 293FT cells after 48 h treatment,,,,,,,1100,Binding affinity of NSD2-PWWP1 domain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00807,828.839,828.2867395,2.59,61,8,12,5,15,234.54,C43H40N8O10,"InChI=1S/C43H40N8O10/c52-35-16-14-32(40(56)49-35)51-42(58)29-3-1-4-31(38(29)43(51)59)45-21-36(53)44-17-2-18-60-28-12-15-34(46-20-28)48-39(55)25-7-5-24(6-8-25)22-50(27-10-11-27)41(57)26-9-13-30-33(19-26)61-23-37(54)47-30/h1,3-9,12-13,15,19-20,27,32,45H,2,10-11,14,16-18,21-23H2,(H,44,53)(H,47,54)(H,46,48,55)(H,49,52,56)",OBZWKPGPTCBYOS-UHFFFAOYSA-N
5292,67,90,67,>90,P03372,ERalpha,CRBN,,,CC(=O)N(CCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)O[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(O)=CC=C3C21,Degradation of ERalpha in MCF-7 cells after 24 h treatment,68,% ERalpha degradation in MCF-7 cells after 24 h treatment at 100 nM,91.2,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.9,CCK-8 cell proliferation assay,,,,,,,,,,,10.1016/j.jsbmb.2022.106154,732.831,732.3370437,3.11,53,7,11,4,13,184.04,C39H48N4O10,"InChI=1S/C39H48N4O10/c1-22(44)42(53-31-21-39(2)28(10-12-32(39)46)26-8-6-23-20-24(45)7-9-25(23)34(26)31)15-17-52-19-18-51-16-14-40-29-5-3-4-27-35(29)38(50)43(37(27)49)30-11-13-33(47)41-36(30)48/h3-5,7,9,20,26,28,30-32,34,40,45-46H,6,8,10-19,21H2,1-2H3,(H,41,47,48)/t26?,28?,30?,31-,32-,34?,39-/m0/s1",UKYOBTPNHRPOON-FQBQYCNXSA-N
5308,140,99,140,,Q15910,EZH2,VHL,,,CCN(C1=CC(C2=CC=C(CN3CCN(C(=O)CCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)CC3)C=C2)=CC(C(=O)NCC2=C(C)C=C(C)[NH]C2=O)=C1C)C1CCOCC1,Degradation of EZH2 in MDA-MB-453 cells after 48 h treatment,,,8.6,Inhibit of EZH2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000/1700/2000,Inhibit of cell growth in BT549/MDA-MB-468/SUM159 cells,,,,,,,,,,,10.1021/acsptsci.2c00100,1154.533,1153.639832,8.11,83,8,12,5,23,209.61,C65H87N9O8S,"InChI=1S/C65H87N9O8S/c1-9-73(51-25-31-82-32-26-51)55-35-50(34-53(44(55)4)61(78)67-38-54-42(2)33-43(3)69-62(54)79)48-21-19-47(20-22-48)39-71-27-29-72(30-28-71)58(77)16-14-12-10-11-13-15-57(76)70-60(65(6,7)8)64(81)74-40-52(75)36-56(74)63(80)66-37-46-17-23-49(24-18-46)59-45(5)68-41-83-59/h17-24,33-35,41,51-52,56,60,75H,9-16,25-32,36-40H2,1-8H3,(H,66,80)(H,67,78)(H,69,79)(H,70,76)/t52-,56+,60-/m1/s1",AOIZISCRIVNZJJ-XWJFFXCMSA-N
5309,252.5,99,252.5,,P09874,PARP1,CRBN,,,NC(=O)C1=CC=CC2=CN(C3=CC=C(C4CCCN(C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C4)C=C3)N=C12,Degradation of PARP1 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmc.2022.116912,576.613,576.212118,2.67,43,7,8,2,5,147.7,C32H28N6O5,"InChI=1S/C32H28N6O5/c33-29(40)23-7-1-4-20-17-37(35-28(20)23)21-11-9-18(10-12-21)19-5-3-15-36(16-19)24-8-2-6-22-27(24)32(43)38(31(22)42)25-13-14-26(39)34-30(25)41/h1-2,4,6-12,17,19,25H,3,5,13-16H2,(H2,33,40)(H,34,39,41)",DNTANRUFOCYNLP-UHFFFAOYSA-N
5316,970,99,970,,P40337,VHL,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCNC(=O)C/C=N/OCC(=O)NCCOCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C(C)(C)C)C=C2)SC=N1,Degradation of pVHL30 in HeLa cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202200275,1232.494,1231.540588,2.89,86,6,19,8,30,330.74,C59H81N11O14S2,"InChI=1S/C59H81N11O14S2/c1-36-50(85-34-64-36)40-13-9-38(10-14-40)27-62-54(77)44-25-42(71)29-69(44)56(79)52(58(3,4)5)67-48(75)31-82-22-20-60-46(73)17-18-66-84-33-47(74)61-19-21-81-23-24-83-32-49(76)68-53(59(6,7)8)57(80)70-30-43(72)26-45(70)55(78)63-28-39-11-15-41(16-12-39)51-37(2)65-35-86-51/h9-16,18,34-35,42-45,52-53,71-72H,17,19-33H2,1-8H3,(H,60,73)(H,61,74)(H,62,77)(H,63,78)(H,67,75)(H,68,76)/b66-18+/t42-,43-,44+,45+,52-,53-/m1/s1",PWSQVDFJBKSXJQ-NEFBSMMZSA-N
5340,53,99,53/3200,,P09874,PARP1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NC(=O)CNCCCCCCCCCC(=O)N4CCN(C(=O)C5=CC(CC6=N[NH]C(=O)C7=CC=CC=C67)=CC=C5F)CC4)=C3C2=O)C(=O)N1,Degradation of PARP1 in MDA-MB-231/L-O2 cells after 24 h treatment,,,2.95,Inhibit of PARP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31/77/2320,Inhibit proliferation of MDA-MB-436/Capan-1/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1016/j.bmc.2022.116908,848.933,848.3657387,3.85,62,7,10,4,17,211.05,C45H49FN8O8,"InChI=1S/C45H49FN8O8/c46-33-17-16-28(26-35-29-11-7-8-12-30(29)41(58)51-50-35)25-32(33)43(60)53-23-21-52(22-24-53)39(57)15-6-4-2-1-3-5-9-20-47-27-38(56)48-34-14-10-13-31-40(34)45(62)54(44(31)61)36-18-19-37(55)49-42(36)59/h7-8,10-14,16-17,25,36,47H,1-6,9,15,18-24,26-27H2,(H,48,56)(H,51,58)(H,49,55,59)",OANIAMLFYSYIJN-UHFFFAOYSA-N
5358,17,84,17,84,Q93009,USP7,CRBN,,,C[C@H](CC(=O)N1CCC(O)(CN2C=NC3=CC(NC(=O)CCC4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)=CC=C3C2=O)CC1)C1=CC=CC=C1,Degradation of USP7 in MM.1S cells after 24 h treatment,85,% USP7 degradation in MM.1S cells after 24 h treatment at 1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cc02094g,927.072,926.4326754,2.48,68,9,12,3,12,211.63,C51H58N8O9,"InChI=1S/C51H58N8O9/c1-32(34-5-3-2-4-6-34)27-45(62)56-25-19-51(68,20-26-56)30-58-31-52-41-28-36(8-10-39(41)48(58)65)53-43(60)13-7-33-15-21-57(22-16-33)47(64)35-17-23-55(24-18-35)37-9-11-38-40(29-37)50(67)59(49(38)66)42-12-14-44(61)54-46(42)63/h2-6,8-11,28-29,31-33,35,42,68H,7,12-27,30H2,1H3,(H,53,60)(H,54,61,63)/t32-,42?/m1/s1",REPLCRNGGWSKTN-JYQLQLLISA-N
5394,147,93,147,93,Q9BY41,HDAC8,CRBN,,,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of HDAC8 in HCT-116 cells after 10 h treatment,85,% HDAC8 degradation in HCT-116 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,754.841,754.3326271,3.74,55,5,10,6,20,212.34,C40H46N6O9,"InChI=1S/C40H46N6O9/c47-33(13-3-6-24-55-29-16-14-26(15-17-29)20-23-43-36(49)27-9-7-10-28(25-27)37(50)45-54)42-22-5-2-1-4-21-41-31-12-8-11-30-35(31)40(53)46(39(30)52)32-18-19-34(48)44-38(32)51/h7-12,14-17,25,32,41,54H,1-6,13,18-24H2,(H,42,47)(H,43,49)(H,45,50)(H,44,48,51)",WYWJHXKHDRJYLX-UHFFFAOYSA-N
5394,4950,99,4950,,Q9UBN7,HDAC6,CRBN,,,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of HDAC6 in HCT-116 cells after 10 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,754.841,754.3326271,3.74,55,5,10,6,20,212.34,C40H46N6O9,"InChI=1S/C40H46N6O9/c47-33(13-3-6-24-55-29-16-14-26(15-17-29)20-23-43-36(49)27-9-7-10-28(25-27)37(50)45-54)42-22-5-2-1-4-21-41-31-12-8-11-30-35(31)40(53)46(39(30)52)32-18-19-34(48)44-38(32)51/h7-12,14-17,25,32,41,54H,1-6,13,18-24H2,(H,42,47)(H,43,49)(H,45,50)(H,44,48,51)",WYWJHXKHDRJYLX-UHFFFAOYSA-N
5402,876,91,876,91,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCC(N5CCN(C(=O)CCCCOC6=CC=C(CCNC(=O)C7=CC=CC(C(=O)NO)=C7)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,Degradation of HDAC8 in HCT-116 cells after 10 h treatment,74.4,% HDAC8 degradation in HCT-116 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,807.905,807.3591761,2.45,59,7,11,4,14,198,C43H49N7O9,"InChI=1S/C43H49N7O9/c51-36-15-14-35(41(55)45-36)50-42(56)33-7-4-8-34(38(33)43(50)57)48-20-17-31(18-21-48)47-22-24-49(25-23-47)37(52)9-1-2-26-59-32-12-10-28(11-13-32)16-19-44-39(53)29-5-3-6-30(27-29)40(54)46-58/h3-8,10-13,27,31,35,58H,1-2,9,14-26H2,(H,44,53)(H,46,54)(H,45,51,55)",QSDRZGJBNUYGJE-UHFFFAOYSA-N
5406,441,77,441,77,Q9BY41,HDAC8,CRBN,,,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1)NCCCCCCNC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1,Degradation of HDAC8 in HCT-116 cells after 10 h treatment,68.9,% HDAC8 degradation in HCT-116 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,754.841,754.3326271,3.19,55,5,10,6,20,212.34,C40H46N6O9,"InChI=1S/C40H46N6O9/c47-34(10-3-6-23-55-30-14-11-26(12-15-30)19-22-43-36(49)27-8-7-9-28(24-27)37(50)45-54)42-21-5-2-1-4-20-41-29-13-16-31-32(25-29)40(53)46(39(31)52)33-17-18-35(48)44-38(33)51/h7-9,11-16,24-25,33,41,54H,1-6,10,17-23H2,(H,42,47)(H,43,49)(H,45,50)(H,44,48,51)",HIMPUSAONKTVMA-UHFFFAOYSA-N
5426,87,98,87,98,Q96C86,DcpS,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCOCCOCCOCCOCCOCCOC3=CC=CC(CN4CCC(COC5=CC=CC6=NC(N)=NC(N)=C56)CC4)=C3)=C2)SC=N1,Degradation of DcpS in MOLM-14 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1100,Inhibit proliferation of MOLM14 cells,,,,,,,,,,,,,,,10.1021/acschembio.2c00145,1174.432,1173.55689,5.4,84,9,19,4,32,257.74,C62H79N9O12S,"InChI=1S/C62H79N9O12S/c1-41(2)56(71-37-47-9-4-5-11-50(47)60(71)74)61(75)70-38-48(72)34-52(70)59(73)65-35-46-15-14-45(57-42(3)66-40-84-57)33-54(46)82-31-29-80-27-25-78-23-21-76-20-22-77-24-26-79-28-30-81-49-10-6-8-44(32-49)36-69-18-16-43(17-19-69)39-83-53-13-7-12-51-55(53)58(63)68-62(64)67-51/h4-15,32-33,40-41,43,48,52,56,72H,16-31,34-39H2,1-3H3,(H,65,73)(H4,63,64,67,68)/t48-,52-,56+/m1/s1",YDPSDENQMOVTAZ-QMZDZVJJSA-N
5433,940,99,1430/940,,Q9BZ95,NSD3,VHL,,,CC1=CC(CNCCCCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC(C)=C1C1=C(C2=CC=NC3=CC(F)=CC=C23)N(C)C=N1,Degradation of NSD3 in NCI-H1703/A549 cells after 72h treatment,58.9,% NSD3 degradation in NCI-H1703 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2740/5490,Inhibit proliferation of NCI-H1703/A549 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114528,971.301,970.530302,10,70,7,10,4,21,154.37,C56H71FN8O4S,"InChI=1S/C56H71FN8O4S/c1-35-27-39(28-36(2)49(35)50-51(64(8)33-60-50)45-24-26-59-46-29-42(57)22-23-44(45)46)31-58-25-16-14-12-10-9-11-13-15-17-48(67)63-53(56(5,6)7)55(69)65-32-43(66)30-47(65)54(68)62-37(3)40-18-20-41(21-19-40)52-38(4)61-34-70-52/h18-24,26-29,33-34,37,43,47,53,58,66H,9-17,25,30-32H2,1-8H3,(H,62,68)(H,63,67)/t37-,43+,47-,53+/m0/s1",BOTJARXURVIORK-NOXIQMFQSA-N
5453,33,99,33,,Q93009,USP7,CRBN,,,C[C@H](CC(=O)N1CCC(O)(CN2C=NC3=C(C4=CC=C(CNCCCCCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4)N(C)N=C3C2=O)CC1)C1=CC=CC=C1,Degradation of USP7 in RS4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.4/227.0/830.3,Inhibit growth of OCI-ly10/RS4;11/MV4;11 cells,,,,,,,,,,,,,,,10.1002/anie.202204395,940.159,939.5006954,6.54,69,8,13,4,22,200.86,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-36(38-16-11-10-12-17-38)32-44(64)60-30-26-53(69,27-31-60)34-61-35-56-46-47(52(61)68)58-59(2)48(46)39-22-20-37(21-23-39)33-54-28-13-8-6-4-3-5-7-9-14-29-55-41-19-15-18-40-45(41)51(67)62(50(40)66)42-24-25-43(63)57-49(42)65/h10-12,15-23,35-36,42,54-55,69H,3-9,13-14,24-34H2,1-2H3,(H,57,63,65)/t36-,42?/m1/s1",BNUWENPJQLIQFO-RTAOZKFSSA-N
5460,35.5,99,35.5,,P00533,EGFR L858R/T790M,CRBN,,,C#CCN(CCC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)CCN(C)C1=CC(OC)=C(NC2=NC=CC(C3=CN(C)C4=CC=CC=C34)=N2)C=C1NC(=O)C=C,Degradation of EGFR L858R/T790M in NCI-H1975 cells after 72h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58.1/1210/>100000,Inhibit proliferation of H1975/HCC827/A549 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114509,822.927,822.3601792,2.9,61,7,12,4,16,183.13,C45H46N10O6,"InChI=1S/C45H46N10O6/c1-6-20-54(21-18-42(58)47-32-13-10-12-29-31(32)27-55(44(29)60)37-15-16-41(57)51-43(37)59)23-22-52(3)38-25-39(61-5)35(24-34(38)48-40(56)7-2)50-45-46-19-17-33(49-45)30-26-53(4)36-14-9-8-11-28(30)36/h1,7-14,17,19,24-26,37H,2,15-16,18,20-23,27H2,3-5H3,(H,47,58)(H,48,56)(H,46,49,50)(H,51,57,59)",XCZMVDGRCQBGPQ-UHFFFAOYSA-N
5461,13.2,99,13.2,,P00533,EGFR L858R/T790M,CRBN,,,C#CCN(CCCC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)CCN(C)C1=CC(OC)=C(NC2=NC=CC(C3=CN(C)C4=CC=CC=C34)=N2)C=C1NC(=O)C=C,Degradation of EGFR L858R/T790M in NCI-H1975 cells after 72h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46.8/1120/>100000,Inhibit proliferation of H1975/HCC827/A549 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114509,836.954,836.3758293,3.25,62,7,12,4,17,183.13,C46H48N10O6,"InChI=1S/C46H48N10O6/c1-6-21-55(22-11-16-42(58)48-33-14-10-13-30-32(33)28-56(45(30)61)38-17-18-43(59)52-44(38)60)24-23-53(3)39-26-40(62-5)36(25-35(39)49-41(57)7-2)51-46-47-20-19-34(50-46)31-27-54(4)37-15-9-8-12-29(31)37/h1,7-10,12-15,19-20,25-27,38H,2,11,16-18,21-24,28H2,3-5H3,(H,48,58)(H,49,57)(H,47,50,51)(H,52,59,60)",MTMBWVDGSVDKJC-UHFFFAOYSA-N
5478,7.1,99,7.1,,P00533,EGFR e19d,VHL,,MS9449,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCN(C(=O)CCCCCCCCCCNC(=O)C[C@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](C2=CC(C)=NO2)C(C)C)C2=CC=C(C3=C(C)N=CS3)C=C2)CC1,Degradation of EGFR Del19 in HCC-827 cells after 16h treatment,,,,,,,10�� 17��,Binding affinity of EGFR/EGFR L858R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,250,Inhibit proliferation of HCC-827 cells,,,,,,,,,,,10.1021/acs.jmedchem.2c00345,1151.848,1150.524086,9.57,81,8,15,4,28,217.48,C60H76ClFN10O8S,"InChI=1S/C60H76ClFN10O8S/c1-38(2)56(53-29-39(3)69-80-53)60(77)72-35-44(73)31-50(72)59(76)68-48(41-16-18-42(19-17-41)57-40(4)66-37-81-57)34-54(74)63-22-13-11-9-7-6-8-10-12-15-55(75)71-26-24-70(25-27-71)23-14-28-79-52-32-45-49(33-51(52)78-5)64-36-65-58(45)67-43-20-21-47(62)46(61)30-43/h16-21,29-30,32-33,36-38,44,48,50,56,73H,6-15,22-28,31,34-35H2,1-5H3,(H,63,74)(H,68,76)(H,64,65,67)/t44-,48+,50+,56-/m1/s1",VDUPETHSNLCFNB-HHHFUCLFSA-N
5519,82,99,82,,P00533,EGFR e19d,CRBN,,MS9427,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCN(C(=O)CCOCCOCCOCCOCCOCCNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,Degradation of EGFR Del19 in HCC-827 cells after 16h treatment,,,,,,,7.1/4.3,Binding affinity of EGFR/EGFR L858R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,870,Inhibit proliferation of HCC-827 cells,,,,,,,,,,,10.1021/acs.jmedchem.2c00345,993.487,992.3846752,2.83,70,7,17,3,28,221.55,C48H58ClFN8O12,"InChI=1S/C48H58ClFN8O12/c1-64-41-30-39-36(45(53-31-52-39)54-33-4-6-38(50)37(49)28-33)29-42(41)70-16-2-11-56-12-14-57(15-13-56)44(60)9-17-65-19-21-67-23-25-69-26-24-68-22-20-66-18-10-51-32-3-5-34-35(27-32)48(63)58(47(34)62)40-7-8-43(59)55-46(40)61/h3-6,27-31,40,51H,2,7-26H2,1H3,(H,52,53,54)(H,55,59,61)",DJJBJKUHJYCNMD-UHFFFAOYSA-N
5546,5.84,96,5.84,96,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C2CCN(CC#CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC2)CC1,Degradation of BTK in Mino cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,104.69,Inhibit cell growth of Jeko-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00324,749.876,749.3438009,4.26,56,9,11,2,7,151.81,C43H43N9O4,"InChI=1S/C43H43N9O4/c44-40-38-39(29-9-11-34(12-10-29)56-33-6-2-1-3-7-33)48-52(41(38)46-27-45-40)32-18-23-50(24-19-32)31-16-21-49(22-17-31)20-4-5-28-8-13-35-30(25-28)26-51(43(35)55)36-14-15-37(53)47-42(36)54/h1-3,6-13,25,27,31-32,36H,14-24,26H2,(H2,44,45,46)(H,47,53,54)",VJBTZFUBOYQFGT-UHFFFAOYSA-N
5564,28,95,28,>95,P31749,AKT1,CRBN,,,CN1N=CC(Cl)=C1C1=C(Cl)OC(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3=CC=C(OCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)C[C@H]2C2=CC=CC(F)=C2)=C1,Degradation of AKT in Jeko-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,205.1/2274.33/23.45,Inhibit cell proliferation of Jeko-1 (7 days)/Mino (7 days)/MM.1S (7 days) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114459,973.843,972.2776233,4.76,68,8,14,5,19,224.46,C47H47Cl2FN8O10,"InChI=1S/C47H47Cl2FN8O10/c1-57-42(34(48)24-53-57)33-23-38(68-43(33)49)45(62)55-36-25-52-29(21-32(36)26-4-2-5-27(50)20-26)22-40(60)54-28-8-10-30(11-9-28)67-19-18-66-17-16-65-15-14-51-35-7-3-6-31-41(35)47(64)58(46(31)63)37-12-13-39(59)56-44(37)61/h2-11,20,23-24,29,32,36-37,51-52H,12-19,21-22,25H2,1H3,(H,54,60)(H,55,62)(H,56,59,61)/t29-,32-,36+,37?/m0/s1",LSIDXOKLOKUYHG-ADRGVZEMSA-N
5611,355.9,83,355.9,83,P00533,EGFR L858R/T790M,CRBN,,,C=CC(=O)NC1=CC=CC(NC2=NC(NC3=CC=C(N4CCN(CC(=O)NCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3OC)=NC=C2C(F)(F)F)=C1,Degradation of EGFR L858R/T790M in H1975 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,750,Inhibit cell proliferation of PC-9 (EGFR Del19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114455,869.862,869.3220773,4.29,63,7,14,6,15,219.33,C42H42F3N11O7,"InChI=1S/C42H42F3N11O7/c1-3-33(57)49-24-6-4-7-25(20-24)50-37-28(42(43,44)45)22-48-41(53-37)51-29-11-10-26(21-32(29)63-2)55-18-16-54(17-19-55)23-35(59)47-15-14-46-30-9-5-8-27-36(30)40(62)56(39(27)61)31-12-13-34(58)52-38(31)60/h3-11,20-22,31,46H,1,12-19,23H2,2H3,(H,47,59)(H,49,57)(H,52,58,60)(H2,48,50,51,53)",FVYDZXSZKLYSRY-UHFFFAOYSA-N
5624,1440,99,1440,,P03436,HA,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOCCNC(=O)[C@]34CCC(C)(C)CC3C3=CCC5[C@@]6(C)CC[C@H](O)C(C)(C)C6CC[C@@]5(C)[C@]3(C)CC4)C(C)(C)C)C=C2)SC=N1,Degradation of HA in 293T cells after 10h treatment,,,,,,,3180,Binding affinity of HA,,,,,,,,,,,,,,,9250,Binding affinity of VHL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4530/5980/8980,Anti-Influenza virus activity of A/WSN/33 (H1N1)/ A/California/08/2009 (H1N1)/ A/Aichi/2/68 (H3N2),,,,,,,,,,,,,10.1021/acs.jmedchem.1c02013,1072.508,1071.669401,8.81,76,8,11,5,19,188.65,C61H93N5O9S,"InChI=1S/C61H93N5O9S/c1-39-50(76-38-64-39)41-14-12-40(13-15-41)36-63-52(70)45-34-42(67)37-66(45)53(71)51(55(2,3)4)65-49(69)20-28-73-30-32-75-33-31-74-29-27-62-54(72)61-25-23-56(5,6)35-44(61)43-16-17-47-58(9)21-19-48(68)57(7,8)46(58)18-22-60(47,11)59(43,10)24-26-61/h12-16,38,42,44-48,51,67-68H,17-37H2,1-11H3,(H,62,72)(H,63,70)(H,65,69)/t42-,44?,45+,46?,47?,48+,51-,58+,59-,60-,61+/m1/s1",GTMVLEBKSVQAQY-ILZWUNRDSA-N
5634,42,77,42,77,P61964,WDR5,CRBN,,,CN1CCN(C2=CC=C(C3=CC=CC(CN4CCN(CCNC(=O)CCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=C3)C=C2NC(=O)C2=C[NH]C(=O)C=C2C(F)(F)F)CC1,Degradation of WDR5 in MV4;11 cells after 18h treatment,,,,,,,125,ITC,,,,-9.381,,ITC,,,,,,,,,14800,ITC,,,,-11,,ITC,,,,,,,,,63.7,ITC,,,,-8.327,,ITC,,,,,,,,,180/510/540,Inhibit cell growth of MV4;11/EOL1/RS4;11 cells,,,,,,,,,,,10.1038/s41388-022-02340-8,995.117,994.467679,4.24,72,8,12,5,19,199.6,C52H61F3N10O7,"InChI=1S/C52H61F3N10O7/c1-61-21-27-64(28-22-61)42-15-14-36(30-41(42)59-48(69)38-32-58-46(68)31-39(38)52(53,54)55)35-10-7-9-34(29-35)33-63-25-23-62(24-26-63)20-19-57-44(66)13-5-3-2-4-6-18-56-40-12-8-11-37-47(40)51(72)65(50(37)71)43-16-17-45(67)60-49(43)70/h7-12,14-15,29-32,43,56H,2-6,13,16-28,33H2,1H3,(H,57,66)(H,58,68)(H,59,69)(H,60,67,70)",STBAQMSNPQNEBZ-UHFFFAOYSA-N
5655,,,43.4,,P00533,EGFR,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NC(=O)COCCOCCN4N=C5[NH]C6=CC=CC=C6N=C5C4=O)=C3C2=O)C(=O)N1,Degradation of EGFR in A549 cells after 48h treatment,,,220,Binding affinity to EGFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7870/3890/6190,Inhibit cell proliferation of MCF-7/HepG-2/HCT-116 cells,,,,,,,,,,,,,,,10.1080/14756366.2022.2062338,587.549,587.1764608,-0.01,43,6,11,3,10,194.68,C28H25N7O8,"InChI=1S/C28H25N7O8/c36-20-9-8-19(25(38)32-20)35-26(39)15-4-3-7-18(22(15)27(35)40)29-21(37)14-43-13-12-42-11-10-34-28(41)23-24(33-34)31-17-6-2-1-5-16(17)30-23/h1-7,19H,8-14H2,(H,29,37)(H,31,33)(H,32,36,38)",OXSXZSPEDPGYSH-UHFFFAOYSA-N
5656,32.9,95,32.9,,P00533,EGFR,CRBN,,,CN1C(=O)C(C(=O)NNCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=NC2=CC=CC=C21,Degradation of EGFR in A549 cells after 48h treatment,,,100,Binding affinity to EGFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3920/3020/3320,Inhibit cell proliferation of MCF-7/HepG-2/HCT-116 cells,,,,,,,,,,,,,,,10.1080/14756366.2022.2062338,619.591,619.2026755,0.26,45,5,12,4,12,207.13,C29H29N7O9,"InChI=1S/C29H29N7O9/c1-35-19-8-3-2-6-17(19)32-24(29(35)43)26(40)34-30-11-12-44-13-14-45-15-22(38)31-18-7-4-5-16-23(18)28(42)36(27(16)41)20-9-10-21(37)33-25(20)39/h2-8,20,30H,9-15H2,1H3,(H,31,38)(H,34,40)(H,33,37,39)",MGPULBDTVXSSAA-UHFFFAOYSA-N
5682,,,>10000,,Q86WV6,STING,CRBN,,,O=C(/C=C/C(=O)NC1=CC=C(NC(=O)C2=CC=C([N+](=O)[O-])O2)C=C1)NCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of STING in THP-1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01948,671.623,671.1975901,2.16,49,5,11,5,13,239.16,C32H29N7O10,"InChI=1S/C32H29N7O10/c40-24(13-14-25(41)35-18-6-8-19(9-7-18)36-30(44)23-11-15-27(49-23)39(47)48)34-17-2-1-16-33-21-5-3-4-20-28(21)32(46)38(31(20)45)22-10-12-26(42)37-29(22)43/h3-9,11,13-15,22,33H,1-2,10,12,16-17H2,(H,34,40)(H,35,41)(H,36,44)(H,37,42,43)/b14-13+",CIXCETJIGABVDS-BUHFOSPRSA-N
5683,9200,99,9200,,Q86WV6,STING,CRBN,,,O=C(/C=C/C(=O)NC1=CC=C(NC(=O)C2=CC=C([N+](=O)[O-])O2)C=C1)NCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of STING in THP-1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01948,685.65,685.2132402,2.52,50,5,11,5,14,239.16,C33H31N7O10,"InChI=1S/C33H31N7O10/c41-25(14-15-26(42)36-19-7-9-20(10-8-19)37-31(45)24-12-16-28(50-24)40(48)49)35-18-3-1-2-17-34-22-6-4-5-21-29(22)33(47)39(32(21)46)23-11-13-27(43)38-30(23)44/h4-10,12,14-16,23,34H,1-3,11,13,17-18H2,(H,35,41)(H,36,42)(H,37,45)(H,38,43,44)/b15-14+",NWONOWWAHGLGNA-CCEZHUSRSA-N
5684,3200,99,3200,,Q86WV6,STING,CRBN,,,O=C(/C=C/C(=O)NC1=CC=C(NC(=O)C2=CC=C([N+](=O)[O-])O2)C=C1)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of STING in THP-1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01948,699.677,699.2288903,2.88,51,5,11,5,15,239.16,C34H33N7O10,"InChI=1S/C34H33N7O10/c42-26(15-16-27(43)37-20-8-10-21(11-9-20)38-32(46)25-13-17-29(51-25)41(49)50)36-19-4-2-1-3-18-35-23-7-5-6-22-30(23)34(48)40(33(22)47)24-12-14-28(44)39-31(24)45/h5-11,13,15-17,24,35H,1-4,12,14,18-19H2,(H,36,42)(H,37,43)(H,38,46)(H,39,44,45)/b16-15+",TXNQXRGOKABDOB-FOCLMDBBSA-N
5712,2000,92,2000,>92,Q9UGN5,PARP2,DCAF16,,,O=C(COC1=CC=C2C(=C1)CCCN2C(=O)CCl)NCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1,Degradation of PARP2 in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26/61/690,Inhibit cell proliferation of MDA-MB-436/Capan-1/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114321,787.333,786.3307892,5.46,56,6,7,2,16,145.01,C42H48ClFN6O6,"InChI=1S/C42H48ClFN6O6/c43-27-40(53)50-19-9-10-30-26-31(15-17-37(30)50)56-28-38(51)45-18-8-4-2-1-3-5-13-39(52)48-20-22-49(23-21-48)42(55)34-24-29(14-16-35(34)44)25-36-32-11-6-7-12-33(32)41(54)47-46-36/h6-7,11-12,14-17,24,26H,1-5,8-10,13,18-23,25,27-28H2,(H,45,51)(H,47,54)",GPQBXTHUVLRKEP-UHFFFAOYSA-N
5720,76,95,104/76,>90/>95,P01116,KRAS G12C,VHL,,,C=CC(=O)N1CCN(C2=NC(=O)N(C3=C(C)C=CN=C3C(C)C)C3=NC(C4=C(F)C=CC=C4OCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)=C(F)C=C23)[C@H](C)C1,Degradation of KRAS G12C in NCI-H358/MIA PaCa-2 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,310/78/>10000,Inhibit proliferation of NCI-H358 (KRAS G12C)/MIA PaCa-2 (KRAS G12C)/ASPC-1 (KRAS G12D) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115857,1073.281,1072.480472,7.02,77,8,14,3,17,205.08,C57H66F2N10O7S,"InChI=1S/C57H66F2N10O7S/c1-10-45(72)66-23-24-67(34(5)29-66)52-39-27-41(59)48(64-53(39)69(56(75)65-52)49-33(4)21-22-60-47(49)32(2)3)46-40(58)14-13-15-43(46)76-25-12-11-16-44(71)63-51(57(7,8)9)55(74)68-30-38(70)26-42(68)54(73)61-28-36-17-19-37(20-18-36)50-35(6)62-31-77-50/h10,13-15,17-22,27,31-32,34,38,42,51,70H,1,11-12,16,23-26,28-30H2,2-9H3,(H,61,73)(H,63,71)/t34-,38-,42+,51-/m1/s1",GOTQXALGADJXCG-MLGQTYOCSA-N
5730,28,95,67/28,>95/>95,P01116,KRAS G12C,VHL,,,C=CC(=O)N1CCN(C2=NC(=O)N(C3=C(C)C=CN=C3C(C)C)C3=NC(C4=C(F)C=CC=C4OCC4CCN(CCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)=C(F)C=C23)[C@@H](C)C1,Degradation of KRAS G12C in NCI-H358/MIA PaCa-2 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91/45/>10000,Inhibit proliferation of NCI-H358 (KRAS G12C)/MIA PaCa-2 (KRAS G12C)/ASPC-1 (KRAS G12D) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115857,1156.415,1155.553971,7.45,83,9,15,3,18,208.32,C62H75F2N11O7S,"InChI=1S/C62H75F2N11O7S/c1-10-50(78)72-27-28-73(38(5)32-72)57-44-30-46(64)53(69-58(44)75(61(81)70-57)54-37(4)20-23-65-52(54)36(2)3)51-45(63)13-11-14-48(51)82-34-41-21-25-71(26-22-41)24-12-15-49(77)68-56(62(7,8)9)60(80)74-33-43(76)29-47(74)59(79)66-31-40-16-18-42(19-17-40)55-39(6)67-35-83-55/h10-11,13-14,16-20,23,30,35-36,38,41,43,47,56,76H,1,12,15,21-22,24-29,31-34H2,2-9H3,(H,66,79)(H,68,77)/t38-,43+,47-,56+/m0/s1",LRCAYGWAXRSIDX-ZNRZZSIMSA-N
5741,1480,84.2,1480,84.2,P50395,GDI2,cIAP1,,,CC1=CC(C)=CC(COC2=CC3=C(C=C2OCC2=CC(C)=CC(C)=C2)[C@H]2C[C@](O)(CC4=CN(CCOCCOCCOCCNC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC5=CC=CC=C5)N=N4)C[C@H](C)N2CC3)=C1,Degradation of GDI2 in AsPC-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacsau.3c00228,1032.337,1031.609577,6.43,75,7,14,5,28,204.78,C59H81N7O9,"InChI=1S/C59H81N7O9/c1-39(2)23-52(62-58(69)56(67)51(60)30-45-11-9-8-10-12-45)57(68)61-14-17-71-19-21-73-22-20-72-18-16-65-36-49(63-64-65)34-59(70)33-44(7)66-15-13-48-31-54(74-37-46-26-40(3)24-41(4)27-46)55(32-50(48)53(66)35-59)75-38-47-28-42(5)25-43(6)29-47/h8-12,24-29,31-32,36,39,44,51-53,56,67,70H,13-23,30,33-35,37-38,60H2,1-7H3,(H,61,68)(H,62,69)/t44-,51+,52+,53+,56-,59+/m0/s1",MJHIWLXBPBFJAP-UROWPWKKSA-N
5742,730,99,730,,P11802,CDK4,CRBN,,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]3(C)CC[C@@]4(C)CC[C@@](C)(C(=O)OCCCOC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C[C@H]4[C@]3(C)CC[C@@]21C,Degradation of CDK4 in 4T1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejps.2023.106624,821.968,821.388745,6.98,60,8,11,3,9,185.48,C47H55N3O10,"InChI=1S/C47H55N3O10/c1-26-27-11-13-33-45(4,29(27)23-32(51)38(26)54)18-20-47(6)34-24-44(3,16-15-43(34,2)17-19-46(33,47)5)42(58)60-22-8-21-59-36(53)25-48-30-10-7-9-28-37(30)41(57)50(40(28)56)31-12-14-35(52)49-39(31)55/h7,9-11,13,23,31,34,48,54H,8,12,14-22,24-25H2,1-6H3,(H,49,52,55)/t31?,34-,43-,44-,45+,46-,47+/m1/s1",ITPPCLZSPZXHER-QQOWXAISSA-N
5742,790,99,790,,P06493,CDK1,CRBN,,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]3(C)CC[C@@]4(C)CC[C@@](C)(C(=O)OCCCOC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C[C@H]4[C@]3(C)CC[C@@]21C,Degradation of CDK1 in 4T1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejps.2023.106624,821.968,821.388745,6.98,60,8,11,3,9,185.48,C47H55N3O10,"InChI=1S/C47H55N3O10/c1-26-27-11-13-33-45(4,29(27)23-32(51)38(26)54)18-20-47(6)34-24-44(3,16-15-43(34,2)17-19-46(33,47)5)42(58)60-22-8-21-59-36(53)25-48-30-10-7-9-28-37(30)41(57)50(40(28)56)31-12-14-35(52)49-39(31)55/h7,9-11,13,23,31,34,48,54H,8,12,14-22,24-25H2,1-6H3,(H,49,52,55)/t31?,34-,43-,44-,45+,46-,47+/m1/s1",ITPPCLZSPZXHER-QQOWXAISSA-N
5742,980,99,980,,P14625,GRP94,CRBN,,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]3(C)CC[C@@]4(C)CC[C@@](C)(C(=O)OCCCOC(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C[C@H]4[C@]3(C)CC[C@@]21C,Degradation of GRP94 in 4T1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejps.2023.106624,821.968,821.388745,6.98,60,8,11,3,9,185.48,C47H55N3O10,"InChI=1S/C47H55N3O10/c1-26-27-11-13-33-45(4,29(27)23-32(51)38(26)54)18-20-47(6)34-24-44(3,16-15-43(34,2)17-19-46(33,47)5)42(58)60-22-8-21-59-36(53)25-48-30-10-7-9-28-37(30)41(57)50(40(28)56)31-12-14-35(52)49-39(31)55/h7,9-11,13,23,31,34,48,54H,8,12,14-22,24-25H2,1-6H3,(H,49,52,55)/t31?,34-,43-,44-,45+,46-,47+/m1/s1",ITPPCLZSPZXHER-QQOWXAISSA-N
5753,4.7,99,4.7,,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC1CCN(C3=CC=C(C(=O)NC4CCC(=O)NC4=O)C(F)=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in MOLT4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00851,745.281,744.2409286,4.46,52,7,10,3,8,150.68,C37H38ClFN8O4S,"InChI=1S/C37H38ClFN8O4S/c1-19-20(2)52-37-32(19)33(23-4-6-24(38)7-5-23)41-29(34-45-44-21(3)47(34)37)17-31(49)40-18-22-12-14-46(15-13-22)25-8-9-26(27(39)16-25)35(50)42-28-10-11-30(48)43-36(28)51/h4-9,16,22,28-29H,10-15,17-18H2,1-3H3,(H,40,49)(H,42,50)(H,43,48,51)/t28?,29-/m0/s1",NTNMFROSEFWETI-XIJSCUBXSA-N
5756,0.59,99,0.59,,O60885,BRD4,CRBN,,,COC1=CC(N2CCC(CNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)CC2)=CC=C1C(=O)NC1CCC(=O)NC1=O,Degradation of BRD4 in MOLT4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00851,757.317,756.2609151,4.33,53,7,11,3,9,159.91,C38H41ClN8O5S,"InChI=1S/C38H41ClN8O5S/c1-20-21(2)53-38-33(20)34(24-5-7-25(39)8-6-24)41-29(35-45-44-22(3)47(35)38)18-32(49)40-19-23-13-15-46(16-14-23)26-9-10-27(30(17-26)52-4)36(50)42-28-11-12-31(48)43-37(28)51/h5-10,17,23,28-29H,11-16,18-19H2,1-4H3,(H,40,49)(H,42,50)(H,43,48,51)/t28?,29-/m0/s1",BIVJJLVZJPBUMK-XIJSCUBXSA-N
5785,25.23,99,25.23,,P09874,PARP1,CRBN,,,NC(=O)C1=CC=CC2=CN(C3=CC=C([C@@H]4CCCN(CCC5CCN(CCC6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C4)C=C3)N=C12,Degradation of PARP1 in MDA-MB-231 cells after 24 h treatment,72.60/84.28/87.96,% PARP1 degradation in MDA-MB-231 cells after 24 h treatment at 10000/1000/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106952,798.989,798.4217168,4.95,59,9,10,2,11,154.18,C46H54N8O5,"InChI=1S/C46H54N8O5/c47-43(56)38-5-1-3-34-29-53(49-42(34)38)35-8-6-32(7-9-35)33-4-2-20-51(28-33)24-17-30-14-21-50(22-15-30)23-16-31-18-25-52(26-19-31)36-10-11-37-39(27-36)46(59)54(45(37)58)40-12-13-41(55)48-44(40)57/h1,3,5-11,27,29-31,33,40H,2,4,12-26,28H2,(H2,47,56)(H,48,55,57)/t33-,40?/m1/s1",LEEQVWADUSPZDL-DGRXGLRRSA-N
5794,217.15,99,217.15,,P17706,PTPN2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTPN2 in Jurkat cells,43.18/81.39/98.51,% PTPN2 degradation in Jurkat cells at 100/1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,960.124,959.3469945,4.25,67,7,13,6,16,245.26,C46H54FN9O9S2,"InChI=1S/C46H54FN9O9S2/c1-26(28-10-12-29(13-11-28)42-27(2)49-25-66-42)51-44(62)35-19-33(57)22-55(35)45(63)43(46(3,4)5)52-37(59)9-7-6-8-16-48-38(60)23-54-21-32(20-50-54)30-14-15-31-18-36(58)41(40(47)34(31)17-30)56-24-39(61)53-67(56,64)65/h10-15,17-18,20-21,25-26,33,35,43,57-58H,6-9,16,19,22-24H2,1-5H3,(H,48,60)(H,51,62)(H,52,59)(H,53,61)/t26-,33+,35-,43+/m0/s1",IIXYRNNDTCOMFH-GCTVZYRCSA-N
5794,13079,99,13079,,P18031,PTP1B,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTP1B in Jurkat cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,960.124,959.3469945,4.25,67,7,13,6,16,245.26,C46H54FN9O9S2,"InChI=1S/C46H54FN9O9S2/c1-26(28-10-12-29(13-11-28)42-27(2)49-25-66-42)51-44(62)35-19-33(57)22-55(35)45(63)43(46(3,4)5)52-37(59)9-7-6-8-16-48-38(60)23-54-21-32(20-50-54)30-14-15-31-18-36(58)41(40(47)34(31)17-30)56-24-39(61)53-67(56,64)65/h10-15,17-18,20-21,25-26,33,35,43,57-58H,6-9,16,19,22-24H2,1-5H3,(H,48,60)(H,51,62)(H,52,59)(H,53,61)/t26-,33+,35-,43+/m0/s1",IIXYRNNDTCOMFH-GCTVZYRCSA-N
5795,94.08,99,94.08,,P17706,PTPN2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTPN2 in Jurkat cells,40.19/83.91/98.69,% PTPN2 degradation in Jurkat cells at 100/1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,974.151,973.3626446,4.79,68,7,13,6,17,245.26,C47H56FN9O9S2,"InChI=1S/C47H56FN9O9S2/c1-27(29-11-13-30(14-12-29)43-28(2)50-26-67-43)52-45(63)36-20-34(58)23-56(36)46(64)44(47(3,4)5)53-38(60)10-8-6-7-9-17-49-39(61)24-55-22-33(21-51-55)31-15-16-32-19-37(59)42(41(48)35(32)18-31)57-25-40(62)54-68(57,65)66/h11-16,18-19,21-22,26-27,34,36,44,58-59H,6-10,17,20,23-25H2,1-5H3,(H,49,61)(H,52,63)(H,53,60)(H,54,62)/t27-,34+,36-,44+/m0/s1",YPNTWELSICLQGZ-PVPOIWBDSA-N
5795,141.99,99,141.99,,P18031,PTP1B,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTP1B in Jurkat cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,974.151,973.3626446,4.79,68,7,13,6,17,245.26,C47H56FN9O9S2,"InChI=1S/C47H56FN9O9S2/c1-27(29-11-13-30(14-12-29)43-28(2)50-26-67-43)52-45(63)36-20-34(58)23-56(36)46(64)44(47(3,4)5)53-38(60)10-8-6-7-9-17-49-39(61)24-55-22-33(21-51-55)31-15-16-32-19-37(59)42(41(48)35(32)18-31)57-25-40(62)54-68(57,65)66/h11-16,18-19,21-22,26-27,34,36,44,58-59H,6-10,17,20,23-25H2,1-5H3,(H,49,61)(H,52,63)(H,53,60)(H,54,62)/t27-,34+,36-,44+/m0/s1",YPNTWELSICLQGZ-PVPOIWBDSA-N
5796,76.94,99,76.94,,P17706,PTPN2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTPN2 in Jurkat cells,37.02/83.96/99.32,% PTPN2 degradation in Jurkat cells at 100/1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,988.178,987.3782947,5.34,69,7,13,6,18,245.26,C48H58FN9O9S2,"InChI=1S/C48H58FN9O9S2/c1-28(30-12-14-31(15-13-30)44-29(2)51-27-68-44)53-46(64)37-21-35(59)24-57(37)47(65)45(48(3,4)5)54-39(61)11-9-7-6-8-10-18-50-40(62)25-56-23-34(22-52-56)32-16-17-33-20-38(60)43(42(49)36(33)19-32)58-26-41(63)55-69(58,66)67/h12-17,19-20,22-23,27-28,35,37,45,59-60H,6-11,18,21,24-26H2,1-5H3,(H,50,62)(H,53,64)(H,54,61)(H,55,63)/t28-,35+,37-,45+/m0/s1",KRXIZJMDUWXHAD-CTBCQDHJSA-N
5796,758.9,99,758.9,,P18031,PTP1B,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTP1B in Jurkat cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,988.178,987.3782947,5.34,69,7,13,6,18,245.26,C48H58FN9O9S2,"InChI=1S/C48H58FN9O9S2/c1-28(30-12-14-31(15-13-30)44-29(2)51-27-68-44)53-46(64)37-21-35(59)24-57(37)47(65)45(48(3,4)5)54-39(61)11-9-7-6-8-10-18-50-40(62)25-56-23-34(22-52-56)32-16-17-33-20-38(60)43(42(49)36(33)19-32)58-26-41(63)55-69(58,66)67/h12-17,19-20,22-23,27-28,35,37,45,59-60H,6-11,18,21,24-26H2,1-5H3,(H,50,62)(H,53,64)(H,54,61)(H,55,63)/t28-,35+,37-,45+/m0/s1",KRXIZJMDUWXHAD-CTBCQDHJSA-N
5798,571.35,99,571.35,,P17706,PTPN2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTPN2 in Jurkat cells,3.61/70.86/98.18,% PTPN2 degradation in Jurkat cells at 100/1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,1030.259,1029.425245,6.96,72,7,13,6,21,245.26,C51H64FN9O9S2,"InChI=1S/C51H64FN9O9S2/c1-31(33-15-17-34(18-16-33)47-32(2)54-30-71-47)56-49(67)40-24-38(62)27-60(40)50(68)48(51(3,4)5)57-42(64)14-12-10-8-6-7-9-11-13-21-53-43(65)28-59-26-37(25-55-59)35-19-20-36-23-41(63)46(45(52)39(36)22-35)61-29-44(66)58-72(61,69)70/h15-20,22-23,25-26,30-31,38,40,48,62-63H,6-14,21,24,27-29H2,1-5H3,(H,53,65)(H,56,67)(H,57,64)(H,58,66)/t31-,38+,40-,48+/m0/s1",DNMZPCNJJYYAJB-AXCUSVARSA-N
5798,1996,99,1996,,P18031,PTP1B,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)CN3C=C(C4=CC=C5C=C(O)C(N6CC(=O)NS6(=O)=O)=C(F)C5=C4)C=N3)C(C)(C)C)C=C2)SC=N1,Degradation of PTP1B in Jurkat cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01348,1030.259,1029.425245,6.96,72,7,13,6,21,245.26,C51H64FN9O9S2,"InChI=1S/C51H64FN9O9S2/c1-31(33-15-17-34(18-16-33)47-32(2)54-30-71-47)56-49(67)40-24-38(62)27-60(40)50(68)48(51(3,4)5)57-42(64)14-12-10-8-6-7-9-11-13-21-53-43(65)28-59-26-37(25-55-59)35-19-20-36-23-41(63)46(45(52)39(36)22-35)61-29-44(66)58-72(61,69)70/h15-20,22-23,25-26,30-31,38,40,48,62-63H,6-14,21,24,27-29H2,1-5H3,(H,53,65)(H,56,67)(H,57,64)(H,58,66)/t31-,38+,40-,48+/m0/s1",DNMZPCNJJYYAJB-AXCUSVARSA-N
5819,332.8,99,332.8,,P27361,ERK1,CRBN,,,CC1=CC=CC(CN2C(=O)C3=CC(C4=NC(NC5=CC=NC(C#CCCNC(=O)CCCCCCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)=C5)=NC=C4C)=CN3C[C@H]2C)=N1,Degradation of ERK1/2 in A375 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>30000/>30000/>30000,Inhibit cell growth of A375/Calu-6/HCT116 cells,,,,,,,,,,,,,,,10.3390/ijms242216290,932.099,931.4493285,6.18,69,8,13,4,19,213.51,C52H57N11O6,"InChI=1S/C52H57N11O6/c1-33-29-56-52(60-47(33)36-27-43-50(68)62(35(3)30-61(43)31-36)32-39-17-13-15-34(2)57-39)58-38-23-26-53-37(28-38)16-10-12-25-55-44(64)20-9-7-5-4-6-8-11-24-54-41-19-14-18-40-46(41)51(69)63(49(40)67)42-21-22-45(65)59-48(42)66/h13-15,17-19,23,26-29,31,35,42,54H,4-9,11-12,20-22,24-25,30,32H2,1-3H3,(H,55,64)(H,59,65,66)(H,53,56,58,60)/t35-,42?/m1/s1",SKCAYGRFKBENTQ-AAHGUQRTSA-N
5830,698.5,99,698.5,,P27361,ERK1,VHL,,,CC1=CC=CC(CN2C(=O)C3=CC(C4=NC(NC5=CC=NC(CCNC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)=C5)=NC=C4C)=CN3C[C@H]2C)=N1,Degradation of ERK1/2 in A375 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3390/ijms242216290,1093.413,1092.573149,7.41,79,8,14,5,23,229.56,C60H76N12O6S,"InChI=1S/C60H76N12O6S/c1-37-31-63-59(69-53(37)44-28-50-57(77)71(39(3)32-70(50)33-44)34-47-17-15-16-38(2)65-47)67-46-25-26-61-45(29-46)24-27-62-51(74)18-13-11-9-10-12-14-19-52(75)68-55(60(6,7)8)58(78)72-35-48(73)30-49(72)56(76)66-40(4)42-20-22-43(23-21-42)54-41(5)64-36-79-54/h15-17,20-23,25-26,28-29,31,33,36,39-40,48-49,55,73H,9-14,18-19,24,27,30,32,34-35H2,1-8H3,(H,62,74)(H,66,76)(H,68,75)(H,61,63,67,69)/t39-,40+,48-,49+,55-/m1/s1",ZNDOVLRATFZLLC-XNPXOGPCSA-N
5831,383,99,383,,P27361,ERK1,VHL,,,CC1=CC=CC(CN2C(=O)C3=CC(C4=NC(NC5=CC=NC(CCNC(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)=C5)=NC=C4C)=CN3C[C@H]2C)=N1,Degradation of ERK1/2 in A375 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7500/>30000/11700,Inhibit cell growth of A375/Calu-6/HCT116 cells,,,,,,,,,,,,,,,10.3390/ijms242216290,1121.467,1120.604449,8.5,81,8,14,5,25,229.56,C62H80N12O6S,"InChI=1S/C62H80N12O6S/c1-39-33-65-61(71-55(39)46-30-52-59(79)73(41(3)34-72(52)35-46)36-49-19-17-18-40(2)67-49)69-48-27-28-63-47(31-48)26-29-64-53(76)20-15-13-11-9-10-12-14-16-21-54(77)70-57(62(6,7)8)60(80)74-37-50(75)32-51(74)58(78)68-42(4)44-22-24-45(25-23-44)56-43(5)66-38-81-56/h17-19,22-25,27-28,30-31,33,35,38,41-42,50-51,57,75H,9-16,20-21,26,29,32,34,36-37H2,1-8H3,(H,64,76)(H,68,78)(H,70,77)(H,63,65,69,71)/t41-,42+,50-,51+,57-/m1/s1",IKIAJCCCQQYJIL-KPTVOSCSSA-N
5832,306.9,99,306.9,,P27361,ERK1,VHL,,,CC1=CC=CC(CN2C(=O)C3=CC(C4=NC(NC5=CC=NC(CCNC(=O)CCCCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)=C5)=NC=C4C)=CN3C[C@H]2C)=N1,Degradation of ERK1/2 in A375 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3390/ijms242216290,1149.521,1148.635749,9.58,83,8,14,5,27,229.56,C64H84N12O6S,"InChI=1S/C64H84N12O6S/c1-41-35-67-63(73-57(41)48-32-54-61(81)75(43(3)36-74(54)37-48)38-51-21-19-20-42(2)69-51)71-50-29-30-65-49(33-50)28-31-66-55(78)22-17-15-13-11-9-10-12-14-16-18-23-56(79)72-59(64(6,7)8)62(82)76-39-52(77)34-53(76)60(80)70-44(4)46-24-26-47(27-25-46)58-45(5)68-40-83-58/h19-21,24-27,29-30,32-33,35,37,40,43-44,52-53,59,77H,9-18,22-23,28,31,34,36,38-39H2,1-8H3,(H,66,78)(H,70,80)(H,72,79)(H,65,67,71,73)/t43-,44+,52-,53+,59-/m1/s1",RBDIPEKZTZKBDR-ZFXOCLDHSA-N
5834,85,99,102/85,,P27361,ERK1,CRBN,,,CC1=CC=CC(CN2C(=O)C3=CC(C4=NC(NC5=CC=NC(C#CCCN(C)CCCCCCCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)=C5)=NC=C4C)=CN3C[C@H]2C)=N1,Degradation of ERK1/2 in HCT116/Calu-6 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16800/6500/17800,Inhibit cell growth of A375/Calu-6/HCT116 cells,,,,,,,,,,,,,,,10.3390/ijms242216290,932.143,931.4857141,7.33,69,8,13,3,20,187.65,C53H61N11O5,"InChI=1S/C53H61N11O5/c1-35-31-56-53(60-48(35)38-29-45-51(68)63(37(3)32-62(45)33-38)34-41-19-15-17-36(2)57-41)58-40-24-26-54-39(30-40)18-11-14-28-61(4)27-13-10-8-6-5-7-9-12-25-55-43-21-16-20-42-47(43)52(69)64(50(42)67)44-22-23-46(65)59-49(44)66/h15-17,19-21,24,26,29-31,33,37,44,55H,5-10,12-14,22-23,25,27-28,32,34H2,1-4H3,(H,59,65,66)(H,54,56,58,60)/t37-,44?/m1/s1",ZZCHFVIHRYRBLS-AWSVAJQLSA-N
5839,1.26,86.8,1.26,86.8,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,58,% FLT3 degradation in MV4-11 cells at 10 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,852.95,852.3918732,2.83,62,8,15,4,13,230.96,C43H52N10O9,"InChI=1S/C43H52N10O9/c1-3-29-39(45-25-13-21-61-22-14-25)49-40(37(47-29)38(44)56)46-26-7-8-30(33(23-26)60-2)51-15-11-27(12-16-51)50-17-19-52(20-18-50)35(55)24-62-32-6-4-5-28-36(32)43(59)53(42(28)58)31-9-10-34(54)48-41(31)57/h4-8,23,25,27,31H,3,9-22,24H2,1-2H3,(H2,44,56)(H2,45,46,49)(H,48,54,57)",RAPZFEJMNCDSTP-UHFFFAOYSA-N
5850,0.98,85,0.98,85,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,60,% FLT3 degradation in MV4-11 cells at 10 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,851.966,851.4078577,3.4,62,8,15,5,13,233.76,C43H53N11O8,"InChI=1S/C43H53N11O8/c1-3-29-39(46-25-13-21-62-22-14-25)50-40(37(48-29)38(44)57)47-26-7-8-31(33(23-26)61-2)52-15-11-27(12-16-52)51-17-19-53(20-18-51)35(56)24-45-30-6-4-5-28-36(30)43(60)54(42(28)59)32-9-10-34(55)49-41(32)58/h4-8,23,25,27,32,45H,3,9-22,24H2,1-2H3,(H2,44,57)(H2,46,47,50)(H,49,55,58)",NSWZQYGDWCUSDT-UHFFFAOYSA-N
5852,2.26,77.2,2.26,77.2,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)CCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,66,% FLT3 degradation in MV4-11 cells at 10 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,908.074,907.4704579,4.37,66,8,15,5,17,233.76,C47H61N11O8,"InChI=1S/C47H61N11O8/c1-3-33-43(50-29-17-26-66-27-18-29)54-44(41(52-33)42(48)61)51-30-11-12-35(37(28-30)65-2)56-20-15-31(16-21-56)55-22-24-57(25-23-55)39(60)10-5-4-6-19-49-34-9-7-8-32-40(34)47(64)58(46(32)63)36-13-14-38(59)53-45(36)62/h7-9,11-12,28-29,31,36,49H,3-6,10,13-27H2,1-2H3,(H2,48,61)(H2,50,51,54)(H,53,59,62)",FYKDAWGISLGSMC-UHFFFAOYSA-N
5860,0.64,94.8,0.64,94.8,P36888,FLT3,CRBN,,LWY713,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)COC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibit proliferation of MV4-11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,838.967,838.4126087,2.89,61,8,14,4,13,213.89,C43H54N10O8,"InChI=1S/C43H54N10O8/c1-3-31-40(45-26-13-21-60-22-14-26)49-41(38(47-31)39(44)56)46-27-7-8-32(35(23-27)59-2)51-15-11-28(12-16-51)50-17-19-52(20-18-50)37(55)25-61-34-6-4-5-29-30(34)24-53(43(29)58)33-9-10-36(54)48-42(33)57/h4-8,23,26,28,33H,3,9-22,24-25H2,1-2H3,(H2,44,56)(H2,45,46,49)(H,48,54,57)",RVOJNJLWNBVPOR-UHFFFAOYSA-N
5861,1.01,99,1.01,,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,838.967,838.4126087,2.89,61,8,14,4,13,213.89,C43H54N10O8,"InChI=1S/C43H54N10O8/c1-3-30-40(45-27-13-21-60-22-14-27)49-41(38(47-30)39(44)56)46-28-7-8-31(34(23-28)59-2)51-15-11-29(12-16-51)50-17-19-52(20-18-50)36(55)25-61-33-6-4-5-26-24-53(43(58)37(26)33)32-9-10-35(54)48-42(32)57/h4-8,23,27,29,32H,3,9-22,24-25H2,1-2H3,(H2,44,56)(H2,45,46,49)(H,48,54,57)",YGEIDQKYJCPMLJ-UHFFFAOYSA-N
5864,,,>10000,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,861.078,860.3931191,7.78,62,7,10,4,16,183.94,C48H56N6O7S,"InChI=1S/C48H56N6O7S/c1-29-43(62-28-52-29)32-15-13-30(14-16-32)25-49-45(57)40-23-34(55)26-54(40)46(58)44(48(2,3)4)53-41(56)12-6-5-9-21-61-35-18-20-37-39(24-35)50-27-51-42(37)33-17-19-36(47(59)60)38(22-33)31-10-7-8-11-31/h13-20,22,24,27-28,31,34,40,44,55H,5-12,21,23,25-26H2,1-4H3,(H,49,57)(H,53,56)(H,59,60)/t34-,40+,44-/m1/s1",MYMMAYKVQURKJF-ATBXCTFTSA-N
5865,2000,99,2000,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,875.105,874.4087692,8.32,63,7,10,4,17,183.94,C49H58N6O7S,"InChI=1S/C49H58N6O7S/c1-30-44(63-29-53-30)33-16-14-31(15-17-33)26-50-46(58)41-24-35(56)27-55(41)47(59)45(49(2,3)4)54-42(57)13-7-5-6-10-22-62-36-19-21-38-40(25-36)51-28-52-43(38)34-18-20-37(48(60)61)39(23-34)32-11-8-9-12-32/h14-21,23,25,28-29,32,35,41,45,56H,5-13,22,24,26-27H2,1-4H3,(H,50,58)(H,54,57)(H,60,61)/t35-,41+,45-/m1/s1",CCOPILDPEARBMO-LOXJIAFCSA-N
5866,510,99,510,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,889.132,888.4244193,8.86,64,7,10,4,18,183.94,C50H60N6O7S,"InChI=1S/C50H60N6O7S/c1-31-45(64-30-54-31)34-17-15-32(16-18-34)27-51-47(59)42-25-36(57)28-56(42)48(60)46(50(2,3)4)55-43(58)14-8-6-5-7-11-23-63-37-20-22-39-41(26-37)52-29-53-44(39)35-19-21-38(49(61)62)40(24-35)33-12-9-10-13-33/h15-22,24,26,29-30,33,36,42,46,57H,5-14,23,25,27-28H2,1-4H3,(H,51,59)(H,55,58)(H,61,62)/t36-,42+,46-/m1/s1",BPKAAGOKQHTKFV-YPLFIJBFSA-N
5867,620,99,620,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,903.159,902.4400693,9.41,65,7,10,4,19,183.94,C51H62N6O7S,"InChI=1S/C51H62N6O7S/c1-32-46(65-31-55-32)35-18-16-33(17-19-35)28-52-48(60)43-26-37(58)29-57(43)49(61)47(51(2,3)4)56-44(59)15-9-7-5-6-8-12-24-64-38-21-23-40-42(27-38)53-30-54-45(40)36-20-22-39(50(62)63)41(25-36)34-13-10-11-14-34/h16-23,25,27,30-31,34,37,43,47,58H,5-15,24,26,28-29H2,1-4H3,(H,52,60)(H,56,59)(H,62,63)/t37-,43+,47-/m1/s1",HOZVXORIADGNTM-IYUQQWMQSA-N
5868,290,99,290,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,917.186,916.4557194,9.95,66,7,10,4,20,183.94,C52H64N6O7S,"InChI=1S/C52H64N6O7S/c1-33-47(66-32-56-33)36-19-17-34(18-20-36)29-53-49(61)44-27-38(59)30-58(44)50(62)48(52(2,3)4)57-45(60)16-10-8-6-5-7-9-13-25-65-39-22-24-41-43(28-39)54-31-55-46(41)37-21-23-40(51(63)64)42(26-37)35-14-11-12-15-35/h17-24,26,28,31-32,35,38,44,48,59H,5-16,25,27,29-30H2,1-4H3,(H,53,61)(H,57,60)(H,63,64)/t38-,44+,48-/m1/s1",OXICLXLJBMPGTO-LMIZGRGHSA-N
5869,530,99,530,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,931.213,930.4713695,10.49,67,7,10,4,21,183.94,C53H66N6O7S,"InChI=1S/C53H66N6O7S/c1-34-48(67-33-57-34)37-20-18-35(19-21-37)30-54-50(62)45-28-39(60)31-59(45)51(63)49(53(2,3)4)58-46(61)17-11-9-7-5-6-8-10-14-26-66-40-23-25-42-44(29-40)55-32-56-47(42)38-22-24-41(52(64)65)43(27-38)36-15-12-13-16-36/h18-25,27,29,32-33,36,39,45,49,60H,5-17,26,28,30-31H2,1-4H3,(H,54,62)(H,58,61)(H,64,65)/t39-,45+,49-/m1/s1",CAQJECYJOOWDAI-QZUXPVMFSA-N
5870,4500,99,4500,,Q96RR4,CAMKK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCOC3=CC=C4C(C5=CC=C(C(=O)O)C(C6CCCC6)=C5)=NC=NC4=C3)C(C)(C)C)C=C2)SC=N1,Degradation of CAMKK2 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01137,945.24,944.4870195,11.03,68,7,10,4,22,183.94,C54H68N6O7S,"InChI=1S/C54H68N6O7S/c1-35-49(68-34-58-35)38-21-19-36(20-22-38)31-55-51(63)46-29-40(61)32-60(46)52(64)50(54(2,3)4)59-47(62)18-12-10-8-6-5-7-9-11-15-27-67-41-24-26-43-45(30-41)56-33-57-48(43)39-23-25-42(53(65)66)44(28-39)37-16-13-14-17-37/h19-26,28,30,33-34,37,40,46,50,61H,5-18,27,29,31-32H2,1-4H3,(H,55,63)(H,59,62)(H,65,66)/t40-,46+,50-/m1/s1",FOOKQZXZENXTRY-HHMKCQLTSA-N
5908,35.8,99,35.8,,P17706,PTPN2,CRBN,,,CCC1=CC=C(C(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CC=C(C(F)(F)P(=O)(O)O)C=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CO[C@H]2C[C@@H](C)CC[C@@H]2C(C)C)C(=O)NCCOCCC(=O)NC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)C=C1,Degradation of TC-PTP in HEK293 cells after 16 h treatment,>95,% TC-PTP degradation in HEK293 cells at 1000 nM for 16h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d3sc04541b,1255.364,1254.557792,5.43,89,7,12,9,31,317.07,C64H81F2N8O14P,"InChI=1S/C64H81F2N8O14P/c1-5-41-18-22-44(23-19-41)58(78)67-30-10-9-15-50(59(79)68-31-33-87-32-29-56(76)69-49-16-11-14-47-48(49)37-74(63(47)83)53-27-28-55(75)73-62(53)82)71-61(81)52(36-43-20-24-45(25-21-43)64(65,66)89(84,85)86)72-60(80)51(35-42-12-7-6-8-13-42)70-57(77)38-88-54-34-40(4)17-26-46(54)39(2)3/h6-8,11-14,16,18-25,39-40,46,50-54H,5,9-10,15,17,26-38H2,1-4H3,(H,67,78)(H,68,79)(H,69,76)(H,70,77)(H,71,81)(H,72,80)(H,73,75,82)(H2,84,85,86)/t40-,46+,50-,51-,52-,53?,54-/m0/s1",TYEKCBCNQAFGHN-QSITVTTKSA-N
5934,1.8,99,1.8,,Q92918,MAP4K1,CRBN,,,COC1=CC=C(C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCOCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=C4)C=C23)C=C1OC,Degradation of HPK1 in Jurkat cells after 24 h treatment,99.29/100/100,% HPK1 degradation in Jurkat cells at 10000/1000/100 nM,140.5,Inhibit of HPK1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.107016,785.858,785.3173113,4.12,58,8,11,3,13,175.5,C43H43N7O8,"InChI=1S/C43H43N7O8/c1-56-35-12-8-27(23-36(35)57-2)32-25-46-40-31(32)22-28(24-45-40)26-6-9-29(10-7-26)48-16-18-49(19-17-48)38(52)14-20-58-21-15-44-33-5-3-4-30-39(33)43(55)50(42(30)54)34-11-13-37(51)47-41(34)53/h3-10,12,22-25,34,44H,11,13-21H2,1-2H3,(H,45,46)(H,47,51,53)",ZMJDTQAJPPHMDH-UHFFFAOYSA-N
5935,21,99,21,,Q92918,MAP4K1,CRBN,,,COC1=CC=C(C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCOCCOCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=C4)C=C23)C=C1OC,Degradation of HPK1 in Jurkat cells after 24 h treatment,89.80/95.80/94.41,% HPK1 degradation in Jurkat cells at 10000/1000/100 nM,159.2,Inhibit of HPK1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.107016,829.911,829.3435261,3.97,61,8,12,3,16,184.73,C45H47N7O9,"InChI=1S/C45H47N7O9/c1-58-37-12-8-29(25-38(37)59-2)34-27-48-42-33(34)24-30(26-47-42)28-6-9-31(10-7-28)50-16-18-51(19-17-50)40(54)14-20-60-22-23-61-21-15-46-35-5-3-4-32-41(35)45(57)52(44(32)56)36-11-13-39(53)49-43(36)55/h3-10,12,24-27,36,46H,11,13-23H2,1-2H3,(H,47,48)(H,49,53,55)",OQWONDHLEIYPFX-UHFFFAOYSA-N
5937,12.7,99,12.7,,Q92918,MAP4K1,CRBN,,,COC1=CC=C(C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCOCCOCCOCCOCCOC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=C4)C=C23)C=C1OC,Degradation of HPK1 in Jurkat cells after 24 h treatment,86.43/93.14/25.19,% HPK1 degradation in Jurkat cells at 10000/1000/100 nM,167.1,Inhibit of HPK1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.107016,919.001,918.3799712,3.11,67,8,14,2,22,200.39,C49H54N6O12,"InChI=1S/C49H54N6O12/c1-61-40-12-8-33(29-42(40)62-2)38-31-51-46-37(38)28-34(30-50-46)32-6-9-35(10-7-32)53-15-17-54(18-16-53)44(57)14-19-63-20-21-64-22-23-65-24-25-66-26-27-67-41-5-3-4-36-45(41)49(60)55(48(36)59)39-11-13-43(56)52-47(39)58/h3-10,12,28-31,39H,11,13-27H2,1-2H3,(H,50,51)(H,52,56,58)",WROHPYHJBGRHKO-UHFFFAOYSA-N
5939,2.6,99,2.6,,Q92918,MAP4K1,CRBN,,,COC1=CC=C(C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(C(=O)CCCCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=C4)C=C23)C=C1OC,Degradation of HPK1 in Jurkat cells after 24 h treatment,86.09/86.94/74.06,% HPK1 degradation in Jurkat cells at 10000/1000/100 nM,614.4,Inhibit of HPK1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.107016,783.886,783.3380468,5.34,58,8,10,3,13,166.27,C44H45N7O7,"InChI=1S/C44H45N7O7/c1-57-36-16-12-28(24-37(36)58-2)33-26-47-41-32(33)23-29(25-46-41)27-10-13-30(14-11-27)49-19-21-50(22-20-49)39(53)9-4-3-5-18-45-34-8-6-7-31-40(34)44(56)51(43(31)55)35-15-17-38(52)48-42(35)54/h6-8,10-14,16,23-26,35,45H,3-5,9,15,17-22H2,1-2H3,(H,46,47)(H,48,52,54)",BJGDGFUAJVQRMP-UHFFFAOYSA-N
5942,9.1,97,9.1,97,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,295.9,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,710.26,709.2238013,3.97,50,8,9,1,5,129.86,C37H36ClN7O4S,"InChI=1S/C37H36ClN7O4S/c1-19-20(2)50-37-32(19)33(23-4-7-26(38)8-5-23)39-28(34-42-41-21(3)45(34)37)17-31(47)43-14-12-22(13-15-43)24-6-9-27-25(16-24)18-44(36(27)49)29-10-11-30(46)40-35(29)48/h4-9,16,22,28-29H,10-15,17-18H2,1-3H3,(H,40,46,48)/t28-,29?/m0/s1",WXSOTMXNHJTFKS-XLTVJXRZSA-N
5943,21.1,65,21.1,65,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,53.8,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,753.329,752.2660005,3.82,53,8,10,2,8,141.89,C39H41ClN8O4S,"InChI=1S/C39H41ClN8O4S/c1-21-22(2)53-39-34(21)35(25-4-7-28(40)8-5-25)42-30(36-45-44-23(3)48(36)39)19-33(50)41-14-17-46-15-12-24(13-16-46)26-6-9-29-27(18-26)20-47(38(29)52)31-10-11-32(49)43-37(31)51/h4-9,18,24,30-31H,10-17,19-20H2,1-3H3,(H,41,50)(H,43,49,51)/t30-,31?/m0/s1",DQGNINFYAAEZKL-FSRLHOSWSA-N
5944,2.3,98,2.3,98,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,41,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,767.356,766.2816505,4.18,54,8,10,2,9,141.89,C40H43ClN8O4S,"InChI=1S/C40H43ClN8O4S/c1-22-23(2)54-40-35(22)36(26-5-8-29(41)9-6-26)43-31(37-46-45-24(3)49(37)40)20-34(51)42-15-4-16-47-17-13-25(14-18-47)27-7-10-30-28(19-27)21-48(39(30)53)32-11-12-33(50)44-38(32)52/h5-10,19,25,31-32H,4,11-18,20-21H2,1-3H3,(H,42,51)(H,44,50,52)/t31-,32?/m0/s1",ZCOPIRBPZIGHDU-CYZZXXEPSA-N
5945,12.8,94,12.8,94,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,43.2,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,781.383,780.2973006,4.54,55,8,10,2,10,141.89,C41H45ClN8O4S,"InChI=1S/C41H45ClN8O4S/c1-23-24(2)55-41-36(23)37(27-6-9-30(42)10-7-27)44-32(38-47-46-25(3)50(38)41)21-35(52)43-16-4-5-17-48-18-14-26(15-19-48)28-8-11-31-29(20-28)22-49(40(31)54)33-12-13-34(51)45-39(33)53/h6-11,20,26,32-33H,4-5,12-19,21-22H2,1-3H3,(H,43,52)(H,45,51,53)/t32-,33?/m0/s1",FOTJPEPDXXOTQF-JEFWXSHNSA-N
5946,1.8,97,1.8,97,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,36.6,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,795.41,794.3129507,4.9,56,8,10,2,11,141.89,C42H47ClN8O4S,"InChI=1S/C42H47ClN8O4S/c1-24-25(2)56-42-37(24)38(28-7-10-31(43)11-8-28)45-33(39-48-47-26(3)51(39)42)22-36(53)44-17-5-4-6-18-49-19-15-27(16-20-49)29-9-12-32-30(21-29)23-50(41(32)55)34-13-14-35(52)46-40(34)54/h7-12,21,27,33-34H,4-6,13-20,22-23H2,1-3H3,(H,44,53)(H,46,52,54)/t33-,34?/m0/s1",OJBZGRZGVKAUHH-CDRRMRQFSA-N
5947,0.7,92,0.7,92,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,36.8,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,809.437,808.3286007,5.25,57,8,10,2,12,141.89,C43H49ClN8O4S,"InChI=1S/C43H49ClN8O4S/c1-25-26(2)57-43-38(25)39(29-8-11-32(44)12-9-29)46-34(40-49-48-27(3)52(40)43)23-37(54)45-18-6-4-5-7-19-50-20-16-28(17-21-50)30-10-13-33-31(22-30)24-51(42(33)56)35-14-15-36(53)47-41(35)55/h8-13,22,28,34-35H,4-7,14-21,23-24H2,1-3H3,(H,45,54)(H,47,53,55)/t34-,35?/m0/s1",OKISKGIPUPRZPL-SFCXHYMASA-N
5948,,,>10000,N.D.,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,52.4,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,732.266,731.2081512,5.03,52,8,9,2,7,138.65,C39H34ClN7O4S,"InChI=1S/C39H34ClN7O4S/c1-20-21(2)52-39-34(20)35(25-7-9-27(40)10-8-25)42-30(36-45-44-22(3)47(36)39)18-33(49)41-28-11-4-23(5-12-28)16-24-6-13-29-26(17-24)19-46(38(29)51)31-14-15-32(48)43-37(31)50/h4-13,17,30-31H,14-16,18-19H2,1-3H3,(H,41,49)(H,43,48,50)/t30-,31?/m0/s1",NAJLKAMZDMZECA-FSRLHOSWSA-N
5949,,,>10000,N.D.,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,57.1,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,775.335,774.2503504,5.15,55,8,10,3,10,150.68,C41H39ClN8O4S,"InChI=1S/C41H39ClN8O4S/c1-22-23(2)55-41-36(22)37(27-7-9-29(42)10-8-27)45-32(38-48-47-24(3)50(38)41)20-35(52)44-17-16-43-30-11-4-25(5-12-30)18-26-6-13-31-28(19-26)21-49(40(31)54)33-14-15-34(51)46-39(33)53/h4-13,19,32-33,43H,14-18,20-21H2,1-3H3,(H,44,52)(H,46,51,53)/t32-,33?/m0/s1",SGHSUUSYNYZHKK-JEFWXSHNSA-N
5950,16.7,48,16.7,48,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,72.3,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,789.362,788.2660005,6.06,56,8,10,3,11,150.68,C42H41ClN8O4S,"InChI=1S/C42H41ClN8O4S/c1-23-24(2)56-42-37(23)38(28-8-10-30(43)11-9-28)46-33(39-49-48-25(3)51(39)42)21-36(53)45-18-4-17-44-31-12-5-26(6-13-31)19-27-7-14-32-29(20-27)22-50(41(32)55)34-15-16-35(52)47-40(34)54/h5-14,20,33-34,44H,4,15-19,21-22H2,1-3H3,(H,45,53)(H,47,52,54)/t33-,34?/m0/s1",BNZBBHXKCFPTND-CDRRMRQFSA-N
5951,,,>10000,N.D.,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,59.4,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,803.389,802.2816505,5.87,57,8,10,3,12,150.68,C43H43ClN8O4S,"InChI=1S/C43H43ClN8O4S/c1-24-25(2)57-43-38(24)39(29-9-11-31(44)12-10-29)47-34(40-50-49-26(3)52(40)43)22-37(54)46-19-5-4-18-45-32-13-6-27(7-14-32)20-28-8-15-33-30(21-28)23-51(42(33)56)35-16-17-36(53)48-41(35)55/h6-15,21,34-35,45H,4-5,16-20,22-23H2,1-3H3,(H,46,54)(H,48,53,55)/t34-,35?/m0/s1",MFAVXSAHTAKLRF-SFCXHYMASA-N
5952,2.6,62,2.6,62,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,79.2,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,817.416,816.2973006,6.22,58,8,10,3,13,150.68,C44H45ClN8O4S,"InChI=1S/C44H45ClN8O4S/c1-25-26(2)58-44-39(25)40(30-10-12-32(45)13-11-30)48-35(41-51-50-27(3)53(41)44)23-38(55)47-20-6-4-5-19-46-33-14-7-28(8-15-33)21-29-9-16-34-31(22-29)24-52(43(34)57)36-17-18-37(54)49-42(36)56/h7-16,22,35-36,46H,4-6,17-21,23-24H2,1-3H3,(H,47,55)(H,49,54,56)/t35-,36?/m0/s1",GUKINEBETXGZNQ-TYIYNAFKSA-N
5953,2,59,2,59,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,96.6,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,831.443,830.3129507,6.58,59,8,10,3,14,150.68,C45H47ClN8O4S,"InChI=1S/C45H47ClN8O4S/c1-26-27(2)59-45-40(26)41(31-11-13-33(46)14-12-31)49-36(42-52-51-28(3)54(42)45)24-39(56)48-21-7-5-4-6-20-47-34-15-8-29(9-16-34)22-30-10-17-35-32(23-30)25-53(44(35)58)37-18-19-38(55)50-43(37)57/h8-17,23,36-37,47H,4-7,18-22,24-25H2,1-3H3,(H,48,56)(H,50,55,57)/t36-,37?/m0/s1",CZJSNFIBYLCJGN-NWDJCJOJSA-N
5954,1.9,95,1.9,95,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CCC3(CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)CC1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,55.2,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,821.448,820.3286007,5.88,58,9,10,2,8,141.89,C44H49ClN8O4S,"InChI=1S/C44H49ClN8O4S/c1-25-26(2)58-43-38(25)39(29-4-7-32(45)8-5-29)47-34(40-50-49-27(3)53(40)43)23-37(55)46-18-21-51-19-16-44(17-20-51)14-12-28(13-15-44)30-6-9-33-31(22-30)24-52(42(33)57)35-10-11-36(54)48-41(35)56/h4-9,22,28,34-35H,10-21,23-24H2,1-3H3,(H,46,55)(H,48,54,56)/t34-,35?/m0/s1",ZKMPZGMDXOECHS-SFCXHYMASA-N
5955,11.2,99,11.2,99,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CC3(CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,53.8,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,793.394,792.2973006,4.8,56,9,10,2,8,141.89,C42H45ClN8O4S,"InChI=1S/C42H45ClN8O4S/c1-23-24(2)56-41-36(23)37(27-4-7-30(43)8-5-27)45-32(38-48-47-25(3)51(38)41)19-35(53)44-16-17-49-21-42(22-49)14-12-26(13-15-42)28-6-9-31-29(18-28)20-50(40(31)55)33-10-11-34(52)46-39(33)54/h4-9,18,26,32-33H,10-17,19-22H2,1-3H3,(H,44,53)(H,46,52,54)/t32-,33?/m0/s1",JFSVSFBLGUFRRC-JEFWXSHNSA-N
5956,11.2,55,11.2,55,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CC(N3CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C1)N=C2C1=CC=C(Cl)C=C1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,37.5,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,808.409,807.3081996,3.7,57,9,11,2,9,145.13,C42H46ClN9O4S,"InChI=1S/C42H46ClN9O4S/c1-23-24(2)57-42-37(23)38(27-4-7-30(43)8-5-27)45-33(39-48-47-25(3)52(39)42)19-36(54)44-14-17-49-21-31(22-49)50-15-12-26(13-16-50)28-6-9-32-29(18-28)20-51(41(32)56)34-10-11-35(53)46-40(34)55/h4-9,18,26,31,33-34H,10-17,19-22H2,1-3H3,(H,44,54)(H,46,53,55)/t33-,34?/m0/s1",LHUVKOFLIPGEIS-CDRRMRQFSA-N
5958,2500,80,2500,80,P53350,PLK1,UBR box,,,C[C@@H](OP(=O)(O)O)[C@@H]1NC(=O)[C@H](CC2=CN=CN2CCCCCCCCC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)CCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)CCC(=O)NCCCC[C@@H](C(N)=O)NC1=O,Degradation of PLK1 in HeLa cells,,,,,,,3480,Binding affinity to PLK1 PBD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17980/20630/17050,Inhibit proliferation of HeLa/A549/PC9 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01493,2750.274,2748.680358,-14.49,193,3,35,57,93,1391.19,C113H210N57O22P,"InChI=1S/C113H210N57O22P/c1-65(192-193(189,190)191)85-101(188)156-69(86(115)173)32-12-14-47-141-83(171)46-45-81(99(186)168-82(100(187)169-85)62-67-63-140-64-170(67)61-15-5-3-2-4-8-28-66-29-9-6-10-30-66)155-84(172)44-11-7-13-48-142-88(175)70(33-17-50-144-103(118)119)158-90(177)72(35-19-52-146-105(122)123)160-92(179)74(37-21-54-148-107(126)127)162-94(181)76(39-23-56-150-109(130)131)164-96(183)78(41-25-58-152-111(134)135)166-98(185)80(43-27-60-154-113(138)139)167-97(184)79(42-26-59-153-112(136)137)165-95(182)77(40-24-57-151-110(132)133)163-93(180)75(38-22-55-149-108(128)129)161-91(178)73(36-20-53-147-106(124)125)159-89(176)71(34-18-51-145-104(120)121)157-87(174)68(114)31-16-49-143-102(116)117/h6,9-10,29-30,63-65,68-82,85H,2-5,7-8,11-28,31-62,114H2,1H3,(H2,115,173)(H,141,171)(H,142,175)(H,155,172)(H,156,188)(H,157,174)(H,158,177)(H,159,176)(H,160,179)(H,161,178)(H,162,181)(H,163,180)(H,164,183)(H,165,182)(H,166,185)(H,167,184)(H,168,186)(H,169,187)(H4,116,117,143)(H4,118,119,144)(H4,120,121,145)(H4,122,123,146)(H4,124,125,147)(H4,126,127,148)(H4,128,129,149)(H4,130,131,150)(H4,132,133,151)(H4,134,135,152)(H4,136,137,153)(H4,138,139,154)(H2,189,190,191)/t65-,68+,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79+,80+,81+,82+,85+/m1/s1",QCRJOZUOMXHCMP-XSBYXYHJSA-N
5971,5,99,5,,,c-Src,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CC(=O)N3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)=N1,Degradation of c-Src in CAL-148 cells after 18h treatment,86,% c-Src degradation in CAL-148 cells at 100 nM after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.3c00548,826.34,825.2572267,3.6,58,8,14,3,9,193.38,C39H40ClN11O6S,"InChI=1S/C39H40ClN11O6S/c1-22-4-3-5-27(40)34(22)46-36(55)29-20-41-39(58-29)44-30-19-31(43-23(2)42-30)49-12-10-47(11-13-49)21-33(53)50-16-14-48(15-17-50)24-6-7-25-26(18-24)38(57)51(37(25)56)28-8-9-32(52)45-35(28)54/h3-7,18-20,28H,8-17,21H2,1-2H3,(H,46,55)(H,45,52,54)(H,41,42,43,44)",VVTSHDQYRBXKMU-UHFFFAOYSA-N
5972,0.8,99,0.8,,,c-Src,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCC(=O)N3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)=N1,Degradation of c-Src in CAL-148 cells after 18h treatment,86,% c-Src degradation in CAL-148 cells at 100 nM after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.3c00548,854.394,853.2885268,3.86,60,8,14,3,11,193.38,C41H44ClN11O6S,"InChI=1S/C41H44ClN11O6S/c1-24-5-3-6-29(42)36(24)48-38(57)31-23-43-41(60-31)46-32-22-33(45-25(2)44-32)51-15-13-49(14-16-51)12-4-7-35(55)52-19-17-50(18-20-52)26-8-9-27-28(21-26)40(59)53(39(27)58)30-10-11-34(54)47-37(30)56/h3,5-6,8-9,21-23,30H,4,7,10-20H2,1-2H3,(H,48,57)(H,47,54,56)(H,43,44,45,46)",KCDOOYAJVJAYEP-UHFFFAOYSA-N
5973,3,99,3,,,c-Src,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CC(=O)N3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=N1,Degradation of c-Src in CAL-148 cells after 18h treatment,78,% c-Src degradation in CAL-148 cells at 100 nM after 18h treatment,,,45,Binding of c-Src,,,,,,,,,,,,,,,30,Binding of cereblon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/74,Inhibit proliferation of MDA-MB-231/CAL51 cells,,,,,,,,,,,10.1021/acschembio.3c00548,826.34,825.2572267,3.6,58,8,14,3,9,193.38,C39H40ClN11O6S,"InChI=1S/C39H40ClN11O6S/c1-22-5-3-7-25(40)34(22)46-36(55)28-20-41-39(58-28)44-29-19-30(43-23(2)42-29)49-13-11-47(12-14-49)21-32(53)50-17-15-48(16-18-50)26-8-4-6-24-33(26)38(57)51(37(24)56)27-9-10-31(52)45-35(27)54/h3-8,19-20,27H,9-18,21H2,1-2H3,(H,46,55)(H,45,52,54)(H,41,42,43,44)",FLJSWUPMVJVFTN-UHFFFAOYSA-N
5974,1,99,1,,,c-Src,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=C(C)C=CC=C3Cl)S2)=CC(N2CCN(CCCC(=O)N3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=N1,Degradation of c-Src in CAL-148 cells after 18h treatment,86,% c-Src degradation in CAL-148 cells at 100 nM after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.3c00548,854.394,853.2885268,3.86,60,8,14,3,11,193.38,C41H44ClN11O6S,"InChI=1S/C41H44ClN11O6S/c1-24-6-3-8-27(42)36(24)48-38(57)30-23-43-41(60-30)46-31-22-32(45-25(2)44-31)51-16-14-49(15-17-51)13-5-10-34(55)52-20-18-50(19-21-52)28-9-4-7-26-35(28)40(59)53(39(26)58)29-11-12-33(54)47-37(29)56/h3-4,6-9,22-23,29H,5,10-21H2,1-2H3,(H,48,57)(H,47,54,56)(H,43,44,45,46)",DCOBLTYPWQOOIW-UHFFFAOYSA-N
5975,17,91,62/70/17,93/92/91,,c-Src,CRBN,,,CC1=NC(NC2=NC=C(C(=O)NC3=CC=C(OC4=CC=CC=C4)C=C3C)S2)=CC(N2CCN(CC(=O)N3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)=N1,Degradation of c-Src in CAL-148/KCL22/MDA-MB-231 cells after 18h treatment,,,,,1500,Binding of c-Src,,,,,,,,,,,,,,,44,Binding of cereblon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,62/500,Inhibit proliferation of MDA-MB-231/CAL51 cells,,,,,,,,,,,10.1021/acschembio.3c00548,883.992,883.3224138,4.5,64,9,15,3,11,202.61,C45H45N11O7S,"InChI=1S/C45H45N11O7S/c1-27-23-30(63-29-7-4-3-5-8-29)11-12-32(27)49-42(60)35-25-46-45(64-35)50-36-24-37(48-28(2)47-36)54-17-15-52(16-18-54)26-39(58)55-21-19-53(20-22-55)33-10-6-9-31-40(33)44(62)56(43(31)61)34-13-14-38(57)51-41(34)59/h3-12,23-25,34H,13-22,26H2,1-2H3,(H,49,60)(H,51,57,59)(H,46,47,48,50)",MBLVMHHXZBDGGP-UHFFFAOYSA-N
5988,5,99,251/5,,,Beta3-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of beta3-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,657.676,657.2322443,4.55,48,5,11,2,13,158.8,C35H35N3O10,"InChI=1S/C35H35N3O10/c1-44-25-14-12-20(10-11-21-18-27(45-2)32(47-4)28(19-21)46-3)17-26(25)48-30(40)9-6-16-36-23-8-5-7-22-31(23)35(43)38(34(22)42)24-13-15-29(39)37-33(24)41/h5,7-8,10-12,14,17-19,24,36H,6,9,13,15-16H2,1-4H3,(H,37,39,41)/b11-10-",KHYSHWVHYFNXOC-KHPPLWFESA-N
5988,32,99,296/32,,,Alpha-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of alpha-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012-10-04,Inhibit proliferation of MCF-7/A549/HepG2 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,657.676,657.2322443,4.55,48,5,11,2,13,158.8,C35H35N3O10,"InChI=1S/C35H35N3O10/c1-44-25-14-12-20(10-11-21-18-27(45-2)32(47-4)28(19-21)46-3)17-26(25)48-30(40)9-6-16-36-23-8-5-7-22-31(23)35(43)38(34(22)42)24-13-15-29(39)37-33(24)41/h5,7-8,10-12,14,17-19,24,36H,6,9,13,15-16H2,1-4H3,(H,37,39,41)/b11-10-",KHYSHWVHYFNXOC-KHPPLWFESA-N
5988,856,99,856/972,,P07437,Beta-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of beta-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,657.676,657.2322443,4.55,48,5,11,2,13,158.8,C35H35N3O10,"InChI=1S/C35H35N3O10/c1-44-25-14-12-20(10-11-21-18-27(45-2)32(47-4)28(19-21)46-3)17-26(25)48-30(40)9-6-16-36-23-8-5-7-22-31(23)35(43)38(34(22)42)24-13-15-29(39)37-33(24)41/h5,7-8,10-12,14,17-19,24,36H,6,9,13,15-16H2,1-4H3,(H,37,39,41)/b11-10-",KHYSHWVHYFNXOC-KHPPLWFESA-N
5989,9,99,Sep-35,,P07437,Beta-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of beta-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,671.703,671.2478944,4.91,49,5,11,2,14,158.8,C36H37N3O10,"InChI=1S/C36H37N3O10/c1-45-26-15-13-21(11-12-22-19-28(46-2)33(48-4)29(20-22)47-3)18-27(26)49-31(41)10-5-6-17-37-24-9-7-8-23-32(24)36(44)39(35(23)43)25-14-16-30(40)38-34(25)42/h7-9,11-13,15,18-20,25,37H,5-6,10,14,16-17H2,1-4H3,(H,38,40,42)/b12-11-",UDHQFXXLYVOUQQ-QXMHVHEDSA-N
5989,18,99,N.D./18,,,Beta3-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of beta3-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,671.703,671.2478944,4.91,49,5,11,2,14,158.8,C36H37N3O10,"InChI=1S/C36H37N3O10/c1-45-26-15-13-21(11-12-22-19-28(46-2)33(48-4)29(20-22)47-3)18-27(26)49-31(41)10-5-6-17-37-24-9-7-8-23-32(24)36(44)39(35(23)43)25-14-16-30(40)38-34(25)42/h7-9,11-13,15,18-20,25,37H,5-6,10,14,16-17H2,1-4H3,(H,38,40,42)/b12-11-",UDHQFXXLYVOUQQ-QXMHVHEDSA-N
5989,105,99,883/105,,,Alpha-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of alpha-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017-12-06,Inhibit proliferation of MCF-7/A549/HepG2 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,671.703,671.2478944,4.91,49,5,11,2,14,158.8,C36H37N3O10,"InChI=1S/C36H37N3O10/c1-45-26-15-13-21(11-12-22-19-28(46-2)33(48-4)29(20-22)47-3)18-27(26)49-31(41)10-5-6-17-37-24-9-7-8-23-32(24)36(44)39(35(23)43)25-14-16-30(40)38-34(25)42/h7-9,11-13,15,18-20,25,37H,5-6,10,14,16-17H2,1-4H3,(H,38,40,42)/b12-11-",UDHQFXXLYVOUQQ-QXMHVHEDSA-N
5990,52,99,165/52,,P07437,Beta-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of beta-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,685.73,685.2635444,5.27,50,5,11,2,15,158.8,C37H39N3O10,"InChI=1S/C37H39N3O10/c1-46-27-16-14-22(12-13-23-20-29(47-2)34(49-4)30(21-23)48-3)19-28(27)50-32(42)11-6-5-7-18-38-25-10-8-9-24-33(25)37(45)40(36(24)44)26-15-17-31(41)39-35(26)43/h8-10,12-14,16,19-21,26,38H,5-7,11,15,17-18H2,1-4H3,(H,39,41,43)/b13-12-",QXCITHRZQTUQSO-SEYXRHQNSA-N
5990,114,99,N.D./114,,,Alpha-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of alpha-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/19/7,Inhibit proliferation of MCF-7/A549/HepG2 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,685.73,685.2635444,5.27,50,5,11,2,15,158.8,C37H39N3O10,"InChI=1S/C37H39N3O10/c1-46-27-16-14-22(12-13-23-20-29(47-2)34(49-4)30(21-23)48-3)19-28(27)50-32(42)11-6-5-7-18-38-25-10-8-9-24-33(25)37(45)40(36(24)44)26-15-17-31(41)39-35(26)43/h8-10,12-14,16,19-21,26,38H,5-7,11,15,17-18H2,1-4H3,(H,39,41,43)/b13-12-",QXCITHRZQTUQSO-SEYXRHQNSA-N
5990,294,99,294/N.D.,,,Beta3-tubulin,CRBN,,,COC1=CC=C(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC(=O)CCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Degradation of beta3-tubulin in A549 / A549/Taxol cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116067,685.73,685.2635444,5.27,50,5,11,2,15,158.8,C37H39N3O10,"InChI=1S/C37H39N3O10/c1-46-27-16-14-22(12-13-23-20-29(47-2)34(49-4)30(21-23)48-3)19-28(27)50-32(42)11-6-5-7-18-38-25-10-8-9-24-33(25)37(45)40(36(24)44)26-15-17-31(41)39-35(26)43/h8-10,12-14,16,19-21,26,38H,5-7,11,15,17-18H2,1-4H3,(H,39,41,43)/b13-12-",QXCITHRZQTUQSO-SEYXRHQNSA-N
5993,90,17,90,17,Q9H8M2,BRD9,DCAF1,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=C(OC)C=C1CN1CCC(OCCCCCC(=O)N2CCN(C3=CC=C4C(NCCN)=NC(C5(C6=CC=C(Cl)C=C6)CCCCC5)=NC4=C3)CC2)CC1,Degradation of BRD9 in HEK293/BRD9-HiBiT cells after 2h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-023-44237-4,970.66,969.503194,7.4,70,9,13,2,18,153.2,C55H68ClN9O5,"InChI=1S/C55H68ClN9O5/c1-62-37-47(43-17-23-58-35-46(43)53(62)67)45-34-49(68-2)38(32-50(45)69-3)36-63-25-18-42(19-26-63)70-31-9-4-6-10-51(66)65-29-27-64(28-30-65)41-15-16-44-48(33-41)60-54(61-52(44)59-24-22-57)55(20-7-5-8-21-55)39-11-13-40(56)14-12-39/h11-17,23,32-35,37,42H,4-10,18-22,24-31,36,57H2,1-3H3,(H,59,60,61)",BJAVCRNLIDSYTK-UHFFFAOYSA-N
5993,360,65,360,65,Q9NPI1,BRD7,DCAF1,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=C(OC)C=C1CN1CCC(OCCCCCC(=O)N2CCN(C3=CC=C4C(NCCN)=NC(C5(C6=CC=C(Cl)C=C6)CCCCC5)=NC4=C3)CC2)CC1,Degradation of BRD7 in HEK293/BRD7-HiBiT cells after 2h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-023-44237-4,970.66,969.503194,7.4,70,9,13,2,18,153.2,C55H68ClN9O5,"InChI=1S/C55H68ClN9O5/c1-62-37-47(43-17-23-58-35-46(43)53(62)67)45-34-49(68-2)38(32-50(45)69-3)36-63-25-18-42(19-26-63)70-31-9-4-6-10-51(66)65-29-27-64(28-30-65)41-15-16-44-48(33-41)60-54(61-52(44)59-24-22-57)55(20-7-5-8-21-55)39-11-13-40(56)14-12-39/h11-17,23,32-35,37,42H,4-10,18-22,24-31,36,57H2,1-3H3,(H,59,60,61)",BJAVCRNLIDSYTK-UHFFFAOYSA-N
6013,32,99,32,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC3=CC(N4C5CCC4CN(C4=CC(C6=CC=CC=C6O)=NN=C4N)C5)=CC=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,993.201,992.4578446,4.05,71,8,17,5,21,239.95,C51H64N10O9S,"InChI=1S/C51H64N10O9S/c1-32-46(71-31-55-32)34-11-9-33(10-12-34)26-54-49(65)42-24-38(62)29-60(42)50(66)47(51(2,3)4)56-44(64)30-69-20-19-67-17-18-68-21-22-70-45-23-35(15-16-53-45)61-36-13-14-37(61)28-59(27-36)41-25-40(57-58-48(41)52)39-7-5-6-8-43(39)63/h5-12,15-16,23,25,31,36-38,42,47,62-63H,13-14,17-22,24,26-30H2,1-4H3,(H2,52,58)(H,54,65)(H,56,64)/t36?,37?,38-,42+,47-/m1/s1",OLXXFJBRZFLJTA-WTHWZOSPSA-N
6013,703,99,703,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOC3=CC(N4C5CCC4CN(C4=CC(C6=CC=CC=C6O)=NN=C4N)C5)=CC=N3)C(C)(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,993.201,992.4578446,4.05,71,8,17,5,21,239.95,C51H64N10O9S,"InChI=1S/C51H64N10O9S/c1-32-46(71-31-55-32)34-11-9-33(10-12-34)26-54-49(65)42-24-38(62)29-60(42)50(66)47(51(2,3)4)56-44(64)30-69-20-19-67-17-18-68-21-22-70-45-23-35(15-16-53-45)61-36-13-14-37(61)28-59(27-36)41-25-40(57-58-48(41)52)39-7-5-6-8-43(39)63/h5-12,15-16,23,25,31,36-38,42,47,62-63H,13-14,17-22,24,26-30H2,1-4H3,(H2,52,58)(H,54,65)(H,56,64)/t36?,37?,38-,42+,47-/m1/s1",OLXXFJBRZFLJTA-WTHWZOSPSA-N
6014,0.76,99,0.76,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCOCCOCCOC4=CC(N5C6CCC5CN(C5=CC(C7=CC=CC=C7O)=NN=C5N)C6)=CC=N4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,989.169,988.4265445,4.8,71,9,18,4,21,236.88,C51H60N10O9S,"InChI=1S/C51H60N10O9S/c1-31(2)47(51(65)60-29-38(62)23-42(60)50(64)54-26-33-8-10-34(11-9-33)48-32(3)55-30-71-48)44-25-46(58-70-44)69-21-19-67-17-16-66-18-20-68-45-22-35(14-15-53-45)61-36-12-13-37(61)28-59(27-36)41-24-40(56-57-49(41)52)39-6-4-5-7-43(39)63/h4-11,14-15,22,24-25,30-31,36-38,42,47,62-63H,12-13,16-21,23,26-29H2,1-3H3,(H2,52,57)(H,54,64)/t36?,37?,38-,42+,47-/m1/s1",KPLOVGJHSWRHKD-WTHWZOSPSA-N
6014,5.9,99,5.9,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCOCCOCCOC4=CC(N5C6CCC5CN(C5=CC(C7=CC=CC=C7O)=NN=C5N)C6)=CC=N4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,989.169,988.4265445,4.8,71,9,18,4,21,236.88,C51H60N10O9S,"InChI=1S/C51H60N10O9S/c1-31(2)47(51(65)60-29-38(62)23-42(60)50(64)54-26-33-8-10-34(11-9-33)48-32(3)55-30-71-48)44-25-46(58-70-44)69-21-19-67-17-16-66-18-20-68-45-22-35(14-15-53-45)61-36-12-13-37(61)28-59(27-36)41-24-40(56-57-49(41)52)39-6-4-5-7-43(39)63/h4-11,14-15,22,24-25,30-31,36-38,42,47,62-63H,12-13,16-21,23,26-29H2,1-3H3,(H2,52,57)(H,54,64)/t36?,37?,38-,42+,47-/m1/s1",KPLOVGJHSWRHKD-WTHWZOSPSA-N
6015,0.39,99,0.39,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6/62 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1013.239,1012.474163,4.95,73,10,18,4,18,224.9,C53H64N12O7S,"InChI=1S/C53H64N12O7S/c1-33(2)49(53(69)64-31-40(66)25-44(64)52(68)56-28-35-8-10-36(11-9-35)50-34(3)57-32-73-50)46-27-48(60-72-46)71-23-21-62-18-16-61(17-19-62)20-22-70-47-24-37(14-15-55-47)65-38-12-13-39(65)30-63(29-38)43-26-42(58-59-51(43)54)41-6-4-5-7-45(41)67/h4-11,14-15,24,26-27,32-33,38-40,44,49,66-67H,12-13,16-23,25,28-31H2,1-3H3,(H2,54,59)(H,56,68)/t38?,39?,40-,44+,49-/m1/s1",UNFIMOMJFZJYFU-MCIXTSDZSA-N
6015,9.5,99,9.5,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1013.239,1012.474163,4.95,73,10,18,4,18,224.9,C53H64N12O7S,"InChI=1S/C53H64N12O7S/c1-33(2)49(53(69)64-31-40(66)25-44(64)52(68)56-28-35-8-10-36(11-9-35)50-34(3)57-32-73-50)46-27-48(60-72-46)71-23-21-62-18-16-61(17-19-62)20-22-70-47-24-37(14-15-55-47)65-38-12-13-39(65)30-63(29-38)43-26-42(58-59-51(43)54)41-6-4-5-7-45(41)67/h4-11,14-15,24,26-27,32-33,38-40,44,49,66-67H,12-13,16-23,25,28-31H2,1-3H3,(H2,54,59)(H,56,68)/t38?,39?,40-,44+,49-/m1/s1",UNFIMOMJFZJYFU-MCIXTSDZSA-N
6016,0.068,99,0.068,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.17/7 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1027.266,1026.489813,5.35,74,10,18,4,18,224.9,C54H66N12O7S,"InChI=1S/C54H66N12O7S/c1-33(2)50(54(70)65-31-41(67)26-45(65)53(69)58-34(3)36-9-11-37(12-10-36)51-35(4)57-32-74-51)47-28-49(61-73-47)72-24-22-63-19-17-62(18-20-63)21-23-71-48-25-38(15-16-56-48)66-39-13-14-40(66)30-64(29-39)44-27-43(59-60-52(44)55)42-7-5-6-8-46(42)68/h5-12,15-16,25,27-28,32-34,39-41,45,50,67-68H,13-14,17-24,26,29-31H2,1-4H3,(H2,55,60)(H,58,69)/t34-,39?,40?,41+,45-,50+/m0/s1",YUXRQCYYCLFFPM-RFMVEUQBSA-N
6016,1.5,99,1.5,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1027.266,1026.489813,5.35,74,10,18,4,18,224.9,C54H66N12O7S,"InChI=1S/C54H66N12O7S/c1-33(2)50(54(70)65-31-41(67)26-45(65)53(69)58-34(3)36-9-11-37(12-10-36)51-35(4)57-32-74-51)47-28-49(61-73-47)72-24-22-63-19-17-62(18-20-63)21-23-71-48-25-38(15-16-56-48)66-39-13-14-40(66)30-64(29-39)44-27-43(59-60-52(44)55)42-7-5-6-8-46(42)68/h5-12,15-16,25,27-28,32-34,39-41,45,50,67-68H,13-14,17-24,26,29-31H2,1-4H3,(H2,55,60)(H,58,69)/t34-,39?,40?,41+,45-,50+/m0/s1",YUXRQCYYCLFFPM-RFMVEUQBSA-N
6017,0.055,99,0.055,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)[C@H](C)C4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.26/12 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1041.293,1040.505464,5.78,75,10,18,4,18,224.9,C55H68N12O7S,"InChI=1S/C55H68N12O7S/c1-33(2)51(55(71)66-31-42(68)25-46(66)54(70)59-35(4)37-10-12-38(13-11-37)52-36(5)58-32-75-52)48-27-50(62-74-48)73-22-20-63-18-19-64(34(3)28-63)21-23-72-49-24-39(16-17-57-49)67-40-14-15-41(67)30-65(29-40)45-26-44(60-61-53(45)56)43-8-6-7-9-47(43)69/h6-13,16-17,24,26-27,32-35,40-42,46,51,68-69H,14-15,18-23,25,28-31H2,1-5H3,(H2,56,61)(H,59,70)/t34-,35+,40?,41?,42-,46+,51-/m1/s1",RLQXXYROWQGBLA-UYJMYZDASA-N
6017,0.71,99,0.71,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)[C@H](C)C4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1041.293,1040.505464,5.78,75,10,18,4,18,224.9,C55H68N12O7S,"InChI=1S/C55H68N12O7S/c1-33(2)51(55(71)66-31-42(68)25-46(66)54(70)59-35(4)37-10-12-38(13-11-37)52-36(5)58-32-75-52)48-27-50(62-74-48)73-22-20-63-18-19-64(34(3)28-63)21-23-72-49-24-39(16-17-57-49)67-40-14-15-41(67)30-65(29-40)45-26-44(60-61-53(45)56)43-8-6-7-9-47(43)69/h6-13,16-17,24,26-27,32-35,40-42,46,51,68-69H,14-15,18-23,25,28-31H2,1-5H3,(H2,56,61)(H,59,70)/t34-,35+,40?,41?,42-,46+,51-/m1/s1",RLQXXYROWQGBLA-UYJMYZDASA-N
6018,0.11,99,0.11,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)C[C@@H]4C)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.72/38 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1041.293,1040.505464,5.78,75,10,18,4,18,224.9,C55H68N12O7S,"InChI=1S/C55H68N12O7S/c1-33(2)51(55(71)66-31-42(68)25-46(66)54(70)59-35(4)37-10-12-38(13-11-37)52-36(5)58-32-75-52)48-27-50(62-74-48)73-23-21-64-19-18-63(28-34(64)3)20-22-72-49-24-39(16-17-57-49)67-40-14-15-41(67)30-65(29-40)45-26-44(60-61-53(45)56)43-8-6-7-9-47(43)69/h6-13,16-17,24,26-27,32-35,40-42,46,51,68-69H,14-15,18-23,25,28-31H2,1-5H3,(H2,56,61)(H,59,70)/t34-,35-,40?,41?,42+,46-,51+/m0/s1",VKROVRQACZNDLN-NZUGOOGTSA-N
6018,2.7,99,2.7,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCN(CCOC5=CC(N6C7CCC6CN(C6=CC(C8=CC=CC=C8O)=NN=C6N)C7)=CC=N5)C[C@@H]4C)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1041.293,1040.505464,5.78,75,10,18,4,18,224.9,C55H68N12O7S,"InChI=1S/C55H68N12O7S/c1-33(2)51(55(71)66-31-42(68)25-46(66)54(70)59-35(4)37-10-12-38(13-11-37)52-36(5)58-32-75-52)48-27-50(62-74-48)73-23-21-64-19-18-63(28-34(64)3)20-22-72-49-24-39(16-17-57-49)67-40-14-15-41(67)30-65(29-40)45-26-44(60-61-53(45)56)43-8-6-7-9-47(43)69/h6-13,16-17,24,26-27,32-35,40-42,46,51,68-69H,14-15,18-23,25,28-31H2,1-5H3,(H2,56,61)(H,59,70)/t34-,35-,40?,41?,42+,46-,51+/m0/s1",VKROVRQACZNDLN-NZUGOOGTSA-N
6019,0.093,99,0.093,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCC(O[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.64/24 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1068.315,1067.505129,6.57,77,11,18,4,18,230.89,C57H69N11O8S,"InChI=1S/C57H69N11O8S/c1-33(2)53(57(72)67-31-41(69)24-48(67)56(71)61-34(3)36-9-11-37(12-10-36)54-35(4)60-32-77-54)50-28-52(64-76-50)73-22-21-65-19-16-42(17-20-65)74-43-25-44(26-43)75-51-23-38(15-18-59-51)68-39-13-14-40(68)30-66(29-39)47-27-46(62-63-55(47)58)45-7-5-6-8-49(45)70/h5-12,15,18,23,27-28,32-34,39-44,48,53,69-70H,13-14,16-17,19-22,24-26,29-31H2,1-4H3,(H2,58,63)(H,61,71)/t34-,39?,40?,41+,43-,44-,48-,53+/m0/s1",MOMWKZXTQZEWBK-PRVCUHQGSA-N
6019,4.9,99,4.9,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCN4CCC(O[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1068.315,1067.505129,6.57,77,11,18,4,18,230.89,C57H69N11O8S,"InChI=1S/C57H69N11O8S/c1-33(2)53(57(72)67-31-41(69)24-48(67)56(71)61-34(3)36-9-11-37(12-10-36)54-35(4)60-32-77-54)50-28-52(64-76-50)73-22-21-65-19-16-42(17-20-65)74-43-25-44(26-43)75-51-23-38(15-18-59-51)68-39-13-14-40(68)30-66(29-39)47-27-46(62-63-55(47)58)45-7-5-6-8-49(45)70/h5-12,15,18,23,27-28,32-34,39-44,48,53,69-70H,13-14,16-17,19-22,24-26,29-31H2,1-4H3,(H2,58,63)(H,61,71)/t34-,39?,40?,41+,43-,44-,48-,53+/m0/s1",MOMWKZXTQZEWBK-PRVCUHQGSA-N
6020,0.085,99,0.085,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCN(CCN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3/11 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1136.438,1135.578963,6.53,82,12,19,4,18,228.14,C61H77N13O7S,"InChI=1S/C61H77N13O7S/c1-37(2)57(61(78)73-35-45(75)28-52(73)60(77)65-38(3)40-9-11-41(12-10-40)58-39(4)64-36-82-58)54-32-55(68-81-54)71-25-23-70(24-26-71)22-21-69-19-16-46(17-20-69)79-47-29-48(30-47)80-56-27-42(15-18-63-56)74-43-13-14-44(74)34-72(33-43)51-31-50(66-67-59(51)62)49-7-5-6-8-53(49)76/h5-12,15,18,27,31-32,36-38,43-48,52,57,75-76H,13-14,16-17,19-26,28-30,33-35H2,1-4H3,(H2,62,67)(H,65,77)/t38-,43?,44?,45+,47-,48-,52-,57+/m0/s1",WILHQSZIOANHQY-IQSLLHNXSA-N
6020,3.2,99,3.2,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCN(CCN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1136.438,1135.578963,6.53,82,12,19,4,18,228.14,C61H77N13O7S,"InChI=1S/C61H77N13O7S/c1-37(2)57(61(78)73-35-45(75)28-52(73)60(77)65-38(3)40-9-11-41(12-10-40)58-39(4)64-36-82-58)54-32-55(68-81-54)71-25-23-70(24-26-71)22-21-69-19-16-46(17-20-69)79-47-29-48(30-47)80-56-27-42(15-18-63-56)74-43-13-14-44(74)34-72(33-43)51-31-50(66-67-59(51)62)49-7-5-6-8-53(49)76/h5-12,15,18,27,31-32,36-38,43-48,52,57,75-76H,13-14,16-17,19-26,28-30,33-35H2,1-4H3,(H2,62,67)(H,65,77)/t38-,43?,44?,45+,47-,48-,52-,57+/m0/s1",WILHQSZIOANHQY-IQSLLHNXSA-N
6021,0.062,99,0.062,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCN(CC5CCN(C[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.72/10 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1120.439,1119.584048,7.06,81,12,18,4,17,218.91,C61H77N13O6S,"InChI=1S/C61H77N13O6S/c1-37(2)57(61(78)73-35-47(75)28-52(73)60(77)65-38(3)42-9-11-43(12-10-42)58-39(4)64-36-81-58)54-30-55(68-80-54)71-23-21-70(22-24-71)31-40-16-19-69(20-17-40)32-41-25-48(26-41)79-56-27-44(15-18-63-56)74-45-13-14-46(74)34-72(33-45)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)76/h5-12,15,18,27,29-30,36-38,40-41,45-48,52,57,75-76H,13-14,16-17,19-26,28,31-35H2,1-4H3,(H2,62,67)(H,65,77)/t38-,41-,45?,46?,47+,48-,52-,57+/m0/s1",DHWDIQLZVJNFJX-SGQYSNGZSA-N
6021,1.4,99,1.4,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCN(CC5CCN(C[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1120.439,1119.584048,7.06,81,12,18,4,17,218.91,C61H77N13O6S,"InChI=1S/C61H77N13O6S/c1-37(2)57(61(78)73-35-47(75)28-52(73)60(77)65-38(3)42-9-11-43(12-10-42)58-39(4)64-36-81-58)54-30-55(68-80-54)71-23-21-70(22-24-71)31-40-16-19-69(20-17-40)32-41-25-48(26-41)79-56-27-44(15-18-63-56)74-45-13-14-46(74)34-72(33-45)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)76/h5-12,15,18,27,29-30,36-38,40-41,45-48,52,57,75-76H,13-14,16-17,19-26,28,31-35H2,1-4H3,(H2,62,67)(H,65,77)/t38-,41-,45?,46?,47+,48-,52-,57+/m0/s1",DHWDIQLZVJNFJX-SGQYSNGZSA-N
6022,0.14,99,0.14,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(O[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.3/4.4 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1024.262,1023.478914,6.68,74,11,17,4,15,221.66,C55H65N11O7S,"InChI=1S/C55H65N11O7S/c1-31(2)51(55(70)65-29-39(67)22-46(65)54(69)59-32(3)34-9-11-35(12-10-34)52-33(4)58-30-74-52)48-26-49(62-73-48)63-19-16-40(17-20-63)71-41-23-42(24-41)72-50-21-36(15-18-57-50)66-37-13-14-38(66)28-64(27-37)45-25-44(60-61-53(45)56)43-7-5-6-8-47(43)68/h5-12,15,18,21,25-26,30-32,37-42,46,51,67-68H,13-14,16-17,19-20,22-24,27-29H2,1-4H3,(H2,56,61)(H,59,69)/t32-,37?,38?,39+,41-,42-,46-,51+/m0/s1",MURQBQPECONVAE-FHFAUZQPSA-N
6022,1.8,99,1.8,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(O[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1024.262,1023.478914,6.68,74,11,17,4,15,221.66,C55H65N11O7S,"InChI=1S/C55H65N11O7S/c1-31(2)51(55(70)65-29-39(67)22-46(65)54(69)59-32(3)34-9-11-35(12-10-34)52-33(4)58-30-74-52)48-26-49(62-73-48)63-19-16-40(17-20-63)71-41-23-42(24-41)72-50-21-36(15-18-57-50)66-37-13-14-38(66)28-64(27-37)45-25-44(60-61-53(45)56)43-7-5-6-8-47(43)68/h5-12,15,18,21,25-26,30-32,37-42,46,51,67-68H,13-14,16-17,19-20,22-24,27-29H2,1-4H3,(H2,56,61)(H,59,69)/t32-,37?,38?,39+,41-,42-,46-,51+/m0/s1",MURQBQPECONVAE-FHFAUZQPSA-N
6023,0.09,99,0.09,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCN(C[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.45/6.8 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1023.278,1022.494899,6.28,74,11,17,4,15,215.67,C55H66N12O6S,"InChI=1S/C55H66N12O6S/c1-32(2)51(55(71)66-30-41(68)24-46(66)54(70)59-33(3)36-9-11-37(12-10-36)52-34(4)58-31-74-52)48-26-49(62-73-48)64-19-17-63(18-20-64)27-35-21-42(22-35)72-50-23-38(15-16-57-50)67-39-13-14-40(67)29-65(28-39)45-25-44(60-61-53(45)56)43-7-5-6-8-47(43)69/h5-12,15-16,23,25-26,31-33,35,39-42,46,51,68-69H,13-14,17-22,24,27-30H2,1-4H3,(H2,56,61)(H,59,70)/t33-,35-,39?,40?,41+,42-,46-,51+/m0/s1",KKNUDCPEIBJOEM-YQZMIBAYSA-N
6023,1.3,99,1.3,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCN(C[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1023.278,1022.494899,6.28,74,11,17,4,15,215.67,C55H66N12O6S,"InChI=1S/C55H66N12O6S/c1-32(2)51(55(71)66-30-41(68)24-46(66)54(70)59-33(3)36-9-11-37(12-10-36)52-34(4)58-31-74-52)48-26-49(62-73-48)64-19-17-63(18-20-64)27-35-21-42(22-35)72-50-23-38(15-16-57-50)67-39-13-14-40(67)29-65(28-39)45-25-44(60-61-53(45)56)43-7-5-6-8-47(43)69/h5-12,15-16,23,25-26,31-33,35,39-42,46,51,68-69H,13-14,17-22,24,27-30H2,1-4H3,(H2,56,61)(H,59,70)/t33-,35-,39?,40?,41+,42-,46-,51+/m0/s1",KKNUDCPEIBJOEM-YQZMIBAYSA-N
6024,0.053,99,0.053,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.23/3.7 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1051.332,1050.526199,6.99,76,11,17,4,15,215.67,C57H70N12O6S,"InChI=1S/C57H70N12O6S/c1-34(2)53(57(73)68-32-43(70)26-48(68)56(72)61-35(3)38-9-11-39(12-10-38)54-36(4)60-33-76-54)50-28-51(64-75-50)66-23-16-37(17-24-66)29-65-21-18-44(19-22-65)74-52-25-40(15-20-59-52)69-41-13-14-42(69)31-67(30-41)47-27-46(62-63-55(47)58)45-7-5-6-8-49(45)71/h5-12,15,20,25,27-28,33-35,37,41-44,48,53,70-71H,13-14,16-19,21-24,26,29-32H2,1-4H3,(H2,58,63)(H,61,72)/t35-,41?,42?,43+,48-,53+/m0/s1",VXCUKZUCDAPINA-LHYPYOHESA-N
6024,0.99,99,0.99,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1051.332,1050.526199,6.99,76,11,17,4,15,215.67,C57H70N12O6S,"InChI=1S/C57H70N12O6S/c1-34(2)53(57(73)68-32-43(70)26-48(68)56(72)61-35(3)38-9-11-39(12-10-38)54-36(4)60-33-76-54)50-28-51(64-75-50)66-23-16-37(17-24-66)29-65-21-18-44(19-22-65)74-52-25-40(15-20-59-52)69-41-13-14-42(69)31-67(30-41)47-27-46(62-63-55(47)58)45-7-5-6-8-49(45)71/h5-12,15,20,25,27-28,33-35,37,41-44,48,53,70-71H,13-14,16-19,21-24,26,29-32H2,1-4H3,(H2,58,63)(H,61,72)/t35-,41?,42?,43+,48-,53+/m0/s1",VXCUKZUCDAPINA-LHYPYOHESA-N
6025,0.27,99,0.27,,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCC#CC4=CC=C(O[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)C=N4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA2 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7/28 ,Inhibit proliferation of H1944/ACalu6 cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1072.262,1071.442529,6.95,78,11,18,4,16,240.54,C58H61N11O8S,"InChI=1S/C58H61N11O8S/c1-33(2)54(58(73)68-31-42(70)23-49(68)57(72)63-34(3)36-11-13-37(14-12-36)55-35(4)62-32-78-55)51-27-53(66-77-51)74-21-7-8-38-15-18-43(28-61-38)75-44-24-45(25-44)76-52-22-39(19-20-60-52)69-40-16-17-41(69)30-67(29-40)48-26-47(64-65-56(48)59)46-9-5-6-10-50(46)71/h5-6,9-15,18-20,22,26-28,32-34,40-42,44-45,49,54,70-71H,16-17,21,23-25,29-31H2,1-4H3,(H2,59,65)(H,63,72)/t34-,40?,41?,42+,44-,45-,49-,54+/m0/s1",HNUMKPYRVODSPV-BVABQKGPSA-N
6025,5.1,99,5.1,,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCC#CC4=CC=C(O[C@H]5C[C@H](OC6=CC(N7C8CCC7CN(C7=CC(C9=CC=CC=C9O)=NN=C7N)C8)=CC=N6)C5)C=N4)=NO3)C(C)C)C=C2)SC=N1,Degradation of SMARCA4 in SW1573 cells after 22h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01781,1072.262,1071.442529,6.95,78,11,18,4,16,240.54,C58H61N11O8S,"InChI=1S/C58H61N11O8S/c1-33(2)54(58(73)68-31-42(70)23-49(68)57(72)63-34(3)36-11-13-37(14-12-36)55-35(4)62-32-78-55)51-27-53(66-77-51)74-21-7-8-38-15-18-43(28-61-38)75-44-24-45(25-44)76-52-22-39(19-20-60-52)69-40-16-17-41(69)30-67(29-40)48-26-47(64-65-56(48)59)46-9-5-6-10-50(46)71/h5-6,9-15,18-20,22,26-28,32-34,40-42,44-45,49,54,70-71H,16-17,21,23-25,29-31H2,1-4H3,(H2,59,65)(H,63,72)/t34-,40?,41?,42+,44-,45-,49-,54+/m0/s1",HNUMKPYRVODSPV-BVABQKGPSA-N
6034,1680,85,1680,85,P36969,GPX4,cIAP1,,,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@@H](CC1=CC=CC=C1)NC(=O)CCCCCCCN1C=C(CNC(=O)C2=CC=C([C@H]3C4=C(C[C@H](C(=O)OC)N3C(=O)CCl)C3=CC=CC=C3[NH]4)C=C2)N=N1,Degradation of GPX4 in HT1080 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2370,Inhibit tumor of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116110,953.538,952.4250032,5.96,68,6,12,5,23,226.94,C50H61ClN8O9,"InChI=1S/C50H61ClN8O9/c1-31(2)25-40(49(65)67-3)55-48(64)46(62)39(26-32-15-9-8-10-16-32)53-42(60)19-11-6-5-7-14-24-58-30-35(56-57-58)29-52-47(63)34-22-20-33(21-23-34)45-44-37(36-17-12-13-18-38(36)54-44)27-41(50(66)68-4)59(45)43(61)28-51/h8-10,12-13,15-18,20-23,30-31,39-41,45-46,54,62H,5-7,11,14,19,24-29H2,1-4H3,(H,52,63)(H,53,60)(H,55,64)/t39-,40+,41-,45+,46+/m1/s1",LUTJVHXGXLJMAW-DDRZEDRFSA-N
6035,,,>100000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,600,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,609.596,609.1441953,0.65,43,6,11,1,6,171.95,C27H24FN7O7S,"InChI=1S/C27H24FN7O7S/c28-43(41,42)17-6-4-16(5-7-17)14-34-15-19(30-31-34)26(39)33-12-10-32(11-13-33)20-3-1-2-18-23(20)27(40)35(25(18)38)21-8-9-22(36)29-24(21)37/h1-7,15,21H,8-14H2,(H,29,36,37)",VAKZMLVWNPDLND-UHFFFAOYSA-N
6036,100,99,<100,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,600,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,623.623,623.1598454,0.29,44,6,11,1,7,171.95,C28H26FN7O7S,"InChI=1S/C28H26FN7O7S/c29-44(42,43)19-6-4-17(5-7-19)15-35-16-18(31-32-35)14-24(38)34-12-10-33(11-13-34)21-3-1-2-20-25(21)28(41)36(27(20)40)22-8-9-23(37)30-26(22)39/h1-7,16,22H,8-15H2,(H,30,37,39)",DVDZGFCFRJISDU-UHFFFAOYSA-N
6037,,,>100000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,>30000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,637.65,637.1754955,0.58,45,6,11,1,8,171.95,C29H28FN7O7S,"InChI=1S/C29H28FN7O7S/c30-45(43,44)20-7-4-18(5-8-20)16-36-17-19(32-33-36)6-11-25(39)35-14-12-34(13-15-35)22-3-1-2-21-26(22)29(42)37(28(21)41)23-9-10-24(38)31-27(23)40/h1-5,7-8,17,23H,6,9-16H2,(H,31,38,40)",RFHMYMAFKIVEME-UHFFFAOYSA-N
6038,100,99,100,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,8000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,651.677,651.1911455,0.94,46,6,11,1,9,171.95,C30H30FN7O7S,"InChI=1S/C30H30FN7O7S/c31-46(44,45)21-9-7-19(8-10-21)17-37-18-20(33-34-37)3-1-6-26(40)36-15-13-35(14-16-36)23-5-2-4-22-27(23)30(43)38(29(22)42)24-11-12-25(39)32-28(24)41/h2,4-5,7-10,18,24H,1,3,6,11-17H2,(H,32,39,41)",VPWYUSNYZSHGTG-UHFFFAOYSA-N
6039,3480,99,3480,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,10000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,665.704,665.2067956,1.3,47,6,11,1,10,171.95,C31H32FN7O7S,"InChI=1S/C31H32FN7O7S/c32-47(45,46)22-10-8-20(9-11-22)18-38-19-21(34-35-38)4-1-2-7-27(41)37-16-14-36(15-17-37)24-6-3-5-23-28(24)31(44)39(30(23)43)25-12-13-26(40)33-29(25)42/h3,5-6,8-11,19,25H,1-2,4,7,12-18H2,(H,33,40,42)",NIAMJNFJULIMGI-UHFFFAOYSA-N
6040,250,99,250,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCCCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,2500,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,679.731,679.2224456,1.84,48,6,11,1,11,171.95,C32H34FN7O7S,"InChI=1S/C32H34FN7O7S/c33-48(46,47)23-11-9-21(10-12-23)19-39-20-22(35-36-39)5-2-1-3-8-28(42)38-17-15-37(16-18-38)25-7-4-6-24-29(25)32(45)40(31(24)44)26-13-14-27(41)34-30(26)43/h4,6-7,9-12,20,26H,1-3,5,8,13-19H2,(H,34,41,43)",WWBGDFQJFZQNHG-UHFFFAOYSA-N
6041,320,99,320,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCCCCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,2800,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,693.758,693.2380957,2.38,49,6,11,1,12,171.95,C33H36FN7O7S,"InChI=1S/C33H36FN7O7S/c34-49(47,48)24-12-10-22(11-13-24)20-40-21-23(36-37-40)6-3-1-2-4-9-29(43)39-18-16-38(17-19-39)26-8-5-7-25-30(26)33(46)41(32(25)45)27-14-15-28(42)35-31(27)44/h5,7-8,10-13,21,27H,1-4,6,9,14-20H2,(H,35,42,44)",SBOFXABJNBDUPF-UHFFFAOYSA-N
6042,,,>100000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCCCCCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,1500,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,707.785,707.2537458,2.92,50,6,11,1,13,171.95,C34H38FN7O7S,"InChI=1S/C34H38FN7O7S/c35-50(48,49)25-13-11-23(12-14-25)21-41-22-24(37-38-41)7-4-2-1-3-5-10-30(44)40-19-17-39(18-20-40)27-9-6-8-26-31(27)34(47)42(33(26)46)28-15-16-29(43)36-32(28)45/h6,8-9,11-14,22,28H,1-5,7,10,15-21H2,(H,36,43,45)",XXWOUXLMITXPRV-UHFFFAOYSA-N
6043,130,99,130,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCCCCCCC5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,7000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,721.812,721.2693958,3.46,51,6,11,1,14,171.95,C35H40FN7O7S,"InChI=1S/C35H40FN7O7S/c36-51(49,50)26-14-12-24(13-15-26)22-42-23-25(38-39-42)8-5-3-1-2-4-6-11-31(45)41-20-18-40(19-21-41)28-10-7-9-27-32(28)35(48)43(34(27)47)29-16-17-30(44)37-33(29)46/h7,9-10,12-15,23,29H,1-6,8,11,16-22H2,(H,37,44,46)",FGKQKSYOPYJDCH-UHFFFAOYSA-N
6044,,,>5000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5=CC=C(C6=CN(CC7=CC=C(S(=O)(=O)F)C=C7)N=N6)C=C5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,>30000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,685.694,685.1754955,1.98,49,7,11,1,7,171.95,C33H28FN7O7S,"InChI=1S/C33H28FN7O7S/c34-49(47,48)23-10-4-20(5-11-23)18-40-19-25(36-37-40)21-6-8-22(9-7-21)31(44)39-16-14-38(15-17-39)26-3-1-2-24-29(26)33(46)41(32(24)45)27-12-13-28(42)35-30(27)43/h1-11,19,27H,12-18H2,(H,35,42,43)",KGLQELXRNLJRSN-UHFFFAOYSA-N
6045,,,>5000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5=CC=CC(C6=CN(CC7=CC=C(S(=O)(=O)F)C=C7)N=N6)=C5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,685.694,685.1754955,1.98,49,7,11,1,7,171.95,C33H28FN7O7S,"InChI=1S/C33H28FN7O7S/c34-49(47,48)23-9-7-20(8-10-23)18-40-19-25(36-37-40)21-3-1-4-22(17-21)31(44)39-15-13-38(14-16-39)26-6-2-5-24-29(26)33(46)41(32(24)45)27-11-12-28(42)35-30(27)43/h1-10,17,19,27H,11-16,18H2,(H,35,42,43)",FMZIPGBWUVTMMH-UHFFFAOYSA-N
6046,,,>5000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)C5=CC=CC=C5C5=CN(CC6=CC=C(S(=O)(=O)F)C=C6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,685.694,685.1754955,1.98,49,7,11,1,7,171.95,C33H28FN7O7S,"InChI=1S/C33H28FN7O7S/c34-49(47,48)21-10-8-20(9-11-21)18-40-19-25(36-37-40)22-4-1-2-5-23(22)31(44)39-16-14-38(15-17-39)26-7-3-6-24-29(26)33(46)41(32(24)45)27-12-13-28(42)35-30(27)43/h1-11,19,27H,12-18H2,(H,35,42,43)",ADBKRHFBENTJBQ-UHFFFAOYSA-N
6047,,,>5000,,O75608,APT1,CRBN,,,NC(CC1=CN(CC2=CC=C(S(=O)(=O)F)C=C2)N=N1)C(=O)N1CCN(C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of APT1 in Raji cells after 4h treatment,,,>30000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,652.665,652.1863945,-0.23,46,6,12,2,8,197.97,C29H29FN8O7S,"InChI=1S/C29H29FN8O7S/c30-46(44,45)19-6-4-17(5-7-19)15-37-16-18(33-34-37)14-21(31)28(42)36-12-10-35(11-13-36)22-3-1-2-20-25(22)29(43)38(27(20)41)23-8-9-24(39)32-26(23)40/h1-7,16,21,23H,8-15,31H2,(H,32,39,40)",BGRAIWZHQANTER-UHFFFAOYSA-N
6048,1000,99,1000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCNC(=O)C5=CC=C(C6=CN(CC7=CC=C(S(=O)(=O)F)C=C7)N=N6)C=C5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,8300,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,756.773,756.2126092,1.23,54,7,12,2,10,201.05,C36H33FN8O8S,"InChI=1S/C36H33FN8O8S/c37-54(52,53)25-10-4-22(5-11-25)20-44-21-27(40-41-44)23-6-8-24(9-7-23)33(48)38-15-14-31(47)43-18-16-42(17-19-43)28-3-1-2-26-32(28)36(51)45(35(26)50)29-12-13-30(46)39-34(29)49/h1-11,21,29H,12-20H2,(H,38,48)(H,39,46,49)",GZNSWKPINWJVBM-UHFFFAOYSA-N
6050,1000,99,1000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(CC5CCN(CC6=CC=C(S(=O)(=O)F)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,5000,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,611.696,611.221383,2.11,43,6,9,1,7,127.41,C30H34FN5O6S,"InChI=1S/C30H34FN5O6S/c31-43(41,42)22-6-4-20(5-7-22)18-33-12-10-21(11-13-33)19-34-14-16-35(17-15-34)24-3-1-2-23-27(24)30(40)36(29(23)39)25-8-9-26(37)32-28(25)38/h1-7,21,25H,8-19H2,(H,32,37,38)",YDNBWXVMHMPVJZ-UHFFFAOYSA-N
6051,5000,99,5000,,O75608,APT1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCN(C(=O)CCCCC5=CN(CC(=O)N6CCN(C(=O)C7=CC=CO7)CC6)N=N5)CC4)=C3C2=O)C(=O)N1,Degradation of APT1 in Raji cells after 4h treatment,,,N.D.,ABPP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cbic.202300736,713.752,713.2921592,-0.12,52,7,12,1,10,191.57,C35H39N9O8,"InChI=1S/C35H39N9O8/c45-28-11-10-26(32(48)36-28)44-33(49)24-6-3-7-25(31(24)35(44)51)39-12-14-40(15-13-39)29(46)9-2-1-5-23-21-43(38-37-23)22-30(47)41-16-18-42(19-17-41)34(50)27-8-4-20-52-27/h3-4,6-8,20-21,26H,1-2,5,9-19,22H2,(H,36,45,48)",CYBLMYICDPTTOC-UHFFFAOYSA-N
6052,1014,96.7,1014,96.7,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1055.335,1054.526279,8.38,76,10,14,5,17,198.27,C58H71FN10O6S,"InChI=1S/C58H71FN10O6S/c1-7-35-12-10-13-38-24-42(70)25-44(48(35)38)50-49(59)51-45(27-60-50)54(68-28-39-20-21-40(29-68)63-39)66-57(65-51)75-31-41-14-11-23-67(41)22-9-8-15-47(72)64-53(58(4,5)6)56(74)69-30-43(71)26-46(69)55(73)62-33(2)36-16-18-37(19-17-36)52-34(3)61-32-76-52/h10,12-13,16-19,24-25,27,32-33,39-41,43,46,53,63,70-71H,7-9,11,14-15,20-23,26,28-31H2,1-6H3,(H,62,73)(H,64,72)/t33-,39-,40+,41-,43+,46-,53+/m0/s1",DZMRIRHUWOIDDQ-XEGPAKOCSA-N
6053,1204,89.7,1204,89.7,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1069.362,1068.541929,8.73,77,10,14,5,18,198.27,C59H73FN10O6S,"InChI=1S/C59H73FN10O6S/c1-7-36-13-11-14-39-25-43(71)26-45(49(36)39)51-50(60)52-46(28-61-51)55(69-29-40-21-22-41(30-69)64-40)67-58(66-52)76-32-42-15-12-24-68(42)23-10-8-9-16-48(73)65-54(59(4,5)6)57(75)70-31-44(72)27-47(70)56(74)63-34(2)37-17-19-38(20-18-37)53-35(3)62-33-77-53/h11,13-14,17-20,25-26,28,33-34,40-42,44,47,54,64,71-72H,7-10,12,15-16,21-24,27,29-32H2,1-6H3,(H,63,74)(H,65,73)/t34-,40-,41+,42-,44+,47-,54+/m0/s1",MATWIHXEJKPGER-QRLWOCTNSA-N
6054,571.9,98.9,571.9,98.9,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1083.389,1082.557579,9.27,78,10,14,5,19,198.27,C60H75FN10O6S,"InChI=1S/C60H75FN10O6S/c1-7-37-14-12-15-40-26-44(72)27-46(50(37)40)52-51(61)53-47(29-62-52)56(70-30-41-22-23-42(31-70)65-41)68-59(67-53)77-33-43-16-13-25-69(43)24-11-9-8-10-17-49(74)66-55(60(4,5)6)58(76)71-32-45(73)28-48(71)57(75)64-35(2)38-18-20-39(21-19-38)54-36(3)63-34-78-54/h12,14-15,18-21,26-27,29,34-35,41-43,45,48,55,65,72-73H,7-11,13,16-17,22-25,28,30-33H2,1-6H3,(H,64,75)(H,66,74)/t35-,41-,42+,43-,45+,48-,55+/m0/s1",YRFWMYLCBNWJEI-HYOUYKGQSA-N
6055,226.3,82.4,226.3,82.4,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1097.416,1096.573229,9.82,79,10,14,5,20,198.27,C61H77FN10O6S,"InChI=1S/C61H77FN10O6S/c1-7-38-15-13-16-41-27-45(73)28-47(51(38)41)53-52(62)54-48(30-63-53)57(71-31-42-23-24-43(32-71)66-42)69-60(68-54)78-34-44-17-14-26-70(44)25-12-10-8-9-11-18-50(75)67-56(61(4,5)6)59(77)72-33-46(74)29-49(72)58(76)65-36(2)39-19-21-40(22-20-39)55-37(3)64-35-79-55/h13,15-16,19-22,27-28,30,35-36,42-44,46,49,56,66,73-74H,7-12,14,17-18,23-26,29,31-34H2,1-6H3,(H,65,76)(H,67,75)/t36-,42-,43+,44-,46+,49-,56+/m0/s1",GZPJFHIWNQNNSD-XAZSKEIWSA-N
6056,165,89.3,165,89.3,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1111.443,1110.588879,10.36,80,10,14,5,21,198.27,C62H79FN10O6S,"InChI=1S/C62H79FN10O6S/c1-7-39-16-14-17-42-28-46(74)29-48(52(39)42)54-53(63)55-49(31-64-54)58(72-32-43-24-25-44(33-72)67-43)70-61(69-55)79-35-45-18-15-27-71(45)26-13-11-9-8-10-12-19-51(76)68-57(62(4,5)6)60(78)73-34-47(75)30-50(73)59(77)66-37(2)40-20-22-41(23-21-40)56-38(3)65-36-80-56/h14,16-17,20-23,28-29,31,36-37,43-45,47,50,57,67,74-75H,7-13,15,18-19,24-27,30,32-35H2,1-6H3,(H,66,77)(H,68,76)/t37-,43-,44+,45-,47+,50-,57+/m0/s1",SQUXSHGWVMZWGG-FBNTUTAJSA-N
6057,1822,89.5,1822,89.5,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1071.334,1070.521194,7.51,77,10,15,5,18,207.5,C58H71FN10O7S,"InChI=1S/C58H71FN10O7S/c1-7-35-10-8-11-38-24-42(70)25-44(48(35)38)50-49(59)51-45(27-60-50)54(68-28-39-17-18-40(29-68)63-39)66-57(65-51)76-31-41-12-9-20-67(41)21-23-75-22-19-47(72)64-53(58(4,5)6)56(74)69-30-43(71)26-46(69)55(73)62-33(2)36-13-15-37(16-14-36)52-34(3)61-32-77-52/h8,10-11,13-16,24-25,27,32-33,39-41,43,46,53,63,70-71H,7,9,12,17-23,26,28-31H2,1-6H3,(H,62,73)(H,64,72)/t33-,39-,40+,41-,43+,46-,53+/m0/s1",ZETUMISSKGCCDQ-XEGPAKOCSA-N
6058,131.6,98.1,131.6,98.1,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1085.361,1084.536844,7.87,78,10,15,5,19,207.5,C59H73FN10O7S,"InChI=1S/C59H73FN10O7S/c1-7-36-11-8-12-39-25-43(71)26-45(49(36)39)51-50(60)52-46(28-61-51)55(69-29-40-18-19-41(30-69)64-40)67-58(66-52)77-32-42-13-9-21-68(42)22-10-23-76-24-20-48(73)65-54(59(4,5)6)57(75)70-31-44(72)27-47(70)56(74)63-34(2)37-14-16-38(17-15-37)53-35(3)62-33-78-53/h8,11-12,14-17,25-26,28,33-34,40-42,44,47,54,64,71-72H,7,9-10,13,18-24,27,29-32H2,1-6H3,(H,63,74)(H,65,73)/t34-,40-,41+,42-,44+,47-,54+/m0/s1",DRTSZGVKXLJNNH-QRLWOCTNSA-N
6059,1310,90.2,1310,90.2,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1099.388,1098.552494,8.23,79,10,15,5,20,207.5,C60H75FN10O7S,"InChI=1S/C60H75FN10O7S/c1-7-37-12-10-13-40-26-44(72)27-46(50(37)40)52-51(61)53-47(29-62-52)56(70-30-41-19-20-42(31-70)65-41)68-59(67-53)78-33-43-14-11-23-69(43)22-8-9-24-77-25-21-49(74)66-55(60(4,5)6)58(76)71-32-45(73)28-48(71)57(75)64-35(2)38-15-17-39(18-16-38)54-36(3)63-34-79-54/h10,12-13,15-18,26-27,29,34-35,41-43,45,48,55,65,72-73H,7-9,11,14,19-25,28,30-33H2,1-6H3,(H,64,75)(H,66,74)/t35-,41-,42+,43-,45+,48-,55+/m0/s1",CMAGYLGVBWUBOU-HYOUYKGQSA-N
6060,164.4,99.4,164.4,99.4,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1085.361,1084.536844,8.32,78,10,15,5,19,207.5,C59H73FN10O7S,"InChI=1S/C59H73FN10O7S/c1-7-36-12-10-13-39-24-43(71)25-45(49(36)39)51-50(60)52-46(27-61-51)55(69-28-40-19-20-41(29-69)64-40)67-58(66-52)77-31-42-14-11-22-68(42)21-8-9-23-76-32-48(73)65-54(59(4,5)6)57(75)70-30-44(72)26-47(70)56(74)63-34(2)37-15-17-38(18-16-37)53-35(3)62-33-78-53/h10,12-13,15-18,24-25,27,33-34,40-42,44,47,54,64,71-72H,7-9,11,14,19-23,26,28-32H2,1-6H3,(H,63,74)(H,65,73)/t34-,40-,41+,42-,44+,47-,54+/m0/s1",KYHAJKMOOZHQFA-QRLWOCTNSA-N
6061,3813,83.6,3813,83.6,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCC(=O)NCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1098.36,1097.532093,6.91,79,10,15,6,18,227.37,C59H72FN11O7S,"InChI=1S/C59H72FN11O7S/c1-7-35-10-8-11-38-24-42(72)25-44(49(35)38)51-50(60)52-45(27-62-51)55(70-28-39-17-18-40(29-70)65-39)68-58(67-52)78-31-41-12-9-22-69(41)23-20-47(74)61-21-19-48(75)66-54(59(4,5)6)57(77)71-30-43(73)26-46(71)56(76)64-33(2)36-13-15-37(16-14-36)53-34(3)63-32-79-53/h8,10-11,13-16,24-25,27,32-33,39-41,43,46,54,65,72-73H,7,9,12,17-23,26,28-31H2,1-6H3,(H,61,74)(H,64,76)(H,66,75)/t33-,39-,40+,41-,43+,46-,54+/m0/s1",XSKRXFBHRXSSKG-YLHACEQSSA-N
6064,133.8,85.1,133.8,85.1,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5C5CC6(CCN(CC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)N[C@@H](C)C7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C5)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1136.453,1135.584128,8.95,82,12,15,5,15,201.51,C63H78FN11O6S,"InChI=1S/C63H78FN11O6S/c1-7-38-10-8-11-41-24-46(76)25-48(52(38)41)54-53(64)55-49(29-65-54)58(73-30-42-17-18-43(31-73)68-42)71-61(70-55)81-34-44-12-9-21-74(44)45-27-63(28-45)19-22-72(23-20-63)33-51(78)69-57(62(4,5)6)60(80)75-32-47(77)26-50(75)59(79)67-36(2)39-13-15-40(16-14-39)56-37(3)66-35-82-56/h8,10-11,13-16,24-25,29,35-36,42-45,47,50,57,68,76-77H,7,9,12,17-23,26-28,30-34H2,1-6H3,(H,67,79)(H,69,78)/t36-,42-,43+,44-,47+,50-,57+/m0/s1",UKRCYNJTZLLRJJ-WMNQMRKPSA-N
6066,38.06,98.9,38.06,98.9,P01116,KRAS G12D,VHL,,,CCC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1103.351,1102.527422,8.43,79,10,15,5,19,207.5,C59H72F2N10O7S,"InChI=1S/C59H72F2N10O7S/c1-7-43-46(60)19-16-37-23-41(72)24-44(49(37)43)51-50(61)52-45(26-62-51)55(70-27-38-17-18-39(28-70)65-38)68-58(67-52)78-30-40-11-10-21-69(40)20-8-9-22-77-31-48(74)66-54(59(4,5)6)57(76)71-29-42(73)25-47(71)56(75)64-33(2)35-12-14-36(15-13-35)53-34(3)63-32-79-53/h12-16,19,23-24,26,32-33,38-40,42,47,54,65,72-73H,7-11,17-18,20-22,25,27-31H2,1-6H3,(H,64,75)(H,66,74)/t33-,38-,39+,40-,42+,47-,54+/m0/s1",KHIURKSPHCFKCV-XCACKJMTSA-N
6067,115.9,99.5,115.9,99.5,P01116,KRAS G12D,VHL,,,C#CC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1099.319,1098.496122,7.87,79,10,15,5,18,207.5,C59H68F2N10O7S,"InChI=1S/C59H68F2N10O7S/c1-7-43-46(60)19-16-37-23-41(72)24-44(49(37)43)51-50(61)52-45(26-62-51)55(70-27-38-17-18-39(28-70)65-38)68-58(67-52)78-30-40-11-10-21-69(40)20-8-9-22-77-31-48(74)66-54(59(4,5)6)57(76)71-29-42(73)25-47(71)56(75)64-33(2)35-12-14-36(15-13-35)53-34(3)63-32-79-53/h1,12-16,19,23-24,26,32-33,38-40,42,47,54,65,72-73H,8-11,17-18,20-22,25,27-31H2,2-6H3,(H,64,75)(H,66,74)/t33-,38-,39+,40-,42+,47-,54+/m0/s1",QJFDDWLFGZVIOI-XCACKJMTSA-N
6068,87.2,96.2,87.2,96.2,P01116,KRAS G12D,VHL,,,CCC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5C[C@@H](F)CN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1121.341,1120.518,8.48,80,10,15,5,19,207.5,C59H71F3N10O7S,"InChI=1S/C59H71F3N10O7S/c1-7-43-46(61)17-14-36-20-41(73)22-44(49(36)43)51-50(62)52-45(24-63-51)55(71-26-38-15-16-39(27-71)66-38)69-58(68-52)79-29-40-21-37(60)25-70(40)18-8-9-19-78-30-48(75)67-54(59(4,5)6)57(77)72-28-42(74)23-47(72)56(76)65-32(2)34-10-12-35(13-11-34)53-33(3)64-31-80-53/h10-14,17,20,22,24,31-32,37-40,42,47,54,66,73-74H,7-9,15-16,18-19,21,23,25-30H2,1-6H3,(H,65,76)(H,67,75)/t32-,37+,38-,39+,40-,42+,47-,54+/m0/s1",BKPOBOXXAAENEJ-RTVISUOMSA-N
6072,13,88,13,88,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,872.946,872.3832806,6.38,63,7,12,4,18,198.18,C45H51F3N8O7,"InChI=1S/C45H51F3N8O7/c1-25(27-18-28(45(46,47)48)20-29(49)19-27)51-40-31-21-36(35(62-4)22-33(31)52-26(2)53-40)63-24-44(15-16-44)23-55(3)38(58)12-7-5-6-8-17-50-32-11-9-10-30-39(32)43(61)56(42(30)60)34-13-14-37(57)54-41(34)59/h9-11,18-22,25,34,50H,5-8,12-17,23-24,49H2,1-4H3,(H,51,52,53)(H,54,57,59)/t25-,34?/m1/s1",WLWKNXUSLSOAGM-HSGLFRJESA-N
6081,45,73,45,73,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,854.956,854.3927024,6.12,62,7,12,4,19,198.18,C45H52F2N8O7,"InChI=1S/C45H52F2N8O7/c1-25(27-18-28(40(46)47)20-29(48)19-27)50-41-31-21-36(35(61-4)22-33(31)51-26(2)52-41)62-24-45(15-16-45)23-54(3)38(57)12-7-5-6-8-17-49-32-11-9-10-30-39(32)44(60)55(43(30)59)34-13-14-37(56)53-42(34)58/h9-11,18-22,25,34,40,49H,5-8,12-17,23-24,48H2,1-4H3,(H,50,51,52)(H,53,56,58)/t25-,34?/m1/s1",RTYVSUBNYZYOJZ-HSGLFRJESA-N
6082,540,72,540,72,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC=CC(C(F)F)=C3F)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,216,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,857.931,857.3723816,6.9,62,7,11,3,19,172.16,C45H50F3N7O7,"InChI=1S/C45H50F3N7O7/c1-25(27-11-9-13-29(39(27)46)40(47)48)50-41-30-21-35(34(61-4)22-32(30)51-26(2)52-41)62-24-45(18-19-45)23-54(3)37(57)15-7-5-6-8-20-49-31-14-10-12-28-38(31)44(60)55(43(28)59)33-16-17-36(56)53-42(33)58/h9-14,21-22,25,33,40,49H,5-8,15-20,23-24H2,1-4H3,(H,50,51,52)(H,53,56,58)/t25-,33?/m1/s1",AXNIHWLGUQGCDA-NHYGQJMQSA-N
6087,151,81,151,81,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,47,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,858.963,858.4040161,5.88,62,7,11,4,18,181.11,C45H53F3N8O6,"InChI=1S/C45H53F3N8O6/c1-26(28-18-29(45(46,47)48)20-30(49)19-28)51-41-32-21-38(37(61-4)22-35(32)52-27(2)53-41)62-25-44(15-16-44)24-55(3)40(58)12-7-5-6-8-17-50-34-11-9-10-31-33(34)23-56(43(31)60)36-13-14-39(57)54-42(36)59/h9-11,18-22,26,36,50H,5-8,12-17,23-25,49H2,1-4H3,(H,51,52,53)(H,54,57,59)/t26-,36?/m1/s1",CKVSRIJZIQJZGE-IERCKHOLSA-N
6090,63,90,63,90,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=C(F)C3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,890.936,890.3738588,6.48,64,7,12,4,18,198.18,C45H50F4N8O7,"InChI=1S/C45H50F4N8O7/c1-24(26-17-27(45(47,48)49)19-28(50)18-26)52-40-29-20-35(34(63-4)21-32(29)53-25(2)54-40)64-23-44(14-15-44)22-56(3)37(59)9-7-5-6-8-16-51-31-11-10-30(46)38-39(31)43(62)57(42(38)61)33-12-13-36(58)55-41(33)60/h10-11,17-21,24,33,51H,5-9,12-16,22-23,50H2,1-4H3,(H,52,53,54)(H,55,58,60)/t24-,33?/m1/s1",MPOBYMKETYQAHT-HVQYUPJGSA-N
6092,44,90,44,90,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)C2CCN(CCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,899.972,899.3941797,5.33,65,8,13,4,15,201.42,C46H52F3N9O7,"InChI=1S/C46H52F3N9O7/c1-25(28-18-29(46(47,48)49)20-30(50)19-28)52-40-32-21-37(36(64-4)22-34(32)53-26(2)54-40)65-24-45(12-13-45)23-56(3)42(61)27-10-15-57(16-11-27)17-14-51-33-7-5-6-31-39(33)44(63)58(43(31)62)35-8-9-38(59)55-41(35)60/h5-7,18-22,25,27,35,51H,8-17,23-24,50H2,1-4H3,(H,52,53,54)(H,55,59,60)/t25-,35?/m1/s1",IFPXXFMXWDLQFQ-SUYFMZKJSA-N
6093,55,75,55,75,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)C2CCN(C3CCC(NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,954.064,953.4411299,6.11,69,9,13,4,14,201.42,C50H58F3N9O7,"InChI=1S/C50H58F3N9O7/c1-27(30-20-31(50(51,52)53)22-32(54)21-30)55-44-36-23-41(40(68-4)24-38(36)56-28(2)57-44)69-26-49(16-17-49)25-60(3)46(65)29-14-18-61(19-15-29)34-10-8-33(9-11-34)58-37-7-5-6-35-43(37)48(67)62(47(35)66)39-12-13-42(63)59-45(39)64/h5-7,20-24,27,29,33-34,39,58H,8-19,25-26,54H2,1-4H3,(H,55,56,57)(H,59,63,64)/t27-,33?,34?,39?/m1/s1",UQTRNIWZKUJRCB-GCXJWZSHSA-N
6094,35,90,35,90,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCOC2CCC(NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,929.01,928.4094954,5.76,67,8,13,4,17,207.41,C48H55F3N8O8,"InChI=1S/C48H55F3N8O8/c1-26(28-19-29(48(49,50)51)21-30(52)20-28)53-43-34-22-39(38(65-4)23-36(34)54-27(2)55-43)67-25-47(16-17-47)24-58(3)41(61)9-6-18-66-32-12-10-31(11-13-32)56-35-8-5-7-33-42(35)46(64)59(45(33)63)37-14-15-40(60)57-44(37)62/h5,7-8,19-23,26,31-32,37,56H,6,9-18,24-25,52H2,1-4H3,(H,53,54,55)(H,57,60,62)/t26-,31?,32?,37?/m1/s1",TWINIHLSGOQBHE-HAMOUJOLSA-N
